PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Slomski, A				Slomski, Anita			Celecoxib Similar to 2 NSAIDs for Cardiovascular Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2589	2589		10.1001/jama.2016.19355	http://dx.doi.org/10.1001/jama.2016.19355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9VN	28027363				2022-12-28	WOS:000394968300006
J	Abbasi, J				Abbasi, Jennifer			New 5-Year Targets Announced for Health Care-Associated Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	127	128	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2588	2588		10.1001/jama.2016.18655	http://dx.doi.org/10.1001/jama.2016.18655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027352				2022-12-28	WOS:000391110200004
J	[Anonymous]				[Anonymous]			First Inactivated Zika Vaccine Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	127	128	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2588	2588		10.1001/jama.2016.19328	http://dx.doi.org/10.1001/jama.2016.19328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9VN	28027352				2022-12-28	WOS:000394968300002
J	Halmin, M; Rostgaard, K; Lee, BK; Wikman, A; Norda, R; Nielsen, KR; Pedersen, OB; Holmqvist, J; Hjalgrim, H; Edgren, G				Halmin, Marit; Rostgaard, Klaus; Lee, Brian K.; Wikman, Agneta; Norda, Rut; Nielsen, Kaspar Rene; Pedersen, Ole B.; Holmqvist, Jacob; Hjalgrim, Henrik; Edgren, Gustaf			Length of Storage of Red Blood Cells and Patient Survival After Blood Transfusion A Binational Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC-SURGERY; CLINICAL-OUTCOMES; CRITICALLY-ILL; INSTRUMENTAL VARIABLES; LIVER-TRANSPLANTATION; ADVERSE OUTCOMES; DURATION; AGE; MORTALITY; TIME	Background: Possible negative effects, including increased mortality, among persons who receive stored red blood cells (RBCs) have recently garnered considerable attention. Despite many studies, including 4 randomized trials, no consensus exists. Objective: To study the association between the length of RBC storage and mortality in a large population-based cohort of patients who received transfusions, allowing detection of small yet clinically significant effects. Design: Binational cohort study. Setting: All transfusion recipients in Sweden and Denmark. Patients: 854 862 adult patients who received transfusions from 2003 to 2012. Measurements: Patients were followed from first blood transfusion. Relative and absolute risks for death in 30 days or 1 year in relation to length of RBC storage were assessed by using 3 independent analytic approaches. All analyses were conducted by using Cox proportional hazards regression. Results: Regardless of the analytic approach, no association was found between the length of RBC storage and mortality. The difference in 30-day cumulative mortality between patients receiving blood stored for 30 to 42 days and those receiving blood stored for 10 to 19 days was -0.2% (95% CI, -0.5% to 0.1%). Even among patients who received more than 6 units of RBCs stored for 30 days or longer, the hazard ratio of death was 1.00 (CI, 0.96 to 1.05) compared with those who received no such units. Limitation: Observational study; risk of confounding by indication. Conclusion: Consistent with previous randomized trials, this study found no association between the length of storage of transfused RBCs and patient mortality. Results were homogeneous, with differences in absolute mortality consistently less than 1% among the most extreme exposure categories. These findings suggest that the current practice of storing RBCs for up to 42 days does not need to be changed.	[Halmin, Marit; Edgren, Gustaf] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Karolinska Univ Hosp, Stockholm, Sweden; Uppsala Univ, Uppsala, Sweden; AnOpIVA, S-65185 Karlstad, Sweden; [Rostgaard, Klaus] Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark; Copenhagen Univ Hosp, Copenhagen, Denmark; [Nielsen, Kaspar Rene] Aalborg Univ Hosp, Dept Clin Immunol, DK-9000 Aalborg, Denmark; [Pedersen, Ole B.] Naestved Hosp, Dept Clin Immunol, DK-4700 Naestved, Denmark; [Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Wikman, Agneta] Karolinska Univ Hosp, Clin Immunol & Transfus Med, C2 66, SE-14186 Huddinge, Sweden; [Norda, Rut] Akad Sjukhuset, Klin Immunol & Transfus Med, S-75185 Uppsala, Sweden; [Holmqvist, Jacob] Centralsjukhuset, AnOpIVA, S-65185 Karlstad, Sweden; [Hjalgrim, Henrik] Afdeling Epidemiol Forskning, Sektor Epidemiol & Smitteberedskab, Artillerivej 5, DK-2300 Copenhagen S, Denmark	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Statens Serum Institut; University of Copenhagen; Aalborg University; Aalborg University Hospital; Naestved Hospital; Drexel University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Uppsala University Hospital	Halmin, M (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	marit.halmin@ki.se; gustaf.edgren@ki.se	Hjalgrim, Henrik/AAG-4973-2021; Edgren, Gustaf/F-4013-2014; Pedersen, Ole Birger/W-8679-2019	Edgren, Gustaf/0000-0002-2198-4745; Pedersen, Ole Birger/0000-0003-2312-5976; Wikman, Agneta/0000-0002-8810-7974; Rostgaard, Klaus/0000-0001-6220-9414	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Society for Medical Research; Strategic Research Program in Epidemiology at Karolinska Institutet; Danish Council for Independent Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society for Medical Research; Strategic Research Program in Epidemiology at Karolinska Institutet; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The Swedish Research Council, Swedish Heart-Lung Foundation, Swedish Society for Medical Research, Strategic Research Program in Epidemiology at Karolinska Institutet, and Danish Council for Independent Research.	Alexander PE, 2016, BLOOD, V127, P400, DOI 10.1182/blood-2015-09-670950; Aubron C, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.01.006; Baltsavias I, 2014, EUR J ANAESTH, V31, P310, DOI 10.1097/EJA.0000000000000024; Brunskill SJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010801.pub2; Carslake D, 2013, ECON HUM BIOL, V11, P351, DOI 10.1016/j.ehb.2012.04.003; Cartotto R, 2014, J BURN CARE RES, V35, P186, DOI 10.1097/BCR.0b013e318295755d; Chen J, 2012, WORLD J SURG, V36, P2436, DOI 10.1007/s00268-012-1691-0; Dhabangi A, 2015, JAMA-J AM MED ASSOC, V314, P2514, DOI 10.1001/jama.2015.13977; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Dunn LK, 2012, LIVER TRANSPLANT, V18, P475, DOI 10.1002/lt.23379; Dzik WH, 2013, TRANSFUSION, V53, P3110, DOI 10.1111/trf.12171; Edgren G, 2015, TRANSFUSION, V55, P1600, DOI 10.1111/trf.12986; Edgren G, 2010, TRANSFUSION, V50, P1185, DOI 10.1111/j.1537-2995.2010.02583.x; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Flegel WA, 2014, BRIT J HAEMATOL, V165, P3, DOI 10.1111/bjh.12747; GAIL MH, 1986, BIOMETRICAL J, V28, P587, DOI 10.1002/bimj.4710280508; Glynn SA, 2016, TRANSFUSION, V56, P1462, DOI 10.1111/trf.13609; Glynn SA, 2010, TRANSFUSION, V50, P1164, DOI 10.1111/j.1537-2995.2010.02674.x; Halmin M, 2016, CRIT CARE MED, V44, P468, DOI 10.1097/CCM.0000000000001410; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; Hassan M, 2011, SHOCK, V35, P3, DOI 10.1097/SHK.0b013e3181e76274; Hod EA, 2011, TRANSFUSION, V51, P881, DOI 10.1111/j.1537-2995.2011.03096.x; Kadar A, 2013, INJURY, V44, P747, DOI 10.1016/j.injury.2013.02.011; Kaukonen KM, 2013, CRIT CARE, V17, DOI 10.1186/cc13045; Kekre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068820; Kekre N, 2011, TRANSFUSION, V51, P2488, DOI 10.1111/j.1537-2995.2011.03166.x; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Korgun Dijle Kipmen, 2001, Research Communications in Molecular Pathology and Pharmacology, V109, P357; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lebiedz P, 2012, TRANSFUS MED HEMOTH, V39, P271, DOI 10.1159/000339807; Lelubre C, 2013, CRIT CARE, V17, DOI 10.1186/cc12600; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Middelburg RA, 2013, TRANSFUS MED REV, V27, P36, DOI 10.1016/j.tmrv.2012.06.002; Middelburg RA, 2012, TRANSFUSION, V52, P658, DOI 10.1111/j.1537-2995.2011.03352.x; Mynster T, 2001, DIS COLON RECTUM, V44, P955, DOI 10.1007/BF02235483; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Ng MSY, 2015, INTENS CARE MED, V41, P2087, DOI 10.1007/s00134-015-4078-5; Patterson JA, 2015, TRANSFUSION, V55, P2730, DOI 10.1111/trf.13230; Pereira A, 2013, TRANSFUSION, V53, P34, DOI 10.1111/j.1537-2995.2012.03656.x; Pettila V, 2011, CRIT CARE, V15, DOI 10.1186/cc10142; Qu LR, 2015, CANCER CONTROL, V22, P26, DOI 10.1177/107327481502200105; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Saager L, 2013, ANESTHESIOLOGY, V118, P51, DOI 10.1097/ALN.0b013e3182746ba4; Sanders J, 2011, TRANSFUSION, V51, P2286, DOI 10.1111/j.1537-2995.2011.03170.x; Sartipy U, 2015, JAMA-J AM MED ASSOC, V314, P1641, DOI 10.1001/jama.2015.8690; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; van de Watering L, 2011, TRANSFUSION, V51, P1847, DOI 10.1111/j.1537-2995.2010.03015.x; Voorhuis FTR, 2013, ANN HEMATOL, V92, P1701, DOI 10.1007/s00277-013-1832-z; Weinberg JA, 2008, J TRAUMA, V65, P794, DOI 10.1097/TA.0b013e318184aa11	53	23	24	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					248	+		10.7326/M16-1415	http://dx.doi.org/10.7326/M16-1415			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	27992899				2022-12-28	WOS:000394786700014
J	Zhu, FC; Wurie, AH; Hou, LH; Liang, Q; Li, YH; Russell, JBW; Wu, SP; Li, JX; Hu, YM; Guo, Q; Xu, WB; Wurie, AR; Wang, WJ; Zhang, Z; Yin, WJ; Ghazzawi, M; Zhang, X; Duan, L; Wang, JZ; Chen, W				Zhu, Feng-Cai; Wurie, Alie H.; Hou, Li-Hua; Liang, Qi; Li, Yu-Hua; Russell, James B. W.; Wu, Shi-Po; Li, Jing-Xin; Hu, Yue-Mei; Guo, Qiang; Xu, Wen-Bo; Wurie, Abdul R.; Wang, Wen-Juan; Zhang, Zhe; Yin, Wen-Jiao; Ghazzawi, Manal; Zhang, Xu; Duan, Lei; Wang, Jun-Zhi; Chen, Wei			Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial	LANCET			English	Article							NEUTRALIZING ANTIBODIES; INFECTION; IMMUNITY; HIV	Background A recombinant adenovirus type-5 vector-based vaccine expressing the glycoprotein of Ebola Zaire Makona variant showed good safety and immunogenicity in a phase 1 trial of healthy Chinese adults. We aimed to assess the safety and immunogenicity of this vaccine in healthy adults in Sierra Leone and to determine the optimal dose. Methods We did a single-centre, randomised, double-blind, placebo-controlled, phase 2 clinical trial at Sierra Leone-China Friendship Hospital, Freetown, Sierra Leone. We recruited healthy adults aged 18-50 years who were HIV negative, had no history of Ebola virus infection, and had no previous immunisation with other Ebola vaccine candidates. Participants were sequentially enrolled and randomly assigned (2:1:1), by computer-generated block randomisation (block size of eight), to receive the high-dose vaccine (1.6x10(11) viral particles), low-dose vaccine (8.0x10(10) viral particles), or placebo (containing only vaccine excipients, with no viral particles). Participants, investigators, and study staff (except two study pharmacists) were masked from treatment allocation. The primary safety outcome was occurrence of solicited adverse reactions within 7 days of vaccination, analysed by intention to treat. The primary immunogenicity outcome was glycoprotein-specifi c antibody responses at days 14, 28, and 168 after vaccination, analysed in all vaccinated participants who had blood samples drawn for antibody tests. The trial is registered with the Pan African Clinical Trials Registry, number PACTR201509001259869, and is completed. Findings During Oct 10-28, 2015, 500 participants were enrolled and randomly assigned to receive the high-dose vaccine (n=250), low-dose vaccine (n=125), or placebo (n=125). 132 (53%) participants in the high-dose group, 60 (48%) in the low-dose group, and 54 (43%) in the placebo group reported at least one solicited adverse reaction within 7 days of vaccination. Most adverse reactions were mild and self-limiting. Solicited injection-site adverse reactions were significantly more frequent in vaccine recipients (65 [26%] in high-dose group and 31 [25%] in low-dose group) than in those receiving placebo (17 [ 14%]; p=0.0169). Glycoprotein-specifi c antibody responses were detected from day 14 onwards (geometric mean titre 1251.0 [95% CI 976.6-1602.5] in low-dose group and 1728.4 [1459.4-2047.0] in high-dose group) and peaked at day 28 (1471.8 [1151.0-1881.8] and 2043.1 [1762.4-2368.4]), but declined quickly in the following months (223.3 [148.2-336.4] and 254.2 [185.0-349.5] at day 168). Geometric mean titres in the placebo group remained around 6.0-6.8 throughout the study period. Three serious adverse events (malaria, gastroenteritis, and one fatal asthma episode) were reported in the high-dose vaccine group, but none was deemed related to the vaccine. Interpretation The recombinant adenovirus type-5 vector-based Ebola vaccine was safe and highly immunogenic in healthy Sierra Leonean adults, and 8.0x10(10) viral particles was the optimal dose.	[Zhu, Feng-Cai; Liang, Qi; Li, Jing-Xin; Hu, Yue-Mei; Wang, Wen-Juan] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Wurie, Alie H.; Russell, James B. W.; Wurie, Abdul R.; Ghazzawi, Manal] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Hou, Li-Hua; Wu, Shi-Po; Guo, Qiang; Zhang, Zhe; Chen, Wei] Beijing Inst Biotechnol, 20 East St, Beijing 100071, Peoples R China; [Li, Yu-Hua; Wang, Jun-Zhi] Natl Inst Food & Drug Control, 2 Tiantanxili, Beijing 100050, Peoples R China; [Xu, Wen-Bo; Yin, Wen-Jiao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Xu; Duan, Lei] Tianjin CanSino Biotechnol, Tianjin, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Ministry of Health & Sanitation Sierra Leone; National Institute of Food & Drug Control - China; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, W (corresponding author), Beijing Inst Biotechnol, 20 East St, Beijing 100071, Peoples R China.; Wang, JZ (corresponding author), Natl Inst Food & Drug Control, 2 Tiantanxili, Beijing 100050, Peoples R China.	wangjz@nicpbp.org.cn; cw0226@foxmail.com	Hu, Yue/HGE-1673-2022; Li, yu/HHZ-5236-2022	Russell, James/0000-0003-4732-6588; Wang, Busen/0000-0001-9041-1919	Chinese Ministry of Science and Technology; National Health and Family Planning Commission; Beijing Institute of Biotechnology; Tianjin CanSino Biotechnology	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Health and Family Planning Commission; Beijing Institute of Biotechnology; Tianjin CanSino Biotechnology	This study is funded by the Chinese Ministry of Science and Technology and the National Health and Family Planning Commission (grant 1061400100275 and 2016ZX09106003001), Beijing Institute of Biotechnology, and Tianjin CanSino Biotechnology. We thank all investigators working at Sierra Leone-China Friendship Hospital (Freetown, Sierra Leone) who contributed to the site work of the trial, and the Pharmacy Board of Sierra Leone and the Sierra Leone Ethics and Scientifi c Review Committee for reviewing and approving this phase 2 trial. We also thank all recruiters and the Medical Officer of Health in Sierra Leone. We thank Wen-Juan Ma (Wuxi Center for Disease Control and Prevention, Wuxi, China), Yu-Xiao Wang (Southeast University, Nanjing, China), Xiao-Hong Song, Yi Chen, Bu-Sen Wang, Jin-Long Zhang, Xiu-Xu Yang, Jun-Jie Xu, Jian-Min Li (Beijing Institute of Biotechnology, Beijing, China), Ling Wang, Jing-Jing Liu (National Institutes for Food and Drug Control, Beijing, China), Rui-Jie Wang, Rong Jiang (Tianjin CanSino Biotechnology, Tianjin, China), En-Hao Ma ( Department of Biology, University of California, San Diego, San Diego, CA, USA), Yan-Zhe Hao (National Institute for Viral Disease Control and Prevention, and Chinese Center for Disease Control and Prevention, Beijing, China), and Yu-Xin Su (Beijing Institute of Disease Control and Prevention, Beijing, China).	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], 2016, EB OUTBR 2014 2015; CFDA, STAND GUID ADV REACT; Choi JH, 2013, MOL PHARMACEUT, V10, P3342, DOI 10.1021/mp4001316; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0; Ledgerwood JE, 2015, NEW ENGL J MED, V373, P776, DOI 10.1056/NEJMc1505499; Marzi A, 2015, LANCET, V385, P2229, DOI 10.1016/S0140-6736(15)60613-4; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Yu B, 2012, J MED VIROL, V84, P1408, DOI 10.1002/jmv.23325; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0	19	112	120	1	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					621	628		10.1016/S0140-6736(16)32617-4	http://dx.doi.org/10.1016/S0140-6736(16)32617-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9AF	28017399				2022-12-28	WOS:000394910800031
J	Bosurgi, R; Horton, R				Bosurgi, Raffaella; Horton, Richard			The Lancet Planetary Health: a new journal for a new discipline-a call for papers	LANCET			English	Editorial Material									[Bosurgi, Raffaella] Lancet Planetary Hlth, London EC2Y 5AS, England; [Horton, Richard] Lancet, London, England		Bosurgi, R (corresponding author), Lancet Planetary Hlth, London EC2Y 5AS, England.	r.bosurgi@lancet.com						Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1	1	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					139	139		10.1016/S0140-6736(16)32590-9	http://dx.doi.org/10.1016/S0140-6736(16)32590-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	28017400				2022-12-28	WOS:000392117600009
J	Bakaeen, FG; Rosengart, TK; Carabello, BA				Bakaeen, Faisal G.; Rosengart, Todd K.; Carabello, Blase A.			Aortic Stenosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LEFT-VENTRICULAR DYSFUNCTION; VALVE-REPLACEMENT; LOW-FLOW; PROGNOSTIC VALUE; NATURAL-HISTORY; EARLY MORTALITY; TRANSCATHETER; RISK; OUTCOMES; SOCIETY											Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; American College of Cardiology, 2015, CHOOS WIS 5 THINGS P; Badheka AO, 2015, AM J CARDIOL, V116, P132, DOI 10.1016/j.amjcard.2015.03.053; Bakaeen FG, 2010, ANN THORAC SURG, V89, P453, DOI 10.1016/j.athoracsur.2009.10.033; Brennan JM, 2013, CIRCULATION, V127, P1647, DOI 10.1161/CIRCULATIONAHA.113.002003; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Brown ML, 2009, J THORAC CARDIOV SUR, V137, P670, DOI 10.1016/j.jtcvs.2008.08.010; Carabello BA, 2013, CIRC RES, V113, P179, DOI 10.1161/CIRCRESAHA.113.300156; Chiang YTP, 2014, JAMA-J AM MED ASSOC, V312, P1323, DOI 10.1001/jama.2014.12679; Clavel MA, 2014, J AM COLL CARDIOL, V64, P1202, DOI 10.1016/j.jacc.2014.05.066; Clavel MA, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0431-x; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; Connolly HM, 1997, CIRCULATION, V95, P2395, DOI 10.1161/01.CIR.95.10.2395; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Du DY, 2014, JAMA INTERN MED, V174, P1788, DOI 10.1001/jamainternmed.2014.4300; Duke Clinical Research Institute, 2015, AD CARD SURG DAT EX; Duncan AI, 2008, ANN THORAC SURG, V85, P2030, DOI 10.1016/j.athoracsur.2008.02.075; Dvir D, 2014, JAMA-J AM MED ASSOC, V312, P162, DOI 10.1001/jama.2014.7246; Dweck MR, 2011, J AM COLL CARDIOL, V58, P1271, DOI 10.1016/j.jacc.2011.03.064; Gohlke-Barwolf C, 2013, CURR PROB CARDIOLOGY, V38, P365, DOI 10.1016/j.cpcardiol.2013.06.003; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Henri C, 2014, CAN J CARDIOL, V30, P1012, DOI 10.1016/j.cjca.2014.03.013; Holmes DR, 2016, ANN THORAC SURG, V101, P789, DOI 10.1016/j.athoracsur.2015.10.049; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kusunose K, 2014, CIRC-CARDIOVASC IMAG, V7, P938, DOI 10.1161/CIRCIMAGING.114.002041; Le Ven F, 2013, J AM COLL CARDIOL, V62, P782, DOI 10.1016/j.jacc.2013.05.044; Lee R, 2011, ANN THORAC SURG, V91, P677, DOI 10.1016/j.athoracsur.2010.11.009; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Li CM, 2013, J AM SOC ECHOCARDIOG, V26, P1245, DOI 10.1016/j.echo.2013.07.018; Michelena HI, 2011, JAMA-J AM MED ASSOC, V306, P1104, DOI 10.1001/jama.2011.1286; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murbraech K, 2016, JACC-CARDIOVASC IMAG, V9, P230, DOI 10.1016/j.jcmg.2015.06.028; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Nwaejike N, 2015, INTERACT CARDIOV TH, V20, P429, DOI 10.1093/icvts/ivu398; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Ong DS, 2013, J HEART VALVE DIS, V22, P883; Osnabrugge RLJ, 2013, J AM COLL CARDIOL, V62, P1002, DOI 10.1016/j.jacc.2013.05.015; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Owens DS, 2008, ARCH INTERN MED, V168, P1200, DOI 10.1001/archinte.168.11.1200; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Pibarot P, 2012, J AM COLL CARDIOL, V60, P1845, DOI 10.1016/j.jacc.2012.06.051; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Rafique AM, 2009, AM J CARDIOL, V104, P972, DOI 10.1016/j.amjcard.2009.05.044; Rahimtoola SH, 2010, J AM COLL CARDIOL, V55, P2413, DOI 10.1016/j.jacc.2009.10.085; Rosenhek R, 2010, CIRCULATION, V121, P151, DOI 10.1161/CIRCULATIONAHA.109.894170; Ross J Jr, 1968, Circulation, V38, P61; Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257; Shahian DM, 2012, ANN THORAC SURG, V94, P2166, DOI 10.1016/j.athoracsur.2012.08.120; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Teo KK, 2011, CAN J CARDIOL, V27, P800, DOI 10.1016/j.cjca.2011.03.012; Thaden JJ, 2014, PROG CARDIOVASC DIS, V56, P565, DOI 10.1016/j.pcad.2014.02.006; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Wood DE, 2013, ANN THORAC SURG, V95, P1130, DOI 10.1016/j.athoracsur.2013.01.008; Yechoor P, 2013, J THORAC CARDIOV SUR, V145, P1550, DOI 10.1016/j.jtcvs.2012.05.013; Zhao ZG, 2015, NAT REV CARDIOL, V12, P123, DOI 10.1038/nrcardio.2014.161	58	12	12	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					ITC1	ITC16		10.7326/AITC201701030	http://dx.doi.org/10.7326/AITC201701030			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030676				2022-12-28	WOS:000391467900001
J	Chen, DF				Chen, Daniel F.			Little White Lies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRUST; MEDICINE		[Chen, Daniel F.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Chen, Daniel F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Chen, Daniel F.] Washington DC Vet Affairs Med Ctr, Div Hosp Med, Washington, DC 20571 USA	George Washington University; Uniformed Services University of the Health Sciences - USA	Chen, DF (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.; Chen, DF (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.; Chen, DF (corresponding author), Washington DC Vet Affairs Med Ctr, Div Hosp Med, Washington, DC 20571 USA.	dfchen@gmail.com						Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Jacobs AK, 2005, CIRCULATION, V111, P3494, DOI 10.1161/CIRCULATIONAHA.105.166277; King SB, 2010, JACC-CARDIOVASC INTE, V3, P1100, DOI 10.1016/j.jcin.2010.09.004	3	0	0	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					27	28		10.1001/jama.2016.11872	http://dx.doi.org/10.1001/jama.2016.11872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030705				2022-12-28	WOS:000391009100013
J	Deak, D; Powers, JH; Outterson, K; Kesselheim, AS				Deak, Dalia; Powers, John H.; Outterson, Kevin; Kesselheim, Aaron S.			The Fight Against Multidrug-Resistant Bacteria RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							NONINFERIORITY TRIALS		[Deak, Dalia; Kesselheim, Aaron S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Deak, Dalia; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02115 USA; [Powers, John H.] George Washington Univ, Sch Med, Washington, DC USA; [Outterson, Kevin] Boston Univ, Sch Law, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; George Washington University; Boston University	Deak, D (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Deak, D (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Outterson, Kevin/0000-0003-2513-3216; Powers III, John H/0000-0002-5150-5119				Fleming TR, 2008, CLIN INFECT DIS, V47, pS108, DOI 10.1086/591390; Larsen J., 2016, BARDAS MARKET RES CL; Prasad P, 2012, CLIN INFECT DIS, V54, P1699, DOI 10.1093/cid/cis270; U.S. Food and Drug Administration, 2016, FAC ANT DRUG DEV PAT	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					79	79		10.7326/L16-0582	http://dx.doi.org/10.7326/L16-0582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030672				2022-12-28	WOS:000391467900020
J	Cheung, WWL; Reygondeau, G; Froicher, TL				Cheung, William W. L.; Reygondeau, Gabriel; Frolicher, Thomas L.			Large benefits to marine fisheries of meeting the 1.5 degrees C global warming target	SCIENCE			English	Article							CLIMATE-CHANGE; COMMUNITIES; IMPACTS; LEADS; GULF	Translating the Paris Agreement to limit global warming to 1.5 degrees C above preindustrial level into impact-related targets facilitates communication of the benefits of mitigating climate change to policymakers and stakeholders. Developing ecologically relevant impact-related targets for marine ecosystem services, such as fisheries, is an important step. Here, we use maximum catch potential and species turnover as climate-risk indicators for fisheries. We project that potential catches will decrease by more than 3 million metric tons per degree Celsius of warming. Species turnover is more than halved when warming is lowered from 3.5 degrees to 1.5 degrees C above the preindustrial level. Regionally, changes in maximum catch potential and species turnover vary across ecosystems, with the biggest risk reduction in the Indo-Pacific and Arctic regions when the Paris Agreement target is achieved.	[Cheung, William W. L.; Reygondeau, Gabriel] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program, Vancouver, BC, Canada; [Cheung, William W. L.; Reygondeau, Gabriel] Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada; [Frolicher, Thomas L.] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys, Zurich, Switzerland	University of British Columbia; University of British Columbia; Swiss Federal Institutes of Technology Domain; ETH Zurich	Cheung, WWL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program, Vancouver, BC, Canada.; Cheung, WWL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada.	w.cheung@oceans.ubc.ca	Froelicher, Thomas/AAG-9598-2019; Frölicher, Thomas L/E-5137-2015; Reygondeau, Gabriel/G-1903-2017	Froelicher, Thomas/0000-0003-2348-7854; Frölicher, Thomas L/0000-0003-2348-7854; Reygondeau, Gabriel/0000-0001-9074-625X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This is a contribution of the Nippon Foundation-Nereus Program. W.W.L.C. also acknowledges funding support from the Natural Sciences and Engineering Research Council of Canada. Data presented in the manuscript are available from the Dryad Digital Repository (DOI: 10.5061/dryad.pq6p2). We acknowledge the courtesy of the Integration and Application Network, University of Maryland Center for Environmental Science, for some images in Fig. 1.	Allison EH, 2015, SCIENCE, V350, P778, DOI 10.1126/science.aac8721; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Beaugrand G, 2015, NAT CLIM CHANGE, V5, P695, DOI [10.1038/NCLIMATE2650, 10.1038/nclimate2650]; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Christiansen JS, 2014, GLOBAL CHANGE BIOL, V20, P352, DOI 10.1111/gcb.12395; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Frolicher T. L., 2016, CYCLES, V30, P1224; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Le Quesne WJF, 2012, FISH FISH, V13, P333, DOI 10.1111/j.1467-2979.2011.00423.x; Lefort S, 2015, GLOBAL CHANGE BIOL, V21, P154, DOI 10.1111/gcb.12679; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rodgers KB, 2015, BIOGEOSCIENCES, V12, P3301, DOI 10.5194/bg-12-3301-2015; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Steinacher M, 2016, BIOGEOSCIENCES, V13, P1071, DOI 10.5194/bg-13-1071-2016; Vancoppenolle M, 2013, GLOBAL BIOGEOCHEM CY, V27, P605, DOI 10.1002/gbc.20055	29	140	143	3	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1591	1594		10.1126/science.aag2331	http://dx.doi.org/10.1126/science.aag2331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008069				2022-12-28	WOS:000390254300054
J	Mackay, I; Sawyer, E				Mackay, Ian; Sawyer, Elinor			Tony R Bull OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		BULL TR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2016	355								i6706	10.1136/bmj.i6706	http://dx.doi.org/10.1136/bmj.i6706			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CL	28011466				2022-12-28	WOS:000390921300003
J	Zhang, Y; Justin, N; Wilson, JR; Gamblin, SJ				Zhang, Ying; Justin, Neil; Wilson, Jon R.; Gamblin, Steven J.			Comment on "Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2"	SCIENCE			English	Editorial Material							LYSINE METHYLTRANSFERASE; INHIBITION; CANCER; PRC2; MUTATION		[Zhang, Ying; Justin, Neil; Wilson, Jon R.; Gamblin, Steven J.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute	Gamblin, SJ (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.	steve.gamblin@crick.ac.uk	Wilson, Jon R/B-7362-2019	Wilson, Jon R/0000-0002-5157-5432; Gamblin, Steve/0000-0001-5331-639X	Cancer Research UK [FC001078] Funding Source: Medline; Wellcome Trust [FC001078] Funding Source: Medline; The Francis Crick Institute [10078] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute		Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lewis PW, 2013, CELL CYCLE, V12, P3241, DOI 10.4161/cc.26356; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Wu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083737; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	14	17	18	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319							1543-a	10.1126/science.aaf6236	http://dx.doi.org/10.1126/science.aaf6236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008037				2022-12-28	WOS:000390254300039
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phillips, WR; Phipps, MG; Pignone, MP; Silverstein, M; Tseng, CW				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Silverstein, Michael; Tseng, Chien-Wen		US Preventive Serv Task Force	Serologic Screening for Genital Herpes Infection US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SIMPLEX-VIRUS TYPE-2; NEONATAL HERPES; PSYCHOSOCIAL IMPACT; CESAREAN DELIVERY; ADOLESCENTS; ACYCLOVIR; DIAGNOSIS; ADULTS	IMPORTANCE Genital herpes is a prevalent sexually transmitted infection in the United States, occurring in almost 1 in 6 persons aged 14 to 49 years. Infection is caused by 2 subtypes of the herpes simplex virus (HSV), HSV-1 and HSV-2. Antiviral medications may provide symptomatic relief from outbreaks but do not cure HSV infection. Neonatal herpes infection, while uncommon, can result in substantial morbidity and mortality. OBJECTIVE To update the 2005 US Preventive Services Task Force (USPSTF) recommendation on screening for genital herpes. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy, benefits, and harms of serologic screening for HSV-2 infection in asymptomatic persons, including those who are pregnant, as well as the effectiveness and harms of preventive medications and behavioral counseling interventions to reduce future symptomatic episodes and transmission to others. FINDINGS Based on the natural history of HSV infection, its epidemiology, and the available evidence on the accuracy of serologic screening tests, the USPSTF concluded that the harms outweigh the benefits of serologic screening for genital HSV infection in asymptomatic adolescents and adults, including those who are pregnant. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends against routine serologic screening for genital HSV infection in asymptomatic adolescents and adults, including those who are pregnant. (D recommendation)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Tseng, Chien-Wen] Univ Hawaii, Manoa, HI USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of Texas System; University of Texas Austin; Boston University; University of Hawaii System; University of Hawaii Manoa	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022; Phillips, William R./V-1065-2017	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	*ACOG COMM PRACT B, 2007, OBSTET GYNECOL, V109, P1489; American College of Obstetricians and Gynecologists, 2011, GUID AD HLTH CAR; [Anonymous], 2000, Int J Gynaecol Obstet, V68, P165; [Anonymous], CLIN PREV SERV REC G; Benedetti JK, 1999, ANN INTERN MED, V131, P14, DOI 10.7326/0003-4819-131-1-199907060-00004; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2321, DOI 10.1001/jama.2016.5824; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Centers for Disease Control and Prevention, 2015, GEN HSV INF; Centers for Disease Control and Prevention, 2016, GEN HERP CDC FACT SH; Feltner C, 2016, JAMA; Feltner C, 2016, AHRQ PUBLICATION, V16-EHC016-EF; Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134; Handel S, 2011, SEX TRANSM DIS, V38, P705, DOI 10.1097/OLQ.0b013e31821b178f; Hollier LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004946.pub2; Kimberlin DW, 2004, NEW ENGL J MED, V350, P1970, DOI 10.1056/NEJMcp023065; LeFevre ML, 2014, ANN INTERN MED, V161, P894, DOI 10.7326/M14-1965; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Mahnert N, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.911; Melville J, 2003, SEX TRANSM INFECT, V79, P280, DOI 10.1136/sti.79.4.280; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Patel R, 2012, SEXUALLY TRANSMITTED; Rosenthal SL, 2006, SEX TRANSM INFECT, V82, P154, DOI 10.1136/sti.2005.016311; Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015; US Preventive Services Task Force, 2005, SCREEN GEN HERP REC; Watts DH, 2003, AM J OBSTET GYNECOL, V188, P836, DOI 10.1067/mob.2003.185; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	28	25	25	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2525	2530		10.1001/jama.2016.16776	http://dx.doi.org/10.1001/jama.2016.16776			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997659	Bronze			2022-12-28	WOS:000390959300020
J	Budenholzer, B				Budenholzer, Brian			Adding glycopyrronium to beclomethasone plus formoterol improved pulmonary function in COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FLUTICASONE		[Budenholzer, Brian] Eastern Virginia Med Sch, Norfolk, VA 23501 USA	Eastern Virginia Medical School	Budenholzer, B (corresponding author), Eastern Virginia Med Sch, Norfolk, VA 23501 USA.							Kew KM, 2014, COCHRANE DB SYST REV; Siler TM, 2015, RESP MED, V109, P1155, DOI 10.1016/j.rmed.2015.06.006; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC67	JC67		10.7326/ACPJC-2016-165-12-067	http://dx.doi.org/10.7326/ACPJC-2016-165-12-067			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992923				2022-12-28	WOS:000391236900006
J	Smoyer, WE; Embi, PJ; Moffatt-Bruce, S				Smoyer, William E.; Embi, Peter J.; Moffatt-Bruce, Susan			Creating Local Learning Health Systems Think Globally, Act Locally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOMEDICAL INFORMATICS; CARE		[Smoyer, William E.] Nationwide Childrens Hosp, Res Inst, 700 Childrens Dr,Room W303, Columbus, OH 43205 USA; [Smoyer, William E.; Embi, Peter J.; Moffatt-Bruce, Susan] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Smoyer, WE (corresponding author), Nationwide Childrens Hosp, Res Inst, 700 Childrens Dr,Room W303, Columbus, OH 43205 USA.	william.smoyer@nationwidechildrens.org	Embi, Peter/AAF-2740-2021	Embi, Peter/0000-0002-7733-0847				Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Embi PJ, 2013, MED CARE, V51, pS87, DOI 10.1097/MLR.0b013e31829b1d66; Embi PJ, 2009, CIRCULATION, V120, P2393, DOI 10.1161/CIRCULATIONAHA.108.795526; Grumbach K, 2014, JAMA-J AM MED ASSOC, V311, P1109, DOI 10.1001/jama.2014.705; Lowes LP, 2017, DEV MED CHILD NEUROL, V59, P183, DOI 10.1111/dmcn.13227; Moffatt-Bruce S, 2014, ADV HEALTH CARE MANA, V16, P51, DOI 10.1108/S1474-823120140000016003; Payne PRO, 2010, J AM MED INFORM ASSN, V17, P615, DOI 10.1136/jamia.2010.005165	7	24	25	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2481	2482		10.1001/jama.2016.16459	http://dx.doi.org/10.1001/jama.2016.16459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG3QH	27997662	Green Submitted			2022-12-28	WOS:000390959300010
J	Weinberger, S				Weinberger, Steven			Curbing Firearm Violence RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Weinberger, Steven] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Weinberger, S (corresponding author), Amer Coll Physicians, Philadelphia, PA 19106 USA.							Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					894	894		10.7326/L16-0540	http://dx.doi.org/10.7326/L16-0540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992906				2022-12-28	WOS:000391236900033
J	Urban, S				Urban, Sinisa			SnapShot: Cartography of Intramembrane Proteolysis	CELL			English	Editorial Material									[Urban, Sinisa] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Room 507 PCTB,725 North Wolfe St, Baltimore, MD 21205 USA	Johns Hopkins University	Urban, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Room 507 PCTB,725 North Wolfe St, Baltimore, MD 21205 USA.								0	6	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1898	1898		10.1016/j.cell.2016.11.043	http://dx.doi.org/10.1016/j.cell.2016.11.043			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984738	Bronze			2022-12-28	WOS:000393114700028
J	Lyon, J				Lyon, Jeff			Congress Delivers Medical Twofer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2348	2348		10.1001/jama.2016.18027	http://dx.doi.org/10.1001/jama.2016.18027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959979				2022-12-28	WOS:000389884600006
J	Ahmadi, M; Alves, BXR; Baker, CJ; Bertsche, W; Butler, E; Capra, A; Carruth, C; Cesar, CL; Charlton, M; Cohen, S; Collister, R; Eriksson, S; Evans, A; Evetts, N; Fajans, J; Friesen, T; Fujiwara, MC; Gill, DR; Gutierrez, A; Hangst, JS; Hardy, WN; Hayden, ME; Isaac, CA; Ishida, A; Ohnson, MAJ; Ones, SAJ; Onsell, SJ; Kurchaninov, L; Madsen, N; Mathers, M; Maxwell, D; McKenna, JTK; Menary, S; Michan, JM; Momose, T; Munich, JJ; Nolan, P; Olchanski, K; Olin, A; Pusa, P; Rasmussen, CO; Robicheaux, F; Sacramento, RL; Sameed, M; Sarid, E; Silveira, DM; Stracka, S; Stutter, G; So, C; Tharp, TD; Thompson, JE; Thompson, RI; van der Werf, DP; Wurtele, JS				Ahmadi, M.; Alves, B. X. R.; Baker, C. J. .; Bertsche, W.; Butler, E.; Capra, A.; Carruth, C.; Cesar, C. L.; Charlton, M.; Cohen, S.; Collister, R.; Eriksson, S.; Evans, A.; Evetts, N.; Fajans, J.; Friesen, T.; Fujiwara, M. C.; Gill, D. R.; Gutierrez, A.; Hangst, J. S.; Hardy, W. N.; Hayden, M. E.; Isaac, C. A.; Ishida, A.; Ohnson, M. A. J.; Ones, S. A. J.; Onsell, S. J.; Kurchaninov, L.; Madsen, N.; Mathers, M.; Maxwell, D.; McKenna, J. T. K.; Menary, S.; Michan, J. M.; Momose, T.; Munich, J. J. .; Nolan, P.; Olchanski, K.; Olin, A.; Pusa, P.; Rasmussen, C. O.; Robicheaux, F.; Sacramento, R. L.; Sameed, M.; Sarid, E.; Silveira, D. M.; Stracka, S.; Stutter, G.; So, C.; Tharp, T. D.; Thompson, J. E.; Thompson, R. I.; van der Werf, D. P.; Wurtele, J. S.			Observation of the 1S-2S transition in trapped antihydrogen	NATURE			English	Article							CHARGE; SPECTROSCOPY; LIMIT	The spectrum of the hydrogen atom has played a central part in fundamental physics over the past 200 years. Historical examples of its importance include the wavelength measurements of absorption lines in the solar spectrum by Fraunhofer, the identification of transition lines by Balmer, Lyman and others, the empirical description of allowed wavelengths by Rydberg, the quantum model of Bohr, the capability of quantum electrodynamics to precisely predict transition frequencies, and modern measurements of the 1S-2S transition by Hansch1 to a precision of a few parts in 10(15). Recent technological advances have allowed us to focus on antihydrogen-the antimatter equivalent of hydrogen(2-4). The Standard Model predicts that there should have been equal amounts of matter and antimatter in the primordial Universe after the Big Bang, but today's Universe is observed to consist almost entirely of ordinary matter. This motivates the study of antimatter, to see if there is a small asymmetry in the laws of physics that govern the two types of matter. In particular, the CPT (charge conjugation, parity reversal and time reversal) theorem, a cornerstone of the Standard Model, requires that hydrogen and antihydrogen have the same spectrum. Here we report the observation of the 1S-2S transition in magnetically trapped atoms of antihydrogen. We determine that the frequency of the transition, which is driven by two photons from a laser at 243 nanometres, is consistent with that expected for hydrogen in the same environment. This laser excitation of a quantum state of an atom of antimatter represents the most precise measurement performed on an anti-atom. Our result is consistent with CPT invariance at a relative precision of about 2 x 10(-10).	[Ahmadi, M.; Nolan, P.; Pusa, P.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Alves, B. X. R.; Friesen, T.; Hangst, J. S.; Rasmussen, C. O.; Stutter, G.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Baker, C. J. .; Charlton, M.; Eriksson, S.; Isaac, C. A.; Ones, S. A. J.; Madsen, N.; Maxwell, D.; Sameed, M.; van der Werf, D. P.] Swansea Univ, Dept Phys, Coll Sci, Swansea SA2 8PP, W Glam, Wales; [Bertsche, W.; Ohnson, M. A. J.] Univ Manchester, Sch Phys & Astron, Manchester M12 9PL, Lancs, England; [Bertsche, W.; Ohnson, M. A. J.] Sci Tech Daresbury, Cockcroft Inst, Warrington WA4 4AD, Cheshire, England; [Butler, E.] CERN, Phys Dept, CH-1211 Geneva 23, Switzerland; [Capra, A.; Collister, R.; Fujiwara, M. C.; Gill, D. R.; Kurchaninov, L.; McKenna, J. T. K.; Michan, J. M.; Olchanski, K.; Olin, A.] TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada; [Carruth, C.; Fajans, J.; Wurtele, J. S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Cesar, C. L.; Sacramento, R. L.; Silveira, D. M.] Univ Fed Rio de Janeiro, Inst Fis, BR-21941 Rio De Janeiro, Brazil; [Cohen, S.] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Evans, A.; So, C.; Thompson, R. I.] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [Evetts, N.; Hardy, W. N.; Momose, T.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Gutierrez, A.] UCL, Dept Med Phys & Biomed Engn, London WC1E 6BT, England; [Hayden, M. E.; Munich, J. J. .] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Ishida, A.] Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Onsell, S. J.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Mathers, M.; Menary, S.; Thompson, J. E.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Michan, J. M.] Ecole Polytech Fed Lausanne, Swiss Plasma Ctr, CH-1015 Lausanne, Switzerland; [Olin, A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Robicheaux, F.] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Sarid, E.] Soreq NRC, IL-81800 Yavne, Israel; [Stracka, S.] Univ Pisa, Largo Pontecorvo 3, I-56127 Pisa, Italy; [Stracka, S.] Sez INFN Pisa, Largo Pontecorvo 3, I-56127 Pisa, Italy; [Tharp, T. D.] Marquette Univ, Dept Phys, POB 1881, Milwaukee, WI 53201 USA; [van der Werf, D. P.] CEA Saclay, IRFU, F-91191 Gif Sur Yvette, France	University of Liverpool; Aarhus University; Swansea University; University of Manchester; STFC Daresbury Laboratory; European Organization for Nuclear Research (CERN); University of British Columbia; University of California System; University of California Berkeley; Universidade Federal do Rio de Janeiro; Ben Gurion University; University of Calgary; University of British Columbia; University of London; University College London; Simon Fraser University; University of Tokyo; Stockholm University; York University - Canada; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Victoria; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Marquette University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Hangst, JS (corresponding author), Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark.	jeffrey.hangst@cern.ch	Hardy, Walter Newbold/AAN-7827-2020; Jonsell, Svante/J-2251-2016; Maxwell, Daniel/B-5730-2018; Madsen, Niels/I-2314-2019; Wurtele, Jonathan S/J-6278-2016; ISHIDA, AKIRA/G-4990-2014; Cesar, Claudio/AAH-4612-2021; Bertsche, William/A-3678-2012; Robicheaux, Francis/F-4343-2014; Stracka, Simone/M-3931-2015	Jonsell, Svante/0000-0003-4969-1714; Maxwell, Daniel/0000-0001-5178-9492; Madsen, Niels/0000-0002-7372-0784; Wurtele, Jonathan S/0000-0001-8401-0297; ISHIDA, AKIRA/0000-0002-9880-6517; Bertsche, William/0000-0002-6565-9282; Cesar, Claudio/0000-0003-2638-0032; Robicheaux, Francis/0000-0002-8054-6040; Johnson, Mark/0000-0002-0654-2658; Stutter, Graham/0000-0002-1629-7588; McKenna, Joseph/0000-0002-7838-4230; Munich, Justine/0000-0001-7475-3070; Rasmussen, Chris Orum/0000-0002-6029-1730; van der Werf, Dirk/0000-0001-5436-5214; Kurchaninov, Leonid/0000-0001-9392-3936; Sameed, Muhammed/0000-0002-9706-8970; Cohen, Snir/0000-0002-4240-0702; Jones, Steven/0000-0001-8205-2186; Capra, Andrea/0000-0001-9499-0380; Friesen, Timothy/0000-0002-7017-9662; Stracka, Simone/0000-0003-0013-4714; Eriksson, Stefan/0000-0002-5390-1879	European Research Council; CNPq (Brazil); FAPERJ (Brazil); RENAFAE (Brazil); NSERC (Canada); NRC/TRIUMF (Canada); EHPDS/EHDRS (Canada); FQRNT (Canada); FNU (Nice Centre) (Denmark); Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC (UK); EPSRC (UK); Royal Society (UK); Leverhulme Trust (UK); DOE (USA); NSF (USA); VR (Sweden); Division Of Physics [1500538, 1500470] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/K017373/1, EP/D040108/1, EP/P024785/1, EP/L014734/1, EP/K040235/1, EP/L014769/1, EP/H026932/1, EP/E016332/1, EP/F033885/1, 1422853, EP/G068968/1, EP/I005692/1, EP/P024769/1, EP/H02431X/1, EP/L005522/1, EP/L014718/1, EP/E048951/1] Funding Source: researchfish; Science and Technology Facilities Council [1686188] Funding Source: researchfish; EPSRC [EP/H02431X/1, EP/L014718/1, EP/E048951/1, EP/L005522/1, EP/G068968/1, EP/D040108/1, EP/P024769/1, EP/I005692/1, EP/K017373/1, EP/L014769/1, EP/H026932/1, EP/E016332/1, EP/P024785/1, EP/L014734/1, EP/F033885/1, EP/K040235/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); RENAFAE (Brazil); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC/TRIUMF (Canada); EHPDS/EHDRS (Canada); FQRNT (Canada)(FQRNT); FNU (Nice Centre) (Denmark); Carlsberg Foundation (Denmark)(Carlsberg Foundation); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel)(Israel Science Foundation); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society (UK)(Royal Society of London); Leverhulme Trust (UK)(Leverhulme Trust); DOE (USA)(United States Department of Energy (DOE)); NSF (USA)(National Science Foundation (NSF)); VR (Sweden)(Swedish Research Council); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	All authors are members of the ALPHA Collaboration. This work was supported by: the European Research Council through its Advanced Grant programme (J.S.H.); CNPq, FAPERJ, RENAFAE (Brazil); NSERC, NRC/TRIUMF, EHPDS/EHDRS, FQRNT (Canada); FNU (Nice Centre), Carlsberg Foundation (Denmark); JSPS Postdoctoral Fellowships for Research Abroad (Japan); ISF (Israel); STFC, EPSRC, the Royal Society and the Leverhulme Trust (UK); DOE, NSF (USA); and VR (Sweden). We are grateful for the efforts of the CERN Antiproton Decelerator team, without which these experiments could not have taken place. We thank J. Tonoli (CERN) and his staff for extensive, time-critical help with machining work. We thank the staff of the Superconducting Magnet Division at Brookhaven National Laboratory for collaboration and fabrication of the trapping magnets. We thank C. Marshall (TRIUMF) for his work on the ALPHA-2 cryostat. We acknowledge the influence of T. Hansch on the methodology and the hardware used here. We thank F. Besenbacher (Aarhus) for timely support in procuring the ALPHA-2 external solenoid. We thank A. Charman (UC Berkeley) for discussions.	Ahmadi M, 2016, NATURE, V529, P373, DOI 10.1038/nature16491; Amole C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4955; Amole C, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013037; Amole C, 2013, NUCL INSTRUM METH A, V732, P134, DOI 10.1016/j.nima.2013.05.188; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; Amoretti M, 2002, NATURE, V419, P456, DOI 10.1038/nature01096; Andresen GB, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/1/011001; Andresen GB, 2011, NAT PHYS, V7, P558, DOI [10.1038/NPHYS2025, 10.1038/nphys2025]; Andresen GB, 2011, PHYS LETT B, V695, P95, DOI 10.1016/j.physletb.2010.11.004; Andresen GB, 2010, NATURE, V468, P673, DOI 10.1038/nature09610; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Cesar CL, 1996, PHYS REV LETT, V77, P255, DOI 10.1103/PhysRevLett.77.255; Charman AE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2787; Donnan PH, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/2/025302; DREVER RWP, 1983, APPL PHYS B-PHOTO, V31, P97, DOI 10.1007/BF00702605; Enomoto Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.243401; Gabrielse G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213401; Hori M, 2016, SCIENCE, V354, P610, DOI 10.1126/science.aaf6702; Maury S, 1997, HYPERFINE INTERACT, V109, P43, DOI 10.1023/A:1012632812327; MURPHY TJ, 1992, PHYS REV A, V46, P5696, DOI 10.1103/PhysRevA.46.5696; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Pohl R, 2016, SCIENCE, V353, P669, DOI 10.1126/science.aaf2468; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Przyborowski J, 1940, BIOMETRIKA, V31, P313, DOI 10.2307/2332612; Surko CM, 1997, HYPERFINE INTERACT, V109, P181, DOI 10.1023/A:1012657517779; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861	26	90	90	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					506	510		10.1038/nature21040	http://dx.doi.org/10.1038/nature21040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28005057	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000396116600045
J	Komaroff, AL				Komaroff, Anthony L.			The Microbiome and Risk for Obesity and Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METABOLIC SYNDROME; GUT MICROBIOTA		[Komaroff, Anthony L.] Harvard Med Sch, Brigham & Womens Hosp, 10 Shattuck St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Komaroff, AL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 10 Shattuck St, Boston, MA 02115 USA.	anthony_komaroff@hms.harvard.edu						Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uusitalo U, 2016, JAMA PEDIATR, V170, P20, DOI 10.1001/jamapediatrics.2015.2757; van Olden C, 2015, CLIN THER, V37, P1172, DOI 10.1016/j.clinthera.2015.03.008; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031	10	160	175	1	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 24	2017	317	4					355	356		10.1001/jama.2016.20099	http://dx.doi.org/10.1001/jama.2016.20099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI5BW	28006047				2022-12-28	WOS:000392509600012
J	Rittmeyer, A; Barlesi, F; Waterkamp, D; Park, K; Ciardiello, F; von Pawel, J; Gadgeel, SM; Hida, T; Kowalski, DM; Dols, MC; Cortinovis, DL; Leach, J; Polikoff, J; Barrios, C; Kabbinavar, F; Frontera, OA; De Marinis, F; Turna, H; Lee, JS; Ballinger, M; Kowanetz, M; He, P; Chen, DS; Sandler, A; Gandara, DR				Rittmeyer, Achim; Barlesi, Fabrice; Waterkamp, Daniel; Park, Keunchil; Ciardiello, Fortunato; von Pawel, Joachim; Gadgeel, Shirish M.; Hida, Toyoaki; Kowalski, Dariusz M.; Dols, Manuel Cobo; Cortinovis, Diego L.; Leach, Joseph; Polikoff, Jonathan; Barrios, Carlos; Kabbinavar, Fairooz; Frontera, Osvaldo Aren; De Marinis, Filippo; Turna, Hande; Lee, Jong-Seok; Ballinger, Marcus; Kowanetz, Marcin; He, Pei; Chen, Daniel S.; Sandler, Alan; Gandara, David R.		OAK Study Grp	Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial	LANCET			English	Article							PROGRAMMED DEATH-1; ANTIBODY MPDL3280A; CLINICAL ACTIVITY; IN-VIVO; NIVOLUMAB; RESPONSES; THERAPY; PATHWAY	Background Atezolizumab is a humanised antiprogrammed death-ligand 1 (PD-L1) monoclonal antibody that inhibits PD-L1 and programmed death-1 (PD-1) and PD-L1 and B7-1 interactions, reinvigorating anticancer immunity. We assessed its efficacy and safety versus docetaxel in previously treated patients with non-small-cell lung cancer. Methods We did a randomised, open-label, phase 3 trial (OAK) in 194 academic or community oncology centres in 31 countries. We enrolled patients who had squamous or non-squamous non-small-cell lung cancer, were 18 years or older, had measurable disease per Response Evaluation Criteria in Solid Tumors, and had an Eastern Cooperative Oncology Group performance status of 0 or 1. Patients had received one to two previous cytotoxic chemotherapy regimens (one or more platinum based combination therapies) for stage IIIB or IV non-small-cell lung cancer. Patients with a history of autoimmune disease and those who had received previous treatments with docetaxel, CD137 agonists, anti-CTLA4, or therapies targeting the PD-L1 and PD-1 pathway were excluded. Patients were randomly assigned (1:1) to intravenously receive either atezolizumab 1200 mg or docetaxel 75 mg/m(2) every 3 weeks by permuted block randomisation (block size of eight) via an interactive voice or web response system. Coprimary endpoints were overall survival in the intention-to-treat (ITT) and PD-L1-expression population TC1/2/3 or IC1/2/3 (>= 1% PD-L1 on tumour cells or tumour-infiltrating immune cells). The primary efficacy analysis was done in the first 850 of 1225 enrolled patients. This study is registered with ClinicalTrials.gov, number NCT02008227. Findings Between March 11, 2014, and April 29, 2015, 1225 patients were recruited. In the primary population, 425 patients were randomly assigned to receive atezolizumab and 425 patients were assigned to receive docetaxel. Overall survival was significantly longer with atezolizumab in the ITT and PD-L1-expression populations. In the ITT population, overall survival was improved with atezolizumab compared with docetaxel (median overall survival was 13.8 months [95% CI 11.8-15.7] vs 9.6 months [8.6-11.2]; hazard ratio [HR] 0.73 [95% CI 0.62-0.87], p=0.0003). Overall survival in the TC1/2/3 or IC1/2/3 population was improved with atezolizumab (n=241) compared with docetaxel (n=222; median overall survival was 15.7 months [95% CI 12.6-18.0] with atezolizumab vs 10.3 months [8.8-12.0] with docetaxel; HR 0.74 [95% CI 0.58-0.93]; p=0.0102). Patients in the PD-L1 low or undetectable subgroup (TC0 and IC0) also had improved survival with atezolizumab (median overall survival 12.6 months vs 8.9 months; HR 0.75 [95% CI 0.59-0.96]). Overall survival improvement was similar in patients with squamous (HR 0.73 [95% CI 0.54-0.98]; n=112 in the atezolizumab group and n= 110 in the docetaxel group) or non-squamous (0.73 [0.60-0.89]; n=313 and n=315) histology. Fewer patients had treatment-related grade 3 or 4 adverse events with atezolizumab (90 [15%] of 609 patients) versus docetaxel (247 [43%] of 578 patients). One treatment-related death from a respiratory tract infection was reported in the docetaxel group. Interpretation To our knowledge, OAK is the first randomised phase 3 study to report results of a PD-L1-targeted therapy, with atezolizumab treatment resulting in a clinically relevant improvement of overall survival versus docetaxel in previously treated non-small-cell lung cancer, regardless of PD-L1 expression or histology, with a favourable safety profile.PD-L1-targeted	[Rittmeyer, Achim] Lungenfachklin Immenhausen, Immenhausen, Germany; [Barlesi, Fabrice] Marseille Univ, AP HP, Marseille, France; [Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Ciardiello, Fortunato] Seconda Univ Napoli, Naples, Italy; [von Pawel, Joachim] Asklepios Fachkliniken Munchen Gauting, Gauting, Germany; [Gadgeel, Shirish M.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Hida, Toyoaki] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Kowalski, Dariusz M.] Inst M Sklodowska Curie, Ctr Oncol, Warsaw, Poland; [Dols, Manuel Cobo] Hosp Reg Univ Carlos Haya, Med Oncol Sect, Malaga, Spain; [Cortinovis, Diego L.] AOU San Gerardo, Med Oncol Unit, Monza, Italy; [Leach, Joseph] Minnesota Oncol, Minneapolis, MN USA; [Polikoff, Jonathan] Southern Calif Permanente Med Grp, San Diego, CA 92120 USA; [Barrios, Carlos] PUCRS Sch Med, Porto Alegre, RS, Brazil; [Kabbinavar, Fairooz] Univ Calif Los Angeles, Los Angeles, CA USA; [Frontera, Osvaldo Aren] Ctr Int Estudios Clin, Santiago, Chile; [De Marinis, Filippo] European Inst Oncol, Milan, Italy; [Turna, Hande] Istanbul Univ, Cerrahpasa Med Fac Hosp, Med Oncol, Istanbul, Turkey; [Lee, Jong-Seok] Seoul Natl Univ, Bundang Hosp, Coll Med, Seongnam, South Korea; [Waterkamp, Daniel; Ballinger, Marcus; Kowanetz, Marcin; He, Pei; Chen, Daniel S.; Sandler, Alan] Genentech Inc, San Francisco, CA 94080 USA; [Gandara, David R.] UC Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Sungkyunkwan University (SKKU); Samsung Medical Center; Universita della Campania Vanvitelli; Barbara Ann Karmanos Cancer Institute; Wayne State University; Aichi Cancer Center; Maria Sklodowska-Curie National Research Institute of Oncology; Hospital Carlos Haya; Permanente Medical Groups; Pontificia Universidade Catolica Do Rio Grande Do Sul; University of California System; University of California Los Angeles; IRCCS European Institute of Oncology (IEO); Istanbul University; Istanbul University - Cerrahpasa; Seoul National University (SNU); Roche Holding; Genentech	Gandara, DR (corresponding author), UC Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA.	drgandara@ucdavis.edu	de Azevedo, Sergio Jobim/P-5115-2015; de Marinis, Filippo/AAR-2826-2020; Rittmeyer, Achim/W-2405-2019; Park, Keunchil/ABD-5852-2021; Cortinovis, Diego/AAC-2076-2022; Turna, Hande/AAA-2972-2020; Chen, Daniel Shin-Yu/AGD-8923-2022; Park, Keunchil/ABD-7072-2021	Park, Keunchil/0000-0002-4846-7449; Turna, Hande/0000-0003-0558-9371; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Rittmeyer, Achim/0000-0002-5280-6052; Kowalski, Dariusz/0000-0002-9452-3229; cortinovis, diego/0000-0001-7611-7369	Roche; Eli Lilly; Bristol-Myers Squibb; AstraZeneca; MSD; Boehringer Ingelheim; Pfizer; Astellas; AVEO; Clovis; Hanmi; KHK Novartis; Ono; Merck Serono; Bayer; Daiichi Sankyo; Vertex; Novartis; Roche/Genentech; Ariad; Chugai; Taiho Pharmaceutical; Nippon Boehringer Ingelheim; Eisai; Takeda; Dainippon Sumitomo Pharma; Abbvie; Merck; Kyowa Hakko Kirin; Amgen; GlaxoSmithKline; Sanofi; Mylan; Merrimack; BioMarin; Abraxis BioScience; AB Science; Asana Biosciences; Medivation; Exelixis; ImClone Systems; LEO Pharma; Millennium; Roche (Genentech); Bioepis; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Roche(Roche Holding); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); MSD; Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); AVEO; Clovis; Hanmi; KHK Novartis(Novartis); Ono; Merck Serono(Merck & Company); Bayer(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); Vertex(Vertex Pharmaceuticals); Novartis(Novartis); Roche/Genentech(Roche HoldingGenentech); Ariad; Chugai; Taiho Pharmaceutical; Nippon Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Takeda(Takeda Pharmaceutical Company Ltd); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Abbvie(AbbVie); Merck(Merck & Company); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Amgen(Amgen); GlaxoSmithKline(GlaxoSmithKline); Sanofi; Mylan; Merrimack; BioMarin; Abraxis BioScience; AB Science; Asana Biosciences; Medivation; Exelixis; ImClone Systems(Eli Lilly); LEO Pharma(LEO Pharma); Millennium(Takeda Pharmaceutical Company Ltd); Roche (Genentech)(Roche HoldingGenentech); Bioepis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AR received grants and personal fees from Roche, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, MSD, Boehringer Ingelheim, and Pfizer. FB received personal fees from Roche. DW, MB, and AS are Genentech employees and holders of Roche stock. KP received personal fees and research funding from AstraZeneca, and personal fees from Astellas, AVEO, Boehringer Ingelheim, Clovis, Eli Lilly, Hanmi, KHK Novartis, Ono, and Roche. FC received personal fees from Merck Serono, AstraZeneca, Eli Lilly, Roche, and Bayer. JvP received advisory board fees paid to institution from Daiichi Sankyo, Clovis, Roche, Vertex, and Novartis. SMG received personal fees from Roche/Genentech, Pfizer, Bristol-Myers Squibb, Ariad, Boehringer Ingelheim, and AstraZeneca. TH received grants and personal fees from Chugai, Eli Lilly, Ono, Novartis, Taiho Pharmaceutical, Nippon Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, Clovis, and AstraZeneca, and grants from Eisai, Takeda, Dainippon Sumitomo Pharma, Abbvie, Merck, Kyowa Hakko Kirin, Daiichi Sankyo, and Astellas. DMK, MCD, DLC, JL, JP, FK, OAF, FDM, HT, J-SL declare no competing interests. CB received clinical research fees from Pfizer, Novartis, Amgen, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Roche/Genentech, Eli Lilly, Sanofi, Taiho Pharmaceutical, Mylan, Merrimack, Merck, Abbvie, Astellas, BioMarin, Bristol-Myers Squibb, Daiichi Sankyo, Abraxis BioScience, AB Science, Asana Biosciences, Medivation, Exelixis, ImClone Systems, LEO Pharma, Millennium, and personal fees from Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer, Roche (Genentech), Eisai, and Bioepis. MK and DSC are Genentech employees, holders of Roche stock, and have a Genentech patent pending for biomarkers and methods treating PD-1-related and PD-L1-related conditions. PH is a Genentech employee, holder of Roche and Amgen stock, and reports that a family member holds Gilead and Allergan stock. DRG received grants for serving as a consultant to Bristol-Myers Squibb, Genentech, and Merck.	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Gandara DR, 2016, JAMA ONCOL, V2, P300, DOI 10.1001/jamaoncol.2015.4920; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Horn L, 2015, J CLIN ONCOL, V33; Kim JU, 2016, J NANOMATER, V2016, DOI 10.1155/2016/7602395; Matsumoto K, 2008, BIOCHEM BIOPH RES CO, V365, P170, DOI 10.1016/j.bbrc.2007.10.156; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Smith DA, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9028; Stinchcombe TE, 2008, ONCOLOGIST, V13, P28, DOI 10.1634/theoncologist.13-S1-28; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	22	2889	3038	14	373	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					255	265		10.1016/S0140-6736(16)32517-X	http://dx.doi.org/10.1016/S0140-6736(16)32517-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9BC	27979383	Green Accepted			2022-12-28	WOS:000392801200027
J	Murray, CJL; Lim, SS; Dieleman, JL				Murray, Christopher J. L.; Lim, Stephen S.; Dieleman, Joseph L.			Expanding GBD collaboration-call for experts in health financing and health systems	LANCET			English	Editorial Material									[Murray, Christopher J. L.; Lim, Stephen S.; Dieleman, Joseph L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu						Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					18	19		10.1016/S0140-6736(16)32569-7	http://dx.doi.org/10.1016/S0140-6736(16)32569-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG7VH	27989559				2022-12-28	WOS:000391264000020
J	Liu, SJ; Horlbeck, MA; Cho, SW; Birk, HS; Malatesta, M; He, D; Attenello, FJ; Villalta, JE; Cho, MY; Chen, YW; Mandegar, MA; Olvera, MP; Gilbert, LA; Conklin, BR; Chang, HY; Weissman, JS; Lim, DA				Liu, S. John; Horlbeck, Max A.; Cho, Seung Woo; Birk, Harjus S.; Malatesta, Martina; He, Daniel; Attenello, Frank J.; Villalta, Jacqueline E.; Cho, Min Y.; Chen, Yuwen; Mandegar, Mohammad A.; Olvera, Michael P.; Gilbert, Luke A.; Conklin, Bruce R.; Chang, Howard Y.; Weissman, Jonathan S.; Lim, Daniel A.			CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells	SCIENCE			English	Article							GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; TRANSCRIPTION; EVOLUTION; CANCER; LNCRNA; INTERFERENCE; ACTIVATION; ENHANCERS	The human genome produces thousands of long noncoding RNAs (lncRNAs)-transcripts >200 nucleotides long that do not encode proteins. Although critical roles in normal biology and disease have been revealed for a subset of lncRNAs, the function of the vast majority remains untested. We developed a CRISPR interference (CRISPRi) platform targeting 16,401 lncRNA loci in seven diverse cell lines, including six transformed cell lines and human induced pluripotent stem cells (iPSCs). Large-scale screening identified 499 lncRNA loci required for robust cellular growth, of which 89% showed growth-modifying function exclusively in one cell type. We further found that lncRNA knockdown can perturb complex transcriptional networks in a cell type-specific manner. These data underscore the functional importance and cell type specificity of many lncRNAs.	[Liu, S. John; Birk, Harjus S.; Malatesta, Martina; He, Daniel; Attenello, Frank J.; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Liu, S. John; Birk, Harjus S.; Malatesta, Martina; He, Daniel; Attenello, Frank J.; Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Horlbeck, Max A.; Villalta, Jacqueline E.; Cho, Min Y.; Chen, Yuwen; Mandegar, Mohammad A.; Olvera, Michael P.; Gilbert, Luke A.; Conklin, Bruce R.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Horlbeck, Max A.; Villalta, Jacqueline E.; Cho, Min Y.; Chen, Yuwen; Gilbert, Luke A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Horlbeck, Max A.; Villalta, Jacqueline E.; Cho, Min Y.; Chen, Yuwen; Gilbert, Luke A.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Horlbeck, Max A.; Villalta, Jacqueline E.; Cho, Min Y.; Chen, Yuwen; Gilbert, Luke A.; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Cho, Seung Woo; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Lim, Daniel A.] San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.; Lim, DA (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94143 USA.; Lim, DA (corresponding author), San Francisco VA Med Ctr, San Francisco, CA USA.	jonathan.weissman@ucsf.edu; daniel.lim@ucsf.edu	Conklin, Bruce/E-4738-2019; Cho, Seung Woo/B-2441-2019; Gilbert, Luke/AAC-5300-2019	Cho, Seung Woo/0000-0001-9091-0937; Mandegar, Mohammad Ali/0000-0002-5323-7891; Weissman, Jonathan/0000-0003-2445-670X; Lim, Daniel/0000-0001-7221-3425; Conklin, Bruce/0000-0003-1463-6061; Gilbert, Luke/0000-0001-5854-0825	NIH [1R01NS091544-01A1, F30 NS092319-01, P50 GM102706, U01 CA168370, R01 DA036858, R35-CA209919, P50-HG007735, U01HL100406, P01HL089707, R01HL130533]; VA grant [5I01 BX000252-07]; NIH Specialized Programs of Research Excellence Developmental Research Program subaward; Shurl and Kay Curci Foundation; LoGlio Foundation; Hana Jabsheh Initiative; Howard Hughes Medical Institutes; Gladstone Institutes; NIH/NCI Pathway to Independence Award [K99CA204602]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA168370, K99CA204602, R35CA209919, T32CA151022, R00CA204602] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100406, P01HL089707, R01HL130533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM102706, T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS092319, R01NS091544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA grant; NIH Specialized Programs of Research Excellence Developmental Research Program subaward; Shurl and Kay Curci Foundation; LoGlio Foundation; Hana Jabsheh Initiative; Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Gladstone Institutes(University of California System); NIH/NCI Pathway to Independence Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	We thank the members of the Lim and Weissman labs, particularly A. Fields, J. Dunn, M. DeVera, M. Cui, and D. Wu, for helpful discussions and assistance; A. Truong for assistance with iPS cell culturing; N. Salomonis for iPSC RNA-seq data; E. Chow and D. Bogdanoff of the UCSF Center for Advanced Technology for sequencing assistance; and L. Bruhn, D. Ryan, L. Fairbairn, and P. Tsang of Agilent Technologies for their assistance on the design and synthesis of oligonucleotide pools. Supported by NIH grant 1R01NS091544-01A1, VA grant 5I01 BX000252-07, NIH Specialized Programs of Research Excellence Developmental Research Program subaward, the Shurl and Kay Curci Foundation, the LoGlio Foundation, and the Hana Jabsheh Initiative (D.A.L.); NIH grant F30 NS092319-01 (S.J.L.); the Howard Hughes Medical Institutes and NIH grants P50 GM102706, U01 CA168370, and R01 DA036858 (M.A.H., J.E.V., M.Y.C., Y.C., L.A.G., and J.S.W.); NIH grants R35-CA209919 and P50-HG007735 (S.W.C. and H.Y.C.); the Gladstone Institutes and NIH grants U01HL100406, P01HL089707, and R01HL130533 (B.R.C. and M.A.M.); and NIH/NCI Pathway to Independence Award K99CA204602 (L.A.G.). Oligonucleotide pools were provided courtesy of the Innovative Genomics Initiative. M.A.H., L.A.G., and J.S.W. are inventors on patent application PCT/US15/40449 submitted by UCSF that covers CRISPRi library design. The human iPSC line WTC expressing the CRISPRi system (WTC-CRISPRi Gen IC) is available from B.R.C. under material transfer agreement from the Gladstone Institutes. The parental iPSC line (WTC) is available from the Coriell Biorepository #GM25256. The CRiNCL libraries are available from J.S.W. (via Addgene for academic users) under a material transfer agreement from UCSF and Agilent Technologies. M.A.H., L.A.G., and J.S.W. are inventors on patent application PCT/US15/40449 submitted by UCSF that covers CRISPRi library design. J.S.W. is a founder of KSQ Therapeutics, a company that uses CRISPR-based screening to identify therapeutic targets. H.Y.C. is a co-founder of Epinomics Inc. and served on the scientific advisory board of RaNA Therapeutics. M.A.H. and L.A.G. are consultants for KSQ Therapeutics.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Braun CJ, 2016, P NATL ACAD SCI USA, V113, pE3892, DOI 10.1073/pnas.1600582113; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0880-9; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Groff AF, 2016, CELL REP, V16, P2178, DOI 10.1016/j.celrep.2016.07.050; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	61	400	409	10	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2017	355	6320							aah7111	10.1126/science.aah7111	http://dx.doi.org/10.1126/science.aah7111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4KK	27980086	Green Accepted			2022-12-28	WOS:000391739900002
J	Hite, RK; Tao, X; MacKinnon, R				Hite, Richard K.; Tao, Xiao; MacKinnon, Roderick			Structural basis for gating the high-conductance Ca2+-activated K+ channel	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; PLANAR LIPID BILAYERS; BK CHANNELS; SKELETAL-MUSCLE; VOLTAGE SENSOR; ELECTRON CRYOMICROSCOPY; QUATERNARY AMMONIUM; CA-2&-ACTIVATED K; KINETIC STRUCTURE; CA2+ BINDING	The precise control of an ion channel gate by environmental stimuli is crucial for the fulfilment of its biological role. The gate in Slo1 K+ channels is regulated by two separate stimuli, intracellular Ca2+ concentration and membrane voltage. Slo1 is thus central to understanding the relationship between intracellular Ca2+ and membrane excitability. Here we present the Slo1 structure from Aplysia californica in the absence of Ca2+ and compare it with the Ca2+-bound channel. We show that Ca2+ binding at two unique binding sites per subunit stabilizes an expanded conformation of the Ca2+ sensor gating ring. These conformational changes are propagated from the gating ring to the pore through covalent linkers and through protein interfaces formed between the gating ring and the voltage sensors. The gating ring and the voltage sensors are directly connected through these interfaces, which allow membrane voltage to regulate gating of the pore by influencing the Ca2+ sensors.	[Hite, Richard K.; Tao, Xiao; MacKinnon, Roderick] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [Hite, Richard K.; Tao, Xiao; MacKinnon, Roderick] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.; MacKinnon, R (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	mackinn@mail.rockefeller.edu			 [GM43949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Yu and R. Huang at the Howard Hughes Medical Institute Janelia Cryo-EM facility for assistance in data collection; R. W. Aldrich for comments on the manuscript and members of the MacKinnon laboratory for assistance. This work was supported in part by GM43949. R.K.H. is a Howard Hughes Medical Institute postdoctoral fellow of the Helen Hay Whitney Foundation and R.M. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Budelli G, 2013, P NATL ACAD SCI USA, V110, P16657, DOI 10.1073/pnas.1313433110; Carrasquel-Ursulaez W, 2015, J GEN PHYSIOL, V145, P61, DOI 10.1085/jgp.201411194; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Geng YY, 2011, J GEN PHYSIOL, V137, P533, DOI 10.1085/jgp.201110616; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2012, J GEN PHYSIOL, V140, P625, DOI 10.1085/jgp.201210849; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; MAGLEBY KL, 1992, P ROY SOC B-BIOL SCI, V249, P133, DOI 10.1098/rspb.1992.0095; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothberg BS, 1998, J GEN PHYSIOL, V111, P751, DOI 10.1085/jgp.111.6.751; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Rothberg BS, 1997, BIOPHYS J, V72, P2524, DOI 10.1016/S0006-3495(97)78897-0; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Savalli N, 2012, J BIOL CHEM, V287, P21741, DOI 10.1074/jbc.M112.346171; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Tao X., 2016, NATURE; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yang H, 2007, P NATL ACAD SCI USA, V104, P18270, DOI 10.1073/pnas.0705873104; Yang JQ, 2013, J GEN PHYSIOL, V141, P217, DOI 10.1085/jgp.201210794; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	52	96	98	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					52	+		10.1038/nature20775	http://dx.doi.org/10.1038/nature20775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27974801	Green Accepted			2022-12-28	WOS:000396119500027
J	Tao, X; Hite, RK; MacKinnon, R				Tao, Xiao; Hite, Richard K.; MacKinnon, Roderick			Cryo-EM structure of the open high-conductance Ca2+-activated K+ channel	NATURE			English	Article							VOLTAGE-DEPENDENT K+; GATING-CHARGE; BK CHANNELS; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; CA2+ BINDING; ACTIVATION; CURRENTS; MOVEMENT; DOMAIN	The Ca2+-activated K+ channel, Slo1, has an unusually large conductance and contains a voltage sensor and multiple chemical sensors. Dual activation by membrane voltage and Ca2+ renders Slo1 central to processes that couple electrical signalling to Ca2+-mediated events such as muscle contraction and neuronal excitability. Here we present the cryoelectron microscopy structure of a full-length Slo1 channel from Aplysia californica in the presence of Ca2+ and Mg2+ at a resolution of 3.5 angstrom. The channel adopts an open conformation. Its voltage-sensor domain adopts a non-domain-swapped attachment to the pore and contacts the cytoplasmic Ca2+-binding domain from a neighbouring subunit. Unique structural features of the Slo1 voltage sensor suggest that it undergoes different conformational changes than other known voltage sensors. The structure reveals the molecular details of three distinct divalent cation-binding sites identified through electrophysiological studies of mutant Slo1 channels.	[Tao, Xiao; Hite, Richard K.; MacKinnon, Roderick] Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA; [Tao, Xiao; Hite, Richard K.; MacKinnon, Roderick] Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10065 USA.; MacKinnon, R (corresponding author), Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	mackinn@mail.rockefeller.edu			 [GM43949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ebrahim for assistance in data collection; R. W. Aldrich for comments on the manuscript; and members of the MacKinnon lab for assistance. This work was supported in part by GM43949. R.K.H. is a Howard Hughes Medical Institute postdoctoral fellow of the Helen Hay Whitney Foundation and R.M. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ALMERS W, 1980, J GEN PHYSIOL, V75, P61, DOI 10.1085/jgp.75.1.61; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; BOCK CW, 1994, INORG CHEM, V33, P419, DOI 10.1021/ic00081a007; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Budelli G, 2013, P NATL ACAD SCI USA, V110, P16657, DOI 10.1073/pnas.1313433110; CONTI F, 1975, Q REV BIOPHYS, V8, P451, DOI 10.1017/S0033583500001967; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guo JT, 2016, NATURE, V531, P196, DOI 10.1038/nature16446; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; Hite R. K., 2016, NATURE; Hite RK, 2015, NATURE, V527, P198, DOI 10.1038/nature14958; Ho B.K., 2008, BMC STRUCT BIOL, V8; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Horrigan FT, 1999, J GEN PHYSIOL, V114, P305, DOI 10.1085/jgp.114.2.305; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lingle CJ, 2006, J NEUROSCI METH, V158, P121, DOI 10.1016/j.jneumeth.2006.05.027; Liu GX, 2010, J GEN PHYSIOL, V135, P449, DOI 10.1085/jgp.201010417; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Noceti F, 1996, J GEN PHYSIOL, V108, P143, DOI 10.1085/jgp.108.3.143; OBERHAUSER A, 1988, J GEN PHYSIOL, V92, P67, DOI 10.1085/jgp.92.1.67; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shi JY, 2001, J GEN PHYSIOL, V118, P589, DOI 10.1085/jgp.118.5.589; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Sweet TB, 2008, J GEN PHYSIOL, V132, P491, DOI 10.1085/jgp.200810094; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Wang WW, 2014, ELIFE, V3, DOI 10.7554/eLife.03671; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang GH, 2010, P NATL ACAD SCI USA, V107, P18700, DOI 10.1073/pnas.1010124107; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhang YL, 2004, J BIOL CHEM, V279, P52324, DOI 10.1074/jbc.M408543200; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	79	122	124	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					46	+		10.1038/nature20608	http://dx.doi.org/10.1038/nature20608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27974795	Green Accepted			2022-12-28	WOS:000396119500026
J	Hampton, T				Hampton, Tracy			Pancreatic Cancer Blocked From Invading Nearby Nerves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					17	17		10.1001/jama.2016.19837	http://dx.doi.org/10.1001/jama.2016.19837			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030691				2022-12-28	WOS:000391009100005
J	Ramaswami, R				Ramaswami, Ramya			A Pregnant Woman Considering n-3 Long-Chain Polyunsaturated Fatty Acid Supplementation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2599	2599		10.1056/NEJMclde1614333	http://dx.doi.org/10.1056/NEJMclde1614333			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	28029929				2022-12-28	WOS:000391175300016
J	Black, N				Black, Nick			Higher Mortality in Weekend Admissions to the Hospital True, False, or Uncertain?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Black, Nick] London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London, England.	nick.black@lshtm.ac.uk						Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Black N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2066; Bray BD, 2016, LANCET, V388, P170, DOI 10.1016/S0140-6736(16)30443-3; Department of health, 2015, RES WEEK EFF PAT OUT; Goddard AF, 2016, JAMA-J AM MED ASSOC, V316, P1445, DOI 10.1001/jama.2016.12029; Hogan H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3239; Li LX, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2648; Meacock R, 2017, J HEALTH SERV RES PO, V22, P12, DOI 10.1177/1355819616649630; Mohammed MA, 2016, QJM, DOI [10.1093/qjmed/hcw104, DOI 10.1093/QJMED/HCW104]	9	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2593	+		10.1001/jama.2016.16410	http://dx.doi.org/10.1001/jama.2016.16410			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027376	Green Submitted, Green Accepted			2022-12-28	WOS:000391110200008
J	[Anonymous]				[Anonymous]			Still No Migraine Relief for Kids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2589	2589		10.1001/jama.2016.19352	http://dx.doi.org/10.1001/jama.2016.19352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9VN	28027364				2022-12-28	WOS:000394968300005
J	Lai, YC; Chuong, CM				Lai, Yung Chih; Chuong, Cheng-Ming			The "tao" of integuments	SCIENCE			English	Editorial Material							SKIN APPENDAGES; EVOLUTION; FEATHERS		[Chuong, Cheng-Ming] China Med Univ, China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung, Taiwan; Univ Southern Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA USA; Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Southern California; National Taiwan University	Chuong, CM (corresponding author), China Med Univ, China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung, Taiwan.	cmchuong@usc.edu	Lai, Yung-Chih/G-9596-2017	Lai, Yung-Chih/0000-0003-1211-4358	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR047364, R01AR042177] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047364, R01 AR042177, R01 AR060306] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chuong C-M, 1998, MOL BASIS EPITHELIAL; Chuong CM, 2013, WIRES DEV BIOL, V2, P97, DOI 10.1002/wdev.74; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; DHOUAILLY D, 1975, ROUX ARCH DEV BIOL, V177, P323, DOI 10.1007/BF00848183; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kamberov YG, 2015, P NATL ACAD SCI USA, V112, P9932, DOI 10.1073/pnas.1511680112; Lei MX, 2016, SCIENCE, V351, P559, DOI 10.1126/science.aaf1635; Lu CP, 2016, SCIENCE, V354, DOI 10.1126/science.aah6102; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Wu P, 2004, INT J DEV BIOL, V48, P249, DOI 10.1387/ijdb.15272390; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293	15	15	18	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1533	1534		10.1126/science.aal4572	http://dx.doi.org/10.1126/science.aal4572			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008029	Green Accepted			2022-12-28	WOS:000390254300028
J	Eisenstein, M				Eisenstein, Michael			A SLOW-MOTION EPIDEMIC	NATURE			English	Editorial Material																			0	23	25	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S98	S99		10.1038/540S98a	http://dx.doi.org/10.1038/540S98a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002393				2022-12-28	WOS:000391190500002
J	Gavrilescu, G				Gavrilescu, Gabriel			Physiotherapy reduced recurrent headaches linked to neck pain and dysfunction in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LOW-BACK-PAIN; EXERCISE		[Gavrilescu, Gabriel] Cleveland Clin Florida, Weston, ACT 33331, Australia	Cleveland Clinic Foundation	Gavrilescu, G (corresponding author), Cleveland Clin Florida, Weston, ACT 33331, Australia.							Meng XG, 2015, AM J PHYS MED REHAB, V94, P358, DOI 10.1097/PHM.0000000000000188; Saper RB, 2009, ALTERN THER HEALTH M, V15, P18; Steffens D, 2014, EUR SPINE J, V23, P113, DOI 10.1007/s00586-013-2846-x	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC68	JC68		10.7326/ACPJC-2016-165-12-068	http://dx.doi.org/10.7326/ACPJC-2016-165-12-068			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992924				2022-12-28	WOS:000391236900007
J	Zhu, YQ; Romain, C; Williams, CK				Zhu, Yunqing; Romain, Charles; Williams, Charlotte K.			Sustainable polymers from renewable resources	NATURE			English	Review							RING-OPENING POLYMERIZATION; LIFE-CYCLE ASSESSMENT; HIGH-MOLECULAR-WEIGHT; ALTERNATING COPOLYMERIZATION; CARBON-DIOXIDE; THERMOPLASTIC ELASTOMERS; LIMONENE OXIDE; LACTIC-ACID; SOYBEAN OIL; EPOXIDES	Renewable resources are used increasingly in the production of polymers. In particular, monomers such as carbon dioxide, terpenes, vegetable oils and carbohydrates can be used as feedstocks for the manufacture of a variety of sustainable materials and products, including elastomers, plastics, hydrogels, flexible electronics, resins, engineering polymers and composites. Efficient catalysis is required to produce monomers, to facilitate selective polymerizations and to enable recycling or upcycling of waste materials. There are opportunities to use such sustainable polymers in both high-value areas and in basic applications such as packaging. Life-cycle assessment can be used to quantify the environmental benefits of sustainable polymers.	[Zhu, Yunqing; Williams, Charlotte K.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Romain, Charles] Imperial Coll London, Dept Chem, London SW7 2AZ, England	University of Oxford; Imperial College London	Williams, CK (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	charlotte.williams@chem.ox.ac.uk	Zhu, Yunqing/N-4972-2019; ROMAIN, Charles/L-3807-2019; Zhu, Yunqing/E-4861-2014	Zhu, Yunqing/0000-0002-2557-003X; ROMAIN, Charles/0000-0002-1851-8612; Zhu, Yunqing/0000-0002-2557-003X; Williams, Charlotte/0000-0002-0734-1575	UK Engineering and Physical Sciences Research Council [EP/K035274/1, EP/M013839/1, EP/L017393/1, EP/K014070/1]; China Scholarship Council Imperial Scholarship; EPSRC [EP/K035274/1, EP/K014676/1, EP/H046380/1, EP/K014668/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C544838/1, EP/K014668/1, EP/H046380/1, EP/K035274/1, EP/K014676/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); China Scholarship Council Imperial Scholarship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The UK Engineering and Physical Sciences Research Council (EP/K035274/1, EP/M013839/1, EP/L017393/1 and EP/K014070/1) and the China Scholarship Council Imperial Scholarship (Y.Z.) are acknowledged for funding.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; Albertsson AC, 2010, BIOMACROMOLECULES, V11, P1406, DOI 10.1021/bm100253e; Altuna FI, 2013, GREEN CHEM, V15, P3360, DOI 10.1039/c3gc41384e; Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043; Auriemma F, 2015, ANGEW CHEM INT EDIT, V54, P1215, DOI 10.1002/anie.201410211; Bolton JM, 2014, ACS MACRO LETT, V3, P717, DOI 10.1021/mz500339h; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Braun B, 2012, BIOMACROMOLECULES, V13, P2013, DOI 10.1021/bm300149w; Burgess SK, 2014, MACROMOLECULES, V47, P1383, DOI 10.1021/ma5000199; Chapman AM, 2015, ACS CATAL, V5, P1581, DOI 10.1021/cs501798s; Chen GQ, 2012, CHEM REV, V112, P2082, DOI 10.1021/cr200162d; Ciriminna R, 2014, CHEM COMMUN, V50, P15288, DOI 10.1039/c4cc06147k; Coates GW, 2004, ANGEW CHEM INT EDIT, V43, P6618, DOI 10.1002/anie.200460442; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Crank M, 2005, 22103 EUR EN; Darensbourg DJ, 2007, CHEM REV, V107, P2388, DOI 10.1021/cr068363q; Darensbourg DJ, 2013, ANGEW CHEM INT EDIT, V52, P10602, DOI 10.1002/anie.201304778; de Jong E, 2012, ACS S SERIES, V1105, P1; De Maria G, 2013, AGRO FOOD IND HI TEC, V24, P10; Delidovich I, 2016, CHEM REV, V116, P1540, DOI 10.1021/acs.chemrev.5b00354; Dusselier M, 2015, SCIENCE, V349, P78, DOI 10.1126/science.aaa7169; Dusselier M, 2013, ENERG ENVIRON SCI, V6, P1415, DOI 10.1039/c3ee00069a; Eerhart AJJE, 2012, ENERG ENVIRON SCI, V5, P6407, DOI 10.1039/c2ee02480b; Ellis WC, 2014, CHEM SCI, V5, P4004, DOI 10.1039/c4sc01686f; Fukushima K, 2011, J POLYM SCI POL CHEM, V49, P1273, DOI 10.1002/pola.24551; Galbis JA, 2016, CHEM REV, V116, P1600, DOI 10.1021/acs.chemrev.5b00242; Gandini A, 2015, PROG POLYM SCI, V48, P1, DOI 10.1016/j.progpolymsci.2014.11.002; Gandini A, 2011, GREEN CHEM, V13, P1061, DOI 10.1039/c0gc00789g; Goffin AL, 2011, BIOMACROMOLECULES, V12, P2456, DOI 10.1021/bm200581h; Goldbach V, 2015, ACS CATAL, V5, P5951, DOI 10.1021/acscatal.5b01508; Groot WJ, 2010, INT J LIFE CYCLE ASS, V15, P970, DOI 10.1007/s11367-010-0225-y; Gross RA, 2010, TRENDS BIOTECHNOL, V28, P435, DOI 10.1016/j.tibtech.2010.05.004; Haba O, 2005, MACROMOLECULES, V38, P3562, DOI 10.1021/ma0476745; Hauenstein O, 2016, GREEN CHEM, V18, P760, DOI 10.1039/c5gc01694k; Hearon K, 2014, ADV MATER, V26, P1552, DOI 10.1002/adma.201304370; Hong M, 2016, NAT CHEM, V8, P42, DOI [10.1038/NCHEM.2391, 10.1038/nchem.2391]; IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034; Inkinen S, 2011, BIOMACROMOLECULES, V12, P523, DOI 10.1021/bm101302t; INOUE S, 1969, J POLYM SCI POL LETT, V7, P287, DOI 10.1002/pol.1969.110070408; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jeon JY, 2014, BEILSTEIN J ORG CHEM, V10, P1787, DOI 10.3762/bjoc.10.187; Jeske RC, 2008, ANGEW CHEM INT EDIT, V47, P6041, DOI 10.1002/anie.200801415; Jeske RC, 2007, J AM CHEM SOC, V129, P11330, DOI 10.1021/ja0737568; Jung YH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8170; Juntaro J, 2008, ADV MATER, V20, P3122, DOI 10.1002/adma.200703176; Klaus S, 2011, COORDIN CHEM REV, V255, P1460, DOI 10.1016/j.ccr.2010.12.002; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Lee SH, 2012, POLYM CHEM-UK, V3, P1215, DOI 10.1039/c2py00010e; Li CL, 2015, EUR POLYM J, V67, P449, DOI 10.1016/j.eurpolymj.2015.01.003; Lindblad MS, 2005, BIOMACROMOLECULES, V6, P684, DOI 10.1021/bm049515z; Liu C, 2011, BIOMACROMOLECULES, V12, P3291, DOI 10.1021/bm2007554; Longo JM, 2014, J AM CHEM SOC, V136, P15897, DOI 10.1021/ja509440g; Lu XB, 2012, ACCOUNTS CHEM RES, V45, P1721, DOI 10.1021/ar300035z; Luinstra GA, 2008, POLYM REV, V48, P192, DOI 10.1080/15583720701834240; Maiorana A, 2016, GREEN CHEM, V18, P4961, DOI 10.1039/c6gc01308b; Maisonneuve L, 2013, POLYM CHEM-UK, V4, P5472, DOI 10.1039/c3py00791j; Markewitz P, 2012, ENERG ENVIRON SCI, V5, P7281, DOI 10.1039/c2ee03403d; Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c; Mialon L, 2010, GREEN CHEM, V12, P1704, DOI 10.1039/c0gc00150c; Mikami K, 2013, J AM CHEM SOC, V135, P6826, DOI 10.1021/ja402319m; Montarnal D, 2011, SCIENCE, V334, P965, DOI 10.1126/science.1212648; MULLER HM, 1993, ANGEW CHEM INT EDIT, V32, P477, DOI 10.1002/anie.199304771; Myers D, 2016, NAT CHEM, V8, P3, DOI 10.1038/nchem.2424; Nozaki K, 1999, J AM CHEM SOC, V121, P11008, DOI 10.1021/ja992433b; Pang JF, 2016, GREEN CHEM, V18, P342, DOI [10.1039/c5gc01771h, 10.1039/C5GC01771H]; Paul S, 2015, CHEM COMMUN, V51, P6459, DOI 10.1039/c4cc10113h; Peng YF, 2013, MACROMOLECULES, V46, P3293, DOI 10.1021/ma400291c; Pepels MPF, 2015, MACROMOLECULES, V48, P4779, DOI 10.1021/acs.macromol.5b00820; Philp JC, 2013, NEW BIOTECHNOL, V30, P635, DOI 10.1016/j.nbt.2012.11.021; Rahimi A, 2014, NATURE, V515, P249, DOI 10.1038/nature13867; Ren WM, 2009, J AM CHEM SOC, V131, P11509, DOI 10.1021/ja9033999; Roesle P, 2014, ANGEW CHEM INT EDIT, V53, P6800, DOI 10.1002/anie.201403991; Santacesaria E, 2014, IND ENG CHEM RES, V53, P8939, DOI 10.1021/ie403268b; Satoh K, 2014, POLYM CHEM-UK, V5, P3222, DOI 10.1039/c3py01320k; Sharma S, 2003, J MACROMOL SCI PURE, VA40, P593, DOI 10.1081/MA-120020867; Sharninghausen LS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6084; Shen L, 2012, BIOFUEL BIOPROD BIOR, V6, P625, DOI 10.1002/bbb.1368; Shen L, 2010, BIOFUEL BIOPROD BIOR, V4, P25, DOI 10.1002/bbb.189; Shin J, 2012, BIOMACROMOLECULES, V13, P3833, DOI 10.1021/bm3012852; Stempfle F, 2016, CHEM REV, V116, P4597, DOI 10.1021/acs.chemrev.5b00705; Stempfle F, 2014, GREEN CHEM, V16, P2008, DOI 10.1039/c4gc00114a; Talon O, 2014, WILEY-ISTE, P91; Upton BM, 2016, CHEM REV, V116, P2275, DOI 10.1021/acs.chemrev.5b00345; van der Ploeg F, 2011, J ECON LIT, V49, P366, DOI 10.1257/jel.49.2.366; von der Assen N, 2014, CHEM SOC REV, V43, P7982, DOI 10.1039/c3cs60373c; von der Assen N, 2014, GREEN CHEM, V16, P3272, DOI 10.1039/c4gc00513a; Wang XY, 2013, ANGEW CHEM INT EDIT, V52, P11499, DOI 10.1002/anie.201304776; Welle F, 2011, RESOUR CONSERV RECY, V55, P865, DOI 10.1016/j.resconrec.2011.04.009; Wilbon PA, 2013, MACROMOL RAPID COMM, V34, P8, DOI 10.1002/marc.201200513; Winkler M, 2015, GREEN CHEM, V17, P300, DOI 10.1039/c4gc01353k; Winnacker M, 2015, CHEMSUSCHEM, V8, P2455, DOI 10.1002/cssc.201500421; Witt T, 2015, ACS CATAL, V5, P4519, DOI 10.1021/acscatal.5b00825; Witt T, 2013, GREEN CHEM, V15, P2361, DOI 10.1039/c3gc40905h; Xiong MY, 2014, P NATL ACAD SCI USA, V111, P8357, DOI 10.1073/pnas.1404596111; Zhang MH, 2013, IND ENG CHEM RES, V52, P9505, DOI 10.1021/ie401157c; Zhu YQ, 2015, J AM CHEM SOC, V137, P12179, DOI 10.1021/jacs.5b04541	97	1314	1332	143	1701	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					354	362		10.1038/nature21001	http://dx.doi.org/10.1038/nature21001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974763	Green Submitted			2022-12-28	WOS:000389716800029
J	Zaninotto, P; Wardle, J; Steptoe, A				Zaninotto, Paola; Wardle, Jane; Steptoe, Andrew			Sustained enjoyment of life and mortality at older ages: analysis of the English Longitudinal Study of Ageing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; POSITIVE AFFECT; HEALTH; HAPPINESS; SURVIVAL; SATISFACTION; ASSOCIATION; LONGEVITY; DECLINE; RISK	OBJECTIVE To test whether the number of reports of enjoyment of life over a four year period is quantitatively associated with all cause mortality, and with death from cardiovascular disease and from other causes. DESIGN AND SETTING Longitudinal observational population study using the English Longitudinal Study of Ageing (ELSA), a nationally representative sample of older men and women living in England. PARTICIPANTS 9365 men and women aged 50 years or older (mean 63, standard deviation 9.3) at recruitment. MAIN OUTCOME MEASURES Time to death, based on mortality between the third phase of data collection (wave 3 in 2006) and March 2013 (up to seven years). RESULTS Subjective wellbeing with measures of enjoyment of life were assessed in 2002 (wave 1), 2004 (wave 2), and 2006 (wave 3). 2264 (24%) respondents reported no enjoyment of life on any assessment, with 1833 (20%) reporting high enjoyment on one report of high enjoyment of life, 2063 (22%) on two reports, and 3205 (34%) on all three occasions. 1310 deaths were recorded during follow-up. Mortality was inversely associated with the number of occasions on which participants reported high enjoyment of life. Compared with the no high enjoyment group, the hazard ratio for all cause mortality was 0.83 (95% confidence interval 0.70 to 0.99) for two reports of enjoyment of life, and 0.76 (0.64 to 0.89) for three reports, after adjustment for demographic factors, baseline health, mobility impairment, and depressive symptoms. The same association was observed after deaths occurring within two years of the third enjoyment measure were excluded (0.90 (0.85 to 0.95) for every additional report of enjoyment), and in the complete case analysis (0.90 (0.83 to 0.96)). CONCLUSIONS This is an observational study, so causal conclusions cannot be drawn. Nonetheless, the results add a new dimension to understanding the significance of subjective wellbeing for health outcomes by documenting the importance of sustained wellbeing over time.	[Zaninotto, Paola; Wardle, Jane; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Steptoe, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.	a.steptoe@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019		National Institute of Aging in the USA; consortium of UK government departments; British Heart Foundation chair; Cancer Research UK; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	National Institute of Aging in the USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of UK government departments; British Heart Foundation chair(British Heart Foundation); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The English Longitudinal Study of Ageing was developed by a team of researchers based at the University College London, NatCen Social Research, the Institute for Fiscal Studies, and the University of Manchester. The data were collected by NatCen Social Research. The funding is provided by the National Institute of Aging in the USA, and a consortium of UK government departments coordinated by the Economic and Social Research Council. The developers and funders of the English Longitudinal Study of Ageing and the UK Data Archive do not bear any responsibility for the analyses or interpretations presented here. AS was funded by the British Heart Foundation chair and JW by Cancer Research UK.	Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Black SV, 2015, AM J PREV MED, V49, P172, DOI 10.1016/j.amepre.2015.03.009; Boehm JK, 2016, J PSYCHOSOM RES, V85, P1, DOI 10.1016/j.jpsychores.2016.03.018; Boehm JK, 2015, PSYCHOL SCI, V26, P1063, DOI 10.1177/0956797615581491; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Boehm JK, 2011, EUR HEART J, V32, P2672, DOI 10.1093/eurheartj/ehr203; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; Friedman EM, 2007, HEALTH PSYCHOL, V26, P305, DOI 10.1037/0278-6133.26.3.305; Gana K, 2016, J PSYCHOSOM RES, V85, P28, DOI 10.1016/j.jpsychores.2016.04.004; Gerstorf D, 2008, DEV PSYCHOL, V44, P1148, DOI 10.1037/0012-1649.44.4.1148; Gerstorf D, 2008, PSYCHOL AGING, V23, P154, DOI 10.1037/0882-7974.23.1.154; Kim ES, 2014, P NATL ACAD SCI USA, V111, P16331, DOI 10.1073/pnas.1414826111; Koopmans TA, 2010, J HAPPINESS STUD, V11, P113, DOI 10.1007/s10902-008-9127-0; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Krijthe BP, 2011, AM J EPIDEMIOL, V173, P1298, DOI 10.1093/aje/kwr012; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P1393, DOI 10.1001/archpsyc.64.12.1393; Lawrence EM, 2015, SOC SCI MED, V145, P115, DOI 10.1016/j.socscimed.2015.09.020; Liu B, 2016, LANCET, V387, P874, DOI 10.1016/S0140-6736(15)01087-9; Mujcic R, 2016, AM J PUBLIC HEALTH, V106, P1504, DOI 10.2105/AJPH.2016.303260; Shirai K, 2009, CIRCULATION, V120, P956, DOI 10.1161/CIRCULATIONAHA.108.834176; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Steptoe A, 2008, J PSYCHOSOM RES, V64, P409, DOI 10.1016/j.jpsychores.2007.11.008; Steptoe A, 2014, CAN MED ASSOC J, V186, pE150, DOI 10.1503/cmaj.131155; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Steptoe A, 2012, ARCH INTERN MED, V172, P273, DOI 10.1001/archinternmed.2011.1028; Steptoe A, 2011, P NATL ACAD SCI USA, V108, P18244, DOI 10.1073/pnas.1110892108; Stone A. A., 2013, SUBJECTIVE WELL BEIN; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Tilvis RS, 2012, ARCH GERONTOL GERIAT, V55, P133, DOI 10.1016/j.archger.2011.06.030; Trudel-Fitzgerald C, 2014, J HYPERTENS, V32, P1222, DOI 10.1097/HJH.0000000000000175	36	26	26	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6267	10.1136/bmj.i6267	http://dx.doi.org/10.1136/bmj.i6267			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF2JN	27965194	Green Published, hybrid			2022-12-28	WOS:000390150800003
J	Hagen, S; Glazener, C; McClurg, D; Macarthur, C; Elders, A; Herbison, P; Wilson, D; Toozs-Hobson, P; Hemming, C; Hay-Smith, J; Collins, M; Dickson, S; Logan, J				Hagen, Suzanne; Glazener, Cathryn; McClurg, Doreen; Macarthur, Christine; Elders, Andrew; Herbison, Peter; Wilson, Don; Toozs-Hobson, Philip; Hemming, Christine; Hay-Smith, Jean; Collins, Marissa; Dickson, Sylvia; Logan, Janet			Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial	LANCET			English	Article							SHORT-FORM; WOMEN; SYMPTOMS; URINARY; HEALTH; QUESTIONNAIRE; INCONTINENCE; TERMINOLOGY; ICIQ	Background Pelvic floor muscle training can reduce prolapse severity and symptoms in women seeking treatment. We aimed to assess whether this intervention could also be effective in secondary prevention of prolapse and the need for future treatment. Methods We did this multicentre, parallel-group, randomised controlled trial at three centres in New Zealand and the UK. Women from a longitudinal study of pelvic floor function after childbirth were potentially eligible for inclusion. Women of any age who had stage 1-3 prolapse, but had not sought treatment, were randomly assigned (1: 1), via remote computer allocation, to receive either one-to-one pelvic floor muscle training (five physiotherapy appointments over 16 weeks, and annual review) plus Pilates-based pelvic floor muscle training classes and a DVD for home use (intervention group), or a prolapse lifestyle advice leaflet (control group). Randomisation was minimised by centre, parity (three or less vs more than three deliveries), prolapse stage (above the hymen vs at or beyond the hymen), and delivery method (any vaginal vs all caesarean sections). Women and intervention physiotherapists could not be masked to group allocation, but allocation was masked from data entry researchers and from the trial statistician until after database lock. The primary outcome was self-reported prolapse symptoms (Pelvic Organ Prolapse Symptom Score [POP-SS]) at 2 years. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01171846. Findings Between Dec 21, 2008, and Feb 24, 2010, in New Zealand, and Oct 27, 2010, and Sept 5, 2011, in the UK, we randomly assigned 414 women to the intervention group (n=207) or the control group (n=207). One participant in each group was excluded after randomisation, leaving 412 women for analysis. At baseline, 399 (97%) women had prolapse above or at the level of the hymen. The mean POP-SS score at 2 years was 3.2 (SD 3.4) in the intervention group versus 4.2 (SD 4.4) in the control group (adjusted mean difference -1.01, 95% CI -1.70 to -0.33; p=0.004). The mean symptom score stayed similar across time points in the control group, but decreased in the intervention group. Three adverse events were reported, all of which were in the intervention group (one women had a fall, one woman had a pain in her tail bone, and one woman had chest pain and shortness of breath). Interpretation Our study shows that pelvic floor muscle training leads to a small, but probably important, reduction in prolapse symptoms. This finding will be important for women and caregivers considering preventive strategies.	[Hagen, Suzanne; McClurg, Doreen; Elders, Andrew; Logan, Janet] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland; [Collins, Marissa] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow, Lanark, Scotland; [Dickson, Sylvia] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Glazener, Cathryn] Univ Aberdeen, Hlth Serv Res Unit, Hlth Sci Bldg, Aberdeen, Scotland; [Hemming, Christine] Univ Aberdeen, Aberdeen Royal Infirm, Foresterhill, Aberdeen, Scotland; [Macarthur, Christine] Univ Birmingham, Dept Epidemiol & Biostat, Birmingham, W Midlands, England; [Herbison, Peter] Dunedin Sch Med, Prevent & Social Med, Dunedin, New Zealand; [Wilson, Don] Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin, New Zealand; [Toozs-Hobson, Philip] Birmingham Womens Hosp, Dept Urogynaecol, Birmingham, W Midlands, England; [Hay-Smith, Jean] Univ Otago, Dept Med, Rehabil Teaching & Res Unit, Wellington, New Zealand	Glasgow Caledonian University; Glasgow Caledonian University; Glasgow Caledonian University; University of Aberdeen; University of Aberdeen; University of Birmingham; University of Otago; University of Otago; Birmingham Women's Hospital; University of Otago	Hagen, S (corresponding author), Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland.	s.hagen@gcu.ac.uk	MacArthur, Christine/ABA-8601-2021; Elders, Andrew/N-4195-2015	MacArthur, Christine/0000-0003-0434-2158; Herbison, Graham Peter/0000-0002-5684-024X; Elders, Andrew/0000-0003-4172-4702; McClurg, Doreen/0000-0002-2872-1702; Collins, Marissa/0000-0002-0896-6673; Toozs-Hobson, Philip/0000-0002-1859-9934; HAGEN, SUZANNE/0000-0002-9741-9160	Wellbeing of Women charity; New Zealand Continence Association; Dean's Bequest Fund of Dunedin School of Medicine; Wellbeing of Women [RG1271] Funding Source: researchfish; Chief Scientist Office [NMAHP2] Funding Source: researchfish	Wellbeing of Women charity(Wellbeing of Women (WoW)); New Zealand Continence Association; Dean's Bequest Fund of Dunedin School of Medicine; Wellbeing of Women(Wellbeing of Women (WoW)); Chief Scientist Office	Wellbeing of Women charity, the New Zealand Continence Association, and the Dean's Bequest Fund of Dunedin School of Medicine.	Alves FK, 2015, MATURITAS, V81, P300, DOI 10.1016/j.maturitas.2015.03.006; [Anonymous], 2013, HOSP EP STAT ADM PAT; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Bo K, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.06.049; Borello-France DF, 2007, PHYS THER, V87, P399, DOI 10.2522/ptj.20060160; Braekken IH, 2010, OBSTET GYNECOL, V115, P317, DOI 10.1097/AOG.0b013e3181cbd35f; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Culligan PJ, 2010, INT UROGYNECOL J, V21, P401, DOI 10.1007/s00192-009-1046-z; Department of Health, 2012, REF COSTS GUID 2011; Due U, 2016, INT UROGYNECOL J, V27, P555, DOI 10.1007/s00192-015-2852-0; Giraudo D, 2011, NEUROUROL URODYNAM, V30, P1009; Hagen S, 2010, NEUROUROL URODYNAM, V29, P1055; Hagen S, 2009, BJOG-INT J OBSTET GY, V116, P25, DOI 10.1111/j.1471-0528.2008.01903.x; Hagen S, 2014, LANCET, V383, P796, DOI 10.1016/S0140-6736(13)61977-7; Hagen S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003882.pub4; Hagen S, 2009, INT UROGYNECOL J, V20, P45, DOI 10.1007/s00192-008-0726-4; Haylen BT, 2016, NEUROUROL URODYNAM, V35, P137, DOI 10.1002/nau.22922; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hensrud DD, 2000, MAYO CLIN PROC, V75, P165; Kashyap R, 2013, INT J GYNECOL OBSTET, V121, P69, DOI 10.1016/j.ijgo.2012.11.012; MacArthur C, 2011, BJOG-INT J OBSTET GY, V118, P1001, DOI 10.1111/j.1471-0528.2011.02964.x; Resende APM, 2012, NEUROUROL URODYNAM, V31, P121, DOI 10.1002/nau.21149; Miedel A, 2011, INT UROGYNECOL J, V22, P461, DOI 10.1007/s00192-010-1305-z; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; Moore K., 2013, INCONTINENCE, P1101, DOI DOI 10.1183/13993003.00541-2019; National Institute for Health and Care Excellence, 2012, GUID MAN; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Panman CMCR, 2017, BJOG-INT J OBSTET GY, V124, P511, DOI 10.1111/1471-0528.13992; Price N, 2006, BJOG-INT J OBSTET GY, V113, P700, DOI 10.1111/j.1471-0528.2006.00938.x; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; SCA Hygiene, COREWELLNESS PROGR; University of Sheffield, HLTH EC DEC SCI; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	35	39	44	2	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					393	402		10.1016/S0140-6736(16)32109-2	http://dx.doi.org/10.1016/S0140-6736(16)32109-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9CK	28010994	Green Submitted, Green Accepted			2022-12-28	WOS:000392804700036
J	Risca, VI; Denny, SK; Straight, AF; Greenleaf, WJ				Risca, Viviana I.; Denny, Sarah K.; Straight, Aaron F.; Greenleaf, William J. .			Variable chromatin structure revealed by in situ spatially correlated DNA cleavage mapping	NATURE			English	Article							NUCLEOSOME; FIBER; RESOLUTION; ARCHITECTURE; CHROMOSOMES; CELLS; MODEL; ORGANIZATION; SEQUENCE; COMPACT	Chromatin structure at the length scale encompassing local nucleosome-nucleosome interactions is thought to play a crucial role in regulating transcription and access to DNA(1-3). However, this secondary structure of chromatin remains poorly understood compared with the primary structure of single nucleosomes or the tertiary structure of long-range looping interactions(4). Here we report the first genome-wide map of chromatin conformation in human cells at the 1-3 nucleosome (50-500 bp) scale, obtained using ionizing radiation-induced spatially correlated cleavage of DNA with sequencing (RICC-seq) to identify DNA-DNA contacts that are spatially proximal. Unbiased analysis of RICC-seq signal reveals regional enrichment of DNA fragments characteristic of alternating rather than adjacent nucleosome interactions in tri-nucleosome units, particularly in H3K9me3-marked heterochromatin. We infer differences in the likelihood of nucleosome-nucleosome contacts among open chromatin, H3K27me3-marked, and H3K9me3-marked repressed chromatin regions. After calibrating RICC-seq signal to three-dimensional distances, we show that compact two-start helical fibre structures with stacked alternating nucleosomes are consistent with RICC-seq fragmentation patterns from H3K9me3-marked chromatin, while non-compact structures and solenoid structures are consistent with open chromatin. Our data support a model of chromatin architecture in intact interphase nuclei consistent with variable longitudinal compaction of two-start helical fibres.	[Risca, Viviana I.; Greenleaf, William J. .] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Denny, Sarah K.; Greenleaf, William J. .] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Straight, Aaron F.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Straight, Aaron F.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Greenleaf, William J. .] Stanford Univ, Dept Appl Phys, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Greenleaf, WJ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Phys, Sch Med, Stanford, CA 94305 USA.	wjg@stanford.edu		Straight, Aaron/0000-0001-5885-7881; Denny, Sarah/0000-0001-8753-6040	Walter V. and Idun Berry Postdoctoral Fellowship; National Institutes of Health (NIH) Predoctoral Molecular Biophysics Training Program; National Science Foundation Graduate Fellowship; National Institutes of Health (NIH) [R01GM106005]; NIH [R21HG007726, P50HG00773501]; Rita Allen Foundation; Baxter Foundation; Human Frontier Science Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, R21HG007726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106005] Funding Source: NIH RePORTER	Walter V. and Idun Berry Postdoctoral Fellowship; National Institutes of Health (NIH) Predoctoral Molecular Biophysics Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Baxter Foundation; Human Frontier Science Program(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge R. Das for conversations and help with capillary sequencing, E. Koslover, A. Spakowitz, and A. Schep for sharing code and sample data, discussions, and reading the manuscript, A. Kathiria for technical assistance, J. Buenrostro and C. Araya for advice and sharing code, I. Whitehouse for sharing a protocol, C. Fuller for nucleosome reconstitution help, P. Zhu and G. Li for sharing their chromatin fibre model, T. Phillips, G. J. Gu, O. Rando and W. Johnson for discussions, and G. Wang for BJ cells. BJ-5ta cells were a gift from J. Cochran. V.I.R. acknowledges the support of the Walter V. and Idun Berry Postdoctoral Fellowship. S.K.D. acknowledges support from a National Institutes of Health (NIH) Predoctoral Molecular Biophysics Training Program grant to Stanford University and from a National Science Foundation Graduate Fellowship. A.F.S. acknowledges support from National Institutes of Health (NIH) grant R01GM106005. W.J.G. acknowledges NIH grants R21HG007726, and P50HG00773501. This work was supported by the Rita Allen Foundation, the Baxter Foundation, and the Human Frontier Science Program.	Alpen E. L., 1998, RAD BIOPHYSICS, P104; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Grigoryev SA, 2016, P NATL ACAD SCI USA, V113, P1238, DOI 10.1073/pnas.1518280113; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Guse A, 2012, NAT PROTOC, V7, P1847, DOI 10.1038/nprot.2012.112; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Risca VI, 2015, TRENDS GENET, V31, P357, DOI 10.1016/j.tig.2015.03.010; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; ROOTS R, 1985, INT J RADIAT ONCOL, V11, P259, DOI 10.1016/0360-3016(85)90147-6; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; Schep AN, 2015, GENOME RES, V25, P1757, DOI 10.1101/gr.192294.115; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou BR, 2015, MOL CELL, V59, P628, DOI 10.1016/j.molcel.2015.06.025	48	97	99	1	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					237	+		10.1038/nature20781	http://dx.doi.org/10.1038/nature20781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	28024297	Green Accepted			2022-12-28	WOS:000396125500045
J	Lewis, CE; Johnson, KC; Rahman, M; Sink, KM; Ambrosius, WT				Lewis, Cora E.; Johnson, Karen C.; Rahman, Mahboob; Sink, Kaycee M.; Ambrosius, Walter T.			Let's Not SPRINT to Judgment About New Blood Pressure Goals	ANNALS OF INTERNAL MEDICINE			English	Letter									[Lewis, Cora E.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Rahman, Mahboob] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sink, Kaycee M.; Ambrosius, Walter T.] Wake Forest Sch Med, Winston Salem, NC USA	University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University; Wake Forest University	Lewis, CE (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.		Sink, Kaycee/AAY-5920-2020	Sink, Kaycee/0000-0001-9608-3856				Chazal RA, 2016, HYPERTENSION, V67, P1053, DOI 10.1161/HYP.0000000000000043; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Ortiz E, 2016, ANN INTERN MED, V164, P692, DOI 10.7326/M15-3123; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939	5	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					889	889		10.7326/L16-0441	http://dx.doi.org/10.7326/L16-0441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992902				2022-12-28	WOS:000391236900024
J	Ortiz, E; James, PA				Ortiz, Eduardo; James, Paul A.			Let's Not SPRINT to Judgment About New Blood Pressure Goals RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[James, Paul A.] Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	James, PA (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.		James, Paul/ABB-2761-2020					Carrasco-Labra A, 2015, USERS GUIDES MED LIT, P259; Olsen LA, 2010, ROUNDTABLE VALUE SCI; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					889	890		10.7326/L16-0442	http://dx.doi.org/10.7326/L16-0442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992903				2022-12-28	WOS:000391236900025
J	Voelker, R				Voelker, Rebecca			Shot in the Arm for Rare Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2474	2474		10.1001/jama.2016.17235	http://dx.doi.org/10.1001/jama.2016.17235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997640				2022-12-28	WOS:000390959300009
J	Smith, EM; Shirey, SB; Nestola, F; Bullock, ES; Wang, JH; Richardson, SH; Wang, WY				Smith, Evan M.; Shirey, Steven B.; Nestola, Fabrizio; Bullock, Emma S.; Wang, Jianhua; Richardson, Stephen H.; Wang, Wuyi			Large gem diamonds from metallic liquid in Earth's deep mantle	SCIENCE			English	Article							II DIAMONDS; IRON CARBIDE; INCLUSIONS; STABILITY; MELT	The redox state of Earth's convecting mantle, masked by the lithospheric plates and basaltic magmatism of plate tectonics, is a key unknown in the evolutionary history of our planet. Here we report that large, exceptional gem diamonds like the Cullinan, Constellation, and Koh-i-Noor carry direct evidence of crystallization from a redox-sensitive metallic liquid phase in the deep mantle. These sublithospheric diamonds contain inclusions of solidified iron-nickel-carbon-sulfur melt, accompanied by a thin fluid layer of methane +/- hydrogen, and sometimes majoritic garnet or former calcium silicate perovskite. The metal-dominated mineral assemblages and reduced volatiles in large gem diamonds indicate formation under metal-saturated conditions. We verify previous predictions that Earth has highly reducing deep mantle regions capable of precipitating a metallic iron phase that contains dissolved carbon and hydrogen.	[Smith, Evan M.; Wang, Wuyi] Gemol Inst Amer, New York, NY 10036 USA; [Shirey, Steven B.; Wang, Jianhua] Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA; [Nestola, Fabrizio] Univ Padua, Dept Geosci, I-35131 Padua, Italy; [Bullock, Emma S.] Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA; [Richardson, Stephen H.] Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa	Carnegie Institution for Science; University of Padua; Carnegie Institution for Science; University of Cape Town	Smith, EM (corresponding author), Gemol Inst Amer, New York, NY 10036 USA.	evan.smith@gia.edu	Nestola, Fabrizio/AAZ-6783-2021; Wang, Jianhua/D-6500-2011	Nestola, Fabrizio/0000-0002-4875-5125; Wang, Jianhua/0000-0002-7671-2413; Smith, Evan/0000-0002-5470-2142	Deep Carbon Observatory; National Science Foundation [EAR1049992]; European Research Council [307322]; Division Of Earth Sciences [1049992] Funding Source: National Science Foundation	Deep Carbon Observatory; National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Sincere thanks go to C. Locke, K. S. Moe, U. D'Haenens-Johansson, P. Johnson, and T. Moses for help with sample selection; A. Chan and J. Lai for help with sample preparation; J. Liao for photography; and K. Smit, L. Loudin, A. Balter, A. Shahar, and D.G. Pearson for valuable discussion and feedback. J. Butler is thanked for donating a sample to this study. Carbon standards were generously lent by C. Jackson and Z. Du. Anonymous reviewers are thanked for their constructive comments. The Deep Carbon Observatory is acknowledged for support to S.B.S. and F.N., the National Science Foundation for support to S.B.S. and J.W. (grant no. EAR1049992), and the European Research Council for support to F.N. (INDIMEDEA, grant no. 307322). Data files with a sample catalog, microprobe analyses, Raman spectra, and x-ray diffraction analyses are available in the supplementary materials.	BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; Bell P., 1976, CARNEGIE I WASHINGTO, V75, P515; Bowen DC, 2009, LITHOS, V112, P767, DOI 10.1016/j.lithos.2009.04.026; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Dobrzhinetskaya LF, 2009, P NATL ACAD SCI USA, V106, P19233, DOI 10.1073/pnas.0905514106; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Girard J, 2016, SCIENCE, V351, P144, DOI 10.1126/science.aad3113; Harte B., 2013, P 10 INT KIMBERLITE, V1, P235, DOI [10.1007/978-81-322-1170-9_15, DOI 10.1007/978-81-322-1170-9_15]; Hustoft JW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001048; Jacob DE, 2004, CONTRIB MINERAL PETR, V146, P566, DOI 10.1007/s00410-003-0518-2; Kaminsky FV, 2011, CAN MINERAL, V49, P555, DOI 10.3749/canmin.49.2.555; Liu JC, 2016, P NATL ACAD SCI USA, V113, P5547, DOI 10.1073/pnas.1519540113; Lord OT, 2009, EARTH PLANET SC LETT, V284, P157, DOI 10.1016/j.epsl.2009.04.017; Mikhail S, 2014, GEOCHEM GEOPHY GEOSY, V15, P855, DOI 10.1002/2013GC005138; MILLEDGE HJ, 1983, NATURE, V303, P791, DOI 10.1038/303791a0; Moore AE, 2014, S AFR J GEOL, V117, P219, DOI 10.2113/gssajg.117.2.219; Moore AE, 2009, S AFR J GEOL, V112, P23, DOI 10.2113/gssajg.112.1.23; Palyanov YN, 2013, P NATL ACAD SCI USA, V110, P20408, DOI 10.1073/pnas.1313340110; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; Rohrbach A, 2014, EARTH PLANET SC LETT, V388, P211, DOI 10.1016/j.epsl.2013.12.007; Rohrbach A, 2011, J PETROL, V52, P717, DOI 10.1093/petrology/egq101; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Smith C M, 1983, THESIS; Smith EM, 2016, DIAM RELAT MATER, V68, P10, DOI 10.1016/j.diamond.2016.05.010; Smith EM, 2014, CAN J EARTH SCI, V51, P510, DOI 10.1139/cjes-2013-0218; Thomson AR, 2016, NATURE, V529, P76, DOI 10.1038/nature16174; Tsuno K, 2015, EARTH PLANET SC LETT, V412, P132, DOI 10.1016/j.epsl.2014.12.018; Wijbrans CH, 2016, CONTRIB MINERAL PETR, V171, DOI 10.1007/s00410-016-1255-7; Zhang Z, 2016, GEOPHYS RES LETT, V43, P3693, DOI 10.1002/2016GL068560; Zhimulev EI, 2012, GEOCHEM INT+, V50, P205, DOI 10.1134/S0016702912030111	31	201	217	10	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1403	1405		10.1126/science.aal1303	http://dx.doi.org/10.1126/science.aal1303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980206				2022-12-28	WOS:000390261300038
J	Hirose, M; Schilf, P; Gupta, Y; Wright, MN; Johren, O; Wagner, AE; Sina, C; Ziegler, A; Ristow, M; Ibrahim, SM				Hirose, Misa; Schilf, Paul; Gupta, Yask; Wright, Marvin N.; Joehren, Olaf; Wagner, Anika E.; Sina, Christian; Ziegler, Andreas; Ristow, Michael; Ibrahim, Saleh M.			Lifespan effects of mitochondrial mutations	NATURE			English	Editorial Material									[Hirose, Misa; Schilf, Paul; Gupta, Yask; Ibrahim, Saleh M.] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany; [Wright, Marvin N.; Ziegler, Andreas] Univ Lubeck, Univ Med Ctr Schleswig Holstein, Inst Med Biometry & Stat, Campus Lubeck, Lubeck, Germany; [Joehren, Olaf] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany; [Joehren, Olaf] Univ Lubeck, CBBM, Lubeck, Germany; [Wagner, Anika E.; Sina, Christian] Univ Lubeck, Inst Nutr Med, Lubeck, Germany; [Ziegler, Andreas] Univ Lubeck, ZKS Lubeck, Lubeck, Germany; [Ziegler, Andreas] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa; [Ristow, Michael] Swiss Fed Inst Technol, Energy Metab Lab, Schwerzenbach, Switzerland	University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Lubeck; University of Lubeck; University of Lubeck; University of Lubeck; University of Kwazulu Natal; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ibrahim, SM (corresponding author), Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany.	saleh.ibrahim@uksh.de	Ibrahim, Saleh/AAO-9541-2020; Hirose, Misa/A-2858-2014; Ristow, Michael/O-9858-2014; Wagner, Anika/AAE-3579-2019	Ristow, Michael/0000-0003-2109-2453; Wagner, Anika/0000-0003-3047-7128; Joehren, Olaf/0000-0002-0532-5133; Ibrahim, Saleh/0000-0001-7827-2290				Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011	10	13	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					E13	+		10.1038/nature20778	http://dx.doi.org/10.1038/nature20778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH7SX	27974775				2022-12-28	WOS:000454392600001
J	Lindor, RA; Homme, J				Lindor, Rachel A.; Homme, James			Patellar Fracture with Sleeve Avulsion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lindor, Rachel A.; Homme, James] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Lindor, RA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	lindor.rachel@mayo.edu		Lindor, Rachel/0000-0003-3099-8388					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					E49	E49		10.1056/NEJMicm1514818	http://dx.doi.org/10.1056/NEJMicm1514818			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27974033				2022-12-28	WOS:000390036500010
J	Yuan, JY; Najafov, A; Py, BF				Yuan, Junying; Najafov, Ayaz; Py, Benedicte F.			Roles of Caspases in Necrotic Cell Death	CELL			English	Review							NF-KAPPA-B; NONCANONICAL INFLAMMASOME ACTIVATION; MIXED LINEAGE KINASE; NLRP3 INFLAMMASOME; GASDERMIN D; TNF RECEPTOR; RIP1 KINASE; A20; NECROPTOSIS; PYROPTOSIS	Caspases were originally identified as important mediators of inflammatory response and apoptosis. Recent discoveries, however, have unveiled their roles in mediating and suppressing two regulated forms of necrotic cell death, termed pyroptosis and necroptosis, respectively. These recent advances have significantly expanded our understanding of the roles of caspases in regulating development, adult homeostasis, and host defense response.	[Yuan, Junying; Najafov, Ayaz] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Yuan, Junying; Najafov, Ayaz] Harvard Med Sch, Ludwig Canc Ctr, 240 Longwood Ave, Boston, MA 02115 USA; [Py, Benedicte F.] Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, CNRS UMR5308, CIRI,Inserm U1111, F-69007 Lyon, France	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Yuan, JY (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Yuan, JY (corresponding author), Harvard Med Sch, Ludwig Canc Ctr, 240 Longwood Ave, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Najafov, Ayaz/AFL-2815-2022; Najafov, Ayaz/AAY-9135-2021	Najafov, Ayaz/0000-0002-1350-2056; Najafov, Ayaz/0000-0002-1350-2056; py, benedicte/0000-0001-6716-7807	NINDS-US [1R01NS082257]; NIA-US [1R01AG047231]; European Research Council [ERC-2013-CoG_616986]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047231] Funding Source: NIH RePORTER	NINDS-US; NIA-US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grants to J.Y. from the NINDS-US (1R01NS082257) and the NIA-US (1R01AG047231) and to B.P. from the European Research Council (ERC-2013-CoG_616986). We thank Palak Amin and Albert D. Yu for comments on the manuscript.	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Arslan SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026069; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hou YJ, 2008, DEV DYNAM, V237, P2926, DOI 10.1002/dvdy.21723; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Joosten LAB, 2010, APMIS, V118, P1000, DOI 10.1111/j.1600-0463.2010.02684.x; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Moulin M, 2012, EMBO J, V31, P1679, DOI 10.1038/emboj.2012.18; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Schlicher L, 2016, EMBO REP, V17, P1485, DOI 10.15252/embr.201642592; Schmid-Burgk JL, 2015, EUR J IMMUNOL, V45, P2911, DOI 10.1002/eji.201545523; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yang DH, 2015, IMMUNITY, V43, P923, DOI 10.1016/j.immuni.2015.10.009; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013; Zilberman-Rudenko J, 2016, P NATL ACAD SCI USA, V113, P1612, DOI 10.1073/pnas.1518163113	95	163	188	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1693	1704		10.1016/j.cell.2016.11.047	http://dx.doi.org/10.1016/j.cell.2016.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984721	Green Accepted, Bronze			2022-12-28	WOS:000393114700010
J	Banatvala, J				Banatvala, Jangu			CHRISTMAS 2016: IN THE LITERATURE Thomas Dover: doctor, privateer, and rescuer of Robinson Crusoe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Banatvala, Jangu] Kings Coll London, Clin Virol, St Thomass Campus, London, England	University of London; King's College London	Banatvala, J (corresponding author), Kings Coll London, Clin Virol, St Thomass Campus, London, England.	jangu@btopenworld.com						Beattie T., 2015, BRIT PRIVATEERING VO, DOI [10.1017/CBO9781782044727, DOI 10.1017/CBO9781782044727]; Cotterell D., 2009, CAMPDEN DISTRICT HIS, VVI; Dewhurst K., 1957, QUICKSILVER DOCTOR L; Macintyre D., 1972, THE PRIVATEERS; MORTON RS, 1968, BRIT J VENER DIS, V44, P342; PHEAR D N, 1954, J Hist Med Allied Sci, V9, P139	6	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6516	10.1136/bmj.i6516	http://dx.doi.org/10.1136/bmj.i6516			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974348				2022-12-28	WOS:000390151300008
J	Williams, L				Williams, Lucy			Colette Denise Gina Le Doux OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6669	10.1136/bmj.i6669	http://dx.doi.org/10.1136/bmj.i6669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965245				2022-12-28	WOS:000390150800014
J	Mauer, J; Luo, XB; Blanjoie, A; Jiao, XF; Grozhik, AV; Patil, DP; Linder, B; Pickering, BF; Vasseur, JJ; Chen, QY; Gross, SS; Elemento, O; Debart, F; Kiledjian, M; Jaffrey, SR				Mauer, Jan; Luo, Xiaobing; Blanjoie, Alexandre; Jiao, Xinfu; Grozhik, Anya V.; Patil, Deepak P.; Linder, Bastian; Pickering, Brian F.; Vasseur, Jean-Jacques; Chen, Qiuying; Gross, Steven S.; Elemento, Olivier; Debart, Francoise; Kiledjian, Megerditch; Jaffrey, Samie R.			Reversible methylation of m(6)A(m) in the 5 ' cap controls mRNA stability	NATURE			English	Article							CELL; PROTEIN; ARGONAUTE; SEQ; N-6-METHYLADENOSINE; DEMETHYLASE; METHYLOME; DATABASE; ALKBH5; CLIP	Internal bases in mRNA can be subjected to modifications that influence the fate of mRNA in cells. One of the most prevalent modified bases is found at the 5' end of mRNA, at the first encoded nucleotide adjacent to the 7-methylguanosine cap. Here we show that this nucleotide, N-6,2'-O-dimethyladenosine (m(6)A(m)), is a reversible modification that influences cellular mRNA fate. Using a transcriptome-wide map of m(6)A(m) we find that m(6)A(m)-initiated transcripts are markedly more stable than mRNAs that begin with other nucleotides. We show that the enhanced stability of m(6)A(m)-initiated transcripts is due to resistance to the mRNA-decapping enzyme DCP2. Moreover, we find that m(6)A(m) is selectively demethylated by fat mass and obesity-associated protein (FTO). FTO preferentially demethylates m(6)A(m) rather than N-6-methyladenosine (m(6)A), and reduces the stability of m(6)A(m) mRNAs. Together, these findings show that the methylation status of m(6)A(m) in the 5' cap is a dynamic and reversible epitranscriptomic modification that determines mRNA stability.	[Mauer, Jan; Grozhik, Anya V.; Patil, Deepak P.; Linder, Bastian; Pickering, Brian F.; Chen, Qiuying; Gross, Steven S.; Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Luo, Xiaobing; Jiao, Xinfu; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Blanjoie, Alexandre; Vasseur, Jean-Jacques; Debart, Francoise] Univ Montpellier ENSCM, IBMM UMR 5247, CNRS, Dept Chem, F-34095 Montpellier 05, France; [Elemento, Olivier] Cornell Univ, Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Elemento, Olivier] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA	Cornell University; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu	Linder, Bastian/G-5111-2012; Linder, Bastian/W-4923-2019; Debart, Francoise/D-4320-2019	Linder, Bastian/0000-0003-1203-3136; Debart, Francoise/0000-0003-3422-3926; Mauer, Jan/0000-0002-0189-5876; Patil, Deepak/0000-0001-8825-0327; Vasseur, Jean-Jacques/0000-0002-4379-6139; Jaffrey, Samie/0000-0003-3615-6958; Kiledjian, Megerditch/0000-0001-8099-0451	NIH [R01DA037755, P01HD67244, R37HL87062, T32HD060600]; Clinical and Translational Science Center Fellowship [T32CA062948, R01GM067005]; French Centre National de la Recherche Scientifique; DFG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244, T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA062948, R01CA186702] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL087062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037755, R01DA037150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Center Fellowship; French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); DFG(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Holliger for assistance with TGK-polymerase, A. O. Olarerin-George for assistance with data analysis, K. Meyer for early contributions on FTO-target mapping, and members of the Jaffrey laboratory for helpful comments and suggestions. This work was supported by NIH grants R01DA037755 (S.R.J.), P01HD67244 and R37HL87062 (S.S.G.), T32HD060600 and a Clinical and Translational Science Center Fellowship (A.V.G.), T32CA062948 (B.F.P.), and R01GM067005 (M.K.), by the French Centre National de la Recherche Scientifique (F.D.) and by the DFG (J.M. and B.L.).	ADAMS JM, 1975, NATURE, V255, P28, DOI 10.1038/255028a0; Barral K, 2013, ANTIVIR RES, V99, P292, DOI 10.1016/j.antiviral.2013.06.001; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Debart F., 2010, CURRENT PROTOCOLS NU, V43; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fallmann J, 2016, NUCLEIC ACIDS RES, V44, pD90, DOI 10.1093/nar/gkv1238; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Heyer EE, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1235; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Imamachi N, 2014, METHODS, V67, P55, DOI 10.1016/j.ymeth.2013.07.014; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Iwasaki S, 2016, NATURE, V534, P558, DOI 10.1038/nature17978; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Kruse S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00126; Lavergne T, 2008, CHEM-EUR J, V14, P9135, DOI 10.1002/chem.200801392; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu L, 2015, MOL BIOSYST, V11, P262, DOI 10.1039/c4mb00604f; Liu SW, 2008, METHOD ENZYMOL, V448, P3, DOI 10.1016/S0076-6879(08)02601-3; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Paesen GC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9749; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; SOMMER S, 1978, J MOL BIOL, V124, P487, DOI 10.1016/0022-2836(78)90183-3; Thillier Y, 2012, RNA, V18, P856, DOI 10.1261/rna.030932.111; Vujovic P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063694; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Xu C, 2014, J BIOL CHEM, V289, P17299, DOI 10.1074/jbc.M114.550350; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zlatev I, 2010, ORG LETT, V12, P2190, DOI 10.1021/ol1004214	60	553	586	11	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2017	541	7637					371	+		10.1038/nature21022	http://dx.doi.org/10.1038/nature21022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QP	28002401	Green Accepted			2022-12-28	WOS:000396128800037
J	Glied, SA; Frank, RG				Glied, Sherry A.; Frank, Richard G.			Care for the Vulnerable vs. Cash for the Powerful - Trump's Pick for HHS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Glied, Sherry A.] NYU, Robert F Wagner Sch Publ Serv, New York, NY 10003 USA; [Frank, Richard G.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Glied, Sherry A.; Frank, Richard G.] US Dept HHS, Planning & Evaluat, Washington, DC 20201 USA	New York University; Harvard University; Harvard Medical School	Glied, SA (corresponding author), NYU, Robert F Wagner Sch Publ Serv, New York, NY 10003 USA.							Agency for Health Care Policy and Research, 1992, AHCPR REP AC PAIN MA; BOWEN OR, 1987, NEW ENGL J MED, V316, P1578, DOI 10.1056/NEJM198706183162505; Price T, 2012, US TODAY; Price T. H.R., 2300 EMPOWERING PATI; White JH, 1992, HLTH PROG, V73, P12	5	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					103	105		10.1056/NEJMp1615714	http://dx.doi.org/10.1056/NEJMp1615714			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	28001473				2022-12-28	WOS:000392198400002
J	Zheleva, B; Atwood, JB				Zheleva, Bistra; Atwood, J. Brian			The invisible child: childhood heart disease in global health	LANCET			English	Editorial Material							SURGERY		[Zheleva, Bistra] Childrens HeartLink, Minneapolis, MN 55436 USA; Brown Univ, Int Studies & Publ Affairs, Providence, RI 02912 USA	Brown University	Zheleva, B (corresponding author), Childrens HeartLink, Minneapolis, MN 55436 USA.	bistra@childrensheartlink.org	Zheleva, Bistra/AAN-6856-2020	Zheleva, Bistra/0000-0002-3209-0261				Children's HeartLink, 2016, TREAT INV CHILD CHIL; Children's HeartLink, 2016, 2015 ANN REP; Children's HeartLink, 2016, VOIC INV CHILD CHILD; Dearani Joseph A, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P35, DOI 10.1053/j.pcsu.2010.02.001; Debas HT, 2015, DIS CONTROL PRIORITI, V1; Gurvitz, 2015, AAP NEWS, V36, P8, DOI [10.1542/ aapnews.2015363-8, DOI 10.1542/AAPNEWS.2015363-8]; Institute for Health Metrics and Evaluation, 2016, GLOB BURD DIS 2015; Jenkins KJ, 2014, PEDIATRICS, V134, pE1422, DOI 10.1542/peds.2014-0356; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Meara JG, 2015, SURGERY, V158, P3, DOI [10.1016/j.surg.2015.04.011, 10.1016/S0140-6736(15)60160-X]; Tchervenkov CI, 2008, CARDIOL YOUNG, V18, P63, DOI 10.1017/S1047951108002801; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6	13	35	37	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2017	389	10064					16	18		10.1016/S0140-6736(16)32185-7	http://dx.doi.org/10.1016/S0140-6736(16)32185-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG7VH	27989557				2022-12-28	WOS:000391264000019
J	Wahl, S; Drong, A; Lehne, B; Loh, M; Scott, WR; Kunze, S; Tsai, PC; Ried, JS; Zhang, WH; Yang, YW; Tan, SL; Fiorito, G; Franke, L; Guarrera, S; Kasela, S; Kriebel, J; Richmond, RC; Adamo, M; Afzal, U; Ala-Korpela, M; Albetti, B; Ammerpohl, O; Apperley, JF; Beekman, M; Bertazzi, PA; Black, SL; Blancher, C; Bonder, MJ; Brosch, M; Carstensen-Kirberg, M; de Craen, AJM; de Lusignan, S; Dehghan, A; Elkalaawy, M; Fischer, K; Franco, OH; Gaunt, TR; Hampe, J; Hashemi, M; Isaacs, A; Jenkinson, A; Jha, S; Kato, N; Krogh, V; Laffan, M; Meisinger, C; Meitinger, T; Mok, ZY; Motta, V; Ng, HK; Nikolakopoulou, Z; Nteliopoulos, G; Panico, S; Pervjakova, N; Prokisch, H; Rathmann, W; Roden, M; Rota, F; Rozario, MA; Sandling, JK; Schafmayer, C; Schramm, K; Siebert, R; Slagboom, PE; Soininen, P; Stolk, L; Strauch, K; Tai, ES; Tarantini, L; Thorand, B; Tigchelaar, EF; Tumino, R; Uitterlinden, AG; van Duijn, C; van Meurs, JBJ; Vineis, P; Wickremasinghe, AR; Wijmenga, C; Yang, TP; Yuan, W; Zhernakova, A; Batterham, RL; Smith, GD; Deloukas, P; Heijmans, BT; Herder, C; Hofman, A; Lindgren, CM; Milani, L; van der Harst, P; Peters, A; Illig, T; Relton, CL; Waldenberger, M; Jarvelin, MR; Bollati, V; Soong, R; Spector, TD; Scott, J; McCarthy, MI; Elliott, P; Bell, JT; Matullo, G; Gieger, C; Kooner, JS; Grallert, H; Chambers, JC				Wahl, Simone; Drong, Alexander; Lehne, Benjamin; Loh, Marie; Scott, William R.; Kunze, Sonja; Tsai, Pei-Chien; Ried, Janina S.; Zhang, Weihua; Yang, Youwen; Tan, Sili; Fiorito, Giovanni; Franke, Lude; Guarrera, Simonetta; Kasela, Silva; Kriebel, Jennifer; Richmond, Rebecca C.; Adamo, Marco; Afzal, Uzma; Ala-Korpela, Mika; Albetti, Benedetta; Ammerpohl, Ole; Apperley, Jane F.; Beekman, Marian; Bertazzi, Pier Alberto; Black, S. Lucas; Blancher, Christine; Bonder, Marc-Jan; Brosch, Mario; Carstensen-Kirberg, Maren; de Craen, Anton J. M.; de Lusignan, Simon; Dehghan, Abbas; Elkalaawy, Mohamed; Fischer, Krista; Franco, Oscar H.; Gaunt, Tom R.; Hampe, Jochen; Hashemi, Majid; Isaacs, Aaron; Jenkinson, Andrew; Jha, Sujeet; Kato, Norihiro; Krogh, Vittorio; Laffan, Michael; Meisinger, Christa; Meitinger, Thomas; Mok, Zuan Yu; Motta, Valeria; Ng, Hong Kiat; Nikolakopoulou, Zacharoula; Nteliopoulos, Georgios; Panico, Salvatore; Pervjakova, Natalia; Prokisch, Holger; Rathmann, Wolfgang; Roden, Michael; Rota, Federica; Rozario, Michelle Ann; Sandling, Johanna K.; Schafmayer, Clemens; Schramm, Katharina; Siebert, Reiner; Slagboom, P. Eline; Soininen, Pasi; Stolk, Lisette; Strauch, Konstantin; Tai, E-Shyong; Tarantini, Letizia; Thorand, Barbara; Tigchelaar, Ettje F.; Tumino, Rosario; Uitterlinden, Andre G.; van Duijn, Cornelia; van Meurs, Joyce B. J.; Vineis, Paolo; Wickremasinghe, Ananda Rajitha; Wijmenga, Cisca; Yang, Tsun-Po; Yuan, Wei; Zhernakova, Alexandra; Batterham, Rachel L.; Smith, George Davey; Deloukas, Panos; Heijmans, Bastiaan T.; Herder, Christian; Hofman, Albert; Lindgren, Cecilia M.; Milani, Lili; van der Harst, Pim; Peters, Annette; Illig, Thomas; Relton, Caroline L.; Waldenberger, Melanie; Jaervelin, Marjo-Riitta; Bollati, Valentina; Soong, Richie; Spector, Tim D.; Scott, James; McCarthy, Mark I.; Elliott, Paul; Bell, Jordana T.; Matullo, Giuseppe; Gieger, Christian; Kooner, Jaspal S.; Grallert, Harald; Chambers, John C.			Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity	NATURE			English	Article							DNA METHYLATION; MENDELIAN RANDOMIZATION; OBESITY; DISEASE; GLUCOSE; HEALTH; TRENDS; TISSUE; BLOOD	Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at risk of developing type (2) diabetes, cardiovascular disease and related metabolic and inflammatory disturbances(1,2). Although the mechanisms linking adiposity to associated clinical conditions are poorly understood, recent studies suggest that adiposity may influence DNA methylation(3-6), a key regulator of gene expression and molecular phenotype(7). Here we use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is associated with widespread changes in DNA methylation (187 genetic loci with P < 1 x 10(-7), range P = 9.2 x 10(-8) to 6.0 x 10(-46); n = 10,261 samples). Genetic association analyses demonstrate that the alterations in DNA methylation are predominantly the consequence of adiposity, rather than the cause. We find that methylation loci are enriched for functional genomic features in multiple tissues (P < 0.05), and show that sentinel methylation markers identify gene expression signatures at 38 loci (P < 9.0 x 10(-6), range P = 5.5 x 10(-6) to 6.1 x 10(-35), n = 1,785 samples). The methylation loci identify genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. Finally, we show that the disturbances in DNA methylation predict future development of type 2 diabetes (relative risk per 1 standard deviation increase in methylation risk score: 2.3 (2.07-2.56); P = 1.1 x 10(-54)). Our results provide new insights into the biologic pathways influenced by adiposity, and may enable development of new strategies for prediction and prevention of type 2 diabetes and other adverse clinical consequences of obesity.	[Wahl, Simone; Kunze, Sonja; Kriebel, Jennifer; Illig, Thomas; Waldenberger, Melanie; Gieger, Christian; Grallert, Harald] Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wahl, Simone; Kunze, Sonja; Kriebel, Jennifer; Meisinger, Christa; Thorand, Barbara; Waldenberger, Melanie; Gieger, Christian; Grallert, Harald] Inst Epidemiol II, German Res Ctr Environm Hlth, Helmholtz Zentrum M nchen, Neuherberg, Germany; [Wahl, Simone; Kriebel, Jennifer; Roden, Michael; Thorand, Barbara; Herder, Christian; Peters, Annette; Grallert, Harald] German Ctr Diabet Res DZD, Neuherberg, Germany; [Drong, Alexander] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England; [Lehne, Benjamin; Loh, Marie; Scott, William R.; Zhang, Weihua; Yang, Youwen; Afzal, Uzma; Elliott, Paul; Kooner, Jaspal S.; Chambers, John C.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostatist, MRC PHE Ctr Environm & Hlth, London W2 1PG, England; [Loh, Marie] Inst Hlth Sci, POB 5000, FI-90014 Oulu, Finland; [Loh, Marie] Translat Lab Genet Med TLGM, Agcy Sci, Technol & Res ASTAR, 8A Biomed Grove, Singapore 138648, Singapore; [Scott, William R.; Zhang, Weihua; Afzal, Uzma; Scott, James; Kooner, Jaspal S.; Grallert, Harald; Chambers, John C.] Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England; [Tsai, Pei-Chien; Yuan, Wei; Spector, Tim D.; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Ried, Janina S.; Strauch, Konstantin] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zhang, Weihua; Afzal, Uzma; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Middlesex UB1 3HW, England; [Mok, Zuan Yu; Ng, Hong Kiat; Soong, Richie] Natl Univ Singapore, Cancer Sci Inst Singapore, Singapore, Singapore; [Fiorito, Giovanni; Guarrera, Simonetta; Matullo, Giuseppe] Human Genet Fdn Torino, Turin, Italy; [Fiorito, Giovanni; Guarrera, Simonetta; Matullo, Giuseppe] Univ Torino, Dept Med Sci, Turin, Italy; [Franke, Lude; Bonder, Marc-Jan; Tigchelaar, Ettje F.; Wijmenga, Cisca; Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Kasela, Silva; Fischer, Krista; Pervjakova, Natalia; Milani, Lili] Univ Tartu, Estonian Genome Ctr, Riia 23b, EE-51010 Tartu, Estonia; [Kasela, Silva; Pervjakova, Natalia] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, Riia 23, EE-51010 Tartu, Estonia; [Richmond, Rebecca C.; Gaunt, Tom R.; Smith, George Davey; Relton, Caroline L.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England; [Adamo, Marco; Elkalaawy, Mohamed; Hashemi, Majid; Jenkinson, Andrew; Batterham, Rachel L.] Univ Coll London Hosp, UCLH Bariatr Ctr Weight Loss, Weight Management & Metab & Endocrine Surg, Ground Floor West Wing,250 Euston Rd, London NW1 2PG, England; [Ala-Korpela, Mika; Soininen, Pasi] Univ Oulu & Biocenter Oulu, Computat Med, Fac Med, Oulu, Finland; [Ala-Korpela, Mika; Soininen, Pasi] Univ Eastern Finland, Sch Pharm, NMR Metabol Lab, Kuopio, Finland; [Ala-Korpela, Mika] Univ Bristol & Med Res Council Integrat Epidemiol, Univ Bristol, Sch Social & Community Med, Computat Med, Bristol, Avon, England; [Albetti, Benedetta; Bertazzi, Pier Alberto; Motta, Valeria; Rota, Federica; Tarantini, Letizia; Bollati, Valentina] Univ Studi Milano & Fondazione IRCCS CaGranda Osp, Dept Clin Sci & Community Hlth, EPIGET Lab, Milan, Italy; [Ammerpohl, Ole; Siebert, Reiner] Univ Hosp Schleswig Holstein, Inst Human Genet, Kiel Campus, Kiel, Germany; [Apperley, Jane F.; Laffan, Michael; Nteliopoulos, Georgios] Imperial Coll London, Dept Med, Centre Haematol, Fac Med, Hammersmith Campus, London W12 0NN, England; [Beekman, Marian; Slagboom, P. Eline] Leiden Univ Med Ctr, Mol Epidemiol, NL-2333 ZC Leiden, Netherlands; [Black, S. Lucas] Imperial Coll London, Dept Med, Sect Infect Dis & Immun, London W12 0NN, England; [Brosch, Mario; Hampe, Jochen] Univ Oxford, High Throughput Genom Oxford Genom Ctr, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Brosch, Mario] Tech Univ Dresden, Univ Hosp, Med Dept 1, Dresden, Germany; [Carstensen-Kirberg, Maren; Roden, Michael; Herder, Christian] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Clin Diabetol, Dusseldorf, Germany; [de Craen, Anton J. M.] Leiden Univ Med Ctr, Gerontol & Geriatr, NL-2300 RC Leiden, Netherlands; [de Lusignan, Simon] Univ Surrey, Dept Clin & Expt Med, Guildford GU2 7PX, Surrey, England; [Dehghan, Abbas; Franco, Oscar H.; Isaacs, Aaron; van Duijn, Cornelia; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Wahl, Simone; Elkalaawy, Mohamed] Univ Alexandria, Med Res Inst, Clin & Expt Surg Dept, Hadara, Alexandria 21561, Egypt; [Jha, Sujeet] Dept Endocrinol, Diabet & Obes, Max Healthcare, New Delhi 110017, India; [Kato, Norihiro] Res Inst, Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Tokyo 1628655, Japan; [Krogh, Vittorio] Epidemiol & Prevent Unit, Fondazione IRCSS Ist Nazl Tumori, Milan, Italy; [Meitinger, Thomas] German Res Ctr Environm Hlth, Int Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Meitinger, Thomas; Prokisch, Holger; Schramm, Katharina] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Meitinger, Thomas; Motta, Valeria; Peters, Annette] Partner site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Nikolakopoulou, Zacharoula] Natl Heart & Lung Inst, London SW3 6LY, England; [Panico, Salvatore] Dipartmento Med Clin Chirurgia Federio II Univ, Naples, Italy; [Rathmann, Wolfgang] Heinrich Heine Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Biometr & Epidemiol, Dusseldorf, Germany; [Roden, Michael] Heinrich Heine Univ Hosp Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Sandling, Johanna K.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Sandling, Johanna K.] Uppsala Univ, Mol Med & Sci Life Lab, Dept Med Sci, S-75144 Uppsala, Sweden; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Visceral & Thorac Surg, Kiel Campus, Kiel, Germany; [Siebert, Reiner] Univ Hosp Ulm, Inst Human Genet, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Stolk, Lisette; van Meurs, Joyce B. J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Inst Med Informat, Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Tai, E-Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Tai, E-Shyong] Duke Natl Univ, Singapore Grad Med Sch, Singapore 169857, Singapore; [Tumino, Rosario] Cancer Registry & Histopathol Unit, Civile MP Arezzo Hosp, ASP 7, Ragusa, Italy; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med & Epidemiol, Rotterdam, Netherlands; [Vineis, Paolo] Imperial Coll London, Epidemiol & Publ Hlth, London, England; [Wickremasinghe, Ananda Rajitha] Univ Kelaniya, Dept Publ Hlth, Fac Med, Box 6,Thalagolla Rd, Ragama 11010, Sri Lanka; [Yuan, Wei] Inst Canc Res, Surrey SM2 5NG, England; [Batterham, Rachel L.] UCL, Rayne Inst, Dept Med, Ctr Obes Res, London WC1E 6JJ, England; [Deloukas, Panos] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Jawhara Brahim Ctr Excellence Res Heredi, Jeddah 21589, Saudi Arabia; [Lindgren, Cecilia M.] Broad Inst, Massachusetts Inst Technol & Harvard Univ, Cambridge, MA 02142 USA; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim] ICIN Netherlands Heart Inst, Durrer Ctr Cardiogenet Res, NL-3511 GC Utrecht, Netherlands; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Feodor Lynen St 15, Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Inst Human Genet, Carl Neuberg St 1, Hannover, Germany; [Jaervelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, MRC Hlth Protect Agcy HPE Ctr Environm & Hlth, Dept Epidemiol & Biostatist, London, England; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, POB 5000, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Epidemiol, Fac Med, POB 5000, Oulu 90014, Finland; [Jaervelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Kajaanintie 50,Box 20, Oulu, Finland; [Soong, Richie] Natl Univ Singapore Hosp, Dept Pathol, Singapore, Singapore; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Oxford NIHR Biomed Res Ctr, Churchill Hosp, Oxford OX3 7LJ, England; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Agency for Science Technology & Research (A*STAR); Imperial College London; University of London; King's College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National University of Singapore; University of Turin; University of Groningen; University of Tartu; University of Tartu; University of Bristol; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Eastern Finland; University of Bristol; University of Kiel; Schleswig Holstein University Hospital; Imperial College London; Leiden University; Leiden University Medical Center (LUMC); Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Leiden University; Leiden University Medical Center (LUMC); University of Surrey; Erasmus University Rotterdam; Erasmus MC; Egyptian Knowledge Bank (EKB); Alexandria University; National Center for Global Health & Medicine - Japan; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Imperial College London; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Wellcome Trust Sanger Institute; Uppsala University; University of Kiel; Schleswig Holstein University Hospital; Ulm University; Erasmus University Rotterdam; Erasmus MC; University of Munich; National University of Singapore; National University of Singapore; Civile M.P. Arezzo Hospital; Erasmus University Rotterdam; Erasmus MC; Imperial College London; University Kelaniya; University of London; Institute of Cancer Research - UK; University of London; King's College London; University College London; University of London; Queen Mary University London; King Abdulaziz University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Groningen; Hannover Medical School; Hannover Medical School; Imperial College London; University of Oulu; University of Oulu; University of Oulu; National University of Singapore; University of Oxford; University of Oxford; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grallert, H (corresponding author), Inst Epidemiol II, German Res Ctr Environm Hlth, Helmholtz Zentrum M nchen, Neuherberg, Germany.; Kooner, JS; Chambers, JC (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostatist, MRC PHE Ctr Environm & Hlth, London W2 1PG, England.; Kooner, JS (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London W12 0NN, England.	j.kooner@ic.ac.uk; harald.grallert@helmholtz-muenchen.de; john.chambers@ic.ac.uk	Krogh, Vittorio/AAA-9171-2019; Sandling, Johanna K/B-2973-2016; Zhernakova, Alexandra/ABA-9372-2020; Beekman, Marian/L-3004-2019; Grallert, Harald/B-3424-2013; Wijmenga, Cisca/AAE-7719-2019; Gaunt, Tom R/O-3918-2014; Bell, Jordana/AAH-7312-2019; zhang, weihua/GXV-1334-2022; Guarrera, Simonetta/AAB-8482-2022; Meitinger, Thomas/O-1318-2015; Dehghan, Abbas/ABE-7377-2020; Krogh, Vittorio/K-2628-2016; Thorand, Barbara/B-5349-2014; Roden, Michael/AAD-3843-2019; Hampe, Jochen/A-2555-2010; Ammerpohl, Ole/G-2691-2010; Kriebel, Jennifer/N-4782-2017; Franco, Óscar H/ABE-2305-2020; Peters, Annette/A-6117-2011; Waldenberger, Melanie/B-5355-2014; Siebert, Reiner/A-8049-2010; Drong, Alexander/AAG-1115-2020; Meisinger, Christine/B-5358-2014; Milani, Lili/N-1097-2019; Sandling, Johanna/AAG-6376-2019; Jha, Dr.Sujeet/ABD-4884-2021; Davey Smith, George/A-7407-2013; Relton, Caroline/AAC-5904-2019; Dehghan, Abbas/B-9896-2008; MATULLO, Giuseppe/K-6383-2016; McCarthy, Mark/M-3763-2015; Franke, Lude/P-7036-2016; bisconti, alessandro/I-8016-2018	Krogh, Vittorio/0000-0003-0122-8624; Sandling, Johanna K/0000-0003-1382-2321; Beekman, Marian/0000-0003-0585-6206; Wijmenga, Cisca/0000-0002-5635-1614; Gaunt, Tom R/0000-0003-0924-3247; Krogh, Vittorio/0000-0003-0122-8624; Thorand, Barbara/0000-0002-8416-6440; Hampe, Jochen/0000-0002-2421-6127; Kriebel, Jennifer/0000-0003-4270-018X; Franco, Óscar H/0000-0002-4606-4929; Peters, Annette/0000-0001-6645-0985; Waldenberger, Melanie/0000-0003-0583-5093; Milani, Lili/0000-0002-5323-3102; Sandling, Johanna/0000-0003-1382-2321; Jha, Dr.Sujeet/0000-0002-1283-4606; Davey Smith, George/0000-0002-1407-8314; tumino, rosario/0000-0003-2666-414X; Fiorito, Giovanni/0000-0002-7651-5452; Richmond, Rebecca/0000-0003-0574-5071; van Meurs, Joyce/0000-0001-6245-2123; Brosch, Mario/0000-0001-8983-6557; Kasela, Silva/0000-0003-4362-0034; Dehghan, Abbas/0000-0001-6403-016X; TSAI, PEI-CHIEN/0000-0003-1575-9020; Loh, Marie/0000-0003-3626-8466; Scott, William/0000-0001-5467-114X; Tai, E Shyong/0000-0003-2929-8966; Lindgren, Cecilia/0000-0002-4903-9374; MATULLO, Giuseppe/0000-0003-0674-7757; Meitinger, Thomas/0000-0002-8838-8403; Black, Lucas/0000-0002-4463-6911; Prokisch, Holger/0000-0003-2379-6286; Relton, Caroline/0000-0003-2052-4840; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Laffan, Michael/0000-0002-8268-3268; Yang, Tsun-Po/0000-0002-9077-4434; Ala-Korpela, Mika/0000-0001-5905-1206; Rota, Federica/0000-0001-9418-4709; s, hema/0000-0002-3440-9475; McCarthy, Mark/0000-0002-4393-0510; Bonder, Marc Jan/0000-0002-8431-3180; Batterham, Rachel/0000-0002-5477-8585; Elliott, Paul/0000-0002-7511-5684; Franke, Lude/0000-0002-5159-8802; Van Duijn, Cornelia/0000-0002-2374-9204; bisconti, alessandro/0000-0002-8474-5733; Bell, Jordana/0000-0002-3858-5986; Kunze, Sonja/0000-0002-9685-2675	British Heart Foundation [RG/14/5/30893, PG/14/56/30976] Funding Source: Medline; Medical Research Council [MC_UU_12013/1, G0700931, MR/N015355/1, MC_UU_12013/2, G9815508, MC_UU_12013/8, G0601966, MC_PC_15018, MR/K002414/1, MC_G0802523] Funding Source: Medline; Wellcome Trust [084723] Funding Source: Medline; Department of Health [RP-PG-0407-10371, RP-2015-06-005] Funding Source: Medline; Action on Hearing Loss [G51] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/I025263/1] Funding Source: researchfish; Medical Research Council [MR/L01341X/1] Funding Source: researchfish; National Institute for Health Research [ACF-2009-18-005, NF-SI-0611-10099, NF-SI-0611-10275, RP-2015-06-005, NF-SI-0611-10136, NF-SI-0514-10027] Funding Source: researchfish; BBSRC [BB/I025263/1] Funding Source: UKRI; MRC [MC_UU_12013/1, G0601966, MR/K002414/1, MC_G0802523, MR/N015355/1, MC_UU_12013/2, MR/L01341X/1, G0700931, MC_UU_12013/8] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; Action on Hearing Loss; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Aron-Wisnewsky J, 2011, J CLIN ENDOCR METAB, V96, P1151, DOI 10.1210/jc.2010-2378; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park D, 2011, J AM CHEM SOC, V133, P2832, DOI 10.1021/ja110226y; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Slieker RC, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-26; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506	30	483	491	5	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					81	+		10.1038/nature20784	http://dx.doi.org/10.1038/nature20784			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	28002404	Green Submitted, Green Accepted			2022-12-28	WOS:000396119500033
J	Culbertson, S; Davis, AM				Culbertson, Sandra; Davis, Andrew M.			Nonsurgical Management of Urinary Incontinence in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Culbertson, Sandra] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA.	adavis@medicine.bsd.uchicago.edu						Bo K, 2005, OBSTET GYNECOL, V105, P999, DOI 10.1097/01.AOG.0000157207.95680.6d; Cameron AP, 2013, THER ADV UROL, V5, P189, DOI 10.1177/1756287213495100; Kammerer-Doak D, 2014, INT UROGYNECOL J, V25, P1303, DOI 10.1007/s00192-014-2485-8; Labrie J, 2013, NEW ENGL J MED, V369, P1124, DOI 10.1056/NEJMoa1210627; Lifford KL, 2008, J AM GERIATR SOC, V56, P1191, DOI 10.1111/j.1532-5415.2008.01747.x; Myers DL, 2014, JAMA-J AM MED ASSOC, V311, P2007, DOI 10.1001/jama.2014.4299; Qaseem A, 2014, ANN INTERN MED, V161, P429, DOI 10.7326/M13-2410; Richardson ML, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.07.006; Schultz Susan E, 2003, Health Rep, V14, P41; Shamliyan T, 2012, NONSURGICAL TREATMEN	10	5	7	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					79	80		10.1001/jama.2016.18433	http://dx.doi.org/10.1001/jama.2016.18433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030686				2022-12-28	WOS:000391009100023
J	Pennisi, E				Pennisi, Elizabeth			Like birds, insects may travel in sync with the seasons	SCIENCE			English	News Item																			0	0	0	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1515	1515		10.1126/science.354.6319.1515	http://dx.doi.org/10.1126/science.354.6319.1515			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008019				2022-12-28	WOS:000390254300012
J	Watson, AJ				Watson, Andrew J.			Oceans on the edge of anoxia	SCIENCE			English	Editorial Material							PHOSPHORUS; EVENTS; LINK		[Watson, Andrew J.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Watson, AJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	andrew.watson@exeter.ac.uk		Watson, Andrew/0000-0002-9654-8147	NERC [NE/K002473/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Handoh IC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002039; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; Mackenzie FT, 2002, CHEM GEOL, V190, P13, DOI 10.1016/S0009-2541(02)00108-0; Mills BJW, 2016, GEOLOGY, V44, P1023, DOI 10.1130/G38231.1; Ozaki K, 2011, EARTH PLANET SC LETT, V304, P270, DOI 10.1016/j.epsl.2011.02.011; Percival LME, 2016, GEOLOGY, V44, P759, DOI 10.1130/G37997.1; Percival LME, 2015, EARTH PLANET SC LETT, V428, P267, DOI 10.1016/j.epsl.2015.06.064; REDFIELD AC, 1958, AM SCI, V46, P205; Sell B, 2014, EARTH PLANET SC LETT, V408, P48, DOI 10.1016/j.epsl.2014.10.008; Shepherd J. G., 2016, M ROYAL SOC LOND 12; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Turgeon SC, 2008, NATURE, V454, P323, DOI 10.1038/nature07076	14	20	21	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1529	1530		10.1126/science.aaj2321	http://dx.doi.org/10.1126/science.aaj2321			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008026				2022-12-28	WOS:000390254300025
J	Deweerdt, S				Deweerdt, Sarah			Clues in the code	NATURE			English	Editorial Material							CROHNS-DISEASE; SUSCEPTIBILITY; ASSOCIATION											Brant S. R, 2016, GASTROENTEROLOGY; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Huang H., 2015, PREPRINT AT BIORXIV; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114	5	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S104	S105		10.1038/540S104a	http://dx.doi.org/10.1038/540S104a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002395				2022-12-28	WOS:000391190500005
J	Machado, FR				Machado, Flavia R.			All in a Day's Work - Equity vs. Equality at a Public ICU in Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Machado, Flavia R.] Univ Fed Sao Paulo, Anesthesiol Pain & Intens Care Dept, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Machado, FR (corresponding author), Univ Fed Sao Paulo, Anesthesiol Pain & Intens Care Dept, Sao Paulo, Brazil.							Agencia Nacional de Saude Suplementar [ANS], 2016, DAD GER BEN PLAN PRI; Conselho Federal de Medicina, 2016, LEV UTIS BRAS; Diniz D, 2014, CIENC SAUDE COLETIVA, V19, P591, DOI 10.1590/1413-81232014192.23072012; UNITED NATIONS, 2015, NAT ACC MAIN AGGR DA; United Nations Development Programme, 2014, UN DEV PROGR HUM DEV	5	8	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2420	2421		10.1056/NEJMp1610059	http://dx.doi.org/10.1056/NEJMp1610059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002700				2022-12-28	WOS:000390091500005
J	Maltagliati, L				Maltagliati, Luca			PLANETARY SCIENCE Frozen in darkness	NATURE			English	Editorial Material																		Platz T, 2017, NAT ASTRON, V1, DOI 10.1038/s41550-016-0007	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					534	534		10.1038/nature21108	http://dx.doi.org/10.1038/nature21108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	27992876	Bronze			2022-12-28	WOS:000391190500041
J	Dahm, P; Wilt, T				Dahm, Philipp; Wilt, Timothy			In prostate cancer, urinary and sexual function were worse with prostatectomy than active monitoring or radiotherapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY		[Dahm, Philipp] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Dahm, P (corresponding author), Minneapolis VA Hlth Care Syst, Minneapolis, MN USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; D'Amico AV, 2016, NEW ENGL J MED, V375, P1482, DOI 10.1056/NEJMe1610395; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Turner EL, 2014, BRIT J CANCER, V110, P2829, DOI 10.1038/bjc.2014.242; Wilt TJ, 2015, J NATL COMPR CANC NE, V13, P1566, DOI 10.6004/jnccn.2015.0182; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	8	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC62	JC63		10.7326/ACPJC-2016-165-12-062	http://dx.doi.org/10.7326/ACPJC-2016-165-12-062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992918				2022-12-28	WOS:000391236900002
J	Finucane, TE				Finucane, Thomas E.			Management of Chronic Insomnia Disorder in Adults	ANNALS OF INTERNAL MEDICINE			English	Letter							CLINICAL-PRACTICE GUIDELINE; AMERICAN-COLLEGE; PHYSICIANS		[Finucane, Thomas E.] Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Finucane, TE (corresponding author), Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA.							CARSKADON MA, 1976, AM J PSYCHIAT, V133, P1382; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Wilt TJ, 2016, ANN INTERN MED, V165, P103, DOI 10.7326/M15-1781	4	1	1	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					891	892		10.7326/L16-0543	http://dx.doi.org/10.7326/L16-0543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992909				2022-12-28	WOS:000391236900028
J	Maxmen, A				Maxmen, Amy			The myth buster	NATURE			English	News Item																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					330	333		10.1038/540330a	http://dx.doi.org/10.1038/540330a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974780	Bronze			2022-12-28	WOS:000389716800011
J	Voelker, R				Voelker, Rebecca			Insurer Curbs Opioid Prescriptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2349	2349		10.1001/jama.2016.17522	http://dx.doi.org/10.1001/jama.2016.17522			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27960002				2022-12-28	WOS:000389884600008
J	Reinhard, CT; Planavsky, NJ; Gill, BC; Ozaki, K; Robbins, LJ; Lyons, TW; Fischer, WW; Wang, CJ; Cole, DB; Konhauser, KO				Reinhard, Christopher T.; Planavsky, Noah J.; Gill, Benjamin C.; Ozaki, Kazumi; Robbins, Leslie J.; Lyons, Timothy W.; Fischer, Woodward W.; Wang, Chunjiang; Cole, Devon B.; Konhauser, Kurt O.			Evolution of the global phosphorus cycle	NATURE			English	Article							MIDDLE PROTEROZOIC OCEAN; MARINE-SEDIMENTS; ORGANIC-CARBON; FERRUGINOUS CONDITIONS; DISSOLVED PHOSPHATE; ATMOSPHERIC OXYGEN; GREEN RUST; IRON; REDOX; NITROGEN	The macronutrient phosphorus is thought to limit primary productivity in the oceans on geological timescales(1). Although there has been a sustained effort to reconstruct the dynamics of the phosphorus cycle over the past 3.5 billion years(2-5), it remains uncertain whether phosphorus limitation persisted throughout Earth's history and therefore whether the phosphorus cycle has consistently modulated biospheric productivity and ocean-atmosphere oxygen levels over time. Here we present a compilation of phosphorus abundances in marine sedimentary rocks spanning the past 3.5 billion years. We find evidence for relatively low authigenic phosphorus burial in shallow marine environments until about 800 to 700 million years ago. Our interpretation of the database leads us to propose that limited marginal phosphorus burial before that time was linked to phosphorus biolimitation, resulting in elemental stoichiometries in primary producers that diverged strongly from the Redfield ratio (the atomic ratio of carbon, nitrogen and phosphorus found in phytoplankton). We place our phosphorus record in a quantitative biogeochemical model framework and find that a combination of enhanced phosphorus scavenging in anoxic, iron-rich oceans(6,7) and a nutrient-based bistability in atmospheric oxygen levels could have resulted in a stable low-oxygen world. The combination of these factors may explain the protracted oxygenation of Earth's surface over the last 3.5 billion years of Earth history(8). However, our analysis also suggests that a fundamental shift in the phosphorus cycle may have occurred during the late Proterozoic eon (between 800 and 635 million years ago), coincident with a previously inferred shift in marine redox states(9), severe perturbations to Earth's climate system(10), and the emergence of animals(11,12).	[Reinhard, Christopher T.; Ozaki, Kazumi] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Planavsky, Noah J.; Cole, Devon B.] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA; [Gill, Benjamin C.] Virginia Tech, Dept Geosci, Blacksburg, VA 24061 USA; [Ozaki, Kazumi] Univ Tokyo, Ctr Earth Surface Syst Dynam, Kashiwanoha 2778561, Japan; [Robbins, Leslie J.; Konhauser, Kurt O.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Fischer, Woodward W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Wang, Chunjiang] China Univ Petr, State Key Lab Petr Resources & Prospecting, Beijing 102249, Peoples R China	University System of Georgia; Georgia Institute of Technology; Yale University; Virginia Polytechnic Institute & State University; University of Tokyo; University of Alberta; University of California System; University of California Riverside; California Institute of Technology; China University of Petroleum	Reinhard, CT (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.; Planavsky, NJ (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	chris.reinhard@eas.gatech.edu; noah.planavsky@yale.edu	Robbins, Leslie/U-4420-2019; Haygarth, Philip Matthew/F-6790-2014; Gill, Benjamin C/B-8047-2012	Robbins, Leslie/0000-0002-6931-5743; Gill, Benjamin C/0000-0001-7402-0811; Konhauser, Kurt/0000-0001-7722-7068	NSF-EAR; NASA Astrobiology Institute; Alfred P. Sloan Foundation; JSPS KAKENHI; Division Of Earth Sciences [1338810, 1338299] Funding Source: National Science Foundation	NSF-EAR(National Science Foundation (NSF)); NASA Astrobiology Institute; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by funds from from NSF-EAR and the NASA Astrobiology Institute. C.T.R. acknowledges support from the Alfred P. Sloan Foundation. K.O. acknowledges support from JSPS KAKENHI.	Algeo TJ, 2008, GEOSPHERE, V4, P872, DOI 10.1130/GES00174.1; Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Algeo TJ, 2004, CHEM GEOL, V206, P289, DOI 10.1016/j.chemgeo.2003.12.009; ANDERSON RF, 1989, GEOCHIM COSMOCHIM AC, V53, P2215, DOI 10.1016/0016-7037(89)90345-1; ANDERSON RF, 1989, GEOCHIM COSMOCHIM AC, V53, P2205, DOI 10.1016/0016-7037(89)90344-X; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BENYAAKO.S, 1973, LIMNOL OCEANOGR, V18, P86, DOI 10.4319/lo.1973.18.1.0086; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; BOUDREAU BP, 1993, GEOCHIM COSMOCHIM AC, V57, P317, DOI 10.1016/0016-7037(93)90434-X; CALVERT SE, 1993, MAR GEOL, V113, P67, DOI 10.1016/0025-3227(93)90150-T; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Dale AW, 2012, CHEM GEOL, V324, P28, DOI 10.1016/j.chemgeo.2011.10.004; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; Derry LA, 2015, GEOPHYS RES LETT, V42, P8538, DOI 10.1002/2015GL065333; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; Fennel K, 2005, AM J SCI, V305, P526, DOI 10.2475/ajs.305.6-8.526; Filippelli GM, 1997, MAR GEOL, V139, P231, DOI 10.1016/S0025-3227(96)00113-2; Filippelli GM, 1996, GEOCHIM COSMOCHIM AC, V60, P1479, DOI 10.1016/0016-7037(96)00042-7; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; FOX LE, 1986, GEOCHIM COSMOCHIM AC, V50, P783, DOI 10.1016/0016-7037(86)90354-6; FOX LE, 1987, ESTUARIES, V10, P1, DOI 10.2307/1352019; FROELICH PN, 1983, GEOCHIM COSMOCHIM AC, V47, P1605; FROELICH PN, 1988, LIMNOL OCEANOGR, V33, P649, DOI 10.4319/lo.1988.33.4_part_2.0649; Goldhammer T, 2010, NAT GEOSCI, V3, P557, DOI [10.1038/ngeo913, 10.1038/NGEO913]; Grotzinger J.P., 2000, CARBONATE SEDIMENTAT, P1; GROTZINGER JP, 1994, NOBEL S, V84, P245; Guilbaud R, 2013, GEOCHIM COSMOCHIM AC, V108, P141, DOI 10.1016/j.gca.2013.01.017; Halverson GP, 2011, EARTH PLANET SC LETT, V309, P100, DOI 10.1016/j.epsl.2011.06.021; Higgins JA, 2009, EARTH PLANET SC LETT, V284, P25, DOI 10.1016/j.epsl.2009.03.039; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Holland HD, 2005, ECON GEOL, V100, P1489, DOI 10.2113/100.8.1489; Holland HD., 1984, CHEM EVOLUTION ATMOS; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL ED, 1990, GEOCHIM COSMOCHIM AC, V54, P373, DOI 10.1016/0016-7037(90)90326-G; JAHNKE RA, 1983, GEOCHIM COSMOCHIM AC, V47, P259, DOI 10.1016/0016-7037(83)90138-2; JAHNKE RA, 1984, AM J SCI, V284, P58, DOI 10.2475/ajs.284.1.58; Jones C, 2015, GEOLOGY, V43, P135, DOI 10.1130/G36044.1; Knoll A. H., 2014, COLD SPRING HARB PER, V8; Konhauser KO, 2007, SCIENCE, V315, P1234, DOI 10.1126/science.1136328; Kuzynetsov I, 2008, ECOL MODEL, V219, P107, DOI 10.1016/j.ecolmodel.2008.08.002; Laakso TA, 2014, EARTH PLANET SC LETT, V388, P81, DOI 10.1016/j.epsl.2013.11.049; Larsson U, 2001, LIMNOL OCEANOGR, V46, P811, DOI 10.4319/lo.2001.46.4.0811; Lepland A, 2014, NAT GEOSCI, V7, P20, DOI [10.1038/ngeo2005, 10.1038/NGEO2005]; Li C, 2015, GEOCHIM COSMOCHIM AC, V150, P90, DOI 10.1016/j.gca.2014.12.005; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; McManus J, 2005, GEOCHIM COSMOCHIM AC, V69, P95, DOI 10.1016/j.gca.2004.06.023; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Ozaki K, 2013, EARTH PLANET SC LETT, V373, P129, DOI 10.1016/j.epsl.2013.04.029; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Planavsky NJ, 2014, NAT GEOSCI, V7, P855, DOI 10.1038/ngeo2307; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Pope MC, 2000, J SEDIMENT RES, V70, P1139, DOI 10.1306/062099701139; Poulton SW, 2006, GEOCHIM COSMOCHIM AC, V70, P5883, DOI 10.1016/j.gca.2006.01.030; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Reinhard C. T., 2013, READING ARCH EARTHS, P1483; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Rooney AD, 2015, GEOLOGY, V43, P459, DOI 10.1130/G36511.1; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Scott C, 2012, CHEM GEOL, V324, P19, DOI 10.1016/j.chemgeo.2012.05.012; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; Shields-Zhou G., 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/GSATG102A.1; Slomp CP, 2007, BIOGEOSCIENCES, V4, P155, DOI 10.5194/bg-4-155-2007; Slomp CP, 2002, GEOCHIM COSMOCHIM AC, V66, P1171, DOI 10.1016/S0016-7037(01)00848-1; Sperling EA, 2015, NATURE, V523, P451, DOI 10.1038/nature14589; Taylor S.R., 1985, CONTINENTAL CRUST IT, P311; Tribovillard N, 2006, CHEM GEOL, V232, P12, DOI 10.1016/j.chemgeo.2006.02.012; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Wang XL, 2016, CHEM GEOL, V423, P19, DOI 10.1016/j.chemgeo.2016.01.003; White AE, 2006, LIMNOL OCEANOGR, V51, P1777, DOI 10.4319/lo.2006.51.4.1777; Zegeye A, 2012, GEOLOGY, V40, P599, DOI 10.1130/G32959.1	85	284	291	60	746	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2017	541	7637					386	+		10.1038/nature20772	http://dx.doi.org/10.1038/nature20772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QP	28002400				2022-12-28	WOS:000396128800040
J	Compton, WM; Han, B; Hughes, A; Jones, CM; Blanco, C				Compton, Wilson M.; Han, Beth; Hughes, Arthur; Jones, Christopher M.; Blanco, Carlos			Use of Marijuana for Medical Purposes Among Adults in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Compton, Wilson M.; Blanco, Carlos] Natl Inst Drug Abuse, 6001 Execut Blvd,MSC 9589, Bethesda, MD 20892 USA; [Han, Beth; Hughes, Arthur] Subst Abuse & Mental Hlth Serv Adm, Rockville, MD USA; [Jones, Christopher M.] US Dept HHS, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Compton, WM (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,MSC 9589, Bethesda, MD 20892 USA.	wcompton@nida.nih.gov	Blanco, Carlos/I-4906-2013	Blanco, Carlos/0000-0001-6187-3057	Substance Abuse and Mental Health Services Administration; National Institute on Drug Abuse of the National Institutes of Health; Office of the Assistant Secretary for Planning and Evaluation of the US Department of Health and Human Services	Substance Abuse and Mental Health Services Administration(United States Department of Health & Human Services); National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of the Assistant Secretary for Planning and Evaluation of the US Department of Health and Human Services	The National Survey on Drug Use and Health was supported by contracts from the Substance Abuse and Mental Health Services Administration. This study was jointly sponsored by the National Institute on Drug Abuse of the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Office of the Assistant Secretary for Planning and Evaluation of the US Department of Health and Human Services.	Chaudhry HJ, 2016, JAMA-J AM MED ASSOC, V316, P577, DOI 10.1001/jama.2016.7741; Lin LA, 2016, ADDICT BEHAV, V61, P99, DOI 10.1016/j.addbeh.2016.05.015; Roy-Byrne P, 2015, AM J ADDICTION, V24, P599, DOI 10.1111/ajad.12270; Schauer GL, 2016, AM J PREV MED, V50, P1, DOI 10.1016/j.amepre.2015.05.027	4	85	85	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2017	317	2					209	211		10.1001/jama.2016.18900	http://dx.doi.org/10.1001/jama.2016.18900			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5PV	27992636	Green Accepted, Bronze			2022-12-28	WOS:000391826200024
J	Fuchs, VR				Fuchs, Victor R.			Social Determinants of Health Caveats and Nuances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, SIEPR, 366 Galvez, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, SIEPR, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Adler NE, 2016, JAMA-J AM MED ASSOC, V316, P1641, DOI 10.1001/jama.2016.14058; [Anonymous], 1988, ARCH INTERN MED, V148, P1023; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1970, JAMA, V213, P1143; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Farrell P, 1982, J Health Econ, V1, P217, DOI 10.1016/0167-6296(82)90001-7	6	23	24	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					25	26		10.1001/jama.2016.17335	http://dx.doi.org/10.1001/jama.2016.17335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030707				2022-12-28	WOS:000391009100012
J	Brown, CE; Alizadeh, D; Starr, R; Weng, LH; Wagner, JR; Naranjo, A; Ostberg, JR; Blanchard, MS; Kilpatrick, J; Simpson, J; Kurien, A; Priceman, SJ; Wang, XL; Harshbarger, TL; D'Apuzzo, M; Ressler, JA; Jensen, MC; Barish, ME; Chen, M; Portnow, J; Forman, SJ; Badie, B				Brown, Christine E.; Alizadeh, Darya; Starr, Renate; Weng, Lihong; Wagner, Jamie R.; Naranjo, Araceli; Ostberg, Julie R.; Blanchard, M. Suzette; Kilpatrick, Julie; Simpson, Jennifer; Kurien, Anita; Priceman, Saul J.; Wang, Xiuli; Harshbarger, Todd L.; D'Apuzzo, Massimo; Ressler, Julie A.; Jensen, Michael C.; Barish, Michael E.; Chen, Mike; Portnow, Jana; Forman, Stephen J.; Badie, Behnam			Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERLEUKIN-13; PERSISTENCE; GLIOMAS; SAFETY; CARS	A patient with recurrent multifocal glioblastoma received chimeric antigen receptor (CAR)-engineered T cells targeting the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13R alpha 2). Multiple infusions of CAR T cells were administered over 220 days through two intracranial delivery routes - infusions into the resected tumor cavity followed by infusions into the ventricular system. Intracranial infusions of IL13R alpha 2-targeted CAR T cells were not associated with any toxic effects of grade 3 or higher. After CAR T-cell treatment, regression of all intracranial and spinal tumors was observed, along with corresponding increases in levels of cytokines and immune cells in the cerebrospinal fluid. This clinical response continued for 7.5 months after the initiation of CAR T-cell therapy. (Funded by Gateway for Cancer Research and others; ClinicalTrials.gov number, NCT02208362.)	[Brown, Christine E.; Alizadeh, Darya; Starr, Renate; Weng, Lihong; Wagner, Jamie R.; Naranjo, Araceli; Ostberg, Julie R.; Kurien, Anita; Priceman, Saul J.; Wang, Xiuli; Forman, Stephen J.] City Hope Beckman Res Inst & Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Cell Therapeut Res Lab T, Duarte, CA USA; [Blanchard, M. Suzette] City Hope Beckman Res Inst & Med Ctr, Dept Informat Sci, Duarte, CA USA; [Kilpatrick, Julie; Simpson, Jennifer] City Hope Beckman Res Inst & Med Ctr, Dept Clin Res, Duarte, CA USA; [Harshbarger, Todd L.; Chen, Mike; Badie, Behnam] City Hope Beckman Res Inst & Med Ctr, Dept Neurosurg, Duarte, CA USA; [D'Apuzzo, Massimo] City Hope Beckman Res Inst & Med Ctr, Dept Pathol, Duarte, CA USA; [Ressler, Julie A.] City Hope Beckman Res Inst & Med Ctr, Dept Diagnost Radiol, Duarte, CA USA; [Barish, Michael E.] City Hope Beckman Res Inst & Med Ctr, Dept Dev & Stem Cell Biol, Duarte, CA USA; [Portnow, Jana] City Hope Beckman Res Inst & Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA	Seattle Children's Hospital	Badie, B (corresponding author), City Hope Beckman Res Inst & Med Ctr, 1500 E Duarte Rd,Med Off Bldg,2nd Fl,Rm 2001, Duarte, CA 91010 USA.	bbadie@coh.org		Wang, Xiuli/0000-0001-5964-4327; Portnow, Jana/0000-0002-4257-0891; Brown, Christine/0000-0003-4915-8207	Gateway for Cancer Research; FOOD AND DRUG ADMINISTRATION [R01FD005129] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA155769, R21CA189223, R21CA131765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081594] Funding Source: NIH RePORTER	Gateway for Cancer Research; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by Gateway for Cancer Research and others	Ahmed N., 2015, J IMMUNOTHER CANCER, V3, pO11, DOI [10.1186/2051-1426-3-S2-O11, DOI 10.1186/2051-1426-3-S2-O11]; Batlevi CL, 2016, NAT REV CLIN ONCOL, V13, P25, DOI 10.1038/nrclinonc.2015.187; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brown CE, 2015, CLIN CANCER RES, V21, P4062, DOI 10.1158/1078-0432.CCR-15-0428; Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Cerny C., 2015, INT TRENDS IMMUNITY, V3, P19, DOI [10.18281/iti.2015.2.3, DOI 10.18281/ITI.2015.2.3]; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Debinski W, 1999, CLIN CANCER RES, V5, P985; Debinski W, 1999, CLIN CANCER RES, V5, p3143S; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Jonnalagadda M, 2015, MOL THER, V23, P757, DOI 10.1038/mt.2014.208; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Kakarla S, 2014, CANCER J, V20, P151, DOI 10.1097/PPO.0000000000000032; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; O'Rourke D. M., 2016, ASCO ANN M P, V34, P2067, DOI DOI 10.1200/JCO.2016.34.15_SUPPL.2067; Priceman SJ, 2015, CURR OPIN ONCOL, V27, P466, DOI 10.1097/CCO.0000000000000232; Ramos CA, 2014, CANCER J, V20, P112, DOI 10.1097/PPO.0000000000000031; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278	25	914	976	31	236	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2561	2569		10.1056/NEJMoa1610497	http://dx.doi.org/10.1056/NEJMoa1610497			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	28029927	Green Accepted, Bronze			2022-12-28	WOS:000391175300009
J	Nango, E; Royant, A; Kubo, M; Nakane, T; Wickstrand, C; Kimura, T; Tanaka, T; Tono, K; Song, CY; Tanaka, R; Arima, T; Yamashita, A; Kobayashi, J; Hosaka, T; Mizohata, E; Nogly, P; Sugahara, M; Nam, D; Nomura, T; Shimamura, T; Im, D; Fujiwara, T; Yamanaka, Y; Jeon, B; Nishizawa, T; Oda, K; Fukuda, M; Andersson, R; Bath, P; Dods, R; Davidsson, J; Matsuoka, S; Kawatake, S; Murata, M; Nureki, O; Owada, S; Kameshima, T; Hatsui, T; Joti, Y; Schertler, G; Yabashi, M; Bondar, AN; Standfuss, J; Neutze, R; Iwata, S				Nango, Eriko; Royant, Antoine; Kubo, Minoru; Nakane, Takanori; Wickstrand, Cecilia; Kimura, Tetsunari; Tanaka, Tomoyuki; Tono, Kensuke; Song, Changyong; Tanaka, Rie; Arima, Toshi; Yamashita, Ayumi; Kobayashi, Jun; Hosaka, Toshiaki; Mizohata, Eiichi; Nogly, Przemyslaw; Sugahara, Michihiro; Nam, Daewoong; Nomura, Takashi; Shimamura, Tatsuro; Im, Dohyun; Fujiwara, Takaaki; Yamanaka, Yasuaki; Jeon, Byeonghyun; Nishizawa, Tomohiro; Oda, Kazumasa; Fukuda, Masahiro; Andersson, Rebecka; Bath, Petra; Dods, Robert; Davidsson, Jan; Matsuoka, Shigeru; Kawatake, Satoshi; Murata, Michio; Nureki, Osamu; Owada, Shigeki; Kameshima, Takashi; Hatsui, Takaki; Joti, Yasumasa; Schertler, Gebhard; Yabashi, Makina; Bondar, Ana-Nicoleta; Standfuss, Jorg; Neutze, Richard; Iwata, So			A three-dimensional movie of structural changes in bacteriorhodopsin	SCIENCE			English	Article							X-RAY-RADIATION; PHOTOACTIVE YELLOW PROTEIN; VECTORIAL PROTON TRANSPORT; L-INTERMEDIATE; SCHIFF-BASE; ANGSTROM RESOLUTION; L-PHOTOINTERMEDIATE; CRYSTAL-STRUCTURE; WATER-MOLECULES; M-STATE	Bacteriorhodopsin (bR) is a light-driven proton pump and a model membrane transport protein. We used time-resolved serial femtosecond crystallography at an x-ray free electron laser to visualize conformational changes in bR from nanoseconds to milliseconds following photoactivation. An initially twisted retinal chromophore displaces a conserved tryptophan residue of transmembrane helix F on the cytoplasmic side of the protein while dislodging a key water molecule on the extracellular side. The resulting cascade of structural changes throughout the protein shows how motions are choreographed as bR transports protons uphill against a transmembrane concentration gradient.	[Nango, Eriko; Kubo, Minoru; Kimura, Tetsunari; Tanaka, Tomoyuki; Song, Changyong; Tanaka, Rie; Arima, Toshi; Yamashita, Ayumi; Kobayashi, Jun; Sugahara, Michihiro; Nomura, Takashi; Owada, Shigeki; Hatsui, Takaki; Yabashi, Makina; Iwata, So] RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan; [Nango, Eriko; Shimamura, Tatsuro; Im, Dohyun; Fujiwara, Takaaki; Yamanaka, Yasuaki; Iwata, So] Kyoto Univ, Dept Cell Biol, Grad Sch Med, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan; [Royant, Antoine] Univ Grenoble Alpes, CNRS, Commissariat Energie Atom & Energies Alternat, Inst Biol Struct, F-38044 Grenoble, France; [Royant, Antoine] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Kubo, Minoru; Nishizawa, Tomohiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Nakane, Takanori; Nishizawa, Tomohiro; Oda, Kazumasa; Fukuda, Masahiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan; [Wickstrand, Cecilia; Andersson, Rebecka; Bath, Petra; Dods, Robert; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden; [Kimura, Tetsunari] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan; [Tono, Kensuke; Kameshima, Takashi; Joti, Yasumasa] Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan; [Song, Changyong; Nam, Daewoong; Jeon, Byeonghyun] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Hosaka, Toshiaki] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Mizohata, Eiichi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Nogly, Przemyslaw; Schertler, Gebhard; Standfuss, Jorg] Paul Scherrer Inst, Lab Biomol Res, Div Biol & Chem, CH-5232 Villigen, Switzerland; [Davidsson, Jan] Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden; [Matsuoka, Shigeru; Kawatake, Satoshi; Murata, Michio] Osaka Univ, Lipid Act Struct Project, JST Exploratory Res Adv Technol ERATO, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan; [Schertler, Gebhard] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Bondar, Ana-Nicoleta] Free Univ Berlin, Dept Phys, Theoret Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany	RIKEN; Kyoto University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Japan Science & Technology Agency (JST); University of Tokyo; University of Gothenburg; Kobe University; Japan Synchrotron Radiation Research Institute; Pohang University of Science & Technology (POSTECH); RIKEN; Osaka University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Uppsala University; Osaka University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Free University of Berlin	Iwata, S (corresponding author), RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.; Iwata, S (corresponding author), Kyoto Univ, Dept Cell Biol, Grad Sch Med, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.; Neutze, R (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, Box 462, SE-40530 Gothenburg, Sweden.	richard.neutze@gu.se; s.iwata@spring8.or.jp	Nogly, Przemyslaw/GQZ-7032-2022; Yabashi, Makina/A-2832-2015; Royant, Antoine/G-3684-2012; Hatsui, Takaki/J-4429-2014; Bondar, Ana-Nicoleta/F-6456-2015; Murata, Michio/AAE-5912-2019; Murata, Michio/AAW-2036-2020; Standfuss, Joerg/G-5126-2011; Nogly, Przemyslaw M/B-8278-2012; Kimura, Tetsunari/AAN-9156-2021; Nogly, Przemyslaw/N-3590-2019; NUREKI, OSAMU/G-4960-2014	Nogly, Przemyslaw/0000-0002-8040-7753; Yabashi, Makina/0000-0002-2472-1684; Royant, Antoine/0000-0002-1919-8649; Hatsui, Takaki/0000-0001-8144-3484; Bondar, Ana-Nicoleta/0000-0003-2636-9773; Nogly, Przemyslaw M/0000-0002-8040-7753; Kimura, Tetsunari/0000-0003-1650-7298; Nogly, Przemyslaw/0000-0002-8040-7753; Nakane, Takanori/0000-0003-2697-2767; murata, michio/0000-0002-1600-145X; Schertler, Gebhard F.X./0000-0002-5846-6810; Fukuda, Masahiro/0000-0002-8824-846X; Nango, Eriko/0000-0001-9851-7355	X-ray Free-Electron Laser Priority Strategy Program (Ministry of Education, Culture, Sports, Science and Technology of Japan); Strategic Basic Research Program (JST); RIKEN Pioneering Project Dynamic Structural Biology; Swedish Research Council [VR 349-2011-6485, 2015-00560]; Swedish Foundation for Strategic Research [SSF SRL 10-0036]; Knut and Alice Wallenberg Foundation [KAW 2012.0284]; French National Research Agency [ANR-11-JSV5-0009]; Japan Society for the Promotion of Science KAKENHI [15H05476]; European Community's Seventh Framework Program [290605]; Swiss National Science Foundation [SNF 31003A_159558, SNF 310030_153145]; NCCR-MUST/FAST program; National Research Foundation of Korea [NRF-2015R1A5A1009962, NRF-2016R1A2B3010980]; POSCO Green Science program; Excellence Initiative of the German Federal Government via the Freie Universitat Berlin; Excellence Initiative of the German State Government via the Freie Universitat Berlin; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center [SFB1078]; Exploratory Research for Advanced Technology of the JST; Grants-in-Aid for Scientific Research [15K18523] Funding Source: KAKEN	X-ray Free-Electron Laser Priority Strategy Program (Ministry of Education, Culture, Sports, Science and Technology of Japan); Strategic Basic Research Program (JST)(Japan Science & Technology Agency (JST)); RIKEN Pioneering Project Dynamic Structural Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); French National Research Agency(French National Research Agency (ANR)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); European Community's Seventh Framework Program(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR-MUST/FAST program; National Research Foundation of Korea(National Research Foundation of Korea); POSCO Green Science program; Excellence Initiative of the German Federal Government via the Freie Universitat Berlin; Excellence Initiative of the German State Government via the Freie Universitat Berlin; Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center(German Research Foundation (DFG)); Exploratory Research for Advanced Technology of the JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Oshimo for her help in culturing Halobacterium salinarum and members of the Engineering Team of RIKEN SPring-8 Center-especially Y. Shimazu, K. Hata, N. Suzuki, and T. Kin-for technical support. XFEL experiments were conducted at BL3 of SACLA, with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal numbers 2014B8051, 2015A8047, and 2015B8054). Crystals were checked for diffraction at BL41XU of SPring-8 with the approval of JASRI (proposal number 2015A1119). This work was supported by the X-ray Free-Electron Laser Priority Strategy Program (Ministry of Education, Culture, Sports, Science and Technology of Japan) and partially by the Strategic Basic Research Program (JST) and RIKEN Pioneering Project Dynamic Structural Biology. We acknowledge computational support from the SACLA High Performance Computing system and the Mini-K supercomputer system. R. N. acknowledges financial support from the Swedish Research Council (grants VR 349-2011-6485 and 2015-00560), the Swedish Foundation for Strategic Research (grant SSF SRL 10-0036), and the Knut and Alice Wallenberg Foundation (grant KAW 2012.0284). A. R. acknowledges financial support from the French National Research Agency (grant ANR-11-JSV5-0009). T. Ki. is supported by Japan Society for the Promotion of Science KAKENHI grant 15H05476. P.N. acknowledges support from the European Community's Seventh Framework Program (FP7/2007-2013) under grant 290605 (PSI-FELLOW/COFUND). J.S. acknowledges support from the Swiss National Science Foundation project grant (SNF 31003A_159558). G.S. acknowledges support from the Swiss National Science Foundation (grant SNF 310030_153145) and the NCCR-MUST/FAST program. C.S. is supported by National Research Foundation of Korea (grants NRF-2015R1A5A1009962 and NRF-2016R1A2B3010980) and the POSCO Green Science program. A.-N.B. acknowledges support in part from the Excellence Initiative of the German Federal and State Governments provided via the Freie Universitat Berlin, the Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center SFB1078 project C4, as well as computing time from the Freie Universitat Berlin and from the North-German Supercomputing Alliance (HLRN). M.M. acknowledges financial support from the Exploratory Research for Advanced Technology of the JST. Author contributions: S.I., R.N., and E.N. conceived the research; T.T., T.A., A. Y., J.K., R.T., E.N., P.N., and J.S. prepared microcrystals; S.M., S.K., and M.M. prepared purple membrane; E.N., C.S., R.N., M.K., and K.T. designed the experimental setup; M.K., T.Ki., T.No., S.O., and J.D. contributed the pump laser setup; E.N., T.T., R.T., T.A., A. Y., J.K., T.Ho., E.M., P.N., M.S., C.S., D.N., R.D., Y.K., T.S., D.I., T.F., Y.Y., B.J., T.Ni., K.O., M.F., C.W., R.A., C.S., P.B., J.S., and R.N. performed data collection; M.K., T.Ki., and T.No. performed time-resolved visible absorption spectroscopy; C.W. and R.N. analyzed the spectral data; T.Na. and O.N. performed data processing; A. R. and E.N. refined the intermediate structures; A.-N.B. performed computations; K.T., C.S., T.Ka., T.Ha., Y.J., and M.Y. developed the SFX systems at SACLA; and R.N.,C.W., E.N., A. R., M.K., and T. Na. wrote the paper with input from all authors. Coordinates and structure factors have been deposited in the Protein Data Bank with IDs 5B6V (bR resting state), 5B6W (Delta t = 16 ns), 5H2H (Delta t = 40 ns), 5H2I (Delta t = 110 ns), 5H2J (Delta t = 290 ns), 5B6X (Delta t = 760 ns), 5H2K (Delta t = 2 mu s), 5H2L (Delta t = 5.; 25 mu s), 5H2M (Delta t = 13.8 mu s), 5B6Y (Delta t = 36.2 mu s), 5H2N (Delta t = 95.2 mu s), 5H2O (Delta t = 250 mu s), 5H2P (Delta t = 657 mu s), and 5B6Z (Delta t = 1.725 mu s). Raw diffraction images have been deposited in the Coherent X-ray Imaging Data Bank (accession ID 53).	Andersson M, 2009, STRUCTURE, V17, P1265, DOI 10.1016/j.str.2009.07.007; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Bondar AN, 2005, J PHYS CHEM B, V109, P14786, DOI 10.1021/jp0531255; Bondar AN, 2008, J PHYS CHEM B, V112, P14729, DOI 10.1021/jp801916f; Borshchevskiy V, 2014, ACTA CRYSTALLOGR D, V70, P2675, DOI 10.1107/S1399004714017295; Borshchevskiy VI, 2011, J MOL BIOL, V409, P813, DOI 10.1016/j.jmb.2011.04.038; CHANG CH, 1988, PHOTOCHEM PHOTOBIOL, V47, P261, DOI 10.1111/j.1751-1097.1988.tb02724.x; Edman K, 2004, J BIOL CHEM, V279, P2147, DOI 10.1074/jbc.M300709200; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Facciotti MT, 2001, BIOPHYS J, V81, P3442, DOI 10.1016/S0006-3495(01)75976-0; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hayashi S, 2002, BIOPHYS J, V83, P1281, DOI 10.1016/S0006-3495(02)73900-3; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Kandori H, 2001, P NATL ACAD SCI USA, V98, P1571, DOI 10.1073/pnas.98.4.1571; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Kouyama T, 2004, J MOL BIOL, V335, P531, DOI 10.1016/j.jmb.2003.10.068; Lanyi JK, 2007, J MOL BIOL, V365, P1379, DOI 10.1016/j.jmb.2006.11.016; Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Maeda A, 2003, BIOCHEMISTRY-US, V42, P14122, DOI 10.1021/bi0301542; Maeda A, 2003, BIOCHEMISTRY-US, V42, P2535, DOI 10.1021/bi020532n; Maeda A, 2002, BIOCHEMISTRY-US, V41, P3803, DOI 10.1021/bi011923p; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; Nass K, 2015, J SYNCHROTRON RADIAT, V22, P225, DOI 10.1107/S1600577515002349; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Pande K, 2016, SCIENCE, V352, P725, DOI 10.1126/science.aad5081; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; Royant A, 2000, NATURE, V406, P645, DOI 10.1038/35020599; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2; SHEVES M, 1986, P NATL ACAD SCI USA, V83, P3262, DOI 10.1073/pnas.83.10.3262; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; Wang T, 2013, STRUCTURE, V21, P290, DOI 10.1016/j.str.2012.12.018; Wickstrand C, 2015, BBA-GEN SUBJECTS, V1850, P536, DOI 10.1016/j.bbagen.2014.05.021	41	271	273	10	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1552	1557		10.1126/science.aah3497	http://dx.doi.org/10.1126/science.aah3497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008064	Green Accepted			2022-12-28	WOS:000390254300044
J	Bender, E				Bender, Eric			CELLS ON TRIAL	NATURE			English	Editorial Material																			0	16	16	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S106	S108		10.1038/540S106a	http://dx.doi.org/10.1038/540S106a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002399	Bronze			2022-12-28	WOS:000391190500006
J	Jabbour, S; Leaning, J; Nuwayhid, I; Horton, R; Das, P				Jabbour, Samer; Leaning, Jennifer; Nuwayhid, Iman; Horton, Richard; Das, Pamela			The Lancet-American University of Beirut Commission on Syria: a new role for global health in conflict and a call for papers	LANCET			English	Editorial Material									[Jabbour, Samer; Nuwayhid, Iman] Amer Univ Beirut, Fac Hlth Sci, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon; [Leaning, Jennifer] Harvard Univ, FXB Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Horton, Richard; Das, Pamela] Lancet, London, England	American University of Beirut; Harvard University	Jabbour, S (corresponding author), Amer Univ Beirut, Fac Hlth Sci, POB 11-0236,Riad El Solh 1107 2020, Beirut, Lebanon.	sj22@aub.edu.lb	Jabbour, Samer/Y-6860-2018	Jabbour, Samer/0000-0002-7150-6856				Hudson John, 2016, FOREIGN POLICY; United Nations, 2016, SYR ENV CLAIMS 40000	2	6	6	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2967	2968		10.1016/S0140-6736(16)32583-1	http://dx.doi.org/10.1016/S0140-6736(16)32583-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998518				2022-12-28	WOS:000390112300009
J	Nooner, SL; Chadwick, WW				Nooner, Scott L.; Chadwick, William W., Jr.			Inflation-predictable behavior and co-eruption deformation at Axial Seamount	SCIENCE			English	Article							ELASTIC HALF-SPACE; DE-FUCA RIDGE; VOLCANIC-ERUPTIONS; APRIL 2011; LAVA FLOW; RESOLUTION; FORECASTS; INSIGHTS; ICELAND; HISTORY	Deformation of the ground surface at active volcanoes provides information about magma movements at depth. Improved seafloor deformation measurements between 2011 and 2015 documented a fourfold increase in magma supply and confirmed that Axial Seamount's eruptive behavior is inflation-predictable, probably triggered by a critical level of magmatic pressure. A 2015 eruption was successfully forecast on the basis of this deformation pattern and marked the first time that deflation and tilt were captured in real time by a new seafloor cabled observatory, revealing the timing, location, and volume of eruption-related magma movements. Improved modeling of the deformation suggests a steeply dipping prolate-spheroid pressure source beneath the eastern caldera that is consistent with the location of the zone of highest melt within the subcaldera magma reservoir determined from multichannel seismic results.	[Nooner, Scott L.] Univ North Carolina Wilmington, Wilmington, NC 28403 USA; [Chadwick, William W., Jr.] Oregon State Univ, Cooperat Inst Marine Resources Studies, Hatfield Marine Sci Ctr, Newport, OR 97365 USA	University of North Carolina; University of North Carolina Wilmington; Oregon State University	Nooner, SL (corresponding author), Univ North Carolina Wilmington, Wilmington, NC 28403 USA.	nooners@uncw.edu	Chadwick, William W./R-7623-2019	Chadwick, William W./0000-0002-5129-4569	NSF [OCE-1356216, 1546616]; National Oceanic and Atmospheric Administration, Pacific Marine Environmental Laboratory (NOAA-PMEL), Earth-Ocean Interactions Program; NOAA-PMEL Engineering Division; Directorate For Geosciences [1546616, 1356216, 1356839] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration, Pacific Marine Environmental Laboratory (NOAA-PMEL), Earth-Ocean Interactions Program; NOAA-PMEL Engineering Division; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The BPR and tilt data presented here are archived at the Integrated Earth Data Applications Marine Geoscience Data System (12, 13) and at the OOI Data Portal (6). This work was supported by NSF awards OCE-1356216 and 1546616 and by the National Oceanic and Atmospheric Administration, Pacific Marine Environmental Laboratory (NOAA-PMEL), Earth-Ocean Interactions Program. We thank M. Fowler and the crews of R/V Thomas G. Thompson, ROV Jason, and AUV Sentry for logistical support at sea during expedition TN327. This work would not have been possible without the support of the NOAA-PMEL Engineering Division and the University of Washington OOI Cabled Array team, led by J. Delaney and D. Kelley. The paper benefited from helpful input from two anonymous reviewers. This is PMEL contribution number 4509.	Arnulf AF, 2014, GEOLOGY, V42, P655, DOI 10.1130/G35629.1; Buck WR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003879; BURT ML, 1994, B VOLCANOL, V56, P87, DOI 10.1007/BF00304104; Caress D. W., 2015, GSA ABSTRACTS PROGRA, V47; Caress DW, 2012, NAT GEOSCI, V5, P483, DOI 10.1038/ngeo1496; Chadwick Jr W. W., 2015, AXIAL INFLATION PRES; Chadwick Jr W. W., 2015, PROCESSED BOTTOM PRE; Chadwick Jr W. W., 2015, ONLINE BLOG DOCUMENT; Chadwick WW, 2016, GEOPHYS RES LETT, V43, P12063, DOI 10.1002/2016GL071327; Chadwick WW, 2013, GEOCHEM GEOPHY GEOSY, V14, P3939, DOI 10.1002/ggge.20202; Chadwick WW, 2012, NAT GEOSCI, V5, P474, DOI 10.1038/ngeo1464; Chadwick WW, 2006, J VOLCANOL GEOTH RES, V150, P313, DOI 10.1016/j.jvolgeores.2005.07.006; Clague DA, 2013, GEOCHEM GEOPHY GEOSY, V14, P4403, DOI 10.1002/ggge.20240; DELANEY PT, 1982, AM J SCI, V282, P856, DOI 10.2475/ajs.282.6.856; Fialko Y, 2001, GEOPHYS J INT, V146, P181, DOI 10.1046/j.1365-246X.2001.00452.x; Fox C. G., 2016, PROCESSED BOTTOM PRE; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; Fox CG, 1999, GEOPHYS RES LETT, V26, P3437, DOI 10.1029/1999GL900491; Hamling IJ, 2010, NAT GEOSCI, V3, P713, DOI 10.1038/NGEO967; Kelley DS, 2014, MAR GEOL, V352, P426, DOI 10.1016/j.margeo.2014.03.010; Nooner SL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002315; NSF Ocean Observatories Initiative, 2016, DAT PORT BOTT PRESS; Okamura A. T., 1988, 1463 US GEOL SURV, P165; Qin R, 2008, EARTH PLANET SC LETT, V265, P466, DOI 10.1016/j.epsl.2007.10.044; Reverso T, 2014, J GEOPHYS RES-SOL EA, V119, P4666, DOI 10.1002/2013JB010569; Sandri L, 2005, GEOPHYS J INT, V163, P1203, DOI 10.1111/j.1365-246X.2005.02757.x; Sasagawa G, 2016, EARTH SPACE SCI, V3, P381, DOI 10.1002/2016EA000190; Segall P, 2013, GEOL SOC SPEC PUBL, V380, P85, DOI 10.1144/SP380.4; Sparks RSJ, 2003, EARTH PLANET SC LETT, V210, P1, DOI 10.1016/S0012-821X(03)00124-9; Sturkell E, 2006, J VOLCANOL GEOTH RES, V150, P14, DOI 10.1016/j.jvolgeores.2005.07.010; SWANSON DA, 1985, J GEODYN, V3, P397, DOI 10.1016/0264-3707(85)90044-4; Wilcock WSD, 2016, SCIENCE, V354, P1395, DOI 10.1126/science.aah5563; YANG XM, 1988, J GEOPHYS RES-SOLID, V93, P4249, DOI 10.1029/JB093iB05p04249	34	64	64	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1399	1403		10.1126/science.aah4666	http://dx.doi.org/10.1126/science.aah4666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980205				2022-12-28	WOS:000390261300037
J	Adamson, B; Norman, TM; Jost, M; Cho, MY; Nunez, JK; Chen, YW; Villalta, JE; Gilbert, LA; Horlbeck, MA; Hein, MY; Pak, RA; Gray, AN; Gross, CA; Dixit, A; Parnas, O; Regev, A; Weissman, JS				Adamson, Britt; Norman, Thomas M.; Jost, Marco; Cho, Min Y.; Nunez, James K.; Chen, Yuwen; Villalta, Jacqueline E.; Gilbert, Luke A.; Horlbeck, Max A.; Hein, Marco Y.; Pak, Ryan A.; Gray, Andrew N.; Gross, Carol A.; Dixit, Atray; Parnas, Oren; Regev, Aviv; Weissman, Jonathan S.			A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response	CELL			English	Article							ENDOPLASMIC-RETICULUM; STEM-CELLS; ER-STRESS; RNA; ACTIVATION; GENOME; GENES; EXPRESSION; PATHWAY; DNA	Functional genomics efforts face tradeoffs between number of perturbations examined and complexity of phenotypes measured. We bridge this gap with Perturb-seq, which combines droplet-based singlecell RNA-seq with a strategy for barcoding CRISPRmediated perturbations, allowing many perturbations to be profiled in pooled format. We applied Perturb-seq to dissect the mammalian unfolded protein response (UPR) using single and combinatorial CRISPR perturbations. Two genome-scale CRISPR interference (CRISPRi) screens identified genes whose repression perturbs ER homeostasis. Subjecting similar to 100 hits to Perturb-seq enabled highprecision functional clustering of genes. Single-cell analyses decoupled the three UPR branches, revealed bifurcated UPR branch activation among cells subject to thesameperturbation, and uncovered differential activation of the branches across hits, including an isolated feedback loop between the translocon and IRE1 alpha. These studies provide insight intohowthe three sensors ofERhomeostasis monitor distinct types of stress and highlight the ability of Perturb-seq to dissect complex cellular responses.	[Adamson, Britt; Norman, Thomas M.; Jost, Marco; Cho, Min Y.; Nunez, James K.; Chen, Yuwen; Villalta, Jacqueline E.; Gilbert, Luke A.; Horlbeck, Max A.; Hein, Marco Y.; Pak, Ryan A.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Adamson, Britt; Norman, Thomas M.; Jost, Marco; Cho, Min Y.; Nunez, James K.; Chen, Yuwen; Villalta, Jacqueline E.; Gilbert, Luke A.; Horlbeck, Max A.; Hein, Marco Y.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Adamson, Britt; Norman, Thomas M.; Jost, Marco; Cho, Min Y.; Nunez, James K.; Chen, Yuwen; Villalta, Jacqueline E.; Gilbert, Luke A.; Horlbeck, Max A.; Hein, Marco Y.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Adamson, Britt; Norman, Thomas M.; Jost, Marco; Cho, Min Y.; Nunez, James K.; Chen, Yuwen; Villalta, Jacqueline E.; Gilbert, Luke A.; Horlbeck, Max A.; Hein, Marco Y.; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Jost, Marco; Gray, Andrew N.; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94158 USA; [Pak, Ryan A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Dixit, Atray] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02142 USA; [Dixit, Atray; Parnas, Oren; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA; [Parnas, Oren] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, BioMed Res Inst Israel Canada,Fac Med IMRIC, IL-91120 Jerusalem, Israel; [Gray, Andrew N.] New England Biolabs Inc, Ipswich, MA 01938 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; New England Biolabs	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu	Hein, Marco/C-2994-2014; Gilbert, Luke/AAC-5300-2019	Hein, Marco/0000-0002-9490-2261; Weissman, Jonathan/0000-0003-2445-670X; Gilbert, Luke/0000-0001-5854-0825; Dixit, Atray/0000-0002-5065-6492	National Institutes of Health [P50 GM102706, U01 CA168370, R01 DA036858, R01 GM102790, R35 GM118061, F32 GM116331]; NIH/NCI Pathway to Independence Award [K99 CA204602]; European Commission [GA-2013-609409, EMBO ALTF 1193-2015]; NDSEG Fellowship; Klarman Cell Observatory; NHGRI [P50 HG006193]; HHMI; NATIONAL CANCER INSTITUTE [K99CA204602, R00CA204602, U01CA168370] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118061, T32GM007618, P50GM102706, R01GM102790, F32GM116331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NDSEG Fellowship; Klarman Cell Observatory; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Chow, D. Bogdanoff, and S. Elmes (UCSF Center for Advanced Technology) and N. Rapicavoli (10x Genomics) for technical expertise and assistance. We thank C.M. Gallagher, D. Acosta-Alvear, J. Peters, and M. Silvis for sharing of protocols and reagents. We thank L.M. Sack and S.J. Elledge for sharing of unpublished results. UCOE sequence was a gift from G. Sienski. We thank members of the J.S.W. lab for input and advice. This work was funded by National Institutes of Health Grants P50 GM102706, U01 CA168370, R01 DA036858 (all to J.S.W.), R01 GM102790, R35 GM118061 (to C.A.G.), and F32 GM116331 (to M.J.). J.S.W. is a Howard Hughes Medical Institute Investigator. T.M.N. is a fellow and B.A. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (B.A. DRG-[2182-14], T.M.N. DRG-[2211-15]). L.A.G. is supported by NIH/NCI Pathway to Independence Award K99 CA204602. M.Y.H. is an EMBO postdoctoral fellow (EMBO ALTF 1193-2015, co-funded by the European Commission FP7, Marie Curie Actions, LTFCOFUND2013, GA-2013-609409). A.D. is supported by an NDSEG Fellowship, and A.R. is supported by the Klarman Cell Observatory, NHGRI (P50 HG006193), and HHMI.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; [Anonymous], 2001, SPRINGE SER STAT N; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kanda S, 2016, P NATL ACAD SCI USA, V113, pE5886, DOI 10.1073/pnas.1604435113; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin Z., 2010, 100920105055 ARXIV, P1, DOI DOI 10.1016/J.JSB.2012.10.010; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Muller-Kuller U, 2015, NUCLEIC ACIDS RES, V43, P1577, DOI 10.1093/nar/gkv019; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Plumb R, 2015, ELIFE, V4, DOI 10.7554/eLife.07426; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Y, 2000, J BIOL CHEM, V275, P27013; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Zheng G.X.Y., 2016, BIORXIV	44	444	491	5	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1867	+		10.1016/j.cell.2016.11.048	http://dx.doi.org/10.1016/j.cell.2016.11.048			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984733	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000393114700023
J	Blaikie, A; Sandford-Smith, J; Tuteja, SY; Williams, CD; O'Callaghan, C				Blaikie, Andrew; Sandford-Smith, John; Tuteja, Sahib Y.; Williams, Christopher D.; O'Callaghan, Christopher			CHRISTMAS 2016: BEING WELL Arclight: a pocket ophthalmoscope for the 21st century	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Blaikie, Andrew; Tuteja, Sahib Y.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Sandford-Smith, John] Leicester Royal Infirm, Infirm Sq, Leicester LE1 5WW, Leics, England; [Williams, Christopher D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [O'Callaghan, Christopher] UCL, UCL Inst Child Hlth, London WC1E 6BT, England	University of St Andrews; University of Leicester; University of Leicester; University of London; University College London	Blaikie, A (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.	ab312@st-andrews.ac.uk		Tuteja, Sahib/0000-0003-2887-9793; Blaikie, Andrew/0000-0001-7913-6872; Williams, Christopher/0000-0001-6036-5157				[Anonymous], 2015, FACT SHEET N300; Armour RH, 2000, BRIT MED J, V321, P1557, DOI 10.1136/bmj.321.7276.1557; Blundell R., 2015, THESIS; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; Fred Hollows Foundation, 2016, TRACH CONTR; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hyrtis M, 2016, THESIS; Keeler CR, 1997, ARCH OPHTHALMOL-CHIC, V115, P1456, DOI 10.1001/archopht.1997.01100160626017; Lowe J, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/743263; Mulwafu W, 2014, TROP DOCT, V44, P135, DOI 10.1177/0049475514524393; SENSE International, 2016, RES STUD EFF IMP EAR; Tuteja S, 2016, THESIS; Williams CD, 2015, OPHTHALMOLOGY MULTIM	13	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6637	10.1136/bmj.i6637	http://dx.doi.org/10.1136/bmj.i6637			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974424	Green Submitted, Green Accepted			2022-12-28	WOS:000390151300010
J	Bucher, K				Bucher, Karen			New Frontiers of Medical Illustration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bucher, Karen] JAMA, Chicago, IL 60611 USA; [Bucher, Karen] Univ Illinois, Dept Biomed Visualizat, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bucher, K (corresponding author), JAMA, Chicago, IL 60611 USA.; Bucher, K (corresponding author), Univ Illinois, Dept Biomed Visualizat, Chicago, IL 60607 USA.	karen.bucher@jamanetwork.org							0	2	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2340	2341		10.1001/jama.2016.17728	http://dx.doi.org/10.1001/jama.2016.17728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959976				2022-12-28	WOS:000389884600001
J	Calwell, M				Calwell, Mary			William Perry Kirkwood Calwell OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6670	10.1136/bmj.i6670	http://dx.doi.org/10.1136/bmj.i6670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965193				2022-12-28	WOS:000390150800015
J	Lyon, J				Lyon, Jeff			If at First You Don't Succeed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2348	2348		10.1001/jama.2016.18029	http://dx.doi.org/10.1001/jama.2016.18029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959980				2022-12-28	WOS:000389884600007
J	Ference, BA; Robinson, JG; Brook, RD; Catapano, AL; Chapman, MJ; Neff, DR; Voros, S; Giugliano, RP; Smith, GD; Fazio, S; Sabatine, MS				Ference, Brian A.; Robinson, Jennifer G.; Brook, Robert D.; Catapano, Alberico L.; Chapman, M. John; Neff, David R.; Voros, Szilard; Giugliano, Robert P.; Smith, George Davey; Fazio, Sergio; Sabatine, Marc S.			Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBTILISIN/KEXIN TYPE 9; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; STATIN THERAPY; MENDELIAN RANDOMIZATION; MONOCLONAL-ANTIBODY; REDUCING LIPIDS; HYPERCHOLESTEROLEMIA; EFFICACY; SAFETY	BACKGROUND Pharmacologic inhibitors of proprotein convertase subtilisin-kexin type 9 (PCSK9) are being evaluated in clinical trials for the treatment of cardiovascular disease. The effect of lowering low-density lipoprotein (LDL) cholesterol levels by inhibiting PCSK9 on the risk of cardiovascular events or diabetes is unknown. METHODS We used genetic scores consisting of independently inherited variants in the genes encoding PCSK9 and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR; the target of statins) as instruments to randomly assign 112,772 participants from 14 studies, with 14,120 cardiovascular events and 10,635 cases of diabetes, to groups according to the number of LDL cholesterol-lowering alleles that they had inherited. We compared the effects of lower LDL cholesterol levels that were mediated by variants in PCSK9, HMGCR, or both on the risk of cardiovascular events and the risk of diabetes. RESULTS Variants in PCSK9 and HMGCR were associated with nearly identical protective effects on the risk of cardiovascular events per decrease of 10 mg per deciliter (0.26 mmol per liter) in the LDL cholesterol level: odds ratio for cardiovascular events, 0.81 (95% confidence interval [CI], 0.74 to 0.89) for PCSK9 and 0.81 (95% CI, 0.72 to 0.90) for HMGCR. Variants in these two genes were also associated with very similar effects on the risk of diabetes: odds ratio for each 10 mg per deciliter decrease in LDL cholesterol, 1.11 (95% CI, 1.04 to 1.19) for PCSK9 and 1.13 (95% CI, 1.06 to 1.20) for HMGCR. The increased risk of diabetes was limited to persons with impaired fasting glucose levels for both scores and was lower in magnitude than the protective effect against cardiovascular events. When present together, PCSK9 and HMGCR variants had additive effects on the risk of both cardiovascular events and diabetes. CONCLUSIONS In this study, variants in PCSK9 had approximately the same effect as variants in HMGCR on the risk of cardiovascular events and diabetes per unit decrease in the LDL cholesterol level. The effects of these variants were independent and additive. (Funded by the Medical Research Council and the National Heart, Lung, and Blood Institute.)	[Ference, Brian A.] Wayne State Univ, Sch Med, Div Cardiovasc Med, 4H 34, Detroit, MI 48202 USA; [Brook, Robert D.] Univ Michigan, Sch Med, Div Cardiovasc Med, Ann Arbor, MI USA; [Neff, David R.] Michigan State Univ, E Lansing, MI 48824 USA; [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Robinson, Jennifer G.] Univ Iowa, Dept Med, Coll Publ Hlth, Iowa City, IA 52242 USA; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Bio Mol Sci, Milan, Italy; [Catapano, Alberico L.] MultiMed Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Chapman, M. John] Pitie Salpetriere Univ Hosp, INSERM, Paris, France; [Voros, Szilard] Global Genom Grp, Richmond, VA USA; [Giugliano, Robert P.; Sabatine, Marc S.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Thrombolysis Myocardial Infarct Study Grp, Boston, MA USA; [Smith, George Davey] Univ Bristol, Integrat Epidemiol Unit, MRC, Bristol, Avon, England; [Fazio, Sergio] Oregon Hlth & Sci Univ, Ctr Prevent Cardiol, Knight Cardiovasc Inst, Portland, OR 97201 USA	Wayne State University; University of Michigan System; University of Michigan; Michigan State University; University of Iowa; University of Iowa; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bristol; Oregon Health & Science University	Ference, BA (corresponding author), Wayne State Univ, Div Cardiovasc Med, Sch Med, UHC, 4H 34, Detroit, MI 48202 USA.	bference@med.wayne.edu	Catapano, alberico/AAC-2827-2019; Sabatine, Marc/AAJ-6751-2020; , Jennifer/AAD-8336-2019; chapman, john/Y-2742-2019; Davey Smith, George/A-7407-2013; Giugliano, Robert/N-7233-2017	Catapano, alberico/0000-0002-7593-2094; Sabatine, Marc/0000-0002-0691-3359; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Giugliano, Robert/0000-0003-4110-7675	Medical Research Council [MC_UU_12013/1]; National Heart, Lung, and Blood Institute [R01HL132985]; MRC [MC_UU_12013/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant (MC_UU_12013/1, to Dr. Davey Smith) from the Medical Research Council and a grant (R01HL132985, to Dr. Fazio) from the National Heart, Lung, and Blood Institute. Funders for the various studies that are discussed in this article are listed in the Supplementary Appendix.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Besseling J, 2015, JAMA-J AM MED ASSOC, V313, P1029, DOI 10.1001/jama.2015.1206; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Koren MJ, 2014, CIRCULATION, V129, P234, DOI 10.1161/CIRCULATIONAHA.113.007012; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Sabatine MS, 2016, AM HEART J, V173, P94, DOI 10.1016/j.ahj.2015.11.015; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Schwartz GG, 2014, AM HEART J, V168, P682, DOI 10.1016/j.ahj.2014.07.028; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	33	443	450	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2144	2153		10.1056/NEJMoa1604304	http://dx.doi.org/10.1056/NEJMoa1604304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED7GN	27959767	Green Published			2022-12-28	WOS:000389030400006
J	Herbert, M; Turnbull, D				Herbert, Mary; Turnbull, Doug			Mitochondrial Donation - Clearing the Final Regulatory Hurdle in the United Kingdom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN OOCYTES; REPLACEMENT		[Herbert, Mary; Turnbull, Doug] Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England; [Herbert, Mary] Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England		Herbert, M (corresponding author), Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.; Herbert, M (corresponding author), Newcastle Fertil Ctr, Newcastle Upon Tyne, Tyne & Wear, England.			Herbert, Mary/0000-0002-8488-2770; Turnbull, Doug/0000-0002-8878-9901	Medical Research Council [1594323, 987165, G0700718B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10077, NF-SI-0510-10187] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish; MRC [MC_G0802536, G0800674, MR/L016354/1, MR/K000608/1, G0700718, MR/J003603/1] Funding Source: UKRI; Medical Research Council [G0800674, MR/L016354/1, G0601157, MR/J003603/1, G0700718, MC_G0802536, MR/K000608/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001	4	12	12	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					171	173		10.1056/NEJMcibr1615669	http://dx.doi.org/10.1056/NEJMcibr1615669			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XI	28030773				2022-12-28	WOS:000392198400014
J	[Anonymous]				[Anonymous]			New Tool to Study Zika Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					18	18		10.1001/jama.2016.19026	http://dx.doi.org/10.1001/jama.2016.19026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030682				2022-12-28	WOS:000391009100006
J	Gavvala, JR; Schuele, SU				Gavvala, Jay R.; Schuele, Stephan U.			New-Onset Seizure in Adults and Adolescents A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							1ST UNPROVOKED SEIZURE; TONIC-CLONIC SEIZURE; CONTROLLED-RELEASE CARBAMAZEPINE; ANTIEPILEPTIC DRUG-WITHDRAWAL; SUDDEN UNEXPECTED DEATH; AMERICAN-ACADEMY; PARTIAL EPILEPSY; GENERIC LAMOTRIGINE; CUTANEOUS REACTIONS; CLINICAL-FEATURES	IMPORTANCE Approximately 8% to 10% of the population will experience a seizure during their lifetime. Only about 2% to 3% of patients go on to develop epilepsy. Understanding the underlying etiology leading to an accurate diagnosis is necessary to ensure appropriate treatment and that patients with low risk for recurrence are not treated unnecessarily. OBSERVATIONS Patients can present with new-onset seizure for a variety of reasons such as acute symptomatic seizures due to acute brain injury ormetabolic derangements, or unprovoked seizures that are the initial manifestation of epilepsy. A patient history and physical examination may identify features more consistent with an epileptic event and laboratory studies and brain imaging can identify an acute insult contributing to the presentation. Patients diagnosed with first-time unprovoked seizure require electroencephalography and epilepsy protocol-specific magnetic resonance imaging of the brain, which includes thin-cut coronal slices to determine risk of recurrence and the need for long-term treatment. In patients who meet the criteria for diagnosis of epilepsy, a carefully selected antiepileptic medication with consideration of comorbidities, adverse effect profile, and type of epilepsy is essential along with appropriate counseling. CONCLUSIONS AND RELEVANCE Approximately 3% of the population will develop epilepsy but 2 to 3 times as many patients will experience a single seizure or seizure-like event. A diagnosis of epilepsy has significant medical, social, and emotional consequences. A careful patient history and physical examination, electroencephalography, and brain imaging are necessary to separate patients with acute symptomatic seizures, single unprovoked seizures, and nonepileptic events from those with new-onset epilepsy.	[Gavvala, Jay R.] Baylor Coll Med, Dept Neurol, 7200 Cambridge 9A, Houston, TX 77030 USA; [Schuele, Stephan U.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Baylor College of Medicine; Northwestern University; Feinberg School of Medicine	Gavvala, JR (corresponding author), Baylor Coll Med, Dept Neurol, 7200 Cambridge 9A, Houston, TX 77030 USA.	jay.gavvala@bcm.edu	Gavvala, Jay/ABF-5040-2021	Gavvala, Jay/0000-0002-9392-6608	American Brain Foundation; American Academy of Neurology; National Institute of Neurological Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; Danny Did Foundation; Sunovion; Eisai	American Brain Foundation; American Academy of Neurology; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Danny Did Foundation; Sunovion; Eisai(Eisai Co Ltd)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gavvala reported receiving support from a research fellowship grant from the American Brain Foundation and the American Academy of Neurology. Dr Schuele reported receiving research support from the National Institute of Neurological Disorders and Stroke, the National Institute on Deafness and Other Communication Disorders, and the Danny Did Foundation; and receiving speaker's fees from Sunovion and Eisai.	Ahmed S Nizam, 2004, WMJ, V103, P49; Andermann F, 2007, EPILEPSIA, V48, P464, DOI 10.1111/j.1528-1167.2007.01007.x; [Anonymous], 1996, Neurology, V47, P600; [Anonymous], 1996, Neurology, V47, P288; Asconape JJ, 2010, NEUROL CLIN, V28, P843, DOI 10.1016/j.ncl.2010.03.026; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Beleza P, 2012, NEUROLOGIST, V18, P109, DOI 10.1097/NRL.0b013e318251e6c3; Bell GS, 2008, NEUROLOGY, V71, P578, DOI 10.1212/01.wnl.0000323813.36193.4d; Berg AT, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01444.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Blume Warren T., 2001, Epilepsia, V42, P1212, DOI 10.1046/j.1528-1157.2001.22001.x; BORA I, 1995, J NEUROL, V242, P157, DOI 10.1007/BF00936889; Brigo F, 2012, EPILEPSY BEHAV, V25, P251, DOI 10.1016/j.yebeh.2012.06.020; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Browne TR, 2001, NEW ENGL J MED, V344, P1145, DOI 10.1056/NEJM200104123441507; Buna DK, 1998, PHARMACOTHERAPY, V18, P235; CHADWICK D, 1991, LANCET, V337, P1175; Chen DK, 2005, NEUROLOGY, V65, P668, DOI 10.1212/01.wnl.0000178391.96957.d0; Cheung YK, 2013, EPILEPSIA, V54, P1307, DOI 10.1111/epi.12217; Cornes Susannah Brock, 2011, Continuum (Minneap Minn), V17, P984, DOI 10.1212/01.CON.0000407056.94789.2d; Cutting S, 2001, EPILEPSIA, V42, P1395, DOI 10.1046/j.1528-1157.2001.14901.x; Delanty N, 1998, LANCET, V352, P383, DOI 10.1016/S0140-6736(98)02158-8; EARNEST MP, 1976, EPILEPSIA, V17, P387, DOI 10.1111/j.1528-1157.1976.tb04450.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fountain NB, 2011, NEUROLOGY, V76, P94, DOI 10.1212/WNL.0b013e318203e9d1; Gerard Elizabeth E, 2016, Continuum (Minneap Minn), V22, P204, DOI 10.1212/CON.0000000000000270; Gilliam FG, 2004, NEUROLOGY, V62, P23, DOI 10.1212/WNL.62.1.23; Goldberg I, 2013, ACTA NEUROL SCAND, V128, P61, DOI 10.1111/ane.12079; Hamiwka LD, 2007, EPILEPSIA, V48, P1062, DOI 10.1111/j.1528-1167.2007.01018.x; Harden Cynthia L, 2014, Continuum (Minneap Minn), V20, P60, DOI 10.1212/01.CON.0000443837.95260.af; Hauser WA, 2008, EPILEPSIA, V49, P8, DOI 10.1111/j.1528-1167.2008.01443.x; Hauser WA, 1998, NEW ENGL J MED, V338, P429, DOI 10.1056/NEJM199802123380704; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; He RQ, 2016, EPILEPSY BEHAV, V64, P233, DOI 10.1016/j.yebeh.2016.08.006; HEINZ ER, 1989, AM J ROENTGENOL, V152, P347, DOI 10.2214/ajr.152.2.347; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Ho K, 2013, NEUROL CLIN PR, P398; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; HOLTZMAN DM, 1989, AM J MED, V87, P173, DOI 10.1016/S0002-9343(89)80693-X; HOPKINS A, 1988, LANCET, V1, P721; Hui ACF, 2001, EPILEPSIA, V42, P94, DOI 10.1046/j.1528-1157.2001.99352.x; Kesselheim AS, 2016, NEUROLOGY, V87, P1796, DOI 10.1212/WNL.0000000000003259; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Krauss GL, 2011, ANN NEUROL, V70, P221, DOI 10.1002/ana.22452; Krumholz A, 2007, NEUROLOGY, V69, P1996, DOI 10.1212/01.wnl.0000285084.93652.43; Krumholz A, 2016, NEUROL CLIN, V34, P427, DOI 10.1016/j.ncl.2015.11.005; Krumholz A, 2015, NEUROLOGY, V84, P1705, DOI 10.1212/WNL.0000000000001487; Krumholz A, 2009, EPILEPSY CURR, V9, P31, DOI 10.1111/j.1535-7511.2008.01283.x; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; Leone MA, 2011, J NEUROL NEUROSUR PS, V82, P924, DOI 10.1136/jnnp.2010.240069; Leung H, 2010, EPILEPSIA, V51, P1570, DOI 10.1111/j.1528-1167.2009.02409.x; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; MATTSON RH, 1992, NEW ENGL J MED, V327, P765, DOI 10.1056/NEJM199209103271104; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; Musicco M, 1997, NEUROLOGY, V49, P991, DOI 10.1212/WNL.49.4.991; Neufeld MY, 2000, EPILEPSY RES, V42, P197, DOI 10.1016/S0920-1211(00)00183-2; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Pillai J, 2006, EPILEPSIA, V47, P14, DOI 10.1111/j.1528-1167.2006.00654.x; Pohlmann-Eden B, 2013, EPILEPTOLOGY, V1, P61; Pohlmann-Eden B, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01445.x; Pohlmann-Eden B, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0663-7; Privitera MD, 2016, LANCET NEUROL, V15, P365, DOI 10.1016/S1474-4422(16)00014-4; Rizvi S, 2016, J NEUROL SCI, V367, P203, DOI 10.1016/j.jns.2016.05.060; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Ryvlin P, 2013, LANCET NEUROL, V12, P966, DOI 10.1016/S1474-4422(13)70214-X; Sabers A, 2003, NEUROLOGY, V61, P570, DOI 10.1212/01.WNL.0000076485.09353.7A; SALINSKY M, 1987, EPILEPSIA, V28, P331, DOI 10.1111/j.1528-1157.1987.tb03652.x; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Schmidt D, 2009, EPILEPSY BEHAV, V15, P56, DOI 10.1016/j.yebeh.2009.02.030; Schreiner A, 2003, CLIN ELECTROENCEPHAL, V34, P140, DOI 10.1177/155005940303400307; SEMPERE AP, 1992, ACTA NEUROL SCAND, V86, P134, DOI 10.1111/j.1600-0404.1992.tb05054.x; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; SHINNAR S, 1990, PEDIATRICS, V85, P1076; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Stroink H, 1998, J NEUROL NEUROSUR PS, V64, P595, DOI 10.1136/jnnp.64.5.595; Ting TY, 2015, EPILEPSIA, V56, P1415, DOI 10.1111/epi.13095; Toledano R, 2008, SEMIN NEUROL, V28, P317, DOI 10.1055/s-2008-1079336; Toledo M, 2013, CLIN NEUROL NEUROSUR, V115, P2111, DOI 10.1016/j.clineuro.2013.07.039; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Velizarova R, 2014, EPILEPSY RES, V108, P1263, DOI 10.1016/j.eplepsyres.2014.04.010; Wellmer J, 2013, EPILEPSIA, V54, P1977, DOI 10.1111/epi.12375; Werhahn KJ, 2015, EPILEPSIA, V56, P450, DOI 10.1111/epi.12926; Wiebe S, 2008, EPILEPSIA, V49, P50, DOI 10.1111/j.1528-1167.2008.01451.x; Wyman AJ, 2016, ANN EMERG MED, P622; Zachry WM, 2009, EPILEPSIA, V50, P493, DOI 10.1111/j.1528-1167.2008.01703.x; Zijlmans M, 2009, J MAGN RESON IMAGING, V30, P256, DOI 10.1002/jmri.21811	98	47	51	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2657	2668		10.1001/jama.2016.18625	http://dx.doi.org/10.1001/jama.2016.18625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027373				2022-12-28	WOS:000391110200019
J	Hosseini, H; Obradovic, MMS; Hoffmann, M; Harper, KL; Sosa, MS; Werner-Klein, M; Nanduri, LK; Werno, C; Ehrl, C; Maneck, M; Patwary, N; Haunschild, G; Guzvic, M; Reimelt, C; Grauvogl, M; Eichner, N; Weber, F; Hartkopf, AD; Taran, FA; Rucker, SYB; Fehm, T; Rack, B; Buchholz, S; Spang, R; Eister, GM; Aguirre-Ghiso, JA; Klein, CA				Hosseini, Hedayatollah; Obradovic, Milan M. S.; Hoffmann, Martin; Harper, Kathryn L.; Sosa, Maria Soledad; Werner-Klein, Melanie; Nanduri, Lahiri Kanth; Werno, Christian; Ehrl, Carolin; Maneck, Matthias; Patwary, Nina; Haunschild, Gundula; Guzvic, Miodrag; Reimelt, Christian; Grauvogl, Michael; Eichner, Norbert; Weber, Florian; Hartkopf, Andreas D.; Taran, Florin-Andrei; Rucker, Sara Y. B.; Fehm, Tanja; Rack, Brigitte; Buchholz, Stefan; Spang, Rainer; Eister, Gunter M.; Aguirre-Ghiso, Julio A.; Klein, Christoph A.			Early dissemination seeds metastasis in breast cancer	NATURE			English	Article							DISSEMINATED TUMOR-CELLS; BONE-MARROW; MOUSE MODEL; MAMMARY; SINGLE; TUMORIGENESIS; NORMALIZATION; EXPRESSION; MUTATIONS; GENE	Accumulating data suggest that metastatic dissemination often occurs early during tumour formation, but the mechanisms of early metastatic spread have not yet been addressed. Here, by studying metastasis in a HER2-driven mouse breast cancer model, we show that progesterone-induced signalling triggers migration of cancer cells from early lesions shortly after HER2 activation, but promotes proliferation in advanced primary tumour cells. The switch from migration to proliferation was regulated by increased HER2 expression and tumour-cell density involving microRNA-mediated progesterone receptor downregulation, and was reversible. Cells from early, low-density lesions displayed more stemness features, migrated more and founded more metastases than cells from dense, advanced tumours. Notably, we found that at least 80% of metastases were derived from early disseminated cancer cells. Karyotypic and phenotypic analysis of human disseminated cancer cells and primary tumours corroborated the relevance of these findings for human metastatic dissemination.	[Hosseini, Hedayatollah; Obradovic, Milan M. S.; Nanduri, Lahiri Kanth; Ehrl, Carolin; Maneck, Matthias; Patwary, Nina; Haunschild, Gundula; Guzvic, Miodrag; Reimelt, Christian; Klein, Christoph A.] Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany; [Hoffmann, Martin; Werno, Christian; Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany; [Harper, Kathryn L.; Sosa, Maria Soledad; Aguirre-Ghiso, Julio A.] Icahn Sch Med Mt Sinai, Div Hematol & Oncol, Dept Med, Dept Otolaryngol,Dept Oncol Sci,Tisch Canc Inst,B, New York, NY 10029 USA; [Werner-Klein, Melanie] Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany; [Grauvogl, Michael; Spang, Rainer] Univ Regensburg, Inst Funct Genom, Dept Stat Bioinformat, D-93053 Regensburg, Germany; [Eichner, Norbert; Eister, Gunter M.] Univ Regensburg, Biochem Ctr Regensburg BZR, Lab RNA Biol, D-93053 Regensburg, Germany; [Weber, Florian] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Hartkopf, Andreas D.; Taran, Florin-Andrei; Rucker, Sara Y. B.] Univ Tubingen, Dept Gynecol & Obstet, D-72076 Tubingen, Germany; [Fehm, Tanja] Univ Dusseldorf, Dept Gynecol & Obstet, D-40225 Dusseldorf, Germany; [Rack, Brigitte] Univ Munich, Dept Gynecol & Obstet, D-80337 Munich, Germany; [Buchholz, Stefan] Univ Med Ctr Regensburg, Dept Gynecol & Obstet, D-93053 Regensburg, Germany; [Obradovic, Milan M. S.] Univ Basel, Univ Basel Hosp, Dept Biomed, Tumor Heterogene Metastasis & Resistance, CH-4031 Basel, Switzerland; [Sosa, Maria Soledad] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pharmacol Sci, One Gustave L Levy Pl, New York, NY 10029 USA; [Nanduri, Lahiri Kanth] Tech Univ Dresden, Dept Gastrointestinal Thorac & Vasc Surg, Med Fak Carl Gustav Carus, D-01307 Dresden, Germany	University of Regensburg; Fraunhofer Gesellschaft; Icahn School of Medicine at Mount Sinai; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf; University of Munich; University of Regensburg; University of Basel; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Klein, CA (corresponding author), Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany.; Klein, CA (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany.	christoph.klein@ukr.de	Taran, Florin-Andrei/GLV-3748-2022; Nanduri, SIva Lahiri Kanth/ABA-5469-2021; Guzvic, Miodrag/AAF-7881-2020	Nanduri, SIva Lahiri Kanth/0000-0002-0258-6055; Guzvic, Miodrag/0000-0001-8089-3969; Weber, Florian/0000-0001-7480-8828; Spang, Rainer/0000-0002-1326-4297; Obradovic, Milan/0000-0002-6313-6226; Fehm, Tanja/0000-0002-4926-0108; Klein, Christoph A./0000-0001-7128-1725	DFG [Kl 1233/2-1, KL 1233/3-1, KL 1233/10-1, Me2064/4-1, SP 938/2-1, INST 89/341-1 FUGG]; Dr Josef Steiner Foundation; ERC [322602]; SWCRF [CA109182, CA196521, CA163131, BC132674, F31 CA183185, BC112380]; NIH [1S10RR024745]; NATIONAL CANCER INSTITUTE [F31CA183185, P30CA196521, U54CA163131, R01CA109182, R03CA191430] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Dr Josef Steiner Foundation; ERC(European Research Council (ERC)European Commission); SWCRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Perry for his critical reading of the manuscript. This work was supported by grants from the DFG (Kl 1233/2-1, KL 1233/3-1, KL 1233/10-1 (C.A.K.); Me2064/4-1, (G.M.); SP 938/2-1 (R.S.); INST 89/341-1 FUGG (TissueFAX)); the Dr Josef Steiner Foundation and ERC (322602) to C.A.K.; the SWCRF, CA109182, CA196521, CA163131, BC132674 (J.A.A.-G.) F31 CA183185 (K.L.H.) BC112380 (M.S.S.), NIH 1S10RR024745 Microscopy CoRE at ISMMS and by a donation from A. Jungmayer.	Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Astolfi A, 2005, AM J PATHOL, V166, P1205, DOI 10.1016/S0002-9440(10)62339-5; Aupperlee MD, 2005, ENDOCRINOLOGY, V146, P3577, DOI 10.1210/en.2005-0346; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Cole BF, 2001, LANCET, V358, P277, DOI 10.1016/S0140-6736(01)05483-6; Dueck A, 2014, FEBS LETT, V588, P632, DOI 10.1016/j.febslet.2014.01.009; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; Fernandez-Valdivia R, 2005, SEMIN REPROD MED, V23, P22, DOI 10.1055/s-2005-864031; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guzvic M, 2014, CANCER RES, V74, P7383, DOI 10.1158/0008-5472.CAN-14-0934; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hafner C, 2010, P NATL ACAD SCI USA, V107, P20780, DOI 10.1073/pnas.1008365107; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mukherjee A, 2010, FASEB J, V24, P4408, DOI 10.1096/fj.10-157982; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; Petti LM, 2000, CELL GROWTH DIFFER, V11, P395; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; VerMilyea MD, 2011, EMBO J, V30, P1841, DOI 10.1038/emboj.2011.92; Yang Y H, 2001, Brief Bioinform, V2, P341, DOI 10.1093/bib/2.4.341; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	55	369	373	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					552	+		10.1038/nature20785	http://dx.doi.org/10.1038/nature20785			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27974799	Green Accepted			2022-12-28	WOS:000391190500045
J	Maitland, K				Maitland, Kathryn			Severe Malaria in African Children - The Need for Continuing Investment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FALCIPARUM-MALARIA; INFECTION		[Maitland, Kathryn] Imperial Coll, Wellcome Ctr Clin Trop Med, London, England	Imperial College London	Maitland, K (corresponding author), Imperial Coll, Wellcome Ctr Clin Trop Med, London, England.			Maitland, Kathryn/0000-0002-0007-0645	MRC [MR/J012483/1, G0601027] Funding Source: UKRI; Medical Research Council [MR/J012483/1, G0601027] Funding Source: Medline; Wellcome Trust [203077] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Medical Research Council, 2011, FEAST CLIN TRIAL FLU; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; WHO, 2013, WORLD MALARIA REPORT 2013, P1	5	27	29	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2416	2417		10.1056/NEJMp1613528	http://dx.doi.org/10.1056/NEJMp1613528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002698	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000390091500003
J	Poduri, A; Pomeroy, SL				Poduri, Annapurna; Pomeroy, Scott L.			Tracking the Fate of Cells in Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Poduri, Annapurna; Pomeroy, Scott L.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Poduri, A (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.							Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758	5	1	1	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2494	2496		10.1056/NEJMcibr1612882	http://dx.doi.org/10.1056/NEJMcibr1612882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002713				2022-12-28	WOS:000390091500015
J	Morgan, J; Kidy, F				Morgan, Jules; Kidy, Farah			Frontline: Working to include London's excluded populations	LANCET			English	Editorial Material									[Kidy, Farah] Doctors World, London, England										0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2974	2974		10.1016/S0140-6736(16)32581-8	http://dx.doi.org/10.1016/S0140-6736(16)32581-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998524				2022-12-28	WOS:000390112300015
J	Harms, A; Maisonneuve, E; Gerdes, K				Harms, Alexander; Maisonneuve, Etienne; Gerdes, Kenn			Mechanisms of bacterial persistence during stress and antibiotic exposure	SCIENCE			English	Review							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; STRINGENT RESPONSE; STAPHYLOCOCCUS-AUREUS; MEDIATED PERSISTENCE; STOCHASTIC INDUCTION; MULTIDRUG TOLERANCE; DRUG TOLERANCE	Bacterial persister cells avoid antibiotic-induced death by entering a physiologically dormant state and are considered a major cause of antibiotic treatment failure and relapsing infections. Such dormant cells form stochastically, but also in response to environmental cues, by various pathways that are usually controlled by the second messenger (p)ppGpp. For example, toxin-antitoxin modules have been shown to play a major role in persister formation in many model systems. More generally, the diversity of molecular mechanisms driving persister formation is increasingly recognized as the cause of physiological heterogeneity that underlies collective multistress and multidrug tolerance of persister subpopulations. In this Review, we summarize the current state of the field and highlight recent findings, with a focus on the molecular basis of persister formation and heterogeneity.	[Harms, Alexander; Maisonneuve, Etienne; Gerdes, Kenn] Ctr Excellence Bacterial Stress Response & Persis, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark		Gerdes, K (corresponding author), Ctr Excellence Bacterial Stress Response & Persis, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kgerdes@bio.ku.dk	Gerdes, Kenn/AAS-5548-2021; Ren, Guogang/P-4540-2017; Harms, Alexander/J-5710-2019	Gerdes, Kenn/0000-0002-7462-4612; Ren, Guogang/0000-0001-8865-1526; Harms, Alexander/0000-0003-2106-1286; maisonneuve, Etienne/0000-0003-3451-1223	Danish National Research Foundation-funded Centre of Excellence BASP [DNRF120]; Novo Nordisk Foundation Laureate Research grant; European Research Council Advanced Investigator grant PERSIST [294517]; European Molecular Biology Organization Long-Term Fellowship [ALTF 564-2016]	Danish National Research Foundation-funded Centre of Excellence BASP; Novo Nordisk Foundation Laureate Research grant; European Research Council Advanced Investigator grant PERSIST; European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO))	This work was supported by the Danish National Research Foundation-funded Centre of Excellence BASP (grant DNRF120), a Novo Nordisk Foundation Laureate Research grant, and the European Research Council Advanced Investigator grant PERSIST (294517). A.H. is grateful for the support of C. Dehio and a European Molecular Biology Organization Long-Term Fellowship (ALTF 564-2016). The authors do not declare any competing interests.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Amato SM, 2015, CURR BIOL, V25, P2090, DOI 10.1016/j.cub.2015.06.034; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Arnoldini M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002627; Baharoglu Z, 2014, FEMS MICROBIOL REV, V38, P1126, DOI 10.1111/1574-6976.12077; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bigger JW, 1944, LANCET, V2, P497; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Brielle R, 2016, CURR OPIN MICROBIOL, V30, P114, DOI 10.1016/j.mib.2016.01.009; Brzozowska I, 2013, PLASMID, V70, P33, DOI 10.1016/j.plasmid.2013.01.007; Cataudella I, 2012, NUCLEIC ACIDS RES, V40, P6424, DOI 10.1093/nar/gks297; Cheverton AM, 2016, MOL CELL, V63, P86, DOI 10.1016/j.molcel.2016.05.002; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Chowdhury N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20519; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Conlon BP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.51, 10.1038/nmicrobiol.2016.51]; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; De Groote VN, 2009, FEMS MICROBIOL LETT, V297, P73, DOI 10.1111/j.1574-6968.2009.01657.x; de Jong IG, 2011, BIOESSAYS, V33, P215, DOI 10.1002/bies.201000127; DeNapoli J, 2013, MOL MICROBIOL, V88, P93, DOI 10.1111/mmi.12172; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Epstein SS, 2009, NATURE, V457, P1083, DOI 10.1038/4571083a; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Fung DKC, 2010, ANTIMICROB AGENTS CH, V54, P1082, DOI 10.1128/AAC.01218-09; Gaca AO, 2015, J BACTERIOL, V197, P1146, DOI 10.1128/JB.02577-14; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; Girgis HS, 2012, P NATL ACAD SCI USA, V109, P12740, DOI 10.1073/pnas.1205124109; Goneau LW, 2014, ANTIMICROB AGENTS CH, V58, P2089, DOI 10.1128/AAC.02552-13; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039185; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hengge Regine, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.5.6.3; Hofsteenge N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-25; Holden DW, 2015, SCIENCE, V347, P30, DOI 10.1126/science.1262033; Hong SH, 2012, MICROB BIOTECHNOL, V5, P509, DOI 10.1111/j.1751-7915.2011.00327.x; Joers A, 2010, J BACTERIOL, V192, P3379, DOI 10.1128/JB.00056-10; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Kim J, 2015, J MICROBIOL, V53, P421, DOI 10.1007/s12275-015-5273-3; Kim JS, 2016, ANTIMICROB AGENTS CH, V60, P2232, DOI 10.1128/AAC.01794-15; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kotte O, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135022; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kwan BW, 2015, ENVIRON MICROBIOL, V17, P4406, DOI 10.1111/1462-2920.12873; Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Leung V, 2012, J BACTERIOL, V194, P2265, DOI 10.1128/JB.06707-11; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levin BR, 2014, CURR OPIN MICROBIOL, V21, P18, DOI 10.1016/j.mib.2014.06.016; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Lobato-Marquez D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09374; Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11; Ma C, 2010, FEMS MICROBIOL LETT, V303, P33, DOI 10.1111/j.1574-6968.2009.01857.x; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Manina G, 2015, CELL HOST MICROBE, V17, P32, DOI 10.1016/j.chom.2014.11.016; Mckay SL, 2015, ANTIMICROB AGENTS CH, V59, P6992, DOI 10.1128/AAC.01532-15; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Michiels JE, 2016, ANTIMICROB AGENTS CH, V60, P4630, DOI 10.1128/AAC.00757-16; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Murakami K, 2005, FEMS MICROBIOL LETT, V242, P161, DOI 10.1016/j.femsle.2004.11.005; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Orman MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8983; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Pu YY, 2016, MOL CELL, V62, P284, DOI 10.1016/j.molcel.2016.03.035; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Schumacher MA, 2015, NATURE, V524, P59, DOI 10.1038/nature14662; Schumacher MA, 2012, CELL REP, V2, P518, DOI 10.1016/j.celrep.2012.08.013; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shan Y, 2015, MBIO, V6, DOI 10.1128/mBio.00078-15; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Stepanyan K, 2015, MOL ECOL, V24, P1572, DOI 10.1111/mec.13127; Stewart B, 2012, EVOLUTION, V66, P933, DOI 10.1111/j.1558-5646.2011.01467.x; Stewart PS, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0010-2014; Stewart PS, 2015, ANTIMICROB AGENTS CH, V59, P3838, DOI 10.1128/AAC.00433-15; Tamman H, 2014, J BACTERIOL, V196, P157, DOI 10.1128/JB.00851-13; Theodore A, 2013, GENETICS, V195, P1265, DOI 10.1534/genetics.113.152306; Tian CZ, 2016, J BACTERIOL, V198, P1918, DOI 10.1128/JB.00062-16; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Torrey HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155127; Van den Bergh B, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.20, 10.1038/nmicrobiol.2016.20]; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Viducic D, 2006, MICROBIOL IMMUNOL, V50, P349, DOI 10.1111/j.1348-0421.2006.tb03793.x; Volzing KG, 2015, MBIO, V6, DOI 10.1128/mBio.00731-15; Vogwill T, 2016, J EVOLUTION BIOL, V29, P1223, DOI 10.1111/jeb.12864; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Walter ND, 2015, J INFECT DIS, V212, P990, DOI 10.1093/infdis/jiv149; Wang WJ, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.7015.01437, 10.3389/fmicb.2015.01437]; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Winther K, 2016, NUCLEIC ACIDS RES, V44, P9860, DOI 10.1093/nar/gkw781; Wood TK, 2016, BIOTECHNOL BIOENG, V113, P476, DOI 10.1002/bit.25721; World Health Organization, 2016, ANTIMICROBIAL RESIST; Wu N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01003; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	134	429	443	71	941	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318							aaf4268	10.1126/science.aaf4268	http://dx.doi.org/10.1126/science.aaf4268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980159				2022-12-28	WOS:000390261300034
J	Sharma, DC				Sharma, Dinesh C.			Delhi looks to expand community clinic initiative	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2855	2855		10.1016/S0140-6736(16)32513-2	http://dx.doi.org/10.1016/S0140-6736(16)32513-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979396				2022-12-28	WOS:000389631700016
J	Ray, LB; Travis, J				Ray, L. Bryan; Travis, John			ON THE CLOCK	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2016	354	6315			SI		987	987						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ED0KQ	28008011				2022-12-28	WOS:000388531800032
J	Myers, SS; Golden, CD; Almada, AA; Osofsky, SA; Pongsiri, MJ				Myers, Samuel S.; Golden, Christopher D.; Almada, Amalia A.; Osofsky, Steven A.; Pongsiri, Montira J.		Planetary Hlth Alliance	Research in planetary health: a call for abstracts	LANCET			English	Editorial Material									[Myers, Samuel S.; Golden, Christopher D.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Myers, Samuel S.; Golden, Christopher D.; Almada, Amalia A.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Osofsky, Steven A.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Pongsiri, Montira J.] Wildlife Conservat Soc, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Cornell University; Wildlife Conservation Society	Myers, SS (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA USA.; Myers, SS (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.			Golden, Christopher/0000-0002-2258-7493				Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1	1	0	0	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2070	2070		10.1016/S0140-6736(16)32054-2	http://dx.doi.org/10.1016/S0140-6736(16)32054-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA1DJ	27968736				2022-12-28	WOS:000386332400010
J	Jack, C; El Helou, T				Jack, Carolyn; El Helou, Therese			Non-healing ulcerative paronychia	LANCET			English	Editorial Material									[Jack, Carolyn; El Helou, Therese] McGill Univ, Div Dermatol, Montreal, PQ H3G 1A4, Canada	McGill University	Jack, C (corresponding author), McGill Univ, Div Dermatol, Montreal, PQ H3G 1A4, Canada.	carolynsarah.jack@mail.mcgill.ca							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1740	1740		10.1016/S0140-6736(16)32400-X	http://dx.doi.org/10.1016/S0140-6736(16)32400-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET3BG	28017401				2022-12-28	WOS:000400151000031
J	Burstein, D; Harrington, LB; Strutt, SC; Probst, AJ; Anantharaman, K; Thomas, BC; Doudna, JA; Banfield, JF				Burstein, David; Harrington, Lucas B.; Strutt, Steven C.; Probst, Alexander J.; Anantharaman, Karthik; Thomas, Brian C.; Doudna, Jennifer A.; Banfield, Jillian F.			New CRISPR-Cas systems from uncultivated microbes	NATURE			English	Article							PROVIDES ACQUIRED-RESISTANCE; SPACER ACQUISITION; ADAPTIVE IMMUNITY; DNA ELEMENTS; SMALL RNA; ARCHAEA; ENDONUCLEASE; GENOMES; CLASSIFICATION; RECOGNITION	CRISPR-Cas systems provide microbes with adaptive immunity by employing short DNA sequences, termed spacers, that guide Cas proteins to cleave foreign DNA(1,2). Class 2 CRISPR-Cas systems are streamlined versions, in which a single RNA-bound Cas protein recognizes and cleaves target sequences(3,4). The programmable nature of these minimal systems has enabled researchers to repurpose them into a versatile technology that is broadly revolutionizing biological and clinical research(5). However, current CRISPR-Cas technologies are based solely on systems from isolated bacteria, leaving the vast majority of enzymes from organisms that have not been cultured untapped. Metagenomics, the sequencing of DNA extracted directly from natural microbial communities, provides access to the genetic material of a huge array of uncultivated organisms(6,7). Here, using genome-resolved metagenomics, we identify a number of CRISPR-Cas systems, including the first reported Cas9 in the archaeal domain of life, to our knowledge. This divergent Cas9 protein was found in little studied nanoarchaea as part of an active CRISPR-Cas system. In bacteria, we discovered two previously unknown systems, CRISPR-CasX and CRISPR-CasY, which are among the most compact systems yet discovered. Notably, all required functional components were identified by metagenomics, enabling validation of robust in vivo RNA-guided DNA interference activity in Escherichia coli. Interrogation of environmental microbial communities combined with in vivo experiments allows us to access an unprecedented diversity of genomes, the content of which will expand the repertoire of microbe-based biotechnologies.	[Burstein, David; Probst, Alexander J.; Anantharaman, Karthik; Thomas, Brian C.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Harrington, Lucas B.; Strutt, Steven C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.; Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	doudna@berkeley.edu; jbanfield@berkeley.edu	Probst, Alexander J/K-2813-2016; Burstein, David/Y-7993-2019; Anantharaman, Karthik/AGM-5680-2022	Burstein, David/0000-0002-6219-1880; Anantharaman, Karthik/0000-0002-9584-2491; Banfield, Jill/0000-0001-8203-8771; Probst, Alexander/0000-0002-9392-6544	EMBO fellowship; US National Science Foundation; German Science Foundation [DFG PR 1603/1-1]; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; National Science Foundation [MCB-1244557]; Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area - US Department of Energy [DE-AC02-05CH11231]	EMBO fellowship(European Molecular Biology Organization (EMBO)); US National Science Foundation(National Science Foundation (NSF)); German Science Foundation(German Research Foundation (DFG)); Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; National Science Foundation(National Science Foundation (NSF)); Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area - US Department of Energy	We thank N. Ma, K. Zhou and D. McGrath for technical assistance; C. Brown, M. Olm, M. O'Connell, J. Chen and S. Floor for reading the manuscript and discussions; and V. Yu for the S. cerevisiae expression strain. D.B. was supported by a long-term EMBO fellowship, L.B.H. by a US National Science Foundation Graduate Research Fellowship, and A.J.P. by a fellowship of the German Science Foundation (DFG PR 1603/1-1). J.A.D. is an Investigator of the Howard Hughes Medical Institute. This research was supported in part by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group, the National Science Foundation (MCB-1244557 to J.A.D.) and the Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area funded by the US Department of Energy (DE-AC02-05CH11231 to J.F.B.). DNA sequencing was conducted at the DOE Joint Genome Institute, a DOE Office of Science User Facility, via the Community Science Program.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Comolli LR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00367; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yelton AP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-485; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2015, ADV SOC BEHAV SCI, V9, P242	35	288	351	8	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 9	2017	542	7640					237	241		10.1038/nature21059	http://dx.doi.org/10.1038/nature21059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK2DJ	28005056	Green Submitted, Green Accepted			2022-12-28	WOS:000393737500042
J	Patel, V; Weobong, B; Weiss, HA; Anand, A; Bhat, B; Katti, B; Dimidjian, S; Araya, R; Hollon, SD; King, M; Vijayakumar, L; Park, AL; McDaid, D; Wilson, T; Velleman, R; Kirkwood, BR; Fairburn, CG				Patel, Vikram; Weobong, Benedict; Weiss, Helen A.; Anand, Arpita; Bhat, Bhargav; Katti, Basavraj; Dimidjian, Sona; Araya, Ricardo; Hollon, Steve D.; King, Michael; Vijayakumar, Lakshmi; Park, A-La; McDaid, David; Wilson, Terry; Velleman, Richard; Kirkwood, Betty R.; Fairburn, Christopher G.			The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial	LANCET			English	Article							COGNITIVE-BEHAVIORAL THERAPY; COMMON MENTAL-DISORDERS; DEVELOPING-COUNTRIES; SYSTEMATIC DEVELOPMENT; ANXIETY; INTERVENTIONS; ACTIVATION; MODERATORS; MEDIATORS; DRINKING	Background Although structured psychological treatments are recommended as first-line interventions for depression, only a small fraction of people globally receive these treatments because of poor access in routine primary care. We assessed the effectiveness and cost-effectiveness of a brief psychological treatment (Healthy Activity Program [HAP]) for delivery by lay counsellors to patients with moderately severe to severe depression in primary health-care settings. Methods In this randomised controlled trial, we recruited participants aged 18-65 years scoring more than 14 on the Patient Health Questionnaire 9 (PHQ-9) indicating moderately severe to severe depression from ten primary health centres in Goa, India. Pregnant women or patients who needed urgent medical attention or were unable to communicate clearly were not eligible. Participants were randomly allocated (1: 1) to enhanced usual care (EUC) alone or EUC combined with HAP in randomly sized blocks (block size four to six [two to four for men]), stratified by primary health centre and sex, and allocation was concealed with use of sequential numbered opaque envelopes. Physicians providing EUC were masked. Primary outcomes were depression symptom severity on the Beck Depression Inventory version II and remission from depression (PHQ-9 score of <10) at 3 months in the intentionto- treat population, assessed by masked field researchers. Secondary outcomes were disability, days unable to work, behavioural activation, suicidal thoughts or attempts, intimate partner violence, and resource use and costs of illness. We assessed serious adverse events in the per-protocol population. This trial is registered with the ISRCTN registry, number ISRCTN95149997. Findings Between Oct 28, 2013, and July 29, 2015, we enrolled and randomly allocated 495 participants (247 [50%] to the EUC plus HAP group [two of whom were subsequently excluded because of protocol violations] and 248 [50%] to the EUC alone group), of whom 466 (95%) completed the 3 month primary outcome assessment (230 [49%] in the EUC plus HAP group and 236 [51%] in the EUC alone group). Participants in the EUC plus HAP group had significantly lower symptom severity (Beck Depression Inventory version II in EUC plus HAP group 19.99 [SD 15.70] vs 27.52 [13.26] in EUC alone group; adjusted mean difference -7.57 [95% CI -10.27 to -4.86]; p< 0.0001) and higher remission (147 [64%] of 230 had a PHQ-9 score of < 10 in the HAP plus EUC group vs 91 [39%] of 236 in the EUC alone group; adjusted prevalence ratio 1.61 [1.34-1.93]) than did those in the EUC alone group. EUC plus HAP showed better results than did EUC alone for the secondary outcomes of disability (adjusted mean difference -2.73 [-4.39 to -1.06]; p= 0.001), days out of work (-2.29 [-3.84 to -0.73]; p= 0.004), intimate partner physical violence in women (0.53 [0.29-0.96]; p= 0.04), behavioural activation (2.17 [1.34-3.00]; p< 0.0001), and suicidal thoughts or attempts (0.61 [0.45-0.83]; p= 0.001). The incremental cost per quality-adjusted life-year gained was $ 9333 (95% CI 3862-28 169; 2015 international dollars), with an 87% chance of being cost-effective in the study setting. Serious adverse events were infrequent and similar between groups (nine [4%] in the EUC plus HAP group vs ten [4%] in the EUC alone group; p= 1.00). Interpretation HAP delivered by lay counsellors plus EUC was better than EUC alone was for patients with moderately severe to severe depression in routine primary care in Goa, India. HAP was readily accepted by this previously untreated population and was cost-effective in this setting. HAP could be a key strategy to reduce the treatment gap for depressive disorders, the leading mental health disorder worldwide. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Patel, Vikram; Anand, Arpita; Bhat, Bhargav; Katti, Basavraj; Velleman, Richard] Sangath Ctr, Bardez Goa 403521, Goa, India; [Patel, Vikram; Weobong, Benedict; Araya, Ricardo; Kirkwood, Betty R.] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, Fac Epidemiol & Populat Hlth, London, England; [Weiss, Helen A.] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, Fac Epidemiol & Populat Hlth, London, England; [Dimidjian, Sona] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Hollon, Steve D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [King, Michael] UCL, Dept Mental Hlth Sci, London, England; [Vijayakumar, Lakshmi] Univ Melbourne, Voluntary Hlth Serv, SNEHA, Melbourne, Vic, Australia; [Park, A-La; McDaid, David] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London, England; [Wilson, Terry] Rutgers Sch Arts & Sci, Dept Psychol, New Brunswick, NJ USA; [Velleman, Richard] Univ Bath, Dept Psychol, Bath, Avon, England; [Fairburn, Christopher G.] Univ Oxford, Dept Psychiat, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Colorado System; University of Colorado Boulder; Vanderbilt University; University of London; University College London; University of Melbourne; University of London; London School Economics & Political Science; Rutgers State University New Brunswick; University of Bath; University of Oxford	Patel, V (corresponding author), Sangath Ctr, Bardez Goa 403521, Goa, India.	vikram.patel@lshtm.ac.uk	weiss, helen/ABC-7823-2021; Park, A-La/W-2101-2018; Velleman, Richard/P-3697-2018; McDaid, David/E-5959-2014; Fairburn, Christopher/AAG-6234-2019; Araya, Ricardo/S-3144-2019; Fairburn, Christopher/AAM-9792-2020	weiss, helen/0000-0003-3547-7936; Park, A-La/0000-0002-4704-4874; McDaid, David/0000-0003-0744-2664; Araya, Ricardo/0000-0002-0420-5148; Fairburn, Christopher/0000-0002-9673-9795; Kirkwood, Betty/0000-0001-5274-6072	Wellcome Trust [091834]; Directorate of Health Services of the Government of Goa	Wellcome Trust(Wellcome TrustEuropean Commission); Directorate of Health Services of the Government of Goa	Wellcome Trust.; This research was funded by a Wellcome Trust Senior Research Fellowship grant to VP (091834). We also acknowledge the generous partnership and support from the Directorate of Health Services of the Government of Goa.	Aggarwal NK, 2014, J AFFECT DISORDERS, V163, P88, DOI 10.1016/j.jad.2014.03.036; Bower P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f540; Burtoff C, 2012, B WORLD HEALTH ORGAN, V90, P813; Chisholm D, 2000, BRIT J PSYCHIAT, V177, pS28, DOI 10.1192/bjp.177.39.s28; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; Chowdhary N, 2016, BRIT J PSYCHIAT, V208, P381, DOI 10.1192/bjp.bp.114.161075; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Cuijpers P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002542; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Driessen E, 2010, PSYCHIAT CLIN N AM, V33, P537, DOI 10.1016/j.psc.2010.04.005; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Hopko DR, 2015, OXFORD HDB COGNITIVE; Kraemer HC, 2016, AM J PSYCHIAT, V173, P672, DOI 10.1176/appi.ajp.2016.15101333; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Maziak W, 2004, INT J TUBERC LUNG D, V8, P403; Minsitry of Statistics and Programme Implementation, 2016, STAT DOM PROD OTH AG; Nadkarni A, 2016, LANCET; Nadkarni A, 2015, ALCOHOL CLIN EXP RES, V39, P522, DOI 10.1111/acer.12653; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533; Patel V, 2000, PSYCHOL MED, V30, P743, DOI 10.1017/S0033291799002147; Patel V, 2006, ARCH GEN PSYCHIAT, V63, P404, DOI 10.1001/archpsyc.63.4.404; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; Patel V., 2016, LANCET; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Patel V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-101; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Richards DA, 2016, LANCET, V388, P871, DOI 10.1016/S0140-6736(16)31140-0; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Singla DR, 2014, BEHAV RES THER, V60, P53, DOI 10.1016/j.brat.2014.06.006; Steer RA, 2001, PSYCHOL REP, V88, P1075, DOI 10.2466/PR0.88.3.1075-1076; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; TAN-TORRES TE, 2003, MAKING CHOICES HLTH; Ustin T, 1995, MENTAL ILLNESS GEN H; van Ginneken N, 2013, COCHRANE DB SYST REV, V11; Vellakkal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134189; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization Mental Health Gap Action Programme (mhGAP), 2008, SCAL CAR MENT NEUR S	43	195	195	2	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					176	185		10.1016/S0140-6736(16)31589-6	http://dx.doi.org/10.1016/S0140-6736(16)31589-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	27988143	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000392117600029
J	Chi, KR				Chi, Kelly Rae			Rising in the East	NATURE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; EPIDEMIOLOGY; PREVALENCE; RISK											Ananthakrishnan AN, 2013, GASTROENTEROLOGY, V145, P970, DOI 10.1053/j.gastro.2013.07.050; Benchimol EI, 2015, AM J GASTROENTEROL, V110, P553, DOI 10.1038/ajg.2015.52; Hilmi I, 2015, J CROHNS COLITIS, V9, P404, DOI 10.1093/ecco-jcc/jjv039; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Ng SC, 2016, INFLAMM BOWEL DIS, V22, P1954, DOI 10.1097/MIB.0000000000000846; Ng Siew C, 2016, Gastroenterol Hepatol (N Y), V12, P193; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587	8	22	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S100	S102		10.1038/540S100a	http://dx.doi.org/10.1038/540S100a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002397	Bronze			2022-12-28	WOS:000391190500003
J	Hodson, R				Hodson, Richard			Inflammatory bowel disease	NATURE			English	Editorial Material																			0	85	89	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S97	S97		10.1038/540S97a	http://dx.doi.org/10.1038/540S97a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002398	Bronze			2022-12-28	WOS:000391190500001
J	Grool, AM; Aglipay, M; Momoli, F; Meehan, WP; Freedman, SB; Yeates, KO; Gravel, J; Gagnon, I; Boutis, K; Meeuwisse, W; Barrowman, N; Ledoux, AA; Osmond, MH; Zemek, R				Grool, Anne M.; Aglipay, Mary; Momoli, Franco; Meehan, William P., III; Freedman, Stephen B.; Yeates, Keith Owen; Gravel, Jocelyn; Gagnon, Isabelle; Boutis, Kathy; Meeuwisse, Willem; Barrowman, Nick; Ledoux, Andree-Anne; Osmond, Martin H.; Zemek, Roger		Pediat Emergency Res Canada PERC	Association Between Early Participation in Physical Activity Following Acute Concussion and Persistent Postconcussive Symptoms in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXERCISE PHYSIOLOGY; PROPENSITY SCORE; AEROBIC FITNESS; BRAIN; SPORT; REST; RISK	IMPORTANCE Although concussion treatment guidelines advocate rest in the immediate postinjury period until symptoms resolve, no clear evidence has determined that avoiding physical activity expedites recovery. OBJECTIVE To investigate the association between participation in physical activity within 7 days postinjury and incidence of persistent postconcussive symptoms (PPCS). DESIGN, SETTING, AND PARTICIPANTS Prospective, multicenter cohort study (August 2013-June 2015) of 3063 children and adolescents aged 5.00-17.99 years with acute concussion from 9 Pediatric Emergency Research Canada network emergency departments (EDs). EXPOSURES Early physical activity participation within 7 days postinjury. MAIN OUTCOMES AND MEASURES Physical activity participation and postconcussive symptom severity were rated using standardized questionnaires in the ED and at days 7 and 28 postinjury. PPCS (>= 3 new orworsening symptoms on the Post-Concussion Symptom Inventory) was assessed at 28 days postenrollment. Early physical activity and PPCS relationships were examined by unadjusted analysis, 1: 1 propensity score matching, and inverse probability of treatment weighting (IPTW). Sensitivity analyses examined patients (>= 3 symptoms) at day 7. RESULTS Among 2413 participants who completed the primary outcome and exposure, (mean [SD] age, 11.77 [3.35] years; 1205 [39.3%] females), PPCS at 28 days occurred in 733 (30.4%); 1677 (69.5%) participated in early physical activity including light aerobic exercise (n = 795 [32.9%]), sport-specific exercise (n = 214 [8.9%]), noncontact drills (n = 143 [5.9%]), full-contact practice (n = 106 [4.4%]), or full competition (n = 419 [17.4%]), whereas 736 (30.5%) had no physical activity. On unadjusted analysis, early physical activity participants had lower risk of PPCS than those with no physical activity (24.6% vs 43.5%; Absolute risk difference [ARD], 18.9%[95% CI, 14.7%-23.0%]). Early physical activity was associated with lower PPCS risk on propensity score matching (n = 1108 [28.7% for early physical activity vs 40.1% for no physical activity]; ARD, 11.4%[95% CI, 5.8%-16.9%]) and on inverse probability of treatment weighting analysis (n = 2099; relative risk [RR], 0.74 [95% CI, 0.65-0.84]; ARD, 9.7%[95% CI, 5.7%-13.7%]). Among only patients symptomatic at day 7 (n = 803) compared with those who reported no physical activity (n = 584; PPCS, 52.9%), PPCS rates were lower for participants of light aerobic activity (n = 494 [46.4%]; ARD, 6.5% [95% CI, 5.7%-12.5%]), moderate activity (n = 176 [38.6%]; ARD, 14.3%[95% CI, 5.9%-22.2%]), and full-contact activity (n = 133 [36.1%]; ARD, 16.8%[95% CI, 7.5%-25.5%]). No significant group difference was observed on propensity-matched analysis of this subgroup (n = 776 [47.2% vs 51.5%]; ARD, 4.4%[95% CI, -2.6% to 11.3%]). CONCLUSIONS AND RELEVANCE Among participants aged 5 to 18 years with acute concussion, physical activity within 7 days of acute injury compared with no physical activity was associated with reduced risk of PPCS at 28 days. A well-designed randomized clinical trial is needed to determine the benefits of early physical activity following concussion.	[Grool, Anne M.; Aglipay, Mary; Momoli, Franco; Barrowman, Nick; Ledoux, Andree-Anne] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp Res Inst, Alberta Childrens Hosp, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 1N4, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Gravel, Jocelyn] Univ Montreal, Hosp Ste Justine, Dept Pediat, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Osmond, Martin H.; Zemek, Roger] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Boston Children's Hospital; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; Universite de Montreal; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Ottawa; Children's Hospital of Eastern Ontario	Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Barlow, Karen/I-6492-2019; Barrowman, Nick/AAL-3166-2020; Yeates, Keith/AAJ-4223-2020; Barlow, Karen/C-1323-2014; Zemek, Roger/H-1039-2018; Freedman, Stephen/H-9102-2012	Barlow, Karen/0000-0003-2612-8507; Barrowman, Nick/0000-0002-4704-9595; Barlow, Karen/0000-0003-2612-8507; Gagnon, Isabelle/0000-0003-2043-1644; Osmond, Martin/0000-0001-8275-8381; Ledoux, Andree-Annne/0000-0002-3163-0844; Freedman, Stephen/0000-0003-2319-6192; Gravel, Jocelyn/0000-0001-5901-4990; Yeates, Keith Owen/0000-0001-7680-2892	Canadian Institutes of Health Research (CIHR) [MOP 126197]; CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury [TM1127047]; CIHR [MRP 119829]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury; CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research (CIHR) operating grant (MOP 126197); a CIHR-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury team grant (TM1127047); and CIHR planning grant (MRP 119829).	Adamo KB, 2009, INT J PEDIATR OBES, V4, P2, DOI 10.1080/17477160802315010; Annest JJ, 2005, PSYCHOL REP, V96, P891, DOI 10.2466/pr0.96.3c.891-898; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Chaddock-Heyman L, 2014, MONOGR SOC RES CHILD, V79, P25, DOI 10.1111/mono.12129; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Farquhar WB, 2015, AUTON NEUROSCI-BASIC, V188, P1, DOI 10.1016/j.autneu.2014.11.001; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haukoos JS, 2015, JAMA-J AM MED ASSOC, V314, P1637, DOI 10.1001/jama.2015.13480; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howie EK, 2012, J SPORT HEALTH SCI, V1, P160, DOI 10.1016/j.jshs.2012.09.003; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Longmuir PE, 2014, APPL PHYSIOL NUTR ME, V39, P1271, DOI 10.1139/apnm-2014-0074; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKay HA, 2000, J PEDIATR-US, V136, P156, DOI 10.1016/S0022-3476(00)70095-3; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Perrey S, 2013, BRAIN SCI, V3, P101, DOI 10.3390/brainsci3010101; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rush E, 2014, MED SPORT SCI, V60, P113, DOI 10.1159/000357341; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scott D.W, 1992, WILEY SERIES PROBABI; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williamson EJ, 2014, RESPIROLOGY, V19, P625, DOI 10.1111/resp.12312; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zemek R., 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	42	174	174	2	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2504	2514		10.1001/jama.2016.17396	http://dx.doi.org/10.1001/jama.2016.17396			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG3QH	27997652				2022-12-28	WOS:000390959300018
J	Palmer, J; Berman, P; Howe, R				Palmer, Joanna; Berman, Philippa; Howe, Rhiannon			2016 Wakley Prize: connections and memories	LANCET			English	Editorial Material									[Palmer, Joanna; Berman, Philippa; Howe, Rhiannon] The Lancet, London EC2Y 5AS, England		Palmer, J (corresponding author), The Lancet, London EC2Y 5AS, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2969	2969		10.1016/S0140-6736(16)32575-2	http://dx.doi.org/10.1016/S0140-6736(16)32575-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27998520				2022-12-28	WOS:000390112300011
J	Wilcock, WSD; Tolstoy, M; Waldhauser, F; Garcia, C; Tan, YJ; Bohnenstiehl, DR; Caplan-Auerbach, J; Dziak, RP; Arnulf, AF; Mann, ME				Wilcock, William S. D.; Tolstoy, Maya; Waldhauser, Felix; Garcia, Charles; Tan, Yen Joe; Bohnenstiehl, DelWayne R.; Caplan-Auerbach, Jacqueline; Dziak, Robert P.; Arnulf, Adrien F.; Mann, M. Everett			Seismic constraints on caldera dynamics from the 2015 Axial Seamount eruption	SCIENCE			English	Article							DE-FUCA RIDGE; FLOOR SPREADING EVENT; EARTHQUAKE LOCATIONS; VOLCANO; FAULT; DEFORMATION; CALIFORNIA	Seismic observations in volcanically active calderas are challenging. A new cabled observatory atop Axial Seamount on the Juan de Fuca ridge allows unprecedented real-time monitoring of a submarine caldera. Beginning on 24 April 2015, the seismic network captured an eruption that culminated in explosive acoustic signals where lava erupted on the seafloor. Extensive seismic activity preceding the eruption shows that inflation is accommodated by the reactivation of an outward-dipping caldera ring fault, with strong tidal triggering indicating a critically stressed system. The ring fault accommodated deflation during the eruption and provided a pathway for a dike that propagated south and north beneath the caldera's east wall. Once north of the caldera, the eruption stepped westward, and a dike propagated along the extensional north rift.	[Wilcock, William S. D.; Garcia, Charles] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Tolstoy, Maya; Waldhauser, Felix; Tan, Yen Joe] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Bohnenstiehl, DelWayne R.; Mann, M. Everett] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA; [Caplan-Auerbach, Jacqueline] Western Washington Univ, Dept Geol, Bellingham, WA 98225 USA; [Dziak, Robert P.] NOAA, Pacific Marine Environm Lab, Newport, OR 97365 USA; [Arnulf, Adrien F.] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA	University of Washington; University of Washington Seattle; Columbia University; University of North Carolina; North Carolina State University; Western Washington University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Texas System; University of Texas Austin	Wilcock, WSD (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	wilcock@uw.edu	Tan, Yen Joe/I-5808-2019; Mann, Michael Everett/AAC-4637-2021; Mann, Michael E/B-8472-2017; Dziak, Robert/AAC-6107-2020	Tan, Yen Joe/0000-0001-6377-7886; Mann, Michael E/0000-0003-3067-296X; Arnulf, Adrien/0000-0002-4398-2142; Wilcock, William/0000-0001-7224-7246; Mann, Michael/0000-0001-8418-078X	National Science Foundation [OCE-1536219, OCE-1536320, OCE-1635276, OCE-1357076, DGE-1256082]; Directorate For Geosciences [1536320, 1536219] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The seismic data used for this study are archived at the Incorporated Research Institutions for Seismology Data Management System and the Ocean Observatories Initiative (OOI) Data Portal. The earthquake catalogs are archived in the Interdisciplinary Earth Data Alliance Marine Geoscience Data System (DOI: 10.1594/IEDA/323843). This work was supported by the National Science Foundation under awards OCE-1536219, OCE-1536320, OCE-1635276, OCE-1357076, and DGE-1256082. The seismic network was installed and is operated by the OOI Cabled Array team, led by J. Delaney and D. Kelley. This paper is Pacific Marine Environmental Laboratory contribution no. 4522.	Acocella V, 2007, EARTH-SCI REV, V85, P125, DOI 10.1016/j.earscirev.2007.08.004; Ahmed A, 2016, GEOPHYS J INT, V205, P1244, DOI 10.1093/gji/ggw068; Arnulf AF, 2014, GEOLOGY, V42, P655, DOI 10.1130/G35629.1; Buchardt S., 2010, B VOLCANOL, V72, P297; Buck WR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003879; Caplan-Auerbach J., 2001, GEOCHEM GEOPHY GEOSY, V2, P1024, DOI DOI 10.1029/2000GC000113; Chadwick WW, 2016, GEOPHYS RES LETT, V43, P12063, DOI 10.1002/2016GL071327; Chadwick WW, 2012, NAT GEOSCI, V5, P474, DOI 10.1038/ngeo1464; CRISP JA, 1984, J VOLCANOL GEOTH RES, V20, P177, DOI 10.1016/0377-0273(84)90039-8; Dziak RP, 2015, GEOPHYS RES LETT, V42, P1480, DOI 10.1002/2014GL062603; Dziak RP, 2012, NAT GEOSCI, V5, P478, DOI 10.1038/ngeo1490; Dziak RP, 1999, GEOPHYS RES LETT, V26, P3429, DOI 10.1029/1999GL002332; EKSTROM G, 1994, EARTH PLANET SC LETT, V128, P707, DOI 10.1016/0012-821X(94)90184-8; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; Geyer A, 2014, FRONT EARTH SC-SWITZ, V2, DOI 10.3389/feart.2014.00022; Gudmundsson A, 1999, J VOLCANOL GEOTH RES, V88, P1, DOI 10.1016/S0377-0273(98)00107-3; Gudmundsson MT, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8988; Helo C, 2011, NAT GEOSCI, V4, P260, DOI [10.1038/NGEO1104, 10.1038/ngeo1104]; Kelley DS, 2014, MAR GEOL, V352, P426, DOI 10.1016/j.margeo.2014.03.010; Kennedy B, 2004, GEOL SOC AM BULL, V116, P515, DOI 10.1130/B25228.1; Michon L, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007636; MORI J, 1987, SCIENCE, V235, P193, DOI 10.1126/science.235.4785.193; Mori J., 1996, FIRE MUD ERUPTIONS L, P335; Newhall C., 1988, USGS, V1855, P210, DOI 10.3133/b1855; Nooner SL, 2016, SCIENCE, V354, P1399, DOI 10.1126/science.aah4666; Prejean S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018334; Roche O, 2000, J GEOPHYS RES-SOL EA, V105, P395, DOI 10.1029/1999JB900298; Schlindwein V, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002706; Sigmundsson F, 2015, NATURE, V517, P191, DOI 10.1038/nature14111; Sohn RA, 2008, NATURE, V453, P1236, DOI 10.1038/nature07075; Stroup DF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030088; Tan YJ, 2016, NATURE, V540, P261, DOI 10.1038/nature20116; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Wilcock WSD, 2001, GEOPHYS RES LETT, V28, P3999, DOI 10.1029/2001GL013370; Wright TJ, 2012, NAT GEOSCI, V5, P242, DOI [10.1038/ngeo1428, 10.1038/NGEO1428]; Zobin V., 2012, INTRO VOLCANIC SEISM	37	74	74	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1395	1399		10.1126/science.aah5563	http://dx.doi.org/10.1126/science.aah5563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980204				2022-12-28	WOS:000390261300036
J	Brar, GA				Brar, Gloria A.			Beyond the Triplet Code: Context Cues Transform Translation	CELL			English	Review							RIBOSOME PROFILING REVEALS; NON-AUG CODONS; DYNAMIC N-1-METHYLADENOSINE METHYLOME; MESSENGER-RNA; GENETIC-CODE; IN-VIVO; MAPPING REVEALS; STOP CODON; NUCLEOTIDE RESOLUTION; WIDESPREAD OCCURRENCE	The elucidation of the genetic code remains among the most influential discoveries in biology. While innumerable studies have validated the general universality of the code and its value in predicting and analyzing protein coding sequences, established and emerging work has also suggested that full genome decryption may benefit from a greater consideration of a codon's neighborhood within an mRNA than has been broadly applied. This Review examines the evidence for context cues in translation, with a focus on several recent studies that reveal broad roles for mRNA context in programming translation start sites, the rate of translation elongation, and stop codon identity.	[Brar, Gloria A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Brar, Gloria A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Brar, GA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Brar, GA (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA.	gabrar@berkeley.edu			NIH [DP2-GM-119138, P50-GM102706]; March of Dimes; Alfred P. Sloan Foundation; Pew Charitable Trusts	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Pew Charitable Trusts	I thank Joshua Dunn and Calvin Jan for critical reading of this manuscript and for helpful discussions. I am grateful for the NIH funding (DP2-GM-119138 and P50-GM102706) that supports research in my lab, along with investigator awards from the March of Dimes, Alfred P. Sloan Foundation, and the Pew Charitable Trusts.	Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Baranov PV, 2015, NAT REV GENET, V16, P517, DOI 10.1038/nrg3963; Bazzini AA, 2016, EMBO J, V35, P2087, DOI 10.15252/embj.201694699; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bekaert M, 2010, NUCLEIC ACIDS RES, V38, pD69, DOI 10.1093/nar/gkp788; BOSSI L, 1980, NATURE, V286, P123, DOI 10.1038/286123a0; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Bustamante CJ, 2014, ANNU REV BIOPHYS, V43, P119, DOI 10.1146/annurev-biophys-051013-022811; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; CARON F, 1985, NATURE, V314, P185, DOI 10.1038/314185a0; Chevance FFV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004392; Chew GL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11663; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; Deng X, 2015, NUCLEIC ACIDS RES, V43, P6557, DOI 10.1093/nar/gkv596; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Elena C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00021; Eswarappa SM, 2015, CANCER RES, V75, P2765, DOI 10.1158/0008-5472.CAN-14-3805; Fernandez IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302; Fields AP, 2015, MOL CELL, V60, P816, DOI 10.1016/j.molcel.2015.11.013; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2012, NUCLEIC ACIDS RES, V40, P10053, DOI 10.1093/nar/gks772; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gonzalez-Flores Jonathan N, 2013, Biomol Concepts, V4, P349, DOI 10.1515/bmc-2013-0007; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Green KM, 2016, BRAIN RES, V1647, P30, DOI 10.1016/j.brainres.2016.04.003; Grosjean H, 2016, NUCLEIC ACIDS RES, V44, P8020, DOI 10.1093/nar/gkw608; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hatfield GW, 2007, BIOTECHNOL ANN REV, V13, P27, DOI 10.1016/S1387-2656(07)13002-7; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hoernes TP, 2016, NUCLEIC ACIDS RES, V44, P852, DOI 10.1093/nar/gkv1182; Hug N, 2016, NUCLEIC ACIDS RES, V44, P1483, DOI 10.1093/nar/gkw010; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jungreis I., 2016, MOL BIOL EVOL; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Komar AA, 2012, GENE, V502, P75, DOI 10.1016/j.gene.2012.04.039; Koutmou KS, 2015, ELIFE, V4, DOI 10.7554/eLife.05534; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/nchembio.1836, 10.1038/NCHEMBIO.1836]; Liu MJ, 2013, PLANT CELL, V25, P3699, DOI 10.1105/tpc.113.114769; Liu NA, 2015, METHOD ENZYMOL, V560, P149, DOI 10.1016/bs.mie.2015.03.005; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Lovejoy AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110799; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Menschaert G, 2013, MOL CELL PROTEOMICS, V12, P1780, DOI 10.1074/mcp.M113.027540; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28; Moura G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000847; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Swart EC, 2016, CELL, V166, P691, DOI 10.1016/j.cell.2016.06.020; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tsai A, 2016, PROG MOL BIOL TRANSL, V139, P1, DOI 10.1016/bs.pmbts.2015.10.006; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Young DJ, 2015, CELL, V162, P872, DOI 10.1016/j.cell.2015.07.041; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108; Zur H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003136	107	36	37	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1681	1692		10.1016/j.cell.2016.09.022	http://dx.doi.org/10.1016/j.cell.2016.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984720	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000393114700009
J	Castillo-Quan, JI; Blackwell, TK				Castillo-Quan, Jorge Ivan; Blackwell, T. Keith			Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging	CELL			English	Editorial Material							C. ELEGANS; MTORC1; AMPK	In this issue of Cell, Wu et al. employed C. elegans and human cell experiments to identify a pathway through which metformin increases lifespan and inhibits growth. A key transcriptional target, ACAD10, is activated when metformin induces nuclear exclusion of the GTPase RagC, thereby inhibiting mTORC1 through an unexpected mechanism.	[Castillo-Quan, Jorge Ivan; Blackwell, T. Keith] Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA; [Castillo-Quan, Jorge Ivan; Blackwell, T. Keith] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Castillo-Quan, Jorge Ivan; Blackwell, T. Keith] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Blackwell, TK (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.; Blackwell, TK (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Blackwell, TK (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA.	keith.blackwell@joslin.harvard.edu	Castillo-Quan, Jorge Ivan/G-2270-2010	Castillo-Quan, Jorge Ivan/0000-0002-6324-2854	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094398] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM094398, R01 GM062891] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Castillo-Quan JI, 2015, ADV GENET, V90, P1, DOI 10.1016/bs.adgen.2015.06.002; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535	9	29	29	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1670	1671		10.1016/j.cell.2016.11.058	http://dx.doi.org/10.1016/j.cell.2016.11.058			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984715	Bronze			2022-12-28	WOS:000393114700004
J	Lynch, SV; Pedersen, O				Lynch, Susan V.; Pedersen, Oluf			The Human Intestinal Microbiome in Health and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN GUT MICROBIOME; FECAL MICROBIOTA; METABOLIC-CHANGES; INNATE IMMUNITY; BACTERIA; EXPOSURE; STRAINS; CELLS; SHAPE; OBESE		[Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, 513 Parnassus Ave,S357D, San Francisco, CA 94143 USA; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	University of California System; University of California San Francisco; Novo Nordisk Foundation; University of Copenhagen	Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, 513 Parnassus Ave,S357D, San Francisco, CA 94143 USA.; Pedersen, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res,DIKU, Univ Pk 1,1st Floor, DK-2100 Copenhagen, Denmark.	susan.lynch@ucsf.edu; oluf@sund.ku.dk	Pedersen, Oluf/AAG-8015-2020					Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Brahe LK, 2015, BRIT J NUTR, V114, P406, DOI 10.1017/S0007114515001786; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Chen ZY, 2014, J CLIN INVEST, V124, P3391, DOI 10.1172/JCI72517; Cheng J, 2016, ISME J, V10, P1002, DOI 10.1038/ismej.2015.177; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duan FP, 2008, APPL ENVIRON MICROB, V74, P7437, DOI 10.1128/AEM.01019-08; Duan FF, 2015, DIABETES, V64, P1794, DOI 10.2337/db14-0635; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Fulde M, 2014, IMMUNOL REV, V260, P21, DOI 10.1111/imr.12190; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Ha CWY, 2014, WORLD J GASTROENTERO, V20, P16498, DOI 10.3748/wjg.v20.i44.16498; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Hollister EB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0101-x; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ijssennagger N, 2015, P NATL ACAD SCI USA, V112, P10038, DOI 10.1073/pnas.1507645112; Johnson CC, 2005, J ALLERGY CLIN IMMUN, V115, P1218, DOI 10.1016/j.jaci.2005.04.020; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Konichi H, 2016, NAT COMMUN; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lakshminarayanan B, 2013, J APPL MICROBIOL, V114, P886, DOI 10.1111/jam.12085; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lozupone CA, 2014, GUT MICROBES, V5, P562, DOI 10.4161/gmic.32132; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Macfarlane S, 2013, ALIMENT PHARM THER, V38, P804, DOI 10.1111/apt.12453; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Marinho FAV, 2010, CLIN EXP ALLERGY, V40, P1541, DOI 10.1111/j.1365-2222.2010.03502.x; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; Neef A, 2013, CURR OPIN CLIN NUTR, V16, P679, DOI 10.1097/MCO.0b013e328365c258; Neuman H, 2015, FEMS MICROBIOL REV, V39, P509, DOI 10.1093/femsre/fuu010; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tvede M, 2015, CLIN MICROBIOL INFEC, V21, P48, DOI 10.1016/j.cmi.2014.07.003; Uusitalo U, 2016, JAMA PEDIATR, V170, P20, DOI 10.1001/jamapediatrics.2015.2757; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Wang WL, 2015, WORLD J GASTROENTERO, V21, P803, DOI 10.3748/wjg.v21.i3.803; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Westendorf AM, 2005, FEMS IMMUNOL MED MIC, V43, P373, DOI 10.1016/j.femsim.2004.10.023; Wu H, 2015, TRENDS ENDOCRIN MET, V26, P758, DOI 10.1016/j.tem.2015.09.011; Yallapragada SG, 2015, PEDIATR ANN, V44, pE265, DOI 10.3928/00904481-20151112-09; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	112	1476	1582	53	758	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2369	2379		10.1056/NEJMra1600266	http://dx.doi.org/10.1056/NEJMra1600266			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	27974040				2022-12-28	WOS:000390036500008
J	Schirmer, M; Smeekens, SP; Vlamakis, H; Jaeger, M; Oosting, M; Franzosa, EA; ter Horst, R; Jansen, T; Jacobs, L; Bonder, MJ; Kurilshikov, A; Fu, JY; Joosten, LAB; Zhernakova, A; Huttenhower, C; Wijmenga, C; Netea, MG; Xavier, RJ				Schirmer, Melanie; Smeekens, Sanne P.; Vlamakis, Hera; Jaeger, Martin; Oosting, Marije; Franzosa, Eric A.; ter Horst, Rob; Jansen, Trees; Jacobs, Liesbeth; Bonder, Marc Jan; Kurilshikov, Alexander; Fu, Jingyuan; Joosten, Leo A. B.; Zhernakova, Alexandra; Huttenhower, Curtis; Wijmenga, Cisca; Netea, Mihai G.; Xavier, Ramnik J.			Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity (vol 167, pg 1125, 2016)	CELL			English	Correction												mihai.netea@radboudumc.nl; xavier@molbio.mgh.harvard.edu	Horst, Rob Ter/G-3536-2016; Kurilshikov, Alexander/GWC-1519-2022; Jaeger, Martin/H-3359-2015; Zhernakova, Alexandra/ABA-9372-2020; Wijmenga, Cisca/AAE-7719-2019; Netea, Mihai/N-5155-2014; Schirmer, Melanie/HDN-5528-2022; Fu, JY/GRR-6179-2022; Fu, Jingyuan/E-8980-2012; Smeekens, Sanne/G-8307-2011; Smeekens, Sanne/AAZ-2061-2021; Joosten, Leo AB/H-3138-2015; Fu, Jingyuan/ABE-6868-2020; Oosting, Marije/H-7437-2015	Horst, Rob Ter/0000-0003-0576-5873; Kurilshikov, Alexander/0000-0003-2541-5627; Jaeger, Martin/0000-0001-6994-493X; Wijmenga, Cisca/0000-0002-5635-1614; Smeekens, Sanne/0000-0002-7835-914X; Smeekens, Sanne/0000-0002-7835-914X; Joosten, Leo AB/0000-0001-6166-9830; Fu, Jingyuan/0000-0001-5578-1236; Bonder, Marc Jan/0000-0002-8431-3180				Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020	1	68	69	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1897	1897		10.1016/j.cell.2016.11.046	http://dx.doi.org/10.1016/j.cell.2016.11.046			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984736	Green Published, Bronze			2022-12-28	WOS:000393114700026
J	Swaffer, MP; Jones, AW; Flynn, HR; Snijders, AP; Nurse, P				Swaffer, Matthew P.; Jones, Andrew W.; Flynn, Helen R.; Snijders, Ambrosius P.; Nurse, Paul			CDK Substrate Phosphorylation and Ordering the Cell Cycle	CELL			English	Article							B-TYPE CYCLIN; YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; PROTEIN-KINASE; S-PHASE; QUANTITATIVE MODEL; GLOBAL ANALYSIS; AMINO-ACIDS; MITOSIS; SPECIFICITY	S phase and mitotic onset are brought about by the action of multiple different cyclin-CDK complexes. However, it has been suggested that changes in the total level of CDK kinase activity, rather than substrate specificity, drive the temporal ordering of S phase and mitosis. Here, we present a phosphoproteomics-based systems analysis of CDK substrates in fission yeast and demonstrate that the phosphorylation of different CDK substrates can be temporally ordered during the cell cycle by a single cyclin-CDK. This is achieved by rising CDK activity and the differential sensitivity of substrates to CDK activity over a wide dynamic range. This is combined with rapid phosphorylation turnover to generate clearly resolved substrate-specific activity thresholds, which in turn ensures the appropriate ordering of downstream cell-cycle events. Comparative analysis with wild-type cells expressing multiple cyclin-CDK complexes reveals how cyclin-substrate specificity works alongside activity thresholds to fine-tune the patterns of substrate phosphorylation.	[Swaffer, Matthew P.; Jones, Andrew W.; Nurse, Paul] Francis Crick Inst, Cell Cycle Lab, London NW1 1AT, England; [Jones, Andrew W.; Flynn, Helen R.; Snijders, Ambrosius P.] Francis Crick Inst, Prot Anal & Prote Platform, London NW1 1AT, England; [Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA; [Swaffer, Matthew P.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Francis Crick Institute; Francis Crick Institute; Rockefeller University; Stanford University	Swaffer, MP (corresponding author), Francis Crick Inst, Cell Cycle Lab, London NW1 1AT, England.; Swaffer, MP (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	matthew.swaffer@crick.ac.uk		Nurse, Paul/0000-0002-9244-7787; Jones, Andrew/0000-0002-5702-3823; Flynn, Helen/0000-0001-7002-9130; Snijders, Bram/0000-0002-5416-8592; Swaffer, Matthew/0000-0002-8019-2887	Francis Crick Institute from Cancer Research UK [FC01121]; UK Medical Research Council [FC01121]; Wellcome Trust [FC01121, 093917]; Lord Leonard and Lady Estelle Wolfson Foundation; Breast Cancer Research Foundation; Rockefeller University; The Francis Crick Institute [10122, 10011, 10121] Funding Source: researchfish	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Lord Leonard and Lady Estelle Wolfson Foundation; Breast Cancer Research Foundation; Rockefeller University; The Francis Crick Institute	This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC01121), the UK Medical Research Council (FC01121), and the Wellcome Trust (FC01121). In addition, this work was supported by the Wellcome Trust (093917), the Lord Leonard and Lady Estelle Wolfson Foundation, the Breast Cancer Research Foundation, and Rockefeller University. We are grateful to Francisco Navarro, Pilar Gutierrez-Escribano, Helena Cantwell, and Jessica Greenwood for critical reading of the manuscript and help with experiments and Hisao Masukata, Ken Sawin, Masamitsu Sato, and Yoshi Watanabe for strains and antibodies.	Aoi Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140063; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bhaduri S, 2011, CURR BIOL, V21, P1615, DOI 10.1016/j.cub.2011.08.033; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; BUENO A, 1991, CELL, V66, P149, DOI 10.1016/0092-8674(91)90147-Q; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; CONNOLLY T, 1994, MOL CELL BIOL, V14, P768, DOI 10.1128/MCB.14.1.768; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Decottignies A, 2001, J CELL SCI, V114, P2627; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Errico A, 2010, ADV ENZYME REGUL, V50, P375, DOI 10.1016/j.advenzreg.2009.12.001; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gutierrez-Escribano P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7871; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LABBE JC, 1988, DEV BIOL, V127, P157, DOI 10.1016/0012-1606(88)90197-2; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; OBARAISHIHARA T, 1994, EMBO J, V13, P1863, DOI 10.1002/j.1460-2075.1994.tb06455.x; Oikonomou C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020788; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; PEEPER DS, 1993, EMBO J, V12, P1947, DOI 10.1002/j.1460-2075.1993.tb05844.x; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stern B, 1996, TRENDS GENET, V12, P345; Torgo L., 2010, DATA MINING R LEARNI; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; WOODS A, 1989, J CELL SCI, V93, P491; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	57	169	171	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1750	+		10.1016/j.cell.2016.11.034	http://dx.doi.org/10.1016/j.cell.2016.11.034			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984725	Green Published, hybrid			2022-12-28	WOS:000393114700014
J	Koller, CF; Alexander, T; Birch, S				Koller, Christopher F.; Alexander, Thomas; Birch, Susan			Population Health - A Bipartisan Agenda for the Incoming Administration from State Leaders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koller, Christopher F.] Milbank Mem Fund, New York, NY 10022 USA; [Alexander, Thomas] South Carolina State Senate, Columbia, SC USA; [Birch, Susan] State Colorado, Dept Hlth Care Policy & Financing, Denver, CO USA; [Alexander, Thomas; Birch, Susan] Reforming States Grp, Execut Comm, New York, NY USA		Koller, CF (corresponding author), Milbank Mem Fund, New York, NY 10022 USA.							Bachrach D., 2016, MEDICAID COVERAGE SO; Bradley EH, 2016, HEALTH AFFAIR, V35, P760, DOI 10.1377/hlthaff.2015.0814; Department of Health and Human Services, 2015, BETT SMART HLTH HIST; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350	4	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2017	376	3					200	202		10.1056/NEJMp1613250	http://dx.doi.org/10.1056/NEJMp1613250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI0XO	27973986				2022-12-28	WOS:000392199100002
J	Magleby, KL				Magleby, Karl L.			STRUCTURAL BIOLOGY Ion-channel mechanisms revealed	NATURE			English	Editorial Material							POTASSIUM CHANNELS; BK CHANNELS; CA2+; CONDUCTANCE; ACTIVATION; VOLTAGE		[Magleby, Karl L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Magleby, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	kmagleby@miami.edu						Geng Y., 2015, FRONT PHYSL; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hite RK, 2017, NATURE, V541, P52, DOI 10.1038/nature20775; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hoshi T, 2013, PHYSIOLOGY, V28, P172, DOI 10.1152/physiol.00055.2012; Naranjo D, 2016, J GEN PHYSIOL, V148, P277, DOI 10.1085/jgp.201611625; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Qian X, 2006, J GEN PHYSIOL, V128, P389, DOI 10.1085/jgp.200609486; Tao X, 2017, NATURE, V541, P46, DOI 10.1038/nature20608; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	12	5	5	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					33	34		10.1038/nature21103	http://dx.doi.org/10.1038/nature21103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6NA	27974804				2022-12-28	WOS:000396119500020
J	Satoh, T; Nakagawa, K; Sugihara, F; Kuwahara, R; Ashihara, M; Yamane, F; Minowa, Y; Fukushima, K; Ebina, I; Yoshioka, Y; Kumanogoh, A; Akira, S				Satoh, Takashi; Nakagawa, Katsuhiro; Sugihara, Fuminori; Kuwahara, Ryusuke; Ashihara, Motooki; Yamane, Fumihiro; Minowa, Yosuke; Fukushima, Kiyoharu; Ebina, Isao; Yoshioka, Yoshichika; Kumanogoh, Atsushi; Akira, Shizuo			Identification of an atypical monocyte and committed progenitor involved in fibrosis	NATURE			English	Article							TRANSCRIPTION FACTOR; HOST RESPONSES; MACROPHAGES; DIFFERENTIATION; HOMEOSTASIS; POLARIZATION; INFLAMMATION; BASOPHILS; RATHER; ORIGIN	Monocytes and macrophages comprise a variety of subsets with diverse functions(1-5). It is thought that these cells play a crucial role in homeostasis of peripheral organs, key immunological processes and development of various diseases. Among these diseases, fibrosis is a life-threatening disease of unknown aetiology. Its pathogenesis is poorly understood, and there are few effective therapies. The development of fibrosis is associated with activation of monocytes and macrophages(6-8). However, the specific subtypes of monocytes and macrophages that are involved in fibrosis have not yet been identified. Here we show that Ceacam1(+)Msr1(+)Ly6C(-)F4/80(-)Mac1(+) monocytes, which we term segregated-nucleus-containing atypical monocytes (SatM), share granulocyte characteristics, are regulated by CCAAT/enhancer binding protein beta (C/EBP beta), and are critical for fibrosis. Cebpb deficiency results in a complete lack of SatM. Furthermore, the development of bleomycin-induced fibrosis, but not inflammation, was prevented in chimaeric mice with Cebpb(-/-) haematopoietic cells. Adoptive transfer of SatM into Cebpb(-/-) mice resulted in fibrosis. Notably, SatM are derived from Ly6C(-)Fc epsilon RI+ granulocyte/macrophage progenitors, and a newly identified SatM progenitor downstream of Ly6C(-)Fc epsilon RI+ granulocyte/macrophage progenitors, but not from macrophage/dendritic-cell progenitors. Our results show that SatM are critical for fibrosis and that C/EBP beta licenses differentiation of SatM from their committed progenitor.	[Satoh, Takashi; Nakagawa, Katsuhiro; Yamane, Fumihiro; Fukushima, Kiyoharu; Ebina, Isao; Akira, Shizuo] Osaka Univ, Immunol Frontier Res Ctr, World Premier Inst, Lab Host Def, Osaka 5650871, Japan; [Satoh, Takashi; Nakagawa, Katsuhiro; Yamane, Fumihiro; Fukushima, Kiyoharu; Ebina, Isao; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis RIMD, Dept Host Def, Osaka 5650871, Japan; [Sugihara, Fuminori; Yoshioka, Yoshichika] Osaka Univ, Immunol Frontier Res Ctr, World Premier Inst, Lab Biofunct Imaging, Osaka 5650871, Japan; [Kuwahara, Ryusuke] Osaka Univ, Res Ctr Ultra High Voltage Elect Microscopy, Osaka 5670047, Japan; [Ashihara, Motooki; Minowa, Yosuke; Ebina, Isao] Chugai Pharmaceut Co Ltd, Discovery Res Dept, Div Res, Kanagawa 2478530, Japan; [Kumanogoh, Atsushi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Tokyo 1000004, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Japan Science & Technology Agency (JST); Osaka University	Akira, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, World Premier Inst, Lab Host Def, Osaka 5650871, Japan.; Akira, S (corresponding author), Osaka Univ, Res Inst Microbial Dis RIMD, Dept Host Def, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Kuwahara, Ryusuke/J-5024-2015; Akira, Shizuo/C-3134-2009	Kuwahara, Ryusuke/0000-0002-7041-0828; Fukushima, Kiyoharu/0000-0002-9767-7899	Government of Japan; Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST) [16H06234, 15H05704]; US National Institutes of Health [P01-AI070167]; 'Visionary Research Fund' from Takeda Science Foundation; Nanotechnology Platform of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [12024046]; Grants-in-Aid for Scientific Research [16H01849] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 'Visionary Research Fund' from Takeda Science Foundation; Nanotechnology Platform of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Saeki, S. Watanabe, R. Takenaka and M. Miyamoto for assistance with experiments, and T. Matsuki, T. Kawasaki, H. Kanemaru, H. Tanaka and K. Kuniyoshi for helpful discussions. We thank T. Kitamura for providing PlatE cells. We also thank E. Kamada for secretarial assistance, and C. Funamoto, N. Kitagaki, A. Wataki, K. Yokoyama and R. Kawaguchi for technical assistance. This work was supported by the Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program), by Japan Science and Technology Agency (JST) thorough funding for a Grant-in-Aid for Young Scientists (A) (16H06234), Specially Promoted Research (15H05704) and the US National Institutes of Health (P01-AI070167) and 'Visionary Research Fund' from Takeda Science Foundation. A part of this work was supported by the Nanotechnology Platform (project number 12024046) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Aoyama K, 2008, ULTRAMICROSCOPY, V109, P70, DOI 10.1016/j.ultramic.2008.08.005; Arinobu Yojiro, 2009, Allergology International, V58, P21, DOI 10.2332/allergolint.08-RAI-0067; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Gutknecht MF, 2014, J LEUKOCYTE BIOL, V96, P969, DOI 10.1189/jlb.1RI0414-195R; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Li YP, 2015, J IMMUNOL, V194, P4328, DOI 10.4049/jimmunol.1500018; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Omori Y, 2015, GENES CELLS, V20, P408, DOI 10.1111/gtc.12233; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Sheel M, 2012, TRENDS PARASITOL, V28, P408, DOI 10.1016/j.pt.2012.07.008; Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Terry RL, 2014, CELL IMMUNOL, V291, P16, DOI 10.1016/j.cellimm.2014.02.008; Tsukui T, 2013, AM J PATHOL, V183, P758, DOI 10.1016/j.ajpath.2013.06.005; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yanez A, 2015, BLOOD, V125, P1452, DOI 10.1182/blood-2014-09-600833; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	28	180	184	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					96	+		10.1038/nature20611	http://dx.doi.org/10.1038/nature20611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	28002407				2022-12-28	WOS:000396119500037
J	Rader, DJ; Damrauer, SM				Rader, Daniel J.; Damrauer, Scott M.			"Pheno" menal value for human health	SCIENCE			English	Editorial Material							FAMILIAL HYPERCHOLESTEROLEMIA; ASSOCIATION; VARIANTS; DISEASE		[Rader, Daniel J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Rader, DJ (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu		Damrauer, Scott/0000-0001-8009-1632				Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Majithia AR, 2016, NAT GENET, V48, P1570, DOI 10.1038/ng.3700	11	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1534	1536		10.1126/science.aal4573	http://dx.doi.org/10.1126/science.aal4573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008030				2022-12-28	WOS:000390254300029
J	Hoberman, A; Paradise, JL; Rockette, HE; Kearney, DH; Bhatnagar, S; Shope, TR; Martin, JM; Kurs-Lasky, M; Copelli, SJ; Colborn, DK; Block, SL; Labella, JJ; Lynch, TG; Cohen, NL; Haralam, M; Pope, MA; Nagg, JP; Green, MD; Shaikh, N				Hoberman, Alejandro; Paradise, Jack L.; Rockette, Howard E.; Kearney, Diana H.; Bhatnagar, Sonika; Shope, Timothy R.; Martin, Judith M.; Kurs-Lasky, Marcia; Copelli, Susan J.; Colborn, D. Kathleen; Block, Stan L.; Labella, John J.; Lynch, Thomas G.; Cohen, Norman L.; Haralam, MaryAnn; Pope, Marcia A.; Nagg, Jennifer P.; Green, Michael D.; Shaikh, Nader			Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; INFANTS	BACKGROUND Limiting the duration of antimicrobial treatment constitutes a potential strategy to reduce the risk of antimicrobial resistance among children with acute otitis media. METHODS We assigned 520 children, 6 to 23 months of age, with acute otitis media to receive amoxicillin-clavulanate either for a standard duration of 10 days or for a reduced duration of 5 days followed by placebo for 5 days. We measured rates of clinical response (in a systematic fashion, on the basis of signs and symptomatic response), recurrence, and nasopharyngeal colonization, and we analyzed episode outcomes using a noninferiority approach. Symptom scores ranged from 0 to 14, with higher numbers indicating more severe symptoms. RESULTS Children who were treated with amoxicillin-clavulanate for 5 days were more likely than those who were treated for 10 days to have clinical failure (77 of 229 children [34%] vs. 39 of 238 [16%]; difference, 17 percentage points [based on unrounded data]; 95% confidence interval, 9 to 25). The mean symptom scores over the period from day 6 to day 14 were 1.61 in the 5-day group and 1.34 in the 10-day group (P=0.07); the mean scores at the day-12-to-14 assessment were 1.89 versus 1.20 (P=0.001). The percentage of children whose symptom scores decreased more than 50% (indicating less severe symptoms) from baseline to the end of treatment was lower in the 5-day group than in the 10-day group (181 of 227 children [80%] vs. 211 of 233 [91%], P=0.003). We found no significant between-group differences in rates of recurrence, adverse events, or nasopharyngeal colonization with penicillin-nonsusceptible pathogens. Clinical-failure rates were greater among children who had been exposed to three or more children for 10 or more hours per week than among those with less exposure (P=0.02) and were also greater among children with infection in both ears than among those with infection in one ear (P<0.001). CONCLUSIONS Among children 6 to 23 months of age with acute otitis media, reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment; in addition, neither the rate of adverse events nor the rate of emergence of antimicrobial resistance was lower with the shorter regimen. (Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources; ClinicalTrials.gov number, NCT01511107.)	[Hoberman, Alejandro; Paradise, Jack L.; Kearney, Diana H.; Bhatnagar, Sonika; Shope, Timothy R.; Martin, Judith M.; Kurs-Lasky, Marcia; Copelli, Susan J.; Colborn, D. Kathleen; Haralam, MaryAnn; Pope, Marcia A.; Nagg, Jennifer P.; Green, Michael D.; Shaikh, Nader] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr UPMC, Dept Pediat,Sch Med, Pittsburgh, PA 15213 USA; [Rockette, Howard E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Labella, John J.; Lynch, Thomas G.; Cohen, Norman L.] Childrens Community Pediat, Pittsburgh, PA USA; [Block, Stan L.] Kentucky Pediat & Adult Res, Bardstown, KY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoberman, A (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Gen Acad Pediat, 3414 5th Ave, Pittsburgh, PA 15213 USA.	hoberman@chp.edu		Shope, Timothy/0000-0002-0974-2639	National Institute of Allergy and Infectious Diseases; National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by the National Institute of Allergy and Infectious Diseases and the National Center for Research Resources	Dagan R, 2002, PEDIATR INFECT DIS J, V21, P894, DOI 10.1097/00006454-200210000-00003; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; KALEIDA PH, 1992, AM J DIS CHILD, V146, P433, DOI 10.1001/archpedi.1992.02160160053013; Kaleida PH, 2009, PEDIATRICS, V124, pE714, DOI 10.1542/peds.2008-2838; Kozyrskyj A, 2010, COCHRANE DB SYST REV, V9; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Schappert Susan M, 2011, Vital Health Stat 13, P1; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Shaikh N, 2009, PEDIATR INFECT DIS J, V28, P5, DOI 10.1097/INF.0b013e318185a387; Shaikh N, 2015, PEDIATR INFECT DIS J, V34, pE41, DOI 10.1097/INF.0000000000000557; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174	14	61	61	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2446	2456		10.1056/NEJMoa1606043	http://dx.doi.org/10.1056/NEJMoa1606043			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1NL	28002709	Green Accepted			2022-12-28	WOS:000390091500008
J	Horton, R				Horton, Richard			Offline: 2016-some lessons to consider	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2970	2970		10.1016/S0140-6736(16)32582-X	http://dx.doi.org/10.1016/S0140-6736(16)32582-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998521	Bronze			2022-12-28	WOS:000390112300012
J	Gulland, A				Gulland, Anne			Syria violence is condemned as evacuation begins	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2016	355								i6750	10.1136/bmj.i6750	http://dx.doi.org/10.1136/bmj.i6750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JX	27986663				2022-12-28	WOS:000390151900008
J	Harper, K				Harper, Kristin			HIV/AIDS in China Beyond the Numbers	SCIENCE			English	Book Review									[Harper, Kristin] Harper Hlth & Sci Commun LLC, Seattle, WA 98117 USA		Harper, K (corresponding author), Harper Hlth & Sci Commun LLC, Seattle, WA 98117 USA.	kristin.nicole.harper@gmail.com						Wu ZY, 2016, HIV AIDS CHINA NUMBE	1	0	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1384	1384		10.1126/science.aal0205	http://dx.doi.org/10.1126/science.aal0205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980176				2022-12-28	WOS:000390261300026
J	Malakoff, D; Service, RF; Cornwall, W				Malakoff, David; Service, Robert F.; Cornwall, Warren			CLIMATE POLICY Trump team targets key climate metric	SCIENCE			English	News Item																			0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1364	1365		10.1126/science.354.6318.1364	http://dx.doi.org/10.1126/science.354.6318.1364			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980166				2022-12-28	WOS:000390261300015
J	Prasanth, SG; Prasanth, KV				Prasanth, Supriya G.; Prasanth, Kannanganattu V.			Easy Stress Relief by EZH2	CELL			English	Editorial Material							RNA-POLYMERASE-II; NONCODING RNAS; B2 RNA; TRANSCRIPTION; GENOME	While we are beginning to appreciate the cellular roles played by long noncoding RNAs, the function of transcripts emerging from repetitive genomic regions remains enigmatic. In this issue, Zovoilis et al. report that the polycomb protein EZH2, upon heat shock, facilitates transcription of stressresponsive genes by inducing the degradation of the transcriptional repressor B2 repeat RNA.	[Prasanth, Supriya G.; Prasanth, Kannanganattu V.] Univ Illinois, Dept Cell & Dev Biol, 601 South Goodwin Ave, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Prasanth, KV (corresponding author), Univ Illinois, Dept Cell & Dev Biol, 601 South Goodwin Ave, Urbana, IL 61801 USA.	kumarp@life.illinois.edu			Direct For Biological Sciences [1243372] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; Kugel JF, 2012, TRENDS BIOCHEM SCI, V37, P144, DOI 10.1016/j.tibs.2011.12.003; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106	8	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1678	1680		10.1016/j.cell.2016.11.051	http://dx.doi.org/10.1016/j.cell.2016.11.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984719	Bronze			2022-12-28	WOS:000393114700008
J	Yang, H; Gao, P; Rajashankar, KR; Patel, DJ				Yang, Hui; Gao, Pu; Rajashankar, Kanagalaghatta R.; Patel, Dinshaw J.			PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease	CELL			English	Article							GUIDED SURVEILLANCE COMPLEX; CRYSTAL-STRUCTURE; RNA; CPF1; CLASSIFICATION; RESISTANCE; IMMUNITY; SYSTEMS	C2c1 is a newly identified guide RNA-mediated type V-B CRISPR-Cas endonuclease that site-specifically targets and cleaves both strands of target DNA. We have determined crystal structures of Alicyclo-bacillus acidoterrestris C2c1 (AacC2c1) bound to sgRNA as a binary complex and to target DNAs as ternary complexes, thereby capturing catalytically competent conformations of AacC2c1 with both target and non-target DNA strands independently positioned within a single RuvC catalytic pocket. Moreover, C2c1-mediated cleavage results in a staggered seven-nucleotide break of target DNA. crRNA adopts a pre-ordered five-nucleotide A-form seed sequence in the binary complex, with release of an inserted tryptophan, facilitating zippering up of 20-bp guide RNA: target DNA heteroduplex on ternary complex formation. Notably, the PAM-interacting cleft adopts a "locked'' conformation on ternary complex formation. Structural comparison of C2c1 ternary complexes with their Cas9 and Cpf1 counterparts highlights the diverse mechanisms adopted by these distinct CRISPR-Cas systems, thereby broadening and enhancing their applicability as genome editing tools.	[Yang, Hui; Gao, Pu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Structurel Biol Program, New York, NY 10065 USA; [Gao, Pu] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, NE CAT, Adv Photon Source, Argonne, IL 60349 USA	Memorial Sloan Kettering Cancer Center; Chinese Academy of Sciences; Institute of Biophysics, CAS; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Yang, H; Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Structurel Biol Program, New York, NY 10065 USA.	yangh3@mskcc.org; pateld@mskcc.org			NIGMS [P41 GM103403]; U.S. Department of Energy [DE-AC02-06CH11357]; NIHORIP HEI grant [S10 RR029205]; NIH [GM104962]; Memorial Sloan Kettering Cancer Center Core Grant [P30CA008748]; Cancer Research Institute Irvington Postdoctoral Fellowship; Institute of Biophysics, Beijing, China; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM104962] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIHORIP HEI grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center Core Grant; Cancer Research Institute Irvington Postdoctoral Fellowship; Institute of Biophysics, Beijing, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Wethank Satoko Ishibi-Murakami for technical assistance in generation of C2c1 mutants. X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by NIGMS grant P41 GM103403 and U.S. Department of Energy grant DE-AC02-06CH11357. The Pilatus 6M detector on 24-ID-C beam line is funded by a NIHORIP HEI grant (S10 RR029205). The research was supported by NIH grant GM104962 to D.J.P., the Memorial Sloan Kettering Cancer Center Core Grant (P30CA008748), Cancer Research Institute Irvington Postdoctoral Fellowship, and start-up funds from the Institute of Biophysics, Beijing, China to P.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	34	126	158	7	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1814	+		10.1016/j.cell.2016.11.053	http://dx.doi.org/10.1016/j.cell.2016.11.053			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984729	Green Accepted, Bronze			2022-12-28	WOS:000393114700019
J	Gostin, LO				Gostin, Lawrence O.			Genetically Modified Food Labeling: A "Right to Know"?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20057 USA; [Gostin, Lawrence O.] World Hlth Org, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20057 USA.; Gostin, LO (corresponding author), World Hlth Org, Collaborating Ctr Publ Hlth Law & Human Rights, Geneva, Switzerland.	gostin@law.georgetown.edu							0	3	3	7	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2345	2346		10.1001/jama.2016.17476	http://dx.doi.org/10.1001/jama.2016.17476			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959986				2022-12-28	WOS:000389884600003
J	Park, E; Ampbell, EBC; MacKinnon, R				Park, Eunyong; Ampbell, Ernest B. C.; MacKinnon, Roderick			Structure of a CLC chloride ion channel by cryo-electron microscopy	NATURE			English	Article							/H+ EXCHANGE TRANSPORTER; TORPEDO ELECTROPLAX; BINDING-SITE; K CHANNELS; ANTIPORTER; KIDNEY; SELECTIVITY; PROTEINS; BARTTIN; CONSERVATION	CLC proteins transport chloride (Cl-) ions across cellular membranes to regulate muscle excitability, electrolyte movement across epithelia, and acidification of intracellular organelles. Some CLC proteins are channels that conduct Cl- ions passively, whereas others are secondary active transporters that exchange two Cl- ions for one H+. The structural basis underlying these distinctive transport mechanisms is puzzling because CLC channels and transporters are expected to share the same architecture on the basis of sequence homology. Here we determined the structure of a bovine CLC channel (CLC-K) using cryo-electron microscopy. A conserved loop in the Cl- transport pathway shows a structure markedly different from that of CLC transporters. Consequently, the cytosolic constriction for Cl- passage is widened in CLC-K such that the kinetic barrier previously postulated for Cl-/H+ transporter function would be reduced. Thus, reduction of a kinetic barrier in CLC channels enables fast flow of Cl- down its electrochemical gradient.	[Park, Eunyong; Ampbell, Ernest B. C.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA; [Park, Eunyong; Ampbell, Ernest B. C.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.; MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			Jane Coffin Childs Memorial Fund fellowship [61-1513]	Jane Coffin Childs Memorial Fund fellowship	We thank M. Ebrahim at the Rockefeller University Cryo-EM Resource Center for help with microscope operation, staff at the Memorial Sloan Kettering Cancer Center Antibody & Bioresource Core Facility for hybridoma generation, Y. C. Hsiung for help with large-scale cell culture, members of the MacKinnon laboratory for helpful discussions, and J. Chen for critical reading of the manuscript. E.P. is supported by the Jane Coffin Childs Memorial Fund fellowship (#61-1513). R.M. is a Howard Hughes Medical Institute investigator.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; ADACHI S, 1994, J BIOL CHEM, V269, P17677; Basilio D, 2014, NAT STRUCT MOL BIOL, V21, P456, DOI 10.1038/nsmb.2814; Bell SP, 2006, BIOCHEMISTRY-US, V45, P6773, DOI 10.1021/bi0523815; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Denton JS, 2013, AM J PHYSIOL-RENAL, V305, pF931, DOI 10.1152/ajprenal.00230.2013; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Feng L, 2012, P NATL ACAD SCI USA, V109, P11699, DOI 10.1073/pnas.1205764109; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; FISHER SE, 1994, HUM MOL GENET, V3, P2053; Gradogna A, 2012, J GEN PHYSIOL, V140, P681, DOI 10.1085/jgp.201210878; Jackson MR, 2007, J PHYS CHEM B, V111, P8242, DOI 10.1021/jp0661995; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jayaram H, 2011, BIOCHEMISTRY-US, V50, P788, DOI 10.1021/bi1019258; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Khantwal CM, 2016, ELIFE, V5, DOI 10.7554/eLife.11189; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; L'Hoste S, 2013, BBA-BIOMEMBRANES, V1828, P2399, DOI 10.1016/j.bbamem.2013.06.012; Lim HH, 2013, NAT CHEM BIOL, V9, P721, DOI [10.1038/NCHEMBIO.1336, 10.1038/nchembio.1336]; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	48	75	77	9	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 26	2017	541	7638					500	505		10.1038/nature20812	http://dx.doi.org/10.1038/nature20812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6LX	28002411	Green Accepted			2022-12-28	WOS:000396116600044
J	Vermeire, S; Schreiber, S; Petryka, R; Kuehbacher, T; Hebuterne, X; Roblin, X; Klopocka, M; Goldis, A; Wisniewska-Jarosinska, M; Baranovsky, A; Sike, R; Stoyanova, K; Tasset, C; Van der Aa, A; Harrison, P				Vermeire, Severine; Schreiber, Stefan; Petryka, Robert; Kuehbacher, Tanja; Hebuterne, Xavier; Roblin, Xavier; Klopocka, Maria; Goldis, Adrian; Wisniewska-Jarosinska, Maria; Baranovsky, Andrey; Sike, Robert; Stoyanova, Kremena; Tasset, Chantal; Van der Aa, Annegret; Harrison, Pille			Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; TOFACITINIB; INHIBITOR; GLPG0634; JAK1; MULTICENTER; THERAPY	Background Filgotinib (GLPG0634, GS-6034) is a once-daily, orally administered, Janus kinase 1 (JAK1)-selective inhibitor. The FITZROY study examined the efficacy and safety of filgotinib for the treatment of moderate-to-severe Crohn's disease. Methods We did a randomised, double-blind, placebo-controlled phase 2 study, which recruited patients from 52 centres in nine European countries. We enrolled eligible patients aged 18-75 years with a documented history of ileal, colonic, or ileocolonic Crohn's disease for 3 months or more before screening, as assessed by colonoscopy and supported by histology, and a Crohn's Disease Activity Index (CDAI) score during screening between 220 and 450 inclusive. Patients were randomly assigned (3: 1) to receive filgotinib 200 mg once a day or placebo for 10 weeks. Patients were stratified according to previous anti-tumour necrosis factor alpha exposure, C-reactive protein concentration at screening (<= 10 mg/L or >10 mg/L), and oral corticosteroid use at baseline, using an interactive web-based response system. The primary endpoint was clinical remission, defined as CDAI less than 150 at week 10. After week 10, patients were assigned based on responder status to filgotinib 100 mg once a day, filgotinib 200 mg once a day, or placebo for an observational period lasting a further 10 weeks. The filgotinib and placebo treatment groups were compared using ANCOVA models and logistic regression models containing baseline values and randomisation stratification factors as fixed effects. Analyses were done on the intention-to-treat non-responder imputation set. The trial was registered at ClinicalTrials.gov, number NCT02048618. Findings Between Feb 3, 2014, and July 10, 2015, we enrolled 174 patients with active Crohn's disease confirmed by centrally read endoscopy (130 in the filgotinib 200 mg group and 44 in the placebo group). In the intention-to-treat population, 60 (47%) of 128 patients treated with filgotinib 200 mg achieved clinical remission at week 10 versus ten (23%) of 44 patients treated with placebo (difference 24 percentage points [95% CI 9-39], p= 0.0077). In a pooled analysis of all periods of filgotinib and placebo exposure over 20 weeks, serious treatment-emergent adverse effects were reported in 14 (9%) of 152 patients treated with filgotinib and three (4%) of 67 patients treated with placebo. Interpretation Filgotinib induced clinical remission in significantly more patients with active Crohn's disease compared with placebo, and had an acceptable safety profile.	[Vermeire, Severine] Univ Hosp Leuven, Dept Gastroenterol, Herestr 49, B-3000 Leuven, Belgium; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Kiel, Germany; [Schreiber, Stefan] Inst Clin Mol Biol, Kiel, Germany; [Petryka, Robert] NZOZ ViVamed, Zamiejska 17, PL-03580 Warsaw, Poland; [Kuehbacher, Tanja] Asklepios Westklinikum, Dept Gastroenterol, Hamburg, Germany; [Kuehbacher, Tanja] Christian Albrecht Univ, Kiel, Germany; [Hebuterne, Xavier] Univ Nice, Le Ctr Hosp, Dept Gastroenterol & Nutr, Archet Hosp 2, Nice, France; [Hebuterne, Xavier] Univ Cote Azur, Nice, France; [Roblin, Xavier] Univ Hosp St Etienne, Dept Gastroenterol, St Etienne, France; [Klopocka, Maria] NC Univ Torun, Coll Med Bydgoszcz, Dept Vasc Dis & Internal Med, Bydgoszcz, Poland; [Goldis, Adrian] Univ Med Timisoara, Gastroenterol Clin, Timisoara, Romania; [Wisniewska-Jarosinska, Maria] Med Univ Lodz, Dept Gastroenterol, Lodz, Poland; [Wisniewska-Jarosinska, Maria] St Family Med Ctr Lodz, Lodz, Poland; [Baranovsky, Andrey] St Petersburg State Univ, Ctr Gastroenterol & Hepatol, Fac Med, St Petersburg, Russia; [Sike, Robert] Szent Margit Hosp, Dept Gastroenterol, Budapest, Hungary; [Stoyanova, Kremena] PSI Pharma Support EOOD, Sofia, Bulgaria; [Tasset, Chantal; Van der Aa, Annegret; Harrison, Pille] Galapagos NV, Gen Wittelaan L11A3, Mechelen, Belgium	KU Leuven; University Hospital Leuven; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU de St Etienne; Nicolaus Copernicus University; Victor Babes University of Medicine & Pharmacy, Timisoara; Medical University Lodz; Saint Petersburg State University; Galapagos NV	Vermeire, S (corresponding author), Univ Hosp Leuven, Dept Gastroenterol, Herestr 49, B-3000 Leuven, Belgium.	severine.vermeire@uzleuven.be	Kłopocka, Maria/I-2199-2014	Kłopocka, Maria/0000-0003-2149-5826; Roblin, Xavier/0000-0002-7929-4878; Harrison, Pille/0000-0003-4117-6910; Wisniewska-Jarosinska, Maria/0000-0003-1846-8114; Vermeire, Severine/0000-0001-9942-3019	Galapagos; Gilead Sciences Inc.	Galapagos(Galapagos NV); Gilead Sciences Inc.(Gilead Sciences)	We wish to thank the study investigators and patients who contributed to this study. We also thank Chohee Yun and Bittoo Kanwar from Gilead Sciences Inc for feedback on the manuscript. Editorial support in the form of developing manuscript drafts in consultation with the authors, assembling tables and figures, collating author comments, copyediting, fact checking, referencing, and graphical services was provided by Louisa Lyon (Aspire Scientific Ltd, Bollington, UK); this support was co-funded by Galapagos and Gilead Sciences Inc.	Ahmad H, 2014, GASTROENTEROL REP, V2, P201, DOI 10.1093/gastro/gou033; Allez M, 2010, J CROHNS COLITIS, V4, P355, DOI 10.1016/j.crohns.2010.04.004; [Anonymous], 2016, ARTHRITIS RHEUMA S10; [Anonymous], 2012, ADV COMM M TOF TREAT; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Boland BS, 2014, GASTROENTEROL CLIN N, V43, P603, DOI 10.1016/j.gtc.2014.05.011; Casellas F, 2005, INFLAMM BOWEL DIS, V11, P488, DOI 10.1097/01.MIB.0000159661.55028.56; CELLIER C, 1994, GUT, V35, P231, DOI 10.1136/gut.35.2.231; Cobrin GM, 2005, IMMUNOL REV, V206, P277, DOI 10.1111/j.0105-2896.2005.00293.x; Cohen RD, 2002, ALIMENT PHARM THER, V16, P1603, DOI 10.1046/j.1365-2036.2002.01323.x; Cohen S, 2014, ARTHRITIS RHEUMATOL, V66, P2924, DOI 10.1002/art.38779; Cote-Daigneault J, 2015, UNITED EUR GASTROENT, V3, P419, DOI 10.1177/2050640615590302; Feagan BG, 2013, GASTROENTEROLOGY, V145, P149, DOI 10.1053/j.gastro.2013.03.025; Genovese M, 2016, ANN RHEUM DIS, V75, P244, DOI 10.1136/annrheumdis-2016-eular.3894; Hendy P., 2013, EMJ GASTROENTEROL, V1, P116; Herrera-deGuise C, 2015, J GASTROEN HEPATOL, V30, P286, DOI 10.1111/jgh.12803; International Conference on Harmonisation Tripartite Guideline, 1996, GUID GOOD CLIN PRACT; Jairath V, 2016, J CROHNS COLITIS; Kavanaugh A, 2016, ANN RHEUM DIS, V75, P247, DOI 10.1136/annrheumdis-2016-eular.3862; Khanna R, 2015, ALIMENT PHARM THER, V41, P77, DOI 10.1111/apt.13001; Lonnfors S, 2014, J CROHNS COLITIS, V8, P1281, DOI 10.1016/j.crohns.2014.03.005; Lundquist LM, 2014, WORLD J ORTHOP, V5, P504, DOI 10.5312/wjo.v5.i4.504; Magro F, 2013, J CROHNS COLITIS, V7, P827, DOI 10.1016/j.crohns.2013.06.001; Menet CJ, 2014, J MED CHEM, V57, P9323, DOI 10.1021/jm501262q; Mojtahed A, 2014, INFLAMM BOWEL DIS, V20, P2092, DOI 10.1097/MIB.0000000000000155; Namour F, 2015, CLIN PHARMACOKINET, V54, P859, DOI 10.1007/s40262-015-0240-z; Panes J, 2016, EUR CROHNS COL ORG A; Panes J, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0239-9; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Sandborn W, 2016, EUR CROHNS COL ORG A; Sandborn WJ, 2014, CLIN GASTROENTEROL H, V12, P1485, DOI 10.1016/j.cgh.2014.01.029; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Van Rompaey L, 2013, J IMMUNOL, V191, P3568, DOI 10.4049/jimmunol.1201348; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745	35	254	260	6	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					266	275		10.1016/S0140-6736(16)32537-5	http://dx.doi.org/10.1016/S0140-6736(16)32537-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9BC	27988142				2022-12-28	WOS:000392801200028
J	Brown, QL; Sarvet, AL; Shmulewitz, D; Martins, SS; Wall, MM; Hasin, DS				Brown, Qiana L.; Sarvet, Aaron L.; Shmulewitz, Dvora; Martins, Silvia S.; Wall, Melanie M.; Hasin, Deborah S.			Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Brown, Qiana L.; Sarvet, Aaron L.; Shmulewitz, Dvora; Martins, Silvia S.; Wall, Melanie M.; Hasin, Deborah S.] Columbia Univ, New York, NY 10032 USA	Columbia University	Hasin, DS (corresponding author), Columbia Univ, Med Ctr, Dept Psychiat, 1051 Riverside Dr 123, New York, NY 10032 USA.	deborah.hasin@gmail.com	Martins, Silvia Saboia/C-9405-2014; Wall, Melanie/AAE-7828-2019	Martins, Silvia Saboia/0000-0003-3059-9993; 	National Institute on Drug Abuse [T32DA031099, R01DA037866, R01DA034244]; New York State Psychiatric Institute; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA031099, R01DA034244, R01DA037866] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); New York State Psychiatric Institute; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants T32DA031099 (Drs Brown and Hasin [program director]), R01DA037866 (Dr Martins), and R01DA034244 (Dr Hasin) from the National Institute on Drug Abuse and the New York State Psychiatric Institute (Hasin, Wall).	American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2015, Obstet Gynecol, V126, P234, DOI 10.1097/01.AOG.0000467192.89321.a6; Calvigioni D, 2014, EUR CHILD ADOLES PSY, V23, P931, DOI 10.1007/s00787-014-0550-y; Center for Behavioral Health Statistics and Quality, 2015, 2014 NATL SURV DRUG; Hasin DS, 2016, JAMA PSYCHIAT, V73, P532, DOI 10.1001/jamapsychiatry.2015.3158; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Ko JY, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.021	6	234	235	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2017	317	2					207	209		10.1001/jama.2016.17383	http://dx.doi.org/10.1001/jama.2016.17383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5PV	27992619	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000391826200023
J	Hoch, NC; Hanzlikova, H; Rulten, SL; Tetreault, M; Komulainen, E; Ju, LM; Hornyak, P; Zeng, ZH; Gittens, W; Rey, SA; Staras, K; Mancini, GMS; McKinnon, PJ; Wang, ZQ; Wagner, JD; Yoon, G; Caldecott, KW				Hoch, Nicolas C.; Hanzlikova, Hana; Rulten, Stuart L.; Tetreault, Martine; Komulainen, Emilia; Ju, Limei; Hornyak, Peter; Zeng, Zhihong; Gittens, William; Rey, Stephanie A.; Staras, Kevin; Mancini, Grazia M. S.; McKinnon, Peter J.; Wang, Zhao-Qi; Wagner, Justin D.; Yoon, Grace; Caldecott, Keith W.		Care4Rare Canada Consortium	XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia	NATURE			English	Article							STRAND BREAK REPAIR; BASE EXCISION-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; SPINOCEREBELLAR ATAXIA; DNA; CELLS; GENE; REPLICATION; DISEASE; RATES	XRCC1 is a molecular scaffold protein that assembles multiprotein complexes involved in DNA single-strand break repair(1,2). Here we show that biallelic mutations in the human XRCC1 gene are associated with ocular motor apraxia, axonal neuropathy, and progressive cerebellar ataxia. Cells from a patient with mutations in XRCC1 exhibited not only reduced rates of single-strand break repair but also elevated levels of protein ADP-ribosylation. This latter phenotype is recapitulated in a related syndrome caused by mutations in the XRCC1 partner protein PNKP3-5 and implicates hyperactivation of poly(ADP-ribose) polymerase/s as a cause of cerebellar ataxia. Indeed, remarkably, genetic deletion of Parp1 rescued normal cerebellar ADP-ribose levels and reduced the loss of cerebellar neurons and ataxia in Xrcc1-defective mice, identifying a molecular mechanism by which endogenous single-strand breaks trigger neuropathology. Collectively, these data establish the importance of XRCC1 protein complexes for normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease.	[Hoch, Nicolas C.; Hanzlikova, Hana; Rulten, Stuart L.; Komulainen, Emilia; Ju, Limei; Hornyak, Peter; Zeng, Zhihong; Gittens, William; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England; [Hoch, Nicolas C.] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Tetreault, Martine] McGill Univ, Dept Human Genet, Montreal, PQ H3A OG4, Canada; [Tetreault, Martine] Genome Quebec Innovat Ctr, Montreal, PQ H3A OG4, Canada; [Rey, Stephanie A.; Staras, Kevin] Univ Sussex, Sch Life Sci, Neurosci, Brighton BN1 9QG, E Sussex, England; [Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Wang, Zhao-Qi] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Wagner, Justin D.] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON K1L 8H1, Canada; [Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Sussex; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); McGill University; University of Sussex; Erasmus University Rotterdam; Erasmus MC; St Jude Children's Research Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton BN1 9RH, E Sussex, England.; Yoon, G (corresponding author), Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.; Yoon, G (corresponding author), Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada.	grace.yoon@utoronto.ca; k.w.caldecott@sussex.ac.uk	Zeng, Zhihong/HEV-8703-2022; Hanzlikova, Hana/O-2615-2019; Caldecott, Keith/S-4245-2019; Hoch, Nicolas/J-5288-2012; Hanzlikova, Hana/G-6183-2014; Komulainen, Emilia/AAR-5657-2021	Hanzlikova, Hana/0000-0001-7235-7269; Hoch, Nicolas/0000-0002-7610-1305; Komulainen, Emilia/0000-0002-2804-1678; Gittens, William/0000-0002-3830-1218; Staras, Kevin/0000-0003-4141-339X; Rey, Stephanie/0000-0002-5476-9208; Caldecott, Keith/0000-0003-4255-9016	MRC [MR/J006750/1, MR/P010121/1]; CAPES Foundation, Ministry of Education, Brazil [BEX9769-13-7]; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children; BBSRC [BB/K019015/1]; National Institutes of Health [NS-37956, CA-21765]; CCSG [P30 CA21765]; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K019015/1] Funding Source: researchfish; Cancer Research UK [16771] Funding Source: researchfish; Medical Research Council [MR/P010121/1, MR/J006750/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CAPES Foundation, Ministry of Education, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Genome Quebec; Children's Hospital of Eastern Ontario Foundation; Hospital for Sick Children; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCSG; American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by MRC Programme Grants (MR/J006750/1 and MR/P010121/1) to K.W.C., a 'Science without Borders' postdoctoral fellowship (CAPES Foundation, Ministry of Education, Brazil, BEX9769-13-7) to N.H., and funding to G.Y. from Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, Ontario Research Fund, Genome Quebec, the Children's Hospital of Eastern Ontario Foundation, and the Hospital for Sick Children. K.S. was funded by the BBSRC grant BB/K019015/1 and P.J.M. acknowledges the National Institutes of Health (NS-37956, CA-21765), the CCSG (P30 CA21765), and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital for support. We thank the patient and her family for their contribution to this study. This work was selected for study by the Care4Rare Canada (Enhanced Care for Rare Genetic Diseases in Canada) Consortium Gene Discovery Steering Committee (for committee members, see below). We thank D. Dyment for his advice and discussion. We thank S. van der Velde-Visser and J. Schuurs-Hoeijmakers for Epstein-Barr virus transformation of the patient's and sibling's LCLs. We also thank S. El-Khamisy and A. Ridley for preliminary analyses and assistance with the mouse work.	BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Breslin C, 2006, METHOD ENZYMOL, V409, P410, DOI 10.1016/S0076-6879(05)09024-5; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; DILLEHAY LE, 1983, MUTAT RES, V109, P283, DOI 10.1016/0027-5107(83)90053-2; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Katyal S, 2014, NAT NEUROSCI, V17, P813, DOI 10.1038/nn.3715; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marras C, 2016, MOVEMENT DISORD, V31, P436, DOI 10.1002/mds.26527; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; PINKEL D, 1985, CANCER RES, V45, P5795; Poulton C, 2013, NEUROGENETICS, V14, P43, DOI 10.1007/s10048-012-0351-8; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Tetreault M, 2015, HUM GENET, V134, P981, DOI 10.1007/s00439-015-1577-y; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	26	157	160	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					87	+		10.1038/nature20790	http://dx.doi.org/10.1038/nature20790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	28002403	Green Accepted			2022-12-28	WOS:000396119500034
J	Yamaji, N; Takemoto, Y; Miyaji, T; Mitani-Ueno, N; Oshida, KTY; Ma, JF				Yamaji, Naoki; Takemoto, Yuma; Miyaji, Takaaki; Mitani-Ueno, Namiki; Oshida, Kaoru T. Y.; Ma, Jian Feng			Reducing phosphorus accumulation in rice grains with an impaired transporter in the node	NATURE			English	Article							EFFICIENCY; SILICON; PHYTATE; CEREAL; CROPS	Phosphorus is an important nutrient for crop productivity. More than 60% of the total phosphorus in cereal crops is finally allocated into the grains and is therefore removed at harvest. This removal accounts for 85% of the phosphorus fertilizers applied to the field each year(1,2). However, because humans and non-ruminants such as poultry, swine and fish cannot digest phytate, the major form of phosphorus in the grains, the excreted phosphorus causes eutrophication of waterways. A reduction in phosphorus accumulation in the grain would contribute to sustainable and environmentally friendly agriculture. Here we describe a rice transporter, SULTR-like phosphorus distribution transporter (SPDT), that controls the allocation of phosphorus to the grain. SPDT is expressed in the xylem region of both enlarged-and diffuse-vascular bundles of the nodes, and encodes a plasma-membrane-localized transporter for phosphorus. Knockout of this gene in rice (Oryza sativa) altered the distribution of phosphorus, with decreased phosphorus in the grains but increased levels in the leaves. Total phosphorus and phytate in the brown de-husked rice were 20-30% lower in the knockout lines, whereas yield, seed germination and seedling vigour were not affected. These results indicate that SPDT functions in the rice node as a switch to allocate phosphorus preferentially to the grains. This finding provides a potential strategy to reduce the removal of phosphorus from the field and lower the risk of eutrophication of waterways.	[Yamaji, Naoki; Takemoto, Yuma; Mitani-Ueno, Namiki; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan; [Miyaji, Takaaki] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Oshida, Kaoru T. Y.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Okayama University; Okayama University; University of Tokyo	Ma, JF (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	Ma, Jianfeng/GZB-0110-2022; YAMAJI, Naoki/B-2524-2011	YAMAJI, Naoki/0000-0002-7499-3004; Miyaji, Takaaki/0000-0002-7257-7621	JSPS [15H04469, 16H06296]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Specially Promoted Research (JSPS KAKENHI Grant Number 15H04469 to N.Y. and 16H06296 to J.F.M.).	Baker A, 2015, J EXP BOT, V66, P3523, DOI 10.1093/jxb/erv210; Batjes NH, 1997, SOIL USE MANAGE, V13, P9, DOI 10.1111/j.1475-2743.1997.tb00550.x; BATTEN GD, 1986, CEREAL CHEM, V63, P384; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Fairhurst T., 2000, RICE NUTRIENT DISORD, V1; KARLEN DL, 1988, AGRON J, V80, P232, DOI 10.2134/agronj1988.00021962008000020018x; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kuwano M, 2006, MOL BREEDING, V18, P263, DOI 10.1007/s11032-006-9038-x; Lott John N. A., 2009, International Journal of Agricultural Resources Governance and Ecology, V8, P351, DOI 10.1504/IJARGE.2009.032640; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MA JF, 1990, PLANT SOIL, V126, P115, DOI 10.1007/BF00041376; Miyaji T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6928; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Pariasca-Tanaka J, 2015, PLANT SOIL, V392, P253, DOI 10.1007/s11104-015-2460-2; Raboy V, 2001, TRENDS PLANT SCI, V6, P458, DOI 10.1016/S1360-1385(01)02104-5; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Rose TJ, 2012, ADV AGRON, V116, P185, DOI 10.1016/B978-0-12-394277-7.00005-1; Syers J., 2008, FAO FERTILIZER PLANT, V18; Takahashi H, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00119; Wang FM, 2016, J EXP BOT, V67, P1221, DOI 10.1093/jxb/erv517; White PJ, 2012, PLANT SOIL, V357, P1, DOI 10.1007/s11104-012-1128-4; Withers PJA, 2014, ENVIRON SCI TECHNOL, V48, P6523, DOI 10.1021/es501670j; Yamaji N, 2015, P NATL ACAD SCI USA, V112, P11401, DOI 10.1073/pnas.1508987112; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564	26	131	141	35	366	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					92	+		10.1038/nature20610	http://dx.doi.org/10.1038/nature20610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	28002408				2022-12-28	WOS:000396119500035
J	Claret, PG; Bobbia, X; de La Coussaye, JE				Claret, Pierre-Geraud; Bobbia, Xavier; de La Coussaye, Jean Emmanuel			Comparing Use of Low-Value Health Care Services Among US Advanced Practice Clinicians and Physicians	ANNALS OF INTERNAL MEDICINE			English	Letter							EMERGENCY-DEPARTMENT; STILL		[Claret, Pierre-Geraud; Bobbia, Xavier; de La Coussaye, Jean Emmanuel] Ctr Hosp Reg Univ Nimes, Nimes, France	Universite de Montpellier; CHU de Nimes	Claret, PG (corresponding author), Ctr Hosp Reg Univ Nimes, Nimes, France.							Dresden SM, 2016, J EMERG MED, V50, P135, DOI 10.1016/j.jemermed.2015.02.047; Mafi JN, 2016, ANN INTERN MED, V165, P237, DOI 10.7326/M15-2152; Pontone S, 2010, ANN FR ANESTH, V29, P862, DOI 10.1016/j.annfar.2010.10.011; Rich EC, 2016, ANN INTERN MED, V165, P290, DOI 10.7326/M16-1326; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026	5	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					76	76		10.7326/L16-0550	http://dx.doi.org/10.7326/L16-0550			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030669				2022-12-28	WOS:000391467900015
J	Chibanda, D; Weiss, HA; Verhey, R; Simms, V; Munjoma, R; Rusakaniko, S; Chingono, A; Munetsi, E; Bere, T; Manda, E; Abas, M; Araya, R				Chibanda, Dixon; Weiss, Helen A.; Verhey, Ruth; Simms, Victoria; Munjoma, Ronald; Rusakaniko, Simbarashe; Chingono, Alfred; Munetsi, Epiphania; Bere, Tarisai; Manda, Ethel; Abas, Melanie; Araya, Ricardo			Effect of a Primary Care-Based Psychological Intervention on Symptoms of Common Mental Disorders in Zimbabwe A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROBLEM-SOLVING THERAPY; FRIENDSHIP BENCH PROJECT; LAY HEALTH-WORKERS; DEPRESSION; PSYCHOTHERAPY; ANXIETY; POPULATION; PREVALENCE; EVENTS; PEOPLE	IMPORTANCE Depression and anxiety are common mental disorders globally but are rarely recognized or treated in low-income settings. Task-shifting of mental health care to lay health workers (LHWs) might decrease the treatment gap. OBJECTIVE To evaluate the effectiveness of a culturally adapted psychological intervention for common mental disorders delivered by LHWs in primary care. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized clinical trial with 6 months' follow-up conducted from September 1, 2014, to May 25, 2015, in Harare, Zimbabwe. Twenty-four clinics were randomized 1: 1 to the intervention or enhanced usual care (control). Participants were clinic attenders 18 years or older who screened positive for common mental disorders on the locally validated Shona Symptom Questionnaire (SSQ-14). INTERVENTIONS The Friendship Bench intervention comprised 6 sessions of individual problem-solving therapy delivered by trained, supervised LHWs plus an optional 6-session peer support program. The control group received standard care plus information, education, and support on common mental disorders. MAIN OUTCOMES AND MEASURES Primary outcome was common mental disorder measured at 6 months as a continuous variable via the SSQ-14 score, with a range of 0 (best) to 14 and a cutpoint of 9. The secondary outcome was depression symptoms measured as a binary variable via the 9-item Patient Health Questionnaire, with a range of 0 (best) to 27 and a cutpoint of 11. Outcomes were analyzed by modified intention-to-treat. RESULTS Among 573 randomized patients (286 in the intervention group and 287 in the control group), 495 (86.4%) were women, median age was 33 years (interquartile range, 27-41 years), 238 (41.7%) were human immunodeficiency virus positive, and 521 (90.9%) completed follow-up at 6 months. Intervention group participants had fewer symptoms than control group participants on the SSQ-14 (3.81; 95% CI, 3.28 to 4.34 vs 8.90; 95% CI, 8.33 to 9.47; adjusted mean difference, -4.86; 95% CI, -5.63 to -4.10; P < .001; adjusted risk ratio [ARR], 0.21; 95% CI, 0.15 to 0.29; P < .001). Intervention group participants also had lower risk of symptoms of depression (13.7% vs 49.9%; ARR, 0.28; 95% CI, 0.22 to 0.34; P < .001). CONCLUSIONS AND RELEVANCE Among individuals screening positive for common mental disorders in Zimbabwe, LHW-administered, primary care-based problem-solving therapy with education and support compared with standard care plus education and support resulted in improved symptoms at 6 months. Scaled-up primary care integration of this intervention should be evaluated.	[Chibanda, Dixon; Verhey, Ruth; Munjoma, Ronald; Rusakaniko, Simbarashe; Munetsi, Epiphania; Bere, Tarisai; Manda, Ethel] Univ Zimbabwe, Dept Community Med, Zimbabwe AIDS Prevent Project, 92 Prince Edward St, Harare, Zimbabwe; [Weiss, Helen A.; Simms, Victoria] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England; [Chingono, Alfred] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Abas, Melanie] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Araya, Ricardo] London Sch Hyg & Trop Med, London, England	University of Zimbabwe; University of London; London School of Hygiene & Tropical Medicine; University of Zimbabwe; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Chibanda, D (corresponding author), Univ Zimbabwe, Dept Community Med, Zimbabwe AIDS Prevent Project, 92 Prince Edward St, Harare, Zimbabwe.	dichi@zol.co.zw	Verhey, Ruth/R-8895-2019; weiss, helen/ABC-7823-2021; Simms, Victoria/AAU-4134-2021; Simms, Victoria/C-3278-2009; Araya, Ricardo/S-3144-2019	Verhey, Ruth/0000-0002-5959-1891; weiss, helen/0000-0003-3547-7936; Simms, Victoria/0000-0002-4897-458X; Araya, Ricardo/0000-0002-0420-5148; abas, melanie/0000-0003-1716-5584	Grand Challenges Canada [KCU-0087-042]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Grand Challenges Canada(CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Grand Challenges Canada (grant KCU-0087-042).	ABAS M, 1994, BRIT J PSYCHIAT, V164, P293, DOI 10.1192/bjp.164.3.293; Abas M, 2003, HARVARD REV PSYCHIAT, V11, P166, DOI 10.1080/10673220303954; Abas M, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0071-9; Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Broadhead JC, 1998, PSYCHOL MED, V28, P29, DOI 10.1017/S0033291797005618; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chibanda D, 2016, J AFFECT DISORDERS, V198, P50, DOI 10.1016/j.jad.2016.03.006; Chibanda D, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0050-1; Chibanda D, 2015, INT J MENT HEALTH SY, V9, DOI 10.1186/s13033-015-0013-y; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; D'Zurilla TJ, 2007, PROBLEM SOLVING THER; Driessen E, 2010, PSYCHIAT CLIN N AM, V33, P537, DOI 10.1016/j.psc.2010.04.005; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Hayes RJ, 2009, INTERD STAT, P3; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Nakimuli-Mpungu E, 2015, LANCET HIV, V2, pE190, DOI 10.1016/S2352-3018(15)00041-7; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 1997, SOC PSYCH PSYCH EPID, V32, P84, DOI 10.1007/BF00788925; Patel V, 1997, BRIT J PSYCHIAT, V171, P60, DOI 10.1192/bjp.171.1.60; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; Seekles W, 2011, PSYCHIAT RES, V187, P113, DOI 10.1016/j.psychres.2010.11.015; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Ventevogel P, 2015, JAMA-J AM MED ASSOC, V314, P511, DOI 10.1001/jama.2015.8383; Verhey R, 2014, FRIENDSHIP BENCH TRA; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7	32	160	160	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2618	2626		10.1001/jama.2016.19102	http://dx.doi.org/10.1001/jama.2016.19102			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG5UN	28027368	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000391110200016
J	Das, RR; Singh, M				Das, Rashmi Ranjan; Singh, Meenu			Oral Zinc for the Common Cold (Withdrawal of Vol 311, Pg 1440, 2014)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Item Withdrawal									[Das, Rashmi Ranjan] All India Inst Med Sci, Dept Pediat, Bhubaneswar, Orissa, India; [Singh, Meenu] Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India	All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, M (corresponding author), Postgrad Inst Med Educ & Res, Dept Pediat, Chandigarh 160012, India.	meenusingh4@gmail.com						Das RR, 2014, JAMA-J AM MED ASSOC, V311, P1440, DOI 10.1001/jama.2014.1404; Singh MK., 2013, J TEXT, V2013, P1, DOI [10.1155/2013/579129, DOI 10.1155/2013/579129]	2	1	1	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2678	2678		10.1001/jama.2016.18134	http://dx.doi.org/10.1001/jama.2016.18134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027374	Bronze			2022-12-28	WOS:000391110200027
J	Clery, D				Clery, Daniel			XPrize finalists mull payloads to the moon	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1510	1511		10.1126/science.354.6319.1510	http://dx.doi.org/10.1126/science.354.6319.1510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008014				2022-12-28	WOS:000390254300007
J	Normile, D				Normile, Dennis			Critics assail paper claiming harm from cancer vaccine	SCIENCE			English	News Item																			0	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1514	1515		10.1126/science.354.6319.1514	http://dx.doi.org/10.1126/science.354.6319.1514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008018				2022-12-28	WOS:000390254300011
J	Cohen, E; Horvath-Puho, E; Ray, JG; Pedersen, L; Adler, N; Ording, AG; Wise, PH; Milstein, A; Sorensen, HT				Cohen, Eyal; Horvath-Puho, Erzsebet; Ray, Joel G.; Pedersen, Lars; Adler, Nancy; Ording, Anne Gulbech; Wise, Paul H.; Milstein, Arnold; Sorensen, Henrik Toft			Association Between the Birth of an Infant With Major Congenital Anomalies and Subsequent Risk of Mortality in Their Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSYCHOLOGICAL STRESS; PREDICTIVE-VALUE; PREMATURE DEATH; HEALTH; CHILDREN; PARENTS; REGISTRATION; NATIONWIDE; ENGLAND; IMPACT	IMPORTANCE Giving birth to a child with a major birth defect is a serious life event for a woman, yet little is known about the long-term health consequences for the mother. OBJECTIVE To assess whether birth of an infant born with a major congenital anomaly was associated with higher maternal risk of mortality. DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study (n = 455 250 women) used individual-level linked Danish registry data for mothers who gave birth to an infant with a major congenital anomaly (41 508) between 1979 and 2010, with follow-up until December 31, 2014. A comparison cohort (413 742) was constructed by randomly sampling, for each mother with an affected infant, up to 10 mothers matched on maternal age, parity, and year of infant's birth. EXPOSURE Live birth of an infant with a major congenital anomaly as defined by the European Surveillance of Congenital Anomalies classification system. MAIN OUTCOMES AND MEASURES Primary outcomewas all-cause mortality. Secondary outcomes included cause-specific mortality. Hazard ratios (HRs) were adjusted for marital status, immigration status, income quartile (since 1980), educational level (since 1981), diabetes mellitus, modified Charlson comorbidity index score, hypertension, depression, history of alcohol-related disease, previous spontaneous abortion, pregnancy complications, smoking (since 1991), and body mass index (since 2004). RESULTS Mothers in both groups were a mean (SD) age of 28.9 (5.1) years at delivery. After a median (IQR) follow-up of 21 (12-28) years, there were 1275 deaths (1.60 per 1000 person-years) among 41 508 mothers of a child with a major congenital anomaly vs 10 112 deaths (1.27 per 1000 person-years) among 413 742 mothers in the comparison cohort, corresponding to an absolute mortality rate difference of 0.33 per 1000 person-years (95% CI, 0.24-0.42), an unadjusted HR of 1.27 (95% CI, 1.20-1.35), and an adjusted HR of 1.22 (95% CI, 1.15-1.29). Mothers with affected infants were more likely to die of cardiovascular disease (rate difference, 0.05 per 1000 person-years [95% CI, 0.02-0.08]; adjusted HR, 1.26 [95% CI, 1.04-1.53]), respiratory disease (rate difference, 0.02 per 1000 person-years [95% CI, 0.00-0.04]; adjusted HR, 1.45 [95% CI, 1.01-2.08]), and other natural causes (rate difference, 0.11 per 1000 person-years [95% CI, 0.07-0.15]; adjusted HR, 1.50 [95% CI, 1.27-1.76]). CONCLUSIONS AND RELEVANCE In Denmark, having a child with a major congenital anomaly was associated with a small but statistically significantly increased mortality risk in the mother compared with women without an affected child. However, the clinical importance of this association is uncertain.	[Cohen, Eyal] Univ Toronto, Hosp Sick Children, Dept Pediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Cohen, Eyal; Horvath-Puho, Erzsebet; Pedersen, Lars; Ording, Anne Gulbech; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Cohen, Eyal; Ray, Joel G.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Cohen, Eyal; Wise, Paul H.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA USA; [Cohen, Eyal; Milstein, Arnold] Stanford Univ, Clin Excellence Res Ctr, Sch Med, Stanford, CA USA; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Adler, Nancy] Univ Calif San Francisco, Ctr Hlth & Community, Sch Med, San Francisco, CA 94143 USA; [Sorensen, Henrik Toft] Stanford Univ, Dept Hlth Res & Policy, Div Epidemiol, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aarhus University; University of Toronto; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of California System; University of California San Francisco; Stanford University	Cohen, E (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	eyal.cohen@sickkids.ca	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Horvath-Puho, Erzsebet/0000-0002-3594-2212	Commonwealth Fund, a private independent foundation based in New York City; Canadian Foundation for Health Care Improvement; Canadian Institutes of Health Research [FDN-143315]; Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation; Norvo Nordisk Foundation; SickKids Foundation; Lundbeck Foundation [R155-2014-2647] Funding Source: researchfish; Novo Nordisk Fonden [NNF14SA0015794] Funding Source: researchfish	Commonwealth Fund, a private independent foundation based in New York City; Canadian Foundation for Health Care Improvement; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation(Lundbeckfonden); Norvo Nordisk Foundation; SickKids Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	Dr Cohen was supported by the Commonwealth Fund, a private independent foundation based in New York City, and the Canadian Foundation for Health Care Improvement as a 2015/2016 Harkness Fellow, and by the Canadian Institutes of Health Research (FDN-143315). Drs Sorensen and Pedersen were supported by the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Norvo Nordisk Foundation. Dr Ray holds a Canadian Institutes for Health Research Chair in Reproductive and Child Health Services and Policy Research, cofunded by the SickKids Foundation.	Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Brehaut JC, 2009, AM J PUBLIC HEALTH, V99, P1254, DOI 10.2105/AJPH.2007.129817; Brent RL, 2004, PEDIATRICS, V113, P957; Brown SL, 2009, PSYCHOL SCI, V20, P488, DOI 10.1111/j.1467-9280.2009.02323.x; Cabizuca M, 2009, HEALTH PSYCHOL, V28, P379, DOI 10.1037/a0014512; Centers for Disease Control and Prevention, 1978, UPD OV PREV MAJ BIRT; Cohen E, 2012, PEDIATRICS, V130, pE1463, DOI 10.1542/peds.2012-0175; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Espinosa J, 2013, ECON HUM BIOL, V11, P371, DOI 10.1016/j.ehb.2012.06.002; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Harper Mairi, 2011, BMJ Support Palliat Care, V1, P306, DOI 10.1136/bmjspcare-2011-000025; Heikkila K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f165; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Knudsen LB, 1998, DAN MED BULL, V45, P320; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Li J, 2002, CANCER, V95, P2237, DOI 10.1002/cncr.10943; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; PATTERSON JM, 1992, J DEV BEHAV PEDIATR, V13, P248; Petersen L, 2002, GENET EPIDEMIOL, V23, P123, DOI 10.1002/gepi.1122; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Ramsay S, 2013, J EPIDEMIOL COMMUN H, V67, P655, DOI 10.1136/jech-2012-202237; Ratliffe Clark E, 2002, Issues Compr Pediatr Nurs, V25, P167, DOI 10.1080/01460860290042558; Roth DL, 2015, GERONTOLOGIST, V55, P309, DOI 10.1093/geront/gnu177; Roth DL, 2013, AM J EPIDEMIOL, V178, P1571, DOI 10.1093/aje/kwt225; Rubak DB, STOTTEMULIGHEDER FOR; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Tennant PWG, 2010, LANCET, V375, P649, DOI 10.1016/S0140-6736(09)61922-X; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	38	22	23	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2515	2524		10.1001/jama.2016.18425	http://dx.doi.org/10.1001/jama.2016.18425			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG3QH	27997654				2022-12-28	WOS:000390959300019
J	Gallus, A				Gallus, Alexander			Review: For warfarin reversal, prothrombin complex concentrates reduce mortality compared with fresh frozen plasma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gallus, Alexander] Flinders Med Ctr, Adelaide, SA, Australia	Flinders Medical Centre	Gallus, A (corresponding author), Flinders Med Ctr, Adelaide, SA, Australia.			Gallus, Alexander/0000-0001-7347-9989					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC65	JC65		10.7326/ACPJC-2016-165-12-065	http://dx.doi.org/10.7326/ACPJC-2016-165-12-065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992921				2022-12-28	WOS:000391236900004
J	Lee, JS; Giesler, DL; Fine, MJ				Lee, Jonathan S.; Giesler, Daniel L.; Fine, Michael J.			Duration of Antibiotic Therapy for Community-Acquired Pneumonia in the Era of Personalized Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES	IMPORTANCE The optimal duration of antibiotic treatment for community acquired pneumonia (CAP) has not been well established. OBJECTIVE To validate Infectious Diseases Society of America/American Thoracic Society guidelines for duration of antibiotic treatment in hospitalized patients with CAP. DESIGN, SETTING, AND PARTICIPANTS This study was a multicenter, noninferiority randomized clinical trial performed at 4 teaching hospitals in Spain from January 1, 2012, through August 31, 2013. A total of 312 hospitalized patients diagnosed as having CAP were studied. Data analysis was performed from January 1, 2014, through February 28, 2015. INTERVENTIONS Patients were randomized at day 5 to an intervention or control group. Those in the intervention group were treated with antibiotics for a minimum of 5 days, and the antibiotic treatment was stopped at this point if their body temperature was 37.8 degrees C or less for 48 hours and they had no more than 1 CAP-associated sign of clinical instability. Duration of antibiotic treatment in the control group was determined by physicians. MAIN OUTCOMES AND MEASURES Clinical success rate at days 10 and 30 since admission and CAP-related symptoms at days 5 and 10 measured with the 18-item CAP symptom questionnaire score range, 0-90; higher scores indicate more severe symptoms. RESULTS Of the 312 patients included, 150 and 162 were randomized to the control and intervention groups, respectively. The mean (SD) age of the patientswas 66.2 (17.9) years and 64.7 (18.7) years in the control and intervention groups, respectively. Therewere 95 men (63.3%) and 55women (36.7%) in the control group and 101 men (62.3%) and 61 women (37.7%) in the intervention group. In the intent-to-treat analysis, clinical success was 48.6%(71 of 150) in the control group and 56.3% (90 of 162) in the intervention group at day 10 (P =.18) and 88.6%(132 of 150) in the control group and 91.9%(147 of 162) in the intervention group at day 30 (P =.33). The mean (SD) CAP symptom questionnaire scoreswere 24.7 (11.4) vs 27.2 (12.5) at day 5 (P =.10) and 18.6 (9.0) vs 17.9 (7.6) at day 10 (P =.69). In the per-protocol analysis, clinical successwas 50.4%(67 of 137) in the control group and 59.7%(86 of 146) in the intervention group at day 10 (P =.12) and 92.7%(126 of 137) in the control group and 94.4%(136 of 146) in the intervention group at day 30 (P = .54). The mean (SD) CAP symptom questionnaire scores were 24.3 (11.4) vs 26.6 (12.1) at day 5 (P = .16) and 18.1 (8.5) vs 17.6 (7.4) at day 10 (P = .81). CONCLUSIONS AND RELEVANCE The Infectious Diseases Society of America/American Thoracic Society recommendations for duration of antibiotic treatment based on clinical stability criteria can be safely implemented in hospitalized patients with CAP.	[Lee, Jonathan S.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA; [Giesler, Daniel L.; Fine, Michael J.] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; [Fine, Michael J.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 151C Univ Dr,Bldg 30, Pittsburgh, PA 15240 USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Fine, MJ (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, 151C Univ Dr,Bldg 30, Pittsburgh, PA 15240 USA.	michael.fine@va.gov						Gadsby NJ, 2016, CLIN INFECT DIS, V62, P817, DOI 10.1093/cid/civ1214; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Li JZ, 2007, AM J MED, V120, P783, DOI 10.1016/j.amjmed.2007.04.023; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Uranga A, 2016, JAMA INTERN MED, V176, P1257, DOI 10.1001/jamainternmed.2016.3633	6	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2544	+		10.1001/jama.2016.17589	http://dx.doi.org/10.1001/jama.2016.17589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997641				2022-12-28	WOS:000390959300022
J	Mukadam, N				Mukadam, Naaheed			Stay with me	LANCET			English	Editorial Material									[Mukadam, Naaheed] UCL, Div Psychiat, London WC1E 6BT, England	University of London; University College London	Mukadam, N (corresponding author), UCL, Div Psychiat, London WC1E 6BT, England.	n.mukadam@ucl.ac.uk							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3085	3086		10.1016/S0140-6736(16)32536-3	http://dx.doi.org/10.1016/S0140-6736(16)32536-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998538				2022-12-28	WOS:000390112300040
J	Schmidt, C; Kowalinski, E; Shanmuganathan, V; Defenouillere, Q; Braunger, K; Heuer, A; Pech, M; Namane, A; Berninghausen, O; Fromont-Racine, M; Jacquier, A; Conti, E; Becker, T; Beckmann, R				Schmidt, Christian; Kowalinski, Eva; Shanmuganathan, Vivekanandan; Defenouillere, Quentin; Braunger, Katharina; Heuer, Andre; Pech, Markus; Namane, Abdelkader; Berninghausen, Otto; Fromont-Racine, Micheline; Jacquier, Alain; Conti, Elena; Becker, Thomas; Beckmann, Roland			The cryo-EM structure of a ribosome-Ski2-Ski3-Ski8 helicase complex	SCIENCE			English	Article							MESSENGER-RNA DECAY; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; EXOSOME COMPLEX; SKI COMPLEX; TRANSLATION; RIBOSOME; DEGRADATION; YEAST; SURVEILLANCE	Ski2-Ski3-Ski8 (Ski) is a helicase complex functioning with the RNA-degrading exosome to mediate the 3-5' messenger RNA (mRNA) decay in turnover and quality-control pathways. We report that the Ski complex directly associates with 80S ribosomes presenting a short mRNA 3' overhang. We determined the structure of an endogenous ribosome-Ski complex using cryo electron microscopy (EM) with a local resolution of the Ski complex ranging from 4 angstroms (angstrom) in the core to about 10 angstrom for intrinsically flexible regions. Ribosome binding displaces the autoinhibitory domain of the Ski2 helicase, positioning it in an open conformation near the ribosomal mRNA entry tunnel. We observe that the mRNA 3 overhang is threaded directly from the small ribosomal subunit to the helicase channel of Ski2, primed for ongoing exosome-mediated 3'-5' degradation.	[Schmidt, Christian; Shanmuganathan, Vivekanandan; Braunger, Katharina; Heuer, Andre; Pech, Markus; Berninghausen, Otto; Becker, Thomas; Beckmann, Roland] Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany; [Schmidt, Christian; Shanmuganathan, Vivekanandan; Braunger, Katharina; Heuer, Andre; Pech, Markus; Berninghausen, Otto; Becker, Thomas; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany; [Kowalinski, Eva; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Munich, Germany; [Defenouillere, Quentin; Namane, Abdelkader; Fromont-Racine, Micheline; Jacquier, Alain] CNRS, UMR 3525, Inst Pasteur, Genet Interact Macromol, Rue Docteur Roux 25-28, F-75724 Paris, France; [Defenouillere, Quentin] UPMC Paris 6, Sorbonne Univ, Complexite Vivant, F-75252 Paris 05, France	University of Munich; University of Munich; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Becker, T; Beckmann, R (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.; Becker, T; Beckmann, R (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.; Conti, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Munich, Germany.	conti@biochem.mpg.de; becker@genzentrum.lmu.de; beckmann@genzentrum.lmu.de	Namane, Abdelkader/O-1857-2013	Namane, Abdelkader/0000-0001-7180-7619; JACQUIER, ALAIN/0000-0001-5707-9184; Defenouillere, Quentin/0000-0003-2255-4859; Kowalinski, Eva/0000-0002-9785-9027; Conti, Elena/0000-0003-1254-5588; Fromont-Racine, Micheline/0000-0001-9906-0334	German Research Council [SFB646, GRK1721, FOR1805, SFB1035]; Max Planck Gesellschaft; Agency Nationale de la Recherche [2011-BSV6-011-02, ANR-14-CE-10-0014-01]; Center for Integrated Protein Science Munich (CiPS-M); Graduate School of Quantitative Biosciences Munich (QBM); European Research Council; Boehringer Ingelheim Fonds; Ministere de l'Enseignernent Suparieur et de la Recherche; Fondation ARC pour la Recherche our le Cancer; Earn EMBO; Marie Curie; Daimler and Benz Stiftung	German Research Council(German Research Foundation (DFG)); Max Planck Gesellschaft(Max Planck Society); Agency Nationale de la Recherche; Center for Integrated Protein Science Munich (CiPS-M); Graduate School of Quantitative Biosciences Munich (QBM); European Research Council(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Ministere de l'Enseignernent Suparieur et de la Recherche; Fondation ARC pour la Recherche our le Cancer; Earn EMBO; Marie Curie(European Commission); Daimler and Benz Stiftung	The crya-EM map for the ribosome-Ski complex and the respective atomic coordinates have been deposited in the EMDataBank and ProteinDataBark with accession,, codes EMD-3461 and 5MC6, respectively. Sequencing dataa are available at Gene Expressing Omnibus (GEO) with the accession number GSE10259. The authors declare no competing financial interests. We thank the Leibnitz-Rechenzentrum Munich (LRZ) for providing computational services and support. This work was supported by the German Research Council (SFB646 to R.B, T.B., and E.C.; GRK1721 to R.B. and E.C.; FOR1805 to R.B; and SFB1035 to E.C.), by the Max Planck Gesellschaft (E.C.), and by the Agency Nationale de la Recherche (2011-BSV6-011-02 and ANR-14-CE-10-0014-01 to Q.D., A.T., and M.F.-R). R.B. and E.C. acknowledge support by the Center for Integrated Protein Science Munich (CiPS-M), the Graduate School of Quantitative Biosciences Munich (QBM), and the European Research Council (Advanced Grants CRYOTRANSLATION and DEAD2THEEND). We also acknowledge the support of Ph.D. and postdoctoral fellowships from Boehringer Ingelheim Fonds (to C.S. and K.B.); from QBM (to V.S.); from the Ministere de l'Enseignernent Suparieur et de la Recherche and from the Fondation ARC pour la Recherche our le Cancer (to Q.D.); and Earn EMBO, Marie Curie, and the Daimler and Benz Stiftung (to E.K.).	Antic S, 2015, MOL CELL BIOL, V35, P2309, DOI 10.1128/MCB.01346-14; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Halbach F, 2013, CELL, V154, P814, DOI 10.1016/j.cell.2013.07.017; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Hu WQ, 2010, NAT STRUCT MOL BIOL, V17, P244, DOI 10.1038/nsmb.1734; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kowalinski E, 2016, MOL CELL, V63, P125, DOI 10.1016/j.molcel.2016.05.028; Kowalinski E, 2015, STRUCTURE, V23, P1336, DOI 10.1016/j.str.2015.04.018; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qu XD, 1998, NUCLEIC ACIDS RES, V26, P4068, DOI 10.1093/nar/26.17.4068; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Schmidt C, 2016, NUCLEIC ACIDS RES, V44, P1944, DOI 10.1093/nar/gkv1517; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107	25	67	68	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1431	1433		10.1126/science.aaf7520	http://dx.doi.org/10.1126/science.aaf7520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980209				2022-12-28	WOS:000390261300045
J	Schiebinger, L; Leopold, SS; Miller, VM				Schiebinger, Londa; Leopold, Seth S.; Miller, Virginia M.			Editorial policies for sex and gender analysis	LANCET			English	Editorial Material							BIAS		[Schiebinger, Londa] Stanford Univ, Dept Hist, Stanford, CA 94305 USA; [Schiebinger, Londa] Stanford Univ, Gendered Innovat Sci Hlth & Med Engn & Environm, Stanford, CA 94305 USA; [Leopold, Seth S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Miller, Virginia M.] Mayo Clin, Womens Hlth Res Ctr, Rochester, MN USA	Stanford University; Stanford University; University of Washington; University of Washington Seattle; Mayo Clinic	Schiebinger, L (corresponding author), Stanford Univ, Dept Hist, Stanford, CA 94305 USA.; Schiebinger, L (corresponding author), Stanford Univ, Gendered Innovat Sci Hlth & Med Engn & Environm, Stanford, CA 94305 USA.	schieb@stanford.edu		Schiebinger, Londa/0000-0003-3438-3081	NIA NIH HHS [P50 AG044170] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG044170] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Canadian Institutes of Health Research, 2010, GEND SEX HLTH RES GU; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405; Clayton JA, 2016, FASEB J, V30, P519, DOI 10.1096/fj.15-279554; Curno MJ, 2011, EUR SCI ED, V37, P104; European Commission, 2013, FACT SHEET GEND EQ H; Fausto-Sterling A., 2012, SEX GENDER BIOL SOCI; Geller SE, 2011, J WOMENS HEALTH, V20, P315, DOI 10.1089/jwh.2010.2469; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Heinrich J, 2001, LETT HONORABLE TOM H; Klein SL, 2015, P NATL ACAD SCI USA, V112, P5257, DOI 10.1073/pnas.1502843112; Legato MJ, 2016, JAMA-J AM MED ASSOC, V316, P1865, DOI 10.1001/jama.2016.13995; Leopold SS, 2014, CLIN ORTHOP RELAT R, V472, P391, DOI 10.1007/s11999-013-3397-5; Miller VM, 2012, PHYSIOL GENOMICS, V44, P485, DOI 10.1152/physiolgenomics.00034.2012; National Institutes of Health, 2015, CONS SEX BIOL VAR NI; Oertelt-Prigione S, 2012, SEX AND GENDER ASPECTS IN CLINICAL MEDICINE, P9, DOI 10.1007/978-0-85729-832-4_3; Regitz-Zagrosek V., 2012, SEX GENDER DIFFERENC; Regitz-Zagrosek V, 2012, EMBO REP, V13, P596, DOI 10.1038/embor.2012.87; SchenckGustafsson K, 2012, HANDBOOK OF CLINICAL GENDER MEDICINE, P1; Shah K, 2014, AM J PHYSIOL-CELL PH, V306, pC3, DOI 10.1152/ajpcell.00281.2013; Taylor KE, 2011, BIOL SEX DIFFER, V1, P1; US Food and Drug Administration, 2014, EV SEX SPEC DAT MED; Yoon DY, 2014, SURGERY, V156, P508, DOI 10.1016/j.surg.2014.07.001	24	61	62	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2841	2842		10.1016/S0140-6736(16)32392-3	http://dx.doi.org/10.1016/S0140-6736(16)32392-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979394				2022-12-28	WOS:000389631700007
J	Watts, G				Watts, Geoff			Gerald Roy Patterson Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2108	2108		10.1016/S0140-6736(16)31925-0	http://dx.doi.org/10.1016/S0140-6736(16)31925-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA1DJ	27968741				2022-12-28	WOS:000386332400022
J	Wang, XM; Zhou, XD; Hesketh, T				Wang, Xiao-Min; Zhou, Xu-Dong; Hesketh, Therese			Massive misuse of antibiotics by university students in China: a cross-sectional survey	LANCET			English	Meeting Abstract	Lancet-Chinese-Academy-of-Medical-Sciences (CAMS) Health Summit	OCT 30-31, 2016	Beijing, PEOPLES R CHINA	Lancet, Chinese Acad Med Sci					[Wang, Xiao-Min; Zhou, Xu-Dong] Zhejiang Univ, Inst Social Med & Family Med, Hangzhou, Zhejiang, Peoples R China; [Hesketh, Therese] UCL, Inst Global Hlth, London, England	Zhejiang University; University of London; University College London		zhouxudong@zju.edu.cn		zhou, xudong/0000-0002-0784-5343; Hesketh, Therese/0000-0002-7564-9221					0	18	19	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT	2016	388			1			94	94		10.1016/S0140-6736(16)32021-9	http://dx.doi.org/10.1016/S0140-6736(16)32021-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	EQ7WA	27968914				2022-12-28	WOS:000398294400095
J	Hauser, SL; Bar-Or, A; Comi, G; Giovannoni, G; Hartung, HP; Hemmer, B; Lublin, F; Montalban, X; Rammohan, KW; Selmaj, K; Traboulsee, A; Wolinsky, JS; Arnold, DL; Klingelschmitt, G; Masterman, D; Fontoura, P; Belachew, S; Chin, P; Mairon, N; Garren, H; Kappos, L				Hauser, S. L.; Bar-Or, A.; Comi, G.; Giovannoni, G.; Hartung, H. -P.; Hemmer, B.; Lublin, F.; Montalban, X.; Rammohan, K. W.; Selmaj, K.; Traboulsee, A.; Wolinsky, J. S.; Arnold, D. L.; Klingelschmitt, G.; Masterman, D.; Fontoura, P.; Belachew, S.; Chin, P.; Mairon, N.; Garren, H.; Kappos, L.		OPERA I OPERA II Clinical	Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL DEPLETION; CANCER-RISK; DISEASE; DISABILITY; RITUXIMAB; PATHOLOGY; ANTIBODY; CD20	BACKGROUND B cells influence the pathogenesis of multiple sclerosis. Ocrelizumab is a humanized monoclonal antibody that selectively depletes CD20+ B cells. METHODS In two identical phase 3 trials, we randomly assigned 821 and 835 patients with relapsing multiple sclerosis to receive intravenous ocrelizumab at a dose of 600 mg every 24 weeks or subcutaneous interferon beta-1a at a dose of 44 mu g three times weekly for 96 weeks. The primary end point was the annualized relapse rate. RESULTS The annualized relapse rate was lower with ocrelizumab than with interferon beta-1a in trial 1 (0.16 vs. 0.29; 46% lower rate with ocrelizumab; P<0.001) and in trial 2 (0.16 vs. 0.29; 47% lower rate; P<0.001). In prespecified pooled analyses, the percentage of patients with disability progression confirmed at 12 weeks was significantly lower with ocrelizumab than with interferon beta-1a (9.1% vs. 13.6%; hazard ratio, 0.60; 95% confidence interval [CI], 0.45 to 0.81; P<0.001), as was the percentage of patients with disability progression confirmed at 24 weeks (6.9% vs. 10.5%; hazard ratio, 0.60; 95% CI, 0.43 to 0.84; P = 0.003). The mean number of gadolinium-enhancing lesions per T 1 -weighted magnetic resonance scan was 0.02 with ocrelizumab versus 0.29 with interferon beta-1a in trial 1 (94% lower number of lesions with ocrelizumab, P<0.001) and 0.02 versus 0.42 in trial 2 (95% lower number of lesions, P<0.001). The change in the Multiple Sclerosis Functional Composite score (a composite measure of walking speed, upper-limb movements, and cognition; for this z score, negative values indicate worsening and positive values indicate improvement) significantly favored ocrelizumab over interferon beta-1a in trial 2 (0.28 vs. 0.17, P = 0.004) but not in trial 1 (0.21 vs. 0.17, P = 0.33). Infusion-related reactions occurred in 34.3% of the patients treated with ocrelizumab. Serious infection occurred in 1.3% of the patients treated with ocrelizumab and in 2.9% of those treated with interferon beta-1a. Neoplasms occurred in 0.5% of the patients treated with ocrelizumab and in 0.2% of those treated with interferon beta-1a. CONCLUSIONS Among patients with relapsing multiple sclerosis, ocrelizumab was associated with lower rates of disease activity and progression than interferon beta-1a over a period of 96 weeks. Larger and longer studies of the safety of ocrelizumab are required. (Funded by F. Hoffmann-La Roche; OPERA I and II ClinicalTrials.gov numbers, NCT01247324 and NCT01412333, respectively.)	[Hauser, S. L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Masterman, D.; Chin, P.; Garren, H.] Genentech Inc, San Francisco, CA USA; [Bar-Or, A.; Arnold, D. L.] McGill Univ, Montreal, PQ, Canada; [Arnold, D. L.] NeuroRx Res, Montreal, PQ, Canada; [Traboulsee, A.] Univ British Columbia, Vancouver, BC, Canada; [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy; [Giovannoni, G.] Barts & London Queen Marys Sch Med & Dent, London, England; [Hartung, H. -P.] Heinrich Heine Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Hemmer, B.] Tech Univ Munich, Munich, Germany; [Hemmer, B.] Munich Cluster Syst Neurol, Munich, Germany; [Lublin, F.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Montalban, X.] Hosp Vall dHebron Univ, Barcelona, Spain; [Rammohan, K. W.] Univ Miami, Miami, FL USA; [Selmaj, K.] Med Univ Lodz, Lodz, Poland; [Selmaj, K.] Ctr Neurol, Lodz, Poland; [Wolinsky, J. S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA; [Klingelschmitt, G.; Fontoura, P.; Belachew, S.; Mairon, N.] F Hoffmann La Roche, Basel, Switzerland; [Kappos, L.] Univ Basel, Univ Basel Hosp, Basel, Switzerland	University of California System; University of California San Francisco; Roche Holding; Genentech; McGill University; University of British Columbia; Vita-Salute San Raffaele University; University of London; Queen Mary University London; Heinrich Heine University Dusseldorf; Technical University of Munich; Icahn School of Medicine at Mount Sinai; University of Miami; Medical University Lodz; University of Texas System; University of Texas Health Science Center Houston; Roche Holding; University of Basel	Hauser, SL (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.; Kappos, L (corresponding author), Univ Basel, Univ Basel Hosp, Petersgraben 4, CH-4301 Basel, Switzerland.	stephen.hauser@ucsf.edu; ludwig.kappos@usb.ch	Belachew, Shibeshih/V-9185-2019; Hemmer, Bernhard/AAT-8388-2021; Montalban, Xavier/J-5938-2016; Aktas, Orhan/B-7623-2009; Platten, Michael/F-2902-2013; Bar-Or, Amit/AIC-1416-2022; Goodman, Andrew D/N-3974-2018; Makarov, Nikolay/D-5539-2017; Ramo-Tello, Cristina M/N-9735-2016; Lublin, Fred/L-8405-2017; Cerqueira, Joao J/B-4579-2008; Traboulsee, Anthony L/AAB-2051-2020; Myhr, Kjell-Morten/H-1528-2018; Hemmer, Bernhard/GPX-8451-2022; Zipp, Frauke/C-9968-2015; Benesova, Yvonne/C-1411-2016	Belachew, Shibeshih/0000-0003-3976-1950; Montalban, Xavier/0000-0002-0098-9918; Aktas, Orhan/0000-0002-2020-9210; Platten, Michael/0000-0002-4746-887X; Ramo-Tello, Cristina M/0000-0001-8643-5053; Cerqueira, Joao J/0000-0003-3155-2775; Myhr, Kjell-Morten/0000-0002-0980-510X; Hemmer, Bernhard/0000-0001-5985-6784; Yaldizli, Ozgur/0000-0002-0800-4845; ZABAD, RANA KHALIL/0000-0003-3170-7108; Pozzilli, Carlo/0000-0002-6360-4798; Roshanisefat, Homayoun/0000-0002-3019-8826; Zipp, Frauke/0000-0002-1231-1928; Benesova, Yvonne/0000-0002-5348-1747; Sazonov, Denis/0000-0003-4127-0704; Selmaj, Krzysztof/0000-0003-1213-7218; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040; Arnold, Douglas/0000-0003-4266-0106; Rodriguez-Antiguedad, Alfredo/0000-0001-5975-725X; YUCEYAR, NUR/0000-0003-4590-6423; Turcani, Peter/0000-0002-4868-6836; Dunn, Jeffrey/0000-0002-1721-6081; Martinez Rodriguez, Jose Enrique/0000-0001-6765-5587; Papais-Alvarenga, Regina Maria/0000-0002-1141-8619; Willekens, Barbara/0000-0002-5212-8837; Alekseenko, Urii Vladimirovic/0000-0002-1356-9496; Reingold, Stephen/0000-0003-4485-8634	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Funded by F. Hoffmann-La Roche; OPERA I and II ClinicalTrials.gov numbers, NCT01247324 and NCT01412333, respectively.	AL-Sobbogh A, 2007, MULT SCLER J, V13, pS8, DOI 10.1177/1352458507077007; [Anonymous], 2010, RIT RIT INJ INTR US; Bar-Or A, 2008, SEMIN NEUROL, V28, P29, DOI 10.1055/s-2007-1019124; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Caon Christina, 2015, Int J MS Care, V17, P191, DOI 10.7224/1537-2073.2014-030; Cohen JA, 2001, ARCH NEUROL-CHICAGO, V58, P961, DOI 10.1001/archneur.58.6.961; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Fischer J.S., 2001, MULTIPLE SCLEROSIS F; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2652, DOI 10.1002/art.23732; Goodin DS, 2012, J NEUROL NEUROSUR PS, V83, P282, DOI 10.1136/jnnp-2011-301178; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hauser SL, 2015, MULT SCLER J, V21, P8, DOI 10.1177/1352458514561911; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use, 2001, J Postgrad Med, V47, P45; Kamburova EG, 2013, AM J TRANSPLANT, V13, P1503, DOI 10.1111/ajt.12220; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Kingwell E, 2012, BRAIN, V135, P2973, DOI 10.1093/brain/aws148; Klein C, 2013, MABS-AUSTIN, V5, P337, DOI 10.4161/mabs.24108; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lehmann-Horn K, 2013, THER ADV NEUROL DISO, V6, P161, DOI 10.1177/1756285612474333; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Nielsen NM, 2006, INT J CANCER, V118, P979, DOI 10.1002/ijc.21437; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rotstein DL, 2015, JAMA NEUROL, V72, P152, DOI 10.1001/jamaneurol.2014.3537; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sorensen PS, 2016, THER ADV NEUROL DISO, V9, P44, DOI 10.1177/1756285615601933; Stern JNH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008879; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; von Budingen HC, 2012, J CLIN INVEST, V122, P4533, DOI 10.1172/JCI63842; Winkelmann A, 2016, NAT REV NEUROL, V12, P217, DOI 10.1038/nrneurol.2016.21; World Medical Association, 2013, WMA DECL HELS ETH PR	42	855	890	0	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2017	376	3					221	234		10.1056/NEJMoa1601277	http://dx.doi.org/10.1056/NEJMoa1601277			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI0XO	28002679	Green Published, Bronze			2022-12-28	WOS:000392199100006
J	Knopf, K; Baum, M; Shimp, WS; Bennett, CL; Faith, D; Fishman, ML; Hrushesky, WJM				Knopf, Kevin; Baum, Michael; Shimp, William S.; Bennett, Charles L.; Faith, Dinah; Fishman, Marc L.; Hrushesky, William J. M.			Interpretation of surrogate endpoints in the era of the 21st Century Cures Act	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METASTATIC BREAST-CANCER; QUALITY-OF-LIFE; PHASE-III TRIAL; CLINICAL-TRIALS; NAB-PACLITAXEL; DRUG APPROVALS; LUNG; COMBINATION; ASSOCIATION; BEVACIZUMAB		[Knopf, Kevin] Oncol Analyt, Commun Explanatory Analyt Div, Plantation, FL USA; [Shimp, William S.; Fishman, Marc L.] Oncol Analyt, Plantation, FL USA; [Faith, Dinah] Oncol Analyt, Adv Analyt, Plantation, FL USA; [Baum, Michael] UCL, Med Humanities, London NW11 7ED, England; [Bennett, Charles L.] Univ South Carolina, Coll Pharm, Medicat Safety & Efficacy, Columbia, SC USA; [Bennett, Charles L.] Univ South Carolina, Coll Pharm, Medicat Safety & Efficacy, Charleston, SC USA; [Bennett, Charles L.] Med Univ South Carolina, Hollings Canc Ctr, Medicat Safety & Efficacy, Columbia, SC USA; [Bennett, Charles L.] Med Univ South Carolina, Hollings Canc Ctr, Medicat Safety & Efficacy, Charleston, SC USA; [Hrushesky, William J. M.] Ambulatory Monitoring, Ardsley, NY USA	University of London; University College London; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; Medical University of South Carolina	Baum, M (corresponding author), UCL, Med Humanities, London NW11 7ED, England.	baum.michael3@gmail.com						Baum M, 2002, LANCET, V359, P2131; Belani CP, 2008, J CLIN ONCOL, V26, P468, DOI 10.1200/JCO.2007.13.1912; Bennett CL, 2014, BRIT J CANCER, V111, P421, DOI 10.1038/bjc.2014.292; Doshi P, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4013; First Data Bank, 2016, US DRUG PRIC POL DAT; Gradishar WJ, 2012, BREAST CANCER-BASIC, V6, P159, DOI 10.4137/BCBCR.S8205; Hellman S, 2014, J CLIN ONCOL, V32, P2804, DOI 10.1200/JCO.2014.56.0466; Hermanson TTO, 2015, J ONCOL PRACT, V11, P363, DOI 10.1200/JOP.2015.005397; Joly F, 2007, ANN ONCOL, V18, P1935, DOI 10.1093/annonc/mdm121; Lathan CS, 2016, J CLIN ONCOL, V34, P1732, DOI 10.1200/JCO.2015.63.2232; Levine MN, 2012, J CLIN ONCOL, V30, P2025, DOI 10.1200/JCO.2011.41.4912; Mailankody S, 2015, JAMA ONCOL, V1, P539, DOI 10.1001/jamaoncol.2015.0373; Marten K, 2006, EUR RADIOL, V16, P781, DOI 10.1007/s00330-005-0036-x; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; National Institutes for Health and Care Excellence, 2014, APPR CONS DOC PACL A; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Prowell TM, 2016, NEW ENGL J MED, V374, P2001, DOI 10.1056/NEJMp1603747; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Raisch DW, 2011, EXPERT OPIN DRUG SAF, V10, P521, DOI 10.1517/14740338.2011.582865; Redberg RF, 2015, JAMA INTERN MED, V175, P1398, DOI 10.1001/jamainternmed.2015.2857; Richey EA, 2009, J CLIN ONCOL, V27, P4398, DOI 10.1200/JCO.2008.21.1961; Rugo HS, 2015, J CLIN ONCOL, V33, P2361, DOI 10.1200/JCO.2014.59.5298; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Socinski MA, 2012, J CLIN ONCOL, V30, P2055, DOI 10.1200/JCO.2011.39.5848; Sorensen SV, 2012, INT J TECHNOL ASSESS, V28, P12, DOI 10.1017/S026646231100064X; Yang YT, 2015, J CLIN ONCOL, V33, P2597, DOI 10.1200/JCO.2015.62.8057; Yu T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007960	27	5	5	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2016	355								i6286	10.1136/bmj.i6286	http://dx.doi.org/10.1136/bmj.i6286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RH	28039123				2022-12-28	WOS:000391173100001
J	Bisgaard, H; Stokholm, J; Chawes, BL; Vissing, NH; Bjarnadottir, E; Schoos, AMM; Wolsk, HM; Pedersen, TM; Vinding, RK; Thorsteinsdottir, S; Folsgaard, NV; Fink, NR; Thorsen, J; Pedersen, AG; Waage, J; Rasmussen, MA; Stark, KD; Olsen, SF; Bonnelykke, K				Bisgaard, Hans; Stokholm, Jakob; Chawes, Bo L.; Vissing, Nadja H.; Bjarnadottir, Elin; Schoos, Ann-Marie M.; Wolsk, Helene M.; Pedersen, Tine M.; Vinding, Rebecca K.; Thorsteinsdottir, Sunna; Folsgaard, Nilofar V.; Fink, Nadia R.; Thorsen, Jonathan; Pedersen, Anders G.; Waage, Johannes; Rasmussen, Morten A.; Stark, Ken D.; Olsen, Sjurdur F.; Bonnelykke, Klaus			Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL-COLONIZATION; HIGH-RISK; BIRTH; N-3; SUPPLEMENTATION; CONSUMPTION; SYMPTOMS; BLOOD; BRONCHIOLITIS; VALIDITY	BACKGROUND Reduced intake of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) may be a contributing factor to the increasing prevalence of wheezing disorders. We assessed the effect of supplementation with n-3 LCPUFAs in pregnant women on the risk of persistent wheeze and asthma in their offspring. METHODS We randomly assigned 736 pregnant women at 24 weeks of gestation to receive 2.4 g of n-3 LCPUFA (fish oil) or placebo (olive oil) per day. Their children formed the Copenhagen Prospective Studies on Asthma in Childhood 2010 (COPSAC 2010) cohort and were followed prospectively with extensive clinical phenotyping. Neither the investigators nor the participants were aware of group assignments during follow-up for the first 3 years of the children's lives, after which there was a 2-year follow-up period during which only the investigators were unaware of group assignments. The primary end point was persistent wheeze or asthma, and the secondary end points included lower respiratory tract infections, asthma exacerbations, eczema, and allergic sensitization. RESULTS A total of 695 children were included in the trial, and 95.5% completed the 3-year, double-blind follow-up period. The risk of persistent wheeze or asthma in the treatment group was 16.9%, versus 23.7% in the control group (hazard ratio, 0.69; 95% confidence interval [CI], 0.49 to 0.97; P=0.035), corresponding to a relative reduction of 30.7%. Prespecified subgroup analyses suggested that the effect was strongest in the children of women whose blood levels of eicosapentaenoic acid and docosahexaenoic acid were in the lowest third of the trial population at randomization: 17.5% versus 34.1% (hazard ratio, 0.46; 95% CI, 0.25 to 0.83; P=0.011). Analyses of secondary end points showed that supplementation with n-3 LCPUFA was associated with a reduced risk of infections of the lower respiratory tract (31.7% vs. 39.1%; hazard ratio, 0.75; 95% CI, 0.58 to 0.98; P=0.033), but there was no statistically significant association between supplementation and asthma exacerbations, eczema, or allergic sensitization. CONCLUSIONS Supplementation with n-3 LCPUFA in the third trimester of pregnancy reduced the absolute risk of persistent wheeze or asthma and infections of the lower respiratory tract in offspring by approximately 7 percentage points, or one third. (Funded by the Lund-beck Foundation and others; ClinicalTrials.gov number, NCT00798226.)	[Bisgaard, Hans; Stokholm, Jakob; Chawes, Bo L.; Vissing, Nadja H.; Bjarnadottir, Elin; Schoos, Ann-Marie M.; Wolsk, Helene M.; Pedersen, Tine M.; Vinding, Rebecca K.; Thorsteinsdottir, Sunna; Folsgaard, Nilofar V.; Fink, Nadia R.; Thorsen, Jonathan; Waage, Johannes; Rasmussen, Morten A.; Bonnelykke, Klaus] Univ Copenhagen, COPSAC Copenhagen Prospect Studies Asthma Childho, Herlev & Gentofte Hosp, Copenhagen, Denmark; [Olsen, Sjurdur F.] Statens Serum Inst, Ctr Fetal Programming, Copenhagen, Denmark; [Stokholm, Jakob; Bjarnadottir, Elin; Pedersen, Tine M.; Vinding, Rebecca K.] Naestved Hosp, Dept Pediat, Naestved, Denmark; [Pedersen, Anders G.] Tech Univ Denmark, DTU Bioinformat, Lyngby, Denmark; [Rasmussen, Morten A.] Univ Copenhagen, Fac Sci Chemometr & Analyt Technol, Copenhagen, Denmark; [Stark, Ken D.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Olsen, Sjurdur F.] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA	University of Copenhagen; Statens Serum Institut; Naestved Hospital; Technical University of Denmark; University of Copenhagen; University of Waterloo; Harvard University; Harvard T.H. Chan School of Public Health	Bisgaard, H (corresponding author), Univ Copenhagen, COPSAC, Herlev & Gentofte Hosp, Ledreborg Alle 34, DK-2820 Copenhagen, Denmark.	bisgaard@copsac.com	Thorsen, Jonathan/AAQ-9269-2021; Schoos, Ann-Marie Malby/AAO-7677-2020; Bisgaard, Hans/N-4761-2016; Arendt, Morten/S-8843-2017; Rasmussen, Morten/AAE-9517-2020; Stark, Ken D/I-1347-2016	Thorsen, Jonathan/0000-0003-0200-0461; Schoos, Ann-Marie Malby/0000-0002-5827-0885; Bisgaard, Hans/0000-0003-4131-7592; Arendt, Morten/0000-0001-7431-5206; Rasmussen, Morten/0000-0001-7431-5206; Stark, Ken D/0000-0001-7828-4072; Pedersen, Anders Gorm/0000-0001-9650-8965; Olsen, Sjurdur/0000-0003-3017-7096; Chawes, Bo/0000-0001-6846-6243; Vinding, Rebecca Kofod/0000-0002-7680-3040; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Lundbeck Foundation; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	Funded by the Lundbeck Foundation and others	Armstrong JM, 2008, LIPIDS, V43, P187, DOI 10.1007/s11745-007-3141-6; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Blumer N, 2007, J PERINAT MED, V35, pS12, DOI 10.1515/JPM.2007.031; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Furuhjelm C, 2009, ACTA PAEDIATR, V98, P1461, DOI 10.1111/j.1651-2227.2009.01355.x; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hansen S, 2016, J ALLERGY CLIN IMMUN; Lands B, 2014, PROG LIPID RES, V55, P17, DOI 10.1016/j.plipres.2014.04.002; LEAF A, 1987, AM J CLIN NUTR, V45, P1048, DOI 10.1093/ajcn/45.5.1048; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; Metherel AH, 2009, PROSTAG LEUKOTR ESS, V81, P417, DOI 10.1016/j.plefa.2009.07.003; Micha Renata, 2014, BMJ, V348, pg2272, DOI 10.1136/bmj.g2272; Mikkelsen TB, 2007, SCAND J PUBLIC HEALT, V35, P172, DOI 10.1080/14034940600975625; Mikkelsen TB, 2006, PUBLIC HEALTH NUTR, V9, P771, DOI 10.1079/PHN2005883; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Olsen SF, 2007, PAEDIATR PERINAT EP, V21, P76, DOI 10.1111/j.1365-3016.2007.00777.x; Palmer DJ, 2013, ALLERGY, V68, P1370, DOI 10.1111/all.12233; Stark KD, 2005, J LIPID RES, V46, P516, DOI 10.1194/jlr.M400394-JLR200; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Willers SM, 2007, THORAX, V62, P773, DOI 10.1136/thx.2006.074187	35	252	258	3	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2530	2539		10.1056/NEJMoa1503734	http://dx.doi.org/10.1056/NEJMoa1503734			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	28029926	Green Published, Bronze			2022-12-28	WOS:000391175300006
J	da Costa, BR; Hari, R; Juni, P				da Costa, Bruno R.; Hari, Roman; Juni, Peter			Intra-articular Corticosteroids for Osteoarthritis of the Knee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[da Costa, Bruno R.; Hari, Roman] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland; [Juni, Peter] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada	University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Juni, P (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	peter.juni@utoronto.ca	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Hari, Roman/0000-0002-3972-9056; R. da Costa, Bruno/0000-0002-1786-6332				DIEPPE PA, 1980, RHEUMATOL REHABIL, V19, P212, DOI 10.1093/rheumatology/19.4.212; Henriksen M, 2015, JAMA INTERN MED, V175, P923, DOI 10.1001/jamainternmed.2015.0461; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Juni P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328.pub3; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003	6	34	34	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2671	2672		10.1001/jama.2016.17565	http://dx.doi.org/10.1001/jama.2016.17565			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027351	Green Published			2022-12-28	WOS:000391110200021
J	Roca, RP; Charen, B; Boronow, J				Roca, Robert P.; Charen, Barbara; Boronow, John			Ensuring Staff Safety When Treating Potentially Violent Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Roca, Robert P.; Charen, Barbara; Boronow, John] Sheppard Pratt Hlth Syst, 6501 N Charles St, Towson, MD 21204 USA		Roca, RP (corresponding author), Sheppard Pratt Hlth Syst, 6501 N Charles St, Towson, MD 21204 USA.	RRoca@sheppardpratt.org						Braun B., 2012, IMPROVING PATIENT WO; Cornaggia CM, 2011, PSYCHIAT RES, V189, P10, DOI 10.1016/j.psychres.2010.12.024; Stahl SM, 2014, CNS SPECTRUMS, V19, P449, DOI 10.1017/S1092852914000376; Toussaint J., 2010, MEND REVOLUTIONIZING; Wyatt R, 2016, JAMA-J AM MED ASSOC, V316, P1037, DOI 10.1001/jama.2016.10384	5	4	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2669	2670		10.1001/jama.2016.18260	http://dx.doi.org/10.1001/jama.2016.18260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027370				2022-12-28	WOS:000391110200020
J	Hawkins, M				Hawkins, Michael			Elizabeth Clare Abernethy OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2016	355								i6708	10.1136/bmj.i6708	http://dx.doi.org/10.1136/bmj.i6708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CL	28011647				2022-12-28	WOS:000390921300005
J	Kolmann, MA; Summers, AP				Kolmann, Matthew A.; Summers, Adam P.			BIOMATERIALS Sharks shift their spine into high gear	NATURE			English	Editorial Material								It emerges that a dogfish shark's spine becomes stiffer as the fish swims faster, enabling the animal to swim efficiently at different speeds. The finding could also provide inspiration for the design of robotic biomaterials.	[Kolmann, Matthew A.; Summers, Adam P.] Univ Washington, Friday Harbor Labs, Dept Biol, Friday Harbor, WA 98250 USA	University of Washington	Kolmann, MA (corresponding author), Univ Washington, Friday Harbor Labs, Dept Biol, Friday Harbor, WA 98250 USA.	mkolmann@gmail.com; fishguy@uw.edu		Summers, Adam/0000-0003-1930-9748				Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Park SJ, 2016, SCIENCE, V353, P158, DOI 10.1126/science.aaf4292; Porter ME, 2014, ZOOLOGY, V117, P19, DOI 10.1016/j.zool.2013.10.007; Porter ME, 2016, J EXP BIOL, V219, P2908, DOI 10.1242/jeb.135251; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Wasse, 1724, PHILOS T R SOC LOND, V33, P87, DOI 10.1098/rstl.1724.0017; Wilga CD, 2004, NATURE, V430, P850, DOI 10.1038/430850a	8	0	0	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					532	533		10.1038/nature21102	http://dx.doi.org/10.1038/nature21102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	27974797				2022-12-28	WOS:000391190500040
J	Chakraborty, S; Bharucha, AE				Chakraborty, Subhankar; Bharucha, Adil E.			In chronic severe functional constipation, electroacupuncture increased complete spontaneous bowel movements	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chakraborty, Subhankar; Bharucha, Adil E.] Mayo Clin, Rochester, MN 55902 USA	Mayo Clinic	Chakraborty, S (corresponding author), Mayo Clin, Rochester, MN 55902 USA.							American Gastroenterological Association, 2013, Gastroenterology, V144, P211, DOI 10.1053/j.gastro.2012.10.029; Bharucha AE, 2013, GASTROENTEROLOGY, V144, P218, DOI 10.1053/j.gastro.2012.10.028; Jin Xun, 2010, Zhongguo Zhen Jiu, V30, P97; Wang Li-juan, 2011, Zhongguo Zhen Jiu, V31, P320	4	2	2	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC69	JC69		10.7326/ACPJC-2016-165-12-069	http://dx.doi.org/10.7326/ACPJC-2016-165-12-069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992925				2022-12-28	WOS:000391236900008
J	Kansagara, D; Wilt, TJ; Starkey, M; Oaseem, A				Kansagara, Devan; Wilt, Timothy J.; Starkey, Melissa; Oaseem, Amir			Management of Chronic Insomnia Disorder in Adults RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kansagara, Devan] Portland Evidence Based Synth Program, Portland, OR 97239 USA; [Kansagara, Devan] Portland VA Med Ctr, Portland, OR 97239 USA; [Wilt, Timothy J.] Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Starkey, Melissa; Oaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of Minnesota System; University of Minnesota Twin Cities; American College of Physicians	Kansagara, D (corresponding author), Portland Evidence Based Synth Program, Portland, OR 97239 USA.; Kansagara, D (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.								0	2	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					892	892		10.7326/L16-0542	http://dx.doi.org/10.7326/L16-0542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992908				2022-12-28	WOS:000391236900029
J	Emmanuel, MA; Greenberg, NR; Oblinsky, DG; Hyster, TK				Emmanuel, Megan A.; Greenberg, Norman R.; Oblinsky, Daniel G.; Hyster, Todd K.			Accessing non-natural reactivity by irradiating nicotinamide-dependent enzymes with light	NATURE			English	Article							ALCOHOL-DEHYDROGENASE; PHOTOREDOX CATALYSIS; RADICAL CATIONS; VISIBLE-LIGHT; KETONES; DEBROMINATION; BIOCATALYSIS; MECHANISMS; REDUCTION; ESTERS	Enzymes are ideal for use in asymmetric catalysis by the chemical industry, because their chemical compositions can be tailored to a specific substrate and selectivity pattern while providing efficiencies and selectivities that surpass those of classical synthetic methods(1). However, enzymes are limited to reactions that are found in nature and, as such, facilitate fewer types of transformation than do other forms of catalysis(2). Thus, a longstanding challenge in the field of biologically mediated catalysis has been to develop enzymes with new catalytic functions(3). Here we describe a method for achieving catalytic promiscuity that uses the photoexcited state of nicotinamide co-factors (molecules that assist enzyme-mediated catalysis). Under irradiation with visible light, the nicotinamide-dependent enzyme known as ketoreductase can be transformed from a carbonyl reductase into an initiator of radical species and a chiral source of hydrogen atoms. We demonstrate this new reactivity through a highly enantioselective radical dehalogenation of lactones-a challenging transformation for small-molecule catalysts(4-7). Mechanistic experiments support the theory that a radical species acts as an intermediate in this reaction, with NADH and NADPH (the reduced forms of nicotinamide adenine nucleotide and nicotinamide adenine dinucleotide phosphate, respectively) serving as both a photoreductant and the source of hydrogen atoms. To our knowledge, this method represents the first example of photo-induced enzyme promiscuity, and highlights the potential for accessing new reactivity from existing enzymes simply by using the excited states of common biological co-factors. This represents a departure from existing light-driven biocatalytic techniques, which are typically explored in the context of co-factor regeneration(8,9).	[Emmanuel, Megan A.; Greenberg, Norman R.; Oblinsky, Daniel G.; Hyster, Todd K.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University	Hyster, TK (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	thyster@princeton.edu	Greenberg, Norman/AIF-4488-2022	Greenberg, Norman/0000-0001-5696-0957; Emmanuel, Megan/0000-0002-0379-2045	Princeton University; Natural Sciences and Engineering Research Council of Canada (NSERC)	Princeton University(Princeton University); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by Princeton University. D.G.O. also acknowledges financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC). We thank the MacMillan group for use of their chiral high-performance liquid-chromatography and cyclic-voltammetry equipment; G. Scholes for providing the time-resolved fluorescence instrument; H. Yayla of the Knowles group for assistance with cyclic-voltammetry experiments; B. Shields of the Doyle group and the Scholes Group for collection of the LED emission spectrum; and G. Huisman of Codexis for conversations regarding the nature of the mutants in the Codexis KRED kit.	Macia-Agullo JA, 2015, CHEM-EUR J, V21, P10940, DOI 10.1002/chem.201406437; Blumenstein M, 1997, ANGEW CHEM INT EDIT, V36, P235, DOI 10.1002/anie.199702351; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Bornscheuer U. T., 2012, ENZYME CATALYSIS ORG, P1695; Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Cuetos A, 2012, ADV SYNTH CATAL, V354, P1743, DOI 10.1002/adsc.201200139; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; FUKUZUMI S, 1983, J AM CHEM SOC, V105, P4722, DOI 10.1021/ja00352a034; Fukuzumi S, 2003, J AM CHEM SOC, V125, P4808, DOI 10.1021/ja029623y; Gabruk M, 2015, BIOCHEMISTRY-US, V54, P5255, DOI 10.1021/acs.biochem.5b00704; Gu YF, 2015, CHEMBIOCHEM, V16, P1880, DOI 10.1002/cbic.201500165; Huisman G. W., 2009, CURR OPIN CHEM BIOL, V14, P1; HUMMEL W, 1990, APPL MICROBIOL BIOT, V34, P15, DOI 10.1007/BF00170916; Jung J, 2016, ADV SYNTH CATAL, V358, P74, DOI 10.1002/adsc.201500734; Kao TH, 2011, J STRUCT BIOL, V174, P485, DOI 10.1016/j.jsb.2011.02.010; Kara S, 2013, ACS CATAL, V3, P2436, DOI 10.1021/cs400535c; MAIDAN R, 1986, J AM CHEM SOC, V108, P1080, DOI 10.1021/ja00265a038; Man H, 2014, TOP CATAL, V57, P356, DOI 10.1007/s11244-013-0191-2; Megger E, 2015, CHEM COMMUN, V51, P3290, DOI 10.1039/c4cc09268f; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Noey EL, 2015, P NATL ACAD SCI USA, V112, pE7065, DOI 10.1073/pnas.1507910112; Park JH, 2015, ANGEW CHEM INT EDIT, V54, P969, DOI 10.1002/anie.201410059; Prier CK, 2015, J AM CHEM SOC, V137, P13992, DOI 10.1021/jacs.5b09348; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Sanli G, 2003, CELL BIOCHEM BIOPHYS, V38, P79, DOI 10.1385/CBB:38:1:79; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xu HJ, 2006, ORG LETT, V8, P3449, DOI 10.1021/ol0610892; Zhu XQ, 2003, CHEM-EUR J, V9, P871, DOI 10.1002/chem.200390108; Zimmerman J, 2006, TOP CURR CHEM, V263, P107, DOI 10.1007/128_027	30	162	162	14	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					414	+		10.1038/nature20569	http://dx.doi.org/10.1038/nature20569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974767				2022-12-28	WOS:000389716800038
J	Ladher, N				Ladher, Navjoyt			CHRISTMAS 2016: IN THE LITERATURE Christmas crackers: highlights from past years of The BMJ's seasonal issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTORS; BACK					nladher@bmj.com						Ashdown HF, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8012; BAERHEIM A, 1994, BRIT MED J, V309, P1689, DOI 10.1136/bmj.309.6970.1689; Chapman C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6326; Cooke FJ, 1999, BRIT MED J, V319, P1616, DOI 10.1136/bmj.319.7225.1616; Feinmann J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6425; Gajendragadkar PR, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7198; Giesinger K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6446; Guarnizo-Herreno CC, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6543; Haynes S., 1880, BMJ-BRIT MED J, V2, P1034, DOI [10.1136/bmj.2.1043.1034-a, DOI 10.1136/BMJ.2.1043.1034-A]; Lendrem BD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7094; Sabelis I, ANN IMPROBABLE RES; Schultz WW, 1999, BRIT MED J, V319, P1596, DOI 10.1136/bmj.319.7225.1596; Solomon AW, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6761; Stepney R, 2006, BMJ-BRIT MED J, V333, P1311, DOI 10.1136/bmj.39049.751701.47; Subramanian P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7506; Witcombe B, 2006, BRIT MED J, V333, P1285, DOI 10.1136/bmj.39027.676690.55; Wolkewitz M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7799	17	2	2	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2016	355								i6679	10.1136/bmj.i6679	http://dx.doi.org/10.1136/bmj.i6679			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JU	27979816	Green Published, Bronze			2022-12-28	WOS:000390151500004
J	Wu, LF; Zhou, B; Oshiro-Rapley, N; Li, M; Paulo, JA; Webster, CM; Mou, F; Kacergis, MC; Talkowski, ME; Carr, CE; Gygi, SP; Zheng, B; Soukas, AA				Wu, Lianfeng; Zhou, Ben; Oshiro-Rapley, Noriko; Li, Man; Paulo, Joao A.; Webster, Christopher M.; Mou, Fan; Kacergis, Michael C.; Talkowski, Michael E.; Carr, Christopher E.; Gygi, Steven P.; Zheng, Bin; Soukas, Alexander A.			An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer	CELL			English	Article							NUCLEAR-PORE COMPLEX; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; PANCREATIC-CANCER; MAMMALIAN TARGET; RAG GTPASES; MTOR; PATHWAY; CELLS; GLUCONEOGENESIS	Metformin has utility in cancer prevention and treatment, though the mechanisms for these effects remain elusive. Through genetic screening in C. elegans, we uncover two metformin response elements: the nuclear pore complex (NPC) and acyl-CoA dehydrogenase family member-10 (ACAD10). We demonstrate that biguanides inhibit growth by inhibiting mitochondrial respiratory capacity, which restrains transit of the RagA-RagC GTPase heterodimer through the NPC. Nuclear exclusion renders RagC incapable of gaining the GDP-bound state necessary to stimulate mTORC1. Biguanide-induced inactivation of mTORC1 subsequently inhibits growth through transcriptional induction of ACAD10. This ancient metformin response pathway is conserved from worms to humans. Both restricted nuclear pore transit and upregulation of ACAD10 are required for biguanides to reduce viability in melanoma and pancreatic cancer cells, and to extend C. elegans lifespan. This pathway provides a unified mechanism by which metformin kills cancer cells and extends lifespan, and illuminates potential cancer targets.	[Wu, Lianfeng; Zhou, Ben; Webster, Christopher M.; Kacergis, Michael C.; Soukas, Alexander A.] Massachusetts Gen Hosp, Dept Med, Diabet Unit, Boston, MA 02114 USA; [Wu, Lianfeng; Zhou, Ben; Webster, Christopher M.; Kacergis, Michael C.; Talkowski, Michael E.; Soukas, Alexander A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Wu, Lianfeng; Zhou, Ben; Webster, Christopher M.; Soukas, Alexander A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wu, Lianfeng; Zhou, Ben; Webster, Christopher M.; Soukas, Alexander A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Oshiro-Rapley, Noriko; Carr, Christopher E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Li, Man; Mou, Fan; Zheng, Bin] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Li, Man; Mou, Fan; Zheng, Bin] Harvard Med Sch, Charlestown, MA 02129 USA; [Paulo, Joao A.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Talkowski, Michael E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Talkowski, Michael E.] Harvard Med Sch, Boston, MA 02114 USA; [Carr, Christopher E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Soukas, AA (corresponding author), Massachusetts Gen Hosp, Dept Med, Diabet Unit, Boston, MA 02114 USA.; Soukas, AA (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.; Soukas, AA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Soukas, AA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	asoukas@mgh.harvard.edu	Paulo, Joao/AAO-3981-2020; Zhou, Ben/AAB-5808-2020; Zhou, Ben/R-9844-2019; Zhou, Ben/G-1850-2017	Paulo, Joao/0000-0002-4291-413X; Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zheng, Bin/0000-0002-0998-7177; Talkowski, Michael/0000-0003-2889-0992	NIH [P40 OD010440, R03DK098436, K08DK087941, R01DK072041, R01CA166717]; Broad Institute SPARC Grant; Ellison Medical Foundation New Scholar in Aging Award; NORC of Harvard [P30DK040561]; Boston Area DERC [P30DK057521]; NATIONAL CANCER INSTITUTE [R01CA166717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101522, K01DK098285, P30DK057521, P30DK040561, K08DK087941, R01DK072041, R03DK098436] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute SPARC Grant; Ellison Medical Foundation New Scholar in Aging Award(Lawrence Ellison Foundation); NORC of Harvard; Boston Area DERC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Broad Institute GPP for lentiviral shRNA reagents. Some worm strains were from the CGC, which is funded by the NIH (P40 OD010440). This work was funded by NIH grants R03DK098436 (A.A.S), K08DK087941 (A.A.S), R01DK072041 (A.A.S), and R01CA166717 (B. Zheng), a Broad Institute SPARC Grant (A.A.S.), the Ellison Medical Foundation New Scholar in Aging Award (A.A.S.), and supported by resources from the NORC of Harvard (P30DK040561) and the Boston Area DERC (P30DK057521). We thank Joseph Avruch, Jose Florez, and Geoffrey Walford for critical reading and discussions.	Back JH, 2011, CELL CYCLE, V10, P3849, DOI 10.4161/cc.10.22.18329; Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bian L, 2010, DIABETOLOGIA, V53, P1349, DOI 10.1007/s00125-010-1695-y; BRENNER S, 1974, GENETICS, V77, P71; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cheng G, 2016, CANCER RES, V76, P3904, DOI 10.1158/0008-5472.CAN-15-2534; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Griss T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002309; Han S, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10722; Hirose E, 1998, J CELL SCI, V111, P11; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kinoshita Y, 2012, AM J PATHOL, V180, P375, DOI 10.1016/j.ajpath.2011.09.024; Kordes S, 2015, LANCET ONCOL, V16, P839, DOI 10.1016/S1470-2045(15)00027-3; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Lord CL, 2015, J CELL BIOL, V208, P729, DOI 10.1083/jcb.201412024; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Oshiro N, 2014, J BIOL CHEM, V289, P2658, DOI 10.1074/jbc.M113.528505; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Prachar J, 2003, GEN PHYSIOL BIOPHYS, V22, P525; Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Simon DN, 2014, ADV EXP MED BIOL, V773, P285, DOI 10.1007/978-1-4899-8032-8_13; Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Yuan P, 2013, P NATL ACAD SCI USA, V110, P18226, DOI 10.1073/pnas.1317577110; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	47	129	131	5	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1705	+		10.1016/j.cell.2016.11.055	http://dx.doi.org/10.1016/j.cell.2016.11.055			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984722	Green Accepted, Bronze			2022-12-28	WOS:000393114700011
J	Goodwin, AJ; Higgins, RA; Moser, KA; Smock, KJ; Chandler, WL; Kottke-Marchant, K; Hartman, SK; Volod, O; Brown, AF; Johari, VP; Burr, S; Polyakov, N; Chen, D				Goodwin, Andrew J.; Higgins, Russell A.; Moser, Karen A.; Smock, Kristi J.; Chandler, Wayne L.; Kottke-Marchant, Kandice; Hartman, Sarah K.; Volod, Oksana; Brown, Alan F.; Johari, Vandita P.; Burr, Sharon; Polyakov, Nataliya; Chen, Dong			Issues Surrounding Age-Adjusted D-Dimer Cutoffs That Practicing Physicians Need to Know When Evaluating Patients With Suspected Pulmonary Embolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VENOUS THROMBOEMBOLISM		[Goodwin, Andrew J.] Univ Vermont, Med Ctr, Dept Pathol, 111 Colchester Ave, Burlington, VT 05401 USA; [Higgins, Russell A.] Univ Texas Hlth San Antonio, Dept Pathol & Lab Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Hartman, Sarah K.] Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA; [Moser, Karen A.] St Louis Univ, Sch Med, Dept Pathol, 1402 South Grand Blvd, St Louis, MO 63104 USA; Univ Utah, Salt Lake City, UT USA; [Smock, Kristi J.] ARUP Labs, 500 Chipeta Way,MSC 115-G04, Salt Lake City, UT 84108 USA; [Chandler, Wayne L.] Seattle Childrens Hosp, Dept Labs, OC 8 720,4800 Sand Point Way Northeast, Seattle, WA 98105 USA; [Kottke-Marchant, Kandice] Cleveland Clin Fdn, 9500 Euclid Ave,L-21, Cleveland, OH 44195 USA; [Volod, Oksana] Cedars Sinai Med Ctr, Beverly Pathol, 8700 Beverly Blvd,Room 4711, Los Angeles, CA 90048 USA; [Johari, Vandita P.] Baystate Med Ctr, Dept Pathol, 759 Chestnut St, Springfield, MA 01199 USA; [Burr, Sharon; Polyakov, Nataliya] Coll Amer Pathologists, 325 Waukegan Rd, Northfield, IL 60093 USA; [Chen, Dong] Mayo Clin, Special Coagulat Lab, Div Hematopathol, 200 First St Southwest, Rochester, MN 55905 USA; [Brown, Alan F.] ARUP Labs, 1166 East Garfield Ave,Apartment 3, Salt Lake City, UT 84105 USA; [Chen, Dong] Mayo Clin, Special Coagulat Lab, 200 1st St Southwest, Rochester, MN 55905 USA	University of Vermont; University of Vermont Medical Center; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Saint Louis University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Seattle Children's Hospital; Cleveland Clinic Foundation; Cedars Sinai Medical Center; Baystate Medical Center; College of American Pathologists; Mayo Clinic; Utah System of Higher Education; University of Utah; ARUP Laboratories; Mayo Clinic	Chen, D (corresponding author), Mayo Clin, Special Coagulat Lab, Div Hematopathol, 200 First St Southwest, Rochester, MN 55905 USA.	chen.dong@mayo.edu	Chen, Dong/V-8825-2019; Volod, Oksana/AAE-8453-2021					[Anonymous], 2015, HEM COAG CHECKL; Dempfle Carl-Erik, 2005, Semin Vasc Med, V5, P315, DOI 10.1055/s-2005-922476; Longstaff C, 2016, THROMB RES, V137, P219, DOI 10.1016/j.thromres.2015.11.031; Mullier F, 2014, BLOOD COAGUL FIBRIN, V25, P309, DOI 10.1097/MBC.0000000000000020; Olson JD, 2011, H59A CLSI; Olson JD, 2013, ARCH PATHOL LAB MED, V137, P1030, DOI 10.5858/arpa.2012-0296-CP; Raja AS, 2015, ANN INTERN MED, V163, P701, DOI 10.7326/M14-1772; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Riley RS, 2016, LAB MED, V47, P90, DOI 10.1093/labmed/lmw001; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492	10	15	16	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					361	+		10.7326/M16-2030	http://dx.doi.org/10.7326/M16-2030			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28024301				2022-12-28	WOS:000396432800009
J	McAchran, SE; Goldman, HB				McAchran, Sarah E.; Goldman, Howard B.			Synthetic midurethral slings redeemed	LANCET			English	Editorial Material									[McAchran, Sarah E.] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Goldman, Howard B.] Cleveland Clin, Lerner Coll Med, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA	University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Cleveland Clinic Foundation	McAchran, SE (corresponding author), Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53705 USA.	mcachran@urology.wisc.edu						Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; Frankel A, 2015, REUTERS         0818; Hufford Austen, 2016, WALL STREET J; Morling JR, 2016, LANCET; Rosenbaum L, 2016, NEW ENGL J MED, V374, P986, DOI 10.1056/NEJMms1516161	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					580	581		10.1016/S0140-6736(16)32597-1	http://dx.doi.org/10.1016/S0140-6736(16)32597-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28010988				2022-12-28	WOS:000394910800007
J	Cannavo, E; Koelling, N; Harnett, D; Garfield, D; Casale, FP; Ciglar, L; Gustafson, HE; Viales, RR; Marco-Ferreres, R; Degner, JF; Zhao, BQ; Stegle, O; Birney, E; Furlong, EEM				Cannavo, Enrico; Koelling, Nils; Harnett, Dermot; Garfield, David; Casale, Francesco P.; Ciglar, Lucia; Gustafson, Hilary E.; Viales, Rebecca R.; Marco-Ferreres, Raquel; Degner, Jacob F.; Zhao, Bingqing; Stegle, Oliver; Birney, Ewan; Furlong, Eileen E. M.			Genetic variants regulating expression levels and isoform diversity during embryogenesis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; 3' UNTRANSLATED REGIONS; ALTERNATIVE POLYADENYLATION; DROSOPHILA-MELANOGASTER; CORRELATED TRAITS; NATURAL VARIATION; MESSENGER-RNAS; MECHANISMS; MOUSE	Embryonic development is driven by tightly regulated patterns of gene expression, despite extensive genetic variation among individuals. Studies of expression quantitative trait loci(1-4) (eQTL) indicate that genetic variation frequently alters gene expression in cell-culture models and differentiated tissues(5,6). However, the extent and types of genetic variation impacting embryonic gene expression, and their interactions with developmental programs, remain largely unknown. Here we assessed the effect of genetic variation on transcriptional (expression levels) and post-transcriptional (3' RNA processing) regulation across multiple stages of metazoan development, using 80 inbred Drosophila wild isolates(7), identifying thousands of developmental-stage-specific and shared QTL. Given the small blocks of linkage disequilibrium in Drosophila(7-9), we obtain near base-pair resolution, resolving causal mutations in developmental enhancers, validated transcription-factor-binding sites and RNA motifs. This fine-grain mapping uncovered extensive allelic interactions within enhancers that have opposite effects, thereby buffering their impact on enhancer activity. QTL affecting 3' RNA processing identify new functional motifs leading to transcript isoform diversity and changes in the lengths of 3' untranslated regions. These results highlight how developmental stage influences the effects of genetic variation and uncover multiple mechanisms that regulate and buffer expression variation during embryogenesis.	[Cannavo, Enrico; Harnett, Dermot; Garfield, David; Ciglar, Lucia; Gustafson, Hilary E.; Viales, Rebecca R.; Marco-Ferreres, Raquel; Degner, Jacob F.; Zhao, Bingqing; Furlong, Eileen E. M.] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Koelling, Nils; Casale, Francesco P.; Stegle, Oliver; Birney, Ewan] EBI, EMBL, Hinxton CB10 ISD, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany.; Birney, E (corresponding author), EBI, EMBL, Hinxton CB10 ISD, England.	birney@ebi.ac.uk; furlong@embl.de	Stegle, Oliver/AAU-9177-2020; Garfield, David/AAG-1524-2020	Stegle, Oliver/0000-0002-8818-7193; Birney, Ewan/0000-0001-8314-8497; Koelling, Nils/0000-0001-5292-4510; Furlong, Eileen/0000-0002-9544-8339; Rodriguez Viales, Rebecca/0000-0003-3739-7438; zhao, bingqing/0000-0001-5000-7436; Gustafson, Eleanor Hilary/0000-0003-3978-8088; Marco-Ferreres, Raquel/0000-0002-6109-3840	European Molecular Biology Laboratory (EMBL) Genomics Core facility; European Research Council (ERC); ERC advanced grant CisRegVar; EMBL predoctoral funds	European Molecular Biology Laboratory (EMBL) Genomics Core facility; European Research Council (ERC)(European Research Council (ERC)); ERC advanced grant CisRegVar; EMBL predoctoral funds	This work was supported technically by the European Molecular Biology Laboratory (EMBL) Genomics Core facility, and financially by the European Research Council (ERC; FP/2007-2013), ERC advanced grant CisRegVar to E.E. M.F., EMBL predoctoral funds to E.E.M.F. and E.B.	Best A, 2014, BIOCHEM SOC T, V42, P1152, DOI 10.1042/BST20140075; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hilgers V, 2012, GENE DEV, V26, P2259, DOI 10.1101/gad.199653.112; Hilgers V, 2011, P NATL ACAD SCI USA, V108, P15864, DOI 10.1073/pnas.1112672108; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Lippert C., 2015, LIMIX GENETIC ANAL M; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Nakamura A, 1999, DEV GROWTH DIFFER, V41, P699; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Vu V, 2015, CELL, V162, P391, DOI 10.1016/j.cell.2015.06.037; Yoon OK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002882; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	32	38	38	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2017	541	7637					402	+		10.1038/nature20802	http://dx.doi.org/10.1038/nature20802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6QP	28024300				2022-12-28	WOS:000396128800044
J	Chaker-Margot, M; Barandun, J; Hunziker, M; Klinge, S				Chaker-Margot, Malik; Barandun, Jonas; Hunziker, Mirjam; Klinge, Sebastian			Architecture of the yeast small subunit processome	SCIENCE			English	Article							PRE-RIBOSOMAL-RNA; EXTERNAL TRANSCRIBED SPACER; SMALL NUCLEOLAR RNA; EUKARYOTIC RIBOSOME; ASSEMBLY FACTOR; U3 SNORNA; IN-VIVO; BIOGENESIS; PROTEIN; PEPTIDE	The small subunit (SSU) processome, a large ribonucleoprotein particle, organizes the assembly of the eukaryotic small ribosomal subunit by coordinating the folding, cleavage, and modification of nascent pre-ribosomal RNA (rRNA). Here, we present the cryo-electron microscopy structure of the yeast SSU processome at 5.1-angstrom resolution. The structure reveals how large ribosome biogenesis complexes assist the 5' external transcribed spacer and U3 small nucleolar RNA in providing an intertwined RNA-protein assembly platform for the separate maturation of 18S rRNA domains. The strategic placement of a molecular motor at the center of the particle further suggests a mechanism for mediating conformational changes within this giant particle. This study provides a structural framework for a mechanistic understanding of eukaryotic ribosome assembly in the model organism Saccharomyces cerevisiae.	[Chaker-Margot, Malik; Barandun, Jonas; Hunziker, Mirjam; Klinge, Sebastian] Rockefeller Univ, Lab Prot & Nucle Acid Chem, New York, NY 10065 USA; [Chaker-Margot, Malik] Rockefeller Univ, Triinst Training Program Chem Biol, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Klinge, S (corresponding author), Rockefeller Univ, Lab Prot & Nucle Acid Chem, New York, NY 10065 USA.	klinge@rockefeller.edu	Barandun, Jonas/AAA-5128-2019	Barandun, Jonas/0000-0003-2971-8190; Hunziker, Mirjam/0000-0002-2912-4993	European Molecular Biology Organization [ALTF 51-2014]; Swiss National Science Foundation [155515]; Natural Sciences and Engineering Research Council of Canada; Robertson Foundation; Alfred P. Sloan Foundation; Irma T. Hirschl Trust; Alexandrine and Alexander L. Sinsheimer Fund; Human Frontier Science Program	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Robertson Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Irma T. Hirschl Trust; Alexandrine and Alexander L. Sinsheimer Fund; Human Frontier Science Program(Human Frontier Science Program)	We thank M. Ebrahim and J. Sotiris for their outstanding support with data collection at the Evelyn Gruss Lipper Cryo-EM Resource Center, B. D. Dill for analysis of mass spectrometry data, and D. Acehan for assistance with negative stain and cryo-EM sample preparation. We further thank T. Walz and G. Alushin for helpful discussions and Z. Sanghai and L. Miller for critical reading of this manuscript. J. B. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 51-2014) and a Swiss National Science Foundation fellowship (155515), M. C.-M. is supported by a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada. S.K. is supported by the Robertson Foundation, the Alfred P. Sloan Foundation, the Irma T. Hirschl Trust, the Alexandrine and Alexander L. Sinsheimer Fund, and the Human Frontier Science Program. The cryo-EM density map for the yeast SSU processome has been deposited in the EM Data Bank with accession code EMD-8473. Atomic coordinates for the yeast SSU processome have been deposited in the Protein Data Bank under accession code 5TZS. S.K. established purification conditions, and M. C.-M. determined the cryo-EM structure of the yeast SSU processome. M. C.-M., J.B., and S.K. built the model; M.H. performed all RNA work; and all authors interpreted the results and wrote the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BELTRAME M, 1994, NUCLEIC ACIDS RES, V22, P5139, DOI 10.1093/nar/22.23.5139; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Delprato A, 2014, NUCLEIC ACIDS RES, V42, P10161, DOI 10.1093/nar/gku682; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dutca LM, 2011, NUCLEIC ACIDS RES, V39, P5164, DOI 10.1093/nar/gkr044; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher JEG, 2004, NUCLEIC ACIDS RES, V32, P1404, DOI 10.1093/nar/gkh318; Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hunziker M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12090; Intine RVA, 1999, J MOL BIOL, V286, P695, DOI 10.1006/jmbi.1998.2502; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimanius D., 2016, BIORXIV, DOI [10.1101/059717, DOI 10.1101/059717]; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Madru C, 2015, GENE DEV, V29, P1432, DOI 10.1101/gad.260349.115; Marmier-Gourrier N, 2011, NUCLEIC ACIDS RES, V39, P9731, DOI 10.1093/nar/gkr675; McCaughan UM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11789; Meyer B, 2011, NUCLEIC ACIDS RES, V39, P1526, DOI 10.1093/nar/gkq931; MOUGEY EB, 1993, GENE DEV, V7, P1609, DOI 10.1101/gad.7.8.1609; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Poll G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114898; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Sharma S, 2015, NUCLEIC ACIDS RES, V43, P2242, DOI 10.1093/nar/gkv075; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Talkish J, 2016, RNA, V22, P852, DOI 10.1261/rna.055780.115; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wegierski T, 2001, RNA, V7, P1254, DOI 10.1017/S1355838201012079; Wells GR, 2016, NUCLEIC ACIDS RES, V44, P5399, DOI 10.1093/nar/gkw213; Will S, 2012, RNA, V18, P900, DOI 10.1261/rna.029041.111; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; YEH LCC, 1992, J MOL BIOL, V228, P827, DOI 10.1016/0022-2836(92)90867-J; Zhang C, 2016, NUCLEIC ACIDS RES, V44, P7475, DOI 10.1093/nar/gkw562; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115; Zheng SD, 2014, ACTA CRYSTALLOGR F, V70, P918, DOI 10.1107/S2053230X14010905	46	88	89	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2017	355	6321							eaal1880	10.1126/science.aal1880	http://dx.doi.org/10.1126/science.aal1880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4LW	27980088				2022-12-28	WOS:000391743700033
J	Matsumoto, A; Pasut, A; Matsumoto, M; Yamashita, R; Fung, J; Monteleone, E; Saghatelian, A; Nakayama, KI; Clohessy, JG; Pandolfi, PP				Matsumoto, Akinobu; Pasut, Alessandra; Matsumoto, Masaki; Yamashita, Riu; Fung, Jacqueline; Monteleone, Emanuele; Saghatelian, Alan; Nakayama, Keiichi I.; Clohessy, John G.; Pandolfi, Pier Paolo			mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide	NATURE			English	Article							AMINO-ACIDS; RAG GTPASES; PEPTIDES; RAGULATOR; REVEALS; GENOME; RAPTOR; CELLS	Although long non-coding RNAs (lncRNAs) are non-protein-coding transcripts by definition, recent studies have shown that a fraction of putative small open reading frames within lncRNAs are translated(1-3). However, the biological significance of these hidden polypeptides is still unclear. Here we identify and functionally characterize a novel polypeptide encoded by the lncRNA LINC00961. This polypeptide is conserved between human and mouse, is localized to the late endosome/lysosome and interacts with the lysosomal v-ATPase to negatively regulate mTORC1 activation. This regulation of mTORC1 is specific to activation of mTORC1 by amino acid stimulation, rather than by growth factors. Hence, we termed this polypeptide 'small regulatory polypeptide of amino acid response' (SPAR). We show that the SPAR-encoding lncRNA is highly expressed in a subset of tissues and use CRISPR/Cas9 engineering to develop a SPAR-polypeptide-specific knockout mouse while maintaining expression of the host lncRNA. We find that the SPAR-encoding lncRNA is downregulated in skeletal muscle upon acute injury, and using this in vivo model we establish that SPAR downregulation enables efficient activation of mTORC1 and promotes muscle regeneration. Our data provide a mechanism by which mTORC1 activation may be finely regulated in a tissue-specific manner in response to injury, and a paradigm by which lncRNAs encoding small polypeptides can modulate general biological pathways and processes to facilitate tissue-specific requirements, consistent with their restricted and highly regulated expression profile.	[Matsumoto, Akinobu; Pasut, Alessandra; Fung, Jacqueline; Monteleone, Emanuele; Clohessy, John G.; Pandolfi, Pier Paolo] Harvard Med Sch, Canc Res Inst, Beth Israel Deaconess Canc Ctr, Dept Med & Pathol,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Matsumoto, Masaki; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Yamashita, Riu] Tohoku Univ, Tohoku Med Megabank Org ToMMo, Dept BioBank, Sendai, Miyagi 9808573, Japan; [Monteleone, Emanuele] Univ Turin, Mol Biotechnol Ctr, Via Nizza 52, I-10126 Turin, Italy; [Monteleone, Emanuele] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Via Nizza 52, I-10126 Turin, Italy; [Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; Tohoku University; University of Turin; University of Turin; Salk Institute	Pandolfi, PP (corresponding author), Harvard Med Sch, Canc Res Inst, Beth Israel Deaconess Canc Ctr, Dept Med & Pathol,Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Monteleone, Emanuele/AAC-4847-2022; Matsumoto, Akinobu/GPF-4945-2022	Monteleone, Emanuele/0000-0001-7440-900X; Pandolfi, Pier Paolo/0000-0002-5352-5295; Matsumoto, Masaki/0000-0002-6987-0288; Clohessy, John/0000-0001-5186-9775; xing zhi, shi zhi/0000-0003-3289-5681; Matsumoto, Akinobu/0000-0002-4077-3935	JSPS; Uehara Memorial Foundation; Naito Foundation; NIH [R01 CA082328, R35 CA197529]; JST; PREST; NATIONAL CANCER INSTITUTE [R01CA082328, R35CA197529] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JST(Japan Science & Technology Agency (JST)); PREST; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the P.P.P. laboratory, C.C. Dibble for critical discussions and Cell Signaling Technology for generation of SPAR antibodies. A.M. was supported by a postdoctoral fellowship from JSPS, The Uehara Memorial Foundation and The Naito Foundation. This work was supported in part by NIH grant R01 CA082328 and R35 CA197529 to P.P.P. and JST and PREST to A.M.	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Lunardi A., 2015, CANCER DISCOV, V5, P740; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pereira MG, 2014, NUTRIENTS, V6, P3981, DOI 10.3390/nu6103981; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Zhang PP, 2015, BIOCHEM BIOPH RES CO, V463, P102, DOI 10.1016/j.bbrc.2015.05.032; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	24	352	389	4	131	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					228	+		10.1038/nature21034	http://dx.doi.org/10.1038/nature21034			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	28024296				2022-12-28	WOS:000396125500043
J	Prettyman, TH; Yamashita, N; Toplis, MJ; McSween, HY; Schorghofer, N; Marchi, S; Feldman, WC; Castillo-Rogez, J; Forni, O; Lawrence, DJ; Ammannito, E; Ehlmann, BL; Sizemore, HG; Joy, SP; Polanskey, CA; Rayman, MD; Raymond, CA; Russell, CT				Prettyman, T. H.; Yamashita, N.; Toplis, M. J.; McSween, H. Y.; Schorghofer, N.; Marchi, S.; Feldman, W. C.; Castillo-Rogez, J.; Forni, O.; Lawrence, D. J.; Ammannito, E.; Ehlmann, B. L.; Sizemore, H. G.; Joy, S. P.; Polanskey, C. A.; Rayman, M. D.; Raymond, C. A.; Russell, C. T.			Extensive water ice within Ceres' aqueously altered regolith: Evidence from nuclear spectroscopy	SCIENCE			English	Article							METEORITE; ASTEROIDS; MODEL	The surface elemental composition of dwarf planet Ceres constrains its regolith ice content, aqueous alteration processes, and interior evolution. Using nuclear spectroscopy data acquired by NASA's Dawn mission, we determined the concentrations of elemental hydrogen, iron, and potassium on Ceres. The data show that surface materials were processed by the action of water within the interior. The non-icy portion of Ceres' carbon-bearing regolith contains similar amounts of hydrogen to those present in aqueously altered carbonaceous chondrites; however, the concentration of iron on Ceres is lower than in the aforementioned chondrites. This allows for the possibility that Ceres experienced modest ice-rock fractionation, resulting in differences between surface and bulk composition. At mid-to-high latitudes, the regolith contains high concentrations of hydrogen, consistent with broad expanses of water ice, confirming theoretical predictions that ice can survive for billions of years just beneath the surface.	[Prettyman, T. H.; Yamashita, N.; Feldman, W. C.; Sizemore, H. G.] Planetary Sci Inst, 1700 East Ft Lowell,Suite 106, Tucson, AZ 85719 USA; [Toplis, M. J.; Forni, O.] Univ Paul Sabatier, CNRS, Inst Rech Astrophys & Planetol, F-31400 Toulouse, France; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Schorghofer, N.] Univ Hawaii, 2680 Woodlawn Dr, Honolulu, HI 96822 USA; [Marchi, S.] Southwest Res Inst, Boulder, CO 80302 USA; [Castillo-Rogez, J.; Ehlmann, B. L.; Polanskey, C. A.; Rayman, M. D.; Raymond, C. A.] CALTECH, JPL, Pasadena, CA 91109 USA; [Lawrence, D. J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Ammannito, E.; Joy, S. P.; Russell, C. T.] Univ Calif Los Angeles, Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Ehlmann, B. L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Tennessee System; University of Tennessee Knoxville; University of Hawaii System; Southwest Research Institute; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of California System; University of California Los Angeles; California Institute of Technology	Prettyman, TH (corresponding author), Planetary Sci Inst, 1700 East Ft Lowell,Suite 106, Tucson, AZ 85719 USA.	prettyman@psi.edu	Schorghofer, Norbert/A-1194-2007; Lawrence, David J/E-7463-2015; Russell, Christopher T/E-7745-2012	Schorghofer, Norbert/0000-0002-5821-4066; Lawrence, David J/0000-0002-7696-6667; Russell, Christopher T/0000-0003-1639-8298	JPL, California Institute of Technology; NASA; NASA Dawn at Ceres Guest Investigator Program; NASA Discovery Program Office	JPL, California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA)); NASA Dawn at Ceres Guest Investigator Program; NASA Discovery Program Office	Portions of this work were performed by the Planetary Science Institute under contract with JPL, California Institute of Technology; by JPL under contract with NASA; and by the NASA Dawn at Ceres Guest Investigator Program. The Dawn mission is led by the University of California, Los Angeles, and is managed by JPL under the auspices of the NASA Discovery Program Office. The Dawn data are archived with the NASA Planetary Data System (http://sbn.psi.edu/pds/archive/dawn.html).	Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Ammannito E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4279; Bland PA, 2009, EARTH PLANET SC LETT, V287, P559, DOI 10.1016/j.epsl.2009.09.004; Brearley A.J., 2003, TREATISE GEOCHEMISTR, V1, P711, DOI [10.1016/B0-08-043751-6/01068-9, DOI 10.1016/B0-08-043751-6/01068-9.]; Britt DT, 2003, METEORIT PLANET SCI, V38, P1161, DOI 10.1111/j.1945-5100.2003.tb00305.x; Castillo-Rogez JC, 2010, ICARUS, V205, P443, DOI 10.1016/j.icarus.2009.04.008; Combe JP, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3010; De Sanctis MC, 2016, NATURE, V536, P54, DOI 10.1038/nature18290; Derenne S, 2010, METEORIT PLANET SCI, V45, P1461, DOI 10.1111/j.1945-5100.2010.01122.x; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Garenne A, 2016, ICARUS, V264, P172, DOI 10.1016/j.icarus.2015.09.005; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; Kuppers M, 2014, NATURE, V505, P525, DOI 10.1038/nature12918; Lodders K., 1998, PLANETARY SCI COMPAN; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; MCSWEEN HY, 1977, GEOCHIM COSMOCHIM AC, V41, P1145, DOI 10.1016/0016-7037(77)90110-7; Neveu M, 2015, GEOPHYS RES LETT, V42, P10197, DOI 10.1002/2015GL066375; Park RS, 2016, NATURE, V537, P515, DOI 10.1038/nature18955; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; Prettyman TH, 2011, SPACE SCI REV, V163, P371, DOI 10.1007/s11214-011-9862-0; Russell CT, 2016, SCIENCE, V353, P1008, DOI 10.1126/science.aaf4219; Schorghofer N, 2016, ICARUS, V276, P88, DOI 10.1016/j.icarus.2016.04.037; Young ED, 2003, EARTH PLANET SC LETT, V213, P249, DOI 10.1016/S0012-821X(03)00345-5	25	129	129	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 6	2017	355	6320					55	58		10.1126/science.aah6765	http://dx.doi.org/10.1126/science.aah6765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4KK	27980087				2022-12-28	WOS:000391739900041
J	Mafi, JN; Landon, BE				Mafi, John N.; Landon, Bruce E.			Comparing Use of Low-Value Health Care Services Among US Advanced Practice Clinicians and Physicians RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							QUALITY-OF-CARE		[Mafi, John N.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Landon, Bruce E.] Harvard Med Sch, Boston, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mafi, JN (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.							Carter Alix J E, 2007, CJEM, V9, P286; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Doan Q, 2011, EMERG MED AUSTRALAS, V23, P7, DOI 10.1111/j.1742-6723.2010.01368.x; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Tsai CL, 2010, AM J EMERG MED, V28, P485, DOI 10.1016/j.ajem.2009.01.041	5	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					77	77		10.7326/L16-0552	http://dx.doi.org/10.7326/L16-0552			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030671				2022-12-28	WOS:000391467900017
J	Abbasi, J				Abbasi, Jennifer			NIH Awards $150 Million for BRAIN Initiative Research in 2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2588	2588		10.1001/jama.2016.19330	http://dx.doi.org/10.1001/jama.2016.19330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9VN	28027354				2022-12-28	WOS:000394968300003
J	Volchenboum, SL; Mayampurath, A; Goksu-Gursoy, G; Edelson, DP; Howell, MD; Churpek, MM				Volchenboum, Samuel L.; Mayampurath, Anoop; Goksu-Gursoy, Gozde; Edelson, Dana P.; Howell, Michael D.; Churpek, Matthew M.			Association Between In-Hospital Critical Illness Events and Outcomes in Patients on the Same Ward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Volchenboum, Samuel L.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Mayampurath, Anoop] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Goksu-Gursoy, Gozde] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Edelson, Dana P.; Churpek, Matthew M.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Howell, Michael D.] Univ Chicago, Ctr Healthcare Delivery Sci & Innovat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Churpek, MM (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave,MC 6076, Chicago, IL 60637 USA.	matthew.churpek@uchospitals.edu		Churpek, Matthew/0000-0002-4030-5250	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121080] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL121080] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berlot G, 2004, EUR J EMERG MED, V11, P24, DOI 10.1097/00063110-200402000-00005; Churpek MM, 2014, AM J RESP CRIT CARE, V190, P649, DOI 10.1164/rccm.201406-1022OC; Churpek MM, 2014, CRIT CARE MED, V42, P841, DOI 10.1097/CCM.0000000000000038; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Stelfox HT, 2012, ARCH INTERN MED, V172, P467, DOI 10.1001/archinternmed.2011.2315	5	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2674	2675		10.1001/jama.2016.15505	http://dx.doi.org/10.1001/jama.2016.15505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027358	Green Accepted			2022-12-28	WOS:000391110200022
J	Applegate, WB; Ip, E				Applegate, William B.; Ip, Edward			The Evolving Taxonomy of Health in Older Persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Applegate, William B.] Wake Forest Sch Med, Dept Internal Med & Geriatr, Winston Salem, NC USA; [Ip, Edward] Wake Forest Sch Med, Dept Publ Hlth Sci, Winston Salem, NC USA	Wake Forest University; Wake Forest University	Applegate, WB (corresponding author), Wake Forest Sch Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA.	wapplega@wakehealth.edu			NIA NIH HHS [P30 AG021332] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Kritchevsky SB, 2014, J NUTR HEALTH AGING, V18, P467, DOI 10.1007/s12603-014-0456-x; Kuhn T.S., 1970, STRUCTURE SCI REVOLU, P174; McClintock MK, 2016, P NATL ACAD SCI USA, V113, pE3071, DOI 10.1073/pnas.1514968113; Slavitt A., PLANS QUALITY PAYMEN	5	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2487	2488		10.1001/jama.2016.16432	http://dx.doi.org/10.1001/jama.2016.16432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997661	Green Accepted			2022-12-28	WOS:000390959300013
J	Dahm, P; Wilt, T				Dahm, Philipp; Wilt, Timothy			In localized prostate cancer, active monitoring, prostatectomy, and radiotherapy did not differ for 10-y cancer deaths	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY		Minneapolis VA Health Care Syst, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Dahm, P (corresponding author), Minneapolis VA Health Care Syst, Minneapolis, MN USA.		Dahm, Philipp/I-1614-2019	Dahm, Philipp/0000-0003-2819-2553				Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; D'Amico AV, 2016, NEW ENGL J MED, V375, P1482, DOI 10.1056/NEJMe1610395; Ilic D, 2013, COCHRANE DATABASE SY; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Turner EL, 2014, BRIT J CANCER, V110, P2829, DOI 10.1038/bjc.2014.242; Wilt TJ, 2015, J NATL COMPR CANC NE, V13, P1566, DOI 10.6004/jnccn.2015.0182; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	8	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC63	JC63		10.7326/ACPJC-2016-165-12-063	http://dx.doi.org/10.7326/ACPJC-2016-165-12-063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992919				2022-12-28	WOS:000391236900036
J	Casassus, B				Casassus, Barbara			Profile: Inserm, Paris, France	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2973	2973		10.1016/S0140-6736(16)32580-6	http://dx.doi.org/10.1016/S0140-6736(16)32580-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998523				2022-12-28	WOS:000390112300014
J	Blum, TR; Miller, ZD; Bates, DM; Guzei, IA; Yoon, TP				Blum, Travis R.; Miller, Zachary D.; Bates, Desiree M.; Guzei, Ilia A.; Yoon, Tehshik P.			Enantioselective photochemistry through Lewis acid-catalyzed triplet energy transfer	SCIENCE			English	Article							2+2 PHOTOCYCLOADDITION REACTIONS; PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; ORGANIC-SYNTHESIS; DUAL-CATALYSIS; COUMARIN; ORGANOCATALYSIS; CYCLOADDITIONS; COMPLEXES	Relatively few catalytic systems are able to control the stereochemistry of electronically excited organic intermediates. Here we report the discovery that a chiral Lewis acid complex can catalyze triplet energy transfer from an electronically excited photosensitizer. We applied this strategy to asymmetric [2 + 2] photocycloadditions of 2'-hydroxychalcones, using tris(bipyridyl) ruthenium(II) as a sensitizer. A variety of electrochemical, computational, and spectroscopic data rule out substrate activation by means of photoinduced electron transfer and instead support a mechanism in which Lewis acid coordination dramatically lowers the triplet energy of the chalcone substrate. We expect that this approach will enable chemists to more broadly apply their detailed understanding of chiral Lewis acid catalysis to stereocontrol in reactions involving electronically excited states.	[Blum, Travis R.; Miller, Zachary D.; Bates, Desiree M.; Guzei, Ilia A.; Yoon, Tehshik P.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yoon, TP (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	tyoon@chem.wisc.edu			NIH [GM09888]; NSF [CHE-0840494]; NIH Chemical Biology Interface Training grant [T32 GM008505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008505, R01GM095666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH Chemical Biology Interface Training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge experimental assistance from M. Arnold and M. Shea in obtaining near-IR luminescence spectra. We also thank J. Schomaker and M. Ju for access to chiral HPLC instrumentation. Experimental details for all studies reported in this paper are described in the supplementary materials. Funding for this project was provided by the NIH (GM09888). The computational resources were supported in part by NSF (CHE-0840494). T.R.B. acknowledges support from a NIH Chemical Biology Interface Training grant (T32 GM008505). T.R.B. conceived the project, conducted the optimization studies described in the supplementary materials, and performed the mechanistic studies. Z.D.M. collected the data reported in Table 1 and Fig. 2 and conducted the cyclic voltammetry studies. D.M.B. and T.R.B. performed the computational studies. I.A.G. collected and analyzed x-ray crystallographic data, which are available free of charge from the Cambridge Crystallographic Data Centre under accession number CCDC 1507886. All authors contributed to the writing and editing of the manuscript.	Alonso R, 2014, ANGEW CHEM INT EDIT, V53, P4368, DOI 10.1002/anie.201310997; Amador AG, 2016, J AM CHEM SOC, V138, P4722, DOI 10.1021/jacs.6b01728; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Brimioulle R, 2015, J AM CHEM SOC, V137, P5170, DOI 10.1021/jacs.5b01740; Brimioulle R, 2015, ANGEW CHEM INT EDIT, V54, P3872, DOI 10.1002/anie.201411409; Brimioulle R, 2014, ANGEW CHEM INT EDIT, V53, P12921, DOI 10.1002/anie.201407832; Brimioulle R, 2012, CHEM-EUR J, V18, P7552, DOI 10.1002/chem.201104032; Cong H, 2008, J AM CHEM SOC, V130, P9214, DOI 10.1021/ja803094u; Cong HA, 2010, J AM CHEM SOC, V132, P7514, DOI 10.1021/ja102482b; DiRocco DA, 2012, J AM CHEM SOC, V134, P8094, DOI 10.1021/ja3030164; Du JN, 2014, SCIENCE, V344, P392, DOI 10.1126/science.1251511; ELLIOTT CM, 1985, J AM CHEM SOC, V107, P4647, DOI 10.1021/ja00302a009; Espelt LR, 2015, J AM CHEM SOC, V137, P2452, DOI 10.1021/ja512746q; Guo H, 2010, ANGEW CHEM INT EDIT, V49, P7782, DOI 10.1002/anie.201003619; HERKSTROETER WG, 1964, J AM CHEM SOC, V86, P4537, DOI 10.1021/ja01075a005; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; JACOBSEN EN, 1991, J AM CHEM SOC, V113, P6703, DOI 10.1021/ja00017a069; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; LEWIS FD, 1989, J AM CHEM SOC, V111, P8653, DOI 10.1021/ja00205a015; LEWIS FD, 1983, J AM CHEM SOC, V105, P3344, DOI 10.1021/ja00348a069; Maturi MM, 2014, ANGEW CHEM INT EDIT, V53, P7661, DOI 10.1002/anie.201403885; Muller C, 2009, ANGEW CHEM INT EDIT, V48, P6640, DOI 10.1002/anie.200901603; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Norikane Y, 2002, J PHYS CHEM A, V106, P2766, DOI 10.1021/jp0133081; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Rono LJ, 2013, J AM CHEM SOC, V135, P17735, DOI 10.1021/ja4100595; Studer A, 2016, ANGEW CHEM INT EDIT, V55, P58, DOI 10.1002/anie.201505090; Troster A, 2016, J AM CHEM SOC, V138, P7808, DOI 10.1021/jacs.6b03221; Uraguchi D, 2015, J AM CHEM SOC, V137, P13768, DOI 10.1021/jacs.5b09329; Vallavoju N, 2014, ANGEW CHEM INT EDIT, V53, P5604, DOI 10.1002/anie.201310940; Wang HJ, 2015, ANGEW CHEM INT EDIT, V54, P14295, DOI 10.1002/anie.201505931	33	225	225	13	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1391	1395		10.1126/science.aai8228	http://dx.doi.org/10.1126/science.aai8228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980203	Green Accepted			2022-12-28	WOS:000390261300035
J	Mattei, S; Glass, B; Hagen, WJH; Krausslich, HG; Briggs, JAG				Mattei, Simone; Glass, Baerbel; Hagen, Wim J. H.; Kraeusslich, Hans-Georg; Briggs, John A. G.			The structure and flexibility of conical HIV-1 capsids determined within intact virions	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ELECTRON CRYOTOMOGRAPHY; CORE; MATURATION; PROTEIN; RECONSTRUCTIONS; TRANSITION; PARTICLES; PATHWAY; REVEAL	HIV-1 contains a cone-shaped capsid encasing the viral genome. This capsid is thought to follow fullerene geometry-a curved hexameric lattice of the capsid protein, CA, closed by incorporating 12 CA pentamers. Current models for core structure are based on crystallography of hexameric and cross-linked pentameric CA, electron microscopy of tubular CA arrays, and simulations. Here, we report subnanometer-resolution cryo-electron tomography structures of hexameric and pentameric CA within intact HIV-1 particles. Whereas the hexamer structure is compatible with crystallography studies, the pentamer forms using different interfaces. Determining multiple structures revealed how CA flexes to form the variably curved core shell. We show that HIV-1 CA assembles both aberrant and perfect fullerene cones, supporting models in which conical cores assemble de novo after maturation.	[Mattei, Simone; Hagen, Wim J. H.; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Mattei, Simone; Kraeusslich, Hans-Georg; Briggs, John A. G.] Univ Klinikum Heidelberg, European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany; [Glass, Baerbel; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Infect Dis, Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Briggs, JAG (corresponding author), Univ Klinikum Heidelberg, European Mol Biol Lab, Mol Med Partnership Unit, Heidelberg, Germany.	john.briggs@embl.de		Mattei, Simone/0000-0002-2005-8977; Hagen, Wim/0000-0001-6229-2692; Krausslich, Hans-Georg/0000-0002-8756-329X; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [BR 3635/2-1, KR 906/7-1]; European Molecular Biology Laboratory; Chica and Heinz Schaller Stiftung; European Molecular Biology Laboratory IT services unit	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Laboratory; Chica and Heinz Schaller Stiftung; European Molecular Biology Laboratory IT services unit	We thank S. Dodonova, K. Qu, F. Schur, and W. Wan for technical assistance and discussion. This study was supported by Deutsche Forschungsgemeinschaft grants BR 3635/2-1 (to J.A.G.B.) and KR 906/7-1 (to H.-G.K.). The Briggs laboratory acknowledges financial support from the European Molecular Biology Laboratory and from the Chica and Heinz Schaller Stiftung. This study was technically supported by the European Molecular Biology Laboratory IT services unit. A representative tomogram, the EM strictures, and the fitted models have been deposited in the Electron Microscopy Data Bank and the PDB. The database accession numbers are listed in fable S3. S.M., H.-G.K., and J.A.G.B. designed the experiments. B.G. and S.M. prepared samples. W.H.J.H. implemented tomography acquisition, schemes. S.M. acquired the data. S.M. performed image processing. S.M. arc. J.A.G.B. analyzed the data.. S.M. and J.A.G.B. wrote the manuscript with support from all authors.	Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Frank GA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6854; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Grime JMA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11568; Hagen WJH, 2016, J STRUCT BIOL; Jacques DA, 2016, NATURE, V536, P349, DOI 10.1038/nature19098; Keller PW, 2013, J VIROL, V87, P13655, DOI 10.1128/JVI.01408-13; Levandovsky A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198102; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mattei S, 2016, CURR OPIN VIROL, V18, P27, DOI 10.1016/j.coviro.2016.02.008; Obal G, 2015, SCIENCE, V349, P95, DOI 10.1126/science.aaa5182; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Woodward CL, 2015, J VIROL, V89, P1267, DOI 10.1128/JVI.02997-14; Yu ZH, 2013, J MOL BIOL, V425, P112, DOI 10.1016/j.jmb.2012.10.006; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	24	148	149	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1434	1437		10.1126/science.aah4972	http://dx.doi.org/10.1126/science.aah4972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980210				2022-12-28	WOS:000390261300046
J	Stephens, IEL; Rossmeisl, J; Chorkendorff, I				Stephens, Ifan Erfyl Lester; Rossmeisl, Jan; Chorkendorff, Ib			Toward sustainable fuel cells	SCIENCE			English	Editorial Material							PERFORMANCE; ALLOY; CATALYSTS		[Stephens, Ifan Erfyl Lester; Rossmeisl, Jan; Chorkendorff, Ib] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark	Technical University of Denmark	Chorkendorff, I (corresponding author), Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark.	ibchork@fysik.dtu.dk	Chorkendorff, Ib/C-7282-2008; Rossmeisl, Jan/A-5714-2011; Stephens, Ifan Erfyl Lester/B-7191-2013	Chorkendorff, Ib/0000-0003-2738-0325; Rossmeisl, Jan/0000-0001-7749-6567; Stephens, Ifan Erfyl Lester/0000-0003-2157-492X	Villum Fonden [00009455] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Bu LZ, 2016, SCIENCE, V354, P1410, DOI 10.1126/science.aah6133; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Escudero-Escribano M, 2016, SCIENCE, V352, P73, DOI 10.1126/science.aad8892; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Han BH, 2015, ENERG ENVIRON SCI, V8, P258, DOI 10.1039/c4ee02144d; Kongkanand A, 2016, J PHYS CHEM LETT, V7, P1127, DOI 10.1021/acs.jpclett.6b00216; Li MF, 2016, SCIENCE, V354, P1414, DOI 10.1126/science.aaf9050; Owejan JP, 2013, J ELECTROCHEM SOC, V160, pF824, DOI 10.1149/2.072308jes; Stamenkovic V. R., 2015, 2015 DOE HYDROGEN FU; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; U.S. Energy Information Administration, 2016, INT EN OUTL 2016; Zalitis CM, 2013, PHYS CHEM CHEM PHYS, V15, P4329, DOI 10.1039/c3cp44431g	14	293	295	15	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1378	1379		10.1126/science.aal3303	http://dx.doi.org/10.1126/science.aal3303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980172				2022-12-28	WOS:000390261300021
J	Green, JJ; Elisseeff, JH				Green, Jordan J.; Elisseeff, Jennifer H.			Mimicking biological functionality with polymers for biomedical applications	NATURE			English	Review							ANTIGEN-PRESENTING CELLS; IN-VIVO; ELECTRON-MICROSCOPY; IMMUNE-RESPONSE; STEM-CELLS; NANOPARTICLES; TISSUE; MATRIX; MEMBRANE; ADHESIVE	The vast opportunities for biomaterials design and functionality enabled by mimicking nature continue to stretch the limits of imagination. As both biological understanding and engineering capabilities develop, more sophisticated biomedical materials can be synthesized that have multifaceted chemical, biological and physical characteristics designed to achieve specific therapeutic goals. Mimicry is being used in the design of polymers for biomedical applications that are required locally in tissues, systemically throughout the body, and at the interface with tissues.	[Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21205 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010; Green, Jordan/B-9001-2009	Elisseeff, Jennifer/0000-0002-5066-1996; Green, Jordan/0000-0003-4176-3808	NIH [1R01EB016721]; Department of Defense including the Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense including the Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank K. Sadtler for contributions and the design of Figs 1 and 4, C. Cherry for editorial assistance, and M. Frisk for critical review and manuscript contributions. J.J.G. was supported in part by the NIH (1R01EB016721). J.H.E. was supported by the Department of Defense including the Armed Forces Institute of Regenerative Medicine.	Ahn BK, 2014, NAT MATER, V13, P867, DOI [10.1038/nmat4037, 10.1038/NMAT4037]; Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859; Anselmo AC, 2014, ACS NANO, V8, P11243, DOI 10.1021/nn503732m; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Banquy X, 2014, J AM CHEM SOC, V136, P6199, DOI 10.1021/ja501770y; Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619; Beck JN, 2013, BIOMATERIALS, V34, P9486, DOI 10.1016/j.biomaterials.2013.08.077; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Chan LW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010383; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/NMAT4489, 10.1038/nmat4489]; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Damo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17622; DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/NMAT4219, 10.1038/nmat4219]; Dingal PCDP, 2015, NAT MATER, V14, P951, DOI [10.1038/NMAT4350, 10.1038/nmat4350]; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang RH, 2014, NANO LETT, V14, P2181, DOI 10.1021/nl500618u; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Hanson MC, 2014, BIOMACROMOLECULES, V15, P2475, DOI 10.1021/bm500337r; Haring M, 2005, NATURE, V436, P1101, DOI 10.1038/4361101a; Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108; Jiang X, 2013, ADV MATER, V25, P227, DOI 10.1002/adma.201202932; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kelich JM, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.47; Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Kumar VA, 2015, ACS BIOMATER SCI ENG, V1, P1300, DOI 10.1021/acsbiomaterials.5b00356; Lai PY, 2015, RSC ADV, V5, P98222, DOI 10.1039/c5ra17447c; Lashof-Sullivan MM, 2014, P NATL ACAD SCI USA, V111, P10293, DOI 10.1073/pnas.1406979111; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/nmat4157, 10.1038/NMAT4157]; Lee Y, 2015, ADV HEALTHC MATER, V4, P2587, DOI 10.1002/adhm.201500419; Leslie DC, 2014, NAT BIOTECHNOL, V32, P1134, DOI 10.1038/nbt.3020; Lin CC, 2011, P NATL ACAD SCI USA, V108, P6380, DOI 10.1073/pnas.1014026108; Liu GQ, 2014, ACS APPL MATER INTER, V6, P20452, DOI 10.1021/am506026e; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Maier GP, 2015, SCIENCE, V349, P628, DOI 10.1126/science.aab0556; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; Meyer RA, 2015, SMALL, V11, P1519, DOI 10.1002/smll.201402369; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Oliva N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1616; Papanna R, 2015, PLACENTA, V36, P888, DOI 10.1016/j.placenta.2015.05.015; Park KC, 2016, NATURE, V531, P78, DOI 10.1038/nature16956; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212; Perica K, 2015, ACS NANO, V9, P6861, DOI 10.1021/acsnano.5b02829; Perry JL, 2011, ACCOUNTS CHEM RES, V44, P990, DOI 10.1021/ar2000315; Roberts RA, 2015, BIOMATERIALS, V72, P1, DOI 10.1016/j.biomaterials.2015.08.040; Roche ET, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2406; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Rosales AM, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.12; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Singh A, 2014, NAT MATER, V13, P988, DOI [10.1038/NMAT4048, 10.1038/nmat4048]; Sosale NG, 2015, BLOOD, V125, P542, DOI 10.1182/blood-2014-06-585299; Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/nmat3945, 10.1038/NMAT3945]; Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050; Sur S, 2012, ACS NANO, V6, P10776, DOI 10.1021/nn304101x; Tsai RK, 2010, BLOOD CELL MOL DIS, V45, P67, DOI [10.1016/j.bcmd.2010.02.016, 10.1016/j.hcmd.2010.02.016]; Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Vestergaard G, 2008, J BACTERIOL, V190, P6837, DOI 10.1128/JB.00795-08; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Xuan MJ, 2015, ADV HEALTHC MATER, V4, P1645, DOI 10.1002/adhm.201500129; Yang SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2715; Ye CH, 2015, ANGEW CHEM INT EDIT, V54, P8490, DOI 10.1002/anie.201502485; Zhao Q, 2016, NAT MATER, V15, P407, DOI [10.1038/NMAT4539, 10.1038/nmat4539]	76	301	303	33	608	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					386	394		10.1038/nature21005	http://dx.doi.org/10.1038/nature21005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974772	Green Accepted			2022-12-28	WOS:000389716800033
J	Ocampo, A; Reddy, P; Martinez-Redondo, P; Platero-Luengo, A; Hatanaka, F; Hishida, T; Li, M; Lam, D; Kurita, M; Beyret, E; Araoka, T; Vazquez-Ferrer, E; Donoso, D; Roman, JL; Xu, JN; Esteban, CR; Nunez, G; Delicado, EN; Campistol, JM; Guillen, I; Guillen, P; Belmonte, JCI				Ocampo, Alejandro; Reddy, Pradeep; Martinez-Redondo, Paloma; Platero-Luengo, Aida; Hatanaka, Fumiyuki; Hishida, Tomoaki; Li, Mo; Lam, David; Kurita, Masakazu; Beyret, Ergin; Araoka, Toshikazu; Vazquez-Ferrer, Eric; Donoso, David; Roman, Jose Luis; Xu, Jinna; Esteban, Concepcion Rodriguez; Nunez, Gabriel; Nunez Delicado, Estrella; Campistol, Josep M.; Guillen, Isabel; Guillen, Pedro; Belmonte, Juan Carlos Izpisua			In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming	CELL			English	Article							BETA-CELL PROLIFERATION; SOMATIC-CELLS; EPIGENETIC REGULATION; QUIESCENCE; REJUVENATION; FIBROBLASTS; METABOLISM; MECHANISMS; CONVERSION; SENESCENT	Aging is the major risk factor for many human diseases. In vitro studies have demonstrated that cellular reprogramming to pluripotency reverses cellular age, but alteration of the aging process through reprogramming has not been directly demonstrated in vivo. Here, we report that partial reprogramming by short-term cyclic expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) ameliorates cellular and physiological hallmarks of aging and prolongs lifespan in a mousemodel of premature aging. Similarly, expression of OSKM in vivo improves recovery from metabolic disease and muscle injury in older wild-type mice. The amelioration of age-associated phenotypes by epigenetic remodeling during cellular reprogramming highlights the role of epigenetic dysregulation as a driver of mammalian aging. Establishing in vivo platforms to modulate age-associated epigenetic marks may provide further insights into the biology of aging.	[Ocampo, Alejandro; Reddy, Pradeep; Martinez-Redondo, Paloma; Platero-Luengo, Aida; Hatanaka, Fumiyuki; Hishida, Tomoaki; Li, Mo; Lam, David; Kurita, Masakazu; Beyret, Ergin; Araoka, Toshikazu; Vazquez-Ferrer, Eric; Donoso, David; Roman, Jose Luis; Xu, Jinna; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Kurita, Masakazu; Araoka, Toshikazu; Nunez Delicado, Estrella] Universidad Catolica San Antonio Murcia UCAM, Campus Jeronimos, Murcia 30107, Spain; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Campistol, Josep M.] Univ Barcelona, Hosp Clin, IDIBAPS, E-08036 Barcelona, Spain; [Guillen, Isabel; Guillen, Pedro] Fdn Dr Pedro Guillen, Clin Cemtro, Madrid 28035, Spain	Salk Institute; Universidad Catolica de Murcia; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	belmonte@salk.edu	Luengo, Aida Platero/ABE-3282-2020; Platero-Luengo, Aida/A-6352-2017; Reddy, Pradeep/G-1770-2014; Núñez-Delicado, Estrella/AAR-9438-2021; Platero Luengo, Aida/GNW-5468-2022; Nuñez, Gabriel/A-7160-2014; Li, Mo/AAM-8266-2021	Luengo, Aida Platero/0000-0002-4693-7654; Platero-Luengo, Aida/0000-0002-4693-7654; Reddy, Pradeep/0000-0002-9173-3845; Núñez-Delicado, Estrella/0000-0002-0554-2365; Li, Mo/0000-0003-0827-8907; KURITA, Masakazu/0000-0001-7626-9565; MARTINEZ REDONDO, PALOMA/0000-0002-5722-8335; Josep M, Campistol/0000-0001-6244-0253; Ocampo, Alejandro/0000-0002-3731-3647; Guillen Garcia, Pedro/0000-0001-8528-7984; BEYRET, ERGIN/0000-0003-1980-532X	US NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship; Muscular Dystrophy Association; Fundacion Alfonso Martin Escudero; Hewitt Foundation; Uehara Memorial Foundation; Nomis Foundation; JSPS Postdoctoral Fellowship for Research Abroad; University of California, San Diego; G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; Moxie Foundation; Glenn Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	US NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Fundacion Alfonso Martin Escudero; Hewitt Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Nomis Foundation; JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of California, San Diego(University of California System); G. Harold and Leila Y. Mathers Charitable Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Moxie Foundation; Glenn Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Schwarz for administrative support. We thank N. Varki from the Department of Pathology and K. McIntyre from the Moores Cancer Center at University of California San Diego. We thank R. Jaenisch for kindly donation of human induced pluripotent stem cells carrying transgenes for the inducible expression of the reprogramming factors. A.O. was partially supported by a US NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship. P.R. was partially supported by the Muscular Dystrophy Association. P.M.-R. was partially supported by Fundacion Alfonso Martin Escudero. A.P.-L. was partially supported by the Hewitt Foundation. F.H. was partially supported by the Uehara Memorial Foundation. T.H. was partially supported by the Nomis Foundation. M. K. was partially supported by a JSPS Postdoctoral Fellowship for Research Abroad. D.L. was partially supported by the University of California, San Diego. This study was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002), The Moxie Foundation, The Glenn Foundation, Universidad Catolica San Antonio de Murcia (UCAM), and Fundacion Dr. Pedro Guillen.	Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KHANNA PB, 1988, AGE AGEING, V17, P257, DOI 10.1093/ageing/17.4.257; KURBAN RS, 1990, J DERMATOL SURG ONC, V16, P908, DOI 10.1111/j.1524-4725.1990.tb01554.x; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Lapasset L, 2011, GENE DEV, V25, P2248, DOI 10.1101/gad.173922.111; Liu BH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2885; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Partridge L, 2014, TRENDS ENDOCRIN MET, V25, P555, DOI 10.1016/j.tem.2014.08.003; Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050; Soultoukis GA, 2016, ANNU REV BIOCHEM, V85, P5, DOI 10.1146/annurev-biochem-060815-014422; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	56	333	341	9	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1719	+		10.1016/j.cell.2016.11.052	http://dx.doi.org/10.1016/j.cell.2016.11.052			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984723	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000393114700012
J	Truby, RL; Lewis, JA				Truby, Ryan L.; Lewis, Jennifer A.			Printing soft matter in three dimensions	NATURE			English	Review							25TH ANNIVERSARY ARTICLE; STRAIN SENSORS; ARCHITECTURES; DESIGN; FABRICATION; COMPOSITES; ULTRALIGHT; ACTUATION; HYDROGELS; TISSUES	Light- and ink-based three-dimensional (3D) printing methods allow the rapid design and fabrication of materials without the need for expensive tooling, dies or lithographic masks. They have led to an era of manufacturing in which computers can control the fabrication of soft matter that has tunable mechanical, electrical and other functional properties. The expanding range of printable materials, coupled with the ability to programmably control their composition and architecture across various length scales, is driving innovation in myriad applications. This is illustrated by examples of biologically inspired composites, shape-morphing systems, soft sensors and robotics that only additive manufacturing can produce.	[Truby, Ryan L.; Lewis, Jennifer A.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Truby, Ryan L.; Lewis, Jennifer A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lewis, JA (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Lewis, JA (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	jalewis@seas.harvard.edu	Truby, Ryan/ABA-7417-2021; Lewis, Jennifer/HCH-4635-2022; Truby, Ryan/A-9866-2017	Lewis, Jennifer/0000-0002-0280-2774; Truby, Ryan/0000-0002-1313-6463				Anderson IA, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740023; Bartlett NW, 2015, SCIENCE, V349, P161, DOI 10.1126/science.aab0129; Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349; Beaman J. J., 1990, U.S. Patent, Patent No. [4938816A, 4938816, US4938816A]; Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655; Boley JW, 2014, ADV FUNCT MATER, V24, P3501, DOI 10.1002/adfm.201303220; Brackett D, 2011, P 22 SOL FREEF FABR, P348, DOI DOI 10.1017/CBO9781107415324.004; Bradshaw S., 2010, INTELLECTUAL PROPERT, V7, P5; Brown E, 2010, P NATL ACAD SCI USA, V107, P18809, DOI 10.1073/pnas.1003250107; Burgert I, 2009, PHILOS T R SOC A, V367, P1541, DOI 10.1098/rsta.2009.0003; Choi JW, 2011, J MATER PROCESS TECH, V211, P318, DOI 10.1016/j.jmatprotec.2010.10.003; Choi JW, 2010, INT J ADV MANUF TECH, V49, P543, DOI 10.1007/s00170-009-2434-8; Chossat JB, 2013, IEEE SENS J, V13, P3405, DOI 10.1109/JSEN.2013.2263797; Clausen A, 2015, ADV MATER, V27, P5523, DOI 10.1002/adma.201502485; Compton BG, 2014, ADV MATER, V26, P5930, DOI 10.1002/adma.201401804; Crump SS., 1992, United States Patent, Patent No. [No. 5,121,329A, 5121329, 5,121,329]; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Derby B, 2010, ANNU REV MATER RES, V40, P395, DOI 10.1146/annurev-matsci-070909-104502; Dimas LS, 2013, ADV FUNCT MATER, V23, P4629, DOI 10.1002/adfm.201300215; Duoss EB, 2014, ADV FUNCT MATER, V24, P4905, DOI 10.1002/adfm.201400451; Farahani RD, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/5/055020; Farahani RD, 2016, ADV MATER, V28, P5794, DOI 10.1002/adma.201506215; Felton S, 2014, SCIENCE, V345, P644, DOI 10.1126/science.1252610; Frenzel T, 2016, ADV MATER, V28, P5865, DOI 10.1002/adma.201600610; FROMM JE, 1984, IBM J RES DEV, V28, P322, DOI 10.1147/rd.283.0322; Frutiger A, 2015, ADV MATER, V27, P2440, DOI 10.1002/adma.201500072; Ge Q, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094007; Ge Q, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819837; Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341; Gissibl T, 2016, NAT PHOTONICS, V10, P554, DOI [10.1038/NPHOTON.2016.121, 10.1038/nphoton.2016.121]; Gladman AS, 2016, NAT MATER, V15, P413, DOI [10.1038/NMAT4544, 10.1038/nmat4544]; Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a; Guo Q, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0598; Gupta MK, 2015, NANO LETT, V15, P5321, DOI 10.1021/acs.nanolett.5b01688; Hansen CJ, 2013, ADV MATER, V25, P96, DOI 10.1002/adma.201203321; Hardin JO, 2015, ADV MATER, V27, P3279, DOI 10.1002/adma.201500222; Herschel WH, 1926, KOLLOID Z, V39, P291, DOI 10.1007/BF01432034; Hu JL, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/5/053001; Hull CW, 1986, US Patent, Patent No. [4,575,330, 4575330]; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Ionov L, 2013, ADV FUNCT MATER, V23, P4555, DOI 10.1002/adfm.201203692; Jones Richard Anthony Lewis, 2002, SOFT CONDENSED MATTE; Kinstlinger IS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147399; KODAMA H, 1981, REV SCI INSTRUM, V52, P1770, DOI 10.1063/1.1136492; Kokkinis D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9643; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kong YL, 2016, NANO TODAY, V11, P330, DOI 10.1016/j.nantod.2016.04.007; Kong YL, 2014, NANO LETT, V14, P7017, DOI 10.1021/nl5033292; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Lee C, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804580; Lee H, 2010, SOFT MATTER, V6, P4342, DOI 10.1039/c0sm00092b; Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434; Lin D, 2014, ACS NANO, V8, P9710, DOI 10.1021/nn504894j; Lipson H., 2013, FABRICATED NEW WORLD; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Lu NS, 2012, ADV FUNCT MATER, V22, P4044, DOI 10.1002/adfm.201200498; Ma XY, 2016, P NATL ACAD SCI USA, V113, P2206, DOI 10.1073/pnas.1524510113; MacCurdy R., 2015, PRINTABLE HYDRAULICS; Majidi C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/105017; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744; Mao YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24761; Mao YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13616; Martin JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9641; Matsuhisa N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8461; Matsuzaki R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23058; Meza LR, 2015, P NATL ACAD SCI USA, V112, P11502, DOI 10.1073/pnas.1509120112; Montemayor L, 2015, MRS BULL, V40, P1122, DOI 10.1557/mrs.2015.263; Morrison RJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010825; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Muth JT, 2014, ADV MATER, V26, P6307, DOI 10.1002/adma.201400334; Ober TJ, 2015, P NATL ACAD SCI USA, V112, P12293, DOI 10.1073/pnas.1509224112; Palleau E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3257; Park YL, 2012, IEEE SENS J, V12, P2711, DOI 10.1109/JSEN.2012.2200790; Peele BN, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/055003; Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013; Raviv D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07422; Rim YS, 2016, ADV MATER, V28, P4415, DOI 10.1002/adma.201505118; Robinson SS, 2015, EXTREME MECH LETT, V5, P47, DOI 10.1016/j.eml.2015.09.005; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sachs EM, 1993, US Patent, Patent No. [5,205,055, 5205055]; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Shan SC, 2015, ADV MATER, V27, P4296, DOI 10.1002/adma.201501708; Sun C, 2005, SENSOR ACTUAT A-PHYS, V121, P113, DOI 10.1016/j.sna.2004.12.011; Suzumori K, 1996, ROBOT AUTON SYST, V18, P135, DOI 10.1016/0921-8890(95)00078-X; Swainson W.A.W.K., 1977, US patent, Patent No. [4,041,476, 4041476, US4041476A]; Therriault D, 2005, ADV MATER, V17, P395, DOI 10.1002/adma.200400481; Tibbits S, 2014, ARCHIT DESIGN, V84, P116, DOI 10.1002/ad.1710; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Vidimce K, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461993; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Wu W, 2011, ADV MATER, V23, pH178, DOI 10.1002/adma.201004625; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291; Zheng XY, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4769050	101	827	855	88	1401	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					371	378		10.1038/nature21003	http://dx.doi.org/10.1038/nature21003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974748				2022-12-28	WOS:000389716800031
J	Cripps, C				Cripps, Christine			John David Elliott Edwards OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6667	10.1136/bmj.i6667	http://dx.doi.org/10.1136/bmj.i6667			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965214				2022-12-28	WOS:000390150800012
J	Hodgkin, P				Hodgkin, Paul			The Gatekeeper and the Wizard: the Gatekeeper goes digital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												paul.hodgkin9@gmail.com						Dowrick C, 2016, BRIT J GEN PRACT, V66, P582, DOI 10.3399/bjgp16X687901; Floridi L., 2014, 4 REVOLUTION INFOSPH; Gilbert S.F., 2015, ECOLOGICAL DEV BIOL; James Mackenzie MD, 1925, BMJ-BRIT MED J, V1, P242; MATHERS N, 1989, BRIT MED J, V298, P172, DOI 10.1136/bmj.298.6667.172; Pickles W. N., 1969, BMJ-BRIT MED J, V1, P719; RSA, 2012, POW NETW; Weinberger D., 2014, TOO BIG KNOW RETHINK	8	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6541	10.1136/bmj.i6541	http://dx.doi.org/10.1136/bmj.i6541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965215				2022-12-28	WOS:000390150800007
J	Williams, R; Alexander, G; Aspinall, R; Bosanquet, J; Camps-Walsh, G; Cramp, M; Day, N; Dhawan, A; Dillon, J; Dyson, J; Ferguson, J; Foster, G; Gardner, R; Gilmore, SI; Hardman, L; Hudson, M; Kelly, D; Langford, A; Liversedge, S; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rolfe, L; Rutter, H; Ryder, S; Samyn, M; Sheron, N; Taylor, A; Thompson, J; Verne, J; Yeoman, A				Williams, Roger; Alexander, Graeme; Aspinall, Richard; Bosanquet, Joanne; Camps-Walsh, Ginette; Cramp, Matthew; Day, Natalie; Dhawan, Anil; Dillon, John; Dyson, Jessica; Ferguson, James; Foster, Graham; Gardner, Richard; Gilmore, Sir Ian; Hardman, Lesley; Hudson, Mark; Kelly, Deirdre; Langford, Andrew; Liversedge, Stephen; Moriarty, Kieran; Newsome, Philip; O'Grady, John; Pryke, Rachel; Rolfe, Liz; Rutter, Harry; Ryder, Stephen; Samyn, Marianne; Sheron, Nick; Taylor, Alison; Thompson, Jeremy; Verne, Julia; Yeoman, Andrew			New metrics for the Lancet Standing Commission on Liver Disease in the UK	LANCET			English	Article							PRIMARY-HEALTH-CARE; ALCOHOL; OBESITY; CONSUMPTION; MANAGEMENT; IMPLEMENTATION; MORTALITY; HEPATITIS; ATTITUDES; CIRRHOSIS		[Williams, Roger; Day, Natalie] Fdn Liver Res, Inst Hepatol, London SE5 9NT, England; [Alexander, Graeme] British Assoc Study Liver, Lichfield, Staffs, England; [Alexander, Graeme] UCL, London, England; [Alexander, Graeme] Cambridge Univ Hosp, Cambridge, England; [Aspinall, Richard] Queen Alexandra Hosp, Portsmouth, Hants, England; [Bosanquet, Joanne; Rolfe, Liz; Verne, Julia] Publ Hlth England, London, England; [Camps-Walsh, Ginette] Med Mkt Consultants, Oxford, England; [Cramp, Matthew] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England; [Cramp, Matthew] Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England; [Dhawan, Anil; O'Grady, John; Samyn, Marianne] Kings Coll Hosp London, London, England; [Dillon, John] Univ Dundee, Med Res Inst, Dundee, Scotland; [Dyson, Jessica; Hudson, Mark] Freeman Rd Hosp, Newcastle, England; [Ferguson, James] Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Foster, Graham] Queen Mary Univ London, London, England; [Gardner, Richard] British Soc Gastroenterol, London, England; [Gilmore, Sir Ian] Univ Liverpool, Liverpool, Merseyside, England; [Hardman, Lesley] NHS Bolton Clin Commissioning Grp, Bolton, England; [Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Langford, Andrew] British Liver Trust, Bournemouth, Dorset, England; [Liversedge, Stephen] Egerton & Dunscar Hlth Ctr, Bolton, England; [Moriarty, Kieran] Royal Bolton Hosp, Bolton, England; [Newsome, Philip] Univ Hosp Birmingham, NIHR Birmingham Liver Biomed Res Unit, Birmingham, W Midlands, England; [Pryke, Rachel] Winyates Hlth Ctr, Redditch, England; [Rutter, Harry] London Sch Hyg & Trop Med, London, England; [Ryder, Stephen] Nottingham Univ NHS Trust, NIHR Biomed Res Unit Gastrointestinal & Liver Dis, Nottingham, England; [Ryder, Stephen] Univ Nottingham, Nottingham, England; [Sheron, Nick] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Taylor, Alison] Childrens Liver Dis Fdn, Birmingham, W Midlands, England; [Thompson, Jeremy] Fulcrum Practice, Middlesbrough, Cleveland, England; [Yeoman, Andrew] Aneurin Bevan Univ Hlth Board, Newport, Gwent, Wales	University of London; University College London; University of London; University College London; University of Cambridge; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Public Health England; University of Plymouth; University of Plymouth; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Dundee; Newcastle Freeman Hospital; University of Birmingham; University of London; Queen Mary University London; University of Liverpool; University of Birmingham; Royal Bolton Hospital; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; Nottingham University Hospital NHS Trust; University of Nottingham; University of Southampton	Williams, R (corresponding author), Fdn Liver Res, Inst Hepatol, London SE5 9NT, England.	r.williams@researchinliver.org.uk	Newsome, Philip N/D-4495-2018; Rutter, Harry/HCI-8765-2022	Newsome, Philip N/0000-0001-6085-3652; Aspinall, Richard/0000-0002-5208-8185; Dhawan, Anil/0000-0002-4942-0845; Dillon, John/0000-0002-2164-4476; Ryder, Stephen David/0000-0001-9649-4444; Sheron, Nick/0000-0002-6156-8367; Rutter, Harry/0000-0002-9322-0656; Foster, Graham/0000-0002-3704-386X; Sheron, Nick/0000-0001-5232-8292	Norgine; Medical Research Council [MR/L022699/1] Funding Source: researchfish; MRC [MR/L022699/1] Funding Source: UKRI	Norgine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Carla Lloyd (Birmingham Children's Hospital) and Patricia McLean (Leeds Teaching Hospitals NHS Trust) for their contributions to data for Recommendation 4, and Koye Balogun and Annastella Costella (PHE) for their contributions to Recommendation 7. Iain Armstrong (alcohol programme manager, PHE) contributed data to Recommendation 5. We thank Stephen Bergin (consultant in public health medicine, Faculty Public Health adviser, Northern Ireland), Gary Maxwell (Health Development Policy Branch, Department of Health), and Neil McDougall (consultant hepatologist, Belfast Health and Social Care Trust), who offered valuable assistance in gathering data relating to Northern Ireland. We thank Norgine for their unrestricted grant to the Foundation for Liver Research, which has enabled the Commission to work with Incisive Health in bringing the work of the Commission to the attention of Parliament. Incisive Health also produced the constituency liver profiles referred to in the introduction. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	Aalto M, 2004, ALCOHOL ALCOHOLISM, V39, P532, DOI 10.1093/alcalc/agh090; All Party Parliamentary Group in Hepatology and Hepatitis C Trust, 2010, DARK AUD HEP C SERV; [Anonymous], 2015, STAT ALC ENGL; [Anonymous], 1995, SENS DRINK REP INT W; Arkley J, 2013, J PEDIAT GASTROENTER, V56, P536; Baker C, 2016, BRIEFING PAPER OBESI; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Black H, 2011, ADDICTION, V106, P729, DOI 10.1111/j.1360-0443.2010.03225.x; Brew IF, 2013, BRIT J GEN PRACT, V63, pE842, DOI 10.3399/bjgp13X675421; British Society of Gastroenterology and Bolton NHS Foundation Trust, 2016, ALC CAR TEAMS RED AC; Department of Health, HLTH RISKS ALC NEW G; Donnan PT, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-54; Dyson JK, 2016, ALIMENT PHARM THER, V44, P1030, DOI 10.1111/apt.13806; Epstein L, 2005, BRIT J GEN PRACT, V55, P750; Foundation for Liver Research, 2016, CONST LIV DIS PROF; Funakoshi N, 2012, ANN HEPATOL, V11, P369, DOI 10.1016/S1665-2681(19)30934-2; Gines P, 2012, J HEPATOL; Hankey CR, 2004, PUBLIC HEALTH NUTR, V7, P337, DOI 10.1079/PHN2003526; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Health and Social Care Information Centre, 2015, STAT OB PHYS ACT DIE; Health Social Care Information Centre, 2016, STAT ALC; HM Government, 2016, CHILDH OB PLAN ACT; HM Government, 2016, BUDG 2016 POL COST; HM Revenue and Customs, UK CUST CLEAR MONTHL; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; House of Commons Health Committee, 2016, PUBL HLTH POST 2013; House of Commons Health Committee, 2015, CHILDH OB BRAV BOLD; Information Analysis Directorate, 2014, AD DRINK PATT NO IR; Institute of Alcohol Studies, 2013, 5500 GP ALC CONS PER; Jones S, 2010, DEV SO AFR, V27, P679, DOI 10.1080/0376835X.2010.522831; Kaner EFS, 1999, ALCOHOL ALCOHOLISM, V34, P559, DOI 10.1093/alcalc/34.4.559; Kirby Institute for Infection and Immunity in Society, 2016, VIR HEP CLIN RES PRO; Lebrec D, 1998, EUR J GASTROEN HEPAT, V10, P549, DOI 10.1097/00042737-199807000-00004; Michie Susan, 2007, Psychol Health Med, V12, P521, DOI 10.1080/13548500701203441; Morris M, 2012, ALCOHOL, V46, P703, DOI 10.1016/j.alcohol.2011.12.006; National Institute for Health and Care Excellence (NICE), HEP B C TEST PEOPL R; National Institute for Health care and excellence (NICE), 2016, NON FATT LIV DIS NAF; National Liver Disease Strategy, 2011, CENS MED WORKF INFR; National Records of Scotland, 2015, ALC REL DEATHS; NCEPOD, 2013, MEAS UN REV PAT WHO; NCEPOD, 2015, GASTR HAEM TIM GET C; NHS Blood and Transplant, ORG DON TRANSPL ACT; NHS Bolton and Bolton Council, 2013, BOLT HLTH MATT; NHS National Services Scotland Information Services Division, 2015, ALC REL HOSP STAT SC; NHS Wales, 2014, ALC HLTH WAL 2014; NHS Wales, 2015, TOG HLTH LIV DIS DEL; NICE, 2012, AC UPP GASTR BLEED; Northern Ireland Department of Health Social Services and Public Safety, 2011, NEW STRAT DIR ALC DR; Office for National Statistics, 2013, DEATHS REG ENGL WAL; Office for National Statistics, 2015, DEATHS REG ENGL WAL; Ogden J, 2008, PATIENT EDUC COUNS, V71, P72, DOI 10.1016/j.pec.2007.11.022; Pryke R, 2015, BR J OBES, V1, P1; Public Health England, 2016, UK IR PREV TRENDS 19; Public Health England, 2014, ALC CAR ENGL HOSP OP; Public Health England, 2016, AC HEP B ENGL ANN RE; Public Health England, SHOOT INF PEOPL WHO; Public Health England, 2015, LAB REP HEP C REG EN; Public Health England. Hepatitis C in the UK: 2015, 2015, HEP C UK 2015; Public Health Information for Scotland, 2016, ALC HLTH HARM; Quality and Outcomes Framework, 2015, PREV ACH EXC REP; Quality and Outcomes Framework, 2014, QOF DAT OB SCOTL 201; Rapley T, 2006, SOC SCI MED, V63, P2418, DOI 10.1016/j.socscimed.2006.05.025; Royal College of General Practitioners, 2015, RCGP STAT OB MALN; Royal College of General Practitioners, 2016, CLIN PRIOR PROGR; Royal College of Physicians, LIV QUEST EXC; Scottish Intercollegiate Guidelines Network, 2010, MAN OB NAT CLIN GUID; Scottish Public Health Observatory, CHRON LIV DIS MORT; Sheron N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1860; Sheron N, 2014, CLIN MED, V14, P396, DOI 10.7861/clinmedicine.14-4-396; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; The Health and Social Care Information Centre, 2015, HLTH SURV ENGL 2014; Verkade HJ, 2016, J HEPATOL, V65, P631, DOI 10.1016/j.jhep.2016.04.032; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Ward D, 2009, QJM-INT J MED, V102, P773, DOI 10.1093/qjmed/hcp116; Welsh Assembly Government, 2010, WORK TOG RED HARM SU; Welsh Assembly Government Social Research, 2011, ASS COSTS NHS ASS AL; Welsh Government, 2016, GEN MED SERV CONTR Q; Welsh Government, 2015, WELSH HLTH SURV 2015; WHO, 2016, MYANM NATL SIMPL TRE; WHO, 2016, GLOB HLTH S IN PRESS; WHO, 2016, MON EV VIR HEP B C R; Williams R, 2015, LANCET, V386, P2098, DOI 10.1016/S0140-6736(15)00680-7; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; Wine and Spirits Trade Association, 2016, RESP GOV ALC STRAT; Wine and Spirits Trade Association, NAT CAMP TOD REV MAJ	85	25	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2017	389	10083					2053	2080		10.1016/S0140-6736(16)32234-6	http://dx.doi.org/10.1016/S0140-6736(16)32234-6			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV1OH	27989558	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000401515300027
J	Durie, BGM; Hoering, A; Abidi, MH; Rajkumar, SV; Epstein, J; Kahanic, SP; Thakuri, M; Reu, F; Reynolds, CM; Sexton, R; Orlowski, RZ; Barlogie, B; Dispenzieri, A				Durie, Brian G. M.; Hoering, Antje; Abidi, Muneer H.; Rajkumar, S. Vincent; Epstein, Joshua; Kahanic, Stephen P.; Thakuri, Mohan; Reu, Frederic; Reynolds, Christopher M.; Sexton, Rachael; Orlowski, Robert Z.; Barlogie, Bart; Dispenzieri, Angela			Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial	LANCET			English	Article							MULTIPLE-MYELOMA; PLUS DEXAMETHASONE; RESPONSE CRITERIA; IMPROVED SURVIVAL; CLINICAL-TRIALS; THERAPY	Background Lenalidomide plus dexamethasone is a reference treatment for patients with newly diagnosed myeloma. The combination of the proteasome inhibitor bortezomib with lenalidomide and dexamethasone has shown significant efficacy in the setting of newly diagnosed myeloma. We aimed to study whether the addition of bortezomib to lenalidomide and dexamethasone would improve progression-free survival and provide better response rates in patients with previously untreated multiple myeloma who were not planned for immediate autologous stem-cell transplant. Methods In this randomised, open-label, phase 3 trial, we recruited patients with newly diagnosed multiple myeloma aged 18 years and older from participating Southwest Oncology Group (SWOG) and National Clinical Trial Network (NCTN) institutions (both inpatient and outpatient settings). Key inclusion criteria were presence of CRAB (C=calcium elevation; R=renal impairment; A=anaemia; B=bone involvement) criteria with measurable disease (measured by assessment of free light chains), Eastern Cooperative Oncology Group (ECOG) performance status of 0-3, haemoglobin concentration 9 g/dL or higher, absolute neutrophil count 1 x 10(3) cells per mm 3 or higher, and a platelet count of 80 000/mm(3) or higher. We randomly assigned (1: 1) patients to receive either an initial treatment of bortezomib with lenalidomide and dexamethasone (VRd group) or lenalidomide and dexamethasone alone (Rd group). Randomisation was stratified based on International Staging System stage (I, II, or III) and intent to transplant (yes vs no). The VRd regimen was given as eight 21-day cycles. Bortezomib was given at 1.3 mg/m(2) intravenously on days 1, 4, 8, and 11, combined with oral lenalidomide 25 mg daily on days 1-14 plus oral dexamethasone 20 mg daily on days 1, 2, 4, 5, 8, 9, 11, and 12. The Rd regimen was given as six 28-day cycles. The standard Rd regimen consisted of 25 mg oral lenalidomide once a day for days 1-21 plus 40 mg oral dexamethasone once a day on days 1, 8, 15, and 22. The primary endpoint was progression-free survival using a prespecified one-sided stratified log rank test at a significance level of 0.02. Analyses were intention to treat. This trial is registered with ClinicalTrials.gov,numberNCT00644228. Findings Between April, 2008, and February, 2012, we randomly assigned 525 patients at 139 participating institutions (264 to VRd and 261 to Rd). In the randomly assigned patients, 21 patients in the VRd group and 31 in the Rd group were deemed ineligible based mainly on missing, insufficient, or early or late baseline laboratory data. Median progression-free survival was significantly improved in the VRd group (43 months vs 30 months in the Rd group; stratified hazard ratio [HR] 0.712, 96% CI 0 .56-0.906; one-sided p value 0.0018). The median overall survival was also significantly improved in the VRd group (75 months vs 64 months in the Rd group, HR 0.709, 95% CI 0.524-0.959; two-sided p value 0.025). The rates of overall response (partial response or better) were 82% (176/216) in the VRd group and 72% (153/214) in the Rd group, and 16% (34/216) and 8% (18/214) of patients who were assessable for response in these respective groups had a complete response or better. Adverse events of grade 3 or higher were reported in 198 (82%) of 241 patients in the VRd group and 169 (75%) of 226 patients in the Rd group; 55 (23%) and 22 (10%) patients discontinued induction treatment because of adverse events, respectively. There were no treatment-related deaths in the Rd group, and two in the VRd group. Interpretation In patients with newly diagnosed myeloma, the addition of bortezomib to lenalidomide and dexamethasone resulted in significantly improved progression-free and overall survival and had an acceptable risk-benefit profile.	[Durie, Brian G. M.] Cedars Sinai Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA; [Hoering, Antje] Canc Res & Biostat, Seattle, WA USA; [Abidi, Muneer H.] Michigan State Univ, Spectrum Hlth Canc Ctr, Grand Rapids, MI USA; [Rajkumar, S. Vincent] Mayo Clin, Rochester, MN USA; [Epstein, Joshua] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA; [Kahanic, Stephen P.] Sanford NCORP Northern Cent Plains, Siouxland Reg Canc Ctr, Sioux City, IA USA; [Thakuri, Mohan] Southeast Clin Oncol Res Consortium NCORP, Canc Care Western North Carolina, Asheville, NC USA; [Reu, Frederic] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Reynolds, Christopher M.] St Joseph Mercy Hosp, Michigan Canc Res Consortium NCORP, Ann Arbor, MI 48104 USA; [Sexton, Rachael] Canc Res & Biostat, Seattle, WA USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Barlogie, Bart] Mt Sinai Sch Med, Myeloma Program, New York, NY USA; [Dispenzieri, Angela] Mayo Clin, Div Hematol, Rochester, MI USA	Cedars Sinai Medical Center; Cancer Research & Biostatistics; Michigan State University; Mayo Clinic; University of Arkansas System; University of Arkansas Medical Sciences; Cleveland Clinic Foundation; Saint Joseph Mercy Health System (SJMHS); Cancer Research & Biostatistics; University of Texas System; UTMD Anderson Cancer Center; Icahn School of Medicine at Mount Sinai; Mayo Clinic	Durie, BGM (corresponding author), Cedars Sinai Samuel Oschin Canc Ctr, Los Angeles, CA 90048 USA.	bdurie@myeloma.org	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833; Orlowski, Robert/0000-0002-5723-4129; Reu, Frederic/0000-0003-1160-8030	NIH/NCI/NCTN grants [CA180888, CA180819, CA180821, CA180820]; NIH/NCI/NCORP grants [CA189858, CA189971, CA189808, CA189821, CA189829, CA189804, CA189953, CA189830, CA189957, CA189853, CA189872, CA189856, CA189860, CA139519, CA189854, CA189952, CA189825]; NIH/NCI legacy grants [CA04919, CA22433, CA58723, CA68183, CA35996, CA73590, CA12644, CA46282, CA13612, CA37981, CA16385, CA45450, CA46113]; Millennium Pharmaceuticals; Takeda Oncology Company; Celgene Corporation; NIH; NCI; NCTN; NATIONAL CANCER INSTITUTE [U10CA139519, UG1CA189830, U10CA180821, UG1CA189872, P30CA016672, U10CA004919, UG1CA189860, UG1CA189804, UG1CA189858, U10CA046282, P30CA015083, UG1CA189829, R01CA126448, U10CA013612, U10CA180819, U10CA012644, UG1CA189953, UG1CA189825, U10CA037981, UG1CA189854, U10CA180888, UG1CA189853, U10CA022433, UG1CA189856, UG1CA189952, U10CA045450, UG1CA189957, UG1CA189821, U10CA180820, U10CA046113, U10CA068183, UG1CA189808, UG1CA189971, P50CA186781, U10CA073590, U10CA016385] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R41AR068183, RC1AR058723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR016385] Funding Source: NIH RePORTER	NIH/NCI/NCTN grants; NIH/NCI/NCORP grants; NIH/NCI legacy grants; Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Takeda Oncology Company; Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCTN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	NIH, NCI, NCTN, Millennium Pharmaceuticals, Takeda Oncology Company, and Celgene Corporation.; This study was funded by grants from NIH/NCI/NCTN grants CA180888, CA180819, CA180821, CA180820; NIH/NCI/NCORP grants CA189858, CA189971, CA189808, CA189821, CA189829, CA189804, CA189953, CA189830, CA189957, CA189853, CA189872, CA189856, CA189860, CA139519, CA189854, CA189952, CA189825; NIH/NCI legacy grants CA04919, CA22433, CA58723, CA68183, CA35996, CA73590, CA12644, CA46282, CA13612, CA37981, CA16385, CA45450, CA46113 and partly by Millennium Pharmaceuticals, The Takeda Oncology Company, and Celgene Corporation for provision of study drug under their respective Cooperative Research and Development Agreements with the NCI.	Agresti A, 2003, CATEGORICAL DATA ANA; Attal M, AUTOLOGOUS TRANSPLAN; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; COX DR, 1972, J R STAT SOC B, V34, P187; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Durie Brian G M, 2003, Hematol J, V4, P379; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2006, HAEMATOLOGICA, V91, P1498; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hideshima T, 2001, CANCER RES, V61, P3071; Jakubowiak AJ, 2010, BLOOD, V116, P679; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Korde N, 2015, JAMA ONCOL, V1, P746, DOI 10.1001/jamaoncol.2015.2010; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lacy MQ, 2007, MAYO CLIN PROC, V82, P1179, DOI 10.4065/82.10.1179; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitsiades N, 2002, BLOOD, V99, P4525, DOI 10.1182/blood.V99.12.4525; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Moreau P, 2013, BORTEZOMIB THALIDOMI; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; Palumbo A, 2014, LANCET ONCOL, V15, P333, DOI 10.1016/S1470-2045(13)70609-0; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rajkumar SV, 2016, MAYO CLIN PROC, V91, P101, DOI 10.1016/j.mayocp.2015.11.007; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479	33	515	536	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					519	527		10.1016/S0140-6736(16)31594-X	http://dx.doi.org/10.1016/S0140-6736(16)31594-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ5UH	28017406	Green Accepted			2022-12-28	WOS:000393283400034
J	Clarke, NE; Clements, ACA; Doi, SA; Wang, DX; Campbell, SJ; Gray, D; Nery, SV				Clarke, Naomi E.; Clements, Archie C. A.; Doi, Suhail A.; Wang, Dongxu; Campbell, Suzy J.; Gray, Darren; Nery, Susana V.			Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis	LANCET			English	Article							PREVENTIVE CHEMOTHERAPY; HOOKWORM INFECTION; ASCARIS-LUMBRICOIDES; SCHOOL-CHILDREN; SCHISTOSOMIASIS; IMPACT; PREVALENCE; EFFICACY; PROGRAM; SCHOOLCHILDREN	Background Soil-transmitted helminth infections are a major global health issue, causing substantial morbidity in the world's poorest populations. Regular delivery of anthelmintic drugs is the mainstay for global soil-transmitted helminth control. Deworming campaigns are often targeted to school-aged children, who are at high risk of soil-transmitted-helminth-associated morbidity. However, findings from modelling studies suggest that deworming campaigns should be expanded community-wide for effective control of soil-transmitted helminth transmission. We aimed to do a systematic review and meta-analysis to compare the effect of mass (community-wide) and targeted (children only) anthelmintic delivery strategies on soil-transmitted helminth prevalence in school-aged children. Methods In this systematic review and meta-analysis, we searched MEDLINE, Embase, and Web of Science for articles published on or before Nov 5, 2015, reporting soil-transmitted helminth prevalence before and after distribution of albendazole or mebendazole, either targeted to children or delivered to the whole community. We excluded studies in which drug delivery was restricted to infected individuals or to a subset of the community or school, or if follow-up time was less than 3 months or greater than 18 months after drug delivery. We extracted data on study year, country, drug administration strategy, drug dose, number of deworming rounds, treatment coverage, diagnostic method, follow-up interval, and soil-transmitted helminth prevalence before and after treatment. We used inverse variance weighted generalised linear models, with prevalence reduction as the outcome variable, to examine the effect of mass versus targeted drug administration, as well as baseline prevalence, number of drug doses, and follow-up time. This study is registered with PROSPERO, number CRD42016026929. Findings Of 10 538 studies identified, 56 studies were eligible for the systematic review and 38 of these were included in meta-analysis. Results of the regression models showed that mass deworming led to a significantly greater reduction in prevalence in children than targeted deworming, for both hookworm (odds ratio 4.6, 95% CI 1.8-11.6; p=0.0020) and Ascaris lumbricoides (16.4, 2.1-125.8; p=0.0092), with no effect seen for Trichuris trichiura. There was significant heterogeneity across studies; for targeted studies I-2 was 97% for A lumbricoides and hookworm, and 96% for T trichiura, and for mass studies, I-2 was 89% for A lumbricoides, 49% for hookworm, and 66% for T trichiura. Interpretation The results of this meta-analysis suggest that expanding deworming programmes community-wide is likely to reduce the prevalence of soil-transmitted helminths in the high-risk group of school-aged children, which could lead to improved morbidity outcomes. These findings are in support of recent calls for re-evaluation of global soil-transmitted helminth control guidelines.	[Clarke, Naomi E.; Clements, Archie C. A.; Doi, Suhail A.; Wang, Dongxu; Campbell, Suzy J.; Gray, Darren; Nery, Susana V.] Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT 0200, Australia; [Doi, Suhail A.] Qatar Univ, Coll Med, Doha, Qatar; [Doi, Suhail A.] Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia	Australian National University; Qatar University; University of Southern Queensland	Clarke, NE (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Canberra, ACT 0200, Australia.	naomi.clarke@anu.edu.au	Clements, Archie/ABD-1615-2020	Clarke, Naomi/0000-0003-1894-8185; Doi, Suhail/0000-0002-2630-2125; Campbell, Suzy/0000-0001-5540-1360; Gray, Darren/0000-0003-3525-1339	National Health and Medical Research Council (NHMRC) Senior Research Fellowship; NHMRC Career Development Fellowship; Australian Postgraduate Award; National Health and Medical Research Council (NHMRC) Senior Research Fellowship; NHMRC Career Development Fellowship; Australian Postgraduate Award	National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	ACAC is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship. DG is supported by an NHMRC Career Development Fellowship. NEC is supported by an Australian Postgraduate Award. We thank Filippo Curtale, Peter de Vries, Deepika Fernando, Matthew Freeman, Le Quoc Hung, Pauline Mwinzi, Birgit Nikolay, Sammy Njenga, and Peter Steinmann, who provided additional information or data upon request on behalf of all authors of their respective papers.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P19, DOI 10.1179/136485908X337436; Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435; Anderson RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003897; Anderson RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002027; ASAOLU SO, 1991, PARASITOLOGY, V103, P291, DOI 10.1017/S0031182000059564; Azene G, 1999, ACTA TROP, V73, P183, DOI 10.1016/S0001-706X(99)00028-5; Belizario VY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1604, DOI 10.1177/1010539513483825; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2014, ADV PARASIT, V58, P197; Brooker SJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008950; BUNDY DAP, 1990, T ROY SOC TROP MED H, V84, P115, DOI 10.1016/0035-9203(90)90399-Y; Campbell SJ, 2016, TRENDS PARASITOL, V32, P97, DOI 10.1016/j.pt.2015.10.006; Campbell SJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002651; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Clarke NE, PILOT FEASI IN PRESS; Cleary JD, 2007, AM J MED SCI, V333, P340, DOI 10.1097/MAJ.0b013e318065bafb; Coffeng LE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1151-4; Cort WW, 1923, AM J HYG, V3, P85, DOI 10.1093/oxfordjournals.aje.a118973; Doi SAR, 2015, CONTEMP CLIN TRIALS, V45, P130, DOI 10.1016/j.cct.2015.05.009; Doi SAR, 2015, EPIDEMIOLOGY, V26, pE42, DOI 10.1097/EDE.0000000000000289; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Hardin JW., 2012, GEN LINEAR MODELS EX; Health NIo, 2014, QUALITY ASSESSMENT T; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Idris MA, 2001, ACTA TROP, V80, P139, DOI 10.1016/S0001-706X(01)00168-1; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; KIGHTLINGER LK, 1995, J PARASITOL, V81, P159, DOI 10.2307/3283914; Knopp S, 2009, AM J TROP MED HYG, V81, P1071, DOI 10.4269/ajtmh.2009.09-0377; Krentel A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002447; Lo NC, 2016, LANCET INFECT DIS, V16, P1065, DOI 10.1016/S1473-3099(16)30073-1; Lo NC, 2015, LANCET GLOB HEALTH, V3, pE629, DOI 10.1016/S2214-109X(15)00047-9; Massa K, 2009, T ROY SOC TROP MED H, V103, P31, DOI 10.1016/j.trstmh.2008.07.009; Massa K, 2009, T ROY SOC TROP MED H, V103, P25, DOI 10.1016/j.trstmh.2008.07.011; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Montresor A, 2007, T ROY SOC TROP MED H, V101, P773, DOI 10.1016/j.trstmh.2007.04.008; Mwandawiro CS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-198; Naish S, 2004, ACTA TROP, V91, P177, DOI 10.1016/j.actatropica.2004.04.004; Nikolay B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004108; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Njenga SM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-74; Olsen A, 2003, ACTA TROP, V86, P255, DOI 10.1016/S0001-706X(03)00046-9; Phommasack B, 2008, T ROY SOC TROP MED H, V102, P1201, DOI 10.1016/j.trstmh.2008.04.036; Pilnick AR, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-90564-1, 10.1155/2014/139030, 10.18280/isi.270101]; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Salam RA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-23; Speich B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1406-8; Staudacher O, 2014, TROP MED INT HEALTH, V19, P812, DOI 10.1111/tmi.12321; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P1031, DOI 10.1016/j.trstmh.2009.03.024; Sunish IP, 2015, INDIAN J MED RES, V141, P330; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; Truscott JE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1135-4; Truscott JE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-266; Tun A, 2013, TROP MED INT HEALTH, V18, P1017, DOI 10.1111/tmi.12130; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1187-5; United Nations, 2015, QUINQ POP 5 YEAR AG; Urbani C, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P201; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, PROGR REP 2000 2010; WHO, 2006, COORD US ANTH DRUGS; World Health Organization, 2012, SOIL TRANSM HELM EL; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; Ziem JB, 2006, TROP MED INT HEALTH, V11, P1764, DOI 10.1111/j.1365-3156.2006.01729.x	73	56	56	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					287	297		10.1016/S0140-6736(16)32123-7	http://dx.doi.org/10.1016/S0140-6736(16)32123-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9BC	27979381				2022-12-28	WOS:000392801200030
J	Nguyen, V; Wilson, C; Hoemberger, M; Stiller, JB; Agafonov, RV; Kutter, S; English, J; Theobald, DL; Kern, D				Vy Nguyen; Wilson, Christopher; Hoemberger, Marc; Stiller, John B.; Agafonov, Roman V.; Kutter, Steffen; English, Justin; Theobald, Douglas L.; Kern, Dorothee			Evolutionary drivers of thermoadaptation in enzyme catalysis	SCIENCE			English	Article							GEOBACILLUS-STEAROTHERMOPHILUS; UPPER TEMPERATURE; ADENYLATE KINASE; LIFE; RECONSTRUCTION; PROTEINS; BACILLUS; BIOCHEMISTRY; LANDSCAPES; PHYLOGENY	With early life likely to have existed in a hot environment, enzymes had to cope with an inherent drop in catalytic speed caused by lowered temperature. Here we characterize the molecular mechanisms underlying thermoadaptation of enzyme catalysis in adenylate kinase using ancestral sequence reconstruction spanning 3 billion years of evolution. We show that evolution solved the enzyme's key kinetic obstacle-how to maintain catalytic speed on a cooler Earth-by exploiting transition-state heat capacity. Tracing the evolution of enzyme activity and stability from the hot-start toward modern hyperthermophilic, mesophilic, and psychrophilic organisms illustrates active pressure versus passive drift in evolution on a molecular level, refutes the debated activity/stability trade-off, and suggests that the catalytic speed of adenylate kinase is an evolutionary driver for organismal fitness.	[Vy Nguyen; Wilson, Christopher; Hoemberger, Marc; Stiller, John B.; Agafonov, Roman V.; Kutter, Steffen; English, Justin; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA; [Vy Nguyen; Wilson, Christopher; Hoemberger, Marc; Stiller, John B.; Agafonov, Roman V.; Kutter, Steffen; English, Justin; Theobald, Douglas L.; Kern, Dorothee] Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University	Kern, D (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA.; Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA.	dkern@brandeis.edu	Theobald, Douglas L/F-3514-2013; Hoemberger, Marc/AAM-5435-2021	Theobald, Douglas L/0000-0002-2695-8343; Hoemberger, Marc/0000-0003-2515-1094; Wilson, Christopher/0000-0002-8012-2440; Kutter, Steffen/0000-0002-0349-8161	Howard Hughes Medical Institute (HHMI); Office of Basic Energy Sciences, Catalysis Science Program; U.S. Department of Energy [DE-FG02-05ER15699]; NIH [GM100966, GM096053, GM094468]; National Institutes of Health, National Institute of General Medical Sciences; HHMI; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100966, T32GM007596, R01GM094468, R01GM096053] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Office of Basic Energy Sciences, Catalysis Science Program; U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (HHMI); the Office of Basic Energy Sciences, Catalysis Science Program; U.S. Department of Energy award DE-FG02-05ER15699; and NIH grant GM100966 (to D.K) and NIH grants GM096053 and GM094468 (to D.L.T.). We thank the Advanced Light Source (ALS), Berkeley, CA, USA, for access to beamlines BL8.2.1 and BL8.2.2. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the HHMI. The ALS is supported by the director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. The Protein Data Bank accession codes are 5G3Y (ANC1*Zn*ADP*ADP), 5G3Z (ANC3*Zn*Mg*Ap5A), 5G40 (ANC4*Zn*AMP*ADP), and 5G41 (ANC4*Zn*Mg*Ap5A).	Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Blochl E, 1997, EXTREMOPHILES, V1, P14; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Canepa C, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-22; Case A, 2003, BIOCHEMISTRY-US, V42, P3335, DOI 10.1021/bi020668l; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; Counago R, 2005, EXTREMOPHILES, V9, P135, DOI 10.1007/s00792-004-0428-x; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Cowan DA, 2004, TRENDS MICROBIOL, V12, P58, DOI 10.1016/j.tim.2003.12.002; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Fralick P, 2011, PRECAMBRIAN RES, V191, P78, DOI 10.1016/j.precamres.2011.09.004; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Goldstein RA, 2011, PROTEINS, V79, P1396, DOI 10.1002/prot.22964; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; Holtmann G, 2004, J BACTERIOL, V186, P1683, DOI 10.1128/JB.186.6.1683-1693.2004; Huber R, 2001, METHOD ENZYMOL, V330, P11; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; Moreno-Letelier A, 2012, ASTROBIOLOGY, V12, P674, DOI 10.1089/ast.2011.0685; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; Nichols David S., 1995, Science Progress, V78, P311; Nussinov R, 2014, PHYS CHEM CHEM PHYS, V16, P6321, DOI 10.1039/c4cp90027h; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Stockbridge RB, 2010, P NATL ACAD SCI USA, V107, P22102, DOI 10.1073/pnas.1013647107; Stockbridge RB, 2009, J BIOL CHEM, V284, P22747, DOI 10.1074/jbc.M109.017806; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wolfenden R, 2014, CELL MOL LIFE SCI, V71, P2909, DOI 10.1007/s00018-014-1587-2; Wolynes PG, 2012, P NATL ACAD SCI USA, V109, P17770, DOI 10.1073/pnas.1215733109; Zeigler DR, 2014, MICROBIOL-SGM, V160, P1, DOI 10.1099/mic.0.071696-0	37	96	99	5	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 20	2017	355	6322					289	293		10.1126/science.aah3717	http://dx.doi.org/10.1126/science.aah3717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI0ZP	28008087	Green Accepted			2022-12-28	WOS:000392204800038
J	Yan, CY; Wan, RX; Bai, R; Huang, GXY; Shi, YG				Yan, Chuangye; Wan, Ruixue; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong			Structure of a yeast step II catalytically activated spliceosome	SCIENCE			English	Article							PRE-MESSENGER-RNA; SPLICING FACTOR PRP18; METAL-ION CATALYSIS; SMALL NUCLEAR RNAS; PREMESSENGER RNA; CONFORMATIONAL REARRANGEMENT; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; CROSS-LINKING; 1ST STEP	Each cycle of precursor messenger RNA (pre-mRNA) splicing comprises two sequential reactions, first freeing the 5' exon and generating an intron lariat-3' exon and then ligating the two exons and releasing the intron lariat. The second reaction is executed by the step II catalytically activated spliceosome (known as the C* complex). Here, we present the cryo-electron microscopy structure of a C* complex from Saccharomyces cerevisiae at an average resolution of 4.0 angstroms. Compared with the preceding spliceosomal complex (C complex), the lariat junction has been translocated by 15 to 20 angstroms to vacate space for the incoming 3'-exon sequences. The step I splicing factors Cwc25 and Yju2 have been dissociated from the active site. Two catalytic motifs from Prp8 (the 1585 loop and the beta finger of the ribonuclease H-like domain), along with the step II splicing factors Prp17 and Prp18 and other surrounding proteins, are poised to assist the second transesterification. These structural features, together with those reported for other spliceosomal complexes, yield a near-complete mechanistic picture on the splicing cycle.	[Yan, Chuangye; Wan, Ruixue; Bai, Rui; Huang, Gaoxingyu; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China	Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2014ZX09507003006]; National Natural Science Foundation of China [31430020, 31321062]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for the cryo-EM facility and computation support. This work was supported by funds from the Ministry of Science and Technology (2014ZX09507003006) and the National Natural Science Foundation of China (31430020 and 31321062). The atomic coordinates have been deposited in the Protein Data Bank with accession code 5WSG, and the EM maps have been deposited in Electron Microscopy Data Bank with accession code EMD-6684. The authors declare no competing financial interests.	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Bacikova D, 2005, MOL CELL BIOL, V25, P2107, DOI 10.1128/MCB.25.6.2107-2116.2005; Bacikova D, 2002, RNA, V8, P1280, DOI 10.1017/S1355838202023099; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; DeLano W.L, PYMOL MOL GRAPHICS S; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; FRANK DN, 1994, MOL CELL BIOL, V14, P2180, DOI 10.1128/MCB.14.3.2180; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; HOROWITZ DS, 1993, GENE DEV, V7, P320, DOI 10.1101/gad.7.2.320; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; Jiang JZ, 2000, P NATL ACAD SCI USA, V97, P3022, DOI 10.1073/pnas.97.7.3022; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Lindsey-Boltz LA, 2000, RNA, V6, P1289, DOI 10.1017/S1355838200000327; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Moore M. J., 1993, COLD SPRING HARBOR M; Newman AJ, 1995, RNA, V1, P968; NEWMAN AJ, 1992, CELL, V68, P743, DOI 10.1016/0092-8674(92)90149-7; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; Schwer B, 2008, MOL CELL, V30, P743, DOI 10.1016/j.molcel.2008.05.003; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; UMEN JG, 1995, RNA, V1, P584; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; WYATT JR, 1992, GENE DEV, V6, P2542, DOI 10.1101/gad.6.12b.2542; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yang K, 2008, P NATL ACAD SCI USA, V105, P13817, DOI 10.1073/pnas.0805960105; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617	47	103	107	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2017	355	6321					149	155		10.1126/science.aak9979	http://dx.doi.org/10.1126/science.aak9979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4LW	27980089				2022-12-28	WOS:000391743700035
J	Rauch, BJ; Silvis, MR; Hultquist, JF; Waters, CS; McGregor, MJ; Krogan, NJ; Bondy-Denomy, J				Rauch, Benjamin J.; Silvis, Melanie R.; Hultquist, Judd F.; Waters, Christopher S.; McGregor, Michael J.; Krogan, Nevan J.; Bondy-Denomy, Joseph			Inhibition of CRISPR-Cas9 with Bacteriophage Proteins	CELL			English	Article							LISTERIA-MONOCYTOGENES; RNA; SEQUENCE; SYSTEMS; DNA; IDENTIFICATION; TRANSCRIPTION; ENDONUCLEASE; INTEGRATION; EXPRESSION	Bacterial CRISPR-Cas systems utilize sequencespecific RNA-guided nucleases to defend against bacteriophage infection. As a countermeasure, numerous phages are known that produce proteins to block the function of class 1 CRISPR-Cas systems. However, currently no proteins are known to inhibit the widely used class 2 CRISPR-Cas9 system. To find these inhibitors, we searched cas9-containing bacterial genomes for the co-existence of a CRISPR spacer and its target, a potential indicator for CRISPR inhibition. This analysis led to the discovery of four unique type II-A CRISPR-Cas9 inhibitor proteins encoded by Listeria monocytogenes prophages. More than half of L. monocytogenes strains with cas9 contain at least one prophage-encoded inhibitor, suggesting widespread CRISPR-Cas9 inactivation. Two of these inhibitors also blocked the widely used Streptococcus pyogenes Cas9 when assayed in Escherichia coli and human cells. These natural Cas9-specific "anti-CRISPRs'' present tools that can be used to regulate the genome engineering activities of CRISPR-Cas9.	[Rauch, Benjamin J.; Silvis, Melanie R.; Waters, Christopher S.; Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Rauch, Benjamin J.; Hultquist, Judd F.; Waters, Christopher S.; McGregor, Michael J.; Krogan, Nevan J.; Bondy-Denomy, Joseph] Univ Calif San Francisco, Quantitat Biosci Inst, QBI, San Francisco, CA 94158 USA; [Silvis, Melanie R.; Waters, Christopher S.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA; [Hultquist, Judd F.; McGregor, Michael J.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Hultquist, Judd F.; McGregor, Michael J.; Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Bondy-Denomy, J (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.; Bondy-Denomy, J (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst, QBI, San Francisco, CA 94158 USA.	joseph.bondy-denomy@ucsf.edu		Hultquist, Judd/0000-0001-6424-4280	University of California, San Francisco Program for Breakthrough in Biomedical Research; Sandler Foundation; NIH Office of the Director Early Independence Award [DP5-OD021344]; National Science Foundation [1144247]; Carol Gross' lab by Mira [R35GM118061]; amFAR Mathilde Krim Fellowship [109504-61-RKRL]; NIH Human Immunology Project Consortium Infrastructure Pilot [U19 AI118610]; NIH [P30 AI027763]; NIH HIV Accessory & Regulatory Complexes (HARC) Center [P50 GM082250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U19AI118610, T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, P50GM082250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021344] Funding Source: NIH RePORTER	University of California, San Francisco Program for Breakthrough in Biomedical Research(University of California System); Sandler Foundation; NIH Office of the Director Early Independence Award; National Science Foundation(National Science Foundation (NSF)); Carol Gross' lab by Mira; amFAR Mathilde Krim Fellowship; NIH Human Immunology Project Consortium Infrastructure Pilot(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HIV Accessory & Regulatory Complexes (HARC) Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Aaron T. Whiteley and Daniel A. Portnoy (UC Berkeley) for providing the prophage-cured strain of L. monocytogenes 10403s as well as the pPL2oexL plasmid. We thank Anna I. Bakardjiev and David E. Lowe (UCSF) for providing wild type strain 10403S and the pKSV7 plasmid. We also acknowledge Martin Wiedmann (Cornell University) for providing strain J0161 and Ariane Pietzka (Austrian Agency for Health and Food Safety) for providing SLCC2482 and SLCC2540. We acknowledge Carol Gross' lab (UCSF) for providing the pBAD24 plasmid and for productive conversations about the project. We specifically thank Carol Gross and Adair Borges for critical reading of the manuscript and thoughtful advice. J.B.-D. was supported by the University of California, San Francisco Program for Breakthrough in Biomedical Research and was funded in part by the Sandler Foundation and an NIH Office of the Director Early Independence Award (DP5-OD021344). M.R.S. was supported by National Science Foundation No. 1144247 and Carol Gross' lab by Mira R35GM118061. J.F.H. was supported by an amFAR Mathilde Krim Fellowship (109504-61-RKRL), an NIH Human Immunology Project Consortium Infrastructure Pilot (U19 AI118610 to N.J.K.), NIH funding for the UCSF-Gladstone Institute of Virology & Immunology Center for AIDS Research (P30 AI027763 to N.J.K.), and from the NIH HIV Accessory & Regulatory Complexes (HARC) Center (P50 GM082250).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Di HL, 2014, BIOCHEM BIOPH RES CO, V454, P399, DOI 10.1016/j.bbrc.2014.10.018; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Sesto N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004065; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	49	288	306	18	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					150	+		10.1016/j.cell.2016.12.009	http://dx.doi.org/10.1016/j.cell.2016.12.009			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	28041849	Green Accepted, Bronze			2022-12-28	WOS:000396246700018
J	Lukarska, M; Fournier, G; Pflug, A; Resa-Infante, P; Reich, S; Naffakh, N; Cusack, S				Lukarska, Maria; Fournier, Guillaume; Pflug, Alexander; Resa-Infante, Patricia; Reich, Stefan; Naffakh, Nadia; Cusack, Stephen			Structural basis of an essential interaction between influenza polymerase and Pol II CTD	NATURE			English	Article							CARBOXYL-TERMINAL DOMAIN; AMINO-ACID MUTATION; RNA-POLYMERASE; A VIRUS; PA SUBUNIT; TRANSCRIPTION; DEGRADATION; REPLICATION; REFINEMENT	The heterotrimeric influenza polymerase (FluPol), comprising subunits PA, PB1 and PB2, binds to the conserved 5' and 3' termini (the 'promoter') of each of the eight single-stranded viral RNA (vRNA) genome segments and performs both transcription and replication of vRNA in the infected cell nucleus(1-3). To transcribe viral mRNAs, FluPol associates with cellular RNA polymerase II (Pol II)(4-7), which enables it to take 5'-capped primers from nascent Pol II transcripts(8,9). Here we present a co-crystal structure of bat influenza A polymerase bound to a Pol II C-terminal domain (CTD) peptide mimic, which shows two distinct phosphoserine-5 (SeP5)-binding sites in the polymerase PA subunit, accommodating four CTD heptad repeats overall. Mutagenesis of the SeP5-contacting basic residues (PA K289, R454, K635 and R638) weakens CTD repeat binding in vitro without affecting the intrinsic cap-primed (transcription) or unprimed (replication) RNA synthesis activity of recombinant polymerase, whereas in cell-based minigenome assays the same mutations substantially reduce overall polymerase activity. Only recombinant viruses with a single mutation in one of the SeP5-binding sites can be rescued, but these viruses are severely attenuated and genetically unstable. Several previously described mutants that modulate virulence can be rationalized by our results, including a second site mutation (PA(C453R)) that enables the highly attenuated mutant virus (PA(R638A)) to revert to near wildtype infectivity(10). We conclude that direct binding of FluPol to the SeP5 Pol II CTD is fine-tuned to allow efficient viral transcription and propose that the CTD-binding site on FluPol could be targeted for antiviral drug development.	[Lukarska, Maria; Pflug, Alexander; Resa-Infante, Patricia; Reich, Stefan; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France; [Fournier, Guillaume; Naffakh, Nadia] Inst Pasteur, Dept Virol, Unite Genet Mol Virus ARN, F-75015 Paris, France; [Fournier, Guillaume; Naffakh, Nadia] CNRS, UMR3569, F-75015 Paris, France; [Fournier, Guillaume; Naffakh, Nadia] Univ Paris Diderot, Unite Genet Mol Virus ARN, Sorbonne Paris Cite, EA302, F-75015 Paris, France	European Molecular Biology Laboratory (EMBL); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France.	cusack@embl.fr	Resa-Infante, Patricia/D-3843-2018	Resa-Infante, Patricia/0000-0002-1727-592X; Fournier, Guillaume/0000-0002-1865-3996; Reich, Stefan/0000-0001-8822-2908; Pflug, Alexander/0000-0002-4680-1298; Naffakh, Nadia/0000-0002-0424-0277; Cusack, Stephen/0000-0002-9324-0796	ERC Advanced Grant V-RNA [322586]; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; Institut Carnot Pasteur Maladies Infectieuses; EU PREDEMICS project [278433]	ERC Advanced Grant V-RNA; Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence; Institut Carnot Pasteur Maladies Infectieuses; EU PREDEMICS project	We thank ESRF for access to X-ray beamlines, the EMBL eukaryotic expression and crystallisation facilities and the biophysical platform within the Partnership for Structural Biology (PSB). D. Guilligay, M. Lethier and S. Gaudon helped with protein expression and crystallization. J. Ortin and T. Wolff supplied plasmids and members of the R. Pillai group (EMBL) provided advice for the minigenome assays. We thank V. Enouf and S. Leandri (Institut Pasteur, Pasteur International Bioresources network, Plateforme de Microbiologie Mutualisee) for the next-generation sequencing analysis and H. Varet (Institut Pasteur) for help with the statistical analysis. We acknowledge A. Politi, N. Daigle and J. Ellenberg for fluorescent microscopy experiments and discussions. This work was supported by ERC Advanced Grant V-RNA (322586) to S.C. and by the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence to N. N. The Institut Carnot Pasteur Maladies Infectieuses and the EU PREDEMICS project (278433) supported G.F.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Afonso EDS, 2005, VIROLOGY, V341, P34, DOI 10.1016/j.virol.2005.06.040; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; DeLano W.L, PYMOL MOL GRAPHICS S; Eisfeld AJ, 2015, NAT REV MICROBIOL, V13, P28, DOI 10.1038/nrmicro3367; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Fodor E, 2003, J VIROL, V77, P5017, DOI 10.1128/JVI.77.8.5017-5020.2003; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gu WF, 2015, RNA, V21, P2067, DOI 10.1261/rna.054221.115; Hsin JP, 2014, MOL CELL BIOL, V34, P2488, DOI 10.1128/MCB.00181-14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Lidschreiber M, 2013, MOL CELL BIOL, V33, P3805, DOI 10.1128/MCB.00361-13; Llompart CM, 2014, J VIROL, V88, P3455, DOI 10.1128/JVI.02263-13; Loucaides EM, 2009, VIROLOGY, V394, P154, DOI 10.1016/j.virol.2009.08.015; MAHY BWJ, 1972, P NATL ACAD SCI USA, V69, P1421, DOI 10.1073/pnas.69.6.1421; Martinez-Alonso M, 2016, J VIROL, V90, P6014, DOI 10.1128/JVI.00494-16; Martinez-Rucobo FW, 2015, MOL CELL, V58, P1079, DOI 10.1016/j.molcel.2015.04.004; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Vreede FT, 2010, VIRULENCE, V1, P436, DOI 10.4161/viru.1.5.12967; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wu NC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005310	38	67	69	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					117	+		10.1038/nature20594	http://dx.doi.org/10.1038/nature20594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	28002402				2022-12-28	WOS:000396119500041
J	Desai, NR; Ross, JS; Kwon, JY; Herrin, J; Dharmarajan, K; Bernheim, SM; Krumholz, HM; Horwitz, LI				Desai, Nihar R.; Ross, Joseph S.; Kwon, Ji Young; Herrin, Jeph; Dharmarajan, Kumar; Bernheim, Susannah M.; Krumholz, Harlan M.; Horwitz, Leora I.			Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMINISTRATIVE CLAIMS MEASURE; INTERRUPTED TIME-SERIES; PERFORMANCE	IMPORTANCE Readmission rates declined after announcement of the Hospital Readmission Reduction Program (HRRP), which penalizes hospitals for excess readmissions for acute myocardial infarction (AMI), heart failure (HF), and pneumonia. OBJECTIVE To compare trends in readmission rates for target and nontarget conditions, stratified by hospital penalty status. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare fee-for-service beneficiaries older than 64 years discharged between January 1, 2008, and June 30, 2015, from 2214 penalty hospitals and 1283 nonpenalty hospitals. Difference-interrupted time-series models were used to compare trends in readmission rates by condition and penalty status. EXPOSURE Hospital penalty status or target condition under the HRRP. MAIN OUTCOMES AND MEASURES Thirty-day risk adjusted, all-cause unplanned readmission rates for target and nontarget conditions. RESULTS The study included 48 137 102 hospitalizations of 20 351 161 Medicare beneficiaries. In January 2008, the mean readmission rates for AMI, HF, pneumonia, and nontarget conditions were 21.9%, 27.5%, 20.1%, and 18.4%, respectively, at hospitals later subject to financial penalties and 18.7%, 24.2%, 17.4%, and 15.7% at hospitals not subject to penalties. Between January 2008 and March 2010, prior to HRRP announcement, readmission rates were stable across hospitals (except AMI at nonpenalty hospitals). Following announcement of HRRP (March 2010), readmission rates for both target and nontarget conditions declined significantly faster for patients at hospitals later subject to financial penalties compared with those at nonpenalized hospitals (for AMI, additional decrease of -1.24 [95% CI, -1.84 to -0.65] percentage points per year relative to nonpenalty discharges; for HF, -.25 [95% CI, -1.64 to -0.86]; for pneumonia, -1.37 [95% CI, -1.80 to -0.95]; and for nontarget conditions, -0.27 [95% CI, -0.38 to -0.17]; P < .001 for all). For penalty hospitals, readmission rates for target conditions declined significantly faster compared with nontarget conditions (for AMI, additional decline of -0.49 [95% CI, -0.81 to -0.16] percentage points per year relative to nontarget conditions [P = .004]; for HF, -0.90 [95% CI, -1.18 to -0.62; P < .001]; and for pneumonia, -0.57 [95% CI, -0.92 to -0.23; P < .001]). In contrast, among nonpenalty hospitals, readmissions for target conditions declined similarly or more slowly compared with nontarget conditions (for AMI, additional increase of 0.48 [95% CI, 0.01-0.95] percentage points per year [P = .05]; for HF, 0.08 [95% CI, -0.30 to 0.46; P = .67]; for pneumonia, 0.53 [95% CI, 0.13-0.93; P = .01]). After HRRP implementation in October 2012, the rate of change for readmission rates plateaued (P < .05 for all except pneumonia at nonpenalty hospitals), with the greatest relative change observed among hospitals subject to financial penalty. CONCLUSIONS AND RELEVANCE Medicare fee-for-service patients at hospitals subject to penalties under the HRRP had greater reductions in readmission rates compared with those at nonpenalized hospitals. Changes were greater for target vs nontarget conditions for patients at the penalized hospitals but not at the other hospitals.	[Desai, Nihar R.; Herrin, Jeph; Dharmarajan, Kumar; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Desai, Nihar R.; Ross, Joseph S.; Kwon, Ji Young; Dharmarajan, Kumar; Bernheim, Susannah M.; Krumholz, Harlan M.] Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Robert Wood Johnson Fdn,Clin Scholars Program, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Horwitz, Leora I.] NYU, Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, New York, NY USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Med, New York, NY USA	Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; New York University; New York University; NYU Langone Medical Center; New York University	Horwitz, LI (corresponding author), NYU, Sch Med, 550 First Ave,TRB 607, New York, NY 10016 USA.	leora.horwitz@nyumc.org	Horwitz, Leora/ABD-1292-2020; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Agency for Healthcare Research and Quality [R01HS022882, K12 HS023000-01]; National Institute on Aging [K23AG048331]; American Federation for Aging Research through Paul B. Beeson Career Development Award Program; Yale Claude D. Pepper Older Americans Independence Center [P30AG021342]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022882, K12HS023000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG048331, P30AG021342] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through Paul B. Beeson Career Development Award Program; Yale Claude D. Pepper Older Americans Independence Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the Agency for Healthcare Research and Quality (grant R01HS022882). Dr Desai is supported by grant K12 HS023000-01 from the Agency for Healthcare Research and Quality. Dr Dharmarajan is supported by grant K23AG048331 from the National Institute on Aging and the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program. He is also supported by grant P30AG021342 via the Yale Claude D. Pepper Older Americans Independence Center.	Boccuti C., 2017, AIMING FEWER HOSP U; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Centers for Medicare & Medicaid Services, 2011, HOSP ENG NETW CONN H; Conover M., 2012, HOSP WIDE ALL CAUSE; DeVore AD, 2016, J AM COLL CARDIOL, V67, P963, DOI 10.1016/j.jacc.2015.12.037; Horwitz LI, 2015, J HOSP MED, V10, P670, DOI 10.1002/jhm.2416; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Horwitz LI, 2013, CTR MED MED SERVICES; Joynt KE, 2016, AM J MANAG CARE, V22, pE287; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Rau J., 2015, KAISER HLTH NEWS; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	16	189	190	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2647	2656		10.1001/jama.2016.18533	http://dx.doi.org/10.1001/jama.2016.18533			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027367	Green Accepted, Bronze			2022-12-28	WOS:000391110200018
J	Weiss, IK				Weiss, Irwin K.			Bearing the Silence of Tragedy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weiss, Irwin K.] Univ Calif Los Angeles, Mattel Childrens Hosp, Div Pediat Crit Care Med, Los Angeles, CA 90095 USA; [Weiss, Irwin K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, IK (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp, Div Pediat Crit Care Med, Los Angeles, CA 90095 USA.; Weiss, IK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	iweiss@mednet.ucla.edu						Goodwin DK., 2015, TEAM RIVALS POLITICA; Newton Hannah, 2012, SICK CHILD EARLY MOD	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2599	2600		10.1001/jama.2016.11184	http://dx.doi.org/10.1001/jama.2016.11184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027372				2022-12-28	WOS:000391110200011
J	[Anonymous]				[Anonymous]			Breakdowns of the year	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1525	1525						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3VZ	28008024				2022-12-28	WOS:000390254300023
J	Perkovic, V				Perkovic, Vlado			Review: Revascularization and medical treatment may be similar in atherosclerotic renal artery stenosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Perkovic, Vlado] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney	Perkovic, V (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.		Perkovic, Vlado/AAY-1933-2021					Tafur-Soto JD, 2015, CARDIOL CLIN, V33, P59, DOI 10.1016/j.ccl.2014.09.006; Wu GF, 2008, J INVASIVE CARDIOL, V20, P76	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC71	JC71		10.7326/ACPJC-2016-165-12-071	http://dx.doi.org/10.7326/ACPJC-2016-165-12-071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992927				2022-12-28	WOS:000391236900010
J	Steinberg, DI				Steinberg, Daniel I.			Review: In adults with asthma, vitamin D-3 reduces rate of severe exacerbation but does not improve symptoms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Steinberg, Daniel I.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Steinberg, DI (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006	1	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC66	JC66		10.7326/ACPJC-2016-165-12-066	http://dx.doi.org/10.7326/ACPJC-2016-165-12-066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992922				2022-12-28	WOS:000391236900005
J	Lyon, J				Lyon, Jeff			Research Across Borders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2348	2348		10.1001/jama.2016.17140	http://dx.doi.org/10.1001/jama.2016.17140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959977				2022-12-28	WOS:000389884600004
J	Geisbert, TW				Geisbert, Thomas W.			First Ebola virus vaccine to protect human beings?	LANCET			English	Editorial Material							NONHUMAN-PRIMATES; INFECTION		[Geisbert, Thomas W.] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Geisbert, TW (corresponding author), Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77550 USA.	twgeisbe@utmb.edu						Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225; Henao-Restrepo AM, 2016, LANCET; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Mire CE, 2015, NATURE, V520, P688, DOI 10.1038/nature14428; Mire CE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001567; Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216	11	8	8	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					479	480		10.1016/S0140-6736(16)32618-6	http://dx.doi.org/10.1016/S0140-6736(16)32618-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28017402	hybrid			2022-12-28	WOS:000393283400010
J	Boucher, HW; Cosgrove, SE; Cox, E; Talbot, GH				Boucher, Helen W.; Cosgrove, Sara E.; Cox, Edward; Talbot, George H.			The Fight Against Multidrug-Resistant Bacteria	ANNALS OF INTERNAL MEDICINE			English	Letter							PROGRESS; UPDATE		[Boucher, Helen W.] Tufts Med Ctr, Boston, MA 02111 USA; [Boucher, Helen W.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Cosgrove, Sara E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Cox, Edward] US FDA, Silver Spring, MD USA; [Talbot, George H.] Talbot Advisors, Anna Maria, FL USA	Tufts Medical Center; Tufts University; Johns Hopkins University; US Food & Drug Administration (FDA)	Boucher, HW (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.; Boucher, HW (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.							Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Deak D, 2016, ANN INTERN MED, V165, P363, DOI 10.7326/M16-0291; Nambiar S, 2014, CLIN PHARMACOL THER, V96, P147, DOI 10.1038/clpt.2014.116; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566	5	2	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					78	79		10.7326/L16-0584	http://dx.doi.org/10.7326/L16-0584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030674				2022-12-28	WOS:000391467900019
J	Weinrauch, LA; D'Elia, JA				Weinrauch, Larry A.; D'Elia, John A.			The Fight Against Multidrug-Resistant Bacteria	ANNALS OF INTERNAL MEDICINE			English	Letter							CALCIUM-CHANNEL BLOCKERS		[Weinrauch, Larry A.] Harvard Med Sch, Boston, MA 02115 USA; [D'Elia, John A.] Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Weinrauch, LA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Deak D, 2016, ANN INTERN MED, V165, P363, DOI 10.7326/M16-0291; Pletz MW, 2013, INT J MED MICROBIOL, V303, P176, DOI 10.1016/j.ijmm.2013.02.014; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; Song LL, 2015, J MICROBIOL IMMUNOL, V48, P471, DOI 10.1016/j.jmii.2014.08.026; WEINRAUCH LA, 1995, CLIN NEPHROL, V44, P185	5	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					77	78		10.7326/L16-0583	http://dx.doi.org/10.7326/L16-0583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030673				2022-12-28	WOS:000391467900018
J	Jiao, LY; Liu, X				Jiao, Lianying; Liu, Xin			Response to Comment on "Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2"	SCIENCE			English	Editorial Material							INHIBITION		[Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Basic Res Div, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.	xin.liu@utsouthwestern.edu	Jiao, Lianying/A-8783-2019	Jiao, Lianying/0000-0002-7911-3811	NIGMS NIH HHS [R01 GM114576, P41 GM103393] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114576, P41GM103393] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236	5	4	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319							1543-b	10.1126/science.aaj2335	http://dx.doi.org/10.1126/science.aaj2335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008038	Green Accepted			2022-12-28	WOS:000390254300040
J	[Anonymous]				[Anonymous]			The Relationship Between Herpes Zoster, Syphilis and Chickenpox (Reprinted from JAMA, vol 73, pg 1629, 1919)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1919, BRAIN 1, V42; Parker WG, 1919, J AMER MED ASSOC, V73, P1629, DOI 10.1001/jama.1919.02610470065031	2	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2555	2555		10.1001/jama.2015.17114	http://dx.doi.org/10.1001/jama.2015.17114			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997644	Green Submitted			2022-12-28	WOS:000390959300031
J	Dagliyan, O; Tarnawski, M; Chu, PH; Shirvanyants, D; Schlichting, I; Dokholyan, NV; Hahn, KM				Dagliyan, Onur; Tarnawski, Miroslaw; Chu, Pei-Hsuan; Shirvanyants, David; Schlichting, Ilme; Dokholyan, Nikolay V.; Hahn, Klaus M.			Engineering extrinsic disorder to control protein activity in living cells	SCIENCE			English	Article							SPATIOTEMPORAL CONTROL; SRC; DYNAMICS; SWITCH; ACTIVATION; MOTILITY; DESIGN; KINASE; SENSOR	Optogenetic and chemogenetic control of proteins has revealed otherwise inaccessible facets of signaling dynamics. Here, we use light-or ligand-sensitive domains to modulate the structural disorder of diverse proteins, thereby generating robust allosteric switches. Sensory domains were inserted into nonconserved, surface-exposed loops that were tight and identified computationally as allosterically coupled to active sites. Allosteric switches introduced into motility signaling proteins (kinases, guanosine triphosphatases, and guanine exchange factors) controlled conversion between conformations closely resembling natural active and inactive states, as well asmodulated themorphodynamics of living cells. Our results illustrate a broadly applicable approach to design physiological protein switches.	[Dagliyan, Onur; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Dagliyan, Onur; Shirvanyants, David; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dagliyan, Onur; Chu, Pei-Hsuan; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Dagliyan, Onur; Chu, Pei-Hsuan; Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tarnawski, Miroslaw; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society	Dokholyan, NV (corresponding author), Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA.; Dokholyan, NV (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.; Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.; Hahn, KM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dokh@email.unc.edu; khahn@med.unc.edu	Dagliyan, Onur/N-5683-2019; Schlichting, Ilme/I-1339-2013; Dokholyan, Nikolay/D-8081-2018	Dagliyan, Onur/0000-0003-1825-1011; Dokholyan, Nikolay/0000-0002-8225-4025; Hahn, Klaus/0000-0002-1970-7562	NIH [P01-GM103723, P41-EB002025, R01GM080742]; Deutsche Forschungsgemeinschaft [FOR1279]; NATIONAL CANCER INSTITUTE [R01CA142833, R01CA175747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115597, P01GM103723, R01GM080742] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants P01-GM103723 and P41-EB002025 (K.M.H.), R01GM080742 (N.V.D.), and by Deutsche Forschungsgemeinschaft grant FOR1279 (I.S.). O.D. is a Howard Hughes Medical Institute International Student Research Fellow. X-ray data were collected at the Swiss Light Source, beamline X10SA and X12SA, Paul Scherrer Institute, Villigen, Switzerland. We thank A. Menzel and T. Barends for collecting the small angle x-ray scattering data, and M. Shobair for his help with PI-Vav2 simulations. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession codes: 5HZJ (PI-ITSN1-WT), 5HZI (PI-ITSN1-C450M), 5HZK (PI-ITSN1-WT: Cdc42), and 5HZH (PI-Rac1-C450A). O.D., N.V.D., and K.M.H. designed the research; M.T. performed the crystallographic work and conducted hydrogen-deuterium exchange coupled to mass spectrometry assays under the directions of I.S. who collected the x-ray data; P.-H.C. helped the characterization of PI-Src; D.S. conducted the simulations of PI-Src; O.D. performed all experiments and computations not listed above; O.D. and K.M.H. wrote the manuscript with input from all authors. The constructs described in this paper are available from K.M.H under a material transfer agreement with the University of North Carolina-Chapel Hill.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Choi JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7968; Chu PH, 2014, P NATL ACAD SCI USA, V111, P12420, DOI 10.1073/pnas.1404487111; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Razidlo GL, 2014, CURR BIOL, V24, P86, DOI 10.1016/j.cub.2013.11.013; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042; Wang H, 2016, NAT METHODS, V13, P755, DOI [10.1038/NMETH.3926, 10.1038/nmeth.3926]; Weitzman M, 2014, CURR OPIN CELL BIOL, V30, P112, DOI 10.1016/j.ceb.2014.08.004; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068; Zhou XX, 2012, SCIENCE, V338, P810, DOI 10.1126/science.1226854; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940	30	131	134	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1441	1444		10.1126/science.aah3404	http://dx.doi.org/10.1126/science.aah3404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980211	Green Accepted, Green Submitted			2022-12-28	WOS:000390261300048
J	Service, RF				Service, Robert F.			ENERGY POLICY Cost of carbon capture drops, but does anyone want it?	SCIENCE			English	News Item																			0	19	20	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1362	1363		10.1126/science.354.6318.1362	http://dx.doi.org/10.1126/science.354.6318.1362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980164				2022-12-28	WOS:000390261300013
J	Wadman, M				Wadman, Meredith			BIOMEDICINE Antisense rescues babies from killer disease	SCIENCE			English	News Item																			0	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1359	1360		10.1126/science.354.6318.1359	http://dx.doi.org/10.1126/science.354.6318.1359			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980162				2022-12-28	WOS:000390261300011
J	Williams, R; Burgess, MG; Ashe, E; Gaines, SD; Reeves, RR				Williams, Rob; Burgess, Matthew G.; Ashe, Erin; Gaines, Steven D.; Reeves, Randall R.			US seafood import restriction presents opportunity and risk	SCIENCE			English	Editorial Material							MARINE MAMMALS; CONSERVATION; MANAGEMENT; BYCATCH; SEA		[Williams, Rob; Ashe, Erin] Oceans Initiat, Seattle, WA 98102 USA; [Williams, Rob; Ashe, Erin] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 8LB, Scotland; [Burgess, Matthew G.; Gaines, Steven D.] Univ Calif Santa Barbara, Sustainable Fisheries Grp, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Burgess, Matthew G.; Gaines, Steven D.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Reeves, Randall R.] Okapi Wildlife Associates, Hudson, PQ J0P 1H0, Canada	University of St Andrews; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Williams, R (corresponding author), Oceans Initiat, Seattle, WA 98102 USA.; Williams, R (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews KY16 8LB, Scotland.	rmcw@st-andrews.ac.uk	Gaines, Steven/Y-3234-2019; Williams, Rob/C-5882-2011	Burgess, Matthew/0000-0002-3750-4347; Ashe, Erin/0000-0001-9918-1419; Williams, Rob/0000-0001-7496-453X				[Anonymous], FED REG; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Food and Agricultural Organization of the United Nations, 2016, FISH COMM TRAD; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Lemos MC, 2006, ANNU REV ENV RESOUR, V31, P297, DOI 10.1146/annurev.energy.31.042605.135621; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; McCauley DJ, 2016, SCIENCE, V351, P1148, DOI 10.1126/science.aad5686; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; National Marine Fishery Service, 2016, MONTHL TRAD DAT PROD; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves RR, 2013, ENDANGER SPECIES RES, V20, P71, DOI 10.3354/esr00481; Rojas-Bracho L, 2013, ENDANGER SPECIES RES, V21, P77, DOI 10.3354/esr00501; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Thomas PO, 2016, MAR MAMMAL SCI, V32, P682, DOI 10.1111/mms.12281; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Werner T, 2006, MAR TECHNOL SOC J, V40, P50, DOI 10.4031/002533206787353204; World Bank Group, 2020, WORLD DEV IND	20	33	34	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1372	1374		10.1126/science.aai8222	http://dx.doi.org/10.1126/science.aai8222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980169				2022-12-28	WOS:000390261300018
J	Lin, Q; Fan, SH; Zhang, YH; Xu, M; Zhang, HX; Yang, YL; Lee, AP; Woltering, JM; Ravi, V; Gunter, HM; Luo, W; Gao, ZX; Lim, ZW; Qin, G; Schneider, RF; Wang, X; Xiong, PW; Li, G; Wang, K; Min, JM; Zhang, C; Qiu, Y; Bai, J; He, WM; Bian, C; Zhang, XH; Shan, D; Qu, HY; Sun, Y; Gao, Q; Huang, LM; Shi, Q; Meyer, A; Venkatesh, B				Lin, Qiang; Fan, Shaohua; Zhang, Yanhong; Xu, Meng; Zhang, Huixian; Yang, Yulan; Lee, Alison P.; Woltering, Joost M.; Ravi, Vydianathan; Gunter, Helen M.; Luo, Wei; Gao, Zexia; Lim, Zhi Wei; Qin, Geng; Schneider, Ralf F.; Wang, Xin; Xiong, Peiwen; Li, Gang; Wang, Kai; Min, Jiumeng; Zhang, Chi; Qiu, Ying; Bai, Jie; He, Weiming; Bian, Chao; Zhang, Xinhui; Shan, Dai; Qu, Hongyue; Sun, Ying; Gao, Qiang; Huang, Liangmin; Shi, Qiong; Meyer, Axel; Venkatesh, Byrappa			The seahorse genome and the evolution of its specialized morphology	NATURE			English	Article							MALE-PREGNANCY; PHYLOGENETIC ANALYSES; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; ADAPTIVE EVOLUTION; GENETIC-BASIS; PELVIC FINS; RNA-SEQ; HIPPOCAMPUS; ALIGNMENT	Seahorses have a specialized morphology that includes a toothless tubular mouth, a body covered with bony plates, a male brood pouch, and the absence of caudal and pelvic fins. Here we report the sequencing and de novo assembly of the genome of the tiger tail seahorse, Hippocampus comes. Comparative genomic analysis identifies higher protein and nucleotide evolutionary rates in H. comes compared with other teleost fish genomes. We identified an astacin metalloprotease gene family that has undergone expansion and is highly expressed in the male brood pouch. We also find that the H. comes genome lacks enamel matrix protein-coding proline/glutamine-rich secretory calcium-binding phosphoprotein genes, which might have led to the loss of mineralized teeth. tbx4, a regulator of hindlimb development, is also not found in H. comes genome. Knockout of tbx4 in zebrafish showed a 'pelvic fin-loss' phenotype similar to that of seahorses.	[Lin, Qiang; Zhang, Yanhong; Zhang, Huixian; Luo, Wei; Qin, Geng; Wang, Xin; Li, Gang; Qu, Hongyue; Huang, Liangmin; Shi, Qiong] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China; [Fan, Shaohua; Woltering, Joost M.; Gunter, Helen M.; Schneider, Ralf F.; Xiong, Peiwen; Meyer, Axel] Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, D-78457 Constance, Germany; [Xu, Meng; Min, Jiumeng; Zhang, Chi; He, Weiming; Shan, Dai; Gao, Qiang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Huixian; Lee, Alison P.; Ravi, Vydianathan; Lim, Zhi Wei; Venkatesh, Byrappa] ASTAR, Biopolis, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Gao, Zexia] Huazhong Agr Univ, Coll Fisheries, Wuhan 430070, Peoples R China; [Qin, Geng; Wang, Xin; Qu, Hongyue; Huang, Liangmin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Kai] Ludong Univ, Sch Agr, Yantai 264025, Peoples R China; [Qiu, Ying; Bai, Jie; Bian, Chao; Zhang, Xinhui; Sun, Ying; Shi, Qiong] BGI, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen Key Lab Marine Genom, Shenzhen 518083, Peoples R China; [Venkatesh, Byrappa] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore; [Fan, Shaohua] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Lee, Alison P.] Bioproc Technol Inst, Biopolis, Singapore 138668, Singapore; [Gunter, Helen M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Lim, Zhi Wei] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; University of Konstanz; Beijing Genomics Institute (BGI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Huazhong Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ludong University; Beijing Genomics Institute (BGI); National University of Singapore; University of Pennsylvania; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); University of Edinburgh; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Shi, Q (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.; Meyer, A (corresponding author), Univ Konstanz, Dept Biol, Chair Zool & Evolutionary Biol, D-78457 Constance, Germany.; Venkatesh, B (corresponding author), ASTAR, Biopolis, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Shi, Q (corresponding author), BGI, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen Key Lab Marine Genom, Shenzhen 518083, Peoples R China.; Venkatesh, B (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119228, Singapore.	shiqiong@genomics.cn; axel.meyer@uni-konstanz.de; mcbbv@imcb.a-star.edu.sg	Ravi, Vydianathan/B-2759-2009; Qin, Geng/Z-4457-2019; Lee, Alison/HCH-1286-2022; Meyer, Axel/C-9826-2009; Schneider, Ralf/I-3385-2019; 耿, 秦/R-1833-2017; Lim, Zhiwei/Q-7858-2016	Ravi, Vydianathan/0000-0003-0807-7697; Lee, Alison/0000-0002-3773-1021; Meyer, Axel/0000-0002-0888-8193; Schneider, Ralf/0000-0001-6015-7219; 耿, 秦/0000-0002-8955-2201; Lim, Zhiwei/0000-0003-4620-1986; Venkatesh, Byrappa/0000-0003-3620-0277; Gunter, Helen/0000-0002-6557-1993; Woltering, Joost/0000-0002-2630-6572; Bian, Chao/0000-0001-9904-721X; Wang, Kai/0000-0003-1091-0959	National Science Fund for Excellent Young Scholars [41322038]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA13020103]; Youth Foundation of National High Technology Research and Development Program (863 Program) [2015AA020909]; Outstanding Youth Foundation in Guangdong Province [S2013050014802]; National Natural Science Foundation of China [41576145]; National Key Basic Research Program of China [2015CB452904]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2013B090800017]; Biomedical Research Council of A*STAR, Singapore	National Science Fund for Excellent Young Scholars; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Foundation of National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Outstanding Youth Foundation in Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Special Project on the Integration of Industry, Education and Research of Guangdong Province; Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	We thank the Laboratory Animal Center of Sun Yat-Sen University for providing experimental facilities and the Agency for Science, Technology and Research (A*STAR) Computational Resource Centre for use of its high-performance computing facilities. This research was supported by the National Science Fund for Excellent Young Scholars (41322038), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020103), the Youth Foundation of National High Technology Research and Development Program (863 Program) (2015AA020909), the Outstanding Youth Foundation in Guangdong Province (S2013050014802), the National Natural Science Foundation of China (41576145), the National Key Basic Research Program of China (2015CB452904), the Special Project on the Integration of Industry, Education and Research of Guangdong Province (no. 2013B090800017) and the Biomedical Research Council of A*STAR, Singapore.	Arora R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002866; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Bailly X, 2003, P NATL ACAD SCI USA, V100, P5885, DOI 10.1073/pnas.1037686100; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bian C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24501; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Don EK, 2016, BIOL OPEN, V5, P359, DOI 10.1242/bio.016295; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GOSLINE WA, 1980, JPN J ICHTHYOL, V27, P1; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harlin-Cognato A, 2006, P NATL ACAD SCI USA, V103, P19407, DOI 10.1073/pnas.0603000103; Harris JE, 1938, J EXP BIOL, V15, P32; Harris RS, 2007, THESIS, DOI [10.5555/1414852, DOI 10.5555/1414852]; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kawaguchi M, 2006, DEV GENES EVOL, V216, P769, DOI 10.1007/s00427-006-0104-5; Kawaguchi M, 2015, J EXP ZOOL PART B, V324, P41, DOI 10.1002/jez.b.22601; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Kawasaki K, 2011, CELLS TISSUES ORGANS, V194, P108, DOI 10.1159/000324225; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Leysen H, 2011, J FISH BIOL, V78, P1799, DOI 10.1111/j.1095-8649.2011.02957.x; Lin Q, 2008, AQUACULTURE, V277, P287, DOI 10.1016/j.aquaculture.2008.02.030; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meredith RW, 2014, SCIENCE, V346, P1336, DOI 10.1126/science.1254390; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Standen EM, 2008, J EXP BIOL, V211, P2931, DOI 10.1242/jeb.018572; Stolting KN, 2007, BIOESSAYS, V29, P884, DOI 10.1002/bies.zm.uzh.ch; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 1999, MECH DEVELOP, V87, P181, DOI 10.1016/S0925-4773(99)00126-4; Tanaka M, 2005, DEV BIOL, V281, P227, DOI 10.1016/j.ydbio.2005.02.016; Teske PR, 2004, MOL PHYLOGENET EVOL, V30, P273, DOI 10.1016/S1055-7903(03)00214-8; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Whittington CM, 2015, MOL BIOL EVOL, V32, P3114, DOI 10.1093/molbev/msv177; Wilson AB, 2001, J HERED, V92, P159, DOI 10.1093/jhered/92.2.159; Yamanoue Y, 2010, J FISH BIOL, V77, P1173, DOI 10.1111/j.1095-8649.2010.02674.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	61	108	123	24	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					395	+		10.1038/nature20595	http://dx.doi.org/10.1038/nature20595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974754	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000389716800034
J	Hilton, D				Hilton, David			Denis Dewhurst Hilton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6665	10.1136/bmj.i6665	http://dx.doi.org/10.1136/bmj.i6665			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965202				2022-12-28	WOS:000390150800010
J	Lewis, RJ; Calis, KA; DeMets, DL				Lewis, Roger J.; Calis, Karim A.; DeMets, David L.			Enhancing the Scientific Integrity and Safety of Clinical Trials Recommendations for Data Monitoring Committees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA; [Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA; [Calis, Karim A.] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA; [Calis, Karim A.] NICHHD, NIH, Bethesda, MD 20892 USA; [DeMets, David L.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wisconsin System; University of Wisconsin Madison	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA.	roger@emedharbor.edu			FOOD AND DRUG ADMINISTRATION [R18FD005292, U19FD003800] Funding Source: NIH RePORTER; FDA [5R18FD005292-02] Funding Source: Federal RePORTER; FDA HHS [R18 FD005292, U19 FD003800] Funding Source: Medline	FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); FDA(United States Department of Health & Human Services); FDA HHS		[Anonymous], 2012, GUID CLIN TRIAL SPON, V31, P3	1	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2359	2360		10.1001/jama.2016.16070	http://dx.doi.org/10.1001/jama.2016.16070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27960001				2022-12-28	WOS:000389884600013
J	Horton, R				Horton, Richard			Offline: Syria-ending the state of denial	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2854	2854		10.1016/S0140-6736(16)32508-9	http://dx.doi.org/10.1016/S0140-6736(16)32508-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979395	Bronze			2022-12-28	WOS:000389631700015
J	Ludwig, H; Delforge, M				Ludwig, Heinz; Delforge, Michel			Multiple myeloma: new treatments gain momentum	LANCET			English	Editorial Material							AUTOLOGOUS TRANSPLANTATION; LENALIDOMIDE; MAINTENANCE; THERAPY		[Ludwig, Heinz] Wilhelminen Canc Res Inst, Dept Med 1, Ctr Oncol Haematol & Palliat Care, A-1160 Vienna, Austria; [Delforge, Michel] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium	Wilhelminenspital; KU Leuven; University Hospital Leuven	Ludwig, H (corresponding author), Wilhelminen Canc Res Inst, Dept Med 1, Ctr Oncol Haematol & Palliat Care, A-1160 Vienna, Austria.	heinz.ludwig@wienkav.at			Celgene; Takeda; AMGEN; Bristol Meyers; Janssen; BMS	Celgene(Bristol-Myers SquibbCelgene Corporation); Takeda(Takeda Pharmaceutical Company Ltd); AMGEN(Amgen); Bristol Meyers; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); BMS(Bristol-Myers Squibb)	HL reports personal fees from Celgene; speaker's honoraria, grants and personal fees from Takeda; research funding, speaker's honoraria, and personal fees from AMGEN; honoraria for advisory boards and speakers board and personal fees from Bristol Meyers; speaker's honoraria and personal fees from Janssen; and speaker's honoraria from Cilag. MD reports grants and personal fees from Celgene and Janssen, and personal fees from Takeda, Amgen, and BMS.	Attal M, 2015, AUTOLOGOUS TRANSPLAN, P391; Cavo M, 2016, EMNO2HO95 MM TRIAL A; Cavo M, 2011, BLOOD, V117, P6063, DOI 10.1182/blood-2011-02-297325; Durie B. G. M., 2016, LANCET; Gay F, 2015, LANCET ONCOL, V16, P1617, DOI 10.1016/S1470-2045(15)00389-7; Jakubowiak A, 2016, COPENHAGEN, pS101; Korde N, 2015, JAMA ONCOL, V1, P746, DOI 10.1001/jamaoncol.2015.2010; Lonial S, 2016, J ONCOL PRACT, V12, P287, DOI 10.1200/JOP.2016.010926; Luptakova K, 2015, CLIN ADV HEMATOL ONC, V13, P767; Magen H, 2016, THER ADV HEMATOL, V7, P187, DOI 10.1177/2040620716652862; Palumbo A, 2014, NEW ENGL J MED, V371, P895, DOI 10.1056/NEJMoa1402888; Rajan AM, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.53; Suzuki R, 2015, PLOS ONE, V2, P10; Usmani SZ, 2016, BLOOD, V128, P37, DOI 10.1182/blood-2016-03-705210	14	2	2	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					480	482		10.1016/S0140-6736(16)32405-9	http://dx.doi.org/10.1016/S0140-6736(16)32405-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28017404				2022-12-28	WOS:000393283400011
J	Agabio, R				Agabio, Roberta			Non-specialist health workers to treat excessive alcohol consumption and depression	LANCET			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY; PRIMARY-CARE; PREVALENCE; DISORDERS; IMPACT; COST		[Agabio, Roberta] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, I-09124 Cagliari, Italy	University of Cagliari	Agabio, R (corresponding author), Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, I-09124 Cagliari, Italy.	agabio@unica.it		Agabio, Roberta/0000-0001-7395-6845				[Anonymous], 2010, PRACTICE GUIDELINE T; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Charlson Fiona J, 2016, Lancet, V388, P376, DOI 10.1016/S0140-6736(16)30590-6; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Keurhorst M, 2015, ADDICTION, V110, P1877, DOI 10.1111/add.13088; Mitchell AJ, 2012, BRIT J PSYCHIAT, V201, P93, DOI 10.1192/bjp.bp.110.091199; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Nadkarni A, 2016, LANCET; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Patel V., 2016, LANCET; Patel V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-101; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Richards DA, 2016, LANCET, V388, P871, DOI 10.1016/S0140-6736(16)31140-0; Sullivan LE, 2005, AM J MED, V118, P330, DOI 10.1016/j.amjmed.2005.01.007; Willenbring ML, 2009, AM FAM PHYSICIAN, V80, P44	20	2	2	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					133	135		10.1016/S0140-6736(16)32566-1	http://dx.doi.org/10.1016/S0140-6736(16)32566-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	27988138	hybrid, Green Submitted			2022-12-28	WOS:000392117600006
J	Dello Russo, N				Dello Russo, N.			More than a day in the life of a comet	SCIENCE			English	Editorial Material							SURFACE; HST		[Dello Russo, N.] Johns Hopkins Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Dello Russo, N (corresponding author), Johns Hopkins Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	neil.dello.russo@jhuapl.edu	Russo, Neil Dello/G-2727-2015	Russo, Neil Dello/0000-0002-8379-7304				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; Filacchione G, 2016, SCIENCE, V354, P1563, DOI 10.1126/science.aag3161; Fornasier S, 2016, SCIENCE, V354, P1566, DOI 10.1126/science.aag2671; KELLER HU, 1988, NATURE, V331, P227, DOI 10.1038/331227a0; Montalto M, 2008, ASTRON ASTROPHYS, V479, pL45, DOI 10.1051/0004-6361:20079130; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; WEAVER HA, 1995, SCIENCE, V267, P1282, DOI 10.1126/science.7871424; Weaver HA, 2001, SCIENCE, V292, P1329, DOI 10.1126/science.1058606	10	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1536	1537		10.1126/science.aal1964	http://dx.doi.org/10.1126/science.aal1964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008031				2022-12-28	WOS:000390254300030
J	Molina, M; Janda, K				Molina, Mario; Janda, Kenneth			Ralph J. Cicerone (1943-2016) OBITUARY	NATURE			English	Biographical-Item									[Molina, Mario] Univ Calif San Diego, La Jolla, CA 92093 USA; [Janda, Kenneth] Univ Calif Irvine, Phys Sci, Irvine, CA 92717 USA	University of California System; University of California San Diego; University of California System; University of California Irvine	Molina, M (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	mjmolina@ucsd.edu; kcjanda@uci.edu						CICERONE R, PUBLICATION LIST	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					342	342		10.1038/540342a	http://dx.doi.org/10.1038/540342a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974774	Bronze			2022-12-28	WOS:000389716800021
J	Vujic, A; Mahmoud, AI; Lee, RT				Vujic, Ana; Mahmoud, Ahmed I.; Lee, Richard T.			A Breakdown in Cooperativity Leads to Cardiac Identity Crisis	CELL			English	Editorial Material							CONGENITAL HEART-DISEASE; MUTATIONS; CELLS	Using induced pluripotent stem cells, Ang et al. elucidate how a mutation in the transcription factor GATA4 causes congenital heart disease. They find that, although the recruitment of GATA4 to cardiac super- enhancers is retained, it no longer functions in partnership with another key transcription factor, leading to misexpression of non-cardiomyocyte genes.	[Vujic, Ana; Mahmoud, Ahmed I.; Lee, Richard T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Vujic, Ana; Mahmoud, Ahmed I.; Lee, Richard T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lee, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Lee, RT (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	richard_lee@harvard.edu	Vujic, Ana/GYJ-6199-2022; Vujic, Ana/AAQ-8417-2020	Vujic, Ana/0000-0002-0559-5299; Lee, Richard/0000-0003-4687-1381; Mahmoud, Ahmed/0000-0003-1528-7393				Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Lee RT, 2016, CIRCULATION, V133, P2618, DOI 10.1161/CIRCULATIONAHA.115.019214; Luna-Zurita L, 2016, CELL, V164, P999, DOI 10.1016/j.cell.2016.01.004; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552	11	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1674	1676		10.1016/j.cell.2016.11.056	http://dx.doi.org/10.1016/j.cell.2016.11.056			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984717	Bronze			2022-12-28	WOS:000393114700006
J	Zou, L				Zou, Lee			A Zygotic Checkpoint for Unrepaired Lesions	CELL			English	Editorial Material							COHESIN RING; ATR	DNA demethylation, a process involving DNA repair, is critical for reprogramming of the paternal genome during the oocyte-to-zygote transition. A new study by Ladstatter and Tachibana-Konwalski shows that a Chk1-mediated zygotic checkpoint monitors the cohesin-dependent repair of DNA lesions arising from DNA demethylation, which prevents zygotes carrying unrepaired lesions from entering mitosis.	[Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp, MGH Canc Ctr, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, MGH Canc Ctr, Charlestown, MA 02129 USA.; Zou, L (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu						Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu N, 2012, GENE DEV, V26, P1473, DOI 10.1101/gad.193615.112; Yazinski SA, 2016, ANNU REV GENET, V50, P155, DOI 10.1146/annurev-genet-121415-121658	9	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1676	1678		10.1016/j.cell.2016.11.049	http://dx.doi.org/10.1016/j.cell.2016.11.049			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984718	Bronze			2022-12-28	WOS:000393114700007
J	Asch, DA; Rosin, R				Asch, David A.; Rosin, Roy			Engineering Social Incentives for Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED-TRIAL; FINANCIAL INCENTIVES		[Asch, David A.; Rosin, Roy] Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Asch, DA (corresponding author), Univ Penn, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA.; Asch, DA (corresponding author), Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA.			Asch, David/0000-0002-7970-286X				Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Patel MS, 2016, J GEN INTERN MED, V31, P746, DOI 10.1007/s11606-016-3627-0; Troxel AB, 2016, AM HEART J, V179, P166, DOI 10.1016/j.ahj.2016.06.006	5	33	33	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2511	2513		10.1056/NEJMp1603978	http://dx.doi.org/10.1056/NEJMp1603978			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	28029924				2022-12-28	WOS:000391175300002
J	Fricker, J				Fricker, Janet			Umberto Veronesi Surgeon who defined modern breast cancer treatment OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												janet.fricker1@btinternet.com						VERONESI U, PUBLICATION LIST, P89615	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2016	355								i6765	10.1136/bmj.i6765	http://dx.doi.org/10.1136/bmj.i6765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CJ	28007705				2022-12-28	WOS:000390921100002
J	Hong, TS; Gray, PJ; Allen, JN; Shellito, PC; Lowry, KP; Zukerberg, LR				Hong, Theodore S.; Gray, Phillip J.; Allen, Jill N.; Shellito, Paul C.; Lowry, Kathryn P.; Zukerberg, Lawrence R.			Case 39-2016: A 74-Year-Old Man with Rectal Bleeding and a History of Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CARCINOMA; RADIOTHERAPY; CHEMOTHERAPY; RADIATION; RISK; CHEMORADIATION; BRACHYTHERAPY; MITOMYCIN		[Hong, Theodore S.; Gray, Phillip J.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Allen, Jill N.] Massachusetts Gen Hosp, Dept Hematol, Boston, MA 02114 USA; [Shellito, Paul C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Lowry, Kathryn P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hong, Theodore S.; Gray, Phillip J.] Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA; [Allen, Jill N.] Harvard Med Sch, Dept Hematol, Boston, MA 02115 USA; [Shellito, Paul C.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Lowry, Kathryn P.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hong, TS (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.; Hong, TS (corresponding author), Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA.							Ajani JA, 2008, JAMA-J AM MED ASSOC, V299, P1914, DOI 10.1001/jama.299.16.1914; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Arnott SJ, 1996, LANCET, V348, P1049; Bartelink H, 1997, J CLIN ONCOL, V15, P2040, DOI 10.1200/JCO.1997.15.5.2040; Bonin SR, 1999, CANCER-AM CANCER SOC, V85, P1226, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1226::AID-CNCR3>3.0.CO;2-B; Gunderson LL, 2012, J CLIN ONCOL, V30, P4344, DOI 10.1200/JCO.2012.43.8085; Hamilton SN, 2014, INT J RADIAT ONCOL, V90, P934, DOI 10.1016/j.ijrobp.2014.07.032; Hinnen KA, 2011, J CLIN ONCOL, V29, P4510, DOI 10.1200/JCO.2011.35.0991; James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106; Kachnic LA, 2013, INT J RADIAT ONCOL, V86, P27, DOI 10.1016/j.ijrobp.2012.09.023; Kerr DA, 2015, AM J SURG PATHOL, V39, P1643, DOI 10.1097/PAS.0000000000000516; Nazarian RM, 2014, AM J SURG PATHOL, V38, P78, DOI 10.1097/PAS.0000000000000111; NIGRO ND, 1983, CANCER, V51, P1826, DOI 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L; Norval M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1495, DOI 10.1562/2006-07-28-IR-987; Surveillance Epidemiology and End Results Program, 2014, SEER CANC STAT REV A; Takam R, 2009, PHYS MED BIOL, V54, P611, DOI 10.1088/0031-9155/54/3/009	16	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2481	2488		10.1056/NEJMcpc1613458	http://dx.doi.org/10.1056/NEJMcpc1613458			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002705				2022-12-28	WOS:000390091500012
J	Feltner, C; Grodensky, C; Ebel, C; Middleton, JC; Harris, RP; Ashok, M; Jonas, DE				Feltner, Cynthia; Grodensky, Catherine; Ebel, Charles; Middleton, Jennifer C.; Harris, Russell P.; Ashok, Mahima; Jonas, Daniel E.			Serologic Screening for Genital Herpes An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SIMPLEX-VIRUS TYPE-2; FOCUS ELISA TESTS; SEROPOSITIVE PERSONS; PSYCHOSOCIAL IMPACT; DAILY VALACYCLOVIR; HSV-2 ANTIBODIES; TRANSMISSION; PERFORMANCE; INFECTION; DIAGNOSIS	IMPORTANCE Genital herpes simplex virus (HSV) infection is a prevalent sexually transmitted infection. Vertical transmission of HSV can lead to fetal morbidity and mortality. OBJECTIVE To assess the evidence on serologic screening and preventive interventions for genital HSV infection in asymptomatic adults and adolescents to support the US Preventive Services Task Force for an updated recommendation statement. DATA SOURCES MEDLINE, Cochrane Library, EMBASE, and trial registries through March 31, 2016. Surveillance for new evidence in targeted publications was conducted through October 31, 2016. STUDY SELECTION English-language randomized clinical trials (RCTs) comparing screening with no screening in persons without past or current symptoms of genital herpes; studies evaluating accuracy and harms of serologic screening tests for HSV-2; RCTs assessing preventive interventions in asymptomatic persons seropositive for HSV-2. DATA EXTRACTION AND SYNTHESIS Dual review of abstracts, full-text articles, and study quality; pooled sensitivities and specificities of screening tests using a hierarchical summary receiver operating characteristic curve analysis when at least 3 similar studies were available. MAIN OUTCOMES AND MEASURES Accuracy of screening tests, benefits of screening, harms of screening, reduction in genital herpes outbreaks. RESULTS A total of 17 studies (n = 9736 participants; range, 24-3290) in 19 publications were included. No RCTs compared screening with no screening. Most studies of the accuracy of screening tests were from populations with high HSV-2 prevalence (greater than 40% based onWestern blot). Pooled estimates of sensitivity and specificity of the most commonly used test at the manufacturer's cutpoint were 99%(95% CI, 97%-100%) and 81%(95% CI, 68%-90%), respectively (10 studies; n = 6537). At higher cutpoints, pooled estimates were 95%(95% CI, 91%-97%) and 89%(95% CI, 82%-93%), respectively (7 studies; n = 5516). Use of this test at the manufacturer's cutpoint in a population of 100 000 with a prevalence of HSV-2 of 16%(the seroprevalence in US adults with unknown symptom status) would result in 15 840 true-positive results and 15 960 false-positive results (positive predictive value, 50%). Serologic screening for genital herpes was associated with psychosocial harms, including distress and anxiety related to positive test results. Four RCTs compared preventive medications with placebo, 2 in nonpregnant asymptomatic adults who were HSV-2 seropositive and 2 in HSV-2-serodiscordant couples. Results in both populations were heterogeneous and inconsistent. CONCLUSIONS AND RELEVANCE Serologic screening for genital herpes is associated with a high rate of false-positive test results and potential psychosocial harms. Evidence from RCTs does not establish whether preventive antiviral medication for asymptomatic HSV-2 infection has benefit.	[Feltner, Cynthia; Grodensky, Catherine; Middleton, Jennifer C.; Harris, Russell P.; Ashok, Mahima; Jonas, Daniel E.] RTI Int Univ North Carolina Chapel Hill, Evidence Based Practice Ctr, Chapel Hill, NC USA; [Feltner, Cynthia; Middleton, Jennifer C.; Harris, Russell P.; Jonas, Daniel E.] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd,CB 7295, Chapel Hill, NC 27599 USA; [Feltner, Cynthia; Harris, Russell P.; Jonas, Daniel E.] Univ North Carolina Chapel Hill, Dept Med, 725 Martin Luther King Jr Blvd,CB 7295, Chapel Hill, NC 27599 USA; [Ebel, Charles; Ashok, Mahima] RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute	Feltner, C (corresponding author), Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd,CB 7295, Chapel Hill, NC 27599 USA.	cindy_feltner@med.unc.edu			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order No. 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Calonge N, 2005, AM FAM PHYSICIAN, V72, P1557; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Golden MR, 2005, SEX TRANSM DIS, V32, P771, DOI 10.1097/01.olq.0000175377.88358.f3; Hogrefe W, 2002, J CLIN MICROBIOL, V40, P3635, DOI 10.1128/JCM.40.10.3635-3640.2002; Kim HN, 2008, SEX TRANSM DIS, V35, P124, DOI 10.1097/OLQ.0b013e31815407d7; LeGoff J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-83; Leone P, 2007, SEX TRANSM DIS, V34, P900, DOI 10.1097/OLQ.0b013e318063c749; Lingappa J, 2010, INT J STD AIDS, V21, P611, DOI 10.1258/ijsa.2009.008477; Mark H, 2008, J AM COLL HEALTH, V56, P291, DOI 10.3200/JACH.57.3.291-296; Mark HD, 2007, SEX TRANSM DIS, V34, P681, DOI 10.1097/01.olq.0000258307.18831.f0; Melville J, 2003, SEX TRANSM INFECT, V79, P280, DOI 10.1136/sti.79.4.280; Morrow RA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-84; Mujugira A, 2013, J INFECT DIS, V208, P1366, DOI 10.1093/infdis/jit333; Mujugira A, 2011, SEX TRANSM INFECT, V87, P238, DOI 10.1136/sti.2010.047415; Ng'ayo MO, 2010, J VIROL METHODS, V163, P276, DOI 10.1016/j.jviromet.2009.10.009; Patel R, 2009, SEXUALLY TRANSMITTED, P165; Rosenthal SL, 2006, SEX TRANSM INFECT, V82, P154, DOI 10.1136/sti.2005.016311; Sacks SL, 2004, J INFECT DIS, V189, P1341, DOI 10.1086/383038; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Sperling RS, 2008, SEX TRANSM DIS, V35, P286, DOI 10.1097/OLQ.0b013e31815b0132; StataCorp, 2015, STAT STAT SOFTW REL; Trinquart L, 2014, COCHRANE DB SYST REV, V8; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; West SL., 2010, COMP EFFECTIVENESS R; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; Wild D, 1995, QUAL LIFE RES, V4, P532, DOI 10.1007/BF00634748; Workowski KA, 2015, CLIN INFECT DIS, V61, pS759, DOI 10.1093/cid/civ771	33	22	23	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2531	2543		10.1001/jama.2016.17138	http://dx.doi.org/10.1001/jama.2016.17138			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997660				2022-12-28	WOS:000390959300021
J	Friedrich, MJ				Friedrich, M. J.			Boosting Breastfeeding Practices in Vietnam and Bangladesh	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2473	2473		10.1001/jama.2016.18560	http://dx.doi.org/10.1001/jama.2016.18560			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997666				2022-12-28	WOS:000390959300006
J	Sklaroff, RB				Sklaroff, Robert B.			Curbing Firearm Violence	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sklaroff, Robert B.] Nazareth Hosp, Philadelphia, PA 19152 USA		Sklaroff, RB (corresponding author), Nazareth Hosp, Philadelphia, PA 19152 USA.							[Anonymous], 2016, SCRIPTED BLOG; Sklaroff RB, 2014, ANN INTERN MED, V160, P876, DOI 10.7326/L14-5012-2; Weinberger SE, 2016, ANN INTERN MED, V165, P221, DOI 10.7326/M16-0968; Wintemute GJ, 2016, ANN INTERN MED, V165, P205, DOI 10.7326/M15-2905	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					893	894		10.7326/L16-0541	http://dx.doi.org/10.7326/L16-0541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992907				2022-12-28	WOS:000391236900032
J	Elsworth, D; Spiers, CJ; Niemeijer, AR				Elsworth, Derek; Spiers, Christopher J.; Niemeijer, Andre R.			Understanding induced seismicity	SCIENCE			English	Editorial Material							FLUID-INJECTION; INCREASE		[Elsworth, Derek] Penn State Univ, Ctr G3, Energy & Mineral Engn & Geosci, University Pk, PA 16802 USA; [Elsworth, Derek] Penn State Univ, EMS Energy Inst, University Pk, PA 16802 USA; [Spiers, Christopher J.; Niemeijer, Andre R.] Univ Utrecht, Dept Earth Sci, HPT Lab, Budapestlaan 4, NL-3484 CD Utrecht, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Utrecht University	Elsworth, D (corresponding author), Penn State Univ, Ctr G3, Energy & Mineral Engn & Geosci, University Pk, PA 16802 USA.; Elsworth, D (corresponding author), Penn State Univ, EMS Energy Inst, University Pk, PA 16802 USA.	elsworth@psu.edu	Elsworth, Derek/D-2844-2015; Niemeijer, Andre/AHE-5571-2022; Niemeijer, Andre/W-5388-2019	Elsworth, Derek/0000-0002-4942-1151; Niemeijer, Andre/0000-0003-3983-9308; Spiers, Christopher/0000-0002-3436-8941				[Anonymous], 2009, NY TIMES; Bao XW, 2016, SCIENCE, V354, P1406, DOI 10.1126/science.aag2583; Egan Matt, 2016, CNN MONEY; Keranen KM, 2014, SCIENCE, V345, P448, DOI 10.1126/science.1255802; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; McJeon H, 2014, NATURE, V514, P482, DOI 10.1038/nature13837; Shirzaei M, 2016, SCIENCE, V353, P1416, DOI 10.1126/science.aag0262; van der Elst NJ, 2013, SCIENCE, V341, P164, DOI 10.1126/science.1238948; Weingarten M, 2015, SCIENCE, V348, P1336, DOI 10.1126/science.aab1345	9	102	108	7	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1380	1381		10.1126/science.aal2584	http://dx.doi.org/10.1126/science.aal2584			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980173				2022-12-28	WOS:000390261300022
J	Kupferschmidt, K				Kupferschmidt, Kai			INFECTIOUS DISEASE New bird flu strain brings death and questions	SCIENCE			English	News Item																			0	4	4	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1363	1364		10.1126/science.354.6318.1363	http://dx.doi.org/10.1126/science.354.6318.1363			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980165				2022-12-28	WOS:000390261300014
J	Grabocka, E; Bar-Sagi, D				Grabocka, Elda; Bar-Sagi, Dafna			Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules	CELL			English	Article							NON-ONCOGENE ADDICTION; HUMAN COLON-CANCER; K-RAS MUTATIONS; COLORECTAL-CANCER; LUNG-CANCER; PROCESSING BODIES; PHASE-II; CYCLOOXYGENASE-2; RESISTANCE; INHIBITOR	There is growing evidence that stress-coping mechanisms represent tumor cell vulnerabilities that may function as therapeutically beneficial targets. Recent work has delineated an integrated stress adaptation mechanism that is characterized by the formation of cytoplasmic mRNA and protein foci, termed stress granules (SGs). Here, we demonstrate that SGs are markedly elevated in mutant KRAS cells following exposure to stress-inducing stimuli. The upregulation of SGs by mutant KRAS is dependent on the production of the signaling lipid molecule 15-deoxy-delta 12,14 prostaglandin J2 (15-d-PGJ2) and confers cytoprotection against stress stimuli and chemotherapeutic agents. The secretion of 15-d-PGJ2 by mutant KRAS cells is sufficient to enhance SG formation and stress resistance in cancer cells that are wild-type for KRAS. Our findings identify a mutant KRAS-dependent cell non-autonomous mechanism that may afford the establishment of a stress-resistant niche that encompasses different tumor subclones. These results should inform the design of strategies to eradicate tumor cell communities.	[Grabocka, Elda; Bar-Sagi, Dafna] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Grabocka, Elda] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, 233 South 10th St,BLSB 1002, Philadelphia, PA 19107 USA	New York University; Jefferson University	Bar-Sagi, D (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA.	dafna.bar-sagi@nyumc.org		Bar-Sagi, Dafna/0000-0003-2597-8948; Grabocka, E/0000-0001-7196-8498	Cancer Center Support at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NIH [R01CA055360, 1F32CA13922]; NATIONAL CANCER INSTITUTE [R01CA055360, P30CA016087, F32CA139922] Funding Source: NIH RePORTER	Cancer Center Support at the Laura and Isaac Perlmutter Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The New York University Langone Medical Center (NYULMC) Office of Collaborative Science Cytometry Core and Histology Core are shared resources partially supported by Cancer Center Support grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. This work was supported by NIH grants R01CA055360 (to D.B.-S.) and 1F32CA13922 (to E.G.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adjibade P, 2015, ONCOTARGET, V6, P43927, DOI 10.18632/oncotarget.5980; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta.14320, 10.3310/hta14320]; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dieterle CP, 2004, CLIN CANCER RES, V10, P641, DOI 10.1158/1078-0432.CCR-1355-02; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Edelman MJ, 2015, J CLIN ONCOL, V33, P189, DOI 10.1200/JCO.2014.55.5789; Faber AC, 2014, CANCER DISCOV, V4, P42, DOI 10.1158/2159-8290.CD-13-0315; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Grana TM, 2002, CANCER RES, V62, P4142; Han K, 2011, ANAL BIOCHEM, V417, P211, DOI 10.1016/j.ab.2011.06.030; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoang B, 2006, BLOOD, V107, P4484, DOI 10.1182/blood-2005-09-3926; Hobor S, 2014, CLIN CANCER RES, V20, P6429, DOI 10.1158/1078-0432.CCR-14-0774; Huss D, 2015, DEVELOPMENT, V142, P2850, DOI 10.1242/dev.121392; Kaehler C, 2014, NUCLEIC ACIDS RES, V42, P6436, DOI 10.1093/nar/gku264; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kopetz S, 2015, J CLIN ONCOL, V33, P4032, DOI 10.1200/JCO.2015.63.2497; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Perez K, 2013, EXP MOL PATHOL, V95, P74, DOI 10.1016/j.yexmp.2013.01.004; Pham H, 2008, MOL CARCINOGEN, V47, P466, DOI 10.1002/mc.20404; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Richman SD, 2011, ANAL CELL PATHOL, V34, P61, DOI [10.1155/2011/393521, 10.3233/ACP-2011-0005]; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; Sheng HM, 2001, CANCER RES, V61, P2670; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Wang L., 2008, Experimental Oncology, V30, P42; WANG ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI [DOI 10.1038/nrgastro.2010.188, DOI 10.1038/NRGASTRO.2010.188]; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	58	86	87	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1803	+		10.1016/j.cell.2016.11.035	http://dx.doi.org/10.1016/j.cell.2016.11.035			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984728	Bronze, Green Accepted			2022-12-28	WOS:000393114700018
J	Patrick, JF; Robb, MJ; Sottos, NR; Moore, JS; White, SR				Patrick, Jason F.; Robb, Maxwell J.; Sottos, Nancy R.; Moore, Jeffrey S.; White, Scott R.			Polymers with autonomous life-cycle control	NATURE			English	Review							SELF-HEALING COMPOSITE; COVALENT BONDS; MECHANICAL PERFORMANCE; DAMAGE; MICROCAPSULES; RESTORATION; MICROENCAPSULATION; VISUALIZATION; TEMPERATURE; ACTIVATION	The lifetime of man-made materials is controlled largely by the wear and tear of everyday use, environmental stress and unexpected damage, which ultimately lead to failure and disposal. Smart materials that mimic the ability of living systems to autonomously protect, report, heal and even regenerate in response to damage could increase the lifetime, safety and sustainability of many manufactured items. There are several approaches to achieving these functions using polymer-based materials, but making them work in highly variable, real-world situations is proving challenging.	[Patrick, Jason F.; Robb, Maxwell J.; Sottos, Nancy R.; Moore, Jeffrey S.; White, Scott R.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Robb, Maxwell J.; Moore, Jeffrey S.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Sottos, Nancy R.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [White, Scott R.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	White, SR (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	swhite@illinois.edu	White, Scott/G-9667-2013; Patrick, Jason/J-5125-2015	White, Scott/0000-0002-0831-9097; Moore, Jeffrey/0000-0001-5841-6269; Patrick, Jason/0000-0003-4378-0812	Arnold and Mabel Beckman Foundation through the Beckman Institute Postdoctoral Fellowship Program; Air Force Office of Scientific Research through the Center of Excellence in Self-Healing, Regeneration, and Structural Remodeling; National Science Foundation [DMR 1307354]; Defense Advanced Research Project Agency [FA8650-13-C-7347]; BP International Center for Advanced Materials (ICAM); Direct For Mathematical & Physical Scien [1307354] Funding Source: National Science Foundation	Arnold and Mabel Beckman Foundation through the Beckman Institute Postdoctoral Fellowship Program; Air Force Office of Scientific Research through the Center of Excellence in Self-Healing, Regeneration, and Structural Remodeling(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); BP International Center for Advanced Materials (ICAM); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.F.P. and M.J.R. are grateful to the Arnold and Mabel Beckman Foundation for financial support through the Beckman Institute Postdoctoral Fellowship Program. The authors thank the Air Force Office of Scientific Research for support through the Center of Excellence in Self-Healing, Regeneration, and Structural Remodeling, the National Science Foundation (DMR 1307354), the Defense Advanced Research Project Agency (FA8650-13-C-7347) and the BP International Center for Advanced Materials (ICAM). We are grateful to D. Loudermilk, C. Klinger, A. Jerez and I. Patrick for assistance with graphics, and G. Wilson and M. Andersson for insightful discussions.	Baginska M, 2012, ADV ENERGY MATER, V2, P583, DOI 10.1002/aenm.201100683; Baker MS, 2015, GREEN CHEM, V17, P4541, DOI 10.1039/c5gc01090j; BaLazs AC, 2007, MATER TODAY, V10, P18, DOI 10.1016/S1369-7021(07)70205-5; Berkowski KL, 2005, MACROMOLECULES, V38, P8975, DOI 10.1021/ma051394n; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Blaiszik BJ, 2012, ADV MATER, V24, P398, DOI 10.1002/adma.201102888; Bluhm J, 2015, ARCH APPL MECH, V85, P1469, DOI 10.1007/s00419-014-0946-7; Borisova D, 2011, ACS NANO, V5, P1939, DOI 10.1021/nn102871v; Brochu ABW, 2014, J BIOMED MATER RES B, V102, P181, DOI 10.1002/jbm.b.32994; Brochu ABW, 2012, J BIOMED MATER RES B, V100B, P1764, DOI 10.1002/jbm.b.32743; Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987; Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc; Burnworth M, 2011, NATURE, V472, P334, DOI 10.1038/nature09963; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Chen YL, 2012, NAT CHEM, V4, P559, DOI [10.1038/nchem.1358, 10.1038/NCHEM.1358]; Coppola AM, 2015, COMPOS PART A-APPL S, V78, P412, DOI 10.1016/j.compositesa.2015.07.012; Coppola AM, 2014, COMPOS PART A-APPL S, V59, P9, DOI 10.1016/j.compositesa.2013.12.006; Cordier P, 2008, NATURE, V451, P977, DOI 10.1038/nature06669; Corten CC, 2009, ADV MATER, V21, P5011, DOI 10.1002/adma.200901940; Cui JX, 2015, NAT MATER, V14, P790, DOI [10.1038/NMAT4325, 10.1038/nmat4325]; Das A, 2015, ACS APPL MATER INTER, V7, P20623, DOI 10.1021/acsami.5b05041; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Denissen W, 2016, CHEM SCI, V7, P30, DOI 10.1039/c5sc02223a; Diesendruck CE, 2015, ANGEW CHEM INT EDIT, V54, P10428, DOI 10.1002/anie.201500484; Diesendruck CE, 2014, NAT CHEM, V6, P624, DOI [10.1038/nchem.1938, 10.1038/NCHEM.1938]; Diesendruck CE, 2012, J AM CHEM SOC, V134, P12446, DOI 10.1021/ja305645x; Dry C, 1996, COMPOS STRUCT, V35, P263, DOI 10.1016/0263-8223(96)00033-5; Esser-Kahn AP, 2011, ADV MATER, V23, P3654, DOI 10.1002/adma.201100933; Esser-Kahn AP, 2010, J AM CHEM SOC, V132, P10266, DOI 10.1021/ja104812p; Garcia SJ, 2011, PROG ORG COAT, V72, P211, DOI 10.1016/j.porgcoat.2011.06.016; Gergely RCR, 2015, ADV FUNCT MATER, V25, P1043, DOI 10.1002/adfm.201403670; Gladman AS, 2016, NAT MATER, V15, P413, DOI [10.1038/NMAT4544, 10.1038/nmat4544]; Gladman AS, 2015, ADV HEALTHC MATER, V4, P202, DOI 10.1002/adhm.201400084; Gossweiler GR, 2014, ACS MACRO LETT, V3, P216, DOI 10.1021/mz500031q; Gupta S, 2006, NAT MATER, V5, P229, DOI 10.1038/nmat1582; Hamilton AR, 2010, ADV MATER, V22, P5159, DOI 10.1002/adma.201002561; Han J.C., 2012, GAS TURBINE HEAT TRA; Hansen CJ, 2011, ADV FUNCT MATER, V21, P4320, DOI 10.1002/adfm.201101553; Hansen CJ, 2009, ADV MATER, V21, P4143, DOI 10.1002/adma.200900588; Hartl DJ, 2016, COMPOS STRUCT, V143, P242, DOI 10.1016/j.compstruct.2016.01.106; Hayes SA, 2007, COMPOS PART A-APPL S, V38, P1116, DOI 10.1016/j.compositesa.2006.06.008; Hentschel J, 2012, ANGEW CHEM INT EDIT, V51, P10561, DOI 10.1002/anie.201204840; Hernandez HL, 2014, ADV MATER, V26, P7637, DOI 10.1002/adma.201403045; Hickenboth CR, 2007, NATURE, V446, P423, DOI 10.1038/nature05681; Hopewell J, 2009, PHILOS T R SOC B, V364, P2115, DOI 10.1098/rstb.2008.0311; Huang CY, 2010, J R SOC INTERFACE, V7, P1229, DOI 10.1098/rsif.2009.0534; Huang MX, 2011, J MATER CHEM, V21, P11123, DOI 10.1039/c1jm10794a; Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325; Imato K, 2012, ANGEW CHEM INT EDIT, V51, P1138, DOI 10.1002/anie.201104069; Jin HH, 2014, ADV MATER, V26, P282, DOI 10.1002/adma.201303179; Jones AS, 2007, J R SOC INTERFACE, V4, P395, DOI 10.1098/rsif.2006.0199; Jones AS, 2010, MECH MATER, V42, P481, DOI 10.1016/j.mechmat.2010.02.002; Kang S, 2015, ACS APPL MATER INTER, V7, P10952, DOI 10.1021/acsami.5b02169; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Kim B, 2015, LANGMUIR, V31, P6027, DOI 10.1021/acs.langmuir.5b01129; Kim H, 2015, ANGEW CHEM INT EDIT, V54, P13063, DOI 10.1002/anie.201506511; Kousourakis A, 2006, COMPOS STRUCT, V75, P610, DOI 10.1016/j.compstruct.2006.04.086; Latnikova A, 2011, SOFT MATTER, V7, P369, DOI 10.1039/c0sm00842g; Lavrenova A, 2015, ACS APPL MATER INTER, V7, P21828, DOI 10.1021/acsami.5b05797; Li J, 2015, ACCOUNTS CHEM RES, V48, P2181, DOI 10.1021/acs.accounts.5b00184; Li WL, 2016, ADV MATER, V28, P2189, DOI 10.1002/adma.201505214; Lowe C, 2002, ADV MATER, V14, P1625, DOI 10.1002/1521-4095(20021118)14:22<1625::AID-ADMA1625>3.0.CO;2-Q; Lu YX, 2012, J AM CHEM SOC, V134, P8424, DOI 10.1021/ja303356z; Maiti S, 2006, J ENG MATER-T ASME, V128, P595, DOI 10.1115/1.2345452; Montarnal D, 2011, SCIENCE, V334, P965, DOI 10.1126/science.1212648; Murphy EB, 2010, PROG POLYM SCI, V35, P223, DOI 10.1016/j.progpolymsci.2009.10.006; Nie ZH, 2005, J AM CHEM SOC, V127, P8058, DOI 10.1021/ja042494w; Norris CJ, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/9/094027; Norris CJ, 2011, ADV FUNCT MATER, V21, P3624, DOI 10.1002/adfm.201101100; Odom SA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737935; Odom SA, 2012, ADV MATER, V24, P2578, DOI 10.1002/adma.201200196; Odom SA, 2011, ACS APPL MATER INTER, V3, P4547, DOI 10.1021/am201048a; Odom SA, 2010, ADV FUNCT MATER, V20, P1721, DOI 10.1002/adfm.201000159; Pang JWC, 2005, COMPOS SCI TECHNOL, V65, P1791, DOI 10.1016/j.compscitech.2005.03.008; Park CW, 2015, ADV MATER, V27, P3783, DOI 10.1002/adma.201501180; Patrick JF, 2014, ADV MATER, V26, P4302, DOI 10.1002/adma.201400248; Peterson GI, 2015, ACS APPL MATER INTER, V7, P577, DOI 10.1021/am506745m; Piermattei A, 2009, NAT CHEM, V1, P133, DOI [10.1038/NCHEM.167, 10.1038/nchem.167]; Ramirez ALB, 2013, NAT CHEM, V5, P757, DOI [10.1038/NCHEM.1720, 10.1038/nchem.1720]; Rebitzer G, 2004, ENVIRON INT, V30, P701, DOI 10.1016/j.envint.2003.11.005; Robb MJ, 2016, ACS CENTRAL SCI, V2, P598, DOI 10.1021/acscentsci.6b00198; Scott TF, 2005, SCIENCE, V308, P1615, DOI 10.1126/science.1110505; Selvakumar N, 2012, PROG ORG COAT, V74, P461, DOI 10.1016/j.porgcoat.2012.01.011; Shchukin D, 2013, SCIENCE, V341, P1458, DOI 10.1126/science.1242895; Shchukin DG, 2013, POLYM CHEM-UK, V4, P4871, DOI 10.1039/c3py00082f; Simon Y. C., MECHANOCHEM IN PRESS; Soghrati S, 2013, INT J HEAT MASS TRAN, V65, P153, DOI 10.1016/j.ijheatmasstransfer.2013.05.054; Tee BCK, 2012, NAT NANOTECHNOL, V7, P825, DOI [10.1038/nnano.2012.192, 10.1038/NNANO.2012.192]; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Toohey KS, 2007, NAT MATER, V6, P581, DOI 10.1038/nmat1934; Trask RS, 2010, J R SOC INTERFACE, V7, P921, DOI 10.1098/rsif.2009.0420; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; van den Dungen ETA, 2010, MACROMOL RAPID COMM, V31, P625, DOI 10.1002/marc.200900728; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; White SR, 2014, SCIENCE, V344, P620, DOI 10.1126/science.1251135; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447; Wu Y, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.154, 10.1038/nenergy.2016.154]; Yoon JA, 2012, MACROMOLECULES, V45, P142, DOI 10.1021/ma2015134; Zhang MQ, 2012, J POLYM SCI POL PHYS, V50, P229, DOI 10.1002/polb.22387	102	222	233	24	577	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					363	370		10.1038/nature21002	http://dx.doi.org/10.1038/nature21002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974778				2022-12-28	WOS:000389716800030
J	Someya, T; Bao, ZN; Malliaras, GG				Someya, Takao; Bao, Zhenan; Malliaras, George G.			The rise of plastic bioelectronics	NATURE			English	Review							FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; ORGANIC ELECTROCHEMICAL TRANSISTOR; ELECTRICALLY CONDUCTING POLYMER; LARGE-AREA; IN-VIVO; ELASTIC CONDUCTORS; NEURAL INTERFACES; SKIN APPLICATIONS; CARBON NANOTUBES	Plastic bioelectronics is a research field that takes advantage of the inherent properties of polymers and soft organic electronics for applications at the interface of biology and electronics. The resulting electronic materials and devices are soft, stretchable and mechanically conformable, which are important qualities for interacting with biological systems in both wearable and implantable devices. Work is currently aimed at improving these devices with a view to making the electronic-biological interface as seamless as possible.	[Someya, Takao] Univ Tokyo, Dept Elect & Elect Engn, Tokyo 1138656, Japan; [Someya, Takao] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Malliaras, George G.] Ecole Natl Super Mines, CMP EMSE, MOC, Dept Bioelect, F-13541 Gardanne, France	University of Tokyo; RIKEN; Stanford University; IMT - Institut Mines-Telecom; Mines Saint-Etienne	Someya, T (corresponding author), Univ Tokyo, Dept Elect & Elect Engn, Tokyo 1138656, Japan.; Someya, T (corresponding author), RIKEN, CEMS, Wako, Saitama 3510198, Japan.	someya@ee.t.u-tokyo.ac.jp	Malliaras, George/HDM-2006-2022; Someya, Takao/H-3052-2015; Bao, Zhenan/AAC-5044-2019	Malliaras, George/0000-0002-4582-8501; Someya, Takao/0000-0003-3051-1138; Bao, Zhenan/0000-0002-0972-1715				Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; [Anonymous], 2013, NAT MATER, V12, P591, DOI 10.1038/nmat3707; Asplund M, 2010, POLYM CHEM-UK, V1, P1374, DOI 10.1039/c0py00077a; Benight SJ, 2013, PROG POLYM SCI, V38, P1961, DOI 10.1016/j.progpolymsci.2013.08.001; Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Bredas J.L., 2016, WSPC REFERENCE ORGAN; Buchko CJ, 2000, J MATER RES, V15, P231, DOI 10.1557/JMR.2000.0038; Campana A, 2014, ADV MATER, V26, P3874, DOI 10.1002/adma.201400263; Chortos A, 2016, ADV MATER, V28, P4441, DOI 10.1002/adma.201501828; Crawford GP, 2005, WILEY-SID SER DISPL, P1, DOI 10.1002/0470870508; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Fitzpatrick, 2015, IMPLANTABLE ELECT ME; Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303; Fukuda K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5147; Gamota D. R., 2013, PRINTED ORGANIC MOL; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Ghezzi D, 2013, NAT PHOTONICS, V7, P400, DOI [10.1038/nphoton.2013.34, 10.1038/NPHOTON.2013.34]; Gong CK, 2013, ADV MATER, V25, P4186, DOI 10.1002/adma.201301069; Green R, 2015, ADV MATER, V27, P7620, DOI 10.1002/adma.201501810; Groenendaal BL, 2000, ADV MATER, V12, P481, DOI 10.1002/(SICI)1521-4095(200004)12:7<481::AID-ADMA481>3.0.CO;2-C; Hassarati RT, 2016, J BIOMED MATER RES B, V104, P712, DOI 10.1002/jbm.b.33497; Huang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039526; Hwang SW, 2014, ADV MATER, V26, P3905, DOI 10.1002/adma.201306050; Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d; Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6; Irimia-Vladu M, 2012, ADV MATER, V24, P375, DOI 10.1002/adma.201102619; Jeon J, 2013, ADV MATER, V25, P850, DOI 10.1002/adma.201204082; Jonsson A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500039; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Kaltenbrunner M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1772; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3133; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2573; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim Y, 2013, NATURE, V500, P59, DOI 10.1038/nature12401; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Kuammel Martin., 2007, KONSONANTENWANDEL; Lay-Ekuakille A., 2010, WEARABLE AUTONOMOUS; Lee K, 2006, NATURE, V441, P65, DOI 10.1038/nature04705; Liang JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8647; Liao CZ, 2015, ADV MATER, V27, P7493, DOI 10.1002/adma.201402625; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Lipomi DJ, 2011, ENERG ENVIRON SCI, V4, P3314, DOI 10.1039/c1ee01881g; Lipomi DJ, 2011, ADV MATER, V23, P1771, DOI 10.1002/adma.201004426; Lochner CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6745; Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007; Luo C, 2014, NANO LETT, V14, P2764, DOI 10.1021/nl500758w; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Martin DC, 2016, CHEMELECTROCHEM, V3, P686, DOI 10.1002/celc.201500555; Matsuhisa N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8461; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Mulla MY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7010; Myny K, 2012, IEEE J SOLID-ST CIRC, V47, P284, DOI 10.1109/JSSC.2011.2170635; Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329; O'Connor B, 2010, ACS NANO, V4, P7538, DOI 10.1021/nn1018768; Oh JY, 2016, ADV MATER, V28, P4455, DOI [10.1002/adma.201502947, 10.1002/adma.201670155]; Ouyang LQ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026005; Park DW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6258; Park M, 2012, NAT NANOTECHNOL, V7, P803, DOI [10.1038/nnano.2012.206, 10.1038/NNANO.2012.206]; Qiu FM, 2015, ADV FUNCT MATER, V25, P1666, DOI 10.1002/adfm.201403891; Ramuz M, 2015, J MATER CHEM B, V3, P5971, DOI 10.1039/c5tb00922g; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E; Rivnay J, 2014, CHEM MATER, V26, P679, DOI 10.1021/cm4022003; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Savagatrup S, 2014, CHEM MATER, V26, P3028, DOI 10.1021/cm501021v; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Shackelford J.F., 2016, CRC MAT SCI ENG HDB, DOI [10.1201/b18971, DOI 10.1201/B18971]; Shin M, 2014, ADV MATER, V26, P3706, DOI 10.1002/adma.201400009; Simon DT, 2009, NAT MATER, V8, P742, DOI [10.1038/NMAT2494, 10.1038/nmat2494]; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Someya T, 2013, IEEE SPECTRUM, V50, P50, DOI 10.1109/MSPEC.2013.6587191; Subramanian V, 2005, P IEEE, V93, P1330, DOI 10.1109/JPROC.2005.850305; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111; Tee BCK, 2015, SCIENCE, V350, P313, DOI 10.1126/science.aaa9306; Tee BCK, 2012, NAT NANOTECHNOL, V7, P825, DOI [10.1038/nnano.2012.192, 10.1038/NNANO.2012.192]; Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692; Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P307, DOI 10.1109/TNSRE.2011.2109399; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775; Wallace GG, 2009, SCIENCE, V324, P185, DOI 10.1126/science.1168346; Wallace GG, 2010, P SOC PHOTO-OPT INS, V7642, DOI 10.1117/12.865989; Wan AMD, 2015, J MATER CHEM B, V3, P5040, DOI 10.1039/c5tb00390c; Wang C, 2013, NAT CHEM, V5, P1042, DOI [10.1038/nchem.1802, 10.1038/NCHEM.1802]; Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/NMAT3755, 10.1038/nmat3755]; Wessling B, 2010, POLYMERS-BASEL, V2, P786, DOI 10.3390/polym2040786; White MS, 2013, NAT PHOTONICS, V7, P811, DOI [10.1038/NPHOTON.2013.188, 10.1038/nphoton.2013.188]; Williams KA, 2007, J R SOC INTERFACE, V4, P359, DOI 10.1098/rsif.2006.0202; Williamson A, 2015, ADV MATER, V27, P3138, DOI 10.1002/adma.201500482; WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201; Worfolk BJ, 2015, P NATL ACAD SCI USA, V112, P14138, DOI 10.1073/pnas.1509958112; Xu LZ, 2015, ADV MATER, V27, P1731, DOI 10.1002/adma.201405017; Xu S, 2014, SCIENCE, V344, P70, DOI 10.1126/science.1250169; Yang Y, 2013, CHEM SOC REV, V42, P7446, DOI 10.1039/c3cs60109a; Yokota T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501856; Yokota T, 2015, P NATL ACAD SCI USA, V112, P14533, DOI 10.1073/pnas.1515650112; Yu KJ, 2016, NAT MATER, V15, P782, DOI [10.1038/nmat4624, 10.1038/NMAT4624]; Yuan YB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4005; Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001	107	949	959	81	1168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					379	385		10.1038/nature21004	http://dx.doi.org/10.1038/nature21004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974769				2022-12-28	WOS:000389716800032
J	Markt, SC; Nuttall, E; Turman, C; Sinnott, J; Rimm, EB; Ecsedy, E; Unger, RH; Fall, K; Finn, S; Jensen, MK; Rider, JR; Kraft, P; Mucci, LA				Markt, Sarah C.; Nuttall, Elizabeth; Turman, Constance; Sinnott, Jennifer; Rimm, Eric B.; Ecsedy, Ethan; Unger, Robert H.; Fall, Katja; Finn, Stephen; Jensen, Majken K.; Rider, Jennifer R.; Kraft, Peter; Mucci, Lorelei A.			Sniffing out significant "Pee values": genome wide association study of asparagus anosmia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ODOR; ABILITY; FOLATE; DIET; RISK; SEX	OBJECTIVE To determine the inherited factors associated with the ability to smell asparagus metabolites in urine. DESIGN Genome wide association study. SETTING Nurses' Health Study and Health Professionals Follow-up Study cohorts. PARTICIPANTS 6909 men and women of European-American descent with available genetic data from genome wide association studies. MAIN OUTCOME MEASURE Participants were characterised as asparagus smellers if they strongly agreed with the prompt "after eating asparagus, you notice a strong characteristic odor in your urine," and anosmic if otherwise. We calculated per-allele estimates of asparagus anosmia for about nine million single nucleotide polymorphisms using logistic regression. P values <5x10(-8) were considered as genome wide significant. RESULTS 58.0% of men (n=1449/2500) and 61.5% of women (n=2712/4409) had anosmia. 871 single nucleotide polymorphisms reached genome wide significance for asparagus anosmia, all in a region on chromosome 1 (1q44: 248139851-248595299) containing multiple genes in the olfactory receptor 2 (OR2) family. Conditional analyses revealed three independent markers associated with asparagus anosmia: rs13373863, rs71538191, and rs6689553. CONCLUSION A large proportion of people have asparagus anosmia. Genetic variation near multiple olfactory receptor genes is associated with the ability of an individual to smell the metabolites of asparagus in urine. Future replication studies are necessary before considering targeted therapies to help anosmic people discover what they are missing.	[Markt, Sarah C.; Nuttall, Elizabeth; Sinnott, Jennifer; Rimm, Eric B.; Unger, Robert H.; Fall, Katja; Rider, Jennifer R.; Kraft, Peter; Mucci, Lorelei A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA; [Rimm, Eric B.; Jensen, Majken K.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Turman, Constance; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA USA; [Sinnott, Jennifer] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Rimm, Eric B.; Jensen, Majken K.; Mucci, Lorelei A.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Ecsedy, Ethan] Cabot Sch, Newton, MA USA; [Fall, Katja] Univ Orebro, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Fall, Katja; Mucci, Lorelei A.] Univ Iceland, Div Publ Hlth Sci, Reykjavik, Iceland; [Finn, Stephen] Trinity Coll Dublin, Dept Pathol, Dublin, Ireland; [Rider, Jennifer R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Orebro University; University of Iceland; Trinity College Dublin; Boston University	Mucci, LA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.; Mucci, LA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA.; Mucci, LA (corresponding author), Univ Iceland, Div Publ Hlth Sci, Reykjavik, Iceland.	lmucci@hsph.harvard.edu	Rider, Jennifer/T-1272-2019; Markt, Sarah/O-7554-2019; Fall, Katja/AAE-1876-2021; Finn, Stephen/V-3236-2019; Kraft, Peter/GQH-8448-2022	Rider, Jennifer/0000-0002-2637-6036; Markt, Sarah/0000-0003-2873-0358; Fall, Katja/0000-0002-3649-2639; Finn, Stephen/0000-0002-8628-5814; Jensen, Majken Karoline/0000-0003-4729-7545; Kraft, Peter/0000-0002-4472-8103; Unger, Robert/0000-0001-7047-5456	National Cancer Institute at the National Institutes of Health (NIH) [UM1 CA167552, R01 HL35464, UM1 CA186107, R01 CA49449, R01 HL034594, R01 HL088521]; National Cancer Institute at the NIH [NIH T32 CA09001]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA009001] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health (NIH); National Cancer Institute at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the National Cancer Institute at the National Institutes of Health (NIH) (UM1 CA167552, R01 HL35464, UM1 CA186107, R01 CA49449, R01 HL034594, R01 HL088521); National Cancer Institute at the NIH training grant (NIH T32 CA09001 to SCM); and the Prostate Cancer Foundation (to LAM and JRR).	al-Nafzawi M, PERFUMED GARDEN SENS; ALLISON AC, 1956, NATURE, V178, P748, DOI 10.1038/178748c0; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Franklin B, 2003, FART PROUDLY WRITING; Franklin B, 1781, COMMUNICATION; GILBERT AN, 1989, NEUROPSYCHOLOGIA, V27, P505, DOI 10.1016/0028-3932(89)90055-9; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Kim BY, 2009, J FOOD SCI, V74, pH204, DOI 10.1111/j.1750-3841.2009.01263.x; Kim DH, 2010, CANCER CAUSE CONTROL, V21, P1919, DOI 10.1007/s10552-010-9620-8; Lemery L, 1745, TREATISE ALL SORTS F; Lindstrom S, 2016, COMPREHENSIVE SURVEY; LISON M, 1980, BRIT MED J, V281, P1676, DOI 10.1136/bmj.281.6256.1676; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P539; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pelchat ML, 2011, CHEM SENSES, V36, P9, DOI 10.1093/chemse/bjq081; Proust M., 1922, SWANNS WAY; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Salemme A, 2016, BRAIN RES BULL, V120, P151, DOI 10.1016/j.brainresbull.2015.11.014; Stromberg J, 2013, WHY ASPARAGUS MAKES; WHITE RH, 1975, SCIENCE, V189, P810, DOI 10.1126/science.1162354; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	24	8	9	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6071	10.1136/bmj.i6071	http://dx.doi.org/10.1136/bmj.i6071			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965198	Green Published, hybrid			2022-12-28	WOS:000390150800001
J	Newton, PN; Timmermann, B				Newton, Paul N.; Timmermann, Brigitte			Fake penicillin, The Third Man, and Operation Claptrap	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Newton, Paul N.] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Newton, Paul N.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Newton, Paul N.] Univ Oxford, WorldWide Antimalarial Resistance Network & Inf, Oxford, England	University of Oxford; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN)	Newton, PN (corresponding author), Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos.; Newton, PN (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England.; Newton, PN (corresponding author), Univ Oxford, WorldWide Antimalarial Resistance Network & Inf, Oxford, England.	paul@tropmedres.ac		Newton, Paul/0000-0002-4608-6431				[Anonymous], 2006, DAILY MOTION    1024; [Anonymous], 2013, LE PARISIEN     0325; [Anonymous], 1946, NEW YORK TIMES  0421, P29; [Anonymous], 1946, TIMES; [Anonymous], 2013, TELEGRAPH; [Anonymous], 1946, WASH POST, P3; British Film Institute, 1999, VIENN PROJ; Bud Robert, 2007, PENICILLIN TRIUMPH T; Drazin C., 2000, SEARCH 3 MAN; Fake penicillin, 1946, MERC HOB TASM, P7; Greene G., 1971, 3 MAN FALLEN IDOL; Mehaffey PC, 1995, DIAGN MICR INFEC DIS, V23, P11, DOI 10.1016/0732-8893(95)00148-4; Milano JU, 2000, SOLDIERS SPIES RAT L; Monge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095353; National Agency for Food and Drug Administration and Control-Government of Nigeria, 2015, CIRC FALS AM AMP; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Sherry N., 2004, LIFE G GREENE, V2, P1939; Timmermann B., 2006, 3 MANS VIENNA	18	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6494	10.1136/bmj.i6494	http://dx.doi.org/10.1136/bmj.i6494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965195	hybrid, Green Published			2022-12-28	WOS:000390150800006
J	Vaughn, VM; Chopra, V; Howell, JD				Vaughn, Valerie M.; Chopra, Vineet; Howell, Joel D.			War games and diagnostic errors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vaughn, Valerie M.; Chopra, Vineet; Howell, Joel D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Howell, Joel D.] Univ Michigan, Dept Hist, Ann Arbor, MI 48109 USA; [Howell, Joel D.] Univ Michigan, Dept Hlth Management, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Vaughn, VM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	valmv@med.umich.edu	Vaughn, Valerie M/L-3649-2018	Vaughn, Valerie/0000-0003-4362-7842; Chopra, Vineet/0000-0001-8670-9376				BREHMER B, 1992, ACTA PSYCHOL, V81, P211, DOI 10.1016/0001-6918(92)90019-A; Croskerry P, 2013, BMJ QUAL SAF, V22, pii58, DOI 10.1136/bmjqs-2012-001712; EVANS JSBT, 1984, BRIT J PSYCHOL, V75, P451, DOI 10.1111/j.2044-8295.1984.tb01915.x; Graber ML, 2013, BMJ QUAL SAF, V22, pii21, DOI 10.1136/bmjqs-2012-001615; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kohn LT, 2000, ERR IS HUMAN BUILDIN, P26; Lambe KA, 2016, BMJ QUAL SAF, V25, P808, DOI 10.1136/bmjqs-2015-004417; Mamede S, 2010, PSYCHOL RES-PSYCH FO, V74, P586, DOI 10.1007/s00426-010-0281-8; Moulton CAE, 2007, ACAD MED, V82, pS109, DOI 10.1097/ACM.0b013e3181405a76; National Security Archive, 2013, 1983 WAR SCAR LAST 2; President's Foreign Intelligence Advisory Board, 1990, SOV WAR SCAR; Schiff GD, 2005, CONCEPTS METHODOLOGY; Stevenson MM, 2013, J ONCOL PRACT, V9, pE77, DOI 10.1200/JOP.2013.000882; Weick K.E., 1995, SENSEMAKING ORG; Zwaan L, 2013, SOC SCI MED, V91, P32, DOI 10.1016/j.socscimed.2013.05.001; Zwaan L, 2012, ACAD MED, V87, P149, DOI 10.1097/ACM.0b013e31823f71e6	17	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6342	10.1136/bmj.i6342	http://dx.doi.org/10.1136/bmj.i6342			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF2JN	27965210				2022-12-28	WOS:000390150800005
J	Anderson, T				Anderson, Tatum			Doctors lobby for better chronic pain management	LANCET			English	Editorial Material																			0	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2856	2858		10.1016/S0140-6736(16)32514-4	http://dx.doi.org/10.1016/S0140-6736(16)32514-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979397				2022-12-28	WOS:000389631700017
J	Avery, E; Clark, J				Avery, Emily; Clark, Jocalyn			Sex-related reporting in randomised controlled trials in medical journals	LANCET			English	Editorial Material							GENDER		[Avery, Emily] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Clark, Jocalyn] The Lancet, London, England	Princeton University	Avery, E (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	eavery@princeton.edu		Clark, Jocalyn/0000-0002-8014-3989; Avery, Emily/0000-0002-8481-3978				[Anonymous], GEND STRAT ACT PLAN; [Anonymous], GEND SEX HLTH RES GU; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405; European Commission, 2016, RES INN SWAFS GEND I; Food and Drug Administration, 2014, FDA ACT PLAN ENH COL; Geller SE, 2011, J WOMENS HEALTH, V20, P315, DOI 10.1089/jwh.2010.2469; Jacobson R, 2014, SCI AM, V25, P15; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Legato MJ, 2016, JAMA-J AM MED ASSOC, V316, P1865, DOI 10.1001/jama.2016.13995; Phillips SP, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.29597	11	31	32	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2839	2840		10.1016/S0140-6736(16)32393-5	http://dx.doi.org/10.1016/S0140-6736(16)32393-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979393				2022-12-28	WOS:000389631700006
J	Hook, EW				Hook, Edward W., III			Syphilis	LANCET			English	Review							TREPONEMA-PALLIDUM; HIGH-RISK; MACROLIDE RESISTANCE; DIAGNOSIS; ASSOCIATION; INFECTIONS; MANAGEMENT; THERAPY; TESTS; MEN	Syphilis is a chronic bacterial infection caused by Treponema pallidum that is endemic in low-income countries and and occurs at lower rates in middle-income and high-income countries. The disease is of both individual and public health importance and, in addition to its direct morbidity, increases risk of HIV infection and can cause lifelong morbidity in children born to infected mothers. Without treatment the disease can progress over years through a series of clinical stages and lead to irreversible neurological or cardiovascular complications. Although syphilis is an ancient disease and the principles of recommended management have been established for decades, diagnosis and management are often challenging because of its varied manifestations and difficulty in interpretation of serological tests used to confirm diagnosis and evaluate response to therapy. In North America and western Europe, incidence of syphilis has increased dramatically in the past decade among men who have sex with men, particularly those with coexistent HIV infection. Only one drug, penicillin, is recommended for syphilis treatment and response to therapy is assessed based on changes over months in serological test titres. Treatment for patients who cannot receive penicillin and management of patients who do not serologically respond to treatment are common clinical problems.	[Hook, Edward W., III] Univ Alabama Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Hook, EW (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.	ehook@uab.edu			US Centers for Disease Control and Prevention; National Institutes of Health for syphilis research	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health for syphilis research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I receive salary support from the US Centers for Disease Control and Prevention and the National Institutes of Health for syphilis research.	Brandt Allan M, 1985, NO MAGIC BULLET SOCI; BROWN ST, 1985, JAMA-J AM MED ASSOC, V253, P1296, DOI 10.1001/jama.253.9.1296; Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P649; Chesny AM, 1924, JAMA-J AM MED ASSOC, V22, P172; DARROW WW, 1987, AM J PUBLIC HEALTH, V77, P479, DOI 10.2105/AJPH.77.4.479; Giacani L, 2014, CLIN MICROBIOL REV, V27, P89, DOI 10.1128/CMR.00070-13; Gjestland T., 1955, J CHRON DIS, V2, P311; Gottlieb SL, 2016, VACCINE, V34, P2939, DOI 10.1016/j.vaccine.2016.03.111; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Holman KM, 2013, EXPERT REV ANTI-INFE, V11, P839, DOI 10.1586/14787210.2013.814865; HOOK EW, 1989, J INFECT DIS, V160, P530, DOI 10.1093/infdis/160.3.530; HOOK EW, 1992, NEW ENGL J MED, V326, P1060, DOI 10.1056/NEJM199204163261606; Hook EW, 2002, SEX TRANSM DIS, V29, P486, DOI 10.1097/00007435-200208000-00010; HUTCHINSON CM, 1994, ANN INTERN MED, V121, P94, DOI 10.7326/0003-4819-121-2-199407150-00003; HUTCHINSON CM, 1991, ARCH INTERN MED, V151, P511, DOI 10.1001/archinte.151.3.511; Kingston M, 2008, INT J STD AIDS, V19, P729, DOI 10.1258/ijsa.2008.008279; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Larsen SA, 1998, MANUAL TESTS SYPHILI; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; LUKEHART SA, 1988, ANN INTERN MED, V109, P855, DOI 10.7326/0003-4819-109-11-855; Marra CM, 2008, CLIN INFECT DIS, V47, P893, DOI 10.1086/591534; Merritt HH., 1946, NEUROSYPHILIS; Mertz KJ, 1998, J INFECT DIS, V178, P1795, DOI 10.1086/314502; Moore JE, 1941, MODERN TREATMENT SYP; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; PARRAN T, 1937, SHADOW LAND; Pathela P, 2015, CLIN INFECT DIS, V61, P281, DOI 10.1093/cid/civ289; Peterman TA, 2014, PUBLIC HEALTH REP, V129, P164, DOI 10.1177/003335491412900210; Phipps W, 2009, SEX TRANSM DIS, V36, P331, DOI 10.1097/OLQ.0b013e3181990c85; Public Health England, 2015, INF REP SEX TRANSM I; Radolf J. D., 2011, Morbidity and Mortality Weekly Report, V60, P133; Riedner G, 2005, NEW ENGL J MED, V353, P1236, DOI 10.1056/NEJMoa044284; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; ROMANOWSKI B, 1991, ANN INTERN MED, V114, P1005, DOI 10.7326/0003-4819-114-12-1005; Sena AC, 2013, CLIN INFECT DIS, V56, P420, DOI 10.1093/cid/cis918; Sena AC, 2011, CLIN INFECT DIS, V53, P1092, DOI 10.1093/cid/cir671; Sena AC, 2010, CLIN INFECT DIS, V51, P700, DOI 10.1086/655832; Sparling PF., 2008, SEX TRANSM DIS, V4th ed, pp. 661; Stamm LV, 2000, ANTIMICROB AGENTS CH, V44, P806, DOI 10.1128/AAC.44.3.806-807.2000; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; THOMAS DL, 1994, J INFECT DIS, V170, P1579, DOI 10.1093/infdis/170.6.1579; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2015, ADDR GLOB SHORT MED; World Health Organization, 2016, GUID TREATM TREP PAL; World Health Organization, 2016, REP GLOB SEX TRANSM	46	193	203	5	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2017	389	10078					1550	1557		10.1016/S0140-6736(16)32411-4	http://dx.doi.org/10.1016/S0140-6736(16)32411-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER7OP	27993382				2022-12-28	WOS:000399002900029
J	Garthwaite, C; Gross, T; Notowidigdo, M; Graves, JA				Garthwaite, Craig; Gross, Tal; Notowidigdo, Matthew; Graves, John A.			Insurance Expansion and Hospital Emergency Department Access: Evidence From the Affordable Care Act	ANNALS OF INTERNAL MEDICINE			English	Article							INTERRUPTED TIME-SERIES; RESPONSE-TIME; YOUNG-ADULTS; MEDICAID; MORTALITY; REFORM; COMPETITION; DISTANCE; SYSTEM; STATES	Background: Little is known about whether insurance expansion affects the location and type of emergency department (ED) use. Understanding these changes can inform state-level decisions about the Medicaid expansion under the Patient Protection and Affordable Care Act (ACA). Objective: To investigate the effect of the 2014 ACA Medicaid expansion on the location, insurance status, and type of ED visits. Design: Quasi-experimental observational study from 2012 to 2014. Setting: 126 investor-owned, hospital-based EDs. Participants: Uninsured and Medicaid-insured adults aged 18 to 64 years. Intervention: ACA expansion of Medicaid in January 2014. Measurements: Number of ED visits overall, type of visit (for example, nondiscretionary or nonemergency), and average travel time to the ED. Interrupted time-series analyses comparing changes from the end of 2013 to end of 2014 for patients from Medicaid expansion versus nonexpansion states were done. Results: There were 1.06 million ED visits among patients from 17 Medicaid expansion states, and 7.87 million ED visits among patients from 19 nonexpansion states. The EDs treating patients from Medicaid expansion states saw an overall 47.1% decrease in uninsured visits (95% CI, -65.0% to -29.3%) and a 125.7% (CI, 89.2% to 162.6%) increase in Medicaid visits after 12 months of ACA expansion. Average travel time for nondiscretionary conditions requiring immediate medical care decreased by 0.9 minutes (-6.2% [CI, -8.9% to -3.5%]) among all Medicaid patients from expansion states. We found little evidence of similar changes among patients from nonexpansion states. Limitation: Results reflect shifts in ED care at investor-owned facilities, which limits generalizability to other hospital types. Conclusion: Meaningful changes in insurance status and location and type of ED visits in the first year of ACA Medicaid expansion were found, suggesting that expansion provides patients with a greater choice of hospital facilities.	Northwestern Univ, Evanston, IL USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Graves, John A.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 West End Ave,Suite 1200, Nashville, TN 37203 USA; [Garthwaite, Craig] Northwestern Kellogg Sch Management, Strategy Dept, 2001 Sheridan Rd, Evanston, IL 60208 USA; [Gross, Tal] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, 722 West 168th St,Room 485, New York, NY 10032 USA; [Notowidigdo, Matthew] Northwestern Univ, Dept Econ, 2001 Sheridan Rd, Evanston, IL 60208 USA	Northwestern University; Columbia University; Vanderbilt University; Vanderbilt University; Northwestern University; Columbia University; Northwestern University	Graves, JA (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 West End Ave,Suite 1200, Nashville, TN 37203 USA.	john.graves@vanderbilt.edu			Robert Wood Johnson State Health Access Reform Evaluation program [72183]	Robert Wood Johnson State Health Access Reform Evaluation program	By the Robert Wood Johnson State Health Access Reform Evaluation program (72183).	Billings J, 2000, Issue Brief (Commonw Fund), P1; Birk HO, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-262; Blackwell TH, 2002, ACAD EMERG MED, V9, P288, DOI 10.1197/aemj.9.4.288; BRONSTEIN JM, 1990, MED CARE, V28, P853, DOI 10.1097/00005650-199009000-00013; Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; CAMPBELL JP, 1993, ANN EMERG MED, V22, P1254, DOI 10.1016/S0196-0644(05)80102-7; Capps C, 2003, RAND J ECON, V34, P737, DOI 10.2307/1593786; Chen C, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109273; Cheung PT, 2012, ANN EMERG MED, V60, P4, DOI 10.1016/j.annemergmed.2012.01.035; Dorn S, 2013, FINANCIAL BENEFIT HO; Doyle JJ, 2015, J POLIT ECON, V123, P170, DOI 10.1086/677756; Gaynor M, 2003, 9471 NAT BUR EC RES; Graves JA, 2012, NEW ENGL J MED, V367, P2365, DOI 10.1056/NEJMp1209450; Hernandez-Boussard T, 2014, HEALTH AFFAIR, V33, P1648, DOI 10.1377/hlthaff.2014.0103; Lee GM, 2012, NEW ENGL J MED, V367, P1428, DOI 10.1056/NEJMsa1202419; Long S, 2015, TAKING STOCK GAINS H; LUFT HS, 1990, JAMA-J AM MED ASSOC, V263, P2899, DOI 10.1001/jama.263.21.2899; Mulcahy A, 2013, NEW ENGL J MED, V368, P2105, DOI 10.1056/NEJMsa1212779; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Shannon GW., 1969, MED CARE REV, V26, P143, DOI 10.1177/107755876902600209; Shen YC, 2015, HEALTH AFFAIR, V34, P1273, DOI 10.1377/hlthaff.2014.1462; Smith JaMC, 2015, CURRENT POPULATION R; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Sommers BD, 2011, NEW ENGL J MED, V365, P100, DOI 10.1056/NEJMp1104948; Stephens J, 2014, JAMA-J AM MED ASSOC, V311, P2471, DOI [10.1001/jama.2014.7077, DOI 10.1001/JAMA.2014.7077]; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183; Town R, 2001, J HEALTH ECON, V20, P733, DOI 10.1016/S0167-6296(01)00096-0; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wilde ET, 2013, HEALTH ECON, V22, P790, DOI 10.1002/hec.2851	32	33	33	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 7	2017	166	3					172	+		10.7326/M16-0086	http://dx.doi.org/10.7326/M16-0086			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL7DL	27992930				2022-12-28	WOS:000394781200006
J	Daw, R; Hansell, C; Helmer, M				Daw, Ros; Hansell, Claire; Helmer, Magdalena			Polymers	NATURE			English	Editorial Material														Hansell, Claire/0000-0002-5242-2817					0	0	0	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					353	353		10.1038/540353a	http://dx.doi.org/10.1038/540353a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27974755	Bronze			2022-12-28	WOS:000389716800028
J	Stunnenberg, HG; Hirst, M				Stunnenberg, Hendrik G.; Hirst, Martin		Int Human Epigenome Consortium	The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery (vol 167, pg 1145, 2016)	CELL			English	Correction												h.stunnenberg@ncmls.ru.nl; mhirst@bcgsc.ca	Arts, Rob JW/P-8678-2015; Stunnenberg, Hendrik G./D-6875-2012; Sun, Hao/J-9964-2013	Arts, Rob JW/0000-0002-6649-7190; Stunnenberg, Hendrik G./0000-0002-0066-1576; Sun, Hao/0000-0002-5547-9501; Bujold, David/0000-0001-7860-3264				Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007	1	53	54	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1897	1897		10.1016/j.cell.2016.12.002	http://dx.doi.org/10.1016/j.cell.2016.12.002			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984737	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000393114700027
J	Ferner, RE; Aronson, JK				Ferner, Robin E.; Aronson, Jeffrey K.			Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)-variants in the spellings of drug names in PubMed: a database review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFUSION	OBJECTIVE To examine how misspellings of drug names could impede searches for published literature. DESIGN Database review. DATA SOURCE PubMed. REVIEW METHODS The study included 30 drug names that are commonly misspelt on prescription charts in hospitals in Birmingham, UK (test set), and 30 control names randomly chosen from a hospital formulary (control set). The following definitions were used: standard names-the international non-proprietary names, variant names-deviations in spelling from standard names that are not themselves standard names in English language nomenclature, and hidden reference variants-variant spellings that identified publications in textword (tw) searches of PubMed or other databases, and which were not identified by textword searches for the standard names. Variant names were generated from standard names by applying letter substitutions, omissions, additions, transpositions, duplications, deduplications, and combinations of these. Searches were carried out in PubMed (30 June 2016) for "standard name[tw]" and "variant name[tw] NOT standard name[tw]." RESULTS The 30 standard names of drugs in the test set gave 325 979 hits in total, and 160 hidden reference variants gave 3872 hits (1.17%). The standard names of the control set gave 470 064 hits, and 79 hidden reference variants gave 766 hits (0.16%). Letter substitutions (particularly i to y and vice versa) and omissions together accounted for 2924 (74%) of the variants. Amitriptyline (8530 hits) yielded 18 hidden reference variants (179 (2.1%) hits). Names ending in "in," "ine," or "micin" were commonly misspelt. Failing to search for hidden reference variants of " gentamicin," "amitriptyline," "mirtazapine," and "trazodone" would miss at least 19 systematic reviews. A hidden reference variant related to Christmas, "No-el", was rare; variants of "X-miss" were rarer. CONCLUSION When performing searches, researchers should include misspellings of drug names among their search terms.	[Ferner, Robin E.] City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Ferner, Robin E.] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England; [Aronson, Jeffrey K.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England	University of Birmingham; University of Birmingham; University of Oxford	Ferner, RE (corresponding author), City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.; Ferner, RE (corresponding author), Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				ARONSON JK, 1995, DRUG SAFETY, V12, P155, DOI 10.2165/00002018-199512030-00001; Bryan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145431; Clarke M, 2008, BAHRAIN MED J, V30, P85; Lambert BL, 1999, MED CARE, V37, P1214, DOI 10.1097/00005650-199912000-00005; Li YJ, 2007, IEEE T PATTERN ANAL, V29, P1091, DOI 10.1109/TPAMI.2007.1070; Ray JG, 1996, BRIT MED J, V313, P1658, DOI 10.1136/bmj.313.7072.1658; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i4854	10.1136/bmj.i4854	http://dx.doi.org/10.1136/bmj.i4854			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974346	hybrid, Green Published			2022-12-28	WOS:000390151300001
J	Grey, A; Bolland, MJ; Dalbeth, N; Gamble, G; Sadler, L				Grey, Andrew; Bolland, Mark J.; Dalbeth, Nicola; Gamble, Greg; Sadler, Lynn			We read spam a lot: prospective cohort study of unsolicited and unwanted academic invitations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								OBJECTIVES To assess the amount, relevance, content, and suppressibility of academic electronic spam invitations to attend conferences or submit manuscripts. DESIGN Prospective cohort study. SETTING Email accounts of participating academics. PARTICIPANTS Five intrepid academics and a great many publishers, editors, and conference organisers. INTERVENTION Unsubscribing from sender's distribution lists. MAIN OUTCOME MEASURES Number of spam invitations received before, immediately after, and one year after unsubscribing from senders' distribution lists. The proportion of duplicate invitations was also assessed and the relevance of each invitation graded to the recipient's research interests. A qualitative assessment of the content of spam invitations was conducted. RESULTS At baseline, recipients received an average of 312 spam invitations each month. Unsubscribing reduced the frequency of the invitations by 39% after one month but by only 19% after one year. Overall, 16% of spam invitations were duplicates and 83% had little or no relevance to the recipients' research interests. Spam invitations were characterised by inventive language, flattery, and exuberance, and they were sometimes baffling and amusing. CONCLUSIONS Academic spam is common, repetitive, often irrelevant, and difficult to avoid or prevent.	[Grey, Andrew; Bolland, Mark J.; Dalbeth, Nicola; Gamble, Greg] Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand; [Sadler, Lynn] Auckland Dist Hlth Board, Womens Hlth, Auckland, New Zealand	University of Auckland; Auckland District Health Board	Grey, A (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	a.grey@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674				Butler D, 2013, NATURE, V495, P433, DOI 10.1038/495433a; Kozak M, 2016, J ASSOC INF SCI TECH, V67, P2009, DOI 10.1002/asi.23521; Mazzarello S, 2016, CURR ONCOL, V23, pE75, DOI 10.3747/co.23.2860; Moher D, 2016, ANN INTERN MED, V164, P616, DOI 10.7326/M15-3015; Moher D, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0423-3; Scholarly Open Access, BOGUS J ACCEPTS PROF	6	15	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i5383	10.1136/bmj.i5383	http://dx.doi.org/10.1136/bmj.i5383			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974354	hybrid, Green Published			2022-12-28	WOS:000390151300002
J	Kolkowitz, S; Bromley, SL; Bothwell, T; Wall, ML; Marti, GE; Koller, AP; Zhang, X; Rey, AM; Ye, J				Kolkowitz, S.; Bromley, S. L.; Bothwell, T.; Wall, M. L.; Marti, G. E.; Koller, A. P.; Zhang, X.; Rey, A. M.; Ye, J.			Spin-orbit-coupled fermions in an optical lattice clock	NATURE			English	Article							EDGE STATES; ATOMS	Engineered spin-orbit coupling (SOC) in cold-atom systems can enable the study of new synthetic materials and complex condensed matter phenomena1-8. However, spontaneous emission in alkali-atom spin-orbit-coupled systems is hindered by heating, limiting the observation of many-body effects(1,2,5) and motivating research into potential alternatives(9-11). Here we demonstrate that spin-orbit-coupled fermions can be engineered to occur naturally in a one-dimensional optical lattice clock(12). In contrast to previous SOC experiments(1-11), here the SOC is both generated and probed using a direct ultra-narrow optical clock transition between two electronic orbital states in Sr-87 atoms. We use clock spectroscopy to prepare lattice band populations, internal electronic states and quasi-momenta, and to produce spin-orbit-coupled dynamics. The exceptionally long lifetime of the excited clock state (160 seconds) eliminates decoherence and atom loss from spontaneous emission at all relevant experimental timescales, allowing subsequent momentum-and spin-resolved in situ probing of the SOC band structure and eigenstates. We use these capabilities to study Bloch oscillations, spin-momentum locking and Van Hove singularities in the transition density of states. Our results lay the groundwork for using fermionic optical lattice clocks to probe new phases of matter.	[Kolkowitz, S.; Bromley, S. L.; Bothwell, T.; Wall, M. L.; Marti, G. E.; Koller, A. P.; Zhang, X.; Rey, A. M.; Ye, J.] Univ Colorado, NIST, JILA, Boulder, CO 80309 USA; [Kolkowitz, S.; Bromley, S. L.; Bothwell, T.; Wall, M. L.; Marti, G. E.; Koller, A. P.; Zhang, X.; Rey, A. M.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wall, M. L.] Johns Hopkins Appl Phys Lab, Laurel, MD 20723 USA; [Zhang, X.] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Peking University	Kolkowitz, S (corresponding author), Univ Colorado, NIST, JILA, Boulder, CO 80309 USA.; Kolkowitz, S (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	shimonk@jila.colorado.edu	Kolkowitz, Shimon/AAD-5921-2019; Ye, Jun/C-3312-2011	Kolkowitz, Shimon/0000-0001-7095-1547; Ye, Jun/0000-0003-0076-2112; Wall, Michael/0000-0002-6223-0800; Marti, G. Edward/0000-0002-3390-436X; Bromley, Sarah/0000-0002-8130-6276	NIST; NSF Physics Frontier Center at JILA [NSF-PFC-1125844]; AFOSR-MURI; AFOSR; DARPA; ARO; NRC	NIST(National Institute of Standards & Technology (NIST) - USA); NSF Physics Frontier Center at JILA(National Science Foundation (NSF)); AFOSR-MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO; NRC(National Research Centre (NRC))	We are grateful to N. R. Cooper for insights and discussions, and S. L. Campbell, N. Darkwah Oppong, A. Goban, R. B. Hutson, D. X. Reed, J. Robinson, L. Sonderhouse and W. Zhang for technical contributions and discussions. This research is supported by NIST, the NSF Physics Frontier Center at JILA (NSF-PFC-1125844), AFOSR-MURI, AFOSR, DARPA and ARO. S.K., M.L.W. and G.E.M. acknowledge the NRC postdoctoral fellowship programme.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; An F. A., 2016, PREPRINT; Atala M, 2014, NAT PHYS, V10, P588, DOI 10.1038/NPHYS2998; Barbarino S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9134; BenDahan M, 1996, PHYS REV LETT, V76, P4508, DOI 10.1103/PhysRevLett.76.4508; Bishof M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052716; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; Burdick NQ, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031022; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Flaschner N, 2016, SCIENCE, V352, P1091, DOI 10.1126/science.aad4568; Galitski V, 2013, NATURE, V494, P49, DOI 10.1038/nature11841; GOLDMAN N, 2014, Patent No. 77126401; Hugel D, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023619; Isaev L, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.135302; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kim P, 1999, PHYS REV LETT, V82, P1225, DOI 10.1103/PhysRevLett.82.1225; Li J, 2016, PHYS REV LETT, V117; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Livi LF, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.220401; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Martin MJ, 2013, SCIENCE, V341, P632, DOI 10.1126/science.1236929; Martin M. J., 2013, THESIS; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Muller T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.200405; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Preiss PM, 2015, SCIENCE, V347, P1229, DOI 10.1126/science.1260364; Song B., 2016, PREPRINT; Spielman IB, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.020702; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; Wall ML, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.035301; Wall ML, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.013610; ZHAI H, 2015, Patent No. 78026001; Zhang X, 2014, SCIENCE, V345, P1467, DOI 10.1126/science.1254978	38	161	162	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					66	+		10.1038/nature20811	http://dx.doi.org/10.1038/nature20811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28002409	Green Submitted			2022-12-28	WOS:000396119300032
J	Dekker, JH				Dekker, Janny H.			Pelvic organ prolapse: prevention by training?	LANCET			English	Editorial Material							NATURAL-HISTORY; WOMEN; TERMINOLOGY; PREVALENCE; DISORDERS; SYMPTOMS; POP		[Dekker, Janny H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, POB 196,HPC FA21, NL-9700 AD Groningen, Netherlands	University of Groningen	Dekker, JH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, POB 196,HPC FA21, NL-9700 AD Groningen, Netherlands.	j.h.dekker@umcg.nl		Dekker, Janny/0000-0001-5005-9324				Bradley CS, 2007, OBSTET GYNECOL, V109, P848, DOI 10.1097/01.AOG.0000255977.91296.5d; Gilchrist AS, 2013, NEUROUROL URODYNAM, V32, P383, DOI 10.1002/nau.22298; Glazener C, 2013, BJOG-INT J OBSTET GY, V120, P161, DOI 10.1111/1471-0528.12075; Hagen S., 2016, LANCET; Handa VL, 2004, AM J OBSTET GYNECOL, V190, P27, DOI 10.1016/j.ajog.2003.07.017; Haylen BT, 2016, INT UROGYNECOL J, V27, P165, DOI 10.1007/s00192-015-2932-1; Lowenstein E, 2015, INT UROGYNECOL J, V26, P49, DOI 10.1007/s00192-014-2413-y; Miedel A, 2011, INT UROGYNECOL J, V22, P461, DOI 10.1007/s00192-010-1305-z; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1037, DOI 10.1007/s00192-009-0902-1; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Toozs-Hobson P, 2014, INT UROGYNECOL J, V25, P445, DOI 10.1007/s00192-013-2260-2; Wiegersma M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7378; Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057	13	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					336	+		10.1016/S0140-6736(16)32108-0	http://dx.doi.org/10.1016/S0140-6736(16)32108-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28010990				2022-12-28	WOS:000392804700006
J	Shin, Y; Berry, J; Pannucci, N; Haataja, MP; Toettcher, JE; Brangwynne, CP				Shin, Yongdae; Berry, Joel; Pannucci, Nicole; Haataja, Mikko P.; Toettcher, Jared E.; Brangwynne, Clifford P.			Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets	CELL			English	Article							RNA-BINDING PROTEINS; STRESS GRANULES; LIQUID DROPLETS; AMYLOID FORMATION; SEPARATION; CELLS; FUS; NUCLEATION; ORGANELLES; MECHANISM	Phase transitions driven by intrinsically disordered protein regions (IDRs) have emerged as a ubiquitous mechanism for assembling liquid-like RNA/protein (RNP) bodies and other membrane-less organelles. However, a lack of tools to control intracellular phase transitions limits our ability to understand their role in cell physiology and disease. Here, we introduce an optogenetic platform that uses light to activate IDR-mediated phase transitions in living cells. We use this "optoDroplet'' system to study condensed phases driven by the IDRs of various RNP body proteins, including FUS, DDX4, and HNRNPA1. Above a concentration threshold, these constructs undergo light-activated phase separation, forming spatiotemporally definable liquid optoDroplets. FUS optoDroplet assembly is fully reversible even after multiple activation cycles. However, cells driven deep within the phase boundary form solid-like gels that undergo aging into irreversible aggregates. This system can thus elucidate not only physiological phase transitions but also their link to pathological aggregates.	[Shin, Yongdae; Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Berry, Joel; Haataja, Mikko P.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Pannucci, Nicole; Toettcher, Jared E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Brangwynne, CP (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.; Toettcher, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	toettcher@princeton.edu; cbrangwy@princeton.edu		Shin, Yongdae/0000-0003-3441-1986; Berry, Joel/0000-0001-8122-4476	NIH 4D Nucleome Program [U01 DA040601]; NIH [1DP2GM105437-01, 1DP2EB024247-01]; Princeton Center for Complex Materials, an NSF [DMR 1420541]; NSF [1253035]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB024247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040601] Funding Source: NIH RePORTER	NIH 4D Nucleome Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Princeton Center for Complex Materials, an NSF; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the C.P.B. and J.E.T. laboratory for discussions. This work was supported by the NIH 4D Nucleome Program (U01 DA040601), as well as NIH Director's New Innovator Awards to C.P.B. (1DP2GM105437-01) and J.E.T. (1DP2EB024247-01). We also acknowledge funding from the Princeton Center for Complex Materials, an NSF-supported MRSEC (DMR 1420541), as well an NSF CAREER award (1253035).	Alves W.J., 1982, USDA TECHNICAL B, V1661; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Cardinaux F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.118301; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dormann D, 2013, MOL CELL NEUROSCI, V56, P475, DOI 10.1016/j.mcn.2013.03.006; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; ISHIMOTO C, 1977, PHYS REV LETT, V39, P474, DOI 10.1103/PhysRevLett.39.474; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; LANGER JS, 1980, PHYS REV A, V21, P948, DOI 10.1103/PhysRevA.21.948; Lee CF, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.088101; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lu PJ, 2008, NATURE, V453, P499, DOI 10.1038/nature06931; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Muschol M, 1997, J CHEM PHYS, V107, P1953, DOI 10.1063/1.474547; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Sagui C, 1999, PHYS REV E, V59, P4175, DOI 10.1103/PhysRevE.59.4175; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Vekilov PG, 2010, SOFT MATTER, V6, P5254, DOI 10.1039/c0sm00215a; VOORHEES PW, 1992, ANNU REV MATER SCI, V22, P197, DOI 10.1146/annurev.ms.22.080192.001213; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Xiang SH, 2015, CELL, V163, P829, DOI 10.1016/j.cell.2015.10.040; Zaccarelli E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/32/323101; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	57	388	399	22	180	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					159	+		10.1016/j.cell.2016.11.054	http://dx.doi.org/10.1016/j.cell.2016.11.054			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	28041848	Bronze, Green Accepted			2022-12-28	WOS:000396246700019
J	Mayor, S				Mayor, Susan			High dose fish oil supplements in late pregnancy reduce asthma in offspring, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Ramsden CE, 2016, NEW ENGL J MED, V375, P2596, DOI 10.1056/NEJMe1611723	2	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2016	355								i6861	10.1136/bmj.i6861	http://dx.doi.org/10.1136/bmj.i6861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RH	28039173				2022-12-28	WOS:000391173100015
J	Hawkins, M				Hawkins, Michael			Robert Desmond Abernethy OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2016	355								i6707	10.1136/bmj.i6707	http://dx.doi.org/10.1136/bmj.i6707			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CL	28011859				2022-12-28	WOS:000390921300004
J	Rinaldi, L				Rinaldi, Luca			Rescuing my time from science	SCIENCE			English	Editorial Material								It was a cold autumn day a couple years ago when I first felt that pursuing a Ph.D. was warping my sense of time. I had started working at 8: 30 in the morning. By 8 in the evening, when almost everybody else had left, I was still in my office. I had so much work still to do that I reluctantly called my life partner to tell her that I would not be home for dinner. As I finally headed home around midnight, walking down dark, empty corridors and through the deserted university square, I realized that I was living in a sort of time warp-which was particularly ironic given that I was studying how daily activities shape our sense of time. Now, though, after years of allowing my work to take over my life, I'm reclaiming my power to decide how to spend my time.	[Rinaldi, Luca] Univ Milano Bicocca, Milan, Italy	University of Milano-Bicocca	Rinaldi, L (corresponding author), Univ Milano Bicocca, Milan, Italy.	SciCareerEditor@aaas.org		Rinaldi, Luca/0000-0003-2017-6102					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1666	1666		10.1126/science.354.6319.1666	http://dx.doi.org/10.1126/science.354.6319.1666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008070				2022-12-28	WOS:000390254300057
J	Drew, L				Drew, Liam			RESEEDING THE GUT	NATURE			English	Editorial Material							FECAL MICROBIOTA TRANSPLANTATION											BENNET JD, 1989, LANCET, V1, P164; Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	5	9	15	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S109	S112		10.1038/540S109a	http://dx.doi.org/10.1038/540S109a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002392				2022-12-28	WOS:000391190500007
J	Legriel, S; Lemiale, V; Schenck, M; Chelly, J; Laurent, V; Daviaud, F; Srairi, M; Hamdi, A; Geri, G; Rossignol, T; Hilly-Ginoux, J; Boisrame-Helms, J; Louart, B; Malissin, I; Mongardon, N; Planquette, B; Thirion, M; Merceron, S; Canet, E; Pico, F; Tran-Dinh, YR; Bedos, JP; Azoulay, E; Resche-Rigon, M; Cariou, A				Legriel, Stephane; Lemiale, Virginie; Schenck, Maleka; Chelly, Jonathan; Laurent, Virginie; Daviaud, Fabrice; Srairi, Mohamed; Hamdi, Aicha; Geri, Guillaume; Rossignol, Thomas; Hilly-Ginoux, Julia; Boisrame-Helms, Julie; Louart, Benjamin; Malissin, Isabelle; Mongardon, Nicolas; Planquette, Benjamin; Thirion, Marina; Merceron, Sybille; Canet, Emmanuel; Pico, Fernando; Tran-Dinh, Yves-Roger; Bedos, Jean-Pierre; Azoulay, Elie; Resche-Rigon, Matthieu; Cariou, Alain		HYBERNATUS Study Grp	Hypothermia for Neuroprotection in Convulsive Status Epilepticus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REFRACTORY STATUS EPILEPTICUS; CRITICALLY-ILL PATIENTS; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; MANAGEMENT; TRIAL; ANTICONVULSANT; TEMPERATURE; PROTOCOL; INJURY	BACKGROUND Convulsive status epilepticus often results in permanent neurologic impairment. We evaluated the effect of induced hypothermia on neurologic outcomes in patients with convulsive status epilepticus. METHODS In a multicenter trial, we randomly assigned 270 critically ill patients with convulsive status epilepticus who were receiving mechanical ventilation to hypothermia (32 to 34 degrees C for 24 hours) in addition to standard care or to standard care alone; 268 patients were included in the analysis. The primary outcome was a good functional outcome at 90 days, defined as a Glasgow Outcome Scale (GOS) score of 5 (range, 1 to 5, with 1 representing death and 5 representing no or minimal neurologic deficit). The main secondary outcomes were mortality at 90 days, progression to electroencephalographically (EEG) confirmed status epilepticus, refractory status epilepticus on day 1, "super-refractory" status epilepticus (resistant to general anesthesia), and functional sequelae on day 90. RESULTS A GOS score of 5 occurred in 67 of 138 patients (49%) in the hypothermia group and in 56 of 130 (43%) in the control group (adjusted common odds ratio, 1.22; 95% confidence interval [CI], 0.75 to 1.99; P=0.43). The rate of progression to EEG-confirmed status epilepticus on the first day was lower in the hypothermia group than in the control group (11% vs. 22%; odds ratio, 0.40; 95% CI, 0.20 to 0.79; P=0.009), but there were no significant differences between groups in the other secondary outcomes. Adverse events were more frequent in the hypothermia group than in the control group. CONCLUSIONS In this trial, induced hypothermia added to standard care was not associated with significantly better 90-day outcomes than standard care alone in patients with convulsive status epilepticus. (Funded by the French Ministry of Health; HYBERNATUS ClinicalTrials.gov number, NCT01359332.)	[Legriel, Stephane; Lemiale, Virginie; Hilly-Ginoux, Julia; Planquette, Benjamin; Merceron, Sybille; Bedos, Jean-Pierre] Ctr Hosp Versailles, Med Surg Intens Care Unit, Site Andre Mignot, Versailles, France; [Pico, Fernando] Ctr Hosp Versailles, Neurol & Stroke Dept, Site Andre Mignot, Versailles, France; [Legriel, Stephane; Cariou, Alain] INSERM, Unite 970, Team 4, Paris Cardiovasc Res Ctr, F-75654 Paris 13, France; [Lemiale, Virginie; Canet, Emmanuel; Azoulay, Elie] St Louis Univ Hosp, AP HP, Med Intens Care Unit, Paris, France; [Resche-Rigon, Matthieu] St Louis Univ Hosp, AP HP, Dept Biostat & Med Informat, Paris, France; [Daviaud, Fabrice; Geri, Guillaume; Mongardon, Nicolas; Cariou, Alain] Cochin Univ Hosp, Hop Univ Paris Ctr, AP HP, Med Intens Care Unit, Paris, France; [Malissin, Isabelle] Lariboisiere Univ Hosp, AP HP, Med Intens Care Unit, Paris, France; [Tran-Dinh, Yves-Roger] Lariboisiere Univ Hosp, AP HP, Dept Neurophysiol, Paris, France; [Resche-Rigon, Matthieu] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, ECSTRA Team,Unite 1153, Paris, France; [Cariou, Alain] Paris Descartes Univ, Sorbonne Paris Cite, Sch Med, Paris, France; [Schenck, Maleka] Hop Univ Strasbourg, Hop Hautepierre, Med Intens Care Unit, Strasbourg, France; [Boisrame-Helms, Julie] Hop Univ Strasbourg, Nouvel Hop Civil, Med Intens Care Unit, Strasbourg, France; [Boisrame-Helms, Julie] Univ Strasbourg, Fac Med, Federat Med Translat Strasbourg, Strasbourg, France; [Chelly, Jonathan] Ctr Hosp Melun, Med Surg Intens Care Unit, Melun, France; [Srairi, Mohamed] Univ Toulouse 3 Paul Sabatier, Toulouse Univ Hosp, Anesthesiol & Crit Care Dept, Toulouse, France; [Hamdi, Aicha] Ctr Hosp Montreuil, Med Surg Intens Care Unit, Montreuil, France; [Rossignol, Thomas] Ctr Hosp Mans, Med Surg Intens Care Unit, Le Mans, France; [Louart, Benjamin] Univ Hosp Nimes, Div Anesthesia Intens Care Pain & Emergency Med, Intens Care Units, Nimes, France; [Thirion, Marina] Ctr Hosp Victor Dupouy, Med Surg Intens Care Unit, Argenteuil, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre Hospitalier Le Mans; Universite de Montpellier; CHU de Nimes	Legriel, S (corresponding author), Ctr Hosp Versailles, Med Surg Intens Care Unit, Site Andre Mignot,177 Rue Versailles, F-78150 Le Chesnay, France.	slegriel@ch-versailles.fr	PLANQUETTE, Benjamin/AAL-7166-2021; Legriel, Stephane/J-1307-2017; Resche-Rigon, Matthieu/ABA-5374-2021	Legriel, Stephane/0000-0003-4782-6734; herbrecht, jean-etienne/0000-0002-6415-5330; Srairi, Mohamed/0000-0001-7219-501X; Mongardon, Nicolas/0000-0003-2756-4052; Helms, Julie/0000-0003-0895-6800; resche-rigon, matthieu/0000-0003-2220-5085; Chelly, Jonathan/0000-0002-8198-1239; Troche, Gilles/0000-0002-8150-6630; JACQ, Gwenaelle/0000-0003-2927-9570	French Ministry of Health	French Ministry of Health	Funded by the French Ministry of Health	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Blanco M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030700; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2002, NEUROLOGY, V58, P139, DOI 10.1212/WNL.58.1.139; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; Gao Q, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1221-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Legriel S, 2008, INTENS CARE MED, V34, P476, DOI 10.1007/s00134-007-0915-5; Legriel S, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0159-z; Legriel S, 2016, J CLIN MED, V5, P53, DOI 10.3390/jcm5050053; Legriel S, 2015, CLIN NEUROL NEUROSUR, V131, P87, DOI 10.1016/j.clineuro.2015.01.013; Legriel S, 2010, CRIT CARE MED, V38, P2295, DOI 10.1097/CCM.0b013e3181f859a6; LIU Z, 1993, BRAIN RES, V631, P51, DOI 10.1016/0006-8993(93)91185-U; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Maeda T, 1999, BRAIN RES, V818, P228, DOI 10.1016/S0006-8993(98)01269-4; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Outin H, 2009, REV NEUROL-FRANCE, V165, P297, DOI 10.1016/j.neurol.2009.01.048; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Rincon F, 2013, NEUROCRIT CARE, V18, P45, DOI 10.1007/s12028-012-9779-9; Rossetti AO, 2014, INTENS CARE MED, V40, P1359, DOI 10.1007/s00134-014-3363-z; Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9; Rossetti AO, 2011, NEUROCRIT CARE, V14, P4, DOI 10.1007/s12028-010-9445-z; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Schmitt FC, 2006, NEUROBIOL DIS, V23, P689, DOI 10.1016/j.nbd.2006.05.008; Shorvon S, 2011, BRAIN, V134, P2802, DOI 10.1093/brain/awr215; Silvapulle MJ, 2001, BIOMETRICS, V57, P1157, DOI 10.1111/j.0006-341X.2001.01157.x; Steiner T, 2010, STROKE, V41, P402, DOI 10.1161/STROKEAHA.109.552919; Sutter R, 2013, CRIT CARE MED, V41, pE475, DOI 10.1097/CCM.0b013e31829eca06; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Zeiler FA, 2015, CAN J NEUROL SCI, V42, P221, DOI 10.1017/cjn.2015.31	40	96	100	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2457	2467		10.1056/NEJMoa1608193	http://dx.doi.org/10.1056/NEJMoa1608193			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1NL	28002714	Bronze			2022-12-28	WOS:000390091500009
J	Mason, DJ				Mason, Diana J.			Partnering With Nurses to Transform Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Mason, Diana J.] CUNY Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA; [Mason, Diana J.] George Washington Univ, Sch Nursing, Washington, DC 20052 USA; [Mason, Diana J.] Amer Acad Nursing, Washington, DC USA	City University of New York (CUNY) System; Hunter College (CUNY); George Washington University	Mason, DJ (corresponding author), CUNY Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA.; Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Washington, DC 20052 USA.	djmasonrn@gmail.com							0	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2471	2472		10.1001/jama.2016.18361	http://dx.doi.org/10.1001/jama.2016.18361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997643				2022-12-28	WOS:000390959300003
J	Mahmoudi, S; Brunet, A				Mahmoudi, Salah; Brunet, Anne			Bursts of Reprogramming: A Path to Extend Lifespan?	CELL			English	Editorial Material							PLURIPOTENCY; CELLS	In a thought-provoking study, Ocampo et al. show that the cyclic expression of stem cell reprogramming factors in vivo increases the lifespan of a mouse model of premature aging and provides health benefits to chronologically old, normal mice.	[Mahmoudi, Salah; Brunet, Anne] Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA; [Brunet, Anne] Stanford Univ, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.; Brunet, A (corresponding author), Stanford Univ, Glenn Labs Biol Aging, Stanford, CA 94305 USA.	anne.brunet@stanford.edu			NIA NIH HHS [P01 AG036695] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P841, DOI 10.1093/gerona/glw090; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584; Studer L, 2015, CELL STEM CELL, V16, P591, DOI 10.1016/j.stem.2015.05.004; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Trabucco SE, 2016, CELL STEM CELL, V18, P305, DOI 10.1016/j.stem.2016.02.002	10	7	7	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1672	1674		10.1016/j.cell.2016.11.050	http://dx.doi.org/10.1016/j.cell.2016.11.050			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984716	Bronze, Green Accepted			2022-12-28	WOS:000393114700005
J	Bynum, B; Bynum, H				Bynum, Bill; Bynum, Helen			Object lessons Silver eye bath	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2107	2107		10.1016/S0140-6736(16)31926-2	http://dx.doi.org/10.1016/S0140-6736(16)31926-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA1DJ	27968740				2022-12-28	WOS:000386332400021
J	Horton, R				Horton, Richard			Offline: Migration and health-from aspiration to desperation	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2071	2071		10.1016/S0140-6736(16)32048-7	http://dx.doi.org/10.1016/S0140-6736(16)32048-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA1DJ	27968737	Bronze			2022-12-28	WOS:000386332400011
J	Erickson, J; Sadeghirad, B; Lytvyn, L; Slavin, J; Johnston, BC				Erickson, Jennifer; Sadeghirad, Behnam; Lytvyn, Lyubov; Slavin, Joanne; Johnston, Bradley C.			The Scientific Basis of Guideline Recommendations on Sugar Intake A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							SWEETENED BEVERAGE CONSUMPTION; TYPE-2 DIABETES-MELLITUS; SOFT DRINK CONSUMPTION; WEIGHT-GAIN; METABOLIC SYNDROME; RISK; HEALTH; YOUNG; METAANALYSIS; PREVENTION	Background: The relationship between sugar and health is affected by energy balance, macronutrient substitutions, and diet and lifestyle patterns. Several authoritative organizations have issued public health guidelines addressing dietary sugars. Purpose: To systematically review guidelines on sugar intake and assess consistency of recommendations, methodological quality of guidelines, and the quality of evidence supporting each recommendation. Data Sources: MEDLINE, EMBASE, and Web of Science (1995 to September 2016); guideline registries; and gray literature (bibliographies, Google, and experts). Study Selection: Guidelines addressing sugar intake that reported their methods of development and were published in English between 1995 and 2016. Data Extraction: Three reviewers independently assessed guideline quality using the Appraisal of Guidelines for Research and Evaluation, 2nd edition (AGREE II), instrument. To assess evidence quality, articles supporting recommendations were independently reviewed and their quality was determined by using GRADE (Grading of Recommendations Assessment, Development and Evaluation) methods. Data Synthesis: The search identified 9 guidelines that offered 12 recommendations. Each of the reviewed guidelines indicated a suggested decrease in the consumption of foods containing nonintrinsic sugars. The guidelines scored poorly on AGREE II criteria, specifically in rigor of development, applicability, and editorial independence. Seven recommendations provided non-quantitative guidance; 5 recommended less than 25% to less than 5% of total calories from nonintrinsic sugars. The recommendations were based on various health concerns, including nutrient displacement, dental caries, and weight gain. Quality of evidence supporting recommendations was low to very low. Limitation: The authors conducted the study independent of the funding source, which is primarily supported by the food and agriculture industry. Conclusion: Guidelines on dietary sugar do not meet criteria for trustworthy recommendations and are based on low-quality evidence. Public health officials (when promulgating these recommendations) and their public audience (when considering dietary behavior) should be aware of these limitations.	[Erickson, Jennifer; Slavin, Joanne] Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA; [Sadeghirad, Behnam] McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; Kerman Univ Med Sci, Kerman, Iran; [Lytvyn, Lyubov; Johnston, Bradley C.] Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Child Hlth Evaluat Sci, 686 Bay St,Room 11-9859 West, Toronto, ON M5G 0A4, Canada; Univ Toronto, Toronto, ON, Canada	University of Minnesota System; University of Minnesota Twin Cities; McMaster University; Kerman University of Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Johnston, BC (corresponding author), Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Prevent Lab,Child Hlth Evaluat Sci, 686 Bay St,Room 11-9859 West, Toronto, ON M5G 0A4, Canada.	bradley.johnston@sickkids.ca	Slavin, Joanne/GOJ-9874-2022; Sadeghirad, Behnam/A-1772-2009	Slavin, Joanne/0000-0003-0720-5300; Sadeghirad, Behnam/0000-0001-9422-5232	Technical Committee on Dietary Carbohydrates of the North American branch of the International Life Sciences Institute [PROSPERO: CRD42015029182]	Technical Committee on Dietary Carbohydrates of the North American branch of the International Life Sciences Institute	Technical Committee on Dietary Carbohydrates of the North American branch of the International Life Sciences Institute. (PROSPERO: CRD42015029182)	Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; Anderson CA, 2009, OBES REV, V10, P41, DOI 10.1111/j.1467-789X.2008.00564.x; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Becker W., 2005, SCANDINAVIAN J NUTR, V49, P68; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Burt B A, 2001, J Dent Educ, V65, P1017; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen L, 2012, J GEN INTERN MED, V27, P1127, DOI 10.1007/s11606-012-2069-6; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478; Erickson J, 2015, NUTRIENTS, V7, P2866, DOI 10.3390/nu7042866; Fogelholm M, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.19103; Food Safety Authority of Ireland, 2011, SCI REC HLTH EAT GUI; Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976; Greenfield S, 2011, CLIN PRACTICE GUIDEL; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hauner H, 2012, ANN NUTR METAB, V60, P1, DOI 10.1159/000335326; Hess J, 2012, FOOD FUNCT, V3, P477, DOI 10.1039/c2fo10250a; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Koch G.G., 1982, ENCY STAT SCI, V4, P212, DOI DOI 10.1002/0471667196.ESS1275.PUB2; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x; Ministry of Health of Brazil, 2014, DIET GUID BRAZ POP; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Murray R, 2015, PEDIATRICS, V135, P575, DOI 10.1542/peds.2014-3902; National Health and Medical Research Council (NHMRC), 2013, AUSTR DIET GUID; National institute of nutrition, 2011, DIET GUID IND MAN; Nissinen K, 2009, PUBLIC HEALTH NUTR, V12, P2018, DOI 10.1017/S1368980009005849; Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I, DOI [10.6027/Nord2014-002., 10.6027/Nord2014-002]; Nutritional Epidemiology Group University of Leeds, 2012, SYST REV EV BEN RISK; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Ruxton CHS, 2010, CRIT REV FOOD SCI, V50, P1, DOI 10.1080/10408390802248569; Sadeghirad B, 2016, SCI BASIS RECOMMENDA; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Sonestedt E, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.19104; Tucker KL, 2006, AM J CLIN NUTR, V84, P936, DOI 10.1093/ajcn/84.4.936; United States Department of Agriculture (USDA) US Department of Health and Human Services, 2015, DIET GUID AM 2015 20, V8th; USDA, 2015, SCI REP 2015 DIET GU; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; (WHO) World Health Organisation, 2015, GUID SUG INT AD CHIL; Wolff Emily, 2008, Medscape J Med, V10, P189; Zhang YH, 2013, J NUTR, V143, P1391, DOI 10.3945/jn.113.175323	52	77	77	1	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					257	+		10.7326/M16-2020	http://dx.doi.org/10.7326/M16-2020			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL7FO	27992898				2022-12-28	WOS:000394786700015
J	Glazener, CMA; Breeman, S; Elders, A; Hemming, C; Cooper, KG; Freeman, RM; Smith, ARB; Reid, F; Hagen, S; Montgomery, I; Kilonzo, M; Boyers, D; McDonald, A; McPherson, G; MacLennan, G; Norrie, J				Glazener, Cathryn M. A.; Breeman, Suzanne; Elders, Andrew; Hemming, Christine; Cooper, Kevin G.; Freeman, Robert M.; Smith, Anthony R. B.; Reid, Fiona; Hagen, Suzanne; Montgomery, Isobel; Kilonzo, Mary; Boyers, Dwayne; McDonald, Alison; McPherson, Gladys; MacLennan, Graeme; Norrie, John		PROSPECT Study Grp	Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT)	LANCET			English	Article							PELVIC ORGAN PROLAPSE; ICS JOINT REPORT; TERMINOLOGY; OUTCOMES	Background The use of transvaginal mesh and biological graft material in prolapse surgery is controversial and has led to a number of enquiries into their safety and efficacy. Existing trials of these augmentations are individually too small to be conclusive. We aimed to compare the outcomes of prolapse repair involving either synthetic mesh inlays or biological grafts against standard repair in women. Methods We did two pragmatic, parallel-group, multicentre, randomised controlled trials for our study (PROSPECT [PROlapse Surgery: Pragmatic Evaluation and randomised Controlled Trials]) in 35 centres (a mix of secondary and tertiary referral hospitals) in the UK. We recruited women undergoing primary transvaginal anterior or posterior compartment prolapse surgery by 65 gynaecological surgeons in these centres. We randomly assigned participants by a remote web-based randomisation system to one of the two trials: comparing standard (native tissue) repair alone with standard repair augmented with either synthetic mesh (the mesh trial) or biological graft (the graft trial). We assigned women (1: 1: 1 or 1: 1) within three strata: assigned to one of the three treatment options, comparison of standard repair with mesh, and comparison of standard repair with graft. Participants, ward staff, and outcome assessors were masked to randomisation where possible; masking was obviously not possible for the surgeon. Follow-up was for 2 years after the surgery; the primary outcomes, measured at 1 year and 2 years, were participant-reported prolapse symptoms (i.e. the Pelvic Organ Prolapse Symptom Score [POP-SS]) and condition-specific (ie, prolapse-related) quality-of-life scores, analysed in the modified intention-to-treat population. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN60695184. Findings Between Jan 8, 2010, and Aug 30, 2013, we randomly allocated 1352 women to treatment, of whom 1348 were included in the analysis. 865 women were included in the mesh trial (430 to standard repair alone, 435 to mesh augmentation) and 735 were included in the graft trial (367 to standard repair alone, 368 to graft augmentation). Because the analyses were carried out separately for each trial (mesh trial and graft trial) some women in the standard repair arm assigned to all treatment options were included in the standard repair group of both trials. 23 of these women did not receive any surgery (15 in the mesh trial, 13 in the graft trial; five were included in both trials) and were included in the baseline analyses only. Mean POP-SS at 1 year did not differ substantially between comparisons (standard 5.4 [SD 5.5] vs mesh 5.5 [5.1], mean difference 0.00, 95% CI-0.70 to 0.71; p=0.99; standard 5.5 [SD 5.6] vs graft 5.6 [5.6]; mean difference-0.15,-0.93 to 0.63; p=0.71). Mean prolapse-related quality-of-life scores also did not differ between groups at 1 year (standard 2.0 [SD 2.7] vs mesh 2.2 [2.7], mean difference 0.13, 95% CI -0.25 to 0.51; p=0.50; standard 2.2 [SD 2.8] vs graft 2.4 [2.9]; mean difference 0.13,-0.30 to 0.56; p=0.54). Mean POP-SS at 2 years were: standard 4.9 (SD 5.1) versus mesh 5.3 (5.1), mean difference 0.32, 95% CI-0.39 to 1.03; p=0.37; standard 4.9 (SD 5.1) versus graft 5.5 (5.7); mean difference 0.32,-0.48 to 1.12; p=0.43. Prolapse-related quality-of-life scores at 2 years were: standard 1.9 (SD 2.5) versus mesh 2.2 (2.6), mean difference 0.15, 95% CI -0.23 to 0.54; p=0.44; standard 2.0 (2.5) versus graft 2.2 (2.8); mean difference 0.10,-0.33 to 0.52; p=0.66. Serious adverse events such as infection, urinary retention, or dyspareunia or other pain, excluding mesh complications, occurred with similar frequency in the groups over 1 year (mesh trial: 31/430 [7%] with standard repair vs 34/435 [8%] with mesh, risk ratio [RR] 1.08, 95% CI 0.68 to 1.72; p=0.73; graft trial: 23/367 [6%] with standard repair vs 36/368 [10%] with graft, RR 1.57, 0.95 to 2.59; p=0.08). The cumulative number of women with a mesh complication over 2 years in women actually exposed to synthetic mesh was 51 (12%) of 434. Interpretation Augmentation of a vaginal repair with mesh or graft material did not improve women's outcomes in terms of effectiveness, quality of life, adverse effects, or any other outcome in the short term, but more than one in ten women had a mesh complication. Therefore, follow-up is vital to identify any longer-term potential benefi ts and serious adverse effects of mesh or graft reinforcement in vaginal prolapse surgery. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.	[Glazener, Cathryn M. A.; Breeman, Suzanne; Montgomery, Isobel; Boyers, Dwayne; McDonald, Alison; McPherson, Gladys; MacLennan, Graeme; Norrie, John] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Kilonzo, Mary; Boyers, Dwayne] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Elders, Andrew; Hagen, Suzanne] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Res Unit, Glasgow, Lanark, Scotland; [Hemming, Christine; Cooper, Kevin G.] Aberdeen Royal Infirm, Dept Obstet & Gynaecol, Aberdeen, Scotland; [Freeman, Robert M.] Plymouth Hosp NHS Trust, Dept Obstet & Gynaecol, Plymouth, Devon, England; [Smith, Anthony R. B.; Reid, Fiona] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Warrell Unit, Manchester, Lancs, England	University of Aberdeen; University of Aberdeen; Glasgow Caledonian University; University of Aberdeen; University of Plymouth; University of Manchester	Glazener, CMA (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	c.glazener@abdn.ac.uk	Boyers, Dwayne/AAJ-8774-2021; Elders, Andrew/N-4195-2015	reid, fiona/0000-0002-6029-7948; MacLennan, Graeme/0000-0002-1039-5646; Kilonzo, Mary/0000-0002-3450-4536; cooper, kevin/0000-0003-1486-0071; Breeman, Suzanne/0000-0001-9950-7079; HAGEN, SUZANNE/0000-0002-9741-9160; Elders, Andrew/0000-0003-4172-4702	UK National Institute of Health Research; National Institute for Health Research [07/60/18] Funding Source: researchfish; Chief Scientist Office [HSRU1, NMAHP2, HERU1] Funding Source: researchfish	UK National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	UK National Institute of Health Research.	Abrams P, 2006, J UROLOGY, V175, P1063, DOI 10.1016/S0022-5347(05)00348-4; Allahdin S, 2008, J OBSTET GYNAECOL, V28, P427, DOI 10.1080/01443610802150077; Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Glazener C, PROLAPSE SURG PRAGMA; Hagen S, 2010, NEUROUROL URODYNAM, V29, P1055; Hagen S, 2009, BJOG-INT J OBSTET GY, V116, P25, DOI 10.1111/j.1471-0528.2008.01903.x; Haylen BT, 2012, INT UROGYNECOL J, V23, P515, DOI 10.1007/s00192-011-1659-x; Haylen BT, 2012, INT UROGYNECOL J, V23, P11, DOI 10.1007/s00192-011-1580-3; Haylen BT, 2011, INT UROGYNECOL J, V22, P3, DOI 10.1007/s00192-010-1324-9; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Jia X, 2008, SYSTEMATIC REV EFFI; Maher C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub3; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012079; McCormack K, 2006, COCHRANE DATABASE SY, V1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Scott NW., 2002, COCHRANE DB SYST REV, pCD002197, DOI [10.1002/14651858, DOI 10.1002/14651858, DOI 10.1002/14651858.CD002197]; Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P527, DOI 10.1007/s00192-012-1726-y; Wilkie L, SCOTTISH INDEPENDENT	22	155	166	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					381	392		10.1016/S0140-6736(16)31596-3	http://dx.doi.org/10.1016/S0140-6736(16)31596-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9CK	28010989	Green Published, hybrid			2022-12-28	WOS:000392804700035
J	Nager, AR; Goldstein, JS; Herranz-Perez, V; Portran, D; Ye, F; Garcia-Verdugo, JM; Nachury, MV				Nager, Andrew R.; Goldstein, Jaclyn S.; Herranz-Perez, Vicente; Portran, Didier; Ye, Fan; Manuel Garcia-Verdugo, Jose; Nachury, Maxence V.			An Actin Network Dispatches Ciliary GPCRs into Extracellular Vesicles to Modulate Signaling	CELL			English	Article							BARDET-BIEDL SYNDROME; PROTEIN-COUPLED RECEPTORS; PRIMARY CILIUM; MEMBRANE; TRAFFICKING; RELEASE; PATHWAY; BBSOME; PHOSPHORYLATION; ENDOCYTOSIS	Signaling receptors dynamically exit cilia upon activation of signaling pathways such as Hedgehog. Here, we find that when activated G protein-coupled receptors (GPCRs) fail to undergo BBSome-mediated retrieval from cilia back into the cell, these GPCRs concentrate into membranous buds at the tips of cilia before release into extracellular vesicles named ectosomes. Unexpectedly, actin and the actin regulators drebrin and myosin 6 mediate ectosome release from the tip of cilia. Mirroring signal-dependent retrieval, signal-dependent ectocytosis is a selective and effective process that removes activated signaling molecules from cilia. Congruently, ectocytosis compensates for BBSome defects as ectocytic removal of GPR161, a negative regulator of Hedgehog signaling, permits the appropriate transduction of Hedgehog signals in Bbs mutants. Finally, ciliary receptors that lack retrieval determinants such as the anorexigenic GPCR NPY2R undergo signal-dependent ectocytosis in wild-type cells. Our data show that signal-dependent ectocytosis regulates ciliary signaling in physiological and pathological contexts.	[Nager, Andrew R.; Goldstein, Jaclyn S.; Portran, Didier; Ye, Fan; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Herranz-Perez, Vicente; Manuel Garcia-Verdugo, Jose] Univ Valencia, CIBERNED, Inst Cavanilles, Lab Neurobiol Comparada, Valencia 46980, Spain; [Herranz-Perez, Vicente; Manuel Garcia-Verdugo, Jose] IIS Hosp La Fe UVEG, Unidad Mixta Esclerosis Multiple & Neurorregenera, Valencia 46026, Spain	Stanford University; CIBERNED; University of Valencia	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	nachury@gmail.com	Nachury, Maxence/H-3695-2019; Herranz-Pérez, Vicente/AAE-9196-2021; García-Verdugo, José Manuel/L-8421-2017; Herranz-Pérez, Vicente/A-4605-2012	Nachury, Maxence/0000-0003-4918-1562; Herranz-Pérez, Vicente/0000-0002-1969-1214; García-Verdugo, José Manuel/0000-0001-9872-6499; Herranz-Pérez, Vicente/0000-0002-1969-1214; Portran, Didier/0000-0002-0356-398X	NIH/NIGMS [GM089933, 1S10RR02678001]; Generalitat Valenciana [PROMETEOII/2014/075]; Fayez Sarofim/Damon Runyon Fellowship [DRG 2160-13]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089933] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fayez Sarofim/Damon Runyon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Bornens, Buss, Janke, Mukhopadhyay, Scales, and Chishti for the gifts of antibodies; Drs. Cheeseman, Mykytyn, Scott, Sheffield, and Ting for the gifts of cDNAs; Novartis for the gift of ACQ090; the M.V.N. lab, Rich Lewis, Bill Snell, David Williams, and Tim Stearns for helpful discussion. This work was supported by grants from NIH/NIGMS to M.V.N. (GM089933) and to Stanford Microscopy Facility (1S10RR02678001), from Generalitat Valenciana to J.M.G.-V. (PROMETEOII/2014/075), and a Fayez Sarofim/Damon Runyon Fellowship to A.R.N. (DRG 2160-13).	Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Cao MQ, 2015, ELIFE, V4, DOI 10.7554/eLife.05242; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Desrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Heissler SM, 2012, FEBS LETT, V586, P3208, DOI 10.1016/j.febslet.2012.07.014; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5622; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Law M, 2015, J IMMUNOL, V195, P426, DOI 10.4049/jimmunol.1401442; Lechtreck KF, 2013, J CELL BIOL, V201, P249, DOI 10.1083/jcb.201207139; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; McIntyre JC, 2016, METHOD CELL BIOL, V132, P35, DOI 10.1016/bs.mcb.2015.11.009; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Pal K, 2016, J CELL BIOL, V212, P861, DOI 10.1083/jcb.201506132; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roth A, 1997, J BIOL CHEM, V272, P23769, DOI 10.1074/jbc.272.38.23769; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; Su XF, 2014, HUM MOL GENET, V23, P5441, DOI 10.1093/hmg/ddu267; Szempruch AJ, 2016, CELL, V164, P246, DOI 10.1016/j.cell.2015.11.051; Von Bartheld CS, 2011, PROG NEUROBIOL, V93, P313, DOI 10.1016/j.pneurobio.2011.01.003; Wang J, 2016, CELL MOL NEUROBIOL, V36, P449, DOI 10.1007/s10571-016-0345-4; Wang J, 2014, CURR BIOL, V24, P519, DOI 10.1016/j.cub.2014.01.002; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Wood CR, 2015, TRENDS CELL BIOL, V25, P276, DOI 10.1016/j.tcb.2014.12.008; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Yue S, 2014, ELIFE, V3, DOI 10.7554/eLife.02555	43	181	185	1	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					252	+		10.1016/j.cell.2016.11.036	http://dx.doi.org/10.1016/j.cell.2016.11.036			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	28017328	Green Accepted, Bronze			2022-12-28	WOS:000396246700026
J	Xu, WG; Liu, WW; Schmidt, JF; Zhao, WJ; Lu, X; Raab, T; Diederichs, C; Gao, WB; Seletskiy, DV; Xiong, QH				Xu, Weigao; Liu, Weiwei; Schmidt, Jan F.; Zhao, Weijie; Lu, Xin; Raab, Timo; Diederichs, Carole; Gao, Weibo; Seletskiy, Denis V.; Xiong, Qihua			Correlated fluorescence blinking in two-dimensional semiconductor heterostructures	NATURE			English	Article							QUANTUM; RECOMBINATION; INTERMITTENCY; INTENSITY; EXCITONS; TRIONS; MOS2	'Blinking', or 'fluorescence intermittency', refers to a random switching between 'ON' (bright) and 'OFF' (dark) states of an emitter; it has been studied widely in zero-dimensional quantum dots(1) and molecules(2,3), and scarcely in one-dimensional systems(4,5). A generally accepted mechanism for blinking in quantum dots involves random switching between neutral and charged states(6,7) (or is accompanied by fluctuations in charge-carrier traps(8)), which substantially alters the dynamics of radiative and non-radiative decay. Here, we uncover a new type of blinking effect in vertically stacked, two-dimensional semiconductor heterostructures(9), which consist of two distinct monolayers of transition metal dichalcogenides (TMDs) that are weakly coupled by van der Waals forces. Unlike zero-dimensional or one-dimensional systems, two-dimensional TMD heterostructures show a correlated blinking effect, comprising randomly switching bright, neutral and dark states. Fluorescence cross-correlation spectroscopy analyses show that a bright state occurring in one monolayer will simultaneously lead to a dark state in the other monolayer, owing to an intermittent interlayer carrier-transfer process. Our findings suggest that bilayer van der Waals heterostructures provide unique platforms for the study of charge-transfer dynamics and non-equilibrium-state physics, and could see application as correlated light emitters in quantum technology.	[Xu, Weigao; Liu, Weiwei; Zhao, Weijie; Lu, Xin; Gao, Weibo; Xiong, Qihua] Nanyang Technol Univ, Div Phys & Appl Phys, Sch Phys & Math Sci, Singapore 637371, Singapore; [Schmidt, Jan F.; Raab, Timo; Seletskiy, Denis V.] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Schmidt, Jan F.; Raab, Timo; Seletskiy, Denis V.] Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany; [Diederichs, Carole] Sorbonne Univ, Univ Paris Diderot, Univ Pierre & Marie Curie,CNRS,Sorbonne Paris Cit, Lab Pierre Aigrain,Ecole Normale Super,PSL Res Un, 24 Rue Lhomond, F-75231 Paris 05, France; [Diederichs, Carole; Xiong, Qihua] Nanyang Technol Univ, NUS, UNS, UMI 3654,MajuLab,CNRS,Joint Res Unit, Singapore, Singapore; [Xiong, Qihua] Nanyang Technol Univ, NOVITAS, Nanoelect Ctr Excellence, Sch Elect & Elect Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Konstanz; University of Konstanz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Xiong, QH (corresponding author), Nanyang Technol Univ, Div Phys & Appl Phys, Sch Phys & Math Sci, Singapore 637371, Singapore.; Xiong, QH (corresponding author), Nanyang Technol Univ, NUS, UNS, UMI 3654,MajuLab,CNRS,Joint Res Unit, Singapore, Singapore.; Xiong, QH (corresponding author), Nanyang Technol Univ, NOVITAS, Nanoelect Ctr Excellence, Sch Elect & Elect Engn, Singapore 639798, Singapore.	qihua@ntu.edu.sg	Seletskiy, Denis V/C-1372-2011; gao, WEIBO/F-9408-2017; Xiong, Qihua/A-4979-2011; Xu, Weigao/T-6776-2017; Lippmann, Jan/O-4491-2017; Zhao, Weijie/O-5416-2019; Lu, Xin/AAS-9830-2021	Seletskiy, Denis V/0000-0003-3480-4595; gao, WEIBO/0000-0003-3971-621X; Xiong, Qihua/0000-0002-2555-4363; Xu, Weigao/0000-0002-3014-756X; Lippmann, Jan/0000-0002-6636-5075; Zhao, Weijie/0000-0001-6597-7865; Lu, Xin/0000-0002-9992-2077; Diederichs, Carole/0000-0002-1383-5598	Singapore National Research Foundation [NRF-NRFI2015-03]; Singapore Ministry of Education [MOE2012-T2-2-086, MOE2015-T2-1-047]; China Scholarship Council [201506160035]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); China Scholarship Council(China Scholarship Council)	We thank Professor C.-D. Ohl for providing us with a high-speed camera for dynamical fluorescence imaging. Q.X. acknowledges the support of the Singapore National Research Foundation through an Investigatorship award (NRF-NRFI2015-03), and the Singapore Ministry of Education via two AcRF Tier 2 grants (MOE2012-T2-2-086 and MOE2015-T2-1-047). W.L. acknowledges scholarship support from the China Scholarship Council (no. 201506160035).	Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Efros AL, 1997, PHYS REV LETT, V78, P1110, DOI 10.1103/PhysRevLett.78.1110; Efros AL, 2016, NAT NANOTECHNOL, V11, P661, DOI [10.1038/NNANO.2016.140, 10.1038/nnano.2016.140]; Frantsuzov P, 2008, NAT PHYS, V4, P519, DOI 10.1038/nphys1001; Frantsuzov PA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207402; Galland C, 2011, NATURE, V479, P203, DOI 10.1038/nature10569; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Helms V., 2008, FLUROSCENCE RESONANC; Hong XP, 2014, NAT NANOTECHNOL, V9, P682, DOI [10.1038/NNANO.2014.167, 10.1038/nnano.2014.167]; Ji BT, 2015, NAT NANOTECHNOL, V10, P170, DOI [10.1038/NNANO.2014.298, 10.1038/nnano.2014.298]; Lui CH, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165403; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Park YS, 2014, ACS NANO, V8, P7288, DOI 10.1021/nn5023473; Peimyoo N, 2013, ACS NANO, V7, P10985, DOI 10.1021/nn4046002; Protasenko V, 2007, J AM CHEM SOC, V129, P13160, DOI 10.1021/ja073642w; Rivera P, 2016, SCIENCE, V351, P688, DOI 10.1126/science.aac7820; Rivera P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7242; Rosen S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157404; Ross JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2498; Sampat S, 2015, ACS PHOTONICS, V2, P1505, DOI 10.1021/acsphotonics.5b00423; Tongay S, 2014, NANO LETT, V14, P3185, DOI 10.1021/nl500515q; VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Yu YF, 2015, NANO LETT, V15, P486, DOI 10.1021/nl5038177; Zhao J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157403; Zhao YY, 2013, NANO LETT, V13, P1007, DOI 10.1021/nl304169w	30	125	126	34	478	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					62	+		10.1038/nature20601	http://dx.doi.org/10.1038/nature20601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27974803				2022-12-28	WOS:000396119500029
J	[Anonymous]				[Anonymous]			Reducing Recurrent Strokes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					18	18		10.1001/jama.2016.19075	http://dx.doi.org/10.1001/jama.2016.19075			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030683				2022-12-28	WOS:000391009100007
J	Maclean, D				Maclean, Derek			Donald Emslie-Smith OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		EMSLIESMITH D, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2016	355								i6709	10.1136/bmj.i6709	http://dx.doi.org/10.1136/bmj.i6709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CL	28011465				2022-12-28	WOS:000390921300006
J	Voosen, P				Voosen, Paul			Scientists flag new causes for surge in methane levels	SCIENCE			English	News Item																			0	1	1	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1513	1513		10.1126/science.354.6319.1513	http://dx.doi.org/10.1126/science.354.6319.1513			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008017				2022-12-28	WOS:000390254300010
J	Cook-Deegan, R; Chandrasekharan, S				Cook-Deegan, Robert; Chandrasekharan, Subhashini			Sequenom v. Ariosa - The Death of a Genetic Testing Patent	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cook-Deegan, Robert] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85281 USA; [Cook-Deegan, Robert] Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85281 USA; [Cook-Deegan, Robert] FasterCures, Milken Inst, Washington, DC 20005 USA; [Chandrasekharan, Subhashini] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Duke University	Cook-Deegan, R (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85281 USA.; Cook-Deegan, R (corresponding author), Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85281 USA.; Cook-Deegan, R (corresponding author), FasterCures, Milken Inst, Washington, DC 20005 USA.			Cook-Deegan, Robert/0000-0002-8251-4237				Agarwal A, 2013, PRENATAL DIAG, V33, P521, DOI 10.1002/pd.4101; Chandrasekharan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008704; Heger M., 2015, GENOMEWEB       0305; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0	4	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2418	2419		10.1056/NEJMp1608555	http://dx.doi.org/10.1056/NEJMp1608555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002697				2022-12-28	WOS:000390091500004
J	Friedrich, MJ				Friedrich, M. J.			Sub-Saharan Mortality Hotspots for Children Younger Than 5 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2473	2473		10.1001/jama.2016.18558	http://dx.doi.org/10.1001/jama.2016.18558			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997665				2022-12-28	WOS:000390959300005
J	Wintemute, GJ; Betz, ME; Ranney, ML				Wintemute, Garen J.; Betz, Marian E.; Ranney, Megan L.			Physicians, Patients, and Firearms RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Wintemute, Garen J.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Betz, Marian E.] Univ Colorado, Sch Med, Denver, CO USA; [Ranney, Megan L.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02903 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Wintemute, GJ (corresponding author), Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA.		Betz, Marian E./H-3303-2017	Betz, Marian E./0000-0003-1643-6565				Betz ME, 2015, JAMA-J AM MED ASSOC, V314, P449, DOI 10.1001/jama.2015.7055; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					893	893		10.7326/L16-0544	http://dx.doi.org/10.7326/L16-0544			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992910				2022-12-28	WOS:000391236900031
J	Komnenic, A				Komnenic, Ana			RESEARCH MISCONDUCT In Canada, case spurs concern over misconduct secrecy	SCIENCE			English	News Item									[Komnenic, Ana] Retract Watch, New York, NY 10036 USA		Komnenic, A (corresponding author), Retract Watch, New York, NY 10036 USA.								0	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1361	1361		10.1126/science.354.6318.1361	http://dx.doi.org/10.1126/science.354.6318.1361			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980163				2022-12-28	WOS:000390261300012
J	Peeks, MD; Claridge, TDW; Anderson, HL				Peeks, Martin D.; Claridge, Timothy D. W.; Anderson, Harry L.			Aromatic and antiaromatic ring currents in a molecular nanoring	NATURE			English	Article							PARAMAGNETIC-SUSCEPTIBILITY; DENSITY FUNCTIONALS; 2-DIMENSIONAL NMR; THERMOCHEMISTRY; KINETICS; EXCHANGE; SERIES	Aromatic and antiaromatic molecules-which have delocalized circuits of [4n + 2] or [4n] electrons, respectively-exhibit ring currents around their perimeters1-4. The direction of the ring current in an aromatic molecule is such as to generate a magnetic field that opposes the external field inside the ring (a 'diatropic' current), while the ring current in an antiaromatic molecule flows in the reverse direction ('paratropic')(5). Similar persistent currents occur in metal or semiconductor rings, when the phase coherence of the electronic wavefunction is preserved around the ring(6,7). Persistent currents in non-molecular rings switch direction as a function of the magnetic flux passing through the ring, so that they can be changed from diatropic ('aromatic') to paratropic ('antiaromatic') simply by changing the external magnetic field. As in molecular systems, the direction of the persistent current also depends on the number of electrons(8). The relationship between ring currents in molecular and non-molecular rings is poorly understood, partly because they are studied in different size regimes: the largest aromatic molecules have diameters of about one nanometre, whereas persistent currents are observed in microfabricated rings with diameters of 20-1,000 nanometres. Understanding the connection between aromaticity and quantum-coherence effects in mesoscopic rings provides a motivation for investigating ring currents in molecules of an intermediate size(9). Here we show, using nuclear magnetic resonance spectroscopy and density functional theory, that a six-porphyrin nanoring template complex, with a diameter of 2.4 nanometres, is antiaromatic in its 4+ oxidation state (80 pi electrons) and aromatic in its 6+ oxidation state (78 pi electrons). The antiaromatic state has a huge paramagnetic susceptibility, despite having no unpaired electrons. This work demonstrates that a global ring current can be promoted in a macrocycle by adjusting its oxidation state to suppress the local ring currents of its components. The discovery of ring currents around a molecule with a circumference of 7.5 nanometres, at room temperature, shows that quantum coherence can persist in surprisingly large molecular frameworks.	[Peeks, Martin D.; Claridge, Timothy D. W.; Anderson, Harry L.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Anderson, HL (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	harry.anderson@chem.ox.ac.uk	Claridge, Tim/A-8324-2018; Anderson, Harry Laurence/E-7843-2011; Peeks, Martin D./N-6628-2017	Claridge, Tim/0000-0001-5583-6460; Anderson, Harry Laurence/0000-0002-1801-8132; Peeks, Martin D./0000-0002-9057-9444	ERC [320969]; EPSRC; John Templeton Foundation; Exeter College, Oxford; EPSRC [EP/M016110/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M016110/1] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); John Templeton Foundation; Exeter College, Oxford; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the ERC (grant 320969), the EPSRC and the John Templeton Foundation for support, B. Odell for help with NMR spectroscopy and the Oxford Advanced Research Computing (ARC) centre for the high-performance computing provision (http://dx.doi.org/10.5281/zenodo.22558). M.D.P. thanks Exeter College, Oxford, for further support.	BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bleszynski-Jayich AC, 2009, SCIENCE, V326, P272, DOI 10.1126/science.1178139; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; Choi CH, 1998, J CHEM PHYS, V108, P6681, DOI 10.1063/1.476083; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; DAUBEN HJ, 1969, J AM CHEM SOC, V91, P1991, DOI 10.1021/ja01036a022; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Geuenich D, 2005, CHEM REV, V105, P3758, DOI 10.1021/cr0300901; Gleiter R., 2012, AROMATICITY OTHER CO, P72; Gomes JANF, 2001, CHEM REV, V101, P1349, DOI 10.1021/cr990323h; GOUTERMAN M, 1961, J MOL SPECTROSC, V6, P138, DOI 10.1016/0022-2852(61)90236-3; GRANT DH, 1995, J CHEM EDUC, V72, P39, DOI 10.1021/ed072p39; GREEN MLH, 1992, ORGANOMETALLICS, V11, P2660, DOI 10.1021/om00043a059; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Karunanithy G, 2016, CHEM COMMUN, V52, P7450, DOI 10.1039/c6cc02544g; Kondratuk DV, 2015, NAT CHEM, V7, P317, DOI [10.1038/NCHEM.2182, 10.1038/nchem.2182]; Krygowski TM, 2000, TETRAHEDRON, V56, P1783, DOI 10.1016/S0040-4020(99)00979-5; Lazzeretti P, 2000, PROG NUCL MAG RES SP, V36, P1, DOI 10.1016/S0079-6565(99)00021-7; Lin VSY, 1995, CHEM-EUR J, V1, P645, DOI 10.1002/chem.19950010913; Liu PP, 2016, ANGEW CHEM INT EDIT, V55, P8358, DOI 10.1002/anie.201602909; Liu SQ, 2015, ANGEW CHEM INT EDIT, V54, P5355, DOI 10.1002/anie.201412293; Lorke A, 2000, PHYS REV LETT, V84, P2223, DOI 10.1103/PhysRevLett.84.2223; LOSS D, 1991, PHYS REV B, V43, P13762, DOI 10.1103/PhysRevB.43.13762; Mayor M, 2003, ANGEW CHEM INT EDIT, V42, P3176, DOI 10.1002/anie.200250763; Peeks M. D., 2016, DATA AROMATIC ANTIAR; Peeks MD, 2016, PHYS CHEM CHEM PHYS, V18, P5264, DOI 10.1039/c5cp06167a; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Piguet C, 1997, J CHEM EDUC, V74, P815, DOI 10.1021/ed074p815; Rassolov VA, 1998, J CHEM PHYS, V109, P1223, DOI 10.1063/1.476673; SCHUBERT EM, 1992, J CHEM EDUC, V69, P62, DOI 10.1021/ed069p62.1; Soncini A, 2004, PHYS CHEM CHEM PHYS, V6, P277, DOI 10.1039/b311487b; Soya T, 2015, CHEM-EUR J, V21, P8341, DOI 10.1002/chem.201500650; Spitler EL, 2006, CHEM REV, V106, P5344, DOI 10.1021/cr050541c; Sprafke JK, 2011, J AM CHEM SOC, V133, P17262, DOI 10.1021/ja2045919; Tait CE, 2015, J AM CHEM SOC, V137, P8284, DOI 10.1021/jacs.5b04511; Tamura R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045418; Tellgren EI, 2009, PHYS CHEM CHEM PHYS, V11, P5489, DOI 10.1039/b822262b; Toriumi N, 2015, J AM CHEM SOC, V137, P82, DOI 10.1021/ja511320f; Wannere CS, 2003, ORG LETT, V5, P865, DOI 10.1021/ol027571b; Yamamoto Y, 2010, J AM CHEM SOC, V132, P12627, DOI 10.1021/ja102817a; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	45	142	142	9	147	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					200	+		10.1038/nature20798	http://dx.doi.org/10.1038/nature20798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	27992878	Green Submitted			2022-12-28	WOS:000396125500037
J	Topol, EJ				Topol, Eric J.			Is There an ICD-10 Code for Hyperbole?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Topol, Eric J.] Scripps Translat Sci Inst, Scripps Genom Med, La Jolla, CA 92037 USA	Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, Scripps Genom Med, La Jolla, CA 92037 USA.	etopol@scripps.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					10	11		10.1001/jama.2016.19011	http://dx.doi.org/10.1001/jama.2016.19011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030677				2022-12-28	WOS:000391009100001
J	Gilhus, NE				Gilhus, Nils E.			Myasthenia Gravis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CLINICAL CHARACTERISTICS; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; CANCER-RISK; PROTEIN 4; TRIAL; AUTOANTIBODIES; AZATHIOPRINE; ANTIBODIES; THYMECTOMY		[Gilhus, Nils E.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Gilhus, Nils E.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Gilhus, NE (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.	nils.gilhus@uib.no						Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Argov Z, 2015, EUR J NEUROL, V22, P31, DOI 10.1111/ene.12604; Ashfaq A, 2016, J PEDIATR SURG, V51, P1078, DOI 10.1016/j.jpedsurg.2015.12.016; Barth D, 2011, NEUROLOGY, V76, P2017, DOI 10.1212/WNL.0b013e31821e5505; Benatar M, 2016, MUSCLE NERVE, V53, P363, DOI 10.1002/mus.24769; Benatar M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005081.pub3; Binks S, 2016, J NEUROL, V263, P826, DOI 10.1007/s00415-015-7963-5; Bryant A, 2016, JAMA NEUROL, V73, P652, DOI 10.1001/jamaneurol.2016.0113; Burns TM, 2015, MUSCLE NERVE, V51, P635, DOI 10.1002/mus.24608; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Cea G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008111.pub2; Chiou-Tan FY, 2015, MUSCLE NERVE, V52, P455, DOI 10.1002/mus.24745; Dalakas MC, 2015, THER ADV NEUROL DISO, V8, P316, DOI 10.1177/1756285615605700; Ferrero S, 2005, EUR J OBSTET GYN R B, V121, P129, DOI 10.1016/j.ejogrb.2005.01.002; Flanagan EP, 2016, ANN NEUROL, V79, P775, DOI 10.1002/ana.24617; Freitas E, 2015, RHEUMATOL INT, V35, P243, DOI 10.1007/s00296-014-3066-3; Gajdos P, 1997, ANN NEUROL, V41, P789, DOI 10.1002/ana.410410615; Gajdos P, 2012, COCHRANE DB SYST REV, V12; Gallardo E, 2014, AUTOIMMUN REV, V13, P1003, DOI 10.1016/j.autrev.2014.08.039; Gasperi C, 2014, NEUROLOGY, V82, P1976, DOI 10.1212/WNL.0000000000000478; Gilhus NE, 2015, EUR J NEUROL, V22, P17, DOI 10.1111/ene.12599; Gilhus NE, 2016, NAT REV NEUROL, V12, P259, DOI 10.1038/nrneurol.2016.44; Gilhus NE, 2015, LANCET NEUROL, V14, P1023, DOI 10.1016/S1474-4422(15)00145-3; Gilhus NE, 2009, NAT CLIN PRACT NEURO, V5, P8, DOI 10.1038/ncpneuro0988; Gotaas HT, 2016, NEUROMUSCULAR DISORD, V26, P337, DOI 10.1016/j.nmd.2016.03.003; Gronseth GS, 2000, NEUROLOGY, V55, P7, DOI 10.1212/WNL.55.1.7; Guptill JT, 2011, MUSCLE NERVE, V44, P36, DOI 10.1002/mus.22006; HART IK, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005224.PUB2; Heldal AT, 2009, NEUROLOGY, V73, P150, DOI 10.1212/WNL.0b013e3181ad53c2; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoff JM, 2007, EUR J NEUROL, V14, P38, DOI 10.1111/j.1468-1331.2006.01538.x; Hong Y, 2016, J NEUROIMMUNOL, V298, P51, DOI 10.1016/j.jneuroim.2016.07.001; Huijbers MG, 2014, J INTERN MED, V275, P12, DOI 10.1111/joim.12163; Iorio R, 2015, J NEUROL, V262, P1115, DOI 10.1007/s00415-014-7532-3; Jordan B, 2016, J NEUROL, V263, P641, DOI 10.1007/s00415-016-8023-5; Kerty E, 2014, EUR J NEUROL, V21, P687, DOI 10.1111/ene.12359; Keung B, 2013, J NEUROL NEUROSUR PS, V84, P1407, DOI 10.1136/jnnp-2012-303664; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Liew WKM, 2013, CURR OPIN PEDIATR, V25, P694, DOI 10.1097/MOP.0b013e328365ad16; Liu CJ, 2012, EUR J NEUROL, V19, P746, DOI 10.1111/j.1468-1331.2011.03621.x; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Mavrogeni S, 2016, INT J CARDIOL, V202, P629, DOI 10.1016/j.ijcard.2015.09.055; Milo R, 2016, AUTOIMMUN REV, V15, P714, DOI 10.1016/j.autrev.2016.03.006; Na RH, 2016, J AM ACAD DERMATOL, V74, P1144, DOI 10.1016/j.jaad.2015.12.044; Nacu A, 2015, AUTOIMMUNITY, V48, P362, DOI 10.3109/08916934.2015.1030614; Norwood F, 2014, J NEUROL NEUROSUR PS, V85, P538, DOI 10.1136/jnnp-2013-305572; Owe JF, 2006, J NEUROL NEUROSUR PS, V77, P203, DOI 10.1136/jnnp.2005.072355; Owe JF, 2010, J NEUROL SCI, V290, P66, DOI 10.1016/j.jns.2009.11.006; Owe JF, 2008, J NEUROL, V255, P1777, DOI 10.1007/s00415-008-0049-x; Palace J, 1998, NEUROLOGY, V50, P1778, DOI 10.1212/WNL.50.6.1778; Pasnoor M, 2016, NEUROLOGY, V87, P57, DOI 10.1212/WNL.0000000000002795; Pedersen EG, 2014, EUR J NEUROL, V21, P773, DOI 10.1111/ene.12383; Pedersen EG, 2014, EUR J NEUROL, V21, P454, DOI 10.1111/ene.12329; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Rae W, 2016, J NEUROIMMUNOL, V293, P82, DOI 10.1016/j.jneuroim.2016.02.015; Reichert JM, 2016, MABS-AUSTIN, V8, P197, DOI 10.1080/19420862.2015.1125583; Renton AE, 2015, JAMA NEUROL, V72, P396, DOI 10.1001/jamaneurol.2014.4103; Romi F, 2005, ARCH NEUROL-CHICAGO, V62, P442, DOI 10.1001/archneur.62.3.442; Romi F, 2012, J NEUROL, V259, P1312, DOI 10.1007/s00415-011-6344-y; Sanders DB, 2008, NEUROLOGY, V71, P394, DOI 10.1212/01.wnl.0000312373.67493.7f; Sanders DB, 2016, NEUROLOGY, V87, P419, DOI 10.1212/WNL.0000000000002790; Sanderson JD, 2015, GASTROENTEROLOGY, V149, P850, DOI 10.1053/j.gastro.2015.08.040; Saruhan-Direskeneli G, 2016, CLIN IMMUNOL, V166, P81, DOI 10.1016/j.clim.2016.05.003; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Staff NP, 2016, NEUROMUSCULAR DISORD, V26, P335, DOI 10.1016/j.nmd.2016.04.010; Steinman L, 2013, JAMA NEUROL, V70, P1100, DOI 10.1001/jamaneurol.2013.3553; Stergiou C, 2016, J NEUROIMMUNOL, V292, P108, DOI 10.1016/j.jneuroim.2016.01.018; Suzuki S, 2014, EUR J NEUROL, V21, P223, DOI 10.1111/ene.12234; Suzuki S, 2009, ARCH NEUROL-CHICAGO, V66, P1334, DOI 10.1001/archneurol.2009.229; TINDALL RSA, 1993, ANN NY ACAD SCI, V681, P539, DOI 10.1111/j.1749-6632.1993.tb22937.x; van den Heuvel TRA, 2016, INT J CANCER, V139, P1270, DOI 10.1002/ijc.30183; VanderPluym J, 2013, PEDIATRICS, V132, pE939, DOI 10.1542/peds.2013-0814; Verschuuren J, 2016, HAND CLINIC, V133, P447, DOI 10.1016/B978-0-444-63432-0.00024-4; Wolfe GI, 2016, NEW ENGL J MED, V375, P511, DOI 10.1056/NEJMoa1602489; Yeh JH, 2014, NEUROMUSCULAR DISORD, V24, P245, DOI 10.1016/j.nmd.2013.11.007; Yoshikawa H, 2011, J NEUROL NEUROSUR PS, V82, P970, DOI 10.1136/jnnp-2011-300148; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zisimopoulou P, 2013, AUTOIMMUN REV, V12, P924, DOI 10.1016/j.autrev.2013.03.002	78	396	422	12	170	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2570	2581		10.1056/NEJMra1602678	http://dx.doi.org/10.1056/NEJMra1602678			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	28029925				2022-12-28	WOS:000391175300010
J	Railey, MT; Railey, KM; Hauptman, PJ				Railey, Michael T.; Railey, Kenyon M.; Hauptman, Paul J.			Reducing Bias in Academic Search Committees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Railey, Michael T.] St Louis Univ, Sch Med, Dept Family & Community Med, 1402 S Grand Blvd,Caroline Bldg,First Floor, St Louis, MO 63104 USA; [Railey, Kenyon M.] Duke Univ, Sch Med, Dept Family & Community Med, Durham, NC USA; [Hauptman, Paul J.] St Louis Univ, Sch Med, Dept Med Cardiol, St Louis, MO USA	Saint Louis University; Duke University; Saint Louis University	Railey, MT (corresponding author), St Louis Univ, Sch Med, Dept Family & Community Med, 1402 S Grand Blvd,Caroline Bldg,First Floor, St Louis, MO 63104 USA.	raileymt@slu.edu						[Anonymous], 1995, 3 DEC MASS IMM LEG 1; Association of American Medical Colleges (AAMC), 2015, TABL 11 DISTR US MED; Hunt V, 2015, WHY DIVERSITY MATTER; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Pew Research Center, 2012, AS AM	5	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2595	2596		10.1001/jama.2016.17540	http://dx.doi.org/10.1001/jama.2016.17540			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027377				2022-12-28	WOS:000391110200009
J	Bouet, PE; Herondelle, C				Bouet, Pierre-Emmanuel; Herondelle, Charlyne			Uterine Rupture with Protruded Legs in a Large Amniocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bouet, Pierre-Emmanuel; Herondelle, Charlyne] CHU Angers, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Bouet, PE (corresponding author), CHU Angers, Angers, France.	pebouet@hotmail.com							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					E51	E51		10.1056/NEJMicm1603843	http://dx.doi.org/10.1056/NEJMicm1603843			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002703				2022-12-28	WOS:000390091500001
J	Griffiths, CA; Sagar, R; Geng, Y; Primavesi, LF; Patel, MK; Passarelli, MK; Gilmore, IS; Steven, RT; Bunch, J; Paul, MJ; Davis, BG				Griffiths, Cara A.; Sagar, Ram; Geng, Yiqun; Primavesi, Lucia F.; Patel, Mitul K.; Passarelli, Melissa K.; Gilmore, Ian S.; Steven, Rory T.; Bunch, Josephine; Paul, Matthew J.; Davis, Benjamin G.			Chemical intervention in plant sugar signalling increases yield and resilience	NATURE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; TREHALOSE 6-PHOSPHATE; MASS-SPECTROMETRY; SCALE SYNTHESIS; CAGED COMPOUNDS; STARCH; TREHALOSE-6-PHOSPHATE; INHIBITION; TISSUES; METABOLITES	The pressing global issue of food insecurity due to population growth, diminishing land and variable climate can only be addressed in agriculture by improving both maximum crop yield potential and resilience(1,2). Genetic modification is one potential solution, but has yet to achieve worldwide acceptance, particularly for crops such as wheat(3). Trehalose-6-phosphate (T6P), a central sugar signal in plants, regulates sucrose use and allocation, underpinning crop growth and development(4,5). Here we show that application of a chemical intervention strategy directly modulates T6P levels in planta. Plant-permeable analogues of T6P were designed and constructed based on a 'signalling-precursor' concept for permeability, ready uptake and sunlight-triggered release of T6P in planta. We show that chemical intervention in a potent sugar signal increases grain yield, whereas application to vegetative tissue improves recovery and resurrection from drought. This technology offers a means to combine increases in yield with crop stress resilience. Given the generality of the T6P pathway in plants and other small-molecule signals in biology, these studies suggest that suitable synthetic exogenous small-molecule signal precursors can be used to directly enhance plant performance and perhaps other organism function.	[Griffiths, Cara A.; Primavesi, Lucia F.; Paul, Matthew J.] Rothamsted Res, Plant Biol & Crop Sci, Harpenden AL5 2JQ, Herts, England; [Sagar, Ram; Geng, Yiqun; Patel, Mitul K.; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Passarelli, Melissa K.; Gilmore, Ian S.; Steven, Rory T.; Bunch, Josephine] Natl Ctr Excellence Mass Spectrometry Imaging NiC, Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Bunch, Josephine] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Sagar, Ram] Shiv Nadar Univ, Sch Nat Sci, Dept Chem, Greater Noida 201314, India	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Oxford; National Physical Laboratory - UK; University of Nottingham; Shiv Nadar University	Paul, MJ (corresponding author), Rothamsted Res, Plant Biol & Crop Sci, Harpenden AL5 2JQ, Herts, England.; Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	matthew.paul@rothamsted.ac.uk; Ben.Davis@chem.ox.ac.uk	Paul, Matthew J/R-6384-2016; Davis, Benjamin G/C-5281-2011; Passarelli, Melissa/AAQ-3407-2021; Sagar, Ram/I-8819-2019	Paul, Matthew J/0000-0002-2001-961X; Davis, Benjamin G/0000-0002-5056-407X; Sagar, Ram/0000-0003-2472-6247; Primavesi, Lucia/0000-0003-3719-4569; Bunch, Josephine/0000-0002-4257-1296	BBSRC Selective Chemical Intervention in Biological Systems initiative [BB/D006112/1]; BBSRC Sparking Impact initiative; ICL Innovations; 3D NanoSIMS and AIMS-HIGHER projects of the Chemical and Biological programme of the National Measurement System of the UK Department of Business, Innovation and Skills; Royal Society Wolfson Research Merit Award; BBSRC; BBSRC [BBS/E/C/00005202, BB/D006112/1, BB/N004205/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N004205/1, BB/D006112/1, BBS/E/C/00005202] Funding Source: researchfish	BBSRC Selective Chemical Intervention in Biological Systems initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Sparking Impact initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ICL Innovations; 3D NanoSIMS and AIMS-HIGHER projects of the Chemical and Biological programme of the National Measurement System of the UK Department of Business, Innovation and Skills(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the BBSRC Selective Chemical Intervention in Biological Systems initiative (grant reference BB/D006112/1), the BBSRC Sparking Impact initiative and ICL Innovations for funding. We thank R. H. Bromilow, S. Powers, E. Tobolkina, for advice and J. Wickens for technical assistance. NiCE-MSI is supported by the 3D NanoSIMS and AIMS-HIGHER projects of the Chemical and Biological programme of the National Measurement System of the UK Department of Business, Innovation and Skills. B.G.D. was a Royal Society Wolfson Research Merit Award recipient during the period of research. Rothamsted Research receives strategic funding from the BBSRC.	ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; Arslan T, 1997, J AM CHEM SOC, V119, P10877, DOI 10.1021/ja971927a; BILLINGTON DC, 1989, CHEM SOC REV, V18, P83, DOI 10.1039/cs9891800083; Bjarnholt N, 2014, NAT PROD REP, V31, P818, DOI 10.1039/c3np70100j; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cha SW, 2008, PLANT J, V55, P348, DOI 10.1111/j.1365-313X.2008.03507.x; Cheng J, 2005, ANAL CHEM, V77, P3651, DOI 10.1021/ac048131w; Clarke ED, 2003, CHIMIA, V57, P731, DOI 10.2533/000942903777678641; Delatte TL, 2009, ANAL BIOCHEM, V389, P12, DOI 10.1016/j.ab.2009.03.003; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Figueroa CM, 2016, PLANT PHYSIOL, V172, P7, DOI 10.1104/pp.16.00417; Givens R S, 1998, Methods Enzymol, V291, P1; GIVENS RS, 1993, CHEM REV, V93, P55, DOI 10.1021/cr00017a004; Hadrich N, 2012, PLANT J, V70, P231, DOI 10.1111/j.1365-313X.2011.04860.x; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Kirkwood R. C., 1991, TARGET SITES HERBICI; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Lobell DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074003; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; McKibbin RS, 2006, PLANT BIOTECHNOL J, V4, P409, DOI 10.1111/j.1467-7652.2006.00190.x; MELDAL M, 1992, CARBOHYD RES, V235, P115, DOI 10.1016/0008-6215(92)80082-C; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; Nunes C, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26626; Pellny TK, 2004, PLANT BIOTECHNOL J, V2, P71, DOI 10.1111/j.1467-7652.2004.00053.x; Race AM, 2012, J PROTEOMICS, V75, P5111, DOI 10.1016/j.jprot.2012.05.035; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; RONNOW TECL, 1994, CARBOHYD RES, V260, P323, DOI 10.1016/0008-6215(94)84050-4; SAMBROOK J, 2000, MOL CLONING LAB MANU; Scheigetz J, 2000, SYNTHETIC COMMUN, V30, P1437, DOI 10.1080/00397910008087172; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Spackman VMT, 2002, J SCI FOOD AGR, V82, P80, DOI 10.1002/jsfa.1005; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Yang M, 2005, CHEMBIOCHEM, V6, P346, DOI 10.1002/cbic.200400100; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	39	110	116	8	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					574	+		10.1038/nature20591	http://dx.doi.org/10.1038/nature20591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27974806	Green Submitted, Green Accepted			2022-12-28	WOS:000391190500050
J	Fernandes, JD; Faust, TB; Strauli, NB; Smith, C; Crosby, DC; Nakamura, RL; Hernandez, RD; Frankel, AD				Fernandes, Jason D.; Faust, Tyler B.; Strauli, Nicolas B.; Smith, Cynthia; Crosby, David C.; Nakamura, Robert L.; Hernandez, Ryan D.; Frankel, Alan D.			Functional Segregation of Overlapping Genes in HIV	CELL			English	Article							READING FRAMES; IMMUNODEFICIENCY-VIRUS; PURIFYING SELECTION; PROTEIN; RNA; EVOLUTION; TAT; IDENTIFICATION; HEMAGGLUTININ; CONSTRAINTS	Overlapping genes pose an evolutionary dilemma as one DNA sequence evolves under the selection pressures of multiple proteins. Here, we perform systematic statistical and mutational analyses of the overlapping HIV-1 genes tat and rev and engineer exhaustive libraries of non-overlapped viruses to perform deep mutational scanning of each gene independently. We find a "segregated'' organization in which overlapped sites encode functional residues of one gene or the other, but never both. Furthermore, this organization eliminates unfit genotypes, providing a fitness advantage to the population. Our comprehensive analysis reveals the extraordinary manner in which HIV minimizes the constraint of overlapping genes and repurposes that constraint to its own advantage. Thus, overlaps are not just consequences of evolutionary constraints, but rather can provide population fitness advantages.	[Fernandes, Jason D.; Faust, Tyler B.; Smith, Cynthia; Crosby, David C.; Nakamura, Robert L.; Frankel, Alan D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Fernandes, Jason D.] Univ Calif San Francisco, Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94158 USA; [Faust, Tyler B.] Univ Calif San Francisco, Tetrad Program, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Strauli, Nicolas B.; Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Strauli, Nicolas B.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frankel, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	frankel@cgl.ucsf.edu		Strauli, Nicolas/0000-0001-8575-006X; Crosby, David/0000-0003-4699-4760; Fernandes, Jason/0000-0002-8625-1796	NIH [T32GM007175, P50GM088250]; Amgen Research Excellence Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175, P50GM082250] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Research Excellence Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. DeRisi and M. Stenglein for barcode sequences and advice for NGS experimental design, and R. Andino and A. Acevedo for use of equipment and advice for performing selection experiments. We also thank P. Babbitt, J. Gross, J. Fraser, R. Andino, M. Daugherty, L. Gitlin and members of the A.D.F. and Andino labs for helpful conversations and review of the manuscript. J.D.F. was supported in part by NIH training grant T32GM007175 and an Amgen Research Excellence Fellowship. This work was supported by NIH grant P50GM088250 to A.D.F.	Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3; Carter JJ, 2013, P NATL ACAD SCI USA, V110, P12744, DOI 10.1073/pnas.1303526110; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Doud MB, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060155; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Feder AF, 2014, GENETICS, V196, P509, DOI 10.1534/genetics.113.158220; Felsenstein J, 2016, THEORETICAL EVOLUTIO; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; Foley B., 2013, HIV SEQUENCE COMPEND; HEIN J, 1995, J MOL EVOL, V40, P181, DOI 10.1007/BF00167112; Hughes AL, 2001, J VIROL, V75, P7966, DOI 10.1128/JVI.75.17.7966-7972.2001; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066211; Keckesova Z, 2009, VIROLOGY, V384, P7, DOI 10.1016/j.virol.2008.10.045; KEESE PK, 1992, P NATL ACAD SCI USA, V89, P9489, DOI 10.1073/pnas.89.20.9489; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Makalowska I, 2005, COMPUT BIOL CHEM, V29, P1, DOI 10.1016/j.compbiolchem.2004.12.006; Maman Y, 2011, J VIROL, V85, P4558, DOI 10.1128/JVI.02142-10; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; MIYATA T, 1978, NATURE, V272, P532, DOI 10.1038/272532a0; Neuveut C, 1996, J VIROL, V70, P5572, DOI 10.1128/JVI.70.8.5572-5581.1996; Ngandu NK, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-160; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pan K, 2011, J R SOC INTERFACE, V8, P1644, DOI 10.1098/rsif.2011.0105; Pavesi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003162; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; Rogozin IB, 2002, TRENDS GENET, V18, P228, DOI 10.1016/S0168-9525(02)02649-5; Sabath N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003996; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SMITH AJ, 1990, J VIROL, V64, P2743, DOI 10.1128/JVI.64.6.2743-2750.1990; Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Thyagarajan B, 2014, ELIFE, V3, DOI 10.7554/eLife.03300; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wei XZ, 2015, GENOME BIOL EVOL, V7, P381, DOI 10.1093/gbe/evu294; Wright S, 1931, GENETICS, V16, P0097; Zaaijer HL, 2007, J GEN VIROL, V88, P2137, DOI 10.1099/vir.0.82906-0; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286	51	30	30	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1762	+		10.1016/j.cell.2016.11.031	http://dx.doi.org/10.1016/j.cell.2016.11.031			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984726	Bronze, Green Accepted			2022-12-28	WOS:000393114700015
J	Zovoilis, A; Cifuentes-Rojas, C; Chu, HP; Hernandez, AJ; Lee, JT				Zovoilis, Athanasios; Cifuentes-Rojas, Catherine; Chu, Hsueh-Ping; Hernandez, Alfredo J.; Lee, Jeannie T.			Destabilization of B2 RNA by EZH2 Activates the Stress Response	CELL			English	Article							REPRESSIVE COMPLEX 2; LONG NONCODING RNAS; POLYMERASE-II TRANSCRIPTION; EMBRYONIC STEM-CELLS; HEAT-SHOCK; POLYCOMB; BINDING; GENOME; IDENTIFICATION; PRC2	More than 98% of the mammalian genome is non-coding, and interspersed transposable elements account for similar to 50% of noncoding space. Here, we demonstrate that a specific interaction between the polycomb protein EZH2 and RNA made from B2 SINE retrotransposons controls stress-responsive genes in mouse cells. In the heat-shock model, B2 RNA binds stress genes and suppresses their transcription. Upon stress, EZH2 is recruited and triggers cleavage of B2 RNA. B2 degradation in turn upregulates stress genes. Evidence indicates that B2 RNA operates as a "speed bump'' against advancement of RNA polymerase II, and temperature stress releases the brakes on transcriptional elongation. These data attribute a new function to EZH2 that is independent of its histone methyltransferase activity and reconcile how EZH2 can be associated with both gene repression and activation. Our study reveals that EZH2 and B2 together control activation of a large network of genes involved in thermal stress.	[Zovoilis, Athanasios; Cifuentes-Rojas, Catherine; Chu, Hsueh-Ping; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Zovoilis, Athanasios; Cifuentes-Rojas, Catherine; Chu, Hsueh-Ping; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Zovoilis, Athanasios; Cifuentes-Rojas, Catherine; Chu, Hsueh-Ping; Lee, Jeannie T.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Hernandez, Alfredo J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Lee, JT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Hernandez, Alfredo J/ABC-8311-2020; Hernandez, Alfredo/AAV-5584-2021	Hernandez, Alfredo J/0000-0002-0903-8932; Zovoilis, Athanasios/0000-0001-6425-0402	German Research Foundation [Zo 287-4-1]; National Institutes of Health [R01-GM090278, K99-GM115868-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090278, K99GM115868] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Lee Lab for many excellent discussions. Special thanks go to J. Froberg for MiSeq experiments, W. Press for optimizing transfection conditions, B. Del Rosario for GST protein, and R. Kingston for sharing the pfastbac plasmids encoding FLAG-EZH2 and -EED. This study was funded by the German Research Foundation (grant no. Zo 287-4-1) to A.Z. and by National Institutes of Health R01-GM090278 to J.T.L. and K99-GM115868-02 to C.C.R. J.T.L. is also an Investigator of the HHMI.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; BACHVAROVA R, 1988, DEV BIOL, V130, P513, DOI 10.1016/0012-1606(88)90346-6; Basenko EY, 2015, P NATL ACAD SCI USA, V112, pE6339, DOI 10.1073/pnas.1511377112; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Budzynski MA, 2015, MOL CELL BIOL, V35, P2530, DOI 10.1128/MCB.00816-14; Chircop M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00304; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Duarte FM, 2016, GENE DEV, V30, P1731, DOI 10.1101/gad.284430.116; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; FORNACE AJ, 1986, NUCLEIC ACIDS RES, V14, P5793, DOI 10.1093/nar/14.14.5793; Hasties N., 1989, GENETIC VARIANTS STR; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Kaczkowski B, 2016, CANCER RES, V76, P216, DOI 10.1158/0008-5472.CAN-15-0484; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kleinmanns JA, 2014, BIOL CHEM, V395, P1291, DOI 10.1515/hsz-2014-0197; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Lowe CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043128; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Moolhuijzen P, 2010, FUNCT INTEGR GENOMIC, V10, P307, DOI 10.1007/s10142-010-0168-1; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Ponicsan Steven L., 2015, Non-Coding RNA, V1, P4, DOI 10.3390/ncrna1010004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Schein A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33605; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simon Matthew D, 2013, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2125s101; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; SINGH K, 1985, NATURE, V314, P553, DOI 10.1038/314553a0; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wagner SD, 2013, EMBO J, V32, P781, DOI 10.1038/emboj.2013.18; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	55	49	49	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1788	+		10.1016/j.cell.2016.11.041	http://dx.doi.org/10.1016/j.cell.2016.11.041			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984727	Green Accepted, Bronze			2022-12-28	WOS:000393114700017
J	Gupta, A; Khanna, S				Gupta, Arjun; Khanna, Sahil			Repeat Clostridium difficile Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION; PREVENTION; DIAGNOSIS; TRIAL; TIME		[Gupta, Arjun] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Khanna, Sahil] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic	Khanna, S (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.	khanna.sahil@mayo.edu						Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Gerding DN, 2015, JAMA-J AM MED ASSOC, V313, P1719, DOI 10.1001/jama.2015.3725; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; Sunkesula VCK, 2013, CLIN INFECT DIS, V57, P494, DOI 10.1093/cid/cit286; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Wadhwa A, 2016, ALIMENT PHARM THER, V44, P576, DOI 10.1111/apt.13737	9	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2422	2423		10.1001/jama.2016.17173	http://dx.doi.org/10.1001/jama.2016.17173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959982				2022-12-28	WOS:000389884600023
J	Jurecic, A; Marchalik, D				Jurecic, Ann; Marchalik, Daniel			From literature to medicine Breathing lessons: Paul Kalanithi's When Breath Becomes Air	LANCET			English	Editorial Material									[Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA; [Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC USA	Rutgers State University New Brunswick; Georgetown University	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2859	2859		10.1016/S0140-6736(16)32470-9	http://dx.doi.org/10.1016/S0140-6736(16)32470-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27979398				2022-12-28	WOS:000389631700018
J	Murphy, HR; Stewart, ZA				Murphy, Helen R.; Stewart, Zoe A.			Automated insulin delivery: what's new, needed, and next?	LANCET			English	Editorial Material							ARTIFICIAL PANCREAS; TYPE-1		[Murphy, Helen R.] Univ East Anglia, Norwich Med Sch, Norwich NR4 7UQ, Norfolk, England; [Stewart, Zoe A.] Univ Cambridge, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge CB2 0QQ, England	University of East Anglia; University of Cambridge	Murphy, HR (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich NR4 7UQ, Norfolk, England.	hm386@medschl.cam.ac.uk		Murphy, Helen/0000-0002-5489-0614	National Institute for Health Research; Diabetes UK; National Institute for Health Research [CDF-2013-06-035, PDF/01/036, ACF-2016-14-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Diabetes UK(Diabetes UK); National Institute for Health Research(National Institute for Health Research (NIHR))	HRM declares grants from the National Institute for Health Research and Diabetes UK; non-financial support from Abbott Diabetes Care USA for previous closed-loop studies; and membership of the European Scientific Advisory Board of Medtronic, an insulin pump manufacturer, and of the UK Key Opinion Leader Board. ZAS declares no competing interests.	Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708; Dassau E, 2013, DIABETES CARE, V36, P801, DOI 10.2337/dc12-0948; El-Khatib FH, 2016, LANCET; Huyett L, 2016, LANCET DIABETES ENDO, V4, P880, DOI 10.1016/S2213-8587(16)30144-9; Kumareswaran Kavita, 2011, J Diabetes Sci Technol, V5, P1352; Lewis Dana, 2016, J Diabetes Sci Technol, V10, P1411; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Russell SJ, 2016, DIABETES CARE, V39, P1161, DOI 10.2337/dc15-2449; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Stewart ZA, 2016, NEW ENGL J MED, V375, P644, DOI 10.1056/NEJMoa1602494; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351	11	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					333	+		10.1016/S0140-6736(16)32591-0	http://dx.doi.org/10.1016/S0140-6736(16)32591-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28007347				2022-12-28	WOS:000392804700004
J	Ananthakrishnan, AN				Ananthakrishnan, Ashwin N.			Filgotinib for Crohn's disease-expanding treatment options	LANCET			English	Editorial Material							DOSE INTENSIFICATION; TOFACITINIB		[Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Ananthakrishnan, Ashwin N.] Harvard Med Sch, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ananthakrishnan, AN (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Ananthakrishnan, AN (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.	aananthakrishnan@mgh.harvard.edu			Merck; Takeda; Exact Sciences; Amgen; US National Institutes of Health [K23 DK097142]	Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); Exact Sciences; Amgen(Amgen); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I have received consultancy fees from: AbbVie unrelated to the current work (served on scientific advisory boards to define unmet needs in delivery of inflammatory bowel disease care); Merck (to identify burden and treatment of recurrent Clostridium difficile infection); Takeda (as a member of a Crohn's and colitis focus group to advance research and clinical care in inflammatory bowel disease); and Exact Sciences (to optimise use of faecal DNA testing for colon cancer screening). I have received research funding from Merck (to define costs associated with recurrent Clostridium difficile infection) and Amgen (to identify predictors of response to biological therapy). I am supported by funding from the US National Institutes of Health (K23 DK097142).	Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Danese S, 2016, AM J PHYSIOL-GASTR L, V310, pG155, DOI 10.1152/ajpgi.00311.2015; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Hazlewood GS, 2015, GASTROENTEROLOGY, V148, P344, DOI 10.1053/j.gastro.2014.10.011; Khanna R, 2016, GUT, V65, P1119, DOI 10.1136/gutjnl-2014-308973; MacDonald JK, 2016, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD007572.PUB3; Sandborn WJ, 2014, CLIN GASTROENTEROL H, V12, P1485, DOI 10.1016/j.cgh.2014.01.029; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Scott Frank I, 2016, Curr Treat Options Gastroenterol, V14, P91, DOI 10.1007/s11938-016-0085-z; Vermeire S, 2016, LANCET	13	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					228	229		10.1016/S0140-6736(16)32538-7	http://dx.doi.org/10.1016/S0140-6736(16)32538-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	27988141				2022-12-28	WOS:000392801200005
J	Nadkarni, A; Weobong, B; Weiss, HA; McCambridge, J; Bhat, B; Katti, B; Murthy, P; King, M; McDaid, D; Park, AL; Wilson, GT; Kirkwood, B; Fairburn, CG; Velleman, R; Patel, V				Nadkarni, Abhijit; Weobong, Benedict; Weiss, Helen A.; McCambridge, Jim; Bhat, Bhargav; Katti, Basavaraj; Murthy, Pratima; King, Michael; McDaid, David; Park, A-La; Wilson, G. Terence; Kirkwood, Betty; Fairburn, Christopher G.; Velleman, Richard; Patel, Vikram			Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial	LANCET			English	Article							USE DISORDERS; SYSTEMATIC DEVELOPMENT; SEVERE DEPRESSION; CONSUMPTION; INTERVENTIONS; OUTCOMES; DRINKERS	Background Although structured psychological treatments are recommended as first-line interventions for harmful drinking, only a small fraction of people globally receive these treatments because of poor access in routine primary care. We assessed the effectiveness and cost-effectiveness of Counselling for Alcohol Problems (CAP), a brief psychological treatment delivered by lay counsellors to patients with harmful drinking attending routine primary health-care settings. Methods In this randomised controlled trial, we recruited male harmful drinkers defined by an Alcohol Use Disorders Identification Test (AUDIT) score of 12-19 who were aged 18-65 years from ten primary health centres in Goa, India. We excluded patients who needed emergency medical treatment or inpatient admission, who were unable to communicate clearly, and who were intoxicated at the time of screening. Participants were randomly allocated (1: 1) by trained health assistants based at the primary health centres to enhanced usual care (EUC) alone or EUC combined with CAP, in randomly sized blocks of four to six, stratified by primary health centre, and allocation was concealed with use of sequential numbered opaque envelopes. Physicians providing EUC and those assessing outcomes were masked. Primary outcomes were remission (AUDIT score of <8) and mean daily alcohol consumed in the past 14 days, at 3 months. Secondary outcomes were the effect of drinking, disability score, days unable to work, suicide attempts, intimate partner violence, and resource use and costs of illness. Analyses were on an intention-to-treat basis. We used logistic regression analysis for remission and zero-inflated negative binomial regression analysis for alcohol consumption. We assessed serious adverse events in the per-protocol population. This trial is registered with the ISCRTN registry, number ISRCTN76465238. Findings Between Oct 28, 2013, and July 29, 2015, we enrolled and randomly allocated 377 participants (188 [50%] to the EUC plus CAP group and 190 [50%] to the EUC alone group [one of whom was subsequently excluded because of a protocol violation]), of whom 336 (89%) completed the 3 month primary outcome assessment (164 [87%] in the EUC plus CAP group and 172 [91%] in the EUC alone group). The proportion with remission (59 [36%] of 164 in the EUC plus CAP group vs 44 [26%] of 172 in the EUC alone group; adjusted prevalence ratio 1.50 [95% CI 1.09-2.07]; p=0.01) and the proportion abstinent in the past 14 days (68 [42%] vs 31 [18%]; adjusted odds ratio 3.00 [1.76-5.13]; p<0.0001) were significantly higher in the EUC plus CAP group than in the EUC alone group, but we noted no effect on mean daily alcohol consumed in the past 14 days among those who reported drinking in this period (37.0 g [SD 44.2] vs 31.0 g [27.8]; count ratio 1.08 [0.79-1.49]; p=0.62). We noted an effect on the percentage of days abstinent in the past 14 days (adjusted mean difference [AMD] 16.0% [8.1-24.1]; p<0.0001), but no effect on the percentage of days of heavy drinking (AMD -0.4% [-5.7 to 4.9]; p=0.88), the effect of drinking (Short Inventory of Problems score AMD-0.03 [-1.93 to 1.86]; p=0.97), disability score (WHO Disability Assessment Schedule score AMD 0.62 [-0.62 to 1.87]; p=0.32), days unable to work (no days unable to work adjusted odds ratio 1.02 [0.61-1.69]; p=0.95), suicide attempts (adjusted prevalence ratio 1.8 [-2.4 to 6.0]; p=0.25), and intimate partner violence (adjusted prevalence ratio 3.0 [-10.4 to 4.4]; p=0.57). The incremental cost per additional remission was $ 217 (95% CI 50-1073), with an 85% chance of being cost-effective in the study setting. We noted no significant difference in the number of serious adverse events between the two groups (six [4%] in the EUC plus CAP group vs 13 [8%] in the EUC alone group; p=0.11). Interpretation CAP delivered by lay counsellors plus EUC was better than EUC alone was for harmful drinkers in routine primary health-care settings, and might be cost-effective. CAP could be a key strategy to reduce the treatment gap for alcohol use disorders, one of the leading causes of the global burden among men worldwide. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Nadkarni, Abhijit; Bhat, Bhargav; Velleman, Richard; Patel, Vikram] Sangath Ctr, Bardez Goa 403521, Goa, India; [Nadkarni, Abhijit; Weobong, Benedict; Weiss, Helen A.; Kirkwood, Betty; Patel, Vikram] London Sch Hyg & Trop Med, London, England; [McCambridge, Jim] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Murthy, Pratima] Natl Inst Mental Hlth & Neurosci, Bengaluru, India; [King, Michael] UCL, Div Psychiat, London, England; [McDaid, David; Park, A-La] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London, England; [Wilson, G. Terence] Rutgers Sch Arts & Sci, Dept Psychol, New Brunswick, NJ USA; [Fairburn, Christopher G.] Univ Oxford, Dept Psychiat, Oxford, England; [Velleman, Richard] Univ Bath, Dept Psychol, Bath, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of York - UK; National Institute of Mental Health & Neurosciences - India; University of London; University College London; University of London; London School Economics & Political Science; Rutgers State University New Brunswick; University of Oxford; University of Bath	Patel, V (corresponding author), Sangath Ctr, Bardez Goa 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Velleman, Richard/P-3697-2018; Fairburn, Christopher/AAM-9792-2020; McDaid, David/E-5959-2014; Park, A-La/W-2101-2018; weiss, helen/ABC-7823-2021; Fairburn, Christopher/AAG-6234-2019; Nadkarni, Abhijit/AAX-7119-2021	Fairburn, Christopher/0000-0002-9673-9795; McDaid, David/0000-0003-0744-2664; Park, A-La/0000-0002-4704-4874; weiss, helen/0000-0003-3547-7936; Nadkarni, Abhijit/0000-0001-5832-5236; McCambridge, Jim/0000-0002-5461-7001; Kirkwood, Betty/0000-0001-5274-6072	Wellcome Trust [091834]; Directorate of Health Services of the Government of Goa; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Directorate of Health Services of the Government of Goa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Wellcome Trust.; This research was funded by a Wellcome Trust Senior Research Fellowship grant to VP (091834). We also acknowledge the generous partnership and support from the Directorate of Health Services of the Government of Goa.	Allen J, 1998, ALCOHOL CLIN EXP RES, V22, P1300; Babor T., 2001, BRIEF INTERVENTION H; Babor TF, 2000, J STUD ALCOHOL, V61, P55, DOI 10.15288/jsa.2000.61.55; Buttorff C, 2012, B WORLD HEALTH ORGAN, V90, P813, DOI 10.2471/BLT.12.104133; Chisholm D, 2000, BRIT J PSYCHIAT, V177, pS28, DOI 10.1192/bjp.177.39.s28; Chowdhary N, 2016, BRIT J PSYCHIAT, V208, P381, DOI 10.1192/bjp.bp.114.161075; Essex HN, 2014, QUAL LIFE RES, V23, P735, DOI 10.1007/s11136-013-0521-7; Goa Sangath, 2016, PREMIUM; Gururaj G, 2016, NATL MENTAL HLTH SUR; HEATHER N, 1989, BRIT J ADDICT, V84, P357; Helander A, 2012, ALCOHOL ALCOHOLISM, V47, P552, DOI 10.1093/alcalc/ags065; Kalinowski A, 2016, ADDICTION, V111, P1293, DOI 10.1111/add.13341; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Knapp M, 2006, HEALTH POLICY PLANN, V21, P157, DOI 10.1093/heapol/czl003; Kypri K, 2016, J STUD ALCOHOL DRUGS, V77, P526, DOI 10.15288/jsad.2016.77.526; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; McCambridge J, 2014, ADDICTION, V109, P538, DOI 10.1111/add.12458; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; Mdege ND, 2013, DRUG ALCOHOL DEPEN, V131, P1, DOI 10.1016/j.drugalcdep.2013.01.023; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Morris TP, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-11; Nadkarni A, 2015, ALCOHOL CLIN EXP RES, V39, P522, DOI 10.1111/acer.12653; Nadkarni A, 2013, ASIAN J PSYCHIATR, V6, P521, DOI 10.1016/j.ajp.2013.06.010; Nayak MB, 2008, ALCOHOL ALCOHOLISM, V43, P713, DOI 10.1093/alcalc/agn074; Noknoy S, 2010, ALCOHOL ALCOHOLISM, V45, P263, DOI 10.1093/alcalc/agq013; Oliver I, 2012, IEEE IC COMP COM NET; Papas RK, 2011, ADDICTION, V106, P2156, DOI 10.1111/j.1360-0443.2011.03518.x; Patel V., 2016, LANCET; Patel V, 2016, LANCET, V387, P1672, DOI 10.1016/S0140-6736(15)00390-6; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; Patel V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-101; Prasad R, 2009, LANCET, V373, P17, DOI 10.1016/S0140-6736(08)61939-X; Public Health England, 2016, HLTH MATT HARMF DRIN; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Singla DR, 2014, BEHAV RES THER, V60, P53, DOI 10.1016/j.brat.2014.06.006; Sobell LC, 2003, ALCOHOL CLIN EXP RES, V27, P1661, DOI 10.1097/01.ALC.0000091227.26627.75; Sterne JAC, 2001, PHYS THER, V81, P1464, DOI 10.1093/ptj/81.8.1464; van Ginneken N, 2013, COCHRANE DB SYST REV, V11; Vellakkal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134189; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2005, MENT HLTH ATL; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2016, MHGAP INT GUID MENT; Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024	48	84	84	3	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					186	195		10.1016/S0140-6736(16)31590-2	http://dx.doi.org/10.1016/S0140-6736(16)31590-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EH9UT	27988144	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000392117600030
J	Nonomura, K; Woo, SH; Chang, RB; Gillich, A; Qiu, Z; Francisco, AG; Ranade, SS; Liberles, SD; Patapoutian, A				Nonomura, Keiko; Woo, Seung-Hyun; Chang, Rui B.; Gillich, Astrid; Qiu, Zhaozhu; Francisco, Allain G.; Ranade, Sanjeev S.; Liberles, Stephen D.; Patapoutian, Ardem			Piezo2 senses airway stretch and mediates lung inflation-induced apnoea	NATURE			English	Article							HERING-BREUER REFLEX; DISTAL ARTHROGRYPOSIS; RESPIRATORY-DISTRESS; VAGAL INNERVATION; NEURAL CREST; DORSAL-ROOT; MOUSE LUNG; MICE; NEURONS; CHANNEL	Respiratory dysfunction is a notorious cause of perinatal mortality in infants and sleep apnoea in adults, but the mechanisms of respiratory control are not clearly understood. Mechanical signals transduced by airway-innervating sensory neurons control respiration; however, the physiological significance and molecular mechanisms of these signals remain obscured. Here we show that global and sensory neuron-specific ablation of the mechanically activated ion channel Piezo2 causes respiratory distress and death in newborn mice. Optogenetic activation of Piezo2(+) vagal sensory neurons causes apnoea in adult mice. Moreover, induced ablation of Piezo2 in sensory neurons of adult mice causes decreased neuronal responses to lung inflation, an impaired Hering-Breuer mechanoreflex, and increased tidal volume under normal conditions. These phenotypes are reproduced in mice lacking Piezo2 in the nodose ganglion. Our data suggest that Piezo2 is an airway stretch sensor and that Piezo2-mediated mechanotransduction within various airway-innervating sensory neurons is critical for establishing efficient respiration at birth and maintaining normal breathing in adults.	[Nonomura, Keiko; Woo, Seung-Hyun; Qiu, Zhaozhu; Francisco, Allain G.; Ranade, Sanjeev S.; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Chang, Rui B.; Liberles, Stephen D.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Gillich, Astrid] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA; [Qiu, Zhaozhu] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Qiu, Zhaozhu] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Qiu, Zhaozhu] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Ranade, Sanjeev S.] Gladstone Inst, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Novartis; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, Mol & Cellular Neurosci, La Jolla, CA 92037 USA.; Liberles, SD (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	Stephen_Liberles@hms.harvard.edu; ardem@scripps.edu		Ranade, Sanjeev/0000-0001-8601-3563; Liberles, Stephen/0000-0002-2177-9741	NIH [R01DE022358, R01HL132255]; Giovanni Armenise-Harvard Foundation; National Center for Complementary & Integrative Health [DP1AT009497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank D. Trajkovic for assistance with histology; M. Wood for assistance with electron microscopy; J. Yu for suggesting that we test the Hering-Breuer reflex; S. M. Cahalan, M. Petrus, J. Mathur, K. Marshall, S. Lee, T. Kawamura, J. Chen and P. Paolo Sanna for technical assistance; and M. Krasnow for discussions. This research was supported by NIH grants R01DE022358 to A. P. and R01HL132255, and a Giovanni Armenise-Harvard Foundation Grant to S.D.L. A.P. is an investigator of the Howard Hughes Medical Institute.	Aleksandrova NP, 2007, J PHYSIOL PHARMACOL, V58, P9; BARKER PM, 1993, AM J PHYSIOL, V265, pL512, DOI 10.1152/ajplung.1993.265.5.L512; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; BONHAM AC, 1990, J PHYSIOL-LONDON, V427, P261, DOI 10.1113/jphysiol.1990.sp018171; Carr MJ, 2003, RESPIROLOGY, V8, P291, DOI 10.1046/j.1440-1843.2003.00473.x; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chamberlin NL, 2004, RESP PHYSIOL NEUROBI, V143, P115, DOI 10.1016/j.resp.2004.03.015; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delle Vedove A, 2016, AM J HUM GENET, V99, P1206, DOI 10.1016/j.ajhg.2016.09.019; Dinh QT, 2004, RESP PHYSIOL NEUROBI, V144, P15, DOI 10.1016/j.resp.2004.08.001; Driessen AK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00378; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Fox EA, 2001, J NEUROSCI, V21, P8602, DOI 10.1523/JNEUROSCI.21-21-08602.2001; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hasan SU, 2000, RESP PHYSIOL, V119, P133, DOI 10.1016/S0034-5687(99)00108-5; Kaczynska K, 2013, PHYSIOL RES, V62, P227, DOI 10.33549/physiolres.932412; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kwong K, 2008, J PHYSIOL-LONDON, V586, P1321, DOI 10.1113/jphysiol.2007.146365; Lee KZ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00031; Lee LY, 2014, COMPR PHYSIOL, V4, P287, DOI 10.1002/cphy.c130020; Li BY, 2011, AM J PHYSIOL-CELL PH, V300, pC1393, DOI 10.1152/ajpcell.00278.2010; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Massey CA, 2015, J NEUROPHYSIOL, V113, P2879, DOI 10.1152/jn.01073.2014; McGovern AE, 2015, BRAIN STRUCT FUNCT, V220, P3683, DOI 10.1007/s00429-014-0883-9; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mortola J. P., 2001, RESP PHYSL NEWBORN M, P24; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Nishino T, 2000, JPN J PHYSIOL, V50, P3, DOI 10.2170/jjphysiol.50.3; Okubo M, 2015, AM J MED GENET A, V167, P1100, DOI 10.1002/ajmg.a.36881; Pan J, 2006, AM J PHYSIOL-LUNG C, V290, pL185, DOI 10.1152/ajplung.00167.2005; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; Rabbette PS, 1998, J APPL PHYSIOL, V85, P2033, DOI 10.1152/jappl.1998.85.6.2033; Ramanantsoa N, 2006, AM J PHYSIOL-REG I, V290, pR1691, DOI 10.1152/ajpregu.00875.2005; Ramirez JM, 2013, RESP PHYSIOL NEUROBI, V189, P344, DOI 10.1016/j.resp.2013.06.004; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Rhoades R. A., 2009, MED PHYSL PRINCIPLES, P328; Ruan HZ, 2003, HISTOCHEM CELL BIOL, V120, P415, DOI 10.1007/s00418-003-0579-3; Schelegle ES, 2001, RESP PHYSIOL, V125, P17, DOI 10.1016/S0034-5687(00)00202-4; Schrenk-Siemens K, 2015, NAT NEUROSCI, V18, P10, DOI 10.1038/nn.3894; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Sun BY, 2010, AUTON NEUROSCI-BASIC, V153, P26, DOI 10.1016/j.autneu.2009.07.003; Thach BT, 2005, RESP PHYSIOL NEUROBI, V149, P343, DOI 10.1016/j.resp.2005.06.011; Tryfon S, 2001, RESPIRATION, V68, P140, DOI 10.1159/000050483; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; VIJAYARAGHAVAN R, 1994, ARCH TOXICOL, V68, P490, DOI 10.1007/s002040050101; Wong KA, 1998, J APPL PHYSIOL, V85, P849, DOI 10.1152/jappl.1998.85.3.849; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Woo SH, 2015, TRENDS CELL BIOL, V25, P74, DOI 10.1016/j.tcb.2014.10.003; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251; Zhang JW, 2006, J APPL PHYSIOL, V101, P986, DOI 10.1152/japplphysiol.00161.2006	58	199	208	9	94	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					176	+		10.1038/nature20793	http://dx.doi.org/10.1038/nature20793			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	28002412	Green Accepted			2022-12-28	WOS:000396125500031
J	McKenzie, K				McKenzie, Katherine			PERSONAL VIEW Supporting human rights, one patient at a time	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKenzie, Katherine] Yale Univ, Yale Ctr Asylum Med, New Haven, CT 06520 USA	Yale University	McKenzie, K (corresponding author), Yale Univ, Yale Ctr Asylum Med, New Haven, CT 06520 USA.	katherine.mckenzie@yale.edu		McKenzie, Katherine/0000-0002-7621-9741				Lustig SL, 2008, J IMMIGR MINOR HEALT, V10, P7, DOI 10.1007/s10903-007-9056-8; Office of the United Nations High Commissioner for Refugees, 2016, GLOB TRENDS FORC DIS	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2016	355								i6798	10.1136/bmj.i6798	http://dx.doi.org/10.1136/bmj.i6798			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RH	28039108				2022-12-28	WOS:000391173100009
J	Robinson, A				Robinson, Andrew			Before Nature Cuneiform Knowledge and the History of Science	SCIENCE			English	Book Review												andrew@andrew-robinson.org						Rochberg F., 2016, NATURE CUNEIFORM KNO	1	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1539	1539		10.1126/science.aal1557	http://dx.doi.org/10.1126/science.aal1557			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3VZ	28008033				2022-12-28	WOS:000390254300033
J	Rubin, R				Rubin, Rita			"Healing" Objets d'art Shine in Minerals in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ritalrubin@gmail.com	Rubin, Rita/AAD-1259-2020						0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2462	2463		10.1001/jama.2016.18435	http://dx.doi.org/10.1001/jama.2016.18435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997635				2022-12-28	WOS:000390959300001
J	Whitaker, R				Whitaker, Robert			Gillian Mary Hunt OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6610	10.1136/bmj.i6610	http://dx.doi.org/10.1136/bmj.i6610			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965216				2022-12-28	WOS:000390150800008
J	Nielsen, BW; Scott, RC				Nielsen, Brian W.; Scott, Rod C.			Brain abnormalities in fetuses: in-utero MRI versus ultrasound	LANCET			English	Editorial Material									[Nielsen, Brian W.] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, 95 Carrigan Dr, Burlington, VT 05405 USA; [Scott, Rod C.] Univ Vermont, Dept Neurol Sci, Burlington, VT 05405 USA; [Scott, Rod C.] Great Ormond St UCL Inst Child Hlth, Paediat Neurosci, London, England	University of Vermont; University of Vermont; University of London; University College London	Nielsen, BW (corresponding author), Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, 95 Carrigan Dr, Burlington, VT 05405 USA.	rodney.scott@med.uvm.edu		Scott, Rod/0000-0002-8944-928X				Glenn OA, 2010, PEDIATR RADIOL, V40, P68, DOI 10.1007/s00247-009-1459-3; Griffiths PD, 2016, LANCET; Paladini D, 2014, ULTRASOUND OBST GYN, V44, P188, DOI 10.1002/uog.13243; Rossi AC, 2014, ULTRASOUND OBST GYN, V44, P388, DOI 10.1002/uog.13429	4	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					483	485		10.1016/S0140-6736(16)32565-X	http://dx.doi.org/10.1016/S0140-6736(16)32565-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	27988139	Green Submitted, hybrid			2022-12-28	WOS:000393283400013
J	Warren, RB; Mrowietz, U; von Kiedrowski, R; Niesmann, J; Wilsmann-Theis, D; Ghoreschi, K; Zschocke, I; Falk, TM; Blodorn-Schlicht, N; Reich, K				Warren, Richard B.; Mrowietz, Ulrich; von Kiedrowski, Ralph; Niesmann, Johannes; Wilsmann-Theis, Dagmar; Ghoreschi, Kamran; Zschocke, Ina; Falk, Thomas M.; Bloedorn-Schlicht, Norbert; Reich, Kristian			An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial	LANCET			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; THERAPY; EFFICACY; SAFETY; INHIBITION; EXPRESSION; TARGET	Background Methotrexate is one of the most commonly used systemic drugs for the treatment of moderate to severe psoriasis; however, high-quality evidence for its use is sparse and limited to use of oral dosing. We aimed to assess the effect of an intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis. Methods We did this prospective, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (METOP) at 16 sites in Germany, France, the Netherlands, and the UK. Eligible patients were aged 18 years or older, had a diagnosis of chronic plaque psoriasis for at least 6 months before baseline, had currently moderate to severe disease, and were methotrexate treatment-naive. Participants were randomly assigned (3: 1), via a computer-generated random number sequence integrated into an electronic data capture system, to receive either methotrexate at a starting dose of 17.5 mg/week or placebo for the first 16 weeks, followed by methotrexate treatment of all patients up to 52 weeks (methotrexate-methotrexate vs placebo-methotrexate groups). Dose escalation to 22.5 mg/week was allowed after 8 weeks of methotrexate treatment if patients had not achieved at least a 50% reduction in baseline Psoriasis Area and Severity Index score (PASI), with corresponding volume increases in placebo injections. Treatment was combined with folic acid 5 mg/week. Group allocation was concealed from participants and investigators from the time of randomisation until an interim database lock at week 16, and was open label from week 16 onwards, with no masking of participants or investigators. The primary efficacy endpoint was a 75% reduction in PASI score (PASI 75) from baseline to week 16. We did analysis by modified intention to treat, with non-responder imputation. This study is registered with EudraCT, number 2012-002716-10. Findings Between Feb 22, 2013, and May 13, 2015, we randomly assigned 120 patients to receive methotrexate (n=91) or placebo (n=29). At week 16, a PASI 75 response was achieved in 37 (41%) patients in the methotrexate group compared with three (10%) patients in the placebo group (relative risk 3.93, 95% CI 1 31-11.81; p=0.0026). Subcutaneous methotrexate was generally well tolerated; no patients died or had serious infections, malignancies, or major adverse cardiovascular events. Serious adverse events were recorded in three (3%) patients who received methotrexate for the full 52 week treatment period. Interpretation Our findings show a favourable 52 week risk-benefit profile of subcutaneous methotrexate in patients with psoriasis. The route of administration and the intensified dosing schedule should be considered when methotrexate is used in this patient group.	[Warren, Richard B.] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England; [Warren, Richard B.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Mrowietz, Ulrich] Univ Med Ctr Schleswig Holstein, Dept Dermatol, Psoriasis Ctr, Campus Kiel, Kiel, Germany; [von Kiedrowski, Ralph] Co Med Study & Serv Selters CMS3 GmbH, Selters, Germany; [Wilsmann-Theis, Dagmar] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Ghoreschi, Kamran] Eberhard Karls Univ Tubingen, Univ Med Ctr, Dept Dermatol, Tubingen, Germany; [Zschocke, Ina; Reich, Kristian] SCIderm GmbH Hamburg, Hamburg, Germany; [Falk, Thomas M.; Bloedorn-Schlicht, Norbert; Reich, Kristian] Dermatologikum Hamburg, D-20354 Hamburg, Germany	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Dermatologikum Hamburg	Reich, K (corresponding author), Dermatologikum Hamburg, D-20354 Hamburg, Germany.	kreich@dermatologikum.de	Warren, Richard/G-4929-2015	Warren, Richard/0000-0002-2918-6481; Ghoreschi, Kamran/0000-0002-5526-7517	Medac Germany; Medac	Medac Germany; Medac	Medac.; METOP was an investigator-initiated trial supported by a grant from Medac Germany to KR. Medac also supplied study medication. The study was designed by consultant experts in psoriasis (RBW, UM, and KR) in conjunction with employees of SCIderm GmbH, Germany, which served as the clinical research organisation for study management, data collection, and statistical analysis.	Barker J, 2011, BRIT J DERMATOL, V165, P1109, DOI 10.1111/j.1365-2133.2011.10615.x; Becker ML, 2011, ARTHRITIS RHEUM-US, V63, P276, DOI 10.1002/art.30080; Braun J, 2008, ARTHRITIS RHEUM-US, V58, P73, DOI 10.1002/art.23144; Dervieux T, 2005, ANN RHEUM DIS, V64, P1180, DOI 10.1136/ard.2004.033399; Finlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x; Goldminz AM, 2015, JAMA DERMATOL, V151, P837, DOI 10.1001/jamadermatol.2015.0452; Hawwa AF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0814-z; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lebwohl MG, 2016, AM J CLIN DERMATOL, V17, P87, DOI 10.1007/s40257-015-0169-x; Mrowietz U, 2011, ARCH DERMATOL RES, V303, P1, DOI 10.1007/s00403-010-1080-1; Organization WH, 2016, GLOB REP PSOR; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Reich K, 2015, ARCH DERMATOL RES, V307, P875, DOI 10.1007/s00403-015-1593-8; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Saurat JH, 2011, BRIT J DERMATOL, V165, P399, DOI 10.1111/j.1365-2133.2011.10399.x; Sbidian E, 2011, J EUR ACAD DERMATOL, V25, P28, DOI 10.1111/j.1468-3083.2011.03993.x; Spurlock CF, 2015, RHEUMATOLOGY, V54, P178, DOI 10.1093/rheumatology/keu279; Stamp LK, 2011, J RHEUMATOL, V38, P2540, DOI 10.3899/jrheum.110481; Talme T, 2016, EUR J IMMUNOL, V46, P1279, DOI 10.1002/eji.201546122; Vincenzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054195; Warren RB, 2008, CLIN EXP DERMATOL, V33, P551, DOI 10.1111/j.1365-2230.2008.02976.x; Warren RB, 2008, J INVEST DERMATOL, V128, P1925, DOI 10.1038/jid.2008.16; West J, 2016, BRIT J DERMATOL, V174, P1407, DOI 10.1111/bjd.14452; West J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153740; Yesudian Paul Devakar, 2016, J Drugs Dermatol, V15, P345; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	29	66	72	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					528	537		10.1016/S0140-6736(16)32127-4	http://dx.doi.org/10.1016/S0140-6736(16)32127-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ5UH	28012564	Green Submitted			2022-12-28	WOS:000393283400035
J	Weinberg, DE; Gross, JD				Weinberg, David E.; Gross, John D.			MOLECULAR BIOLOGY Messenger RNAs marked for longer life	NATURE			English	Editorial Material							ADULT OBESITY; FTO; GENE; NUCLEOSIDES; CHILDHOOD; SUBSTRATE; MASS		[Weinberg, David E.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Weinberg, David E.] Univ Calif San Francisco, Sandler Fac Fellows Program, San Francisco, CA 94143 USA; [Gross, John D.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberg, DE (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Weinberg, DE (corresponding author), Univ Calif San Francisco, Sandler Fac Fellows Program, San Francisco, CA 94143 USA.	david.weinberg@ucsf.edu			NIGMS NIH HHS [R01 GM078360] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1975, NATURE, V255, P28, DOI 10.1038/255028a0; Coller J, 2016, NAT STRUCT MOL BIOL, V23, P954, DOI 10.1038/nsmb.3315; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151	13	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 19	2017	541	7637					293	294		10.1038/nature21109	http://dx.doi.org/10.1038/nature21109			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6QP	28002405				2022-12-28	WOS:000396128800023
J	Fulton, EA				Fulton, Elizabeth A.			A stitch in time saves nine ... billion	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; FISHERIES		[Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas 7001, Australia; [Fulton, Elizabeth A.] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Fulton, EA (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas 7001, Australia.; Fulton, EA (corresponding author), Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia.	beth.fulton@csiro.au	Fulton, Beth/A-2871-2008	Fulton, Beth/0000-0002-5904-7917				Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Blanchard JL, 2014, J APPL ECOL, V51, P612, DOI 10.1111/1365-2664.12238; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Collie JS, 2016, FISH FISH, V17, P101, DOI 10.1111/faf.12093; Fulton EA, 2014, MARINE ECOSYSTEM BAS, V16, P121; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Guiot J, 2016, SCIENCE, V354, P465, DOI 10.1126/science.aah5015; IEA, 2015, WORLD EN OUTL SPEC B; IPCC, 2018, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324; Kahneman D., 2011, THINKING FAST SLOW; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Scichl H., 2004, MODELING LANGUAGES M; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Zipes J, 2012, IRRESISTIBLE FAIRY TALE: THE CULTURAL AND SOCIAL HISTORY OF A GENRE, P1	15	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1530	1531		10.1126/science.aal2777	http://dx.doi.org/10.1126/science.aal2777			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008027				2022-12-28	WOS:000390254300026
J	Martin, WH				Martin, Wade H.			Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE			English	Letter							EXERCISE		[Martin, Wade H.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Martin, Wade H.] St Louis Vet Affairs Hlth Care Syst, St Louis, MO 63106 USA	Washington University (WUSTL)	Martin, WH (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.; Martin, WH (corresponding author), St Louis Vet Affairs Hlth Care Syst, St Louis, MO 63106 USA.							Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Mark DB, 2016, ANN INTERN MED, V165, P94, DOI 10.7326/M15-2639; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Martin WH, 2015, NEW ENGL J MED, V373, P89, DOI 10.1056/NEJMc1505594; Squires D., 2015, US HLTH CARE GLOBAL	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					890	891		10.7326/L16-0481	http://dx.doi.org/10.7326/L16-0481			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992904				2022-12-28	WOS:000391236900026
J	Wang, HH; Summerskill, W				Wang, Helena Hui; Summerskill, William			China-a call for papers	LANCET			English	Editorial Material									[Wang, Helena Hui] Lancet, Beijing 100738, Peoples R China; Lancet, London EC2Y 5AS, England		Wang, HH (corresponding author), Lancet, Beijing 100738, Peoples R China.								0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2969	2969		10.1016/S0140-6736(16)32584-3	http://dx.doi.org/10.1016/S0140-6736(16)32584-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27998519				2022-12-28	WOS:000390112300010
J	Califf, RM; Robb, MA; Bindman, AB; Briggs, JP; Collins, FS; Conway, PH; Coster, TS; Cunningham, FE; De Lew, N; DeSalvo, KB; Dymek, C; Dzau, VJ; Fleurence, RL; Frank, RG; Gaziano, M; Kaufmann, P; Lauer, M; Marks, PW; McGinnis, JM; Richards, C; Selby, JV; Shulkin, DJ; Shuren, J; Slavitt, AM; Smith, SR; Washington, BV; White, PJ; Woodcock, J; Woodson, J; Sherman, RE				Califf, Robert M.; Robb, Melissa A.; Bindman, Andrew B.; Briggs, Josephine P.; Collins, Francis S.; Conway, Patrick H.; Coster, Trinka S.; Cunningham, Francesca E.; De Lew, Nancy; DeSalvo, Karen B.; Dymek, Christine; Dzau, Victor J.; Fleurence, Rachael L.; Frank, Richard G.; Gaziano, Michael; Kaufmann, Petra; Lauer, Michael; Marks, Peter W.; McGinnis, J. Michael; Richards, Chesley; Selby, Joe V.; Shulkin, David J.; Shuren, Jeffrey; Slavitt, Andrew M.; Smith, Scott R.; Washington, B. Vindell; White, P. Jon; Woodcock, Janet; Woodson, Jonathan; Sherman, Rachel E.			Transforming Evidence Generation to Support Health and Health Care Decisions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TECHNOLOGY; GUIDELINES; SYSTEM		[Califf, Robert M.; Sherman, Rachel E.] US FDA, Off Commissioner, Silver Spring, MD USA; [Robb, Melissa A.; Sherman, Rachel E.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Marks, Peter W.] US FDA, Biol Evaluat & Res, Silver Spring, MD USA; [Shuren, Jeffrey] US FDA, Devices & Radiol Hlth, Silver Spring, MD USA; [Bindman, Andrew B.] Agcy Healthcare Res & Qual, Off Director, Rockville, MD USA; [Dymek, Christine] Agcy Healthcare Res & Qual, Ctr Evidence & Practice Improvement, Rockville, MD USA; [Briggs, Josephine P.] NIH, Natl Ctr Complementary & Integrat Hlth, Bldg 10, Bethesda, MD 20892 USA; [Collins, Francis S.] NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA; [Kaufmann, Petra] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Lauer, Michael] NIH, Off Extramural Res Act, Bldg 10, Bethesda, MD 20892 USA; [Conway, Patrick H.; Slavitt, Andrew M.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA; [Coster, Trinka S.] US Army, Off Surg Gen Pharmacovigilance Ctr, Falls Church, VA USA; [Shulkin, David J.] Dept Vet Affairs, Off Secretary Hlth, Washington, DC USA; [De Lew, Nancy; DeSalvo, Karen B.] Off Assistant Secretary Planning & Evaluat, Off Hlth Policy, Washington, DC USA; [DeSalvo, Karen B.] Off Assistant Secretary Hlth, Washington, DC USA; [Washington, B. Vindell; White, P. Jon] Off Natl Coordinator Hlth Informat Technol, Washington, DC USA; [Dzau, Victor J.; McGinnis, J. Michael] Natl Acad Med, Dept Hlth & Human Serv, Washington, DC USA; [Fleurence, Rachael L.; Selby, Joe V.] Patient Centered Outcomes Res Inst, Washington, DC USA; [Cunningham, Francesca E.] Dept Vet Affairs, Ctr Medicat Safety, Hines, IL USA; [Frank, Richard G.] Harvard Univ, Dept Hlth Care Policy, Boston, MA 02115 USA; [McGinnis, J. Michael] Brigham & Womens Hosp, Div Aging, Mill Veteran Program, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA; [McGinnis, J. Michael] Harvard Med Sch, Boston, MA USA; [Woodson, Jonathan] Boston Univ, Sch Med, Dept Surg, Boston, MA 02118 USA; [Richards, Chesley] Ctr Dis Control & Prevent, Off Publ Hlth Sci Serv, Atlanta, GA USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Agency for Healthcare Research & Quality; Agency for Healthcare Research & Quality; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; Centers for Medicare & Medicaid Services; National Academies of Sciences, Engineering & Medicine; Harvard University; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Boston University; Centers for Disease Control & Prevention - USA	Califf, RM (corresponding author), US FDA, Off Commissioner, Silver Spring, MD USA.							Califf R., 2012, ENVISIONING TRANSFOR; Chambers DA, 2016, JAMA-J AM MED ASSOC, V315, P1941, DOI 10.1001/jama.2016.3867; ELLWOOD PM, 1988, NEW ENGL J MED, V318, P1549, DOI 10.1056/NEJM198806093182329; Han H, 2015, J AM COLL CARDIOL, V65, P2726, DOI 10.1016/j.jacc.2015.04.050; HealthIT.gov, SHAR NAT INT ROADM V; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Institute of Medicine, 2008, EVIDENCE BASED MED C; Institute of Medicine, 2007, LEARN HEALTHC SYST; Institute of Medicine, 2011, WORKSH SER SUMM; [Office of the Assistant Secretary for Planning and Evaluation Department of Health and Human Services], M ACA MAND BUILD DAT; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; U. S. Preventive Services Task Force, 2014, HIGH PRIOR EV GAPS C	13	92	92	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2395	2400		10.1056/NEJMsb1610128	http://dx.doi.org/10.1056/NEJMsb1610128			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27974039	Bronze, Green Published			2022-12-28	WOS:000390036500014
J	Ervin, AM; Taylor, HA; Ehrhardt, S				Ervin, Ann-Margret; Taylor, Holly A.; Ehrhardt, Stephan			NIH Policy on Single-IRB Review - A New Era in Multicenter Studies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ervin, Ann-Margret; Ehrhardt, Stephan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Taylor, Holly A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Taylor, Holly A.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Ervin, AM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.		Ehrhardt, Stephan/D-8957-2017		NHGRI NIH HHS [R01 HG008558] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008558] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abbott L, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.1.3; [Anonymous], 2016, FIN NH POL US SINGL; [Anonymous], 2016, SCEN ILL US DIR IND; Ervin AM, 2015, SCIENCE, V350, P632, DOI 10.1126/science.aac4872; Kaufmann P, 2015, ACAD MED, V90, P321, DOI 10.1097/ACM.0000000000000562	5	19	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2315	2317		10.1056/NEJMp1608766	http://dx.doi.org/10.1056/NEJMp1608766			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27974026	Green Accepted			2022-12-28	WOS:000390036500002
J	Wang, GS; Hauver, J; Thomas, Z; Darst, SA; Pertsinidis, A				Wang, Guanshi; Hauver, Jesse; Thomas, Zachary; Darst, Seth A.; Pertsinidis, Alexandros			Single-Molecule Real-Time 3D Imaging of the Transcription Cycle by Modulation Interferometry	CELL			English	Article							COLI RNA-POLYMERASE; NUCLEAR-PORE COMPLEX; POINT-SPREAD FUNCTION; ESCHERICHIA-COLI; IN-VIVO; SUPERRESOLUTION MICROSCOPY; FLUORESCENCE MICROSCOPY; PERICENTRIOLAR MATERIAL; SIGMA(70) SUBUNIT; DIFFRACTION-LIMIT	Many essential cellular processes, such as gene control, employ elaborate mechanisms involving the coordination of large, multi-component molecular assemblies. Few structural biology tools presently have the combined spatial-temporal resolution and molecular specificity required to capture the movement, conformational changes, and subunit association-dissociation kinetics, three fundamental elements of how such intricate molecular machines work. Here, we report a 3D single-molecule superresolution imaging study using modulation interferometry and phase-sensitive detection that achieves <2 nm axial localization precision, well below the few-nanometer-sized individual protein components. To illustrate the capability of this technique in probing the dynamics of complex macromolecular machines, we visualize the movement of individual multi-subunit E. coli RNA polymerases through the complete transcription cycle, dissect the kinetics of the initiation-elongation transition, and determine the fate of sigma(70) initiation factors during promoter escape. Modulation interferometry sets the stage for single-molecule studies of several hitherto difficult-to-investigate multi-molecular transactions that underlie genome regulation.	[Wang, Guanshi; Hauver, Jesse; Thomas, Zachary; Pertsinidis, Alexandros] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wang, Guanshi] Cornell Univ, Weill Cornell Med, BCMB Grad Program, New York, NY 10065 USA; [Hauver, Jesse] Triinst PhD Program Chem Biol, New York, NY 10065 USA; [Hauver, Jesse; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA; [Thomas, Zachary] CUNY City Coll, New York, NY 10031 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Rockefeller University; City University of New York (CUNY) System; City College of New York (CUNY)	Pertsinidis, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pertsina@mskcc.org			NIH [R01 GM053759]; Dorris J. Hutchison Student Fellowship; National Cancer Institute Cancer Center Support Grant [P30 CA008748]; National Institutes of Health (NIH) Director's New Innovator Award [1DP2GM105443-01]; Louis V. Gerstner, Jr. Young Investigators Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM105443, R35GM118130, R01GM053759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris J. Hutchison Student Fellowship; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis V. Gerstner, Jr. Young Investigators Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.P. thanks Sang Ryul Park for assistance with a prototype setup construction and Steven Chu for making facilities and equipment available at the initial stages of the project. We thank Ricardo Toledo-Crow for useful discussions and Elias Coutavas and Gunter Blobel for providing the Nup358 antibody and advice on NPC immunostaining. This work is supported by NIH R01 GM053759 (S.A.D.), a Dorris J. Hutchison Student Fellowship (G.W.), a National Cancer Institute Cancer Center Support Grant (P30 CA008748), and by the National Institutes of Health (NIH) Director's New Innovator Award (1DP2GM105443-01) and the Louis V. Gerstner, Jr. Young Investigators Fund (A.P.).	Aquino D, 2011, NAT METHODS, V8, P353, DOI [10.1038/NMETH.1583, 10.1038/nmeth.1583]; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bae B, 2013, P NATL ACAD SCI USA, V110, P19772, DOI 10.1073/pnas.1314576110; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Feklistov A, 2008, P NATL ACAD SCI USA, V105, P14820, DOI 10.1073/pnas.0802822105; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Gustafsson MGL, 1999, J MICROSC-OXFORD, V195, P10, DOI 10.1046/j.1365-2818.1999.00576.x; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Huve J, 2008, BIOPHYS J, V95, P877, DOI 10.1529/biophysj.107.127449; Iinuma R, 2014, SCIENCE, V344, P65, DOI 10.1126/science.1250944; Izban MG, 1998, J BIOL CHEM, V273, P27009, DOI 10.1074/jbc.273.41.27009; JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z; Jia S, 2014, NAT PHOTONICS, V8, P302, DOI [10.1038/nphoton.2014.13, 10.1038/NPHOTON.2014.13]; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; MANDEL L, 1965, REV MOD PHYS, V37, P231, DOI 10.1103/RevModPhys.37.231; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; METZGER W, 1993, J MOL BIOL, V232, P35, DOI 10.1006/jmbi.1993.1368; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; OOSTRA BA, 1981, BIOCHIM BIOPHYS ACTA, V655, P446, DOI 10.1016/0005-2787(81)90056-3; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Pleiner T, 2015, ELIFE, V4, DOI [10.7554/eLife.11349, 10.7554/eLife.15597]; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Raffaelle M, 2005, MOL CELL, V20, P357, DOI 10.1016/j.molcel.2005.10.011; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Ris H., 1989, I PHYS C SER, V98, P657; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmied JJ, 2012, NAT METHODS, V9, P1133, DOI 10.1038/nmeth.2254; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Susa M, 2002, J BIOL CHEM, V277, P15407, DOI 10.1074/jbc.M112481200; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tolic-Norrelykke SF, 2004, J BIOL CHEM, V279, P3292, DOI 10.1074/jbc.M310290200; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; Twist KA, 2011, PROTEIN SCI, V20, P986, DOI 10.1002/pro.622; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; von Appen A, 2016, J MOL BIOL, V428, P2001, DOI 10.1016/j.jmb.2016.01.004; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	80	21	21	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1839	+		10.1016/j.cell.2016.11.032	http://dx.doi.org/10.1016/j.cell.2016.11.032			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984731	Green Accepted, Bronze			2022-12-28	WOS:000393114700021
J	Desai, S; Jena, AB				Desai, Sunita; Jena, Anupam B.			Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK-REDUCING MASTECTOMY; BREAST RECONSTRUCTION; CANCER	OBJECTIVE To examine the effect on BRCA testing and mastectomy rates of a widely viewed 2013 New York Times editorial by public figure Angelina Jolie that endorsed BRCA testing and announced Jolie's decision to undergo preventive mastectomy. DESIGN Observational study with difference-in-difference analysis. SETTING Commercially insured US population. PARTICIPANTS Women aged 18-64 years with claims in the Truven MarketScan commercial claims database (n= 9 532 836). MAIN OUTCOME MEASURES Changes in BRCA testing rates in the 15 business days before versus after 14 May 2013 (editorial date) compared with the change in the same period in 2012; mastectomy rates in the months before and after publication, both overall and within 60 days of BRCA testing among women who were tested; national estimates of incremental tests and expenditures associated with Jolie's article in the 15 days after publication. RESULTS Daily BRCA test rates increased immediately after the 2013 editorial, from 0.71 tests/100 000 women in the 15 business days before to 1.13 tests/100 000 women in the 15 business days after publication. In comparison, daily test rates were similar in the same period in 2012 (0.58/100 000 women in the 15 business days before 14 May versus 0.55/100 000 women in the 15 business days after), implying a difference-in-difference absolute daily increase of 0.45 tests/100 000 women or a 64% relative increase (P<0.001). The editorial was associated with an estimated increase of 4500 BRCA tests and $13.5m (10.8m; pound (sic)12.8) expenditure nationally among commercially insured adult women in those 15 days. Increased BRCA testing rates were sustained throughout 2013. Overall mastectomy rates remained unchanged in the months after publication, but 60 day mastectomy rates among women who had a BRCA test fell from 10% in the months before publication to 7% in the months after publication, suggesting that women who underwent tests as a result of to the editorial had a lower pre-test probability of having the BRCA mutation than women tested before the editorial. CONCLUSIONS Celebrity endorsements can have a large and immediate effect on use of health services. Such announcements can be a low cost means of reaching a broad audience quickly, but they may not effectively target the subpopulations that are most at risk for the relevant underlying condition.	[Desai, Sunita; Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.; Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Jena, AB (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health [1DP5OD017897-01]; Marshall J Seidman fellowship at Harvard Medical School	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marshall J Seidman fellowship at Harvard Medical School	This research was supported by a grant from the Office of the Director, National Institutes of Health (ABJ: NIH early independence award; grant 1DP5OD017897-01) and the Marshall J Seidman fellowship at Harvard Medical School (SD). Study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	[Anonymous], 2014, NEW YORK TIMESS MOST; Evans DG, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0650-8; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Hansen LG, 2011, HLTH RES DATA REAL W; Jagsi R, 2016, ANN SURG, V263, P219, DOI 10.1097/SLA.0000000000001177; Jolie A., 2013, NEW YORK TIMES; Juthe RH, 2015, GENET MED, V17, P545, DOI 10.1038/gim.2014.141; Kehl KL, 2016, BREAST CANCER RES TR, V155, P165, DOI 10.1007/s10549-015-3658-y; Malcolm CM, 2016, J PLAST RECONSTR AES, V69, P288, DOI 10.1016/j.bjps.2015.10.018; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747	10	57	58	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6357	10.1136/bmj.i6357	http://dx.doi.org/10.1136/bmj.i6357			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974323	Green Published, hybrid			2022-12-28	WOS:000390151300005
J	Morling, JR; McAllister, DA; Agur, W; Fischbacher, CM; Glazener, CMA; Guerrero, K; Hopkins, L; Wood, R				Morling, Joanne R.; McAllister, David A.; Agur, Wael; Fischbacher, Colin M.; Glazener, Cathryn M. A.; Guerrero, Karen; Hopkins, Leanne; Wood, Rachael			Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997-2016: a population-based cohort study	LANCET			English	Article							RANDOMIZED TRIAL; COMPLICATIONS	Background Concerns have been raised about the safety of surgery for stress urinary incontinence and pelvic organ prolapse using transvaginal mesh. We assessed adverse outcomes after first, single mesh procedures and comparable non-mesh procedures. Methods We did a cohort study of women in Scotland aged 20 years or older undergoing a first, single incontinence procedure or prolapse procedure during 1997-98 to 2015-16 identified from a national hospital admission database. Primary outcomes were immediate postoperative complications and subsequent (within 5 years) readmissions for later postoperative complications, further incontinence surgery, or further prolapse surgery. Poisson regression models were used to compare outcomes after procedures carried out with and without mesh. Findings Between April 1, 1997, and March 31, 2016, 16 660 women underwent a first, single incontinence procedure, 13 133 (79%) of which used mesh. Compared with non-mesh open surgery (colposuspension), mesh procedures had a lower risk of immediate complications (adjusted relative risk [aRR] 0.44 [95% CI 0.36-0.55]) and subsequent prolapse surgery (adjusted incidence rate ratio [aIRR] 0.30 [0.24-0.39]), and a similar risk of further incontinence surgery (0.90 [0.73-1.11]) and later complications (1.12 [0.98-1.27]); all ratios are for retropubic mesh. During the same time period, 18 986 women underwent a first, single prolapse procedure, 1279 (7%) of which used mesh. Compared with non-mesh repair, mesh repair of anterior compartment prolapse was associated with a similar risk of immediate complications (aRR 0.93 [ 95% CI 0.49-1.79]); an increased risk of further incontinence (aIRR 3.20 [2.06-4.96]) and prolapse surgery (1.69 [1.29-2.20]); and a substantially increased risk of later complications (3.15 [2.46-4.04]). Compared with nonmesh repair, mesh repair of posterior compartment prolapse was associated with a similarly increased risk of repeat prolapse surgery and later complications. No difference in any outcome was observed between vaginal and, separately, abdominal mesh repair of vaginal vault prolapse compared with vaginal non-mesh repair. Interpretation Our results support the use of mesh procedures for incontinence, although further research on longer term outcomes would be beneficial. Mesh procedures for anterior and posterior compartment prolapse cannot be recommended for primary prolapse repair. Both vaginal and abdominal mesh procedures for vaginal vault prolapse repair are associated with similar effectiveness and complication rates to non-mesh vaginal repair. These results therefore do not clearly favour any particular vault repair procedure.	[Morling, Joanne R.; McAllister, David A.; Fischbacher, Colin M.; Hopkins, Leanne; Wood, Rachael] Natl Hlth Serv Natl Serv Scotland, Informat Serv Div, Gyle Sq,1 South Gyle Crescent, Edinburgh EH12 9EB, Midlothian, Scotland; [Morling, Joanne R.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England; [McAllister, David A.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Agur, Wael] Univ Hosp Crosshouse, Ayrshire Matern Unit, Obstet & Gynaecol Unit, Kilmarnock, Scotland; [Glazener, Cathryn M. A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Guerrero, Karen] Queen Elizabeth Univ Hosp, Dept Urogynaecol, Glasgow, Lanark, Scotland	NHS National Services Scotland; University of Nottingham; University of Glasgow; University of Aberdeen; Queen Elizabeth University Hospital (QEUH)	Wood, R (corresponding author), Natl Hlth Serv Natl Serv Scotland, Informat Serv Div, Gyle Sq,1 South Gyle Crescent, Edinburgh EH12 9EB, Midlothian, Scotland.	rachaelwood@nhs.net	Morling, Jo/AAH-7385-2020; Agur, Wael/AAE-8921-2020	Morling, Jo/0000-0003-0772-2893; Agur, Wael/0000-0003-4836-6581; Fischbacher, Colin/0000-0003-3090-1857; Wood, Rachael/0000-0003-4453-623X; McAllister, David/0000-0003-3550-1764; guerrero, karen lesley/0000-0001-9591-059X	Wellcome Trust [01492/Z/16/Z]; MRC [MR/P008348/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DAM is funded by an Intermediate Clinical Fellowship from the Wellcome Trust (01492/Z/16/Z). We thank Sarah McKay and Maighread Simpson (NHS National Services Scotland) for assistance with analysis of SMR01 patients records from the PROSPECT study; and members of the Scottish Government Independent Review of Transvaginal Mesh Implants for advice on clinical aspects of study design.	Abdel-fattah M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000206; Chughtai B, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2685; Drugwatch, 2016, TRANSV MESH SETTL; Drugwatch, TRANSV MESH LAWS; Endo Pharmaceuticals, END ANN WIND DOWN AS; Ford AA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub3; Glazener CMA, 2016, LANCET; Information Services Division, 2012, ASS SMR01 DAT 2010 2; Information Services Division, 2015, SCOTT HLTH SERV COST; Kelly EC, 2016, OBSTET GYNECOL, V128, P65, DOI 10.1097/AOG.0000000000001450; Keltie K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-126; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kirchin V, 2012, SYST REV, V2; Lapitan MCM, 2016, COCHRANE DB SYST REV, V2; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012079; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Naqa E, 2015, POSTHYSTERECTOMY VAG; National Institute for Health and Care Excellence, 2013, CG171 NAT I HLTH CAR; NHS England, 2015, MESH WORK GROU INT R; Norton P, 2006, LANCET, V367, P57, DOI 10.1016/S0140-6736(06)67925-7; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Oliphant SS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.007; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Rehman H, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001754.pub3; Rogo-Gupta L, 2012, OBSTET GYNECOL, V120, P1105, DOI [10.1097/AOG.0b013e31826ebcc2, http://10.1097/AOG.0b013e31826ebcc2]; Scientific Committee on Emerging and Newly Identified Health Risks, 2015, OP SAF SURG MESH US; Scottish Government, SCOTT IND MULT DEPR; Scottish Government, 2015, IND REV VAG MESH IMP; Slack M, 2010, 19 ROYAL COLL OBST G; Sung VW, 2007, AM J OBSTET GYNECOL, V197, P3, DOI 10.1016/j.ajog.2006.09.025; UK Medicines and Healthcare Products Regulatory Agency, 2014, SUMM EV BEN RISKS VA; US Food and Drug Administration, 2011, UPD SER COMPL ASS TR; Ward K, 2002, BMJ-BRIT MED J, V325, P67, DOI 10.1136/bmj.325.7355.67; Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081; Welk B, 2015, JAMA SURG, V150, P1167, DOI 10.1001/jamasurg.2015.2590; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286	36	90	95	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					629	640		10.1016/S0140-6736(16)32572-7	http://dx.doi.org/10.1016/S0140-6736(16)32572-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9AF	28010993	Green Accepted, Green Submitted			2022-12-28	WOS:000394910800032
J	Pascual, G; Avgustinova, A; Mejetta, S; Martin, M; Castellanos, A; Attolini, CSO; Berenguer, A; Prats, N; Toll, A; Hueto, JA; Bescos, C; Di Croce, L; Benitah, SA				Pascual, Gloria; Avgustinova, Alexandra; Mejetta, Stefania; Martin, Merce; Castellanos, Andres; Stephan-Otto Attolini, Camille; Berenguer, Antoni; Prats, Neus; Toll, Agusti; Antonio Hueto, Juan; Bescos, Coro; Di Croce, Luciano; Aznar Benitah, Salvador			Targeting metastasis-initiating cells through the fatty acid receptor CD36	NATURE			English	Article							BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELL; BRAIN-METASTASIS; STROMAL CELLS; TUMOR-GROWTH; CARCINOMA; PROGRESSION; METABOLISM; CHEMORESISTANCE	The fact that the identity of the cells that initiate metastasis in most human cancers is unknown hampers the development of antimetastatic therapies. Here we describe a subpopulation of CD44(bright) cells in human oral carcinomas that do not overexpress mesenchymal genes, are slow-cycling, express high levels of the fatty acid receptor CD36 and lipid metabolism genes, and are unique in their ability to initiate metastasis. Palmitic acid or a high-fat diet specifically boosts the metastatic potential of CD36(+) metastasis- initiating cells in a CD36-dependent manner. The use of neutralizing antibodies to block CD36 causes almost complete inhibition of metastasis in immunodeficient or immunocompetent orthotopic mouse models of human oral cancer, with no side effects. Clinically, the presence of CD36(+) metastasis- initiating cells correlates with a poor prognosis for numerous types of carcinomas, and inhibition of CD36 also impairs metastasis, at least in human melanoma- and breast cancer-derived tumours. Together, our results indicate that metastasis- initiating cells particularly rely on dietary lipids to promote metastasis.	[Pascual, Gloria; Avgustinova, Alexandra; Martin, Merce; Castellanos, Andres; Stephan-Otto Attolini, Camille; Berenguer, Antoni; Prats, Neus; Aznar Benitah, Salvador] BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Mejetta, Stefania; Di Croce, Luciano] BIST, CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Toll, Agusti] Hosp Mar, Dept Dermatol, IMIM, Barcelona 08003, Spain; [Antonio Hueto, Juan; Bescos, Coro] Univ Autonoma Barcelona, Dept Oral & Maxillofacial Surg, Vall DHebron Hosp Barcelona, Barcelona 08035, Spain; [Di Croce, Luciano; Aznar Benitah, Salvador] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Di Croce, Luciano] UPF, Barcelona 08002, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; ICREA; Pompeu Fabra University	Benitah, SA (corresponding author), BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Benitah, SA (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain.	salvador.aznar-benitah@irbbarcelona.org	Angulo, Gloria Pascual/AAA-7668-2019; Aznar-Benitah, Salvador/F-4761-2016; Castellanos, Andres/F-3302-2016; Di Croce, Luciano/E-7759-2015; Avgustinova, Alexandra/ABE-7886-2020	Angulo, Gloria Pascual/0000-0003-3810-6647; Aznar-Benitah, Salvador/0000-0002-9059-5049; Castellanos, Andres/0000-0003-2864-7271; Di Croce, Luciano/0000-0003-3488-6228; Avgustinova, Alexandra/0000-0001-6016-2931; Bescos, Coro/0000-0002-3865-3037; Toll, Agustin/0000-0003-2656-0076; Stephan-Otto Attolini, Camille/0000-0001-8045-320X; Berenguer-LLergo, Antoni/0000-0002-3742-8161	European Research Council (ERC); Government of Cataluna; Fundacion Botin and Banco Santander, through Santander Universities; Worldwide Cancer Research; Beug Stiftung Foundation; La Caixa International; EU Cofound postdoctoral fellowship; Spanish 'Ministerio de Educacion y Ciencia' [SAF2013-48926-P]; European Commission's 7th Framework Program 4DCellFate grant [277899]; Severo Ochoa Award of Excellence from MINECO (Government of Spain); ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)); Government of Cataluna; Fundacion Botin and Banco Santander, through Santander Universities; Worldwide Cancer Research; Beug Stiftung Foundation; La Caixa International; EU Cofound postdoctoral fellowship; Spanish 'Ministerio de Educacion y Ciencia'(Spanish Government); European Commission's 7th Framework Program 4DCellFate grant; Severo Ochoa Award of Excellence from MINECO (Government of Spain); ICREA(ICREA)	Research in the laboratory of S.A.B. for this project is supported by the European Research Council (ERC), the Government of Cataluna (SGR grant), the Fundacion Botin and Banco Santander, through Santander Universities, and Worldwide Cancer Research. We would like to thank the Beug Stiftung Foundation for their support. S.M. was supported by a La Caixa International PhD fellowship. A. A. was supported by an EU Cofound postdoctoral fellowship. L.D.C. was supported by the Spanish 'Ministerio de Educacion y Ciencia' (SAF2013-48926-P) and the European Commission's 7th Framework Program 4DCellFate grant number 277899. We thank the Vall D'Hebron Research Institute Tumor Biobank for their assistance with the human samples. We also thank R. Wong for the Ln-7 cell line and J. Zuber for the PMSCV-Luc2-PGKneo-Ires GFP vector. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain). We thank V. Raker for manuscript editing.	Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benaich N, 2014, CELL REP, V9, P104, DOI 10.1016/j.celrep.2014.08.062; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bragado P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029974; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Hale JS, 2014, STEM CELLS, V32, P1746, DOI 10.1002/stem.1716; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; Holmes RS, 2012, BIOMOLECULES, V2, P389, DOI 10.3390/biom2030389; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kennedy DJ, 2011, METAB SYNDR RELAT D, V9, P239, DOI 10.1089/met.2011.0003; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Klenotic PA, 2013, ARTERIOSCL THROM VAS, V33, P1655, DOI 10.1161/ATVBAHA.113.301523; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Myers JN, 2002, CLIN CANCER RES, V8, P293; Nath A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18669; Nath A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14752; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pavlovic M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv256; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pein M, 2015, AM J PHYSIOL-CELL PH, V309, pC627, DOI 10.1152/ajpcell.00145.2015; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weber JM, 2011, J EXP BIOL, V214, P286, DOI 10.1242/jeb.047050; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu ZK, 2008, CLIN CANCER RES, V14, P1897, DOI 10.1158/1078-0432.CCR-07-4615; Yumoto K, 2014, CYTOM PART A, V85A, P548, DOI 10.1002/cyto.a.22434; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	70	665	690	16	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					41	+		10.1038/nature20791	http://dx.doi.org/10.1038/nature20791			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27974793				2022-12-28	WOS:000396119500025
J	[Anonymous]				[Anonymous]			Implantable Device Reverses Leg Paralysis in Monkeys	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					17	17		10.1001/jama.2016.19835	http://dx.doi.org/10.1001/jama.2016.19835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030690				2022-12-28	WOS:000391009100004
J	Koh, HK; O'Connell, JJ				Koh, Howard K.; O'Connell, James J.			Improving Health Care for Homeless People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Koh, Howard K.] Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA; [Koh, Howard K.] Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Koh, Howard K.] US Dept HHS, Hlth, Washington, DC 20201 USA; [O'Connell, James J.] Boston Hlth Care Homeless Program, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Koh, HK (corresponding author), Harvard TH Chan Sch Publ Hlth, Practice Publ Hlth Leadership, Boston, MA 02115 USA.; Koh, HK (corresponding author), Harvard Kennedy Sch, Cambridge, MA 02138 USA.; Koh, HK (corresponding author), US Dept HHS, Hlth, Washington, DC 20201 USA.	hkoh@hsph.harvard.edu							0	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2586	2587		10.1001/jama.2016.18760	http://dx.doi.org/10.1001/jama.2016.18760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027356	Bronze			2022-12-28	WOS:000391110200003
J	Deng, MT; Vaitiekenas, S; Hansen, EB; Danon, J; Leijnse, M; Flensberg, K; Nygard, J; Krogstrup, P; Marcus, CM				Deng, M. T.; Vaitiekenas, S.; Hansen, E. B.; Danon, J.; Leijnse, M.; Flensberg, K.; Nygard, J.; Krogstrup, P.; Marcus, C. M.			Majorana bound state in a coupled quantum-dot hybrid-nanowire system	SCIENCE			English	Article							BIAS CONDUCTANCE PEAK; TOPOLOGICAL SUPERCONDUCTOR; FERMIONS; PARITY; GAP	Hybrid nanowires combining semiconductor and superconductor materials appear well suited for the creation, detection, and control of Majorana bound states (MBSs). We demonstrate the emergence of MBSs from coalescing Andreev bound states (ABSs) in a hybrid InAs nanowire with epitaxial Al, using a quantum dot at the end of the nanowire as a spectrometer. Electrostatic gating tuned the nanowire density to a regime of one or a few ABSs. In an applied axial magnetic field, a topological phase emerges in which ABSs move to zero energy and remain there, forming MBSs. We observed hybridization of the MBS with the end-dot bound state, which is in agreement with a numerical model. The ABS/MBS spectra provide parameters that are useful for understanding topological superconductivity in this system.	[Deng, M. T.; Vaitiekenas, S.; Hansen, E. B.; Danon, J.; Leijnse, M.; Flensberg, K.; Nygard, J.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Ctr Quantum Devices, DK-2100 Copenhagen, Denmark; [Deng, M. T.; Vaitiekenas, S.; Hansen, E. B.; Danon, J.; Leijnse, M.; Flensberg, K.; Nygard, J.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Niels Bohr Inst, Stn Copenhagen Q, DK-2100 Copenhagen, Denmark; [Deng, M. T.] Natl Univ Def Technol, State Key Lab High Performance Comp, Changsha 410073, Hunan, Peoples R China; [Vaitiekenas, S.] Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany; [Danon, J.] Univ Copenhagen, Niels Bohr Int Acad, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Leijnse, M.] Lund Univ, Div Solid State Phys & NanoLund, Box 118, S-22100 Lund, Sweden	University of Copenhagen; University of Copenhagen; Niels Bohr Institute; National University of Defense Technology - China; Free University of Berlin; University of Copenhagen; Niels Bohr Institute; Lund University	Marcus, CM (corresponding author), Univ Copenhagen, Ctr Quantum Devices, DK-2100 Copenhagen, Denmark.; Marcus, CM (corresponding author), Univ Copenhagen, Niels Bohr Inst, Stn Copenhagen Q, DK-2100 Copenhagen, Denmark.	marcus@nbi.dk	Hansen, Esben Bork/P-3712-2019; Leijnse, Martin/D-3116-2015; Nygård, Jesper/F-5113-2014; Deng, Mingtang/I-2692-2015; Flensberg, Karsten/N-4718-2014; Krogstrup, Peter/G-4323-2011; Danon, Jeroen/E-6641-2015	Hansen, Esben Bork/0000-0003-1775-6624; Leijnse, Martin/0000-0003-3639-8594; Nygård, Jesper/0000-0002-4639-5314; Deng, Mingtang/0000-0003-2809-6158; Flensberg, Karsten/0000-0002-8311-0103; Krogstrup, Peter/0000-0002-1930-8553; Vaitiekenas, Saulius/0000-0002-5007-461X; Danon, Jeroen/0000-0001-8088-8772	Microsoft Research; Project Q; Danish National Research Foundation; Villum Foundation; European Commission; Crafoord Foundation; Swedish Research Council (VR)	Microsoft Research(Microsoft); Project Q; Danish National Research Foundation(Danmarks Grundforskningsfond); Villum Foundation(Villum Fonden); European Commission(European CommissionEuropean Commission Joint Research Centre); Crafoord Foundation; Swedish Research Council (VR)(Swedish Research Council)	We thank R. Aguado, S. Albrecht, J. Alicea, L. Glazman, A. Higginbotham, B. van Heck, T. Sand Jespersen, F. Kuemmeth, R. Lutchyn, and J. Paaske for valuable discussions and V. Kirsebom, S. Moore, M. Ravn, D. Sherman, C. Sorensen, G. Ungaretti, and S. Upadhyay for contributions to growth, fabrication, and analysis. This research was supported by Microsoft Research, Project Q, the Danish National Research Foundation, the Villum Foundation, and the European Commission. M. L. acknowledges the Crafoord Foundation and the Swedish Research Council (VR). P.K., J.N., and C.M.M. are co-inventors on patent application PCT/EP2015/065110, submitted by the University of Copenhagen, covering epitaxial semiconductor-superconductor nanowires.	Aasen D, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031016; Albrecht SM, 2016, NATURE, V531, P206, DOI 10.1038/nature17162; Alicea J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125318; Chang W, 2015, NAT NANOTECHNOL, V10, P232, DOI [10.1038/NNANO.2014.306, 10.1038/nnano.2014.306]; Chang W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217005; Chevallier D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165401; CHUBOV PN, 1969, SOV PHYS JETP-USSR, V28, P389; Churchill HOH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241401; Das A, 2012, NAT PHYS, V8, P887, DOI [10.1038/NPHYS2479, 10.1038/nphys2479]; Das Sarma S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220506; Deng MT, 2014, SCI REP-UK, V4, DOI 10.1038/srep07261; Deng MT, 2012, NANO LETT, V12, P6414, DOI 10.1021/nl303758w; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Hyart T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035121; Kitaev A.Y., 2001, PHYS USPEKHI, V131, P130; Krogstrup P, 2015, NAT MATER, V14, P400, DOI [10.1038/nmat4176, 10.1038/NMAT4176]; Landau LA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.050501; Lee EJH, 2014, NAT NANOTECHNOL, V9, P79, DOI [10.1038/nnano.2013.267, 10.1038/NNANO.2013.267]; Leijnse M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.140501; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; MESERVEY R, 1964, PHYS REV, V135, pA24, DOI 10.1103/PhysRev.135.A24; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020407; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Rainis D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024515; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Stanescu TD, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094518; Stanescu TD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.266402; Takei S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.186803; van Heck B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/035019; Vazifeh MM, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.206802; Vernek E, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165314; Zitko R, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045441	40	684	688	18	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1557	1562		10.1126/science.aaf3961	http://dx.doi.org/10.1126/science.aaf3961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008065	Green Submitted			2022-12-28	WOS:000390254300045
J	Savage, N; Weinstock, J				Savage, Neil; Weinstock, Joel			Worm charmer	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S103	S103		10.1038/540S103a	http://dx.doi.org/10.1038/540S103a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002396	Bronze			2022-12-28	WOS:000391190500004
J	Ang, YS; Rivas, RN; Ribeiro, AJS; Srivas, R; Rivera, J; Stone, NR; Pratt, K; Mohamed, TMA; Fu, JD; Spencer, CI; Tippens, ND; Li, ML; Narasimha, A; Radzinsky, E; Moon-Grady, AJ; Yu, HY; Pruitt, BL; Snyder, MP; Srivastava, D				Ang, Yen-Sin; Rivas, Renee N.; Ribeiro, Alexandre J. S.; Srivas, Rohith; Rivera, Janell; Stone, Nicole R.; Pratt, Karishma; Mohamed, Tamer M. A.; Fu, Ji-Dong; Spencer, C. Ian; Tippens, Nathaniel D.; Li, Molong; Narasimha, Anil; Radzinsky, Ethan; Moon-Grady, Anita J.; Yu, Haiyuan; Pruitt, Beth L.; Snyder, Michael P.; Srivastava, Deepak			Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis	CELL			English	Article							PLURIPOTENT STEM-CELLS; HEART TUBE FORMATION; VENTRAL MORPHOGENESIS; CARDIAC DEVELOPMENT; ATRIAL SEPTATION; GENE-EXPRESSION; CARDIOMYOCYTES; CHROMATIN; TBX5; DIFFERENTIATION	Mutation of highly conserved residues in transcription factors may affect protein-protein or protein-DNA interactions, leading to gene network dysregulation and human disease. Human mutations in GATA4, a cardiogenic transcription factor, cause cardiac septal defects and cardiomyopathy. Here, iPS-derived cardiomyocytes from subjects with a heterozygous GATA4-G296S missense mutation showed impaired contractility, calcium handling, and metabolic activity. In human cardiomyocytes, GATA4 broadly co-occupied cardiac enhancers with TBX5, another transcription factor that causes septal defects when mutated. The GATA4-G296S mutation disrupted TBX5 recruitment, particularly to cardiac super-enhancers, concomitant with dysregulation of genes related to the phenotypic abnormalities, including cardiac septation. Conversely, the GATA4-G296S mutation led to failure of GATA4 and TBX5-mediated repression at non-cardiac genes and enhanced open chromatin states at endothelial/endocardial promoters. These results reveal how disease-causing missense mutations can disrupt transcriptional cooperativity, leading to aberrant chromatin states and cellular dysfunction, including those related to morphogenetic defects.	[Ang, Yen-Sin; Rivas, Renee N.; Rivera, Janell; Stone, Nicole R.; Pratt, Karishma; Mohamed, Tamer M. A.; Fu, Ji-Dong; Spencer, C. Ian; Li, Molong; Radzinsky, Ethan; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ang, Yen-Sin; Rivas, Renee N.; Rivera, Janell; Stone, Nicole R.; Pratt, Karishma; Mohamed, Tamer M. A.; Fu, Ji-Dong; Spencer, C. Ian; Li, Molong; Radzinsky, Ethan; Srivastava, Deepak] Roddenberry Ctr Stem Cell Biol & Med, San Francisco, CA 94158 USA; [Ang, Yen-Sin; Rivas, Renee N.; Stone, Nicole R.; Mohamed, Tamer M. A.; Moon-Grady, Anita J.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ang, Yen-Sin; Rivas, Renee N.; Stone, Nicole R.; Mohamed, Tamer M. A.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Ribeiro, Alexandre J. S.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Srivas, Rohith; Narasimha, Anil; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Srivas, Rohith; Narasimha, Anil; Snyder, Michael P.] Stanford Univ, Ctr Genom & Personalized Med, Stanford, CA 94305 USA; [Tippens, Nathaniel D.; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; Cornell University	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.; Srivastava, D (corresponding author), Roddenberry Ctr Stem Cell Biol & Med, San Francisco, CA 94158 USA.; Srivastava, D (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Srivastava, D (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	dsrivastava@gladstone.ucsf.edu		Moon-Grady, Anita/0000-0003-3822-693X; Srivastava, Deepak/0000-0002-3480-5953; Fu, Jidong/0000-0003-2797-5193; Srivas, Rohith/0000-0001-9495-9949; Tippens, Nathaniel/0000-0003-4377-8691; Snyder, Michael/0000-0003-0784-7987; Pruitt, Beth L./0000-0002-4861-2124	NIH [P01 HL098707, U01 HL098179, R01 HL057181, U01 HL100406, R21 HL13099301, R01 GM097358, R01 GM104424, UM1 HG009393, R01 HD082568]; SFARI Grant [367561, R01 EB006745]; AHA [14POST18360018, 13POST17390040]; NSF [MIKS-1136790]; Damon Runyon Foundation [DRG-2187-14]; Roddenberry Foundation; L.K. Whittier Foundation; Younger Family Fund; NIH/NCRR [C06 RR018928]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122887, P01HL089707, R01HL057181, U01HL100406, R21HL130993, UM1HL098179, U01HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; National Centre for the Replacement [NC/S01302/1] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SFARI Grant; AHA(American Heart Association); NSF(National Science Foundation (NSF)); Damon Runyon Foundation; Roddenberry Foundation; L.K. Whittier Foundation; Younger Family Fund; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Centre for the Replacement	We thank all family members for their participation, D.S. lab members for technical assistance and helpful suggestions, G. Howard for scientific editing, K.N. Ivey and K. Metzler for assistance with patient sample collection, and B. Taylor for assistance with manuscript preparation. Generous software support from Ayasdi was provided for topological data analysis. This work was supported by NIH P01 HL098707 (D.S.), U01 HL098179 (D.S.), R01 HL057181 (D.S.), U01 HL100406 (D.S.); R21 HL13099301 (B.L.P.), R01 GM097358 (H.Y.), R01 GM104424 (H.Y.), UM1 HG009393 (H.Y.), R01 HD082568 (H.Y.); SFARI Grant 367561 (H.Y.), R01 EB006745 (B.L.P.); by AHA 14POST18360018 (A.J.S.R.) and 13POST17390040 (Y.-S.A.); by NSF MIKS-1136790 (B.L.P.); and by Damon Runyon Foundation DRG-2187-14 (R.S.). D.S. was supported by the Roddenberry Foundation, the L.K. Whittier Foundation, and the Younger Family Fund. This work was also supported by NIH/NCRR grant C06 RR018928 to the Gladstone Institutes. This work is dedicated to Ian Spencer. D.S. is a scientific cofounder of Tenaya Therapeutics.	Aanhaanen WTJ, 2011, J CLIN INVEST, V121, P534, DOI 10.1172/JCI44350; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hoffmann AD, 2009, DEVELOPMENT, V136, P1761, DOI 10.1242/dev.034157; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Luna-Zurita L, 2016, CELL, V164, P999, DOI 10.1016/j.cell.2016.01.004; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misra C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002690; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Porto MPR, 2010, GENET MOL BIOL, V33, P232, DOI 10.1590/S1415-47572010005000051; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Srivastava D, 2006, ANNU REV PATHOL-MECH, V1, P199, DOI 10.1146/annurev.pathol.1.110304.100039; Stefanovic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4680; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao L, 2014, INT J MOL MED, V33, P654, DOI 10.3892/ijmm.2013.1600	47	129	138	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1734	+		10.1016/j.cell.2016.11.033	http://dx.doi.org/10.1016/j.cell.2016.11.033			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984724	Bronze, Green Accepted			2022-12-28	WOS:000393114700013
J	Dwyer-Lindgren, L; Bertozzi-Villa, A; Stubbs, RW; Morozoff, C; Kutz, MJ; Huynh, C; Barber, RM; Shackelford, KA; Mackenbach, JP; van Lenthe, FJ; Flaxman, AD; Naghavi, M; Mokdad, AH; Murray, CJL				Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Kutz, Michael J.; Huynh, Chantal; Barber, Ryan M.; Shackelford, Katya A.; Mackenbach, Johan P.; van Lenthe, Frank J.; Flaxman, Abraham D.; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.			US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUBLIC-HEALTH UTILITY; LIFE EXPECTANCY; GEOGRAPHIC PATTERNS; UNITED-STATES; DISEASE; DISPARITIES; PREVALENCE; RACE	IMPORTANCE County-level patterns in mortality rates by cause have not been systematically described but are potentially useful for public health officials, clinicians, and researchers seeking to improve health and reduce geographic disparities. OBJECTIVES To demonstrate the use of a novel method for county-level estimation and to estimate annual mortality rates by US county for 21 mutually exclusive causes of death from 1980 through 2014. DESIGN, SETTING, AND PARTICIPANTS Redistribution methods for garbage codes (implausible or insufficiently specific cause of death codes) and small area estimation methods (statistical methods for estimating rates in small subpopulations) were applied to death registration data from the National Vital Statistics System to estimate annual county-level mortality rates for 21 causes of death. These estimates were raked (scaled along multiple dimensions) to ensure consistency between causes and with existing national-level estimates. Geographic patterns in the age-standardized mortality rates in 2014 and in the change in the age-standardized mortality rates between 1980 and 2014 for the 10 highest-burden causes were determined. EXPOSURE County of residence. MAIN OUTCOMES AND MEASURES Cause-specific age-standardized mortality rates. RESULTS A total of 80 412 524 deaths were recorded from January 1, 1980, through December 31, 2014, in the United States. Of these, 19.4 million deaths were assigned garbage codes. Mortality rates were analyzed for 3110 counties or groups of counties. Large between-county disparities were evident for every cause, with the gap in age-standardized mortality rates between counties in the 90th and 10th percentiles varying from 14.0 deaths per 100 000 population (cirrhosis and chronic liver diseases) to 147.0 deaths per 100 000 population (cardiovascular diseases). Geographic regions with elevated mortality rates differed among causes: for example, cardiovascular disease mortality tended to be highest along the southern half of the Mississippi River, while mortality rates from self-harm and interpersonal violence were elevated in southwestern counties, and mortality rates from chronic respiratory disease were highest in counties in eastern Kentucky and western West Virginia. Counties also varied widely in terms of the change in cause-specific mortality rates between 1980 and 2014. For most causes (eg, neoplasms, neurological disorders, and self-harm and interpersonal violence), both increases and decreases in county-level mortality rates were observed. CONCLUSIONS AND RELEVANCE In this analysis of US cause-specific county-level mortality rates from 1980 through 2014, there were large between-county differences for every cause of death, although geographic patterns varied substantially by cause of death. The approach to county-level analyses with small area models used in this study has the potential to provide novel insights into US disease-specific mortality time trends and their differences across geographic regions.	[Dwyer-Lindgren, Laura; Bertozzi-Villa, Amelia; Stubbs, Rebecca W.; Morozoff, Chloe; Kutz, Michael J.; Huynh, Chantal; Barber, Ryan M.; Shackelford, Katya A.; Flaxman, Abraham D.; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA; [Mackenbach, Johan P.; van Lenthe, Frank J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Robert Wood Johnson Foundation [72305]; National Institute on Aging [5P30AG047845-02]; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grant 72305 from the Robert Wood Johnson Foundation, grant 5P30AG047845-02 from the National Institute on Aging, and a philanthropic gift from John W. Stanton and Theresa E. Gillespie.	Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; [Anonymous], 1996, ATLAS US MORTALITY; Casper M, 2016, CIRCULATION, V133, P1171, DOI 10.1161/CIRCULATIONAHA.115.018663; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chien LC, 2013, SPAT SPATIO-TEMPORAL, V5, P27, DOI 10.1016/j.sste.2013.03.002; Dwyer-Lindgren L, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-5; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; FABSITZ R, 1980, AM J EPIDEMIOL, V111, P315, DOI 10.1093/oxfordjournals.aje.a112903; FIENBERG SE, 1970, ANN MATH STAT, V41, P907, DOI 10.1214/aoms/1177696968; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Howard G, 2001, STROKE, V32, P2213, DOI 10.1161/hs1001.096047; Hoyert DL, 1997, PUBLIC HEALTH REP, V112, P497; Kristensen K, 2016, J STAT SOFTW, V70, P1; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Center for Health Statistics, 2012, BRIDG RAC INT EST RE; National Center for Health Statistics, 2015, VINT 2014 POSTC EST; National Center for Health Statistics, 2004, BRIDG RAC INT EST RE; National Center for Health Statistics, 2014, NAT VIT STAT SYST MU; Office of Management and Budget, 1997, FED REGISTER, V62, P58782; Rossen LM, 2013, AM J PREV MED, V45, pE19, DOI 10.1016/j.amepre.2013.07.012; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; US Census Bureau, 2004, INT COUNT EST AG SE; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd	29	153	155	7	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2385	2401		10.1001/jama.2016.13645	http://dx.doi.org/10.1001/jama.2016.13645			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959996	Green Accepted			2022-12-28	WOS:000389884600020
J	Schillinger, D; Kearns, C				Schillinger, Dean; Kearns, Cristin			Guidelines to Limit Added Sugar Intake: Junk Science or Junk Food?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INDUSTRY		[Schillinger, Dean] Zuckerberg San Francisco Gen Hosp, UCSF Div Gen Internal Med, 1001 Potrero Ave,UCSF Box 1364, San Francisco, CA 94143 USA; [Schillinger, Dean] UCSF Ctr Vulnerable Populat, San Francisco, CA USA; [Kearns, Cristin] UCSF Phillip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Kearns, Cristin] UCSF Sch Dent, San Francisco, CA USA; [Kearns, Cristin] Univ Calif San Francisco, 530 Parnassus Ave,Suite 366, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schillinger, D (corresponding author), Zuckerberg San Francisco Gen Hosp, UCSF Div Gen Internal Med, 1001 Potrero Ave,UCSF Box 1364, San Francisco, CA 94143 USA.	dean.schillinger@ucsf.edu			NIDCR NIH HHS [T32 DE007306] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 2003, BBC NEWS; Bolsen T, 2015, J COMMUN, V65, P745, DOI 10.1111/jcom.12171; Erickson J, 2017, ANN INTERN MED, V166, P257, DOI 10.7326/M16-2020; ILSI North America, 2016, 2015 ANN REP; Kearns CE, 2016, JAMA INTERN MED, V176, P1680, DOI 10.1001/jamainternmed.2016.5394; Norum K. R., 2005, Scandinavian Journal of Nutrition, V49, P83, DOI 10.1080/11026480510037147; Samet JM, 2001, AM J PUBLIC HEALTH, V91, P1742, DOI 10.2105/AJPH.91.11.1742; Schillinger D, 2016, ANN INTERN MED, V165, P895, DOI 10.7326/L16-0534; The AGREE Research Trust, 2009, APPR GUID RES EV 2 I; U.S. Department of Health and Human Services U.S. Department of Agriculture, 2015, SER SYST REV REL DIE	10	8	8	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2017	166	4					305	+		10.7326/M16-2754	http://dx.doi.org/10.7326/M16-2754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL7FO	27992900				2022-12-28	WOS:000394786700024
J	Griffiths, PD; Bradburn, M; Campbell, MJ; Cooper, CL; Graham, R; Jarvis, D; Kilby, MD; Mason, G; Mooney, C; Robson, SC; Wailoo, A				Griffiths, Paul D.; Bradburn, Michael; Campbell, Michael J.; Cooper, Cindy L.; Graham, Ruth; Jarvis, Deborah; Kilby, Mark D.; Mason, Gerald; Mooney, Cara; Robson, Stephen C.; Wailoo, Allan		MERIDIAN Collaborative Grp	Use of MRI in the diagnosis of fetal brain abnormalities in utero (MERIDIAN): a multicentre, prospective cohort study	LANCET			English	Article							PRENATAL ULTRASOUND DIAGNOSIS; AUTOPSY FINDINGS; PATHOLOGICAL FINDINGS; 2ND TRIMESTER; ANOMALIES; PREGNANCIES; EXPOSURE	Background In-utero MRI (iuMRI) has shown promise as an adjunct to ultrasound but the comparative diagnostic performance has been poorly defined. We aimed to assess whether the diagnostic accuracy and confidence of the prenatal diagnosis of fetal brain abnormalities is improved with iuMRI and assess the clinical impact and patient acceptability of iuMRI. Methods We did a multicentre, prospective, cohort study in the UK, at 16 fetal medicine centres, of pregnant women aged 16 years or older whose fetus had a brain abnormality detected by ultrasound at a gestational age of 18 weeks or more, had no contraindications to iuMRI, and consented to enter the study. Women carrying a fetus suspected of having a brain anomaly on ultrasound had iuMRI done within 14 days of ultrasound. The findings were reviewed by two independent panels and used to estimate diagnostic accuracy and confidence by comparison with outcome diagnoses. Changes in diagnosis, prognosis, and clinical management brought about by iuMRI and patient acceptability were assessed. Findings Participants were recruited between July 29, 2011, and Aug 31, 2014. The cohort was subdivided by gestation into the 18 weeks to less than 24 weeks fetus cohort (n=369) and into the 24 weeks or older fetus cohort (n=201). Diagnostic accuracy was improved by 23% (95% CI 18-27) in the 18 weeks to less than 24 weeks group and 29% (23-36) in the 24 weeks and older group (p<0.0001 for both groups). The overall diagnostic accuracy was 68% for ultrasound and 93% for iuMRI (difference 25%, 95% CI 21-29). Dominant diagnoses were reported with high confidence on ultrasound in 465 (82%) of 570 cases compared with 544 (95%) of 570 cases on iuMRI. IuMRI provided additional diagnostic information in 387 (49%) of 783 cases, changed prognostic information in at least 157 (20%), and led to changes in clinical management in more than one in three cases. IuMRI also had high patient acceptability with at least 95% of women saying they would have an iuMRI study if a future pregnancy were complicated by a fetal brain abnormality. Interpretation iuMRI improves diagnostic accuracy and confidence for fetal brain anomalies and leads to management changes in a high proportion of cases. This finding, along with the high patient acceptability, leads us to propose that any fetus with a suspected brain abnormality on ultrasound should have iuMRI to better inform counselling and management decisions.	[Griffiths, Paul D.; Jarvis, Deborah] Univ Sheffield, Acad Unit Radiol, Sheffield, S Yorkshire, England; [Bradburn, Michael; Campbell, Michael J.; Cooper, Cindy L.; Mooney, Cara] Univ Sheffield, Sch Hlth & Related Res, Clin Trials Res Unit, Sheffield S1 4DA, S Yorkshire, England; [Griffiths, Paul D.] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Wailoo, Allan] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England; [Graham, Ruth; Robson, Stephen C.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Kilby, Mark D.] Univ Birmingham, Inst Metab & Syst Res, Ctr Womens & Newborn Hlth, Birmingham, W Midlands, England; [Kilby, Mark D.] Birmingham Hlth Partners, Birmingham Womens Fdn Trust, Fetal Med Ctr, Birmingham, W Midlands, England; [Mason, Gerald] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Newcastle University - UK; University of Birmingham; University of Leeds	Mooney, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Clin Trials Res Unit, Sheffield S1 4DA, S Yorkshire, England.	c.d.mooney@sheffield.ac.uk	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Campbell, Michael J/I-4253-2014; Professor Dilly Anumba MBBS, FWACS/A-6358-2011	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Campbell, Michael J/0000-0003-3529-2739; Professor Dilly Anumba MBBS, FWACS/0000-0003-2502-3033; Mooney, Cara/0000-0002-3086-7348; Wailoo, Allan/0000-0002-9324-1617; Graham, Ruth/0000-0001-9432-760X	Perinatal Trust Funds; National Institute for Health Research (NIHR) Health Technology Assessment Programme [09/06/01]; National Institute for Health Research Health Technology Assessment programme; National Institute for Health Research [09/06/01] Funding Source: researchfish	Perinatal Trust Funds; National Institute for Health Research (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment programme.; We would like to thank The Perinatal Trust Funds for supporting the study. This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment Programme (project number 09/06/01). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Health Technology Assessment Programme, NIHR, National Health Service, or the Department of Health. We gratefully acknowledge the support and advice from the members of our Trial Steering Committee and Data Monitoring and Ethics Committee. We off er special thanks to the research midwives and the research teams at the participating Trusts for their hard work and support.	Akgun H, 2007, PRENATAL DIAG, V27, P457, DOI 10.1002/pd.1710; American College of Radiology Society for Pediatric Radiology., 2010, ACR SPR PRACT GUID S, P10; Amini H, 2006, ACTA OBSTET GYN SCAN, V85, P1208, DOI 10.1080/00016340600880886; [Anonymous], 1992, Arch Dis Child, V67, P770; Antonsson P, 2008, J PERINAT MED, V36, P59, DOI 10.1515/JPM.2008.005; Boyd PA, 2004, BRIT MED J, V328, P137, DOI 10.1136/bmj.37939.570104.EE; Carroll SGM, 2000, ULTRASOUND OBST GYN, V16, P149, DOI 10.1046/j.1469-0705.2000.00199.x; Fadda GM, 2009, EUR J OBSTET GYN R B, V144, P110, DOI 10.1016/j.ejogrb.2009.02.045; Grandjean H, 1999, AM J OBSTET GYNECOL, V181, P446, DOI 10.1016/S0002-9378(99)70577-6; International Electrotechnical Commission, 2008, 60601233 IEC; Kok RD, 2004, MAGN RESON IMAGING, V22, P851, DOI 10.1016/j.mri.2004.01.047; Likert R.A., 1932, ARCH PSYCHOL, V22, P5, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Mundy L, 2007, MRI DETECTION FOETAL; Ng CS, 2007, BRIT J RADIOL, V80, P152, DOI 10.1259/bjr/64096611; Reeves MJ, 2010, RADIOLOGY, V257, P802, DOI 10.1148/radiol.10092366; Richmond S, 2005, BJOG-INT J OBSTET GY, V112, P1349, DOI 10.1111/j.1471-0528.2005.00660.x; Rossi AC, 2014, ULTRASOUND OBST GYN, V44, P388, DOI 10.1002/uog.13429; Sun CCJ, 1999, PEDIATR DEVEL PATHOL, V2, P131, DOI 10.1007/s100249900101; Van Doorn M, 2015, J MATERN-FETAL NEO M, V23, P1, DOI DOI 10.3109/14767058.2015.1109621	19	154	170	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					538	546		10.1016/S0140-6736(16)31723-8	http://dx.doi.org/10.1016/S0140-6736(16)31723-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ5UH	27988140	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000393283400036
J	Kaneda, MM; Messer, KS; Ralainirina, N; Li, HY; Leem, CJ; Gorjestani, S; Woo, G; Nguyen, AV; Figueiredo, CC; Foubert, P; Schmid, MC; Pink, M; Winkler, DG; Rausch, M; Palombella, VJ; Kutok, J; McGovern, K; Frazer, KA; Wu, XF; Karin, M; Sasik, R; Cohen, EEW; Varner, JA				Kaneda, Megan M.; Messer, Karen S.; Ralainirina, Natacha; Li, Hongying; Leem, Christopher J.; Gorjestani, Sara; Woo, Gyunghwi; Nguyen, Abraham V.; Figueiredo, Camila C.; Foubert, Philippe; Schmid, Michael C.; Pink, Melissa; Winkler, David G.; Rausch, Matthew; Palombella, Vito J.; Kutok, Jeffery; McGovern, Karen; Frazer, Kelly A.; Wu, Xuefeng; Karin, Michael; Sasik, Roman; Cohen, Ezra E. W.; Varner, Judith A.			PI3K gamma is a molecular switch that controls immune suppression (vol 539, pg 437, 2016)	NATURE			English	Correction																		Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834	1	20	20	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					124	124		10.1038/nature21026	http://dx.doi.org/10.1038/nature21026			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	27974794				2022-12-28	WOS:000396119300044
J	Leduc, C; Quoix, E				Leduc, Charlotte; Quoix, Elisabeth			Programmed death of chemotherapy in non-small-cell lung cancer?	LANCET			English	Editorial Material							DOCETAXEL; NIVOLUMAB; TRIAL		[Leduc, Charlotte; Quoix, Elisabeth] Univ Hosp, Dept Pneumol, Strasbourg, France		Quoix, E (corresponding author), Univ Hosp, Dept Pneumol, Strasbourg, France.	elisabeth.quoix@chru-strasbourg.fr						[Anonymous], [No title captured]; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Passiglia F, 2016, ONCOTARGET, V7, P19738, DOI 10.18632/oncotarget.7582; Reck M., 2016, N ENGL J MED; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954	10	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					227	228		10.1016/S0140-6736(16)32535-1	http://dx.doi.org/10.1016/S0140-6736(16)32535-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	27979385				2022-12-28	WOS:000392801200004
J	Honein, MA; Dawson, AL; Petersen, EE; Jones, AM; Lee, EH; Yazdy, MM; Ahmad, N; Macdonald, J; Evert, N; Bingham, A; Ellington, SR; Shapiro-Mendoza, CK; Oduyebo, T; Fine, AD; Brown, CM; Sommer, JN; Gupta, J; Cavicchia, P; Slavinski, S; White, JL; Owen, SM; Petersen, LR; Boyle, C; Meaney-Delman, D; Jamieson, DJ				Honein, Margaret A.; Dawson, April L.; Petersen, Emily E.; Jones, Abbey M.; Lee, Ellen H.; Yazdy, Mahsa M.; Ahmad, Nina; Macdonald, Jennifer; Evert, Nicole; Bingham, Andrea; Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.; Oduyebo, Titilope; Fine, Anne D.; Brown, Catherine M.; Sommer, Jamie N.; Gupta, Jyoti; Cavicchia, Philip; Slavinski, Sally; White, Jennifer L.; Owen, S. Michele; Petersen, Lyle R.; Boyle, Coleen; Meaney-Delman, Dana; Jamieson, Denise J.		US Zika Pregnancy Registry	Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UPDATE INTERIM GUIDANCE; UNITED-STATES; TRANSMISSION; EXPOSURE; BRAZIL; RISK	IMPORTANCE Understanding the risk of birth defects associated with Zika virus infection during pregnancy may help guide communication, prevention, and planning efforts. In the absence of Zika virus, microcephaly occurs in approximately 7 per 10 000 live births. OBJECTIVE To estimate the preliminary proportion of fetuses or infants with birth defects after maternal Zika virus infection by trimester of infection and maternal symptoms. DESIGN, SETTING, AND PARTICIPANTS Completed pregnancies with maternal, fetal, or infant laboratory evidence of possible recent Zika virus infection and outcomes reported in the continental United States and Hawaii from January 15 to September 22, 2016, in the US Zika Pregnancy Registry, a collaboration between the CDC and state and local health departments. EXPOSURES Laboratory evidence of possible recent Zika virus infection in a maternal, placental, fetal, or infant sample. MAIN OUTCOMES AND MEASURES Birth defects potentially Zika associated: brain abnormalities with or without microcephaly, neural tube defects and other early brain malformations, eye abnormalities, and other central nervous system consequences. RESULTS Among 442 completed pregnancies in women (median age, 28 years; range, 15-50 years) with laboratory evidence of possible recent Zika virus infection, birth defects potentially related to Zika virus were identified in 26 (6%; 95% CI, 4%-8%) fetuses or infants. There were 21 infants with birth defects among 395 live births and 5 fetuses with birth defects among 47 pregnancy losses. Birth defects were reported for 16 of 271 (6%; 95% CI, 4%-9%) pregnant asymptomatic women and 10 of 167 (6%; 95% CI, 3%-11%) symptomatic pregnant women. Of the 26 affected fetuses or infants, 4 had microcephaly and no reported neuroimaging, 14 had microcephaly and brain abnormalities, and 4 had brain abnormalities without microcephaly; reported brain abnormalities included intracranial calcifications, corpus callosum abnormalities, abnormal cortical formation, cerebral atrophy, ventriculomegaly, hydrocephaly, and cerebellar abnormalities. Infants with microcephaly (18/442) represent 4% of completed pregnancies. Birth defects were reported in 9 of 85 (11%; 95% CI, 6%-19%) completed pregnancies with maternal symptoms or exposure exclusively in the first trimester (or first trimester and periconceptional period), with no reports of birth defects among fetuses or infants with prenatal exposure to Zika virus infection only in the second or third trimesters. CONCLUSIONS AND RELEVANCE Among pregnant women in the United States with completed pregnancies and laboratory evidence of possible recent Zika infection, 6% of fetuses or infants had evidence of Zika-associated birth defects, primarily brain abnormalities and microcephaly, whereas among women with first-trimester Zika infection, 11% of fetuses or infants had evidence of Zika-associated birth defects. These findings support the importance of screening pregnant women for Zika virus exposure.	[Honein, Margaret A.; Dawson, April L.; Petersen, Emily E.; Jones, Abbey M.; Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.; Oduyebo, Titilope; Meaney-Delman, Dana; Jamieson, Denise J.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA; [Lee, Ellen H.; Fine, Anne D.; Slavinski, Sally] New York City Dept Hlth & Mental Hyg, Queens, NY USA; [Yazdy, Mahsa M.; Brown, Catherine M.] Massachusetts Dept Publ Hlth, Boston, MA USA; [Ahmad, Nina; Sommer, Jamie N.; White, Jennifer L.] New York State Dept Hlth, Albany, NY USA; [Macdonald, Jennifer; Gupta, Jyoti] Virginia Dept Hlth, Richmond, VA USA; [Evert, Nicole] Texas Dept State Hlth Serv, Austin, TX USA	Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene; Massachusetts Department of Public Health; State University of New York (SUNY) System; Texas Department of State Health Services	Honein, MA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	mrh7@cdc.gov	Shapiro-Mendoza, Carrie/H-3596-2019; Shapiro-Mendoza, Carrie/B-3236-2009; amsalu, ribka/G-8780-2019	Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Yazdy, Mahsa/0000-0002-7415-5350; Jamieson, Denise/0000-0003-2597-1201				Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.3201/eid2206.160062, 10.32032/eid2206.160062]; Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397; Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA US EM; Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126; Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882; Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587; de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; de Paula Freitas Bruno, 2016, JAMA Ophthalmol, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Leal MC, BRAZ J OTORHINOLARYN; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2; Pacheco O., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]; Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769; Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1; van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784; Webster WS, 1998, TERATOLOGY, V58, P13	39	326	329	4	416	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					59	68		10.1001/jama.2016.19006	http://dx.doi.org/10.1001/jama.2016.19006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	27960197	Bronze			2022-12-28	WOS:000391009100020
J	Lipoff, JB; Steele, KT; Jariwala, N				Lipoff, Jules B.; Steele, Katherine T.; Jariwala, Neha			Eyebrow and Eyelash Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LEPROSY		[Lipoff, Jules B.; Steele, Katherine T.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Jariwala, Neha] Drexel Coll Med, Philadelphia, PA USA	University of Pennsylvania; Drexel University	Lipoff, JB (corresponding author), Univ Penn, Dept Dermatol, Penn Med Univ City, 3737 Market St,Ste 1100, Philadelphia, PA 19104 USA.	jules.lipoff@uphs.upenn.edu						Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Kar HK, 2015, CLIN DERMATOL, V33, P55, DOI 10.1016/j.clindermatol.2014.07.007; Krishnan Ajay, 2012, Int J Trichology, V4, P179, DOI 10.4103/0974-7753.100092; Kumar Annapurna, 2012, Int J Trichology, V4, P3, DOI 10.4103/0974-7753.96079; Talhari C, 2015, CLIN DERMATOL, V33, P26, DOI 10.1016/j.clindermatol.2014.07.002; Truman RW, 2011, NEW ENGL J MED, V364, P1626, DOI 10.1056/NEJMoa1010536	6	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					81	82		10.1001/jama.2016.17688	http://dx.doi.org/10.1001/jama.2016.17688			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030678				2022-12-28	WOS:000391009100024
J	[Anonymous]				[Anonymous]			Long-Acting Oral Drug Device May Help Combat Malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					17	17		10.1001/jama.2016.18686	http://dx.doi.org/10.1001/jama.2016.18686			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030689				2022-12-28	WOS:000391009100003
J	Cho, A				Cho, Adrian			The cosmos aquiver	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1516	1517		10.1126/science.354.6319.1516	http://dx.doi.org/10.1126/science.354.6319.1516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008020				2022-12-28	WOS:000390254300013
J	Hu, G; Lim, KS; Horvitz, N; Clark, SJ; Reynolds, DR; Sapir, N; Chapman, JW				Hu, Gao; Lim, Ka S.; Horvitz, Nir; Clark, Suzanne J.; Reynolds, Don R.; Sapir, Nir; Chapman, Jason W.			Mass seasonal bioflows of high-flying insect migrants	SCIENCE			English	Article							MIGRATION; TRANSPORT; ENERGY; MOTHS	Migrating animals have an impact on ecosystems directly via influxes of predators, prey, and competitors and indirectly by vectoring nutrients, energy, and pathogens. Although linkages between vertebrate movements and ecosystem processes have been established, the effects of mass insect "bioflows" have not been described. We quantified biomass flux over the southern United Kingdom for high-flying (>150 meters) insects and show that similar to 3.5 trillion insects (3200 tons of biomass) migrate above the region annually. These flows are not randomly directed in insects larger than 10 milligrams, which exploit seasonally beneficial tailwinds. Large seasonal differences in the southward versus northward transfer of biomass occur in some years, although flows were balanced over the 10-year period. Our long-term study reveals a major transport process with implications for ecosystem services, processes, and biogeochemistry.	[Hu, Gao] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Hu, Gao; Lim, Ka S.; Clark, Suzanne J.; Chapman, Jason W.] Rothamsted Res, Harpenden, Herts, England; [Hu, Gao; Chapman, Jason W.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Hu, Gao; Chapman, Jason W.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Horvitz, Nir] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Movement Ecol Lab, Jerusalem, Israel; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Sapir, Nir] Univ Haifa, Dept Evolutionary & Environm Biol, Anim Flight Lab, Haifa, Israel	Nanjing Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter; University of Exeter; Hebrew University of Jerusalem; University of Greenwich; University of Haifa	Hu, G (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.; Hu, G; Chapman, JW (corresponding author), Rothamsted Res, Harpenden, Herts, England.; Hu, G; Chapman, JW (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.; Hu, G; Chapman, JW (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	hugao@njau.edu.cn; j.chapman2@exeter.ac.uk	Reynolds, Donald R/C-7361-2013; Sapir, Nir/V-9634-2019; Lim, Ka Sing/B-4480-2012	Sapir, Nir/0000-0002-2477-0515; Lim, Ka Sing/0000-0002-9166-2928; Reynolds, Donald/0000-0001-8749-7491; Hu, Gao/0000-0002-1000-5687	China Scholarship Council; COST-European Cooperation in Science and Technology through the Action [ES1305]; UK Biotechnology and Biological Sciences Research Council [BB/J004286/1]; BBSRC [BBS/E/C/00005195] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/OS/NW/000004, BBS/E/C/00005195] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); COST-European Cooperation in Science and Technology through the Action; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	G.H.'s visiting scholarship was funded by the China Scholarship Council. We acknowledge the support provided by COST-European Cooperation in Science and Technology through the Action ES1305 "ENRAM." The project was supported by UK Biotechnology and Biological Sciences Research Council grant BB/J004286/1 to J.W.C. Data are available at Dryad at http://dx.doi.org/10.5061/dryad.6kt29.	Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2015, CURR BIOL, V25, pR751, DOI 10.1016/j.cub.2015.07.074; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Drake V. J, 2012, LIPOIC ACID; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Green K, 2011, AUSTRAL ECOL, V36, P25, DOI 10.1111/j.1442-9993.2010.02109.x; Hahn S, 2009, OIKOS, V118, P624, DOI 10.1111/j.1600-0706.2009.17309.x; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kelly JF, 2016, GLOBAL ECOL BIOGEOGR, V25, P1159, DOI 10.1111/geb.12473; Landry JS, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1265; Mouritsen H, 2016, ANNU REV PHYSIOL, V78, P133, DOI 10.1146/annurev-physiol-021115-105054; Stefanescu C, 2013, ECOGRAPHY, V36, P474, DOI 10.1111/j.1600-0587.2012.07738.x; Varpe O, 2005, OECOLOGIA, V146, P443, DOI 10.1007/s00442-005-0219-9; Warrant E, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00077; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	21	167	180	20	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1584	1587		10.1126/science.aah4379	http://dx.doi.org/10.1126/science.aah4379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008067	Green Accepted, Green Submitted			2022-12-28	WOS:000390254300052
J	Pulla, P				Pulla, Priyanka			In India, elite institutes in shady journals	SCIENCE			English	News Item																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1511	1512		10.1126/science.354.6319.1511	http://dx.doi.org/10.1126/science.354.6319.1511			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008015				2022-12-28	WOS:000390254300008
J	Takahashi, N; Oertner, TG; Hegemann, P; Larkum, ME				Takahashi, Naoya; Oertner, Thomas G.; Hegemann, Peter; Larkum, Matthew E.			Active cortical dendrites modulate perception	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL CELLS; MOUSE BARREL CORTEX; IN-VIVO; CELLULAR MECHANISM; SENSORY PERCEPTION; CEREBRAL-CORTEX; CA2+ SPIKES; INHIBITION; NEURONS; POTENTIALS	There is as yet no consensus concerning the neural basis of perception and how it operates at a mechanistic level. We found that Ca2+ activity in the apical dendrites of a subset of layer 5 (L5) pyramidal neurons in primary somatosensory cortex (S1) in mice is correlated with the threshold for perceptual detection of whisker deflections. Manipulating the activity of apical dendrites shifted the perceptual threshold, demonstrating that an active dendritic mechanism is causally linked to perceptual detection.	[Takahashi, Naoya; Larkum, Matthew E.] Humboldt Univ, Inst Biol, Neuronal Plast, D-10117 Berlin, Germany; [Oertner, Thomas G.] Univ Med Ctr Hamburg Eppendorf, Inst Synapt Physiol, D-20251 Hamburg, Germany; [Hegemann, Peter] Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Humboldt University of Berlin	Larkum, ME (corresponding author), Humboldt Univ, Inst Biol, Neuronal Plast, D-10117 Berlin, Germany.	matthew.larkum@hu-berlin.de	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528; Larkum, Matthew/0000-0001-9799-2656; Takahashi, Naoya/0000-0002-6008-4627	Deutsche Forschungsgemeinschaft (EXC NeuroCure) [LA 3442/3-1, SPP1665, SFB1078 B2]; European Union [72070/HBP SGA1, 670118/ERC ActiveCortex]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science	Deutsche Forschungsgemeinschaft (EXC NeuroCure)(German Research Foundation (DFG)); European Union(European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science	We thank J. Sigl-Glockner for assistance with histology; M. Suzuki for assistance with transgenic animals; J. S. Wiegert for viral constructs; and W. A. Phillips for comments and discussions on the manuscript. This study was supported by the Deutsche Forschungsgemeinschaft (EXC NeuroCure, LA 3442/3-1, SPP1665, SFB1078 B2), European Union Horizon 2020 Research and Innovation Programme (under grant agreement numbers 72070/HBP SGA1 and 670118/ERC ActiveCortex), the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and the Kanae Foundation for the Promotion of Medical Science. N.T. and M.E.L. conceived the project and designed the experiments. N.T. performed all the experiments and data analysis. N.T. and M.E.L. wrote the paper. T.G.O. and P.H. provided the viral construct iChloC. Original data are kept on local hard drives (with backups). P.H. is Hertie Senior Professor for Neuroscience. Processed data for this study (including extracted calcium traces) are additionally kept and curated on servers of the Charite Universitatsmedizin-Berlin. The authors declare that they have no competing financial interests.	Bachmann T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01947; Carandini M, 2013, NAT NEUROSCI, V16, P824, DOI 10.1038/nn.3410; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; CORSO JF, 1963, PSYCHOL BULL, V60, P356, DOI 10.1037/h0040633; Doron G, 2014, NEURON, V81, P653, DOI 10.1016/j.neuron.2013.11.032; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gambino F, 2014, NATURE, V515, P116, DOI 10.1038/nature13664; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Kwon SE, 2016, NAT NEUROSCI, V19, P1243, DOI 10.1038/nn.4356; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LIBET B, 1967, SCIENCE, V158, P1597, DOI 10.1126/science.158.3808.1597; Manita S, 2015, NEURON, V86, P1304, DOI 10.1016/j.neuron.2015.05.006; Meyer K, 2015, ANESTHESIOLOGY, V122, P1415, DOI 10.1097/ALN.0000000000000673; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Murayama M, 2009, P NATL ACAD SCI USA, V106, P20482, DOI 10.1073/pnas.0910379106; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Murphy SC, 2016, ELIFE, V5, DOI 10.7554/eLife.13598; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Palva S, 2005, J NEUROSCI, V25, P5248, DOI 10.1523/JNEUROSCI.0141-05.2005; Perez-Garci E, 2013, J PHYSIOL-LONDON, V591, P1599, DOI 10.1113/jphysiol.2012.245464; Phillips WA, 2015, NEUROSCI BIOBEHAV R, V52, P1, DOI 10.1016/j.neubiorev.2015.02.010; Pleger B, 2013, PROG NEUROBIOL, V103, P76, DOI 10.1016/j.pneurobio.2012.10.002; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rockland K. S., 1997, EXTRASTRIATE CORTEX, P243; Sachidhanandam S, 2013, NAT NEUROSCI, V16, P1671, DOI 10.1038/nn.3532; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Wietek J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14807; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601	33	188	188	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1587	1590		10.1126/science.aah6066	http://dx.doi.org/10.1126/science.aah6066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008068				2022-12-28	WOS:000390254300053
J	Patel, K				Patel, Kushal			Pay inequity spells a winter of discontent for junior doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Patel, Kushal] Univ Coll Hosp, London, England; North Cent Thames Fdn Sch, London, England	University of London; University College London	Patel, K (corresponding author), Univ Coll Hosp, London, England.	kushalpatel@live.co.uk						NHS Employers, 2015, PAY COND CIRC M D 1; NHS Employers, 2016, PAY COND CIRC M D 2; Rimmer A., 2016, JUNIOR DOCTORS RAISE	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2016	355								i6809	10.1136/bmj.i6809	http://dx.doi.org/10.1136/bmj.i6809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CJ	28007699				2022-12-28	WOS:000390921100005
J	Bu, LZ; Zhang, N; Guo, SJ; Zhang, X; Li, J; Yao, JL; Wu, T; Lu, G; Ma, JY; Su, D; Huang, XQ				Bu, Lingzheng; Zhang, Nan; Guo, Shaojun; Zhang, Xu; Li, Jing; Yao, Jianlin; Wu, Tao; Lu, Gang; Ma, Jing-Yuan; Su, Dong; Huang, Xiaoqing			Biaxially strained PtPb/Pt core/shell nanoplate boosts oxygen reduction catalysis	SCIENCE			English	Article							COMPUTATIONAL DESIGN; PLATINUM; ELECTROCATALYSTS; SURFACES; NANOPARTICLES; NANOCRYSTALS; NANOSHEETS; METHANOL; FACETS; ALLOY	Compressive surface strains have been necessary to boost oxygen reduction reaction (ORR) activity in core/shell M/platinum (Pt) catalysts (where M can be nickel, cobalt, or iron). We report on a class of platinum-lead/platinum (PtPb/Pt) core/shell nanoplate catalysts that exhibit large biaxial strains. The stable Pt (110) facets of the nanoplates have high ORR specific and mass activities that reach 7.8 milliampere (mA) per centimeter squared and 4.3 ampere per milligram of platinum at 0.9 volts versus the reversible hydrogen electrode (RHE), respectively. Density functional theory calculations reveal that the edge-Pt and top (bottom)-Pt (110) facets undergo large tensile strains that help optimize the Pt-O bond strength. The intermetallic core and uniform four layers of Pt shell of the PtPb/Pt nanoplates appear to underlie the high endurance of these catalysts, which can undergo 50,000 voltage cycles with negligible activity decay and no apparent structure and composition changes.	[Bu, Lingzheng; Zhang, Nan; Yao, Jianlin; Wu, Tao; Huang, Xiaoqing] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Jiangsu, Peoples R China; [Guo, Shaojun] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China; [Guo, Shaojun] Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China; [Guo, Shaojun] Peking Univ, Beijing Innovat Ctr Engn Sci & Adv Technol BIC ES, Coll Engn, Beijing 100871, Peoples R China; [Guo, Shaojun] Peking Univ, Key Lab Theory & Technol Adv Batteries Mat, Coll Engn, Beijing 100871, Peoples R China; [Zhang, Xu; Lu, Gang] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Li, Jing; Su, Dong] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Ma, Jing-Yuan] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China	Soochow University - China; Peking University; Peking University; Peking University; Peking University; California State University System; California State University Northridge; United States Department of Energy (DOE); Brookhaven National Laboratory; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Huang, XQ (corresponding author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Jiangsu, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Coll Engn, Dept Energy & Resources Engn, Beijing 100871, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Beijing Innovat Ctr Engn Sci & Adv Technol BIC ES, Coll Engn, Beijing 100871, Peoples R China.; Guo, SJ (corresponding author), Peking Univ, Key Lab Theory & Technol Adv Batteries Mat, Coll Engn, Beijing 100871, Peoples R China.; Su, D (corresponding author), Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA.	guosj@pku.edu.cn; dsu@bnl.gov; hxq006@suda.edu.cn	Wu, Tao/H-5754-2012; Su, Dong/A-8233-2013; Guo, Shaojun/A-8449-2011	Su, Dong/0000-0002-1921-6683; Guo, Shaojun/0000-0002-5941-414X	National Key Research and Development Program of China [2016YEB0100201]; National Natural Science Foundation of China [21571135, 51671003]; Ministry of Science and Technology [2016YFA0204100]; Soochow University; Peking University; Young Thousand Talented Program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Energy (DOE), Office of Basic Energy Science [DE-SC0012704]; U.S. Army Research Office via the MURI grant [W911NF-11-1-0353]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Soochow University; Peking University(Peking University); Young Thousand Talented Program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); U.S. Department of Energy (DOE), Office of Basic Energy Science(United States Department of Energy (DOE)); U.S. Army Research Office via the MURI grant	This work was financially supported by the National Key Research and Development Program of China (2016YEB0100201), the National Natural Science Foundation of China (21571135 and 51671003), the Ministry of Science and Technology (2016YFA0204100), the start-up funding from Soochow University and Peking University, Young Thousand Talented Program, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Part of the electron microscopy work was performed at the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy (DOE), Office of Basic Energy Science, under contract DE-SC0012704. The work at California State University Northridge was supported by the U.S. Army Research Office via the MURI grant W911NF-11-1-0353. We thank S. Cheng for his help in the simulation of STEM imaging. All data are reported in the main text and supplementary materials.	Bian T, 2015, NANO LETT, V15, P7808, DOI 10.1021/acs.nanolett.5b02960; Chen AC, 2010, CHEM REV, V110, P3767, DOI 10.1021/cr9003902; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen L, 2014, NANO LETT, V14, P7201, DOI 10.1021/nl504126u; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Dresselhaus MS, 2001, NATURE, V414, P332, DOI 10.1038/35104599; Francis MF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7261; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Ghosh T, 2010, J AM CHEM SOC, V132, P906, DOI 10.1021/ja905850c; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI [10.1038/nnano.2010.235, 10.1038/NNANO.2010.235]; Li L, 2013, J PHYS CHEM LETT, V4, P222, DOI 10.1021/jz3018286; Macia MD, 2004, J ELECTROANAL CHEM, V564, P141, DOI 10.1016/j.jelechem.2003.09.035; MARKOVIC NM, 1994, J ELECTROANAL CHEM, V377, P249, DOI 10.1016/0022-0728(94)03467-2; Mavrikakis M, 1998, PHYS REV LETT, V81, P2819, DOI 10.1103/PhysRevLett.81.2819; Mazumder V, 2009, J AM CHEM SOC, V131, P4588, DOI 10.1021/ja9004915; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Roychowdhury C, 2006, CHEM MATER, V18, P3365, DOI 10.1021/cm060480e; Saleem F, 2013, J AM CHEM SOC, V135, P18304, DOI 10.1021/ja4101968; Stamenkovic V, 2006, ANGEW CHEM INT EDIT, V45, P2897, DOI 10.1002/anie.200504386; Strasser P, 2015, SCIENCE, V349, P379, DOI 10.1126/science.aac7861; Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]; van der Vliet DF, 2012, NAT MATER, V11, P1051, DOI [10.1038/NMAT3457, 10.1038/nmat3457]; Wang C, 2011, J AM CHEM SOC, V133, P14396, DOI 10.1021/ja2047655; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/NMAT3458, 10.1038/nmat3458]; Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k; Xia XH, 2012, J PHYS CHEM C, V116, P21647, DOI 10.1021/jp306063p; Xu XL, 2014, ANGEW CHEM INT EDIT, V53, P12522, DOI 10.1002/anie.201406497; Yang HZ, 2010, ANGEW CHEM INT EDIT, V49, P6848, DOI 10.1002/anie.201002888; Yu HS, 2015, NUCL SCI TECH, V26, DOI 10.13538/j.1001-8042/nst.26.050102; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z; Zhang L, 2015, SCIENCE, V349, P412, DOI 10.1126/science.aab0801; Zhang X, 2014, J PHYS CHEM LETT, V5, P292, DOI 10.1021/jz4024699; Zhu HY, 2013, J AM CHEM SOC, V135, P7130, DOI 10.1021/ja403041g	37	989	1004	104	2035	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1410	1414		10.1126/science.aah6133	http://dx.doi.org/10.1126/science.aah6133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980207	Green Submitted			2022-12-28	WOS:000390261300040
J	Dodds, PN; Lagudah, ES				Dodds, Peter N.; Lagudah, Evans S.			Starving the enemy	SCIENCE			English	Editorial Material							RESISTANCE; TRANSPORT		[Dodds, Peter N.; Lagudah, Evans S.] CSIR, Org Agr & Food, Canberra, ACT 2601, Australia		Dodds, PN (corresponding author), CSIR, Org Agr & Food, Canberra, ACT 2601, Australia.	peter.dodds@csiro.au	Lagudah, Evans/A-2007-2010; Dodds, Peter/D-1181-2009	Lagudah, Evans/0000-0002-6234-1789; Dodds, Peter/0000-0003-0620-5923				Boch J, 2014, NEW PHYTOL, V204, P823, DOI 10.1111/nph.13015; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Harrison MJ, 1999, J EXP BOT, V50, P1013, DOI 10.1093/jexbot/50.suppl_1.1013; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Lemonnier P, 2014, PLANT MOL BIOL, V85, P473, DOI 10.1007/s11103-014-0198-5; Moore JW, 2015, NAT GENET, V47, P1494, DOI 10.1038/ng.3439; Voegele RT, 2011, EUPHYTICA, V179, P41, DOI 10.1007/s10681-011-0358-5; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Yamada K, 2016, SCIENCE, V354, P1427, DOI 10.1126/science.aah5692	11	17	18	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1377	1378		10.1126/science.aal4273	http://dx.doi.org/10.1126/science.aal4273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980171				2022-12-28	WOS:000390261300020
J	Messiou, C; Vanel, D; Pollock, R; Cooke, M; Moskovic, E; Savidge, C; King, L; Patel, A; Jones, RL				Messiou, Christina; Vanel, Daniel; Pollock, Rob; Cooke, Martyn; Moskovic, Eleanor; Savidge, Cate; King, Laurence; Patel, Anisha; Jones, Robin L.			CHRISTMAS 2016: FAMOUS FIGURES Dear John Hunter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIGH-GRADE		[Messiou, Christina; Moskovic, Eleanor; Savidge, Cate; King, Laurence; Patel, Anisha; Jones, Robin L.] Royal Marsden NHS Fdn Trust, Sarcoma Unit, London, England; [Vanel, Daniel] Ist Ortoped Rizzoli Bologna, Bologna, Italy; [Pollock, Rob] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Cooke, Martyn] Royal Coll Surgeons England, Hunterian Museum, London, England	Royal Marsden NHS Foundation Trust; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Royal College of Surgeons of England	Messiou, C (corresponding author), Royal Marsden NHS Fdn Trust, Sarcoma Unit, London, England.	christina.messiou@rmh.nhs.uk	Jones, Robin L/AAO-3738-2020	Jones, Robin L/0000-0003-4173-3844; Messiou, Christina/0000-0002-0557-9379; King, Laurence/0000-0003-0775-780X				Bernthal NM, 2012, CANCER-AM CANCER SOC, V118, P5888, DOI 10.1002/cncr.27651; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6515	10.1136/bmj.i6515	http://dx.doi.org/10.1136/bmj.i6515			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974313				2022-12-28	WOS:000390151300007
J	Voelker, R				Voelker, Rebecca			Health Workers' Risks for Respiratory Virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2349	2349		10.1001/jama.2016.17557	http://dx.doi.org/10.1001/jama.2016.17557			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27960003				2022-12-28	WOS:000389884600009
J	Mathai, SK; Josephson, SA; Badlam, J; Saint, S; Janssen, WJ				Mathai, Susan K.; Josephson, S. Andrew; Badlam, Jessica; Saint, Sanjay; Janssen, William J.			Scratching Below the Surface	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NMDA RECEPTOR ENCEPHALITIS; DIAGNOSIS; ADULTS	On a summer afternoon, a 27-year-old Japanese woman was brought to the emergency department with a 5-day history of "strange behavior." Her illness had begun 7 days before presentation, with nausea and palpitations, followed 2 days later by short-term memory loss and anxiety. Her symptoms progressed to agitation, visual and auditory hallucinations, intermittent muscle rigidity, and involuntary jerking movements of the arms and legs.	[Mathai, Susan K.; Badlam, Jessica; Janssen, William J.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Janssen, William J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Josephson, S. Andrew] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Hlth Serv Res & Dev Ctr Excellence, Dept Vet Affairs, Ann Arbor, MI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Mathai, SK (corresponding author), Acad Off 1,12631 E 17th Ave,C323, Aurora, CO 80045 USA.	susan.mathai@ucdenver.edu	Saint, Sanjay/AAF-5126-2019		Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for serving on advisory boards from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	Armangue T, 2015, NEUROLOGY, V85, P1736, DOI 10.1212/WNL.0000000000002125; Armangue T, 2014, CURR OPIN NEUROL, V27, P361, DOI 10.1097/WCO.0000000000000087; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Gresa-Arribas N, 2014, LANCET NEUROL, V13, P167, DOI 10.1016/S1474-4422(13)70282-5; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; Jagota P, 2014, NEUROLOGY, V82, P1662, DOI 10.1212/WNL.0000000000000384; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Pruss H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12805; Ramanathan S, 2014, J CLIN NEUROSCI, V21, P722, DOI 10.1016/j.jocn.2013.07.017; Schmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8; Schubert RD, 2015, CURR OPIN NEUROL, V28, P283, DOI 10.1097/WCO.0000000000000198; Titulaer MJ, 2011, EUR J NEUROL, V18, P19, DOI 10.1111/j.1468-1331.2010.03220.x	15	0	0	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2188	2193		10.1056/NEJMcps1603154	http://dx.doi.org/10.1056/NEJMcps1603154			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED7GN	27959764				2022-12-28	WOS:000389030400012
J	Clark, J				Clark, Jocalyn			Wendy Graham and Oona Campbell: maternal health mavericks	LANCET			English	Biographical-Item														Clark, Jocalyn/0000-0002-8014-3989					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2016	388	10056					2104	2104		10.1016/S0140-6736(16)31896-7	http://dx.doi.org/10.1016/S0140-6736(16)31896-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA1DJ	27968738				2022-12-28	WOS:000386332400020
J	Balzarotti, F; Eilers, Y; Gwosch, KC; Gynna, AH; Westphal, V; Stefani, FD; Elf, J; Hell, SW				Balzarotti, Francisco; Eilers, Yvan; Gwosch, Klaus C.; Gynna, Arvid H.; Westphal, Volker; Stefani, Fernando D.; Elf, Johan; Hell, Stefan W.			Nanometer resolution imaging and tracking of fluorescent molecules with minimal photon fluxes	SCIENCE			English	Article							DISTANCE MEASUREMENTS; LOCALIZATION ANALYSIS; STIMULATED-EMISSION; SINGLE MOLECULES; DNA ORIGAMI; MICROSCOPY; FLUOROPHORES; NANOSCOPY; DYNAMICS; PROTEIN	We introduce MINFLUX, a concept for localizing photon emitters in space. By probing the emitter with a local intensity minimum of excitation light, MINFLUX minimizes the fluorescence photons needed for high localization precision. In our experiments, 22 times fewer fluorescence photons are required as compared to popular centroid localization. In superresolutionmicroscopy, MINFLUXattained similar to 1-nanometer precision, resolving molecules only 6 nanometers apart. MINFLUX tracking of single fluorescent proteins increased the temporal resolution and the number of localizations per trace by a factor of 100, as demonstrated with diffusing 30S ribosomal subunits in living Escherichia coli. As conceptual limits have not been reached, we expect this localization modality to break new ground for observing the dynamics, distribution, and structure of macromolecules in living cells and beyond.	[Balzarotti, Francisco; Eilers, Yvan; Gwosch, Klaus C.; Westphal, Volker; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany; [Gynna, Arvid H.; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Stefani, Fernando D.] Consejo Nacl Invest Cient & Tecn, Ctr Invest Bionanociencias CIBION, Buenos Aires, DF, Argentina; [Stefani, Fernando D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Buenos Aires, DF, Argentina; [Hell, Stefan W.] Max Planck Inst Med Res, Dept Opt Nanoscopy, Heidelberg, Germany; [Hell, Stefan W.] German Canc Res Ctr, Opt Nanoscopy Div, Heidelberg, Germany	Max Planck Society; Uppsala University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ)	Balzarotti, F; Hell, SW (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Gottingen, Germany.; Hell, SW (corresponding author), Max Planck Inst Med Res, Dept Opt Nanoscopy, Heidelberg, Germany.; Hell, SW (corresponding author), German Canc Res Ctr, Opt Nanoscopy Div, Heidelberg, Germany.	francisco.balzarotti@mpibpc.mpg.de; stefan.hell@mpibpc.mpg.de		Balzarotti, Francisco/0000-0003-1471-8120; Gynna, Arvid/0000-0001-8087-7715; Stefani, Fernando/0000-0002-3277-7215; Gwosch, Klaus/0000-0002-8897-2335; elf, johan/0000-0001-5522-1810	Cusanuswerk; European Research Council; Knut and Alice Wallenberg Foundation	Cusanuswerk; European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank F. Persson for early discussions about implementations of the concept and initial tracking experiments. E. D'Este and S. J. Sahl are acknowledged for critical reading. K.C.G. and F.D.S. thank the Cusanuswerk for a stipend and the Max Planck Society for a partner group grant, respectively. A.H.G. and J. E. acknowledge the European Research Council and the Knut and Alice Wallenberg Foundation for funding. S.W.H. is inventor on patent applications WO 2013/072273 and WO 2015/097000 submitted by the Max Planck Society that cover basic principles and arrangements of MINFLUX. Further patent applications with F.B., Y.E., K.C.G., and S.W.H. as inventors have been submitted by the Max Planck Society, covering selected embodiments and procedures. S.W.H. consults and owns shares of Abberior Instruments GmbH, a manufacturer of superresolution microscopes.	ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Cohen AE, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1872220; Dai MJ, 2016, NAT NANOTECHNOL, V11, P798, DOI [10.1038/NNANO.2016.95, 10.1038/nnano.2016.95]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; Heisenberg W., 1930, PHYS PRINCIPLES QUAN; Hell S. W., 2015, Patent No. [WO 2015/097000 A1, 2015097000]; Hell S. W., 2013, Patent No. [WO 2013/072273 A1 B2, 2013072273]; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2015, ANGEW CHEM INT EDIT, V54, P8054, DOI 10.1002/anie.201504181; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; Lew MD, 2013, NANO LETT, V13, P3967, DOI 10.1021/nl304359p; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Michalet X, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061916; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Pellegrotti JV, 2014, NANO LETT, V14, P2831, DOI 10.1021/nl500841n; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Sanamrad A, 2014, P NATL ACAD SCI USA, V111, P11413, DOI 10.1073/pnas.1411558111; Schmied JJ, 2012, NAT METHODS, V9, P1133, DOI 10.1038/nmeth.2254; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Vestergaard CL, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.022401; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Weisenburger S, 2014, CHEMPHYSCHEM, V15, P763, DOI 10.1002/cphc.201301080; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k	37	483	514	39	504	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 10	2017	355	6325					606	612		10.1126/science.aak9913	http://dx.doi.org/10.1126/science.aak9913			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK0SF	28008086	Green Submitted, Green Published			2022-12-28	WOS:000393636700043
J	Yi, P; Park, JS; Melton, DA				Yi, Peng; Park, Ji-Sun; Melton, Douglas A.			RETRACTION: Betatrophin: A Hormone that Controls Pancreatic beta Cell Proliferation (Retraction of Vol 153, Pg 747, 2013)	CELL			English	Retraction									[Yi, Peng; Park, Ji-Sun; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008	1	42	47	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					326	326		10.1016/j.cell.2016.12.017	http://dx.doi.org/10.1016/j.cell.2016.12.017			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	28038792	Bronze, Green Accepted			2022-12-28	WOS:000396246700032
J	Abbasi, J				Abbasi, Jennifer			23andMe, Big Data, and the Genetics of Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	8	8	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					14	16		10.1001/jama.2016.14136	http://dx.doi.org/10.1001/jama.2016.14136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030700				2022-12-28	WOS:000391009100002
J	Li, HT; Luo, SS; Trasande, L; Hellerstein, S; Kang, CY; Li, JX; Zhang, YL; Liu, JM; Blustein, J				Li, Hong-Tian; Luo, Shusheng; Trasande, Leonardo; Hellerstein, Susan; Kang, Chuyun; Li, Jia-Xin; Zhang, Yali; Liu, Jian-Meng; Blustein, Jan			Geographic Variations and Temporal Trends in Cesarean Delivery Rates in China, 2008-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SECTION RATES	IMPORTANCE The increasing use of cesarean delivery is an emerging global health issue. Prior estimates of China's cesarean rate have been based on surveys with limited geographic coverage. OBJECTIVE To provide updated information about cesarean rates and geographic variation in cesarean use in China. DESIGN, SETTING, AND DATA SOURCES Descriptive study, covering every county (n = 2865) in mainland China's 31 provinces, using county-level aggregated information on the number of live births, cesarean deliveries, maternal deaths, and perinatal deaths, collected by the Office for National Maternal & Child Health Statistics of China, from 2008 through 2014. EXPOSURES Live births. MAIN OUTCOMES AND MEASURES Annual rate of cesarean deliveries. RESULTS Over the study period, there were 100 873 051 live births, of which 32 947 229 (32.7%) were by cesarean delivery. In 2008, there were 13 160 634 live births, of which 3 788 029 (28.8%) were by cesarean delivery and in 2014 there were 15 123 276 live births, of which 5 280 124 (34.9%) were by cesarean delivery. Rates varied markedly by province, from 4.0% to 62.5% in 2014. Despite the overall increase, by 2014 rates of cesarean delieries in 14 of the nation's 17 "super cities" had declined by 4.1 to 17.5 percentage points from their earlier peak values (median, 11.4; interquartile range, 6.3-15.4). In 4 super cities with the largest decreases, there was no increase in maternal or perinatal mortality. CONCLUSIONS AND RELEVANCE Between 2008 and 2014, the overall annual rate of cesarean deliveries increased in China, reaching 34.9%. There was major geographic variation in rates and trends over time, with rates declining in some of the largest urban areas.	[Li, Hong-Tian; Zhang, Yali; Liu, Jian-Meng] Peking Univ, Hlth Sci Ctr, Minist Hlth, Inst Reprod & Child Hlth,Key Lab Reprod Hlth, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Li, Hong-Tian; Zhang, Yali; Liu, Jian-Meng] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Li, Hong-Tian; Luo, Shusheng; Kang, Chuyun; Zhang, Yali; Liu, Jian-Meng] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Off Natl Maternal & Child Hlth Stat China, Beijing, Peoples R China; [Luo, Shusheng; Kang, Chuyun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Child Adolescent & Womens Hlth, Beijing, Peoples R China; [Trasande, Leonardo] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo] NYU, Dept Environm Med, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Trasande, Leonardo; Blustein, Jan] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Trasande, Leonardo; Li, Jia-Xin; Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY USA; [Hellerstein, Susan] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA USA	Peking University; Peking University; Peking University; Peking University; New York University; New York University; New York University; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, JM (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Hlth, Inst Reprod & Child Hlth,Key Lab Reprod Hlth, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	liujm@pku.edu.cn	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X	National Health and Family Planning Commission of China from the National Natural Science Foundation of China [81273163, 81571517]; Beijing Young Talent Program	National Health and Family Planning Commission of China from the National Natural Science Foundation of China; Beijing Young Talent Program	This study was funded by grants from the National Health and Family Planning Commission of China, 81273163 and 81571517 from the National Natural Science Foundation of China, and from the Beijing Young Talent Program.	[Anonymous], 1995, POPUL, V21, P698, DOI [10.2307/2137767, DOI 10.2307/2137767]; Blustein J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2410; Bragg F, 2010, BMJ-BRIT MED J, V341, pc5065; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chen H, 2014, ELECTRON J QUAL THEO, V2014, P22, DOI DOI 10.1002/SMLL.201401298; Feng XL, 2012, B WORLD HEALTH ORGAN, V90, P30, DOI 10.2471/BLT.11.090399; Hamilton Brady E, 2015, Natl Vital Stat Rep, V64, P1; Hellerstein S, 2015, BJOG-INT J OBSTET GY, V122, P160, DOI 10.1111/1471-0528.12971; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Mi J, 2014, LANCET, V383, P1463, DOI 10.1016/S0140-6736(14)60716-9; Minkoff H, 2003, NEW ENGL J MED, V348, P946, DOI 10.1056/NEJMsb022734; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; National Health and Family Planning Commission of China, 2015, NAT DAT REP REG HLTH; National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN; Ruan XL, 2014, ZHONGGUO GONGGONGWEI, V30, P767; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Wu MH, 2010, MATERN CHILD HLTH CA, V25, P4832	18	184	236	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					69	76		10.1001/jama.2016.18663	http://dx.doi.org/10.1001/jama.2016.18663			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030701	Bronze			2022-12-28	WOS:000391009100021
J	Stark, DE; Shah, NH				Stark, David E.; Shah, Nigam H.			Funding and Publication of Research on Gun Violence and Other Leading Causes of Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							FIREARMS		[Stark, David E.] Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, 770 Lexington Ave,14th Floor, New York, NY 10065 USA; [Stark, David E.] Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA; [Shah, Nigam H.] Stanford Univ, Sch Med, Div Biomed Informat Res, Stanford, CA 94305 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University	Stark, DE (corresponding author), Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, 770 Lexington Ave,14th Floor, New York, NY 10065 USA.	david.stark@mssm.edu						Centers for Disease Control and Prevention, 1999, COMPR MORT; JAGGER J, 1986, JAMA-J AM MED ASSOC, V255, P3143, DOI 10.1001/jama.255.22.3143; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Ladapo JA, 2013, JAMA-J AM MED ASSOC, V310, P532, DOI 10.1001/jama.2013.119355; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P1689, DOI 10.1001/jama.2016.1707	5	93	93	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					84	86		10.1001/jama.2016.16215	http://dx.doi.org/10.1001/jama.2016.16215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030692	Bronze			2022-12-28	WOS:000391009100025
J	Voelker, R				Voelker, Rebecca			Relief for Painful Intercourse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					18	18		10.1001/jama.2016.19077	http://dx.doi.org/10.1001/jama.2016.19077			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030684				2022-12-28	WOS:000391009100008
J	Harrison, M				Harrison, Michelle			Herbert Percival Cooper Harrison OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		HARRISON HPC, PUBLICATION LIST	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2016	355								i6704	10.1136/bmj.i6704	http://dx.doi.org/10.1136/bmj.i6704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RH	28039152				2022-12-28	WOS:000391173100004
J	Kaplan, JL; Rincon, SP; Duhaime, AC				Kaplan, Jess L.; Rincon, Sandra P.; Duhaime, Ann-Christine			Case 40-2016: A 14-Month-Old Girl with Recurrent Vomiting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NORTH-AMERICAN SOCIETY; PEDIATRIC GASTROENTEROLOGY; 3RD VENTRICULOSTOMY; CHILDREN; HEPATOLOGY; DIAGNOSIS		[Kaplan, Jess L.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Rincon, Sandra P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Kaplan, Jess L.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Rincon, Sandra P.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Duhaime, Ann-Christine] Harvard Med Sch, Dept Neurosurg, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kaplan, JL (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Kaplan, JL (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.				Harvard Medical School Department of Continuing Education	Harvard Medical School Department of Continuing Education	This case was presented at the postgraduate course, "Primary Care Pediatrics," codirected by Peter Greenspan, M.D., John Patrick T. Co, M.D., M.P.H., Ronni L. Goldsmith, M.D., Janice A. Lowe, M.D., and Benjamin A. Nelson, M.D., and sponsored by the Harvard Medical School Department of Continuing Education.	Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; Drake JM, 2007, NEUROSURGERY, V60, P881, DOI 10.1227/01.NEU.0000255420.78431.E7; Hader WJ, 2002, J NEUROSURG, V97, P211, DOI 10.3171/jns.2002.97.1.0211; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Levy PA, 2009, PEDIATR REV, V30, pE22, DOI 10.1542/pir.30-4-e22; Li BUK, 2008, J PEDIATR GASTR NUTR, V47, P379, DOI 10.1097/MPG.0b013e318173ed39; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P371, DOI 10.1097/ACI.0b013e32832d6315; Pfau BT, 1996, PEDIATRICS, V97, P364; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18	10	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2583	2593		10.1056/NEJMcpc1613468	http://dx.doi.org/10.1056/NEJMcpc1613468			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	28029921				2022-12-28	WOS:000391175300013
J	Meng, Q; Liu, LC				Meng, Qiang; Liu, Lingchun			Disseminated Cysticercosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Meng, Qiang; Liu, Lingchun] First Peoples Hosp Yunnan Prov, Kunming, Peoples R China		Meng, Q (corresponding author), First Peoples Hosp Yunnan Prov, Kunming, Peoples R China.	mq301@sina.com.cn							0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					E52	E52		10.1056/NEJMicm1601189	http://dx.doi.org/10.1056/NEJMicm1601189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	28029917				2022-12-28	WOS:000391175300012
J	Wade, L				Wade, Lizzie			AFTER THE VANISHING	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1369	1371		10.1126/science.354.6318.1369	http://dx.doi.org/10.1126/science.354.6318.1369			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980168				2022-12-28	WOS:000390261300017
J	Jaitin, DA; Weiner, A; Yofe, I; Lara-Astiaso, D; Keren-Shaul, H; David, E; Salame, TM; Tanay, A; van Oudenaarden, A; Amit, I				Jaitin, Diego Adhemar; Weiner, Assaf; Yofe, Ido; Lara-Astiaso, David; Keren-Shaul, Hadas; David, Eyal; Salame, Tomer Meir; Tanay, Amos; van Oudenaarden, Alexander; Amit, Ido			Dissecting Immune Circuits by Linking CRISPR-Pooled Screens with Single-Cell RNA-Seq	CELL			English	Article							ONE-STEP GENERATION; GENOME-WIDE; DENDRITIC CELLS; BONE-MARROW; MACROPHAGE; MOUSE; VECTORS; SYSTEM; HETEROGENEITY; COMBINATIONS	In multicellular organisms, dedicated regulatory circuits control cell type diversity and responses. The crosstalk and redundancies within these circuits and substantial cellular heterogeneity pose a major research challenge. Here, we present CRISPseq, an integrated method for massively parallel single-cell RNA sequencing (RNA-seq) and clustered regularly interspaced short palindromic repeats (CRISPR)-pooled screens. We show that profiling the genomic perturbation and transcriptome in the same cell enables us to simultaneously elucidate the function of multiple factors and their interactions. We applied CRISP-seq to probe regulatory circuits of innate immunity. By sampling tens of thousands of perturbed cells in vitro and in mice, we identified interactions and redundancies between developmental and signaling-dependent factors. These include opposing effects of Cebpb and Irf8 in regulating the monocyte/macrophage versus dendritic cell lineages and differential functions for Rela and Stat1/2 in monocyte versus dendritic cell responses to pathogens. This study establishes CRISP-seq as a broadly applicable, comprehensive, and unbiased approach for elucidating mammalian regulatory circuits.	[Jaitin, Diego Adhemar; Weiner, Assaf; Yofe, Ido; Lara-Astiaso, David; Keren-Shaul, Hadas; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Weiner, Assaf; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Salame, Tomer Meir] Weizmann Inst Sci, Dept Biol Serv, Flow Cytometry Unit, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Weizmann Institute of Science; Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il	van Oudenaarden, Alexander/AAA-1705-2019		European Research Council [ERC-AdG 294325-GeneNoiseControl]; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; Israel Science Foundation; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists	European Research Council(European Research Council (ERC)European Commission); European Research Council Consolidator Grant (ERC-COG); Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; Abramson Family Center for Young Scientists	We thank Dana Peer for discussions on CRISP-seq analysis and Feng Zhang and Ophir Shalem for critical advice and reagents. We also thank Genia Brodsky for help with the artwork. A.v.O. is supported by European Research Council Advanced Grant ERC-AdG 294325-GeneNoiseControl. I.A. is supported by the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; the Israel Science Foundation; the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; the Helen and Martin Kimmel award for innovative investigation; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology, and Space; the David and Fela Shapell Family Foundation; and the Abramson Family Center for Young Scientists. I.A. is the incumbent of the Alan and Laraine Fischer Career Development Chair. A patent application has been filed related to this work, and the authors have made the CRISP-seq vectors widely available to the academic community through Addgene.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alon U., 2006, INTRO SYSTEMS BIOL D; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Kurotaki D, 2016, J INTERF CYTOK RES, V36, P433, DOI 10.1089/jir.2015.0138; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Moignard V, 2014, BIOESSAYS, V36, P419, DOI 10.1002/bies.201300102; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Semrau S, 2015, ANNU REV CELL DEV BI, V31, P317, DOI 10.1146/annurev-cellbio-100814-125300; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Vidigal JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9083; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yosef N, 2016, SCIENCE, V354, P64, DOI 10.1126/science.aaf5453; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	58	373	384	5	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1883	+		10.1016/j.cell.2016.11.039	http://dx.doi.org/10.1016/j.cell.2016.11.039			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984734	Bronze			2022-12-28	WOS:000393114700024
J	Dholakia, S; Friend, PJ; Maguire, L				Dholakia, S.; Friend, P. J.; Maguire, L.			CHRISTMAS 2016: FAMOUS FIGURES A Christmas renaissance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dholakia, S.; Friend, P. J.] Churchill Hosp, Nuffield Dept Surg Sci, Oxford OX3 7LE, England; [Maguire, L.] Univ Oxford, English, Oxford, England	University of Oxford; University of Oxford	Maguire, L (corresponding author), Univ Oxford, English, Oxford, England.	laurie.maguire@magd.ox.ac.uk	Friend, Peter/AAH-6512-2019					Parker P., 2008, ALTERNATIVE SHAKESPE; Sugg R., 2007, MURDER DEATH LIT ANA	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6603	10.1136/bmj.i6603	http://dx.doi.org/10.1136/bmj.i6603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974364				2022-12-28	WOS:000390151300009
J	Oldfield, BJ; Young, RK				Oldfield, Benjamin J.; Young, Roxanne K.			Coauthors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Oldfield, Benjamin J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Oldfield, Benjamin J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Oldfield, Benjamin J.] Yale Univ, Sch Med, Natl Clinician Scholars Program, New Haven, CT 06520 USA	Johns Hopkins University; Johns Hopkins University; Yale University	Oldfield, BJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Oldfield, BJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.; Oldfield, BJ (corresponding author), Yale Univ, Sch Med, Natl Clinician Scholars Program, New Haven, CT 06520 USA.	benjamin.oldfield@yale.edu		Oldfield, Benjamin/0000-0003-1708-803X				Charon R, 2004, NEW ENGL J MED, V350, P862, DOI 10.1056/NEJMp038249; Foucault M., 1994, BIRTH CLIN; Malcolm X, 1999, AUTOBIOGRAPHY MALCOL; Portelli A., 1991, DEATH LUIGI TRASTULL	4	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2361	2362		10.1001/jama.2016.10942	http://dx.doi.org/10.1001/jama.2016.10942			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959999				2022-12-28	WOS:000389884600014
J	Williams, J; Bull, P				Williams, John; Bull, Peter			Eric William Taylor OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		TAYLOR EW, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6611	10.1136/bmj.i6611	http://dx.doi.org/10.1136/bmj.i6611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965208				2022-12-28	WOS:000390150800009
J	Brincat, C; Brubaker, L				Brincat, Cynthia; Brubaker, Linda			Mesh, graft, or standard repair for prolapse surgery?	LANCET			English	Editorial Material							PELVIC ORGAN PROLAPSE; VAGINAL PROLAPSE; INCONTINENCE		[Brincat, Cynthia; Brubaker, Linda] Loyola Univ, Chicago, IL 60611 USA	Loyola University Chicago	Brubaker, L (corresponding author), Loyola Univ, Chicago, IL 60611 USA.	lbrubaker@luc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589	National Institute for Health Research; Diabetes UK	National Institute for Health Research(National Institute for Health Research (NIHR)); Diabetes UK(Diabetes UK)	HRM declares grants from the National Institute for Health Research and Diabetes UK; non-financial support from Abbott Diabetes Care USA for previous closed-loop studies; and membership of the European Scientific Advisory Board of Medtronic, an insulin pump manufacturer, and of the UK Key Opinion Leader Board. ZAS declares no competing interests.	Barber MD, 2014, JAMA-J AM MED ASSOC, V311, P1023, DOI 10.1001/jama.2014.1719; Brubaker L, 2012, J UROLOGY, V187, P1324, DOI 10.1016/j.juro.2011.11.087; Chmielewski L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.027; Culligan PJ, 2002, AM J OBSTET GYNECOL, V187, P1473, DOI 10.1067/mob.2002.129160; Glazener CMA, 2016, LANCET; Gotthart PT, 2012, INT UROGYNECOL J, V23, P1221, DOI 10.1007/s00192-012-1736-9; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Unger CA, 2016, FEMALE PELVIC MED RE; Wei JT, 2012, NEW ENGL J MED, V366, P2358, DOI 10.1056/NEJMoa1111967	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					334	336		10.1016/S0140-6736(16)32595-8	http://dx.doi.org/10.1016/S0140-6736(16)32595-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	28010987	hybrid			2022-12-28	WOS:000392804700005
J	Wei, YJ; Chiang, WC; Sumpter, R; Mishra, P; Levine, B				Wei, Yongjie; Chiang, Wei-Chung; Sumpter, Rhea, Jr.; Mishra, Prashant; Levine, Beth			Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor	CELL			English	Article							PATERNAL MITOCHONDRIA; SELECTIVE AUTOPHAGY; CRISTAE MORPHOGENESIS; SPERM MITOCHONDRIA; MEDIATED MITOPHAGY; CELL-PROLIFERATION; C. ELEGANS; IN-VIVO; PARKIN; ROLES	The removal of unwanted or damaged mitochondria by autophagy, a process called mitophagy, is essential for key events in development, cellular homeostasis, tumor suppression, and prevention of neuro-degeneration and aging. However, the precise mechanisms of mitophagy remain uncertain. Here, we identify the inner mitochondrialmembrane protein, prohibitin 2 (PHB2), as a crucial mitophagy receptor involved in targeting mitochondria for autophagic degradation. PHB2 binds the autophagosomal membrane- associatedprotein LC3 through an LC3-interaction region (LIR) domain uponmitochondrial depolarization and proteasome-dependent outer membrane rupture. PHB2 is required for Parkin-induced mitophagy in mammalian cells and for the clearance of paternal mitochondria after embryonic fertilization in C. elegans. Our findings pinpoint a conservedmechanism of eukaryotic mitophagy and demonstrate a function of prohibitin 2 that may underlie its roles in physiology, aging, and disease.	[Wei, Yongjie; Chiang, Wei-Chung; Sumpter, Rhea, Jr.; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75230 USA; [Wei, Yongjie; Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75230 USA; [Mishra, Prashant] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75230 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75230 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75230 USA.; Levine, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75230 USA.; Levine, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75230 USA.	beth.levine@utsouthwestern.edu	Chiang, Wei-Chung/AAZ-5494-2020; Sumpter, Jr., Rhea/N-8152-2018	Chiang, Wei-Chung/0000-0003-3149-435X; 	NIH [KO8AI099150, U19AI199725, RO1CA109618]; Cancer Prevention Research Institute of Texas (CPRIT) grant [RP120718]; Leducq Foundation [15CBD04]; Burroughs Wellcome Career Award for Medical Scientists; NATIONAL CANCER INSTITUTE [R01CA109618, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, K08AI099150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT) grant; Leducq Foundation(Leducq Foundation); Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. Langer and A.-L. Hsu for providing critical reagents; L. Nguyen for expert technical assistance; D. Xue and M.Y. Lee for helpful discussions; X. Chen and Z. Chen for assistance with mass spectrometry; K. Luby-Phelps and A. Darehshouri for assistance with SIM imaging and immunogold EM, respectively; and H. Smith for assistance with manuscript preparation. SIM and EM studies were carried out in UT Southwestern Live Cell and Electron Microscopy Facilities. This work was supported by NIH grants, KO8AI099150 (R.S.), U19AI199725 (B.L.), and RO1CA109618 (B.L.), Cancer Prevention Research Institute of Texas (CPRIT) grant RP120718 (B.L.), Leducq Foundation grant 15CBD04 (B.L.), and a Burroughs Wellcome Career Award for Medical Scientists (R.S.).	Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Bingol B., 2016, FREE RADIC BIOL ME S, VS0891, P30033; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Gloeckner CJ, 2009, CURR PROTOC PROTEIN; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; HODGKIN J, 1986, GENETICS, V114, P15; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480; Liau WS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-8; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005; Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333; Shibutani ST, 2014, CELL MICROBIOL, V16, P1619, DOI 10.1111/cmi.12357; Sumpter R, 2016, CELL, V165, P867, DOI 10.1016/j.cell.2016.04.006; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Wang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12569; Yamaguchi O, 2016, J MOL CELL CARDIOL, V95, P50, DOI 10.1016/j.yjmcc.2016.03.010; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777; Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182	39	396	415	11	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2017	168	1-2					224	+		10.1016/j.cell.2016.11.042	http://dx.doi.org/10.1016/j.cell.2016.11.042			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN8JM	28017329	Green Accepted, Bronze			2022-12-28	WOS:000396246700024
J	Kelley, M				Kelley, Michael			Comparing Use of Low-Value Health Care Services Among US Advanced Practice Clinicians and Physicians	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kelley, Michael] ProVita, Abu Dhabi, U Arab Emirates		Kelley, M (corresponding author), ProVita, Abu Dhabi, U Arab Emirates.							Mafi JN, 2016, ANN INTERN MED, V165, P237, DOI 10.7326/M15-2152	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					76	76		10.7326/L16-0551	http://dx.doi.org/10.7326/L16-0551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030670				2022-12-28	WOS:000391467900016
J	[Anonymous]				[Anonymous]			As Teenage Pregnancies Decline, So Do Preterm Births	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2590	2590		10.1001/jama.2016.18236	http://dx.doi.org/10.1001/jama.2016.18236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027379				2022-12-28	WOS:000391110200006
J	Dewey, FE; Murray, MF; Overton, JD; Habegger, L; Leader, JB; Fetterolf, SN; O'Dushlaine, C; Van Hout, CV; Staples, J; Gonzaga-Jauregui, C; Metpally, R; Pendergrass, SA; Giovanni, MA; Kirchner, HL; Balasubramanian, S; Abul-Husn, NS; Hartzel, DN; Lavage, DR; Kost, KA; Packer, JS; Lopez, AE; Penn, J; Mukherjee, S; Gosalia, N; Kanagaraj, M; Li, AH; Mitnaul, LJ; Adams, LJ; Person, TN; Praveen, K; Marcketta, A; Lebo, MS; Austin-Tse, CA; Mason-Suares, HM; Bruse, S; Mellis, S; Phillips, R; Stahl, N; Murphy, A; Economides, A; Skelding, KA; Still, CD; Elmore, JR; Borecki, IB; Yancopoulos, GD; Davis, FD; Faucett, WA; Gottesman, O; Ritchie, MD; Shuldiner, AR; Reid, JG; Ledbetter, DH; Baras, A; Carey, DJ				Dewey, Frederick E.; Murray, Michael F.; Overton, John D.; Habegger, Lukas; Leader, Joseph B.; Fetterolf, Samantha N.; O'Dushlaine, Colm; Van Hout, Cristopher V.; Staples, Jeffrey; Gonzaga-Jauregui, Claudia; Metpally, Raghu; Pendergrass, Sarah A.; Giovanni, Monica A.; Kirchner, H. Lester; Balasubramanian, Suganthi; Abul-Husn, Noura S.; Hartzel, Dustin N.; Lavage, Daniel R.; Kost, Korey A.; Packer, Jonathan S.; Lopez, Alexander E.; Penn, John; Mukherjee, Semanti; Gosalia, Nehal; Kanagaraj, Manoj; Li, Alexander H.; Mitnaul, Lyndon J.; Adams, Lance J.; Person, Thomas N.; Praveen, Kavita; Marcketta, Anthony; Lebo, Matthew S.; Austin-Tse, Christina A.; Mason-Suares, Heather M.; Bruse, Shannon; Mellis, Scott; Phillips, Robert; Stahl, Neil; Murphy, Andrew; Economides, Aris; Skelding, Kimberly A.; Still, Christopher D.; Elmore, James R.; Borecki, Ingrid B.; Yancopoulos, George D.; Davis, F. Daniel; Faucett, William A.; Gottesman, Omri; Ritchie, Marylyn D.; Shuldiner, Alan R.; Reid, Jeffrey G.; Ledbetter, David H.; Baras, Aris; Carey, David J.			Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR Study	SCIENCE			English	Article							OF-FUNCTION VARIANTS; B SYNTHESIS INHIBITOR; IDENTIFIES RARE; DENSITY-LIPOPROTEIN; HEART-DISEASE; LOW-FREQUENCY; RISK; GENOME; ASSOCIATION; PCSK9	The DiscovEHR collaboration between the Regeneron Genetics Center and Geisinger Health System couples high-throughput sequencing to an integrated health care system using longitudinal electronic health records (EHRs). We sequenced the exomes of 50,726 adult participants in the DiscovEHR study to identify similar to 4.2 million rare single-nucleotide variants and insertion/deletion events, of which similar to 176,000 are predicted to result in a loss of gene function. Linking these data to EHR-derived clinical phenotypes, we find clinical associations supporting therapeutic targets, including genes encoding drug targets for lipid lowering, and identify previously unidentified rare alleles associated with lipid levels and other blood level traits. About 3.5% of individuals harbor deleterious variants in 76 clinically actionable genes. The DiscovEHR data set provides a blueprint for large-scale precision medicine initiatives and genomics-guided therapeutic discovery.	[Dewey, Frederick E.; Overton, John D.; Habegger, Lukas; O'Dushlaine, Colm; Van Hout, Cristopher V.; Staples, Jeffrey; Gonzaga-Jauregui, Claudia; Balasubramanian, Suganthi; Abul-Husn, Noura S.; Packer, Jonathan S.; Lopez, Alexander E.; Penn, John; Mukherjee, Semanti; Gosalia, Nehal; Kanagaraj, Manoj; Li, Alexander H.; Mitnaul, Lyndon J.; Praveen, Kavita; Marcketta, Anthony; Bruse, Shannon; Economides, Aris; Borecki, Ingrid B.; Gottesman, Omri; Shuldiner, Alan R.; Reid, Jeffrey G.; Baras, Aris] Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Murray, Michael F.; Leader, Joseph B.; Fetterolf, Samantha N.; Metpally, Raghu; Pendergrass, Sarah A.; Giovanni, Monica A.; Kirchner, H. Lester; Hartzel, Dustin N.; Lavage, Daniel R.; Kost, Korey A.; Adams, Lance J.; Person, Thomas N.; Skelding, Kimberly A.; Still, Christopher D.; Elmore, James R.; Davis, F. Daniel; Faucett, William A.; Ritchie, Marylyn D.; Ledbetter, David H.; Carey, David J.] Geisinger Hlth Syst, Danville, PA 17822 USA; [Lebo, Matthew S.; Austin-Tse, Christina A.; Mason-Suares, Heather M.] Mol Med Lab, Cambridge, MA 02139 USA; [Mellis, Scott; Phillips, Robert; Stahl, Neil; Murphy, Andrew; Yancopoulos, George D.] Regeneron Pharmaceut, Tarrytown, NY 10591 USA	Regeneron; Geisinger Health System; Regeneron	Dewey, FE (corresponding author), Regeneron Genet Ctr, Tarrytown, NY 10591 USA.; Carey, DJ (corresponding author), Geisinger Hlth Syst, Danville, PA 17822 USA.	frederick.dewey@regeneron.com; djcarey@geisinger.edu	Austin-Tse, Christina/AFR-2048-2022; Gonzaga-Jauregui, Claudia/H-4752-2019; Van Hout, Cristopher V./AAQ-3494-2021; Mason-Suares, Heather/AAW-6668-2020	Austin-Tse, Christina/0000-0001-6492-6716; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Van Hout, Cristopher V./0000-0001-9689-5344; Mason-Suares, Heather/0000-0002-0146-4881; Packer, Jonathan/0000-0003-4025-0007; Pendergrass, Rion/0000-0002-0565-6522; Gosalia, Nehal/0000-0002-1444-5786; Balasubramanian, Suganthi/0000-0003-2243-5948; Lebo, Matthew/0000-0002-9733-5207; Abul-Husn, Noura/0000-0002-5179-1944; Economides, Aris/0000-0002-6508-8942; Lavage, Dani/0000-0002-9570-2931; Shuldiner, Alan/0000-0001-9921-4305				Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Elbers CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050198; Fu WQ, 2014, AM J HUM GENET, V95, P421, DOI 10.1016/j.ajhg.2014.09.006; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Li AH, 2015, NAT GENET, V47, P640, DOI 10.1038/ng.3270; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; PRAKASH UBS, 1987, MAYO CLIN PROC, V62, P499, DOI 10.1016/S0025-6196(12)65477-9; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Suzuki T, 2011, EUR RESPIR J, V37, P201, DOI 10.1183/09031936.00090610; Tanaka T, 2011, J MED GENET, V48, P205, DOI 10.1136/jmg.2010.082586; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Thorne RF, 2007, FEBS LETT, V581, P1227, DOI 10.1016/j.febslet.2007.02.043; Timpson NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5871; van Dijk TB, 1998, BLOOD, V92, P3636, DOI 10.1182/blood.V92.10.3636.422k45_3636_3646; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Welty FK, 2014, CURR OPIN LIPIDOL, V25, P161, DOI 10.1097/MOL.0000000000000072; WITTY LA, 1994, MEDICINE, V73, P103, DOI 10.1097/00005792-199403000-00003; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	77	331	333	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319							aaf6814	10.1126/science.aaf6814	http://dx.doi.org/10.1126/science.aaf6814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008009				2022-12-28	WOS:000390254300041
J	Savage, N; Szigethy, E				Savage, Neil; Szigethy, Eva			Gut feelings	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					S113	S113		10.1038/540S113a	http://dx.doi.org/10.1038/540S113a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	28002394	Bronze			2022-12-28	WOS:000391190500008
J	Trotter, JM; Hunt, L; Peter, MB				Trotter, J. M.; Hunt, L.; Peter, M. B.			CLINICAL UPDATES Ischaemic colitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; SONOGRAPHY; MANAGEMENT; SPECTRUM; OUTCOMES; TRIAL; CARE		[Trotter, J. M.; Peter, M. B.] Scarborough Gen Hosp, Dept Surg, Scarborough YO12 6QL, England; [Hunt, L.] Royal Hallamshire Hosp, Sheffield Teaching Hosp, Dept Diabet Endocrinol & Metab, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Trotter, JM (corresponding author), Scarborough Gen Hosp, Dept Surg, Scarborough YO12 6QL, England.	j.trotter@nhs.net						Antolovic D, 2008, LANGENBECK ARCH SURG, V393, P507, DOI 10.1007/s00423-008-0300-z; Behzadi J, 2015, AM J GASTROENTEROL, V110, pS152, DOI 10.14309/00000434-201510001-00348; Berritto D, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150821; Bielefeldt K, 2016, DIGEST DIS SCI, V61, P2655, DOI 10.1007/s10620-016-4162-x; BOLEY SJ, 1963, SURG GYNECOL OBSTET, V116, P53; Brandt LJ, 2015, AM J GASTROENTEROL, V110, P18, DOI [10.1038/ajg.2014.395, 10.1038/ajg.2014.295]; Brandt LJ, 2010, AM J GASTROENTEROL, V105, P2245, DOI 10.1038/ajg.2010.217; Castleberry AW, 2013, J GASTROINTEST SURG, V17, P784, DOI 10.1007/s11605-012-2117-x; Cruz C, 2015, EMERG RADIOL, V22, P357, DOI 10.1007/s10140-015-1304-y; da Silva E, 2014, AM J GASTROENTEROL, V109, pS397, DOI 10.14309/00000434-201410002-01350; Danse EM, 2000, AM J ROENTGENOL, V175, P1151, DOI 10.2214/ajr.175.4.1751151; Gatt M, 2005, BRIT J SURG, V92, P1354, DOI 10.1002/bjs.5187; Gatt M, 2010, BRIT J SURG, V97, P1629, DOI 10.1002/bjs.7155; GRIFFITHS J D, 1956, Ann R Coll Surg Engl, V19, P241; Hass DJ, 2007, AM J GASTROENTEROL, V102, P1765, DOI 10.1111/j.1572-0241.2007.01260.x; Hourmand-Ollivier I, 2003, AM J GASTROENTEROL, V98, P1573, DOI 10.1016/S0002-9270(03)00258-2; Leone M, 2015, INTENS CARE MED, V41, P667, DOI 10.1007/s00134-015-3690-8; LIM JH, 1994, AM J ROENTGENOL, V163, P343, DOI 10.2214/ajr.163.2.8037027; Longstreth GF, 2009, CLIN GASTROENTEROL H, V7, P1075, DOI 10.1016/j.cgh.2009.05.026; Mosele M, 2010, SCAND J GASTROENTERO, V45, P428, DOI 10.3109/00365520903513225; National Institute for Health and Care Excellence, 2010, VEN THROMB RED RISK; O'Neill S, 2012, COLORECTAL DIS, V14, pE751, DOI 10.1111/j.1463-1318.2012.03171.x; O'Neill S, 2012, INT J COLORECTAL DIS, V27, P187, DOI 10.1007/s00384-011-1301-x; Office formational statistics, 2015, OFFICE FORMATIONAL S; Omar H, 2014, AM J GASTROENTEROL, V109, pS453, DOI 10.14309/00000434-201410002-01538; Perry RJT, 2008, J VASC SURG, V48, P272, DOI 10.1016/j.jvs.2008.03.040; Reissfelder C, 2011, SURGERY, V149, P585, DOI 10.1016/j.surg.2010.11.008; Ripolles T, 2005, AM J ROENTGENOL, V184, P777, DOI 10.2214/ajr.184.3.01840777; Sawczenko A, 2003, ARCH DIS CHILD, V88, P995, DOI 10.1136/adc.88.11.995; UK Sepsis Trust, 2013, SEPS 6; Weber DG, 2014, BRIT J SURG, V101, pE109, DOI 10.1002/bjs.9360; WOLF EL, 1992, SURG CLIN N AM, V72, P107; Working Party of the British Society of Gastroenterology, 2005, GUT, V54, P1, DOI DOI 10.1136/GUT.2004.047126; Yadav S, 2015, CLIN GASTROENTEROL H, V13, P731, DOI 10.1016/j.cgh.2014.07.061; Zou XP, 2009, DIGEST DIS SCI, V54, P2009, DOI 10.1007/s10620-008-0579-1	35	23	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2016	355								i6600	10.1136/bmj.i6600	http://dx.doi.org/10.1136/bmj.i6600			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3CJ	28007701				2022-12-28	WOS:000390921100001
J	Kachalia, A				Kachalia, Allen			Inpatient Notes: Mistakes in the Hospital-Communicating, Apologizing, and Beyond	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kachalia, Allen] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Kachalia, A (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	akachalia@partners.org						Agency for Healthcare Research and Quality, 2016, COMM OPT RES CANDOR; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Schaffer AC, 2014, J HOSP MED, V9, P750, DOI 10.1002/jhm.2244; Wachter RM, 2016, NEW ENGL J MED, V375, P1009, DOI 10.1056/NEJMp1607958	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					H02	H03		10.7326/M16-2545	http://dx.doi.org/10.7326/M16-2545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992915				2022-12-28	WOS:000391236900001
J	Voelker, R				Voelker, Rebecca			Progress for Soft Tissue Sarcoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2474	2474		10.1001/jama.2016.17232	http://dx.doi.org/10.1001/jama.2016.17232			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997639				2022-12-28	WOS:000390959300008
J	Burkett, PR; Kuchroo, VK				Burkett, Patrick R.; Kuchroo, Vijay K.			IL-17 Blockade in Psoriasis	CELL			English	Editorial Material									[Burkett, Patrick R.; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Burkett, Patrick R.; Kuchroo, Vijay K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Burkett, Patrick R.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Kuchroo, VK (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.	vkuchroo@evergrande.hms.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI123516] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	37	41	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1669	1669		10.1016/j.cell.2016.11.044	http://dx.doi.org/10.1016/j.cell.2016.11.044			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984714	Bronze			2022-12-28	WOS:000393114700003
J	Dixit, A; Pamas, O; Li, BY; Chen, J; Fulco, CP; Jerby-Amon, L; Marjanovic, ND; Dionne, D; Burks, T; Raychowdhury, R; Adamson, B; Norman, TM; Lander, ES; Weissman, JS; Friedman, N; Regev, A				Dixit, Atray; Pamas, Oren; Li, Biyu; Chen, Jenny; Fulco, Charles P.; Jerby-Amon, Livnat; Marjanovic, Nemanja D.; Dionne, Danielle; Burks, Tyler; Raychowdhury, Raktima; Adamson, Britt; Norman, Thomas M.; Lander, Eric S.; Weissman, Jonathan S.; Friedman, Nir; Regev, Aviv			Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens	CELL			English	Article							MOUSE BONE-MARROW; TRANSCRIPTIONAL NETWORK; MITOCHONDRIAL BIOGENESIS; REGULATORY NETWORKS; FITNESS LANDSCAPES; DENDRITIC CELLS; IMMUNE CELLS; EXPRESSION; GENOME; DISCOVERY	Genetic screens help infer gene function in mammalian cells, but it has remained difficult to assay complex phenotypes-such as transcriptional profiles-at scale. Here, we develop Perturb-seq, combining single-cell RNA sequencing (RNA-seq) and clustered regularly interspaced short palindromic repeats (CRISPR)-based perturbations to perform many such assays in a pool. We demonstrate Perturb-seq by analyzing 200,000 cells in immune cells and cell lines, focusing on transcription factors regulating the response of dendritic cells to lipopolysaccharide (LPS). Perturb-seq accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and their genetic interactions. We posit new functions for regulators of differentiation, the anti-viral response, and mitochondrial function during immune activation. By decomposing many high content measurements into the effects of perturbations, their interactions, and diverse cell metadata, Perturb-seq dramatically increases the scope of pooled genomic assays.	[Dixit, Atray; Pamas, Oren; Li, Biyu; Chen, Jenny; Fulco, Charles P.; Jerby-Amon, Livnat; Marjanovic, Nemanja D.; Dionne, Danielle; Burks, Tyler; Raychowdhury, Raktima; Lander, Eric S.; Friedman, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Dixit, Atray; Chen, Jenny] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Marjanovic, Nemanja D.] MIT, Computat & Syst Biol, Cambridge, MA 02140 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Adamson, Britt; Norman, Thomas M.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biosci, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Lander, Eric S.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Weissman, Jonathan S.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Pamas, Oren] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, BioMed Res Inst Israel Canada,Fac Med IMRIC, IL-91120 Jerusalem, Israel	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Cambridge, MA 02140 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	aregev@broadinstitute.org	Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550; Chen, Jenny/0000-0002-6664-2597; Dionne, Danielle/0000-0002-8338-4323; Weissman, Jonathan/0000-0003-2445-670X; Dixit, Atray/0000-0002-5065-6492	NDSEG Fellowship; NIH [T32GM87232]; Klarman Cell Observatory; NHGRI [RM1HG006193]; HHMI; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036858] Funding Source: NIH RePORTER	NDSEG Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Basu, C. Muus, C. Rodman, and N. Rogel for help in unpublished pilot; D. Feldman for feedback; K. Shekhar for vector design; B. Cleary and A. Bloemendal for discussions on combinatorial models; T. Wang for an unpublished plasmid; L. Gaffney for help with figures; and the Genomics Platform for sequencing. Support was from NDSEG Fellowship (A.D.), NIH T32GM87232 (N.M.), Klarman Cell Observatory (A.R.), NHGRI RM1HG006193 (N.F., A.R.), and HHMI (A.R.). J.S.W. is a founder of KSQ Therapeutics, a CRISPR functional genomics company. J.S.W. has filed a patent application related to CRISPRi and CRISPRa screening (PCT/US15/40449), and A.D., O.P., B.A., T.M.N., E.S.L., J.S.W., and A.R. have filed a patent application related to Perturb-seq. A.R. is an SAB member of ThermoFisher, Syros, and Driver. The Broad Institute, which E.S.L. directs, holds patents and has filed patent applications on technologies related to other aspects of CRISPR.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Beerenwinkel N, 2007, STAT SINICA, V17, P1317; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Cannoodt R., 2016, BIORXIV; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Du D.Z., 2000, COMBINATORIAL GROUP; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fan HC, 2015, SCIENCE, V347, DOI 10.1126/science.1258367; Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Guo Y., 2015, BIORXIV; Haber JE, 2013, CELL REP, V3, P2168, DOI 10.1016/j.celrep.2013.05.007; Heimberg G, 2016, CELL SYST, V2, P239, DOI 10.1016/j.cels.2016.04.001; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Loh PL, 2012, ANN STAT, V40, P1637, DOI 10.1214/12-AOS1018; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sisler JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144444; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Villagra A, 2007, J BIOL CHEM, V282, P35457, DOI 10.1074/jbc.M701719200; Wei L, 2008, J INTERF CYTOK RES, V28, P541, DOI 10.1089/jir.2007.0136; WEINBERGER ED, 1991, BIOL CYBERN, V65, P321, DOI 10.1007/BF00216965; Yang ZF, 2014, MOL CELL BIOL, V34, P3194, DOI 10.1128/MCB.00492-12; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zetsche B., 2016, MULTIPLEX GENE EDITI; Zheng G. X. Y., 2016, MASSIVELY PARALLEL D; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	606	664	11	96	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1853	+		10.1016/j.cell.2016.11.038	http://dx.doi.org/10.1016/j.cell.2016.11.038			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984732	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000393114700022
J	Nel, A; van Niekerk, N; Kapiga, S; Bekker, LG; Gama, C; Gill, K; Kamali, A; Kotze, P; Louw, C; Mabude, Z; Miti, N; Kusemererwa, S; Tempelman, H; Carstens, H; Devlin, B; Isaacs, M; Malherbe, M; Mans, W; Nuttall, J; Russell, M; Ntshele, S; Smit, M; Solai, L; Spence, P; Steytler, J; Windle, K; Borremans, M; Resseler, S; Van Roey, J; Parys, W; Vangeneugden, T; Van Baelen, B; Rosenberg, Z				Nel, A.; van Niekerk, N.; Kapiga, S.; Bekker, L. -G.; Gama, C.; Gill, K.; Kamali, A.; Kotze, P.; Louw, C.; Mabude, Z.; Miti, N.; Kusemererwa, S.; Tempelman, H.; Carstens, H.; Devlin, B.; Isaacs, M.; Malherbe, M.; Mans, W.; Nuttall, J.; Russell, M.; Ntshele, S.; Smit, M.; Solai, L.; Spence, P.; Steytler, J.; Windle, K.; Borremans, M.; Resseler, S.; Van Roey, J.; Parys, W.; Vangeneugden, T.; Van Baelen, B.; Rosenberg, Z.		Ring Study Team	Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; INFECTION; ADHERENCE	BACKGROUND The incidence of human immunodeficiency virus (HIV) infection remains high among women in sub-Saharan Africa. We evaluated the safety and efficacy of extended use of a vaginal ring containing dapivirine for the prevention of HIV infection in 1959 healthy, sexually active women, 18 to 45 years of age, from seven communities in South Africa and Uganda. METHODS In this randomized, double-blind, placebo-controlled, phase 3 trial, we randomly assigned participants in a 2:1 ratio to receive vaginal rings containing either 25 mg of dapivirine or placebo. Participants inserted the rings themselves every 4 weeks for up to 24 months. The primary efficacy end point was the rate of HIV type 1 (HIV-1) seroconversion. RESULTS A total of 77 participants in the dapivirine group underwent HIV-1 seroconversion during 1888 person-years of follow-up (4.1 seroconversions per 100 person-years), as compared with 56 in the placebo group who underwent HIV-1 seroconversion during 917 person-years of follow-up (6.1 seroconversions per 100 person-years). The incidence of HIV-1 infection was 31% lower in the dapivirine group than in the placebo group (hazard ratio, 0.69; 95% confidence interval [CI], 0.49 to 0.99; P = 0.04). There was no significant difference in efficacy of the dapivirine ring among women older than 21 years of age (hazard ratio for infection, 0.63; 95% CI, 0.41 to 0.97) and those 21 years of age or younger (hazard ratio, 0.85; 95% CI, 0.45 to 1.60; P = 0.43 for treatment-by-age interaction). Among participants with HIV-1 infection, nonnucleoside reverse-transcriptase inhibitor resistance mutations were detected in 14 of 77 participants in the dapivirine group (18.2%) and in 9 of 56 (16.1%) in the placebo group. Serious adverse events occurred more often in the dapivirine group (in 38 participants [2.9%]) than in the placebo group (in 6 [0.9%]). However, no clear pattern was identified. CONCLUSIONS Among women in sub-Saharan Africa, the dapivirine ring was not associated with any safety concerns and was associated with a rate of acquisition of HIV-1 infection that was lower than the rate with placebo. (Funded by the International Partnership for Microbicides; ClinicalTrials. gov number, NCT01539226.)	[Nel, A.; van Niekerk, N.; Carstens, H.; Devlin, B.; Isaacs, M.; Malherbe, M.; Mans, W.; Nuttall, J.; Russell, M.; Ntshele, S.; Smit, M.; Solai, L.; Spence, P.; Steytler, J.; Windle, K.; Rosenberg, Z.] Int Partnership Microbicides, 8401 Colesville Rd,Suite 200, Silver Spring, MD 20910 USA; [Kapiga, S.] London Sch Hyg & Trop Med, London, England; [Kapiga, S.] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Bekker, L. -G.; Gill, K.] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Gama, C.; Mabude, Z.] Maternal Adolescent & Child Hlth Res, Edendale, South Africa; [Kotze, P.] Qhakaza Mbokodo Res Clin, Ladysmith, South Africa; [Miti, N.] Prevent HIV & AIDS Project, Pinetown, South Africa; [Louw, C.] Univ Pretoria, Dept Family Med, Fac Hlth Sci, Madibeng Ctr Res,Brits, Pretoria, South Africa; [Tempelman, H.] Ndlovu Care Grp, Elandsdoorn, South Africa; [Kamali, A.; Kusemererwa, S.] Med Res Council Uganda Virus Res Inst Res Unit AI, Entebbe, Uganda; [Borremans, M.; Resseler, S.] SGS Life Sci Serv Biometr, Mechelen, Belgium; [Van Roey, J.; Parys, W.; Vangeneugden, T.; Van Baelen, B.] Janssen Res & Dev, Beerse, Belgium	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Pretoria; Johnson & Johnson; Janssen Pharmaceuticals	van Niekerk, N (corresponding author), Int Partnership Microbicides, 8401 Colesville Rd,Suite 200, Silver Spring, MD 20910 USA.	nvanniekerk@ipmglobal.org.za	Gill, Katherine/ABG-3230-2021; Bekker, Linda-Gail/AAZ-8929-2020; Nuttall, Jeremy/AAI-3444-2020	Gill, Katherine/0000-0002-3372-9506; Nuttall, Jeremy/0000-0003-1346-3357; Ruzagira, Eugene/0000-0002-7291-1693; Kotze, Philip/0000-0003-1346-7833; Kapiga, Saidi/0000-0003-1753-4060; BEKKER, LINDA-GAIL/0000-0002-0755-4386	International Partnership for Microbicides; Bill and Melinda Gates Foundation; Irish Aid; Ministry of Foreign Affairs of Denmark; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; U.K. Department for International Development; American people through the U.S. Agency for International Development; President's Emergency Plan for AIDS Relief; Medical Research Council [G0901756] Funding Source: researchfish; MRC [G0901756] Funding Source: UKRI	International Partnership for Microbicides; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Irish Aid(CGIAR); Ministry of Foreign Affairs of Denmark; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; U.K. Department for International Development; American people through the U.S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the International Partnership for Microbicides (a not-for-profit product-development partnership), which receives support from the Bill and Melinda Gates Foundation, Irish Aid, the Ministry of Foreign Affairs of Denmark, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation, the U.K. Department for International Development, the American people through the U.S. Agency for International Development, and the President's Emergency Plan for AIDS Relief.	Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Division of AIDS, 2009, DIV AIDS TABL GRAD S; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Loomba Foundation, 2015, GLOB WID REP 2015 GL; Lyndgaard LB, 2014, J RAMAN SPECTROSC, V45, P149, DOI 10.1002/jrs.4433; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, C RETR OPP INF SEATT; Molina JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-186; Nel AM, 2014, HIV RES PREV R4P 201; Nel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147743; Nel AA, 2009, AIDS, V23, P1531, DOI 10.1097/QAD.0b013e32832c413d; Rees H, 2015, C RETR OPP INF SEATT; Spence P, 2016, J PHARMACEUT BIOMED, V125, P94, DOI 10.1016/j.jpba.2016.03.023; UNAIDS, 2014, 2014 PROGR REP GLOB; UNAIDS, 2015, AIDS NUMB 2015; UNAIDS, 2014, THE GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2015, AIDS, V29, P2161, DOI 10.1097/QAD.0000000000000801; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	26	280	283	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2133	2143		10.1056/NEJMoa1602046	http://dx.doi.org/10.1056/NEJMoa1602046			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED7GN	27959766	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000389030400005
J	Gladman, DD				Gladman, Dafna D.			Should methotrexate remain the first-line drug for psoriasis?	LANCET			English	Editorial Material							PLAQUE PSORIASIS; MODERATE; TRIALS; EFFICACY; THERAPY; SAFETY		[Gladman, Dafna D.] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gladman, DD (corresponding author), Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON M5T 2S8, Canada.	dafna.gladman@utoronto.ca			Amgen; AbbVie; BMS; Celgene; Eli Lilly; Janssen; Novartis; Pfizer; UCB	Amgen(Amgen); AbbVie(AbbVie); BMS(Bristol-Myers Squibb); Celgene(Bristol-Myers SquibbCelgene Corporation); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Pfizer(Pfizer); UCB(UCB Pharma SA)	I have received grants and personal fees from Amgen for a trial of etanercept and methotrexate; grants and personal fees from AbbVie for a trial of adalimumab; personal fees from BMS for a trial of abatacept; grants and personal fees from Celgene for a trial of apremilast; personal fees from Eli Lilly for a trial of ixekizumab; grants and personal fees from Janssen for trials of infliximab, golimumbab, and ustekinumab; grants and personal fees from Novartis; grants and personal fees from Pfizer for a trial of tofacitinib; and grants and personal fees from UCB for a trial of certolizumab.	Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menting SP, 2016, ACTA DERM-VENEREOL, V96, P23, DOI 10.2340/00015555-2081; Ni C, 2014, CLIN COSMET INVESTI, V7, P119, DOI 10.2147/CCID.S44843; Reich K, 2011, NEW ENGL J MED, V365, P1586, DOI 10.1056/NEJMoa1010858; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Warren RB, 2008, CLIN EXP DERMATOL, V33, P551, DOI 10.1111/j.1365-2230.2008.02976.x; Warren RB, 2016, LANCET; West J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153740	12	7	7	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					482	483		10.1016/S0140-6736(16)32574-0	http://dx.doi.org/10.1016/S0140-6736(16)32574-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28012563				2022-12-28	WOS:000393283400012
J	Montalban, X; Hauser, SL; Kappos, L; Arnold, DL; Bar-Or, A; Comi, G; de Seze, J; Giovannoni, G; Hartung, HP; Hemmer, B; Lublin, F; Rammohan, KW; Selmaj, K; Traboulsee, A; Sauter, A; Masterman, D; Fontoura, P; Belachew, S; Garren, H; Mairon, N; Chin, P; Wolinsky, JS				Montalban, X.; Hauser, S. L.; Kappos, L.; Arnold, D. L.; Bar-Or, A.; Comi, G.; de Seze, J.; Giovannoni, G.; Hartung, H. -P.; Hemmer, B.; Lublin, F.; Rammohan, K. W.; Selmaj, K.; Traboulsee, A.; Sauter, A.; Masterman, D.; Fontoura, P.; Belachew, S.; Garren, H.; Mairon, N.; Chin, P.; Wolinsky, J. S.		ORATORIO Clinical Investigators	Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MULTICENTER TRIAL; CANCER-RISK; CD20; DEMYELINATION; PATHOLOGY; ANTIBODY; DAMAGE	BACKGROUND An evolving understanding of the immunopathogenesis of multiple sclerosis suggests that depleting B cells could be useful for treatment. We studied ocrelizumab, a humanized monoclonal antibody that selectively depletes CD20-expressing B cells, in the primary progressive form of the disease. METHODS In this phase 3 trial, we randomly assigned 732 patients with primary progressive multiple sclerosis in a 2: 1 ratio to receive intravenous ocrelizumab (600 mg) or placebo every 24 weeks for at least 120 weeks and until a prespecified number of confirmed disability progression events had occurred. The primary end point was the percentage of patients with disability progression confirmed at 12 weeks in a time-to-event analysis. RESULTS The percentage of patients with 12-week confirmed disability progression was 32.9% with ocrelizumab versus 39.3% with placebo (hazard ratio, 0.76; 95% confidence interval [CI], 0.59 to 0.98; P=0.03). The percentage of patients with 24-week confirmed disability progression was 29.6% with ocrelizumab versus 35.7% with placebo (hazard ratio, 0.75; 95% CI, 0.58 to 0.98; P=0.04). By week 120, performance on the timed 25-foot walk worsened by 38.9% with ocrelizumab versus 55.1% with placebo (P=0.04); the total volume of brain lesions on T 2 -weighted magnetic resonance imaging (MRI) decreased by 3.4% with ocrelizumab and increased by 7.4% with placebo (P<0.001); and the percentage of brain-volume loss was 0.90% with ocrelizumab versus 1.09% with placebo (P=0.02). There was no significant difference in the change in the Physical Component Summary score of the 36-Item Short-Form Health Survey. Infusion-related reactions, upper respiratory tract infections, and oral herpes infections were more frequent with ocrelizumab than with placebo. Neoplasms occurred in 2.3% of patients who received ocrelizumab and in 0.8% of patients who received placebo; there was no clinically significant difference between groups in the rates of serious adverse events and serious infections. CONCLUSIONS Among patients with primary progressive multiple sclerosis, ocrelizumab was associated with lower rates of clinical and MRI progression than placebo. Extended observation is required to determine the long-term safety and efficacy of ocrelizumab. (Funded by F. Hoffmann-La Roche; ORATORIO ClinicalTrials.gov number, NCT01194570.)	[Wolinsky, J. S.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA; [Montalban, X.] Hosp Vall dHebron Univ, Barcelona, Spain; [Hauser, S. L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Masterman, D.; Garren, H.; Chin, P.] Genentech Inc, San Francisco, CA USA; [Kappos, L.] Univ Basel, Univ Basel Hosp, Basel, Switzerland; [Sauter, A.; Fontoura, P.; Belachew, S.; Mairon, N.] F Hoffmann La Roche, Basel, Switzerland; [Arnold, D. L.; Bar-Or, A.] McGill Univ, Montreal, PQ, Canada; [Arnold, D. L.] NeuroRx Res, Montreal, PQ, Canada; [Traboulsee, A.] Univ British Columbia, Vancouver, BC, Canada; [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy; [de Seze, J.] Univ Hosp Strasbourg, Clin Investigat Ctr, INSERM Unite 1434, Federat Med Translat Strasbourg, Strasbourg, France; [Giovannoni, G.] Barts & London Queen Marys Sch Med & Dent, London, England; [Hartung, H. -P.] Heinrich Heine Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Hemmer, B.] Tech Univ Munich, Munich, Germany; [Hemmer, B.] Munich Cluster Syst Neurol, Munich, Germany; [Lublin, F.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Rammohan, K. W.] Univ Miami, Miami, FL USA; [Selmaj, K.] Med Univ Lodz, Lodz, Poland	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Francisco; Roche Holding; Genentech; University of Basel; Roche Holding; McGill University; University of British Columbia; Vita-Salute San Raffaele University; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; Queen Mary University London; Heinrich Heine University Dusseldorf; Technical University of Munich; Icahn School of Medicine at Mount Sinai; University of Miami; Medical University Lodz	Montalban, X (corresponding author), Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya, Neurol Neuroimmunol Dept, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.; Montalban, X (corresponding author), Hosp Univ Vall dHebron, Ctr Esclerosi Multiple Catalunya, Neurorehabil Unit, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.; Wolinsky, JS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, 6431 Fannin St, Houston, TX 77030 USA.	xavier.montalban@cem-cat.org; jerry.s.wolinsky@uth.tmc.edu	Lublin, Fred/L-8405-2017; Bar-Or, Amit/AIC-1416-2022; Platten, Michael/F-2902-2013; Belachew, Shibeshih/V-9185-2019; Hemmer, Bernhard/GPX-8451-2022; Pashkovskyy, Valeriy/C-1120-2017; Montalban, Xavier/J-5938-2016; Nehrych, Tetyana I/L-7555-2016; Bertolotto, Antonio/K-8346-2015; Krasulová, Eva/F-8993-2017; Hemmer, Bernhard/AAT-8388-2021; Traboulsee, Anthony L/AAB-2051-2020; Benesova, Yvonne/C-1411-2016	Platten, Michael/0000-0002-4746-887X; Belachew, Shibeshih/0000-0003-3976-1950; Hemmer, Bernhard/0000-0001-5985-6784; Pashkovskyy, Valeriy/0000-0001-6066-371X; Montalban, Xavier/0000-0002-0098-9918; Nehrych, Tetyana I/0000-0003-0170-511X; Bertolotto, Antonio/0000-0002-7052-1907; Krasulová, Eva/0000-0001-8259-7530; Martins da Silva, Ana/0000-0002-1409-0831; Airas, Laura/0000-0002-9751-5881; Reingold, Stephen/0000-0003-4485-8634; Selmaj, Krzysztof/0000-0003-1213-7218; Arnold, Douglas/0000-0003-4266-0106; Karni, Arnonk/0000-0002-5625-7900; Martinez Rodriguez, Jose Enrique/0000-0001-6765-5587; lebrun-frenay, christine/0000-0002-3713-2416; Yaldizli, Ozgur/0000-0002-0800-4845; Laplaud, David/0000-0001-6113-6938; Wipfler, Peter/0000-0003-4982-4855; Benesova, Yvonne/0000-0002-5348-1747	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Funded by F. Hoffmann-La Roche; ORATORIO ClinicalTrials.gov number, NCT01194570.	[Anonymous], 2010, RIT RIT PRESCR INF I; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2652, DOI 10.1002/art.23732; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Kappos L, 2011, LANCET, V378, P1779, DOI 10.1016/S0140-6736(11)61649-8; Kingwell E, 2012, BRAIN, V135, P2973, DOI 10.1093/brain/aws148; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab4176; LOKEN MR, 1987, BLOOD, V70, P1316; Lublin F, 2016, LANCET, V387, P1075, DOI 10.1016/S0140-6736(15)01314-8; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Nielsen NM, 2006, INT J CANCER, V118, P979, DOI 10.1002/ijc.21437; Palanichamy A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008930; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; STASHENKO P, 1980, J IMMUNOL, V125, P1678; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; World Medical Association, 2013, WMA DECL HELS ETH PR	29	880	915	3	153	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2017	376	3					209	220		10.1056/NEJMoa1606468	http://dx.doi.org/10.1056/NEJMoa1606468			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI0XO	28002688	Green Published			2022-12-28	WOS:000392199100005
J	Joynt, KE; Orav, EJ; Zheng, J; Jha, AK				Joynt, Karen E.; Orav, E. John; Zheng, Jie; Jha, Ashish K.			Public Reporting of Mortality Rates for Hospitalized Medicare Patients RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							OUTCOMES		[Joynt, Karen E.; Orav, E. John] Brigham & Womens Hosp, Boston, MA 02115 USA; [Zheng, Jie; Jha, Ashish K.] Harvard Sch Publ Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.				NHLBI NIH HHS [K23 HL109177] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Lindenauer PK, 2012, JAMA-J AM MED ASSOC, V307, P1405, DOI 10.1001/jama.2012.384; McCabe JM, 2014, CIRCULATION, V129, P194, DOI 10.1161/CIRCULATIONAHA.113.006165	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					75	76		10.7326/L16-0546	http://dx.doi.org/10.7326/L16-0546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030667	Green Accepted			2022-12-28	WOS:000391467900014
J	Munro, WJ; Nemoto, K				Munro, William J.; Nemoto, Kae			Optical circulators reach the quantum level	SCIENCE			English	Editorial Material									[Munro, William J.] NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan; [Munro, William J.; Nemoto, Kae] Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan	Nippon Telegraph & Telephone Corporation; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Munro, WJ (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.; Munro, WJ (corresponding author), Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	william.munro@lab.ntt.co.jp	Nemoto, Kae/A-8833-2011; Munro, William/A-8453-2011	Munro, William/0000-0003-1835-2250				HOGAN CL, 1956, P IRE, V44, P1345, DOI 10.1109/JRPROC.1956.274979; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Matsko AB, 2006, IEEE J SEL TOP QUANT, V12, P3, DOI 10.1109/JSTQE.2005.862952; Meschede D., 2007, OPTICS LIGHT LASERS; Nemoto K, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031022; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; O'Shea D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.193601; Sayrin C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041036; Scheucher M, 2016, SCIENCE, V354, P1577, DOI 10.1126/science.aaj2118	9	0	0	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1532	1532		10.1126/science.aal3163	http://dx.doi.org/10.1126/science.aal3163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008028				2022-12-28	WOS:000390254300027
J	Mark, DB; Douglas, PS; Daniels, MR				Mark, Daniel B.; Douglas, Pamela S.; Daniels, Melanie R.			Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Mark, Daniel B.; Douglas, Pamela S.; Daniels, Melanie R.] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Mark, DB (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.			Daniels, Melanie/0000-0003-4360-5635; Douglas, Pamela/0000-0001-9876-4049				Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Douglas PS, 2014, AM HEART J, V167, P796, DOI 10.1016/j.ahj.2014.03.003; Squires D., 2015, US HLTH CARE GLOBAL; 2015, LANCET, V385, P2383, DOI DOI 10.1016/S0140-6736(15)60291-4	4	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					891	891		10.7326/L16-0482	http://dx.doi.org/10.7326/L16-0482			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992905				2022-12-28	WOS:000391236900027
J	Tanner, M				Tanner, Michael			In type 1 diabetes, adding liraglutide to insulin increased hypoglycemia and hyperglycemia with ketosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Tanner, Michael] NYU, Sch Med, New York, NY 10003 USA	New York University	Tanner, M (corresponding author), NYU, Sch Med, New York, NY 10003 USA.			Tanner, Michael/0000-0002-3012-8641				Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC64	JC64		10.7326/ACPJC-2016-165-12-064	http://dx.doi.org/10.7326/ACPJC-2016-165-12-064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992920				2022-12-28	WOS:000391236900003
J	Mohammadi, D				Mohammadi, Dara			2016: year in review	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2971	2972		10.1016/S0140-6736(16)32579-X	http://dx.doi.org/10.1016/S0140-6736(16)32579-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27998522				2022-12-28	WOS:000390112300013
J	Ibisch, PL; Hoffmann, MT; Kreft, S; Pe'er, G; Kati, V; Biber-Freudenberger, L; DellaSala, DA; Vale, MM; Hobson, PR; Selva, N				Ibisch, Pierre L.; Hoffmann, Monika T.; Kreft, Stefan; Pe'er, Guy; Kati, Vassiliki; Biber-Freudenberger, Lisa; DellaSala, Dominick A.; Vale, Mariana M.; Hobson, Peter R.; Selva, Nuria			A global map of roadless areas and their conservation status	SCIENCE			English	Article							TERRESTRIAL	Roads fragment landscapes and trigger human colonization and degradation of ecosystems, to the detriment of biodiversity and ecosystem functions. The planet's remaining large and ecologically important tracts of roadless areas sustain key refugia for biodiversity and provide globally relevant ecosystem services. Applying a 1-kilometer buffer to all roads, we present a global map of roadless areas and an assessment of their status, quality, and extent of coverage by protected areas. About 80% of Earth's terrestrial surface remains roadless, but this area is fragmented into similar to 600,000 patches, more than half of which are <1 square kilometer and only 7% of which are larger than 100 square kilometers. Global protection of ecologically valuable roadless areas is inadequate. International recognition and protection of roadless areas is urgently needed to halt their continued loss.	[Ibisch, Pierre L.; Hoffmann, Monika T.; Kreft, Stefan; Biber-Freudenberger, Lisa; Hobson, Peter R.] Eberswalde Univ Sustainable Dev, Ctr Econ & Ecosyst Management, Alfred Moeller Str 1, D-16225 Eberswalde, Germany; [Ibisch, Pierre L.; Kreft, Stefan; Pe'er, Guy; Kati, Vassiliki; Hobson, Peter R.] Europe Sect, Soc Conservat Biol, 1133 15th St Northwest,Suite 300, Washington, DC 20005 USA; [Pe'er, Guy] UFZ Ctr Environm Res, Dept Conservat Biol, Permoserstr 15, D-04318 Leipzig, Germany; [Pe'er, Guy] German Ctr Integrat Biodivers Res iDiv, Halle Jena Leipzig,Deutsch Pl 5e, D-04103 Leipzig, Germany; [Kati, Vassiliki] Univ Patras, Dept Environm & Nat Resources Management, Seferi 2, Agrinion 30100, Greece; [Biber-Freudenberger, Lisa] Univ Bonn, Res Dev Ctr, Dept Ecol & Nat Resources Management, Walter Flex Str 3, D-53113 Bonn, Germany; [DellaSala, Dominick A.] Geos Inst, 84 4th St, Ashland, OR 97520 USA; [DellaSala, Dominick A.] North Amer Sect, Soc Conservat Biol, 1133 15th St Northwest,Suite 300, Washington, DC 20005 USA; [Vale, Mariana M.] Univ Fed Rio de Janeiro, Dept Ecol, Ave Brg Trompowski S-N, BR-21044020 Rio De Janeiro, Brazil; [Vale, Mariana M.] Latin Amer & Caribbean Sect, Soc Conservat Biol, 1133 15th St Northwest,Suite 300, Washington, DC 20005 USA; [Hobson, Peter R.] Writtle Coll, Lordship Rd, Chelmsford CM1 3RR, Essex, England; [Selva, Nuria] Polish Acad Sci, Inst Nat Conservat, Mickiewicza 33, PL-31120 Krakow, Poland	Eberswalde University for Sustainable Development; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Patras; University of Bonn; Universidade Federal do Rio de Janeiro; Writtle College; Polish Academy of Sciences	Ibisch, PL (corresponding author), Eberswalde Univ Sustainable Dev, Ctr Econ & Ecosyst Management, Alfred Moeller Str 1, D-16225 Eberswalde, Germany.; Ibisch, PL (corresponding author), Europe Sect, Soc Conservat Biol, 1133 15th St Northwest,Suite 300, Washington, DC 20005 USA.; Selva, N (corresponding author), Polish Acad Sci, Inst Nat Conservat, Mickiewicza 33, PL-31120 Krakow, Poland.	pierre.ibisch@hnee.de; nuriselva@gmail.com	Selva, Nuria/J-6970-2013; Vale, Mariana M./I-9408-2012; Kati, Vassiliki I/AAB-9418-2020; Kreft, Stefan/AAE-5558-2021; Biber-Freudenberger, Lisa/H-9867-2019	Selva, Nuria/0000-0003-3389-201X; Vale, Mariana M./0000-0003-0734-4925; Kati, Vassiliki I/0000-0003-3357-4556; Ibisch, Pierre/0000-0001-9820-9272; Hoffmann, Monika Teresa/0000-0003-4451-847X; Biber-Freudenberger, Lisa/0000-0001-8106-5372	Centre for Econics and Ecosystem Management at Eberswalde University for Sustainable Development, Germany; Academy of Sciences and Literature, Mainz, Germany ("Biodiversity in Change," Nees Institute Bonn University); Institute of Nature Conservation, Polish Academy of Sciences; Eberswalde University for Sustainable Development; European Union [308454]; National Science Center [DEC-2013/08/M/NZ9/00469]; National Centre for Research and Development in Poland (Norway) [POLNOR/198352/85/2013]; STFC [ST/N001273/1, ST/H000925/1, ST/J005479/1, ST/M004775/1, ST/I003622/1, ST/M002020/1, ST/L005603/1, ST/H000925/2, ST/K001639/1, PP/E000479/1, PP/E002803/1, ST/I000305/1, ST/K001531/1, ST/J004871/1, ST/K003542/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E002803/1, ST/K001639/1 CMS Upgrades, ST/I003622/1 GRIDPP, ST/H000925/2, ST/K003224/1 CMS Upgrades, ST/H000925/1, ST/K001639/1, CMS, ST/I000305/1, ST/J005479/1, ST/M004775/1 GRIDPP, ST/N001273/1, ST/I003622/1, PP/E000479/1, ST/K003542/1 GRIDPP, ST/L005603/1, ST/K001531/1, ST/K003542/1 GRID PP, ST/K003542/1, ST/M004775/1, ST/M002020/1, ST/J004871/1] Funding Source: researchfish	Centre for Econics and Ecosystem Management at Eberswalde University for Sustainable Development, Germany; Academy of Sciences and Literature, Mainz, Germany ("Biodiversity in Change," Nees Institute Bonn University); Institute of Nature Conservation, Polish Academy of Sciences; Eberswalde University for Sustainable Development; European Union(European Commission); National Science Center(National Science Centre, Poland); National Centre for Research and Development in Poland (Norway); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The data set is available through www.roadless.online and Dryad at http://dx.doi.org/10.5061/dryad.q4975. The study was funded by the Centre for Econics and Ecosystem Management at Eberswalde University for Sustainable Development, Germany; the Academy of Sciences and Literature, Mainz, Germany ("Biodiversity in Change," Nees Institute Bonn University); and the Institute of Nature Conservation, Polish Academy of Sciences. Special thanks go to W. Barthlott for continued inspiration and support. The authors declare that they have no competing interests. P.L.I. acknowledges the research professorships "Biodiversity and natural resource management under global change" (2009-2015) and "Ecosystem-based sustainable development" (2015 onward) awarded by Eberswalde University for Sustainable Development. G.P. acknowledges funding from the European Union Framework Programme 7 project EU BON (ref. 308454). N.S. acknowledges funding from the National Science Center (DEC-2013/08/M/NZ9/00469) and the National Centre for Research and Development in Poland (Norway grants, POLNOR/198352/85/2013). P.L.I., N.S. and V.K. conceived the study. M.T.H. collected and analyzed all data with assistance torn P.L.I., L.B.-F., arid G.P. P.L.I. wrote a first draft of the text and moderated its critical revision with important contributions by M.T.H., S.K., N.S., and D.A.D. All authors contributed to the interpretation of the data and critical revision of further versions. N.S., M.T.H., M.M.V., V.K. S.K., L.B.-F., and P.L.I. elaborated the supplementary materials. We appreciate the extraordinary contribution of D. Biber who adapted Insensa-GIS to our needs. We acknowledge J. Sauermands contributions to data processing. J.-P. Mund suggested exploring the OpenStreetMap data set. This study is part of the Roadless Areas Initiative of the Society for Conservation Biology, led by the Policy Committee of the Europe Section.	Convention on Biological Diversity, 2010, UN ENV PROGR C BIOL; Dulac J., 2013, GLOBAL LAND TRANSPOR; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Freudenberger L, 2012, ECOL COMPLEX, V12, P13, DOI 10.1016/j.ecocom.2012.08.002; Laurance WF, 2015, CURR BIOL, V25, pR259, DOI 10.1016/j.cub.2015.02.050; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2013, NATURE, V495, P308, DOI 10.1038/495308a; Leadley P. W., 2013, TECHNICAL REPORT; Mandle L, 2016, CONSERV LETT, V9, P221, DOI 10.1111/conl.12201; Selva N, 2015, HANDBOOK OF ROAD ECOLOGY, P16; Selva N, 2011, ENVIRON MANAGE, V48, P865, DOI 10.1007/s00267-011-9751-z; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; UN, 2015, 2030 AG SUST DEV	14	266	278	16	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1423	1427		10.1126/science.aaf7166	http://dx.doi.org/10.1126/science.aaf7166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980208				2022-12-28	WOS:000390261300043
J	Borman, AM; Johnson, EM				Borman, Andrew M.; Johnson, Elizabeth M.			CHRISTMAS 2016: BEING WELL Open toe sandals syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Borman, Andrew M.; Johnson, Elizabeth M.] Publ Hlth England Natl Mycol Reference Lab, Bristol, Avon, England		Borman, AM (corresponding author), Publ Hlth England Natl Mycol Reference Lab, Bristol, Avon, England.	Andy.Borman@uhBristol.nhs.uk	Borman, Andy/H-3663-2019	Borman, Andy/0000-0003-0585-5721					0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2016	355								i6496	10.1136/bmj.i6496	http://dx.doi.org/10.1136/bmj.i6496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JU	27979822				2022-12-28	WOS:000390151500001
J	Rooduijn, M				Rooduijn, Matthijs			Simply studying populism is no longer enough	NATURE			English	Editorial Material									[Rooduijn, Matthijs] Utrecht Univ Netherlands, Dept Sociol, Utrecht, Netherlands	Utrecht University	Rooduijn, M (corresponding author), Utrecht Univ Netherlands, Dept Sociol, Utrecht, Netherlands.	m.rooduijn@uu.nl							0	4	5	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					317	317		10.1038/540317a	http://dx.doi.org/10.1038/540317a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE6JR	27974782	Bronze			2022-12-28	WOS:000389716800004
J	McClain, SL; Bohan, JG; Stevens, DL				McClain, Sarah L.; Bohan, Jefferson G.; Stevens, Dennis L.			Advances in the medical management of skin and soft tissue infections	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE BACTERIAL SKIN; RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO ACTIVITY; ANTIMICROBIAL SURVEILLANCE PROGRAM; GRAM-POSITIVE PATHOGENS; SINGLE-DOSE ORITAVANCIN; ONCE-WEEKLY DALBAVANCIN; DOUBLE-BLIND; COMPLICATED SKIN; RETAPAMULIN OINTMENT	Skin and soft tissue infections are some of the most common infectious disease diagnoses in both inpatient and outpatient settings. With bacterial resistance to antimicrobials growing, decision making on empiric antibiotics is becoming increasingly difficult. Additionally, the most recent guidance from a professional society on the treatment of skin and soft tissue infections was published in 2014 by the Infectious Diseases Society of America and is now two years old. New antimicrobial agents have been developed and approved for the treatment of skin and soft tissue infections since then, and more are in the pipeline. This review summarizes the evidence on treatments that are new or in development and the potential repurposing of old antimicrobials. The clinical utility of these treatments is also discussed.	[McClain, Sarah L.; Bohan, Jefferson G.; Stevens, Dennis L.] Boise Vet Affairs Med Ctr, 500 W Ft St, Boise, ID 83702 USA; [Stevens, Dennis L.] Univ Washington, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	McClain, SL (corresponding author), Boise Vet Affairs Med Ctr, 500 W Ft St, Boise, ID 83702 USA.	sarah.mcclain@va.gov		Bohan, Jefferson/0000-0001-8657-0490				Barber KE, 2016, J ANTIMICROB CHEMOTH, V71, P152, DOI 10.1093/jac/dkv302; Basilea Pharmaceutica, 2016, CEFT; Bassetti M, 2014, CLIN MICROBIOL INFEC, V20, P3, DOI 10.1111/1469-0691.12463; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P918, DOI 10.1128/AAC.00766-08; Boucher HW, 2014, NEW ENGL J MED, V370, P2169, DOI 10.1056/NEJMoa1310480; Brade KD, 2016, INFECT DIS THER, V5, P1, DOI 10.1007/s40121-016-0103-4; Bradley JS, 2016, PEDIATR INFECT DIS J, V35, P628, DOI 10.1097/INF.0000000000001096; Bradley JS, 2015, PEDIATR INFECT DIS J, V34, P748, DOI 10.1097/INF.0000000000000646; Burdette SD, 2015, CLIN INFECT DIS, V61, P1315, DOI 10.1093/cid/civ501; Carrel M, 2015, EMERG INFECT DIS, V21, P1973, DOI 10.3201/eid2111.150452; Corey GR, 2015, CLIN INFECT DIS, V60, P254, DOI 10.1093/cid/ciu778; Corey GR, 2014, NEW ENGL J MED, V370, P2180, DOI 10.1056/NEJMoa1310422; Corey GR, 2011, CLIN INFECT DIS, V52, pS469, DOI 10.1093/cid/cir162; Covington P, 2011, ANTIMICROB AGENTS CH, V55, P5790, DOI 10.1128/AAC.05044-11; Darpo B, 2010, J CLIN PHARMACOL, V50, P895, DOI 10.1177/0091270009355449; Dauner DG, 2010, AM J HEALTH-SYST PH, V67, P983, DOI 10.2146/ajhp090285; Davenport JM, 2012, CLIN PHARM DRUG DEV, V1, P121, DOI 10.1177/2160763X12454714; Draper MP, 2014, ANTIMICROB AGENTS CH, V58, P1279, DOI 10.1128/AAC.01066-13; Drusano GL, 2011, ANTIMICROB AGENTS CH, V55, P5300, DOI 10.1128/AAC.00502-11; Dunne MW, 2016, CLIN INFECT DIS, V62, P545, DOI 10.1093/cid/civ982; Dunne MW, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0081-5; Dunne MW, 2015, INT J ANTIMICROB AG, V45, P393, DOI 10.1016/j.ijantimicag.2014.12.021; Eriksson B, 1996, CLIN INFECT DIS, V23, P1091, DOI 10.1093/clinids/23.5.1091; Farrell DJ, 2012, DIAGN MICR INFEC DIS, V74, P73, DOI 10.1016/j.diagmicrobio.2012.05.031; Farrell DJ, 2010, JNJ Q2 NEW FLUOROQUI; Flanagan S, 2014, ANTIMICROB AGENTS CH, V58, P6471, DOI 10.1128/AAC.03431-14; Flanagan S, 2013, ANTIMICROB AGENTS CH, V57, P3060, DOI 10.1128/AAC.00431-13; Flanagan S, 2015, ANTIMICROB AGENTS CH, V59, P178, DOI 10.1128/AAC.03684-14; [Food and Drug Administration Center for Drug Evaluation Research Guidance for industry US Department of Health and Human Services], 2013, GUID IND AC BACT SKI; Gentry DR, 2007, ANTIMICROB AGENTS CH, V51, P2048, DOI 10.1128/AAC.01066-06; Gropper S, 2014, FUTURE MICROBIOL, V9, P1013, DOI [10.2217/FMB.14.78, 10.2217/fmb.14.78]; Gropper Savion, 2014, Future Microbiol, V9, pS17, DOI 10.2217/fmb.14.83; Gropper Savion, 2014, Future Microbiol, V9, pS33, DOI 10.2217/fmb.14.85; Health Canada, 2015, REG DEC SUMM ZEVT; Hoover R, 2016, CLIN THER, V38, P53, DOI 10.1016/j.clinthera.2015.11.019; Hoover R, 2016, CLIN THER, V38, P39, DOI 10.1016/j.clinthera.2015.10.016; Iovino SM, 2011, INT J CLIN EXP PATHO, V4, P587; Jauregui LE, 2005, CLIN INFECT DIS, V41, P1407, DOI 10.1086/497271; Jones RN, 2006, ANTIMICROB AGENTS CH, V50, P2583, DOI 10.1128/AAC.01432-05; Jones RN, 2016, ANTIMICROB AGENTS CH, V60, P3174, DOI 10.1128/AAC.03029-15; Jones RN, 2015, DIAGN MICR INFEC DIS, V82, P73, DOI 10.1016/j.diagmicrobio.2015.01.017; Jones RN, 2015, ANTIMICROB AGENTS CH, V59, P2405, DOI 10.1128/AAC.05098-14; Jones RN, 2013, DIAGN MICR INFEC DIS, V76, P239, DOI 10.1016/j.diagmicrobio.2013.01.002; Jones RN, 2013, DIAGN MICR INFEC DIS, V75, P304, DOI 10.1016/j.diagmicrobio.2012.11.024; Jorgensen D, 2015, RANDOMIZED DOUBLE BL; Kanayama S, 2016, J INFECT CHEMOTHER, V22, P720, DOI 10.1016/j.jiac.2016.03.006; Kingsley J, 2016, J ANTIMICROB CHEMOTH, V71, P821, DOI 10.1093/jac/dkv411; Koning S, 2008, BRIT J DERMATOL, V158, P1077, DOI 10.1111/j.1365-2133.2008.08485.x; Kosowska-Shick K, 2006, ANTIMICROB AGENTS CH, V50, P765, DOI 10.1128/AAC.50.2.765-769.2006; Kumar A, 2011, INT J ARTIF ORGANS, V34, P1067, DOI 10.5301/ijao.5000008; Lemaire S, 2011, ANTIMICROB AGENTS CH, V55, P649, DOI 10.1128/AAC.01201-10; Litwin JS, 2015, ANTIMICROB AGENTS CH, V59, P3469, DOI 10.1128/AAC.04813-14; Lopez Y, 2013, ANTIMICROB AGENTS CH, V57, P6389, DOI 10.1128/AAC.01509-13; Lundberg CV, 2013, INT J ANTIMICROB AG, V42, P272, DOI 10.1016/j.ijantimicag.2013.05.008; Macone AB, 2014, ANTIMICROB AGENTS CH, V58, P1127, DOI 10.1128/AAC.01242-13; Marbury T, 2009, J CLIN PHARMACOL, V49, P465, DOI 10.1177/0091270008330162; McEwen A, 2015, XENOBIOTICA, V45, P1054, DOI 10.3109/00498254.2015.1042946; McNeil JC, 2014, ANTIMICROB AGENTS CH, V58, P2878, DOI 10.1128/AAC.02707-13; Mendes RE, 2015, J ANTIMICROB CHEMOTH, V70, P498, DOI 10.1093/jac/dku421; Mendes RE, 2014, J ANTIMICROB CHEMOTH, V69, P1579, DOI 10.1093/jac/dku016; Mensa B, 2014, ANTIMICROB AGENTS CH, V58, P5136, DOI 10.1128/AAC.02955-14; Moran GJ, 2014, LANCET INFECT DIS, V14, P696, DOI 10.1016/S1473-3099(14)70737-6; Morgan A, 2009, FUTURE MICROBIOL, V4, P131, DOI 10.2217/17460913.4.2.131; Nilius AM, 2003, ANTIMICROB AGENTS CH, V47, P3260, DOI 10.1128/AAC.47.10.3260-3269.2003; Noel GJ, 2008, CLIN INFECT DIS, V46, P647, DOI 10.1086/526527; Noel GJ, 2008, ANTIMICROB AGENTS CH, V52, P37, DOI 10.1128/AAC.00551-07; Noel GJ, 2012, ANTIMICROB AGENTS CH, V56, P5650, DOI 10.1128/AAC.00948-12; NovaBay Pharmaceuticals, 2016, AG; O'Riordan W, 2015, INT J INFECT DIS, V30, P67, DOI 10.1016/j.ijid.2014.10.009; Ong V, 2014, DRUG METAB DISPOS, V42, P1275, DOI 10.1124/dmd.113.056697; Oranje AP, 2007, DERMATOLOGY, V215, P331, DOI 10.1159/000107776; Paukner S, 2013, ANTIMICROB AGENTS CH, V57, P4489, DOI 10.1128/AAC.00358-13; Prince WT, 2013, ANTIMICROB AGENTS CH, V57, P2087, DOI 10.1128/AAC.02106-12; Prokocimer P, 2011, ANTIMICROB AGENTS CH, V55, P583, DOI 10.1128/AAC.00076-10; Prokocimer P, 2013, JAMA-J AM MED ASSOC, V309, P559, DOI 10.1001/jama.2013.241; Reffert JL, 2014, PHARMACOTHERAPY, V34, P845, DOI 10.1002/phar.1434; Remy JM, 2012, J ANTIMICROB CHEMOTH, V67, P2814, DOI 10.1093/jac/dks307; Rittenhouse S, 2006, ANTIMICROB AGENTS CH, V50, P3882, DOI 10.1128/AAC.00178-06; Rodriguez-Avial I, 2012, J ANTIMICROB CHEMOTH, V67, P167, DOI 10.1093/jac/dkr403; Roussos N, 2009, INT J ANTIMICROB AG, V34, P506, DOI 10.1016/j.ijantimicag.2009.08.013; Rubino CM, 2015, ANTIMICROB AGENTS CH, V59, P3365, DOI 10.1128/AAC.00176-15; Rybak JM, 2014, PHARMACOTHERAPY, V34, P1198, DOI 10.1002/phar.1491; Scangarella-Oman NE, 2009, EXPERT REV ANTI-INFE, V7, P269, DOI [10.1586/eri.09.7, 10.1586/ERI.09.7]; Schintler MV, 2009, J ANTIMICROB CHEMOTH, V64, P574, DOI 10.1093/jac/dkp230; Shorr AF, 2015, ANTIMICROB AGENTS CH, V59, P864, DOI 10.1128/AAC.03688-14; Sitali L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0935-7; Smith JR, 2015, INFECT DIS THER, V4, P245, DOI 10.1007/s40121-015-0077-7; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Talan DA, 2016, CLIN INFECT DIS, V62, P1505, DOI 10.1093/cid/ciw177; Thompson MK, 2014, BIOCHEMISTRY-US, V53, P755, DOI 10.1021/bi4015852; Van Bambeke F, 2015, FUTURE MICROBIOL, V10, P1111, DOI 10.2217/fmb.15.39; Vilay AM, 2010, BLOOD PURIFICAT, V30, P37, DOI 10.1159/000316685; Woodford N, 2008, J ANTIMICROB CHEMOTH, V62, P766, DOI 10.1093/jac/dkn266; Yamakawa T, 2002, J ANTIMICROB CHEMOTH, V49, P455, DOI 10.1093/jac/49.3.455; Yu XH, 2014, J ANTIBIOT, V67, P369, DOI 10.1038/ja.2014.5; Zhanel GG, 2012, CLIN INFECT DIS, V54, pS214, DOI 10.1093/cid/cir920; Zhanel GG, 2010, DRUGS, V70, P859, DOI 10.2165/11534440-000000000-00000; Zurenko G, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0046-0	98	5	6	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6004	10.1136/bmj.i6004	http://dx.doi.org/10.1136/bmj.i6004			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974335				2022-12-28	WOS:000390151300003
J	Lyon, J				Lyon, Jeff			Fixing Obamacare Takes Back Seat, Poll Finds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2348	2348		10.1001/jama.2016.18025	http://dx.doi.org/10.1001/jama.2016.18025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959978				2022-12-28	WOS:000389884600005
J	Joynt, KE; De Lew, N; Sheingold, SH; Conway, PH; Goodrich, K; Epstein, AM				Joynt, Karen E.; De Lew, Nancy; Sheingold, Steven H.; Conway, Patrick H.; Goodrich, Kate; Epstein, Arnold M.			Should Medicare Value-Based Purchasing Take Social Risk into Account?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Joynt, Karen E.; Epstein, Arnold M.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Joynt, Karen E.; Epstein, Arnold M.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Joynt, Karen E.; De Lew, Nancy; Sheingold, Steven H.] Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Conway, Patrick H.; Goodrich, Kate] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Centers for Medicare & Medicaid Services	Joynt, KE (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Joynt, KE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Joynt, KE (corresponding author), Dept Hlth & Human Serv, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA.							Department of Health and Human Services, REP C SOC RISK FACT	1	79	79	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 9	2017	376	6					510	513		10.1056/NEJMp1616278	http://dx.doi.org/10.1056/NEJMp1616278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8XL	28029802				2022-12-28	WOS:000393510500003
J	El-Khatib, FH; Balliro, C; Hillard, MA; Magyar, KL; Ekhlaspour, L; Sinha, M; Mondesir, D; Esmaeili, A; Hartigan, C; Thompson, MJ; Malkani, S; Lock, JP; Harlan, DM; Clinton, P; Frank, E; Wilson, DM; DeSalvo, D; Norlander, L; Ly, T; Buckingham, BA; Diner, J; Dezube, M; Young, LA; Goley, A; Kirkman, MS; Buse, JB; Zheng, H; Selagamsetty, RR; Damiano, ER; Russell, SJ				El-Khatib, Firas H.; Balliro, Courtney; Hillard, Mallory A.; Magyar, Kendra L.; Ekhlaspour, Laya; Sinha, Manasi; Mondesir, Debbie; Esmaeili, Aryan; Hartigan, Celia; Thompson, Michael J.; Malkani, Samir; Lock, J. Paul; Harlan, David M.; Clinton, Paula; Frank, Eliana; Wilson, Darrell M.; DeSalvo, Daniel; Norlander, Lisa; Ly, Trang; Buckingham, Bruce A.; Diner, Jamie; Dezube, Milana; Young, Laura A.; Goley, April; Kirkman, M. Sue; Buse, John B.; Zheng, Hui; Selagamsetty, Rajendranath R.; Damiano, Edward R.; Russell, Steven J.			Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial	LANCET			English	Article							ESTIMATED AVERAGE GLUCOSE; ARTIFICIAL PANCREAS; SEVERE HYPOGLYCEMIA; GLYCEMIC CONTROL; CHILDREN; ADOLESCENTS; KETOACIDOSIS; DELIVERY; SAFETY; YOUTH	Background The safety and effectiveness of a continuous, day-and-night automated glycaemic control system using insulin and glucagon has not been shown in a free-living, home-use setting. We aimed to assess whether bihormonal bionic pancreas initialised only with body mass can safely reduce mean glycaemia and hypoglycaemia in adults with type 1 diabetes who were living at home and participating in their normal daily routines without restrictions on diet or physical activity. Methods We did a random-order crossover study in volunteers at least 18 years old who had type 1 diabetes and lived within a 30 min drive of four sites in the USA. Participants were randomly assigned (1: 1) in blocks of two using sequentially numbered sealed envelopes to glycaemic regulation with a bihormonal bionic pancreas or usual care (conventional or sensor-augmented insulin pump therapy) first, followed by the opposite intervention. Both study periods were 11 days in length, during which time participants continued all normal activities, including athletics and driving. The bionic pancreas was initialised with only the participant's body mass. Autonomously adaptive dosing algorithms used data from a continuous glucose monitor to control subcutaneous delivery of insulin and glucagon. The coprimary outcomes were the mean glucose concentration and time with continuous glucose monitoring (CGM) glucose concentration less than 3.3 mmol/L, analysed over days 2-11 in participants who completed both periods of the study. This trial is registered with ClinicalTrials.gov,number NCT02092220. Findings We randomly assigned 43 participants between May 6, 2014, and July 3, 2015, 39 of whom completed the study: 20 who were assigned to bionic pancreas first and 19 who were assigned to the comparator first. The mean CGM glucose concentration was 7.8 mmol/L (SD 0.6) in the bionic pancreas period versus 9.0 mmol/L (1.6) in the comparator period (difference 1.1 mmol/L, 95% CI 0.7-1.6; p<0.0001), and the mean time with CGM glucose concentration less than 3.3 mmol/L was 0.6% (0.6) in the bionic pancreas period versus 1.9% (1.7) in the comparator period (difference 1.3%, 95% CI 0.8-1.8; p<0. 0001). The mean nausea score on the Visual Analogue Scale (score 0-10) was greater during the bionic pancreas period (0.52 [SD 0.83]) than in the comparator period (0.05 [0.17]; difference 0.47, 95% CI 0.21-0.73; p=0.0024). Body mass and laboratory parameters did not differ between periods. There were no serious or unexpected adverse events in the bionic pancreas period of the study. Interpretation Relative to conventional and sensor-augmented insulin pump therapy, the bihormonal bionic pancreas, initialised only with participant weight, was able to achieve superior glycaemic regulation without the need for carbohydrate counting. Larger and longer studies are needed to establish the long-term benefits and risks of automated glycaemic management with a bihormonal bionic pancreas.	[El-Khatib, Firas H.; Selagamsetty, Rajendranath R.; Damiano, Edward R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Balliro, Courtney; Hillard, Mallory A.; Magyar, Kendra L.; Ekhlaspour, Laya; Sinha, Manasi; Mondesir, Debbie; Esmaeili, Aryan; Russell, Steven J.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Balliro, Courtney; Hillard, Mallory A.; Magyar, Kendra L.; Ekhlaspour, Laya; Sinha, Manasi; Mondesir, Debbie; Esmaeili, Aryan; Russell, Steven J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Hartigan, Celia; Thompson, Michael J.; Malkani, Samir; Lock, J. Paul; Harlan, David M.] Univ Massachusetts, Sch Med, Ctr Clin & Translat Sci, Worcester, MA USA; [Hartigan, Celia; Thompson, Michael J.; Malkani, Samir; Lock, J. Paul; Harlan, David M.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA USA; [Clinton, Paula; Frank, Eliana; Wilson, Darrell M.; DeSalvo, Daniel; Norlander, Lisa; Ly, Trang; Buckingham, Bruce A.] Stanford Univ, Sch Med, Div Pediat Endocrinol & Diabet, Palo Alto, CA 94304 USA; [Diner, Jamie; Dezube, Milana; Young, Laura A.; Goley, April; Kirkman, M. Sue; Buse, John B.] Univ North Carolina Chapel Hill, Diabet Care Ctr, Sch Med, Chapel Hill, NC USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Russell, SJ (corresponding author), Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.	sjrussell@mgh.harvard.edu	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876; Buckingham, Bruce/0000-0003-4581-4887	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health; National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453, UL1TR001111, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028, DP3DK101084, R01DK097657] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and National Center for Advancing Translational Sciences.	ADOCIA, BIOCHAPERONE HUM GLU; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Basu A, 2016, DIABETES TECHNOL THE, V18, P43, DOI 10.1089/dia.2015.0410; Beck RW, 2012, J CLIN ENDOCR METAB, V97, P4383, DOI 10.1210/jc.2012-1561; Blauw H, 2016, DIABETES OBES METAB, V18, P671, DOI 10.1111/dom.12663; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Cersosima E, 2014, DIABETES S1A, V63, P1; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Del Favero S, 2016, DIABETES CARE, V39, P1180, DOI 10.2337/dc15-2815; Dexacom, DEXC G4 PLAT US GUID; El-Khatib Firas H, 2007, J Diabetes Sci Technol, V1, P181; El-Khatib FH, 2014, J CLIN ENDOCR METAB, V99, P1701, DOI 10.1210/jc.2013-4151; El-Khatib Firas H, 2009, J Diabetes Sci Technol, V3, P789; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Haidar A, 2016, J CLIN ENDOCR METAB, V101, P213, DOI 10.1210/jc.2015-3003; Haidar A, 2015, LANCET DIABETES ENDO, V3, P595, DOI 10.1016/S2213-8587(15)00141-2; Haymond MW, 2016, DIABETES CARE, V39, P465, DOI 10.2337/dc15-2124; Kovatchev BP, 2014, DIABETES CARE, V37, P1789, DOI 10.2337/dc13-2076; Leelarathna L, 2014, DIABETES CARE, V37, P1931, DOI 10.2337/dc13-2911; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Maahs DM, 2015, DIABETES CARE, V38, pE158, DOI 10.2337/dc15-1096; McGarraugh G, 2009, DIABETES TECHNOL THE, V11, pS17, DOI 10.1089/dia.2008.0133; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; MOLNAR GD, 1972, DIABETOLOGIA, V8, P342, DOI 10.1007/BF01218495; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; O'Riordan SMP, 2014, DIABETIC MED, V31, P36, DOI 10.1111/dme.12285; Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025; Russell SJ, 2016, DIABETES CARE, V39, P1161, DOI 10.2337/dc15-2449; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Russell SJ, 2015, CURR OPIN ENDOCRINOL, V22, P106, DOI 10.1097/MED.0000000000000142; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Russell SJ, 2012, DIABETES CARE, V35, P2148, DOI 10.2337/dc12-0071; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Taleb N, 2017, DIABETES OBES METAB, V19, P13, DOI 10.1111/dom.12789; Tauschmann M, 2016, DIABETES CARE, V39, P1168, DOI 10.2337/dc15-2078; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; van Bon AC, 2014, DIABETES TECHNOL THE, V16, P131, DOI 10.1089/dia.2013.0166; Weinstock RS, 2013, J CLIN ENDOCR METAB, V98, P3411, DOI 10.1210/jc.2013-1589; Willi SM, 2015, PEDIATRICS, V135, P424, DOI 10.1542/peds.2014-1774; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959; Zealand Pharma, DAS ZP4207 MULT DOS	45	129	130	4	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					369	380		10.1016/S0140-6736(16)32567-3	http://dx.doi.org/10.1016/S0140-6736(16)32567-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI9CK	28007348	Green Accepted, Green Submitted			2022-12-28	WOS:000392804700034
J	Sollars, ESA; Harper, AL; Kelly, LJ; Sambles, CM; Ramirez-Gonzalez, RH; Swarbreck, D; Kaithakottil, G; Cooper, ED; Uauy, C; Havlickova, L; Worswick, G; Studholme, DJ; Zohren, J; Salmon, DL; Clavijo, BJ; Li, Y; He, ZS; Fellgett, A; McKinney, LV; Nielsen, LR; Douglas, GC; Kjaer, ED; Downie, JA; Boshier, D; Lee, S; Clark, J; Grant, M; Bancroft, I; Caccamo, M; Buggs, RJA				Sollars, Elizabeth S. A.; Harper, Andrea L.; Kelly, Laura J.; Sambles, Christine M.; Ramirez-Gonzalez, Ricardo H.; Swarbreck, David; Kaithakottil, Gemy; Cooper, Endymion D.; Uauy, Cristobal; Havlickova, Lenka; Worswick, Gemma; Studholme, David J.; Zohren, Jasmin; Salmon, Deborah L.; Clavijo, Bernardo J.; Li, Yi; He, Zhesi; Fellgett, Alison; McKinney, Lea Vig; Nielsen, Lene Rostgaard; Douglas, Gerry C.; Kjaer, Erik Dahl; Downie, J. Allan; Boshier, David; Lee, Steve; Clark, Jo; Grant, Murray; Bancroft, Ian; Caccamo, Mario; Buggs, Richard J. A.			Genome sequence and genetic diversity of European ash trees	NATURE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC ANALYSIS; FRAXINUS-EXCELSIOR; FLOWERING SIGNALS; SPECTROMETRY DATA; PROVIDES INSIGHT; ALIGNMENT; RNA; PROGRAM; ANNOTATION	Ash trees (genus Fraxinus, family Oleaceae) are widespread throughout the Northern Hemisphere, but are being devastated in Europe by the fungus Hymenoscyphus fraxineus, causing ash dieback, and in North America by the herbivorous beetle Agrilus planipennis(1,2). Here we sequence the genome of a low-heterozygosity Fraxinus excelsior tree from Gloucestershire, UK, annotating 38,852 protein-coding genes of which 25% appear ash specific when compared with the genomes of ten other plant species. Analyses of paralogous genes suggest a whole-genome duplication shared with olive (Olea europaea, Oleaceae). We also re-sequence 37 F. excelsior trees from Europe, finding evidence for apparent long-term decline in effective population size. Using our reference sequence, we reanalyse association transcriptomic data(3), yielding improved markers for reduced susceptibility to ash dieback. Surveys of these markers in British populations suggest that reduced susceptibility to ash dieback may be more widespread in Great Britain than in Denmark. We also present evidence that susceptibility of trees to H. fraxineus is associated with their iridoid glycoside levels. This rapid, integrated, multidisciplinary research response to an emerging health threat in a non-model organism opens the way for mitigation of the epidemic.	[Sollars, Elizabeth S. A.; Kelly, Laura J.; Cooper, Endymion D.; Worswick, Gemma; Buggs, Richard J. A.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England; [Sollars, Elizabeth S. A.] QIAGEN Aarhus AS, Silkeborgvej 2, DK-8000 Aarhus C, Denmark; [Harper, Andrea L.; Havlickova, Lenka; Li, Yi; He, Zhesi; Fellgett, Alison; Bancroft, Ian] Univ York, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Sambles, Christine M.; Studholme, David J.; Salmon, Deborah L.; Grant, Murray] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter EX4 4QD, Devon, England; [Ramirez-Gonzalez, Ricardo H.; Swarbreck, David; Kaithakottil, Gemy; Clavijo, Bernardo J.; Caccamo, Mario] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Uauy, Cristobal; Downie, J. Allan] John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [McKinney, Lea Vig; Nielsen, Lene Rostgaard; Kjaer, Erik Dahl] Univ Copenhagen, Dept Geosci & Nat Resource Management, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark; [Worswick, Gemma; Douglas, Gerry C.] Agr & Food Dev Author, Teagasc, Dublin D15 KN3K, Ireland; [Boshier, David] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Lee, Steve] Northern Res Stn, Forest Res, Roslin EH25 9SY, Midlothian, Scotland; [Clark, Jo] Earth Trust Little Wittenham, Abingdon OX14 4QZ, Oxon, England; [Caccamo, Mario] Natl Inst Agr Bot, Cambridge CB3 0LE, England; [Buggs, Richard J. A.] Royal Bot Gardens Kew, Richmond TW9 3AB, Surrey, England; [Grant, Murray] Univ Warwick, Sch Life Sci, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England	University of London; Queen Mary University London; University of York - UK; University of Exeter; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Copenhagen; Teagasc; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Oxford; Royal Botanic Gardens, Kew; University of Warwick	Buggs, RJA (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	r.buggs@qmul.ac.uk	Bancroft, Ian/AAH-3831-2020; Havlickova, Lenka/V-7307-2019; Buggs, Richard J. A./A-9826-2008; Uauy, Cristobal/T-4382-2019; Kjaer, Erik D/D-6534-2017; Ramírez, Ricardo/H-4808-2019; Boshier, David/E-6148-2016; Nielsen, Lene/E-6769-2015	Havlickova, Lenka/0000-0002-5874-8615; Buggs, Richard J. A./0000-0003-4495-3738; Uauy, Cristobal/0000-0002-9814-1770; Kjaer, Erik D/0000-0001-8624-1611; Ramírez, Ricardo/0000-0001-5745-7085; Bancroft, Ian/0000-0001-7707-1171; Nielsen, Lene/0000-0002-7214-8691; Harper, Andrea/0000-0003-3859-1152; Swarbreck, David/0000-0002-5453-1013; Kelly, Laura/0000-0003-1159-939X; Clavijo, Bernardo J./0000-0002-7597-2774; Downie, Allan/0000-0003-1011-4960; Sambles, Christine/0000-0002-7219-0398; Kaithakottil, Gemy/0000-0003-1360-7808	Natural Environment Research Council (NERC) [NE/K01112X/1]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/J/000CA5323]; Department for Environment, Food Rural Affairs; 'Nornex' project; European Diversity Panel - Earlham Institute National Capability in Genomics [BB/J010375/1]; Living with Environmental Change (LWEC) Tree Health and Plant Biosecurity Initiative - Phase 2 grant [BB/L012162/1]; BBSRC; Defra; Economic and Social Research Council; Forestry Commission; NERC; Scottish Government; Teagasc Walsh Fellowship [2014001]; Marie Sklodowska-Curie Individual Fellowship 'FraxiFam' [660003]; Marie Sklodowska-Curie Initial Training Network INTERCROSSING; Norwich Research Park PhD Studentship; Earlham Institute Funding and Maintenance Grant; Engineering and Physical Sciences Research Council [EP/K000128/1]; NERC EOS Cloud; BBSRC [BB/N021452/1]; BBSRC [BB/L012162/1, BBS/E/J/000PR9780, BBS/E/J/000C0628, BBS/E/T/000PR6193, BB/F011652/1, BBS/E/T/000PR5885, BBS/E/J/000CA523] Funding Source: UKRI; EPSRC [EP/K000128/1] Funding Source: UKRI; NERC [NE/K01112X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N021452/1, BB/L012162/1, BB/F011652/1, BBS/E/J/000CA523, BBS/E/T/000PR5885, BBS/E/T/000PR6193, BBS/E/J/000PR9780, BBS/E/J/000C0628] Funding Source: researchfish; Natural Environment Research Council [NE/K01112X/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); 'Nornex' project; European Diversity Panel - Earlham Institute National Capability in Genomics; Living with Environmental Change (LWEC) Tree Health and Plant Biosecurity Initiative - Phase 2 grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Forestry Commission; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Teagasc Walsh Fellowship; Marie Sklodowska-Curie Individual Fellowship 'FraxiFam'; Marie Sklodowska-Curie Initial Training Network INTERCROSSING; Norwich Research Park PhD Studentship; Earlham Institute Funding and Maintenance Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC EOS Cloud; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Eurofins MWG provided a discounted service for Illumina and 454 sequencing of the reference genome, funded by Natural Environment Research Council (NERC) Urgency Grant NE/K01112X/1 to R.J.A.B. The associative transcriptomic and metabolomic work was part of the 'Nornex' project led by J. A. D. funded jointly by the UK Biotechnology and Biological Sciences Research Council (BBSRC) (BBS/E/J/000CA5323) and the Department for Environment, Food & Rural Affairs. The Earlham Institute, Norwich, UK, sequenced 'Tree 35' funded by 'Nornex' and the European Diversity Panel funded by the Earlham Institute National Capability in Genomics (BB/J010375/1) grant. W. Crowther assisted with DNA extractions for the KASP assay; The John Innes Centre contributed KASP analyses. J. F. Miranda assisted with RNA extractions and quantitative PCR with reverse transcription (qRT-PCR) at the University of York. H. V. Florance, N. Smirnoff and the Exeter Metabolomics Facility developed metabolomic methods and ran samples, and T. P. Howard helped with statistics. L.J.K. and R.J.A.B. were partly funded by Living with Environmental Change (LWEC) Tree Health and Plant Biosecurity Initiative - Phase 2 grant BB/L012162/1 to R.J.A.B., S.L. and P. Jepson funded jointly by a grant from the BBSRC, Defra, Economic and Social Research Council, the Forestry Commission, NERC and the Scottish Government, under the Tree Health and Plant Biosecurity Initiative. G.W. was funded by Teagasc Walsh Fellowship 2014001 to R.J.A.B. and G.C.D. E.D.C. was funded by a Marie Sklodowska-Curie Individual Fellowship 'FraxiFam' (grant agreement 660003) to E.D.C. and R.J.A.B. E.S.A.S. and J.Z. were funded by the Marie Sklodowska-Curie Initial Training Network INTERCROSSING. J.A.D. received a John Innes Foundation fellowship. We thank A. Joecker for supervising E. S. A. S. at Qiagen and for helpful discussions. R. H. R. G. is supported by a Norwich Research Park PhD Studentship and Earlham Institute Funding and Maintenance Grant. This research used Queen Mary's MidPlus computational facilities, supported by QMUL Research-IT and funded by Engineering and Physical Sciences Research Council grant EP/K000128/1 and NERC EOS Cloud. D. J. S. acknowledges the support of BBSRC grant BB/N021452/1, which partly supported M. G., C. M. S. and D. J. S. during this work.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2013, SCIENCE, V342, P1241089, DOI [10.1126/science.1241089, DOI 10.1126/SCIENCE.1241089]; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carmona MJ, 1998, PLANTA, V207, P181, DOI 10.1007/s004250050471; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Ding JH, 2016, CURR OPIN PLANT BIOL, V29, P73, DOI 10.1016/j.pbi.2015.11.007; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dorca-Fornell C, 2011, PLANT J, V67, P1006, DOI 10.1111/j.1365-313X.2011.04653.x; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Etherington GJ, 2015, BIOINFORMATICS, V31, P2565, DOI 10.1093/bioinformatics/btv178; Eyles A, 2007, J CHEM ECOL, V33, P1430, DOI 10.1007/s10886-007-9312-3; FRAXIGEN, 2005, ASH SPECIES IN EUROP, P128; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Gupta S. D., 2010, REACTIVE OXYGEN SPEC, V323; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harper AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep19335; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110; Heuertz M, 2006, MOL ECOL, V15, P2131, DOI 10.1111/j.1365-294X.2006.02897.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen SR, 2002, PHYTOCHEMISTRY, V60, P213, DOI 10.1016/S0031-9422(02)00102-4; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; KUBO I, 1985, J CHEM ECOL, V11, P251, DOI 10.1007/BF00988207; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara AJ, 2007, ADV SOFT COMP, V44, P361; Leggett RM, 2014, BIOINFORMATICS, V30, P566, DOI 10.1093/bioinformatics/btt702; Li CM, 2008, RAPID COMMUN MASS SP, V22, P1941, DOI 10.1002/rcm.3579; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mazet O, 2016, HEREDITY, V116, P362, DOI 10.1038/hdy.2015.104; Meglecz E, 2014, MOL ECOL RESOUR, V14, P1302, DOI 10.1111/1755-0998.12271; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Obermayer R, 2002, ANN BOT-LONDON, V90, P209, DOI 10.1093/aob/mcf167; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Poland TM, 2006, J FOREST, V104, P118; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Popescu AA, 2014, GENETICS, V198, P1421, DOI 10.1534/genetics.114.171314; Pritchard JK, 2000, GENETICS, V155, P945; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Ramirez-Gonzalez RH, 2015, BIOINFORMATICS, V31, P2038, DOI 10.1093/bioinformatics/btv069; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Valenta V, 2015, FORESTS, V6, P3075, DOI 10.3390/f6093075; Wang J, 2016, GENETICS, V202, P1185, DOI 10.1534/genetics.115.183152; Wells CE, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0436-2; Wilson DC, 2013, PLANT MOL BIOL, V83, P235, DOI 10.1007/s11103-013-0083-7; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	111	108	110	5	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					212	+		10.1038/nature20786	http://dx.doi.org/10.1038/nature20786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	28024298	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000396125500040
J	Levesque, JF; Sutherland, K				Levesque, Jean-Frederic; Sutherland, Kim			Public Reporting of Mortality Rates for Hospitalized Medicare Patients	ANNALS OF INTERNAL MEDICINE			English	Letter									[Levesque, Jean-Frederic; Sutherland, Kim] Bur Hlth Informat, Chatswood, NSW, Australia		Levesque, JF (corresponding author), Bur Hlth Informat, Chatswood, NSW, Australia.		Levesque, Jean-Frederic/ABH-7122-2020	Levesque, Jean-Frederic/0000-0002-5418-8593				Joynt KE, 2016, ANN INTERN MED, V165, P153, DOI 10.7326/M15-1462	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					75	75		10.7326/L16-0547	http://dx.doi.org/10.7326/L16-0547			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	28030668				2022-12-28	WOS:000391467900013
J	Arnold, BF; Ercumen, A				Arnold, Benjamin F.; Ercumen, Ayse			Negative Control Outcomes A Tool to Detect Bias in Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Arnold, Benjamin F.; Ercumen, Ayse] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, 101 Haviland Hall,MC 7358, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Arnold, BF (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, 101 Haviland Hall,MC 7358, Berkeley, CA 94720 USA.	benarnold@berkeley.edu	Arnold, Benjamin/AAE-9656-2020	Arnold, Benjamin/0000-0001-6105-7295; Ercumen, Ayse/0000-0001-6002-1514	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD078912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI119180] Funding Source: NIH RePORTER; NIAID NIH HHS [K01 AI119180] Funding Source: Medline; NICHD NIH HHS [R01 HD078912] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arnold BF, 2016, EPIDEMIOLOGY, V27, P637, DOI 10.1097/EDE.0000000000000504; Dusetzina SB, 2015, HEALTH SERV RES, V50, P1432, DOI 10.1111/1475-6773.12279; Ercumen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121907; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Roze JC, 2015, JAMA-J AM MED ASSOC, V313, P2441, DOI 10.1001/jama.2015.6734; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	8	28	30	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2597	2598		10.1001/jama.2016.17700	http://dx.doi.org/10.1001/jama.2016.17700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027378	Green Accepted			2022-12-28	WOS:000391110200010
J	Abul-Husn, NS; Manickam, K; Jones, LK; Wright, EA; Hartzel, DN; Gonzaga-Jauregui, C; O'Dushlaine, C; Leader, JB; Kirchner, HL; Lindbuchler, DM; Barr, ML; Giovanni, MA; Ritchie, MD; Overton, JD; Reid, JG; Metpally, RPR; Wardeh, AH; Borecki, IB; Yancopoulos, GD; Baras, A; Shuldiner, AR; Gottesman, O; Ledbetter, DH; Carey, DJ; Dewey, FE; Murray, MF				Abul-Husn, Noura S.; Manickam, Kandamurugu; Jones, Laney K.; Wright, Eric A.; Hartzel, Dustin N.; Gonzaga-Jauregui, Claudia; O'Dushlaine, Colm; Leader, Joseph B.; Kirchner, H. Lester; Lindbuchler, D'Andra M.; Barr, Marci L.; Giovanni, Monica A.; Ritchie, Marylyn D.; Overton, John D.; Reid, Jeffrey G.; Metpally, Raghu P. R.; Wardeh, Amr H.; Borecki, Ingrid B.; Yancopoulos, George D.; Baras, Aris; Shuldiner, Alan R.; Gottesman, Omri; Ledbetter, David H.; Carey, David J.; Dewey, Frederick E.; Murray, Michael F.			Genetic identification of familial hypercholesterolemia within a single US health care system	SCIENCE			English	Article							ASSOCIATION EXPERT PANEL; GENERAL-POPULATION; PREVALENCE; MANAGEMENT; DIAGNOSIS; RECOMMENDATIONS; CHOLESTEROL; VARIANTS; GENOME; GUIDELINES	Familial hypercholesterolemia (FH) remains underdiagnosed despite widespread cholesterol screening. Exome sequencing and electronic health record (EHR) data of 50,726 individuals were used to assess the prevalence and clinical impact of FH-associated genomic variants in the Geisinger Health System. The estimated FH prevalence was 1: 256 in unselected participants and 1: 118 in participants ascertained via the cardiac catheterization laboratory. FH variant carriers had significantly increased risk of coronary artery disease. Only 24% of carriers met EHR-based presequencing criteria for probable or definite FH diagnosis. Active statin use was identified in 58% of carriers; 46% of statin-treated carriers had a low-density lipoprotein cholesterol level below 100 mg/dl. Thus, we find that genomic screening can prompt the diagnosis of FH patients, most of whom are receiving inadequate lipid-lowering therapy.	[Abul-Husn, Noura S.; Gonzaga-Jauregui, Claudia; O'Dushlaine, Colm; Overton, John D.; Reid, Jeffrey G.; Borecki, Ingrid B.; Yancopoulos, George D.; Baras, Aris; Shuldiner, Alan R.; Gottesman, Omri; Dewey, Frederick E.] Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Manickam, Kandamurugu; Jones, Laney K.; Wright, Eric A.; Hartzel, Dustin N.; Leader, Joseph B.; Kirchner, H. Lester; Lindbuchler, D'Andra M.; Barr, Marci L.; Giovanni, Monica A.; Ritchie, Marylyn D.; Metpally, Raghu P. R.; Wardeh, Amr H.; Ledbetter, David H.; Carey, David J.; Murray, Michael F.] Geisinger Hlth Syst, Danville, PA 17822 USA	Regeneron; Geisinger Health System	Murray, MF (corresponding author), Geisinger Hlth Syst, Danville, PA 17822 USA.	mfmurray1@geisinger.edu	Gonzaga-Jauregui, Claudia/H-4752-2019; Girelli, Domenico/B-1183-2008	Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Girelli, Domenico/0000-0001-9684-1899; Shuldiner, Alan/0000-0001-9921-4305; Wright, Eric/0000-0003-1721-4104; Abul-Husn, Noura/0000-0002-5179-1944; Jones, Laney/0000-0002-6182-5634	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	We would like to thank the MyCode Community Health Initiative participants for their permission to use their health and genomics information. We would also like to thank K. Wilemon and K. Myers from the Familial Hypercholesterolemia Foundation for input on the manuscript. The study was funded by Regeneron Pharmaceuticals. In addition to employment by Regeneron Pharmaceuticals, G.D.Y. is a cofounder, member of the board of directors, and stockholder in Regeneron Pharmaceuticals. Pathogenic and predicted pathogenic variants reported in this paper are tabulated in table S2. All variants will be clinically confirmed by the Laboratory of Molecular Medicine (Partners Healthcare) and deposited into ClinVar (www.ncbi.nlm.nih.gov/clinvar/). At the time of publication, 11 of the 35 reported variants had been deposited into ClinVar. Additional information for reproducing and extending the results described in the article is available under a data use agreement with Regeneron Genetics Center LLC and Geisinger Clinic.	Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112; [Anonymous], 1991, BMJ, V303, P893; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Benn M, 2016, EUR HEART J, V37, P1384, DOI 10.1093/eurheartj/ehw028; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Bowen MS, 2012, PUBLIC HEALTH GENOM, V15, P327, DOI 10.1159/000341889; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Chen CX, 2015, INT J CARDIOL, V181, P417, DOI 10.1016/j.ijcard.2014.12.070; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hopkins PN, 2011, J CLIN LIPIDOL, V5, pS9, DOI 10.1016/j.jacl.2011.03.452; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Khoury MJ, 2015, JAMA-J AM MED ASSOC, V313, P2117, DOI 10.1001/jama.2015.3382; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Packer JS, 2016, BIOINFORMATICS, V32, P133, DOI 10.1093/bioinformatics/btv547; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Robinson JG, 2011, J CLIN LIPIDOL, V5, pS18, DOI 10.1016/j.jacl.2011.03.451; Shen HQ, 2010, ARCH INTERN MED, V170, P1850, DOI 10.1001/archinternmed.2010.384; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Staples J, 2014, AM J HUM GENET, V95, P553, DOI 10.1016/j.ajhg.2014.10.005; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tada H, 2014, CIRC-CARDIOVASC GENE, V7, P583, DOI 10.1161/CIRCGENETICS.113.000420; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Troeung L, 2016, HEART, V102, P855, DOI 10.1136/heartjnl-2015-308824; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Vodnala D, 2012, AM J CARDIOL, V110, P823, DOI 10.1016/j.amjcard.2012.04.062; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6; Wonderling David, 2004, Semin Vasc Med, V4, P97; World Health Organization, 1998, FAM HYP REP 2 WHO CO; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	48	238	244	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319							aaf7000	10.1126/science.aaf7000	http://dx.doi.org/10.1126/science.aaf7000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008010				2022-12-28	WOS:000390254300042
J	Servick, K				Servick, Kelly			New blood tests make strides in detecting prion disease	SCIENCE			English	News Item																			0	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1512	1512		10.1126/science.354.6319.1512	http://dx.doi.org/10.1126/science.354.6319.1512			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008016				2022-12-28	WOS:000390254300009
J	Sorenson, O; Assenova, V; Li, GC; Boada, J; Fleming, L				Sorenson, Olav; Assenova, Valentina; Li, Guan-Cheng; Boada, Jason; Fleming, Lee			Expand innovation finance via crowdfunding	SCIENCE			English	Editorial Material									[Sorenson, Olav; Assenova, Valentina] Yale Univ, Sch Management, New Haven, CT 06520 USA; [Li, Guan-Cheng; Boada, Jason; Fleming, Lee] Univ Calif Berkeley, Coll Engn, Fung Inst, Berkeley, CA 94720 USA; [Fleming, Lee] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	Yale University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Sorenson, O (corresponding author), Yale Univ, Sch Management, New Haven, CT 06520 USA.	olav.sorenson@yale.edu	Sorenson, Olav/ABE-5373-2020	Sorenson, Olav/0000-0002-0599-6738; /0000-0002-5637-8139				Guzman J, 2015, SCIENCE, V347, P606, DOI 10.1126/science.aaa0201; Kitchens R., EC DEV J; Krugman P., 1991, GEOGRAPHY TRADE; Rider CI, 2012, ADMIN SCI QUART, V57, P453, DOI 10.1177/0001839212461633; Shane S, 2002, MANAGE SCI, V48, P154, DOI 10.1287/mnsc.48.1.154.14280; Sorenson O, 2001, AM J SOCIOL, V106, P1546, DOI 10.1086/321301; Zacharakis AL, 1998, J BUS VENTURING, V13, P57, DOI 10.1016/S0883-9026(97)00004-9	7	71	72	2	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1526	1528		10.1126/science.aaf6989	http://dx.doi.org/10.1126/science.aaf6989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3VZ	28008025	Green Published			2022-12-28	WOS:000390254300024
J	McQueen, K; Murphy-Oikonen, J				McQueen, Karen; Murphy-Oikonen, Jodie			Neonatal Abstinence Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LENGTH-OF-STAY; SUBLINGUAL BUPRENORPHINE; INCREASING INCIDENCE; METHADONE EXPOSURE; UNITED-STATES; SUBSTANCE USE; USE DISORDER; ROOMING-IN; INFANTS; WITHDRAWAL		[McQueen, Karen] Lakehead Univ, Sch Nursing, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada; [Murphy-Oikonen, Jodie] Lakehead Univ, Sch Social Work, Thunder Bay, ON, Canada	Lakehead University; Lakehead University	McQueen, K (corresponding author), Lakehead Univ, Sch Nursing, 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	kmcqueen@lakeheadu.ca						ACOG Committee on Health Care for Underserved Women, 2012, Obstet Gynecol, V119, P1070, DOI 10.1097/AOG.0b013e318256496e; Ailes Elizabeth C, 2015, MMWR Morb Mortal Wkly Rep, V64, P37; Bagley SM, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-19; Balain M., 2014, INFANT, V10, P9; Bio LL, 2011, J PERINATOL, V31, P692, DOI 10.1038/jp.2011.116; Brogly SB, 2014, AM J EPIDEMIOL, V180, P673, DOI 10.1093/aje/kwu190; Cicero TJ, 2015, NEW ENGL J MED, V373, P1789, DOI 10.1056/NEJMc1505541; Clark L, 2015, MCN-AM J MATERN-CHIL, V40, P87, DOI 10.1097/NMC.0000000000000117; Cleary BJ, 2011, AM J OBSTET GYNECOL, V205, pE11, DOI 10.1016/j.ajog.2011.06.015; Cotten SW, 2012, CLIN LAB MED, V32, P449, DOI 10.1016/j.cll.2012.06.008; D'Apolito KC, 2014, J PERINAT NEONAT NUR, V28, P220, DOI 10.1097/JPN.0000000000000056; Davies H, 2016, ARCH DIS CHILD-FETAL, V101, P26, DOI 10.1136/archdischild-2015-308948; Dow K, 2012, J POPUL THER CLIN PH, V19, pE488; Eichel MM, 2014, NEWBORN INFANT NURS, V14, P17, DOI 10.1053/j.nainr.2013.12.004; Epstein RA, 2013, ANN EPIDEMIOL, V23, P498, DOI 10.1016/j.annepidem.2013.05.017; Farst KJ, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/951616; FINNEGAN LP, 1975, ADDICT DIS, V2, P141; Garcia AM, 2013, J LAW MED ETHICS, V41, P42, DOI 10.1111/jlme.12037; Gawronski KM, 2014, SAGE OPEN MED, V2, DOI 10.1177/2050312114530282; Gomes Tara, 2016, Healthc Q, V18, P8; GREEN M, 1981, AM J DRUG ALCOHOL AB, V8, P203, DOI 10.3109/00952998108999125; Grim K, 2013, CLIN PERINATOL, V40, P509, DOI 10.1016/j.clp.2013.05.004; Hall ES, 2015, J PEDIATR-US, V167, P1221, DOI 10.1016/j.jpeds.2015.09.038; Hall ES, 2014, PEDIATRICS, V134, pE527, DOI 10.1542/peds.2013-4036; Hall ES, 2016, J PEDIAT, V170, pe1; Holmes AV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2929; Hudak ML, 2012, PEDIATRICS, V129, pE540, DOI 10.1542/peds.2011-3212; Jansson LM, 2012, CURR OPIN PEDIATR, V24, P252, DOI 10.1097/MOP.0b013e32834fdc3a; Jansson LM, 2011, PEDIATR REV, V32, P5, DOI 10.1542/pir.32-1-5; Jansson Lauren M, 2009, J Opioid Manag, V5, P47; Jansson LM, 2016, NEONATAL ABSTINENCE; Jones HE, 2016, AM J ADDICTION, V25, P370, DOI 10.1111/ajad.12388; Jones HE, 2015, PREV MED, V80, P12, DOI 10.1016/j.ypmed.2015.07.017; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Jumah NA, 2016, SUBST ABUS-RES TREAT, V10, P35, DOI 10.4137/SART.S34547; Kaltenbach K, 2016, J ADDICT MED, V10, P217, DOI 10.1097/ADM.0000000000000207; Kelly LE, 2015, PEDIATR DRUGS, V17, P151, DOI 10.1007/s40272-014-0096-y; Kocherlakota P, 2014, PEDIATRICS, V134, pE547, DOI 10.1542/peds.2013-3524; Kraft WK, 2016, SEMIN PERINATOL, V40, P203, DOI 10.1053/j.semperi.2015.12.007; Kraft WK, 2011, ADDICTION, V106, P574, DOI 10.1111/j.1360-0443.2010.03170.x; Kramlich D, 2015, MCN-AM J MATERN-CHIL, V40, P320, DOI 10.1097/NMC.0000000000000160; Krans EE, 2016, OBSTET GYNECOL, V128, P4, DOI 10.1097/AOG.0000000000001446; Krans EE, 2015, CLIN OBSTET GYNECOL, V58, P370, DOI 10.1097/GRF.0000000000000098; Lee J, 2015, POPUL HEALTH MANAG, V18, P392, DOI 10.1089/pop.2014.0134; Lefevere J, 2015, ARCH DIS CHILD, V100, P414, DOI 10.1136/archdischild-2015-308275; Lendoiro E, 2013, THER DRUG MONIT, V35, P296, DOI 10.1097/FTD.0b013e318288453f; LIPSITZ PJ, 1975, CLIN PEDIATR, V14, P592, DOI 10.1177/000992287501400613; Liu A, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/935631; Lozano J, 2007, THER DRUG MONIT, V29, P711, DOI 10.1097/FTD.0b013e31815c14ce; MacMullen Nancy J, 2014, Pediatr Nurs, V40, P165; MacMullen NJ, 2014, PEDIAT NURS, V40, P203; Maguire D, 2013, ADV NEONAT CARE, V13, P430, DOI 10.1097/ANC.0000000000000033; McKnight S, 2016, AM J PERINAT, V33, P495, DOI 10.1055/s-0035-1566295; McQueen Karen A, 2011, Adv Neonatal Care, V11, P282, DOI 10.1097/ANC.0b013e318225a30c; Murphy-Oikonen J, 2010, J PERINAT NEONAT NUR, V24, P366, DOI 10.1097/JPN.0b013e3181fa13ea; Narkowicz S, 2013, ENVIRON INT, V54, P141, DOI 10.1016/j.envint.2013.01.011; Newman A, 2015, CAN FAM PHYSICIAN, V61, pE555; Newnam KM, 2014, ADV NEONAT CARE, V14, P181, DOI 10.1097/ANC.0000000000000095; Ng CM, 2015, PHARMACOTHERAPY, V35, P670, DOI 10.1002/phar.1610; O'Donnell M, 2009, PEDIATRICS, V123, pE614, DOI 10.1542/peds.2008-2888; Ohio Children's Hospitals Neonatal Research Consortium, 2013, ENT MORPH METH PROT; Orlando S, 2014, J PERINAT NEONAT NUR, V28, P212, DOI 10.1097/JPN.0000000000000043; Osborn DA, 2010, COCHRANE DB SYST REV, V10; Osborn DA, 2010, COCHRANE DB SYST REV; Patrick SW, 2015, J PERINATOL, V35, P650, DOI 10.1038/jp.2015.36; Patrick SW, 2014, J PERINATOL, V34, P867, DOI 10.1038/jp.2014.114; Patrick SW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2901; Patrick SW, 2015, J PEDIATR-US, V167, P1189, DOI 10.1016/j.jpeds.2015.09.047; Patrick SW, 2015, PEDIATRICS, V135, P842, DOI 10.1542/peds.2014-3299; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Pritham UA, 2012, JOGNN-J OBST GYN NEO, V41, P180, DOI 10.1111/j.1552-6909.2011.01330.x; Reece-Stremtan S, 2015, BREASTFEED MED, V10, P135, DOI 10.1089/bfm.2015.9992; Siu Anita, 2014, J Pediatr Pharmacol Ther, V19, P147, DOI 10.5863/1551-6776-19.3.147; Smirk CL, 2014, ACTA PAEDIATR, V103, P601, DOI 10.1111/apa.12603; Smirk CL, 2014, J PAEDIATR CHILD H, V50, P352, DOI 10.1111/jpc.12513; Stover MW, 2015, SEMIN PERINATOL, V39, P561, DOI 10.1053/j.semperi.2015.08.013; Streetz VN, 2016, ANN PHARMACOTHER, V50, P301, DOI 10.1177/1060028015626438; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Tsai LC, 2016, J HUM LACT, V32, P521, DOI 10.1177/0890334416641909; Uebel H, 2015, PEDIATRICS, V136, pE811, DOI 10.1542/peds.2014-2767; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; Visconti KC, 2015, AM J PERINAT, V32, P27, DOI 10.1055/s-0034-1374817; Wachman EM, 2016, TRANSL PEDIATR, V5, P12, DOI 10.3978/j.issn.2224-4336.2015.12.03; Wachman EM, 2013, JAMA-J AM MED ASSOC, V309, P1821, DOI 10.1001/jama.2013.3411; Wachman EM, 2011, J ADDICT MED, V5, P293, DOI 10.1097/ADM.0b013e3182266a3a; Wachman EM, 2010, BREASTFEED MED, V5, P159, DOI 10.1089/bfm.2009.0079; Warren MD, 2015, MMWR-MORBID MORTAL W, V64, P125; Welle-Strand GK, 2013, ACTA PAEDIATR, V102, P1060, DOI 10.1111/apa.12378; Wexelblatt SL, 2015, J PEDIATR-US, V166, P582, DOI 10.1016/j.jpeds.2014.10.004; Whiteman VE, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/906723; Wiles JR, 2015, J PEDIATR-US, V167, P1214, DOI 10.1016/j.jpeds.2015.08.032; Wiles JR, 2014, J PEDIATR-US, V165, P440, DOI 10.1016/j.jpeds.2014.05.010; Wong S, 2011, J OBSTET GYNAECOL CA, V33, P367, DOI 10.1016/S1701-2163(16)34855-1; Worley J, 2014, J PERINAT NEONAT NUR, V28, P196, DOI 10.1097/JPN.0000000000000039; Yazdy MM, 2015, J PEDIATR GENET, V4, P56, DOI 10.1055/s-0035-1556740; Zahorodny W, 1998, J DEV BEHAV PEDIATR, V19, P89, DOI 10.1097/00004703-199804000-00005	96	182	183	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2468	2479		10.1056/NEJMra1600879	http://dx.doi.org/10.1056/NEJMra1600879			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002715	Bronze			2022-12-28	WOS:000390091500010
J	Feinmann, J				Feinmann, Jane			CHRISTMAS 2016: BEING WELL The BMJ Christmas appeal 2016-17: changing children's lives through cataract surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2016	355								i6650	10.1136/bmj.i6650	http://dx.doi.org/10.1136/bmj.i6650			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JU	27979852				2022-12-28	WOS:000390151500003
J	Pawluk, A; Amrani, N; Zhang, Y; Garcia, B; Hidalgo-Reyes, Y; Lee, JY; Edraki, A; Shah, M; Sontheimer, EJ; Maxwell, KL; Davidson, AR				Pawluk, April; Amrani, Nadia; Zhang, Yan; Garcia, Bianca; Hidalgo-Reyes, Yurima; Lee, Jooyoung; Edraki, Alireza; Shah, Megha; Sontheimer, Erik J.; Maxwell, Karen L.; Davidson, Alan R.			Naturally Occurring Off-Switches for CRISPR-Cas9	CELL			English	Article							PLURIPOTENT STEM-CELLS; NEISSERIA-MENINGITIDIS; CAS SYSTEMS; DNA CLEAVAGE; NUCLEASE SPECIFICITY; HIGH-THROUGHPUT; HUMAN GENOME; GENE DRIVE; DUAL-RNA; CRISPR/CAS9	CRISPR-Cas9 technology would be enhanced by the ability to inhibit Cas9 function spatially, temporally, or conditionally. Previously, we discovered small proteins encoded by bacteriophages that inhibit the CRISPR-Cas systems of their host bacteria. These"anti-CRISPRs'' were specific to type I CRISPR-Cas systems that do not employ the Cas9 protein. We posited that nature would also yield Cas9 inhibitors in response to the evolutionary arms race between bacteriophages and their hosts. Here, we report the discovery of three distinct families of anti-CRISPRs that specifically inhibit the CRISPR-Cas9 system of Neisseria meningitidis. We show that these proteins bind directly to N. meningitidis Cas9 (NmeCas9) and can be used as potent inhibitors of genome editing by this system in human cells. These anti-CRISPR proteins now enable "off-switches'' for CRISPR-Cas9 activity and provide a genetically encodable means to inhibit CRISPR-Cas9 genome editing in eukaryotes.	[Pawluk, April; Shah, Megha; Maxwell, Karen L.; Davidson, Alan R.] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Amrani, Nadia; Zhang, Yan; Lee, Jooyoung; Edraki, Alireza; Sontheimer, Erik J.] Univ Massachusetts, RNA Therapeut Inst, Program Mol Med, Sch Med, 368 Plantat St, Worcester, MA 01605 USA; [Garcia, Bianca; Hidalgo-Reyes, Yurima; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada; [Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University of Toronto	Maxwell, KL; Davidson, AR (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Sontheimer, EJ (corresponding author), Univ Massachusetts, RNA Therapeut Inst, Program Mol Med, Sch Med, 368 Plantat St, Worcester, MA 01605 USA.; Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Maxwell, KL (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	erik.sontheimer@umassmed.edu; karen.maxwell@utoronto.ca; alan.davidson@utoronto.ca	Amrani, Nadia/AAG-7474-2021	Amrani, Nadia/0000-0001-6871-7962; Pawluk, April/0000-0002-6136-2086; Maxwell, Karen/0000-0002-0211-5480; Lee, Jooyoung/0000-0003-4752-3792; Edraki, Alireza/0000-0003-0849-4888; Edraki, Alireza/0000-0003-3113-1233	Canadian Institutes of Health Research Doctoral Award; NIH [K99 GM117268, R01 GM115911]; Canadian Institutes of Health Research grants [MOP-130482, MOP-136845]	Canadian Institutes of Health Research Doctoral Award(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR))	The authors would like to thank Sabrina Stanley for technical assistance. The AnaCas9 expression construct was a generous gift from Lucas Harrington, Enbo Ma, and Jennifer Doudna. We are grateful to David Grunwald and members of his lab for help and advice with fluorescence imaging and to Andrew Franck for help and advice with NmeCas9 purification. We thank Scot Wolfe and Wen Xue for helpful discussions and comments on the manuscript. This work was supported by a Canadian Institutes of Health Research Doctoral Award to A.P., NIH grant K99 GM117268 to Y.Z., NIH grant R01 GM115911 to E.J.S., and Canadian Institutes of Health Research grants to A.R.D. (MOP-130482) and K.L.M. (MOP-136845). E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics. The authors have filed for a patent related to this work.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Duffin PM, 2012, FEMS MICROBIOL LETT, V334, P44, DOI 10.1111/j.1574-6968.2012.02612.x; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Gophna U, 2015, ISME J, V9, P2021, DOI 10.1038/ismej.2015.20; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Touchon M, 2016, ISME J, V10, P2744, DOI 10.1038/ismej.2016.47; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	61	239	255	8	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1829	+		10.1016/j.cell.2016.11.017	http://dx.doi.org/10.1016/j.cell.2016.11.017			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984730	Green Accepted, Bronze			2022-12-28	WOS:000393114700020
J	[Anonymous]				[Anonymous]			From Internal Combustion to Electricity (Reprinted from JAMA, vol 198, pg 1208, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1966, J AMER MED ASSOC, V198, P1208; HOFFMAN GA, 1966, SCI AM, V215, P34, DOI 10.1038/scientificamerican1066-34	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2435	2435		10.1001/jama.2015.17113	http://dx.doi.org/10.1001/jama.2015.17113			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27959987				2022-12-28	WOS:000389884600034
J	Punwani, D; Zhang, Y; Yu, J; Cowan, MJ; Rana, S; Kwan, A; Adhikari, AN; Lizama, CO; Mendelsohn, BA; Fahl, SP; Chellappan, A; Srinivasan, R; Brenner, SE; Wiest, DL; Puck, JM				Punwani, Divya; Zhang, Yong; Yu, Jason; Cowan, Morton J.; Rana, Sadhna; Kwan, Antonia; Adhikari, Aashish N.; Lizama, Carlos O.; Mendelsohn, Bryce A.; Fahl, Shawn P.; Chellappan, Ajithavalli; Srinivasan, Rajgopal; Brenner, Steven E.; Wiest, David L.; Puck, Jennifer M.			Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELL; GENE-EXPRESSION; HUMAN-DISEASE; ZEBRAFISH; MUTATIONS; ACTIVATION; MIGRATION	BACKGROUND Severe combined immunodeficiency (SCID) is characterized by arrested T-lymphocyte production and by B-lymphocyte dysfunction, which result in life-threatening infections. Early diagnosis of SCID through population-based screening of newborns can aid clinical management and help improve outcomes; it also permits the identification of previously unknown factors that are essential for lymphocyte development in humans. METHODS SCID was detected in a newborn before the onset of infections by means of screening of T-cell-receptor excision circles, a biomarker for thymic output. On confirmation of the condition, the affected infant was treated with allogeneic hematopoietic stem-cell transplantation. Exome sequencing in the patient and parents was followed by functional analysis of a prioritized candidate gene with the use of human hematopoietic stem cells and zebrafish embryos. RESULTS The infant had "leaky" SCID (i.e., a form of SCID in which a minimal degree of immune function is preserved), as well as craniofacial and dermal abnormalities and the absence of a corpus callosum; his immune deficit was fully corrected by hematopoietic stem-cell transplantation. Exome sequencing revealed a heterozygous de novo missense mutation, p.N441K, in BCL11B. The resulting BCL11B protein had dominant negative activity, which abrogated the ability of wild-type BCL11B to bind DNA, thereby arresting development of the T-cell lineage and disrupting hematopoietic stem-cell migration; this revealed a previously unknown function of BCL11B. The patient's abnormalities, when recapitulated in bcl11ba-deficient zebrafish, were reversed by ectopic expression of functionally intact human BCL11B but not mutant human BCL11B. CONCLUSIONS Newborn screening facilitated the identification and treatment of a previously unknown cause of human SCID. Coupling exome sequencing with an evaluation of candidate genes in human hematopoietic stem cells and in zebrafish revealed that a constitutional BCL11B mutation caused human multisystem anomalies with SCID and also revealed a prethymic role for BCL11B in hematopoietic progenitors. (Funded by the National Institutes of Health and others.)	[Punwani, Divya; Yu, Jason; Cowan, Morton J.; Kwan, Antonia; Mendelsohn, Bryce A.; Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Punwani, Divya; Yu, Jason; Cowan, Morton J.; Kwan, Antonia; Mendelsohn, Bryce A.; Puck, Jennifer M.] UCSF Benioff Childrens Hosp, San Francisco, CA USA; [Lizama, Carlos O.] UCSF, Cardiovasc Res Inst, San Francisco, CA USA; [Adhikari, Aashish N.; Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Zhang, Yong; Fahl, Shawn P.; Wiest, David L.] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Rana, Sadhna; Chellappan, Ajithavalli; Srinivasan, Rajgopal] Tata Consultancy Serv, Innovat Labs, Hyderabad, Telangana, India	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Fox Chase Cancer Center; Tata Sons; Tata Consultancy Services Limited (TCS)	Puck, JM (corresponding author), UCSF Smith Cardiovasc Res Inst, 555 Mission Bay Blvd S,Rm SC 252K, San Francisco, CA 94143 USA.	jennifer.puck@ucsf.edu	Fahl, Shawn/ABC-9986-2021; Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185; Wiest, David/0000-0002-0792-3188; Fahl, Shawn/0000-0002-0489-2048; Lizama, Carlos/0000-0002-0471-8525	National Institutes of Health (NIH) [P30 CA006927, R01 AI105776, R01 AI078248, R21 AI111208, U54 AI082973]; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases [NIAID]; M.D. Anderson Cancer Center (Leukemia SPORE grant) [CA100632]; Fox Chase Cancer Center; Tata Consultancy Services; NIAID [R01 AI105776]; Jeffrey Modell Foundation; Lisa and Douglas Goldman Fund; Michelle Platt-Ross Foundation; NATIONAL CANCER INSTITUTE [P30CA006927, P50CA100632, T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078248, R13AI094943, R01AI105776, R21AI111208, U54AI082973] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Allergy and Infectious Diseases [NIAID](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); M.D. Anderson Cancer Center (Leukemia SPORE grant); Fox Chase Cancer Center; Tata Consultancy Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jeffrey Modell Foundation; Lisa and Douglas Goldman Fund; Michelle Platt-Ross Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health (NIH) (core grant P30 CA006927 to Dr. Wiest; grant R01 AI105776 to Drs. Puck and Brenner; grant R01 AI078248 to Dr. Puck; and R21 AI111208 to Drs. Wiest and Puck; and grant U54 AI082973 to Drs. Puck and Cowan for the Primary Immune Deficiency Treatment Consortium, a part of the Rare Diseases Clinical Research Network, an initiative of the NIH Office of Rare Diseases Research, funded through collaboration between the National Center for Advancing Translational Sciences and the National Institute of Allergy and Infectious Diseases [NIAID]); an appropriation from the Commonwealth of Pennsylvania (to Dr. Wiest); the M.D. Anderson Cancer Center (Leukemia SPORE grant CA100632 to Dr. Zhang); the Fox Chase Cancer Center (William J. Avery fellowship to Dr. Zhang); Tata Consultancy Services (support to Dr. Brenner); NIAID (grant R01 AI105776 to Dr. Brenner); and the Jeffrey Modell Foundation, the Lisa and Douglas Goldman Fund, and the Michelle Platt-Ross Foundation (support to Dr. Puck).	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Avram D, 2014, J IMMUNOL, V193, P2059, DOI 10.4049/jimmunol.1400930; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Baranek C, 2012, P NATL ACAD SCI USA, V109, P3546, DOI 10.1073/pnas.1108718109; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Cismasiu VB, 2006, BLOOD, V108, P2695, DOI 10.1182/blood-2006-05-021790; Cismasiu VB, 2009, BIOCHEM J, V417, P457, DOI 10.1042/BJ20080925; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Holmes G, 2015, GENE EXPR PATTERNS, V17, P16, DOI 10.1016/j.gep.2014.12.001; Kominami R, 2012, P JPN ACAD B-PHYS, V88, P72, DOI 10.2183/pjab.88.72; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Langenau DM, 2005, NAT REV IMMUNOL, V5, P307, DOI 10.1038/nri1590; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Mallott J, 2013, J CLIN IMMUNOL, V33, P540, DOI 10.1007/s10875-012-9846-1; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neumann M, 2015, ONCOTARGET, V6, P2754, DOI 10.18632/oncotarget.2218; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Patel JP, 2015, J CLIN IMMUNOL, V35, P227, DOI 10.1007/s10875-015-0136-6; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Sarzotti M, 2003, J IMMUNOL, V170, P2711, DOI 10.4049/jimmunol.170.5.2711; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Verbsky JW, 2012, J CLIN IMMUNOL, V32, P82, DOI 10.1007/s10875-011-9609-4; Vilboux T, 2013, NEW ENGL J MED, V369, P54, DOI 10.1056/NEJMoa1301296; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zlotoff DA, 2011, ANN NY ACAD SCI, V1217, P122, DOI 10.1111/j.1749-6632.2010.05881.x	34	59	61	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2165	2176		10.1056/NEJMoa1509164	http://dx.doi.org/10.1056/NEJMoa1509164			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED7GN	27959755	Green Accepted, Bronze			2022-12-28	WOS:000389030400008
J	Wasfy, JH; Zigler, CM; Choirat, C; Wang, Y; Dominici, F; Yeh, RW				Wasfy, Jason H.; Zigler, Corwin Matthew; Choirat, Christine; Wang, Yun; Dominici, Francesca; Yeh, Robert W.			Readmission Rates After Passage of the Hospital Readmissions Reduction Program	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; 30-DAY MORTALITY-RATES; MEDICARE BENEFICIARIES; HEART-FAILURE; PERFORMANCE; OUTCOMES; ENGLAND; PAY	Background: Whether hospitals with the highest riskstandardized readmission rates (RSRRs) subsequently experienced the greatest improvement after passage of the Medicare Hospital Readmissions Reduction Program (HRRP) is unknown. Objective: To evaluate whether passage of the HRRP was followed by acceleration in improvement in 30-day RSRRs after hospitalizations for acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia and whether the lowestperforming hospitals had faster acceleration in improvement after passage of the law than hospitals that were already performing well. Design: Pre-post analysis stratified by hospital performance groups. Setting: U.S. acute care hospitals. Patients: 15 170 008 Medicare patients discharged alive from 2000 to 2013. Intervention: Passage of the HRRP. Measurements: 30-day readmission rates after hospitalization for AMI, CHF, or pneumonia for hospitals in the highestperformance (0% penalty), average-performance (>0% and <0.50% penalty), low-performance (>= 0.50% and <0.99% penalty), and lowest-performance (>= 0.99% penalty) groups. Results: Of 2868 hospitals serving 1 109 530 Medicare discharges annually, 30.1% were highest performers, 44.0% were average performers, 16.8% were low performers, and 9.0% were lowest performers. After controlling for prelaw trends, an additional 67.6 (95% CI, 66.6 to 68.4), 74.8 (CI, 74.0 to 75.4), 85.4 (CI, 84.0 to 86.8), and 95.1 (CI, 92.6 to 97.5) readmissions per 10 000 discharges were found to have been averted per year in the highest-, average-, low-, and lowest-performance groups, respectively, after passage of the law. Limitation: Inability to distinguish between improvement caused by the magnitude of the penalty or by different levels of health improvement in different patient populations. Conclusion: After passage of the HRRP, 30-day RSRRs for myocardial infarction, heart failure, and pneumonia decreased more rapidly than before the law's passage. Improvement was most marked for hospitals with the lowest prelaw performance.	[Wasfy, Jason H.] Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA; [Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Off Dean, 655 Huntington Ave, Boston, MA 02115 USA; [Yeh, Robert W.] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave, Boston, MA 02215 USA; [Zigler, Corwin Matthew; Choirat, Christine; Wang, Yun; Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Dominici, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Off Dean, 655 Huntington Ave, Boston, MA 02115 USA.; Yeh, RW (corresponding author), Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, 375 Longwood Ave, Boston, MA 02215 USA.; Dominici, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	jwasfy@mgh.harvard.edu	Yeh, Robert/AAJ-3463-2020; Hug, Balthasar L./G-1568-2010	Choirat, Christine/0000-0002-3745-9718	National Institutes of Health; NATIONAL CANCER INSTITUTE [R35CA197449, P01CA134294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012054, R01ES024332, R21ES022585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health.	Barnett ML, 2015, JAMA INTERN MED, V175, P1803, DOI 10.1001/jamainternmed.2015.4660; Barr CD, 2012, AM J EPIDEMIOL, V176, P642, DOI 10.1093/aje/kws267; Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Berkowitz SA, 2013, J HOSP MED, V8, P639, DOI 10.1002/jhm.2074; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare Medicaid Services, 2016, READM RED PROGR; Cuellar AE, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.6.77; Department of Health and Human Services, 2014, HHS DAT SHOWS MAJ ST; French B, 2008, STAT MED, V27, P5005, DOI 10.1002/sim.3340; Himmelstein D., 2015, HLTH AFFAIRS BLOG; James J., 2013, HLTH AFFAIRS BLOG; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Khullar D, 2015, NEW ENGL J MED, V372, P2281, DOI 10.1056/NEJMp1502312; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Pope GC., 2000, DIAGNOSTIC COST GROU; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Rosetta L, 2009, SALT LAKE TRIBU 0709; Soumerai SB, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150187; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Zigler CM, 2014, AM J EPIDEMIOL, V180, P1133, DOI 10.1093/aje/kwu263; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	25	124	124	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 7	2017	166	5					324	+		10.7326/M16-0185	http://dx.doi.org/10.7326/M16-0185			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO1BO	28024302	Green Accepted			2022-12-28	WOS:000396432800005
J	Grobusch, MP; Goorhuis, A				Grobusch, Martin P.; Goorhuis, Abraham			Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine	LANCET			English	Editorial Material									[Grobusch, Martin P.; Goorhuis, Abraham] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, NL-1100 DE Amsterdam, Netherlands; [Grobusch, Martin P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Grobusch, Martin P.; Goorhuis, Abraham] Lion Heart Med Res Unit, Yele, Sierra Leone	University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen	Grobusch, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, NL-1100 DE Amsterdam, Netherlands.; Grobusch, MP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.; Grobusch, MP (corresponding author), Lion Heart Med Res Unit, Yele, Sierra Leone.	m.p.grobusch@amc.uva.nl	Kuijper, ed/AAB-7853-2022	Kuijper, ed/0000-0001-5726-2405; Goorhuis, Abraham/0000-0001-7423-6217				Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Enria L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3799-x; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1; Lanini S, 2015, LANCET INFECT DIS, V15, P738, DOI 10.1016/S1473-3099(15)70106-4; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Medaglini D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3106; Moekotte AL, 2016, EXPERT OPIN INV DRUG, V25, P1325, DOI 10.1080/13543784.2016.1240785; Wang YX, 2017, HUM VACC IMMUNOTHER, V13, P153, DOI 10.1080/21645515.2016.1225637; Zhu FC, 2016, LANCET; Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0	12	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 11	2017	389	10069					578	580		10.1016/S0140-6736(16)32619-8	http://dx.doi.org/10.1016/S0140-6736(16)32619-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9AF	28017405	Bronze			2022-12-28	WOS:000394910800006
J	Wong, BW; Wang, XW; Zecchin, A; Thienpont, B; Cornelissen, I; Kalucka, J; Garcia-Caballero, M; Missiaen, R; Huang, HL; Burning, U; Blacher, S; Vinckier, S; Goveia, J; Knobloch, M; Zhao, H; Dierkes, C; Shi, CY; Hagerling, R; Moral-Darde, V; Wyns, S; Lippens, M; Jessberger, S; Fendt, SM; Luttun, A; Noel, A; Kiefer, F; Ghesquiere, B; Moons, L; Schoonjans, L; Dewerchin, M; Eelen, G; Lambrechts, D; Carmeliet, P				Wong, Brian W.; Wang, Xingwu; Zecchin, Annalisa; Thienpont, Bernard; Cornelissen, Ivo; Kalucka, Joanna; Garcia-Caballero, Melissa; Missiaen, Rindert; Huang, Hongling; Burning, Ulrike; Blacher, Silvia; Vinckier, Stefan; Goveia, Jermaine; Knobloch, Marlen; Zhao, Hui; Dierkes, Cathrin; Shi, Chenyan; Haegerling, Rene; Moral-Darde, Veronica; Wyns, Sabine; Lippens, Martin; Jessberger, Sebastian; Fendt, Sarah-Maria; Luttun, Aernout; Noel, Agnes; Kiefer, Friedemann; Ghesquiere, Bart; Moons, Lieve; Schoonjans, Luc; Dewerchin, Mieke; Eelen, Guy; Lambrechts, Diether; Carmeliet, Peter			The role of fatty acid beta-oxidation in lymphangiogenesis	NATURE			English	Article							ENDOTHELIAL-CELLS; LYMPHATIC VASCULATURE; HISTONE H3; IDENTITY; PROX1; TUMOR; GENE; MAINTENANCE; INHIBITION; METABOLISM	Lymphatic vessels are lined by lymphatic endothelial cells (LECs), and are critical for health. However, the role of metabolism in lymphatic development has not yet been elucidated. Here we report that in transgenic mouse models, LEC-specific loss of CPT1A, a rate-controlling enzyme in fatty acid beta-oxidation, impairs lymphatic development. LECs use fatty acid beta-oxidation to proliferate and for epigenetic regulation of lymphatic marker expression during LEC differentiation. Mechanistically, the transcription factor PROX1 upregulates CPT1A expression, which increases acetyl coenzyme A production dependent on fatty acid beta-oxidation. Acetyl coenzyme A is used by the histone acetyltransferase p300 to acetylate histones at lymphangiogenic genes. PROX1-p300 interaction facilitates preferential histone acetylation at PROX1-target genes. Through this metabolism-dependent mechanism, PROX1 mediates epigenetic changes that promote lymphangiogenesis. Notably, blockade of CPT1 enzymes inhibits injury-induced lymphangiogenesis, and replenishing acetyl coenzyme A by supplementing acetate rescues this process in vivo.	[Wong, Brian W.; Wang, Xingwu; Zecchin, Annalisa; Cornelissen, Ivo; Kalucka, Joanna; Missiaen, Rindert; Huang, Hongling; Burning, Ulrike; Vinckier, Stefan; Goveia, Jermaine; Shi, Chenyan; Moral-Darde, Veronica; Wyns, Sabine; Lippens, Martin; Moons, Lieve; Schoonjans, Luc; Dewerchin, Mieke; Eelen, Guy; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium; [Wong, Brian W.; Wang, Xingwu; Zecchin, Annalisa; Cornelissen, Ivo; Kalucka, Joanna; Missiaen, Rindert; Huang, Hongling; Burning, Ulrike; Vinckier, Stefan; Goveia, Jermaine; Shi, Chenyan; Moral-Darde, Veronica; Wyns, Sabine; Lippens, Martin; Schoonjans, Luc; Dewerchin, Mieke; Eelen, Guy; Carmeliet, Peter] VIB, VIB Vesalius Res Ctr, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium; [Thienpont, Bernard; Zhao, Hui; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Thienpont, Bernard; Zhao, Hui; Lambrechts, Diether] VIB, VIB Vesalius Res Ctr, Lab Translat Genet, B-3000 Leuven, Belgium; [Garcia-Caballero, Melissa] Univ Liege, GIGA Canc, Lab Biol Tumor & Dev, B-4000 Liege, Belgium; [Jessberger, Sebastian] Univ Zurich, Brain Res Inst, Fac Med & Sci, CH-8057 Zurich, Switzerland; [Dierkes, Cathrin; Haegerling, Rene; Kiefer, Friedemann] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Mammalian Cell Signaling Lab, D-48161 Munster, Germany; [Moral-Darde, Veronica] VIB, VIB Vesalius Res Ctr, Metabol Core Facil, B-3000 Leuven, Belgium; [Fendt, Sarah-Maria] VIB, VIB Vesalius Res Ctr, Lab Cellular Metab & Metab Regulat, B-3000 Leuven, Belgium; [Fendt, Sarah-Maria] Katholieke Univ Leuven, Dept Oncol, Lab Cellular Metab & Metab Regulat, B-3000 Leuven, Belgium; [Fendt, Sarah-Maria] Leuven Canc Inst LKI, B-3000 Leuven, Belgium; [Luttun, Aernout] Katholieke Univ Leuven, Dept Cardiovasc Sci, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Lab Neural Circuit Dev & Regenerat, B-3000 Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); University of Liege; University of Zurich; Max Planck Society; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium.	peter.carmeliet@vib-kuleuven.be	Luttun, Aernout/AAZ-6540-2020; Shi, Chenyan/H-7436-2018; Ghesquiere, Bart/HGU-8736-2022; García-Caballero, Melissa/A-6978-2018; Jessberger, Sebastian/AAJ-4032-2020; Thienpont, Bernard/AAG-5423-2019; Knobloch, Marlen/A-9565-2015; Wong, Brian/B-6168-2009; Darde, Veronica Moral/Y-4214-2018; Lambrechts, Diether/AAJ-3167-2020; Carmeliet, Peter/AAQ-5140-2020	Luttun, Aernout/0000-0001-7902-9524; Shi, Chenyan/0000-0002-1898-4170; Ghesquiere, Bart/0000-0003-1547-1705; García-Caballero, Melissa/0000-0002-4263-5536; Knobloch, Marlen/0000-0002-7490-0285; Wong, Brian/0000-0001-8447-3064; Darde, Veronica Moral/0000-0001-6425-1851; Lambrechts, Diether/0000-0002-3429-302X; Carmeliet, Peter/0000-0001-7961-1821; Noel, Agnes/0000-0002-7670-6179; Kalucka, Joanna/0000-0003-4887-7672; Fendt, Sarah-Maria/0000-0001-6018-9296; Kiefer, Friedemann/0000-0002-3002-8237; Jessberger, Sebastian/0000-0002-0056-8275; Thienpont, Bernard/0000-0002-8772-6845; Hagerling, Rene/0000-0002-6830-2043; Moons, Lieve (Godelieve)/0000-0003-0186-1411	FWO; fellowship from Marie Curie; EMBO; LERN/FDRS; IUAP [P7/03]; Flemish Government; FWO [G.0598.12, G.0532.10, G.0817.11, G.0834.13, 1.5.202.10.N Krediet aan navorsers]; Leducq Transatlantic Network Artemis; AXA Research Fund [1465]; Foundation against Cancer; ERC [EU-ERC269073, IMAGINED-201293]; German Research Foundation (D.F.G.) [CRC629, CRC656]; KU Leuven Methusalem	FWO(FWO); fellowship from Marie Curie; EMBO(European Molecular Biology Organization (EMBO)); LERN/FDRS; IUAP; Flemish Government(European Commission); FWO(FWO); Leducq Transatlantic Network Artemis(Leducq Foundation); AXA Research Fund(AXA Research Fund); Foundation against Cancer; ERC(European Research Council (ERC)European Commission); German Research Foundation (D.F.G.)(German Research Foundation (DFG)); KU Leuven Methusalem(KU Leuven)	We thank R. Adams and T. Makinen for providing the VE-cadherin(PAC)-cre<SUP>ERT2</SUP> and Prox1-cre<SUP>ERT2</SUP> mice, respectively. This work was supported by: fellowships from FWO (to B.W.W., X.W., B.T., J.K., R.M., U.B., J.G., B.G.), Marie Curie (to B.W.W., M.G., U.B.), EMBO (to H.H.) and LE&RN/FDRS (A.Z.); and supporting grants from IUAP P7/03 (P.C.), Methusalem funding by the Flemish Government (P.C.), FWO (G.0598.12, G.0532.10, G.0817.11, G.0834.13, 1.5.202.10.N Krediet aan navorsers, to P.C.), Leducq Transatlantic Network Artemis (P.C.), AXA Research Fund (1465, to P.C.), Foundation against Cancer (P.C.), ERC Advanced Research Grant (EU-ERC269073, to P.C.), ERC Starting Grant (IMAGINED-201293, to A.L.), German Research Foundation (D.F.G.) Grants (CRC629, CRC656, to F.K.), and co-funding by KU Leuven Methusalem (S.M.F.). We would like to thank A. Bouche, A. Carton, A. Manderveld, K. Peeters, N. Dai, J. Souffreau, A. van Nuffelen, B. Tembuyser, A. Van Den Eynde, S. Christen, K. Feyen, W. Martens, K. Brepoels, P.J. Coolen, M. Nijs, P. Vanwesemael, B. Verherstraeten, G. Dubois, E. Van Dyck, E. Gils, B. Vanwetswinkel, D. Smeets, G. Peuteman, T. Van Brussel, B. Boeckx, A. Acosta Sanchez and D. Verdegem for their technical assistance, and various laboratory members for their feedback and discussions. We thank S. Aerts, H. Gerhardt and M. Mazzone for critical suggestions and discussions.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Aranguren XL, 2013, J CELL SCI, V126, P1164, DOI 10.1242/jcs.116293; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; Basu SS, 2012, NAT PROTOC, V7, P1, DOI 10.1038/nprot.2011.421; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Blacher S, 2009, EXP EYE RES, V89, P274, DOI 10.1016/j.exer.2009.02.021; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Hirashima M, 2008, DEV BIOL, V316, P149, DOI 10.1016/j.ydbio.2008.01.023; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Ichise T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051639; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lin FJ, 2010, J CLIN INVEST, V120, P1694, DOI 10.1172/JCI40101; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Mouta-Bellum C, 2009, DEV DYNAM, V238, P2670, DOI 10.1002/dvdy.22078; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2014, GENE DEV, V28, P2175, DOI 10.1101/gad.216226.113; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Stanczuk L., 2015, CELL REP; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Xu YM, 2014, PROTEOMICS, V14, P2047, DOI 10.1002/pmic.201300435; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	178	183	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 2	2017	542	7639					49	+		10.1038/nature21028	http://dx.doi.org/10.1038/nature21028			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6MY	28024299	Green Accepted			2022-12-28	WOS:000396119300030
J	Beck, LE; Raj, A				Beck, Lauren E.; Raj, Arjun			SYSTEMS BIOLOGY Molecular memoirs of a cellular family	NATURE			English	Editorial Material							CAENORHABDITIS-ELEGANS; NEMATODE		[Beck, Lauren E.; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Beck, LE (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	labeck@seas.upenn.edu; arjunraj@seas.upenn.edu		Raj, Arjun/0000-0002-2915-6960				Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4	11	2	2	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					38	39		10.1038/nature21101	http://dx.doi.org/10.1038/nature21101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN6NA	27974796				2022-12-28	WOS:000396119500024
J	Dai, XH; Li, ZH; Lai, M; Shu, S; Du, YS; Zhou, ZH; Sun, R				Dai, Xinghong; Li, Zhihai; Lai, Mason; Shu, Sara; Du, Yushen; Zhou, Z. Hong; Sun, Ren			In situ structures of the genome and genome-delivery apparatus in a single-stranded RNA virus	NATURE			English	Article							PHAGE R17 INFECTION; F-PILI; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; PARTICLE; COMPLEX; BACTERIOPHAGE-MS2; INJECTION; SYSTEM	Packaging of the genome into a protein capsid and its subsequent delivery into a host cell are two fundamental processes in the life cycle of a virus. Unlike double-stranded DNA viruses, which pump their genome into a preformed capsid(1-3), single-stranded RNA (ssRNA) viruses, such as bacteriophage MS2, co-assemble their capsid with the genome(4-7); however, the structural basis of this co-assembly is poorly understood. MS2 infects Escherichia coli via the host 'sex pilus' (F-pilus) 8; it was the first fully sequenced organism(9) and is a model system for studies of translational gene regulation(10,11), RNA-protein interactions(12-14), and RNA virus assembly(15-17). Its positive-sense ssRNA genome of 3,569 bases is enclosed in a capsid with one maturation protein monomer and 89 coat protein dimers arranged in a T = 3 icosahedral lattice(18,19). The maturation protein is responsible for attaching the virus to an F-pilus and delivering the viral genome into the host during infection(8), but how the genome is organized and delivered is not known. Here we describe the MS2 structure at 3.6 angstrom resolution, determined by electron-counting cryo-electron microscopy (cryoEM) and asymmetric reconstruction. We traced approximately 80% of the backbone of the viral genome, built atomic models for 16 RNA stem-loops, and identified three conserved motifs of RNA-coat protein interactions among 15 of these stem-loops with diverse sequences. The stem-loop at the 3' end of the genome interacts extensively with the maturation protein, which, with just a six-helix bundle and a six-stranded beta-sheet, forms a genome-delivery apparatus and joins 89 coat protein dimers to form a capsid. This atomic description of genome-capsid interactions in a spherical ssRNA virus provides insight into genome delivery via the host sex pilus and mechanisms underlying ssRNA-capsid co-assembly, and inspires speculation about the links between nucleoprotein complexes and the origins of viruses.	[Dai, Xinghong; Shu, Sara; Du, Yushen; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Dai, Xinghong; Li, Zhihai; Zhou, Z. Hong; Sun, Ren] Univ Calif Los Angeles, CNSI, Los Angeles, CA 90095 USA; [Li, Zhihai; Lai, Mason; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Li, Zhihai] Xiamen Univ, Sch Life Sci, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen 361102, Fujian, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Xiamen University	Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Zhou, ZH; Sun, R (corresponding author), Univ Calif Los Angeles, CNSI, Los Angeles, CA 90095 USA.	Hong.Zhou@UCLA.edu; RSun@mednet.ucla.edu	Zhou, Z Hong/HDN-0747-2022	Dai, Xinghong/0000-0002-4102-3175; Shu, Sara/0000-0002-7419-7251	National Institutes of Health [GM071940, DE025567, DE023591, CA177322, AI094386]; National Science Foundation [DMR-1548924]; UCLA; NIH [1S10OD018111, 1U24GM116792]; NSF [DBI-1338135]; China Scholarship Council; NATIONAL CANCER INSTITUTE [P01CA177322] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025567, R01DE023591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U24GM116792, R01GM071940] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported in part by grants from the National Institutes of Health (GM071940, DE025567, DE023591, CA177322 and AI094386) and National Science Foundation (DMR-1548924). We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines (supported by UCLA and by instrumentation grants from the NIH (1S10OD018111, 1U24GM116792) and NSF (DBI-1338135)). X.D. and Z.L. were supported in part by fellowships from the China Scholarship Council. We appreciate critical reading of the manuscript by F. Guo.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basnak G, 2010, J MOL BIOL, V395, P924, DOI 10.1016/j.jmb.2009.11.018; Borodavka A, 2012, P NATL ACAD SCI USA, V109, P15769, DOI 10.1073/pnas.1204357109; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Clarke M, 2008, P NATL ACAD SCI USA, V105, P17978, DOI 10.1073/pnas.0806786105; Convery MA, 1998, NAT STRUCT BIOL, V5, P133, DOI 10.1038/nsb0298-133; DANZIGER RE, 1970, VIROLOGY, V40, P554, DOI 10.1016/0042-6822(70)90199-6; Dent KC, 2013, STRUCTURE, V21, P1225, DOI 10.1016/j.str.2013.05.012; Dykeman EC, 2013, J MOL BIOL, V425, P3235, DOI 10.1016/j.jmb.2013.06.005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FIERS W, 1976, NATURE, V260, P500, DOI 10.1038/260500a0; GOLMOHAMMADI R, 1993, J MOL BIOL, V234, P620, DOI 10.1006/jmbi.1993.1616; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Horn WT, 2006, STRUCTURE, V14, P487, DOI 10.1016/j.str.2005.12.006; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Klug A, 1999, PHILOS T ROY SOC B, V354, P531, DOI 10.1098/rstb.1999.0404; KOZAK M, 1971, NATURE-NEW BIOL, V234, P209, DOI 10.1038/newbio234209a0; KRAHN PM, 1972, VIROLOGY, V47, P628, DOI 10.1016/0042-6822(72)90552-1; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Liu HR, 2015, SCIENCE, V349, P1347, DOI 10.1126/science.aaa4938; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Patel N, 2015, P NATL ACAD SCI USA, V112, P2227, DOI 10.1073/pnas.1420812112; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plevka P, 2008, PROTEIN SCI, V17, P1731, DOI 10.1110/ps.036905.108; Poot RA, 1997, P NATL ACAD SCI USA, V94, P10110, DOI 10.1073/pnas.94.19.10110; Rolfsson O, 2016, J MOL BIOL, V428, P431, DOI 10.1016/j.jmb.2015.11.014; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rowsell S, 1998, NAT STRUCT BIOL, V5, P970, DOI 10.1038/2946; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHMIDT BF, 1987, J MOL BIOL, V195, P505, DOI 10.1016/0022-2836(87)90179-3; SHIBA T, 1975, NATURE, V254, P157, DOI 10.1038/254157a0; SILVERMAN PM, 1969, J GEN VIROL, V4, P111, DOI 10.1099/0022-1317-4-1-111; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Toropova K, 2011, J MOL BIOL, V408, P408, DOI 10.1016/j.jmb.2011.02.040; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; VALENTINE RC, 1965, SCIENCE, V148, P511, DOI 10.1126/science.148.3669.511; WITHERELL GW, 1991, PROG NUCLEIC ACID RE, V40, P185; Zhang X, 2015, NATURE, V527, P531, DOI 10.1038/nature15767	47	91	91	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 5	2017	541	7635					112	+		10.1038/nature20589	http://dx.doi.org/10.1038/nature20589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6NA	27992877	Green Accepted, Green Submitted			2022-12-28	WOS:000396119500040
J	Zenilman, ME				Zenilman, Michael E.			Delirium: An Important Postoperative Complication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGERY	IMPORTANCE Major postoperative complications and delirium contribute independently to adverse outcomes and high resource use in patients who undergo major surgery; however, their interrelationship is not well examined. OBJECTIVE To evaluate the association of major postoperative complications and delirium, alone and combined, with adverse outcomes after surgery. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study in 2 large academic medical centers of 566 patients who were 70 years or older without recognized dementia or a history of delirium and underwent elective major orthopedic, vascular, or abdominal surgical procedures with a minimum 3-day hospitalization between June 18, 2010, and August 8, 2013. Data analysis took place from December 13,2013, through May 1,2015. MAIN OUTCOMES AND MEASURES Major postoperative complications, defined as life-altering or life-threatening events (Accordion Severity grade 2 or higher), were identified by expert-panel adjudication. Delirium was measured daily with the Confusion Assessment Method and a validated medical record review method. The following 4 subgroups were analyzed: (1) no complications or delirium; (2) complications only; (3) delirium only; and (4) complications and delirium. Adverse outcomes included a length of stay (LOS) of more than 5 days, institutional discharge, and rehospitalization within 30 days of discharge. RESULTS In the 566 participants, the mean (SD) age was 76.7 (5.2) years, 236 (41.7%) were male, and 523 (92.4%) were white. Forty-seven patients (8.3%) developed major complications and 135 (23.9%) developed delirium. Compared with no complications or delirium as the reference group, major complications only contributed to prolonged LOS only (relative risk [RR], 2.8; 95% CI, 1.9-4.0); by contrast, delirium only significantly increased all adverse outcomes, including prolonged LOS (RR, 1.9; 95% CI, 1.4-2.7), institutional discharge (RR, 1.5; 95% CI, 1.3-1.7), and 30-day readmission (RR, 2.3; 95% CI, 1.4-3.7). The subgroup with complications and delirium had the highest rates of all adverse outcomes, including prolonged LOS (RR, 3.4; 95% CI, 2.3-4.8), institutional discharge (RR, 1.8; 95% CI, 1.4-2.5), and 30-day readmission (RR, 3.0; 95% CI, 1.3-6.8). Delirium exerted the highest attributable risk at the population level (5.8%; 95% CI, 4.7-6.8) compared with all other adverse events (prolonged LOS, institutional discharge, or readmission). CONCLUSIONS AND RELEVANCE Major postoperative complications and delirium are separately associated with adverse events and demonstrate a combined effect. Delirium occurs more frequently and has a greater effect at the population level than other major complications.	[Zenilman, Michael E.] Cornell Univ, Weill Cornell Med, New York, NY 10021 USA; [Zenilman, Michael E.] New York Methodist Hosp, Dept Surg, Brooklyn, NY USA	Cornell University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital	Zenilman, ME (corresponding author), New York Methodist Hosp, 506 Sixth St,Buckley Bldg, Brooklyn, NY 11215 USA.	miz9022@med.cornell.edu						[Anonymous], 2015, J AM COLL SURGEONS, V220, P136, DOI 10.1016/j.jamcollsurg.2014.10.019; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; Gleason LJ, 2015, JAMA SURG, V150, P1134, DOI 10.1001/jamasurg.2015.2606; Hanfer K., 2016, NY TIMES; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; Robinson Thomas N, 2014, Bull Am Coll Surg, V99, P21; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Yang AD, 2016, JAMA-J AM MED ASSOC, V315, P2113, DOI 10.1001/jama.2016.5422; Zenilman ME, 2015, AM J SURG, V209, P943, DOI 10.1016/j.amjsurg.2015.01.016; Zenilman ME, 2014, JAMA SURG, V149, P640, DOI 10.1001/jamasurg.2014.192	10	24	31	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					77	+		10.1001/jama.2016.18174	http://dx.doi.org/10.1001/jama.2016.18174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030685				2022-12-28	WOS:000391009100022
J	Dombi, E; Baldwin, A; Marcus, LJ; Fisher, MJ; Weiss, B; Kim, A; Whitcomb, P; Martin, S; Aschbacher-Smith, LE; Rizvi, TA; Wu, JQ; Ershler, R; Wolters, P; Therrien, J; Glod, J; Belasco, JB; Schorry, E; Brofferio, A; Starosta, AJ; Gillespie, A; Doyle, AL; Ratner, N; Widemann, BC				Dombi, Eva; Baldwin, Andrea; Marcus, Leigh J.; Fisher, Michael J.; Weiss, Brian; Kim, AeRang; Whitcomb, Patricia; Martin, Staci; Aschbacher-Smith, Lindsey E.; Rizvi, Tilat A.; Wu, Jianqiang; Ershler, Rachel; Wolters, Pamela; Therrien, Janet; Glod, John; Belasco, Jean B.; Schorry, Elizabeth; Brofferio, Alessandra; Starosta, Amy J.; Gillespie, Andrea; Doyle, Austin L.; Ratner, Nancy; Widemann, Brigitte C.			Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FARNESYLTRANSFERASE INHIBITOR TIPIFARNIB; CONSORTIUM PHASE-II; CLINICAL-TRIALS; TUMOR-SUPPRESSOR; HYPERACTIVE RAS; MEK INHIBITION; SOLID TUMORS; YOUNG-ADULTS; CHILDREN; CANCER	BACKGROUND Effective medical therapies are lacking for the treatment of neurofibromatosis type 1-related plexiform neurofibromas, which are characterized by elevated RAS-mitogen-activated protein kinase (MAPK) signaling. METHODS We conducted a phase 1 trial of selumetinib (AZD6244 or ARRY-142886), an oral selective inhibitor of MAPK kinase (MEK) 1 and 2, in children who had neurofibromatosis type 1 and inoperable plexiform neurofibromas to determine the maximum tolerated dose and to evaluate plasma pharmacokinetics. Selumetinib was administered twice daily at a dose of 20 to 30 mg per square meter of body-surface area on a continuous dosing schedule (in 28-day cycles). We also tested selumetinib using a mouse model of neurofibromatosis type 1-related neurofibroma. Response to treatment (i.e., an increase or decrease from baseline in the volume of plexiform neurofibromas) was monitored by using volumetric magnetic resonance imaging analysis to measure the change in size of the plexiform neurofibroma. RESULTS A total of 24 children (median age, 10.9 years; range, 3.0 to 18.5) with a median tumor volume of 1205 ml (range, 29 to 8744) received selumetinib. Patients were able to receive selumetinib on a long-term basis; the median number of cycles was 30 (range, 6 to 56). The maximum tolerated dose was 25 mg per square meter (approximately 60% of the recommended adult dose). The most common toxic effects associated with selumetinib included acneiform rash, gastrointestinal effects, and asymptomatic creatine kinase elevation. The results of pharmacokinetic evaluations of selumetinib among the children in this trial were similar to those published for adults. Treatment with selumetinib resulted in confirmed partial responses (tumor volume decreases from baseline of >= 20%) in 17 of the 24 children (71%) and decreases from baseline in neurofibroma volume in 12 of 18 mice (67%). Disease progression (tumor volume increase from baseline of >= 20%) has not been observed to date. Anecdotal evidence of decreases in tumor-related pain, disfigurement, and functional impairment was observed. CONCLUSIONS Our early-phase data suggested that children with neurofibromatosis type 1 and inoperable plexiform neurofibromas benefited from long-term dose-adjusted treatment with selumetinib without having excess toxic effects. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01362803.)	[Dombi, Eva; Baldwin, Andrea; Marcus, Leigh J.; Whitcomb, Patricia; Martin, Staci; Ershler, Rachel; Wolters, Pamela; Therrien, Janet; Glod, John; Starosta, Amy J.; Gillespie, Andrea; Widemann, Brigitte C.] Ctr Canc Res, Pediatr Oncol Branch, Bethesda, MD USA; [Doyle, Austin L.] Canc Therapy Evaluat Program, Shady Grove, MD USA; [Brofferio, Alessandra] NCI, Bethesda, MD 20892 USA; [Brofferio, Alessandra] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Marcus, Leigh J.; Ershler, Rachel] NIH, Silver Spring, MD USA; [Marcus, Leigh J.; Ershler, Rachel] US FDA, Silver Spring, MD USA; [Fisher, Michael J.; Belasco, Jean B.] Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Fisher, Michael J.; Belasco, Jean B.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kim, AeRang] Childrens Natl Hlth Syst, Washington, DC USA; [Weiss, Brian; Aschbacher-Smith, Lindsey E.; Rizvi, Tilat A.; Wu, Jianqiang; Schorry, Elizabeth; Ratner, Nancy] Cincinnati Childrens Hosp, Cincinnati, OH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Children's National Health System; Cincinnati Children's Hospital Medical Center	Widemann, BC (corresponding author), NCI, Pediat Oncol Branch, 10 Ctr Dr,Bldg 10 CRC,Rm 1-3752,MSC 1101, Bethesda, MD 20892 USA.	widemanb@mail.nih.gov	Glod, John/U-9925-2019; Starosta, Amy/AAV-1665-2020	RATNER, NANCY/0000-0001-5030-9354	National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086219, R01NS028840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and others	[Anonymous], 1988, Neurofibromatosis, V1, P172; Balagula Y, 2011, INVEST NEW DRUG, V29, P1114, DOI 10.1007/s10637-010-9567-3; Banerjee A, 2014, J CLIN ONCOL S, V32, p5s; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Canavese F, 2011, J PEDIATR ORTHOPED, V31, P303, DOI 10.1097/BPO.0b013e31820cad77; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Dombi E, 2007, NEUROLOGY, V68, P643, DOI 10.1212/01.wnl.0000250332.89420.e6; Dombi E, 2013, NEUROLOGY, V81, pS33, DOI 10.1212/01.wnl.0000435744.57038.af; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; Gutmann DH, 2013, EXPERT OPIN INV DRUG, V22, P443, DOI 10.1517/13543784.2013.772979; Hirbe AC, 2014, LANCET NEUROL, V13, P834, DOI 10.1016/S1474-4422(14)70063-8; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jakacki RI, 2016, NEUROONCOL; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Kim A, 2009, NEUROLOGY, V73, P1273, DOI 10.1212/WNL.0b013e3181bd1326; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Mautner VF, 2008, NEURO-ONCOLOGY, V10, P593, DOI 10.1215/15228517-2008-011; Needle MN, 1997, J PEDIATR-US, V131, P678, DOI 10.1016/S0022-3476(97)70092-1; Nguyen R, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-75; Packer RJ, 2002, NEUROLOGY, V58, P1461, DOI 10.1212/WNL.58.10.1461; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Riekert K., 2001, THESIS; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Robertson KA, 2012, LANCET ONCOL, V13, P1218, DOI 10.1016/S1470-2045(12)70414-X; Nguyen R, 2011, J PEDIATR-US, V159, P652, DOI 10.1016/j.jpeds.2011.04.008; Smith M, 1998, J CLIN ONCOL, V16, P966, DOI 10.1200/JCO.1998.16.3.966; Solomon J, 2004, COMPUT MED IMAG GRAP, V28, P257, DOI 10.1016/j.compmedimag.2004.03.002; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Weiss B, 1999, AM J MED GENET, V89, P14, DOI 10.1002/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.3.CO;2-W; Weiss B, 2015, NEURO-ONCOLOGY, V17, P596, DOI 10.1093/neuonc/nou235; Weiss B, 2014, PEDIATR BLOOD CANCER, V61, P982, DOI 10.1002/pbc.24873; Widemann BC, 2006, J CLIN ONCOL, V24, P507, DOI 10.1200/JCO.2005.03.8638; Widemann BC, 2014, PEDIATR BLOOD CANCER, V61, P1598, DOI 10.1002/pbc.25041; Widemann BC, 2014, NEURO-ONCOLOGY, V16, P707, DOI 10.1093/neuonc/nou004; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Wu JQ, 2012, PEDIATR BLOOD CANCER, V58, P173, DOI 10.1002/pbc.23015; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041	43	325	335	3	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2550	2560		10.1056/NEJMoa1605943	http://dx.doi.org/10.1056/NEJMoa1605943			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6SC	28029918	Green Accepted, Bronze			2022-12-28	WOS:000391175300008
J	Wolff, JL; Feder, J; Schulz, R				Wolff, Jennifer L.; Feder, Judy; Schulz, Richard			Supporting Family Caregivers of Older Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Wolff, Jennifer L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Feder, Judy] Georgetown Univ, Urban Inst, Washington, DC USA; [Feder, Judy] Georgetown Univ, McCourt Sch Publ Policy, Washington, DC USA; [Wolff, Jennifer L.; Feder, Judy; Schulz, Richard] Natl Acad, Comm Family Caregiving Older Adults, Hlth & Med Div, Washington, DC 20001 USA; [Schulz, Richard] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University; Urban Institute; Georgetown University; National Academies of Sciences, Engineering & Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wolff, JL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.; Wolff, JL (corresponding author), Natl Acad, Comm Family Caregiving Older Adults, Hlth & Med Div, Washington, DC 20001 USA.							Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; Congressional Budget Office, 2013, RIS DEM LONG TERM SE; National Academies of Sciences Engineering and Medicine, 2008, RET AG AM BUILD HLTH; National Academies of Sciences Engineering and Medicine, 2016, FAM CAR AG AM; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350	5	62	63	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2513	2515		10.1056/NEJMp1612351	http://dx.doi.org/10.1056/NEJMp1612351			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	28029922				2022-12-28	WOS:000391175300003
J	Dieleman, JL; Baral, R; Birger, M; Bui, AL; Bulchis, A; Chapin, A; Hamavid, H; Horst, C; Johnson, EK; Joseph, J; Lavado, R; Lomsadze, L; Reynolds, A; Squires, E; Campbell, M; DeCenso, B; Dicker, D; Flaxman, AD; Gabert, R; Highfill, T; Naghavi, M; Nightingale, N; Templin, T; Tobias, MI; Vos, T; Murray, CJL				Dieleman, Joseph L.; Baral, Ranju; Birger, Maxwell; Bui, Anthony L.; Bulchis, Anne; Chapin, Abigail; Hamavid, Hannah; Horst, Cody; Johnson, Elizabeth K.; Joseph, Jonathan; Lavado, Rouselle; Lomsadze, Liya; Reynolds, Alex; Squires, Ellen; Campbell, Madeline; DeCenso, Brendan; Dicker, Daniel; Flaxman, Abraham D.; Gabert, Rose; Highfill, Tina; Naghavi, Mohsen; Nightingale, Noelle; Templin, Tara; Tobias, Martin I.; Vos, Theo; Murray, Christopher J. L.			US Spending on Personal Health Care and Public Health, 1996-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							188 COUNTRIES; DISEASE; COMPLICATIONS; EXPENDITURES; GROWTH; BURDEN; COST	IMPORTANCE US health care spending has continued to increase, and now accounts for more than 17% of the US economy. Despite the size and growth of this spending, little is known about how spending on each condition varies by age and across time. OBJECTIVE To systematically and comprehensively estimate US spending on personal health care and public health, according to condition, age and sex group, and type of care. DESIGN AND SETTING Government budgets, insurance claims, facility surveys, household surveys, and official US records from 1996 through 2013 were collected and combined. In total, 183 sources of data were used to estimate spending for 155 conditions (including cancer, which was disaggregated into 29 conditions). For each record, spending was extracted, along with the age and sex of the patient, and the type of care. Spending was adjusted to reflect the health condition treated, rather than the primary diagnosis. EXPOSURES Encounter with US health care system. MAIN OUTCOMES AND MEASURES National spending estimates stratified by condition, age and sex group, and type of care. RESULTS From 1996 through 2013, $30.1 trillion of personal health care spending was disaggregated by 155 conditions, age and sex group, and type of care. Among these 155 conditions, diabetes had the highest health care spending in 2013, with an estimated $101.4 billion (uncertainty interval [UI], $96.7 billion-$106.5 billion) in spending, including 57.6%(UI, 53.8%-62.1%) spent on pharmaceuticals and 23.5%(UI, 21.7%-25.7%) spent on ambulatory care. Ischemic heart disease accounted for the second-highest amount of health care spending in 2013, with estimated spending of $88.1 billion (UI, $82.7 billion-$92.9 billion), and low back and neck pain accounted for the third-highest amount, with estimated health care spending of $87.6 billion (UI, $67.5 billion-$94.1 billion). The conditions with the highest spending levels varied by age, sex, type of care, and year. Personal health care spending increased for 143 of the 155 conditions from 1996 through 2013. Spending on low back and neck pain and on diabetes increased the most over the 18 years, by an estimated $57.2 billion (UI, $47.4 billion-$64.4 billion) and $64.4 billion (UI, $57.8 billion-$70.7 billion), respectively. From 1996 through 2013, spending on emergency care and retail pharmaceuticals increased at the fastest rates (6.4% [UI, 6.4%-6.4%] and 5.6%[UI, 5.6%-5.6%] annual growth rate, respectively), which were higher than annual rates for spending on inpatient care (2.8%[UI, 2.8%-2.8%] and nursing facility care (2.5%[UI, 2.5%-2.5%]). CONCLUSIONS AND RELEVANCE Modeled estimates of US spending on personal health care and public health showed substantial increases from 1996 through 2013; with spending on diabetes, ischemic heart disease, and low back and neck pain accounting for the highest amounts of spending by disease category. The rate of change in annual spending varied considerably among different conditions and types of care. This information may have implications for efforts to control US health care spending.	[Dieleman, Joseph L.; Birger, Maxwell; Chapin, Abigail; Hamavid, Hannah; Horst, Cody; Johnson, Elizabeth K.; Joseph, Jonathan; Reynolds, Alex; Squires, Ellen; Campbell, Madeline; Dicker, Daniel; Flaxman, Abraham D.; Gabert, Rose; Naghavi, Mohsen; Nightingale, Noelle; Vos, Theo; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA; [Baral, Ranju; Bulchis, Anne] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Bui, Anthony L.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lavado, Rouselle] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Lomsadze, Liya] Northwell Hlth, New Hyde Pk, NY USA; [DeCenso, Brendan] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Highfill, Tina] US Bur Econ Anal, Washington, DC USA; [Templin, Tara] Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA; [Tobias, Martin I.] New Zealand Minist Hlth, Wellington, New Zealand	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; The World Bank; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	Dieleman, JL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	dieleman@uw.edu		Highfill, Tina/0000-0002-1513-5798	National Institute on Aging of the National Institutes of Health [P30AG047845]; Vitality Institute; NATIONAL INSTITUTE ON AGING [P30AG047845] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Vitality Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grant P30AG047845 from the National Institute on Aging of the National Institutes of Health and by the Vitality Institute.	Aizcorbe Ana, 2012, Stat J IAOS, V28, P43, DOI 10.3233/SJI-2012-0743; Bernard D, 2012, MED MED RES REV, V2; Dunn A, 2016, HEALTH AFFAIR, V35, P132, DOI 10.1377/hlthaff.2015.1109; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Hamavid H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157912; Highfill T, MEASURING NURSING HO; Hodgson TA, 1999, PREV MED, V29, P173, DOI 10.1006/pmed.1999.0534; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Lassman D, 2014, HEALTH AFFAIR, V33, P815, DOI 10.1377/hlthaff.2013.1224; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Patil A, PYMC2; Roehrig C, 2016, HEALTH AFFAIR, V35, P1130, DOI 10.1377/hlthaff.2015.1659; Roehrig C, 2009, HEALTH AFFAIR, V28, pW358, DOI 10.1377/hlthaff.28.2.w358; Roehrig CS, 2011, HEALTH AFFAIR, V30, P1657, DOI 10.1377/hlthaff.2010.0644; Rosen AB, 2009, MED CARE, V47, pS7, DOI 10.1097/MLR.0b013e3181a23e12; Sing M, 2006, HEALTH CARE FINANC R, V28, P25; Substance Abuse and Mental Health Services Administration, 2013, NAT EXP MENT HLTH SE; Thorpe KE, 2004, HLTH AFF MILLWOOD S; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yabroff KR, 2011, CANCER EPIDEM BIOMAR, V20, P2006, DOI 10.1158/1055-9965.EPI-11-0650; Yamamoto DH, HLTH CARE COSTS FROM	24	615	623	8	144	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2627	2646		10.1001/jama.2016.16885	http://dx.doi.org/10.1001/jama.2016.16885			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027366	Green Accepted			2022-12-28	WOS:000391110200017
J	Zeng, CJ; Chen, YX; Kirschbaum, K; Lambright, KJ; Jin, RC				Zeng, Chenjie; Chen, Yuxiang; Kirschbaum, Kristin; Lambright, Kelly J.; Jin, Rongchao			Emergence of hierarchical structural complexities in nanoparticles and their assembly	SCIENCE			English	Article							NANOCRYSTAL; DNA; CRYSTALLIZATION; SUPERLATTICES; RESOLUTION; MONOLAYER; POLYHEDRA; LATTICE	We demonstrate that nanoparticle self-assembly can reach the same level of hierarchy, complexity, and accuracy as biomolecules. The precise assembly structures of gold nanoparticles (246 gold core atoms with 80 p-methylbenzenethiolate surface ligands) at the atomic, molecular, and nanoscale levels were determined from x-ray diffraction studies. We identified the driving forces and rules that guide the multiscale assembly behavior. The protecting ligands self-organize into rotational and parallel patterns on the nanoparticle surface via C-H center dot center dot center dot pi interaction, and the symmetry and density of surface patterns dictate directional packing of nanoparticles into crystals with orientational, rotational, and translational orders. Through hierarchical interactions and symmetry matching, the simple building blocks evolve into complex structures, representing an emergent phenomenon in the nanoparticle system.	[Zeng, Chenjie; Chen, Yuxiang; Jin, Rongchao] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Kirschbaum, Kristin; Lambright, Kelly J.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA	Carnegie Mellon University; University System of Ohio; University of Toledo	Jin, RC (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	rongchao@andrew.cmu.edu	Chen, Yuxiang/Y-3291-2018	Chen, Yuxiang/0000-0003-1972-9208; Jin, Rongchao/0000-0002-2525-8345; Lambright, Kelly/0000-0002-1723-5303; Zeng, Chenjie/0000-0002-2904-5590	Air Force Office of Scientific Research [FA9550-15-1-9999 (FA9550-15-1-0154)]; Camille Dreyfus Teacher-Scholar Awards Program	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Camille Dreyfus Teacher-Scholar Awards Program	R.J. thanks the Air Force Office of Scientific Research [award no. FA9550-15-1-9999 (FA9550-15-1-0154)] and the Camille Dreyfus Teacher-Scholar Awards Program for financial support. All data are available in the main text and in the supplementary materials. The x-ray crystallographic coordinates have been deposited in Cambridge Crystallographic Data Centre with CCDC number 1511348.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Chen YX, 2015, J AM CHEM SOC, V137, P10076, DOI 10.1021/jacs.5b05378; Choi JJ, 2011, J AM CHEM SOC, V133, P3131, DOI 10.1021/ja110454b; CLEVELAND CL, 1991, J CHEM PHYS, V94, P7376, DOI 10.1063/1.460169; Damasceno PF, 2012, SCIENCE, V337, P453, DOI 10.1126/science.1220869; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; ELDRIDGE MD, 1993, NATURE, V365, P35, DOI 10.1038/365035a0; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Grzybowski BA, 2016, NAT NANOTECHNOL, V11, P584, DOI [10.1038/NNANO.2016.116, 10.1038/nnano.2016.116]; Henzie J, 2012, NAT MATER, V11, P131, DOI [10.1038/nmat3178, 10.1038/NMAT3178]; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Luedtke WD, 1996, J PHYS CHEM-US, V100, P13323, DOI 10.1021/jp961721g; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Nishio M, 2011, PHYS CHEM CHEM PHYS, V13, P13873, DOI 10.1039/c1cp20404a; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; Wang T, 2012, SCIENCE, V338, P358, DOI 10.1126/science.1224221; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Whetten RL, 1999, ACCOUNTS CHEM RES, V32, P397, DOI 10.1021/ar970239t; Ye XC, 2013, NAT CHEM, V5, P466, DOI [10.1038/NCHEM.1651, 10.1038/nchem.1651]; Zeng CJ, 2016, J AM CHEM SOC, V138, P8710, DOI 10.1021/jacs.6b04835; Zeng CJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500045	29	383	386	20	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319					1580	1584		10.1126/science.aak9750	http://dx.doi.org/10.1126/science.aak9750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008066				2022-12-28	WOS:000390254300051
J	Worrall, LJ; Hong, C; Vuckovic, M; Deng, W; Bergeron, JRC; Majewski, DD; Huang, RK; Spreter, T; Finlay, BB; Yu, Z; Strynadka, NCJ				Worrall, L. J.; Hong, C.; Vuckovic, M.; Deng, W.; Bergeron, J. R. C.; Majewski, D. D.; Huang, R. K.; Spreter, T.; Finlay, B. B.; Yu, Z.; Strynadka, N. C. J.			Near-atomic-resolution cryo-EM analysis of the Salmonella T3S injectisome basal body	NATURE			English	Article							III SECRETION SYSTEM; STRUCTURAL-CHARACTERIZATION; MEMBRANE INSERTION; NEEDLE COMPLEX; PROTEIN; MODEL; IDENTIFICATION; VISUALIZATION; VALIDATION; PLATFORM	The type III secretion (T3S) injectisome is a specialized protein nanomachine that is critical for the pathogenicity of many Gram-negative bacteria, including purveyors of plague, typhoid fever, whooping cough, sexually transmitted infections and major nosocomial infections. This syringe-shaped 3.5-MDa macromolecular assembly spans both bacterial membranes and that of the infected host cell. The internal channel formed by the injectisome allows for the direct delivery of partially unfolded virulence effectors into the host cytoplasm(1). The structural foundation of the injectisome is the basal body, a molecular lock-nut structure composed predominantly of three proteins that form highly oligomerized concentric rings spanning the inner and outer membranes(2-5). Here we present the structure of the prototypical Salmonella enterica serovar Typhimurium pathogenicity island 1 basal body, determined using single-particle cryo-electron microscopy, with the inner-membrane-ring and outer-membranering oligomers defined at 4.3 angstrom and 3.6 angstrom resolution, respectively. This work presents the first, to our knowledge, high-resolution structural characterization of the major components of the basal body in the assembled state, including that of the widespread class of outer-membrane portals known as secretins.	[Worrall, L. J.; Vuckovic, M.; Bergeron, J. R. C.; Majewski, D. D.; Spreter, T.; Strynadka, N. C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Worrall, L. J.; Vuckovic, M.; Bergeron, J. R. C.; Majewski, D. D.; Spreter, T.; Strynadka, N. C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Hong, C.; Huang, R. K.; Yu, Z.] Howard Hughes Med Inst, CryoEM Shared Resources, Janelia Res Campus, Ashburn, VA 20147 USA; [Deng, W.; Finlay, B. B.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Bergeron, J. R. C.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Spreter, T.] Zymeworks, Vancouver, BC V6H 3V9, Canada	University of British Columbia; University of British Columbia; Howard Hughes Medical Institute; University of British Columbia; University of Washington; University of Washington Seattle	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.; Strynadka, NCJ (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada.; Yu, Z (corresponding author), Howard Hughes Med Inst, CryoEM Shared Resources, Janelia Res Campus, Ashburn, VA 20147 USA.	yuz@janelia.hhmi.org; ncjs@mail.ubc.ca	Bergeron, Julien/AGY-1707-2022		Canadian Institutes of Health Research (CIHR); Michael Smith Foundation of Health Research; CIHR; Howard Hughes International Senior Scholar program; Canada Research Chair in Antibiotic Discovery	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation of Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes International Senior Scholar program; Canada Research Chair in Antibiotic Discovery	We thank A. Cheung for assistance with the expression trials of the PrgH<INF>130-392</INF> GFP-fused basal body, C. Lizak for advice on GFP variants and membrane-protein purification and C. Yip and J. Rubenstein for advice on negative-stain TEM techniques. We thank UBC Bioimaging for access to TEM infrastructure. We thank K.-M. Moon and J. Rogalski at the Michael Smith Labs Proteomics Core Facility for assistance with LC-MS/MS. We thank F. Rosell at the LMB Spectroscopy and Kinetics Hub for assistance with circular dichroism. We thank S. Miller for providing the S. Typhimurium deletion strains and plasmids, as well as the InvG antibody. This work was funded by scholarships to L.W. and J.B. from the Canadian Institutes of Health Research (CIHR) and Michael Smith Foundation of Health Research, respectively, and operating grants from CIHR to N.C.J.S. and B.B.F., and the Howard Hughes International Senior Scholar program to N.C.J.S. N.C.J.S. is a Tier I Canada Research Chair in Antibiotic Discovery.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergeron JRC, 2015, STRUCTURE, V23, P161, DOI 10.1016/j.str.2014.10.021; Bergeron JRC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003307; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chang YW, 2016, SCIENCE, V351, DOI 10.1126/science.aad2001; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; Disconzi E, 2014, J BACTERIOL, V196, P121, DOI 10.1128/JB.00750-13; Dunstan RA, 2015, MOL MICROBIOL, V97, P616, DOI 10.1111/mmi.13055; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Gu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002531; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2014, STRUCTURE, V22, P582, DOI 10.1016/j.str.2014.02.009; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hoang HH, 2011, MBIO, V2, DOI 10.1128/mBio.00246-11; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Huysmans GHM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15068; Huysmans GHM, 2013, J BIOL CHEM, V288, P30700, DOI 10.1074/jbc.M113.489112; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Koo J, 2012, FEMS MICROBIOL LETT, V328, P1, DOI 10.1111/j.1574-6968.2011.02464.x; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Kowal J, 2013, STRUCTURE, V21, P2152, DOI 10.1016/j.str.2013.09.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Linderoth NA, 1996, J BACTERIOL, V178, P1962, DOI 10.1128/jb.178.7.1962-1970.1996; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Nans A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10114; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Spagnuolo J, 2010, MOL MICROBIOL, V76, P133, DOI 10.1111/j.1365-2958.2010.07085.x; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Worrall LJ, 2011, CURR OPIN MICROBIOL, V14, P3, DOI 10.1016/j.mib.2010.10.009; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	59	85	87	5	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					597	+		10.1038/nature20576	http://dx.doi.org/10.1038/nature20576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27974800				2022-12-28	WOS:000391190500055
J	Merchant, RM; Volpp, KG; Asch, DA				Merchant, Raina M.; Volpp, Kevin G.; Asch, David A.			Learning by Listening-Improving Health Care in the Era of Yelp	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT EXPERIENCE		[Merchant, Raina M.; Asch, David A.] Univ Penn, Perelman Sch Med, Penn Med Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Merchant, Raina M.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Merchant, RM (corresponding author), Univ Penn, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	raina.merchant@uphs.upenn.edu		Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599				Greaves F, 2012, BMJ QUAL SAF, V21, P600, DOI 10.1136/bmjqs-2012-000906; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Loew L., 2013, LOS ANGELES COUNTY R; Ranard BL, 2016, HEALTH AFFAIR, V35, P697, DOI 10.1377/hlthaff.2015.1030; Schlesinger M, 2015, NEW ENGL J MED, V373, P675, DOI 10.1056/NEJMsb1502361	5	19	19	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2483	2484		10.1001/jama.2016.16754	http://dx.doi.org/10.1001/jama.2016.16754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997663				2022-12-28	WOS:000390959300011
J	Voelker, R				Voelker, Rebecca			Heater-Cooler Cautions Updated	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2474	2474		10.1001/jama.2016.17115	http://dx.doi.org/10.1001/jama.2016.17115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997638				2022-12-28	WOS:000390959300007
J	Gastel, B				Gastel, Barbara			Living up to my mentors	SCIENCE			English	Editorial Material									[Gastel, Barbara] Texas A&M Univ, Vet Integrat Biosci, College Stn, TX 77843 USA; [Gastel, Barbara] Texas A&M Univ, Humanities Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Gastel, B (corresponding author), Texas A&M Univ, Vet Integrat Biosci, College Stn, TX 77843 USA.; Gastel, B (corresponding author), Texas A&M Univ, Humanities Med, College Stn, TX 77843 USA.	SciCareerEditor@aaas.org							0	0	0	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1494	1494		10.1126/science.354.6318.1494	http://dx.doi.org/10.1126/science.354.6318.1494			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980213				2022-12-28	WOS:000390261300049
J	Moran-Thomas, A				Moran-Thomas, Amy			Breakthroughs for Whom? Global Diabetes Care and Equitable Design	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN		[Moran-Thomas, Amy] MIT, Anthropol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moran-Thomas, A (corresponding author), MIT, Anthropol Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			/0000-0001-5411-1046				Benjamin R, 2015, BENCH LAB BENCH WHAT; Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Bukhman G, 2015, LANCET DIABETES ENDO, V3, P402, DOI 10.1016/S2213-8587(15)00138-2; Greene JA, 2015, NEW ENGL J MED, V372, P1171, DOI 10.1056/NEJMms1411398; Mol A, 2009, LANCET, V373, P1756, DOI 10.1016/S0140-6736(09)60971-5	5	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2317	2319		10.1056/NEJMp1611475	http://dx.doi.org/10.1056/NEJMp1611475			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27974035	Green Published, Green Submitted			2022-12-28	WOS:000390036500003
J	Streit, JA; Matsumoto, E				Streit, Judy A.; Matsumoto, Eiyu			African Trypanosomiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Streit, Judy A.; Matsumoto, Eiyu] Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Streit, JA (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.			Matsumoto, Eiyu/0000-0002-5632-4990; Cecil, Stephanie/0000-0003-4461-3004; streit, judy/0000-0001-8629-3622					0	2	3	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2380	2380		10.1056/NEJMicm1604333	http://dx.doi.org/10.1056/NEJMicm1604333			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27974038				2022-12-28	WOS:000390036500009
J	Lenardo, MJ				Lenardo, Michael J.			Focus on Research Clinical Genomics - Molecular Pathogenesis Revealed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lenardo, Michael J.] NIAID, Mol Dev Immune Syst Sect, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lenardo, Michael J.] NIAID, Clin Genom Program, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lenardo, MJ (corresponding author), NIAID, Mol Dev Immune Syst Sect, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Lenardo, MJ (corresponding author), NIAID, Clin Genom Program, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000717, ZIAAI000566] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dias C, 2016, AM J HUM GENET, V99, P253, DOI 10.1016/j.ajhg.2016.05.030; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Kingsmore SF, 2016, GENET MED, V18, P214, DOI 10.1038/gim.2015.172; Lenardo M, 2016, ANNU REV IMMUNOL, V34, P121, DOI 10.1146/annurev-immunol-041015-055620	4	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2016	375	22					2117	2119		10.1056/NEJMp1611419	http://dx.doi.org/10.1056/NEJMp1611419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED7GN	27959769				2022-12-28	WOS:000389030400003
J	Press, MJ; Howe, R; Schoenbaum, M; Cavanaugh, S; Marshall, A; Baldwin, L; Conway, PH				Press, Matthew J.; Howe, Ryan; Schoenbaum, Michael; Cavanaugh, Sean; Marshall, Ann; Baldwin, Lindsey; Conway, Patrick H.			Medicare Payment for Behavioral Health Integration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Press, Matthew J.; Howe, Ryan; Cavanaugh, Sean; Marshall, Ann; Baldwin, Lindsey; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA; [Schoenbaum, Michael] NIMH, Bethesda, MD 20892 USA	Centers for Medicare & Medicaid Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Press, MJ (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA.		Schoenbaum, Michael/GRR-3988-2022					Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P80170; Mechanic D, 2014, HEALTH AFFAIR, V33, P1416, DOI 10.1377/hlthaff.2014.0504; Schwenk TL, 2016, JAMA-J AM MED ASSOC, V316, P822, DOI 10.1001/jama.2016.11031	5	65	65	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 2	2017	376	5					405	407		10.1056/NEJMp1614134	http://dx.doi.org/10.1056/NEJMp1614134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ8WH	27973984				2022-12-28	WOS:000393507200001
J	Koukounari, A; Hollingsworth, TD				Koukounari, Artemis; Hollingsworth, T. Deirdre			A strengthening evidence-base for mass deworming, but questions remain	LANCET			English	Editorial Material							TRANSMITTED HELMINTH INFECTIONS; EFFICACY; METAANALYSIS		[Koukounari, Artemis] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, Crespigny Pk, London SE5 8AF, England; [Hollingsworth, T. Deirdre] Univ Warwick, Math Inst, Coventry, W Midlands, England; [Hollingsworth, T. Deirdre] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of London; King's College London; University of Warwick; University of Warwick	Koukounari, A (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, Crespigny Pk, London SE5 8AF, England.		Hollingsworth, Deirdre/D-2421-2009; Koukounari, Artemis/AAB-2791-2022	Hollingsworth, Deirdre/0000-0001-5962-4238; Koukounari, Artemis/0000-0001-5574-3934	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London	AK is supported by a grant funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of NIHR, the NHS, or the UK Government Department of Health. TDH declares no competing interests.	Anderson RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003897; Clarke NE, 2016, LANCET; Kappagoda S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6512; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Levecke B, 2014, PARASITOLOGY, V141, P1826, DOI 10.1017/S0031182013002266; Lo NC, 2015, LANCET GLOB HEALTH, V3, pE629, DOI 10.1016/S2214-109X(15)00047-9; Nagpal S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002238; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Speich B, 2015, LANCET INFECT DIS, V15, P277, DOI 10.1016/S1473-3099(14)71050-3; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub6; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1187-5; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2	12	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					231	233		10.1016/S0140-6736(16)32452-7	http://dx.doi.org/10.1016/S0140-6736(16)32452-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	27979384	Green Submitted, Green Published			2022-12-28	WOS:000392801200007
J	Adams, AJ; Banister, SD; Irizarry, L; Trecki, J; Schwartz, M; Gerona, R				Adams, Axel J.; Banister, Samuel D.; Irizarry, Lisandro; Trecki, Jordan; Schwartz, Michael; Gerona, Roy			"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AB-FUBINACA; DESIGNER DRUGS; PINACA; 5F-AB-PINACA; PHARMACOLOGY; 5F-AMB	BACKGROUND New psychoactive substances constitute a growing and dynamic class of abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass intoxication of 33 persons in one New York City neighborhood, in an event described in the popular press as a "zombie" outbreak because of the appearance of the intoxicated persons. METHODS We obtained and tested serum, whole blood, and urine samples from 8 patients among the 18 who were transported to local hospitals; we also tested a sample of the herbal "incense" product "AK-47 24 Karat Gold,"which was implicated in the outbreak. Samples were analyzed by means of liquid chromatography-quadrupole time-of-flight mass spectrometry. RESULTS The synthetic cannabinoid methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (AMB-FUBINACA, also known as MMB-FUBINACA or FUB-AMB) was identified in AK-47 24 Karat Gold at a mean (+/- SD) concentration of 16.0 +/- 3.9 mg per gram. The de-esterified acid metabolite was found in the serum or whole blood of all eight patients, with concentrations ranging from 77 to 636 ng per milliliter. CONCLUSIONS The potency of the synthetic cannabinoid identified in these analyses is consistent with strong depressant effects that account for the "zombielike" behavior reported in this mass intoxication. AMB-FUBINACA is an example of the emerging class of "ultrapotent" synthetic cannabinoids and poses a public health concern. Collaboration among clinical laboratory staff, health professionals, and law enforcement agencies facilitated the timely identification of the compound and allowed health authorities to take appropriate action.	[Adams, Axel J.; Gerona, Roy] Univ Calif San Francisco, Clin Toxicol & Environm Biomonitoring Lab, San Francisco, CA 94143 USA; [Adams, Axel J.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Banister, Samuel D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Palo Alto, CA 94304 USA; [Irizarry, Lisandro] Wyckoff Hts Med Ctr, Dept Emergency Med, New York, NY USA; [Trecki, Jordan] Drug Enforcement Adm, Drug & Chem Evaluat Sect, Off Divers Control, Springfield, VA USA; [Schwartz, Michael] Dept Homeland Secur, Off Hlth Affairs, Chem Def Program, Washington, DC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Gerona, R (corresponding author), Univ Calif San Francisco, Clin Toxicol & Environm Biomonitoring Lab, San Francisco, CA 94143 USA.	roy.gerona@ucsf.edu	Banister, Samuel/G-8501-2012	Banister, Samuel/0000-0002-4690-4318				Akamatsu S, 2016, J MASS SPECTROM, V51, P28, DOI 10.1002/jms.3722; Andersson M, 2016, RAPID COMMUN MASS SP, V30, P1067, DOI 10.1002/rcm.7538; [Anonymous], 2014, DHH ADDS 2 NEW SYNTH; [Anonymous], 2016, LOOK SO FAR MY US FU; Auwarter V, 2013, NOVEL PSYCHOACTIVE SUBSTANCES: CLASSIFICATION, PHARMACOLOGY AND TOXICOLOGY, P317, DOI 10.1016/B978-0-12-415816-0.00013-4; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Banister SD, 2016, ACS CHEM NEUROSCI, V7, P1241, DOI 10.1021/acschemneuro.6b00137; Banister SD, 2015, ACS CHEM NEUROSCI, V6, P1546, DOI 10.1021/acschemneuro.5b00112; Banister SD, 2015, ACS CHEM NEUROSCI, V6, P1445, DOI 10.1021/acschemneuro.5b00107; Barratt MJ, 2013, DRUG ALCOHOL REV, V32, P141, DOI 10.1111/j.1465-3362.2012.00519.x; Buser GL, 2014, CLIN TOXICOL, V52, P664, DOI 10.3109/15563650.2014.932365; Drug Enforcement Administration, 2011, CHEM US SPIC K2 TYP; Drug Enforcement Administration Department of Justice, 2016, Fed Regist, V81, P6175; Egde SG, 2009, Intl patent, Patent No. [PCT/IB2009/000432, 2009000432]; European Monitoring Centre for Drugs and Drug Addiction & Eurojust, 2016, NEW PSYCH SUBST EUR; Holpuch A., 2016, GUARDIAN; Longworth M, 2016, FORENSIC TOXICOL, V34, P286, DOI 10.1007/s11419-016-0316-y; MECHOULA.R, 1965, J AM CHEM SOC, V87, P3273, DOI 10.1021/ja01092a065; Nichols D, 2011, NATURE, V469, P7, DOI 10.1038/469007a; Rominger A, 2013, EUR NEUROPSYCHOPHARM, V23, P1606, DOI 10.1016/j.euroneuro.2013.01.009; Rosenberg Eli, 2016, NY TIMES; Schwartz MD, 2015, J EMERG MED, V48, P573, DOI 10.1016/j.jemermed.2014.12.038; Shanks KG, 2016, FORENSIC SCI INT, V262, pE21, DOI 10.1016/j.forsciint.2016.03.004; Trecki J, 2015, NEW ENGL J MED, V373, P103, DOI 10.1056/NEJMp1505328; Tyndall JA, 2015, CLIN TOXICOL, V53, P950, DOI 10.3109/15563650.2015.1100306; Uchiyama N, 2013, FORENSIC TOXICOL, V31, P93, DOI 10.1007/s11419-012-0171-4; United Nations Office on Drugs and Crime, 2015, WORLD DRUG REP 2015; Vandrey R, 2012, DRUG ALCOHOL DEPEN, V120, P238, DOI 10.1016/j.drugalcdep.2011.07.011; Wiley JL, 2016, NEUROPHARMACOLOGY, V110, P143, DOI 10.1016/j.neuropharm.2016.07.016; Winstock AR, 2016, GLOBAL DRUG SURVEY 2	30	179	184	8	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 19	2017	376	3					235	242		10.1056/NEJMoa1610300	http://dx.doi.org/10.1056/NEJMoa1610300			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI0XO	27973993	Bronze			2022-12-28	WOS:000392199100007
J	Mi, X; Cady, JV; Zajac, DM; Deelman, PW; Petta, JR				Mi, X.; Cady, J. V.; Zajac, D. M.; Deelman, P. W.; Petta, J. R.			Strong coupling of a single electron in silicon to a microwave photon	SCIENCE			English	Article							QUANTUM STATE; CAVITY; CIRCUIT; STORAGE; SPINS; DOTS	Silicon is vital to the computing industry because of the high quality of its native oxide and well-established doping technologies. Isotopic purification has enabled quantum coherence times on the order of seconds, thereby placing silicon at the forefront of efforts to create a solid-state quantum processor. We demonstrate strong coupling of a single electron in a silicon double quantum dot to the photonic field of a microwave cavity, as shown by the observation of vacuum Rabi splitting. Strong coupling of a quantum dot electron to a cavity photon would allow for long-range qubit coupling and the long-range entanglement of electrons in semiconductor quantum dots.	[Mi, X.; Cady, J. V.; Zajac, D. M.; Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Deelman, P. W.] HRL Labs LLC, 3011 Malibu Canyon Rd, Malibu, CA 90265 USA; [Cady, J. V.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Princeton University; HRL Laboratories; University of California System; University of California Santa Barbara	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu			Army Research Office [W911NF-15-1-0149]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4535]; NSF [DMR-1409556, DMR-1420541]; U.S. Department of Defense [H98230-15-C0453]; Direct For Mathematical & Physical Scien [1409556] Funding Source: National Science Foundation	Army Research Office; Gordon and Betty Moore Foundation's EPiQS Initiative; NSF(National Science Foundation (NSF)); U.S. Department of Defense(United States Department of Defense); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with T. M. Hazard, Y. Liu, S. Putz, M. Reed, and J. Stehlik. Supported by Army Research Office grant W911NF-15-1-0149, the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4535, and NSF grants DMR-1409556 and DMR-1420541. This material is based on work supported by the U.S. Department of Defense under contract H98230-15-C0453. Devices were fabricated in the Princeton University Quantum Device Nanofabrication Laboratory.	Basset J, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892828; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Deng GW, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.126804; Eichler C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240501; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Haroche S., 2006, EXPLORING QUANTUM; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Macklin C, 2015, SCIENCE, V350, P307, DOI 10.1126/science.aaa8525; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Medford J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050501; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Petersson KD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246804; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Stockklauser A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.046802; Takeda K, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600694; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Viennot JJ, 2015, SCIENCE, V349, P408, DOI 10.1126/science.aaa3786; Viennot JJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165404; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wallraff A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.249701; Walls D., 2008, QUANTUM OPT, DOI DOI 10.1007/978-3-540-28574-8; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013	34	174	176	2	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 13	2017	355	6321					156	+		10.1126/science.aal2469	http://dx.doi.org/10.1126/science.aal2469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH4LW	28008085	Green Submitted			2022-12-28	WOS:000391743700036
J	Volkow, ND; Compton, WM; Wargo, EM				Volkow, Nora D.; Compton, Wilson M.; Wargo, Eric M.			The Risks of Marijuana Use During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Volkow, Nora D.; Compton, Wilson M.; Wargo, Eric M.] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Wargo, EM (corresponding author), NIDA, Off Sci Policy & Commun, Sci Policy Branch, 6001 Execut Blvd,Room 5235, Bethesda, MD 20892 USA.	wargoem@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Gunn JKL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009986; Roberson Emily K, 2014, Hawaii J Med Public Health, V73, P283; Sulik KK, NEUROTOXICOL TERATOL, DOI [10.1016/j.ntt.2015.12.004, DOI 10.1016/J.NTT.2015]; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wu CS, 2011, FUTUR NEUROL, V6, P459, DOI 10.2217/FNL.11.27	6	77	77	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2017	317	2					129	130		10.1001/jama.2016.18612	http://dx.doi.org/10.1001/jama.2016.18612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5PV	27992628				2022-12-28	WOS:000391826200009
J	[Anonymous]				[Anonymous]			Preventi-Thought (Reprinted from vol 199, pg 38, 1967)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1967, JAMA, V199, P38	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					92	92		10.1001/jama.2016.18575	http://dx.doi.org/10.1001/jama.2016.18575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030688				2022-12-28	WOS:000391009100036
J	Limb, M				Limb, Matthew			Neil Blair Pride OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												limb@btinternet.com						PRIDE NB, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2016	355								i6851	10.1136/bmj.i6851	http://dx.doi.org/10.1136/bmj.i6851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RD	28034877				2022-12-28	WOS:000391172700003
J	Green, MJ; Czerwiec, MK				Green, Michael J.; Czerwiec, M. K.			Graphic Medicine The Best of 2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMICS		[Green, Michael J.] Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA; [Green, Michael J.] Penn State Coll Med, Dept Med, Hershey, PA 17033 USA; [Czerwiec, M. K.] Northwestern Feinberg Sch Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwestern University; Feinberg School of Medicine	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities, Hershey, PA 17033 USA.; Green, MJ (corresponding author), Penn State Coll Med, Dept Med, Hershey, PA 17033 USA.; Czerwiec, MK (corresponding author), Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.	mgreen@hmc.psu.edu; comicnurse@mac.com	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749				Green MJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c863; SUDC Foundation, SUDC FACTS STAT; Williams ICM, 2012, MED HUMANIT, V38, P21, DOI 10.1136/medhum-2011-010093	3	3	3	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2580	2581		10.1001/jama.2016.19200	http://dx.doi.org/10.1001/jama.2016.19200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	28027346				2022-12-28	WOS:000391110200001
J	Lu, CP; Polak, L; Keyes, BE; Fuchs, E				Lu, Catherine P.; Polak, Lisa; Keyes, Brice E.; Fuchs, Elaine			Spatiotemporal antagonism in mesenchymal-epithelial signaling in sweat versus hair fate decision	SCIENCE			English	Article							ECTODERMAL DYSPLASIA; STEM-CELLS; FOLLICLE DEVELOPMENT; PROTEIN PATHWAY; EXPRESSION; MOUSE; GLAND; MICE; WNT; SHH	The gain of eccrine sweat glands in hairy body skin has empowered humans to run marathons and tolerate temperature extremes. Epithelial-mesenchymal cross-talk is integral to the diverse patterning of skin appendages, but the molecular events underlying their specification remain largely unknown. Using genome-wide analyses and functional studies, we show that sweat glands are specified by mesenchymal-derived bone morphogenetic proteins (BMPs) and fibroblast growth factors that signal to epithelial buds and suppress epithelial-derived sonic hedgehog (SHH) production. Conversely, hair follicles are specified when mesenchymal BMP signaling is blocked, permitting SHH production. Fate determination is confined to a critical developmental window and is regionally specified in mice. In contrast, a shift from hair to gland fates is achieved in humans when a spike in BMP silences SHH during the final embryonic wave(s) of bud morphogenesis.	[Lu, Catherine P.; Polak, Lisa; Keyes, Brice E.; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Fuchs, Elaine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Keyes, Brice E.] Calico Life Sci, San Francisco, CA 94080 USA	Rockefeller University; Howard Hughes Medical Institute	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.; Fuchs, E (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Lu, Catherine/0000-0003-4593-327X	National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [K01-AR066073]; Robertson Therapeutic Development Fund; NIH [R01-AR050452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066073, R01AR050452] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Robertson Therapeutic Development Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Fuchs laboratory members, particularly M. Genander, T. Ouspenskaia, H.A. Pasolli, H. Yang, V. Fiore, S. Liu, and Y. Ge for reagents and helpful discussions, and J. Levorse, J. Racelis, and S. Chai for technical assistance. We thank Rockefeller Comparative Bioscience Center (Association for Assessment and Accreditation of Laboratory Animal Care-accredited) for care of mice in accordance with National Institutes of Health (NIH) guidelines, Bioimaging Resource Center (A. North, director), and Flow Cytometry Resource Center (S. Mazel, director, and S. Semova, S. Tadesse, and S. Han). E.F. is an investigator of the Howard Hughes Medical Institute. C.P.L. is a recipient of fellowships from the National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant K01-AR066073) and Robertson Therapeutic Development Fund. This work was supported by NIH grant R01-AR050452 (E.F.). All reagents engineered in the course of this study are available from jdelacruz@rockefeller.edu under a materials transfer agreement with the Rockefeller University. C.P.L. and E.F. conceived the project, designed the experiments, and wrote the manuscript. C.P.L. performed the experiments. C.P.L. and L.P. performed mouse surgical procedures. B.E.K. and C.P.L. performed RNA-seq data analyses. RNA-seq data are deposited in the Gene Expression Omnibus under accession number GSE85249 (www.ncbi.nlm.nih.gov/geo). The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to E.F. (fuchslb@rockefeller.edu).	Ahtiainen L, 2014, DEV CELL, V28, P588, DOI 10.1016/j.devcel.2014.02.003; Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Cui CY, 2014, DEVELOPMENT, V141, P3752, DOI 10.1242/dev.109231; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DHOUAILLY D, 1978, DEV BIOL, V65, P58, DOI 10.1016/0012-1606(78)90179-3; Ferraris C, 2000, DEVELOPMENT, V127, P5487; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kamberov YG, 2015, P NATL ACAD SCI USA, V112, P9932, DOI 10.1073/pnas.1511680112; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; KING JA, 1994, DEV BIOL, V166, P112, DOI 10.1006/dbio.1994.1300; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; KRATOCHWIL K, 1969, DEV BIOL, V20, P46, DOI 10.1016/0012-1606(69)90004-9; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Long FX, 2001, DEVELOPMENT, V128, P5099; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mayer JA, 2008, AM J PATHOL, V173, P1339, DOI 10.2353/ajpath.2008.070920; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Narita T, 2000, DEVELOPMENT, V127, P981; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Noramly S, 1998, DEVELOPMENT, V125, P3775; Ouspenskaia T, 2016, CELL, V164, P156, DOI 10.1016/j.cell.2015.11.058; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Prin F, 2004, INT J DEV BIOL, V48, P137, DOI 10.1387/ijdb.15272378; Pummila M, 2007, DEVELOPMENT, V134, P117, DOI 10.1242/dev.02708; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; SENGEL P, 1990, International Journal of Developmental Biology, V34, P33; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Youssef KK, 2012, NAT CELL BIOL, V14, P1282, DOI 10.1038/ncb2628; Zhang Y, 2009, APPL MATH COMPUT, V215, P524, DOI 10.1016/j.amc.2009.05.018; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	53	73	74	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2016	354	6319							aah6102	10.1126/science.aah6102	http://dx.doi.org/10.1126/science.aah6102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3VZ	28008008	Green Accepted			2022-12-28	WOS:000390254300043
J	Harper, KL; Sosa, MS; Entenberg, D; Hosseini, H; Cheung, JF; Nobre, R; Avivar-Valderas, A; Nagi, C; Girnius, N; Davis, RJ; Farias, EF; Condeelis, J; Klein, CA; Aguirre-Ghiso, JA				Harper, Kathryn L.; Sosa, Maria Soledad; Entenberg, David; Hosseini, Hedayatollah; Cheung, Julie F.; Nobre, Rita; Avivar-Valderas, Alvaro; Nagi, Chandandaneep; Girnius, Nomeda; Davis, Roger J.; Farias, Eduardo F.; Condeelis, John; Klein, Christoph A.; Aguirre-Ghiso, Julio A.			Mechanism of early dissemination and metastasis in Her2(+) mammary cancer	NATURE			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; TUMOR-CELLS; BONE-MARROW; EXPRESSION; DIAGNOSIS; EMT	Metastasis is the leading cause of cancer-related deaths; metastatic lesions develop from disseminated cancer cells (DCCs) that can remain dormant(1). Metastasis-initiating cells are thought to originate from a subpopulation present in progressed, invasive tumours(2). However, DCCs detected in patients before the manifestation of breast-cancer metastasis contain fewer genetic abnormalities than primary tumours or than DCCs from patients with metastases(3-5). These findings, and those in pancreatic cancer(6) and melanoma(7) models, indicate that dissemination might occur during the early stages of tumour evolution(3,8,9). However, the mechanisms that might allow early disseminated cancer cells (eDCCs) to complete all steps of metastasis are unknown(8). Here we show that, in early lesions in mice and before any apparent primary tumour masses are detected, there is a sub-population of Her2(+) p-p38lop-Atf2loTwist1hiE-cadlo early cancer cells that is invasive and can spread to target organs. Intra-vital imaging and organoid studies of early lesions showed that Her2(+) eDCC precursors invaded locally, intravasated and lodged in target organs. Her2(+) eDCCs activated a Wnt-dependent epithelial-mesenchymal transition (EMT)-like dissemination program but without complete loss of the epithelial phenotype, which was reversed by Her2 or Wnt inhibition. Notably, although the majority of eDCCs were Twist1(hi)E-cadlo and dormant, they eventually initiated metastasis. Our work identifies a mechanism for early dissemination in which Her2 aberrantly activates a program similar to mammary ductal branching that generates eDCCs that are capable of forming metastasis after a dormancy phase.	[Harper, Kathryn L.; Sosa, Maria Soledad; Cheung, Julie F.; Nobre, Rita; Avivar-Valderas, Alvaro; Nagi, Chandandaneep; Farias, Eduardo F.; Aguirre-Ghiso, Julio A.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Oncol Sci,Tisch Canc Inst, Div Hematol & Oncol,Dept Med,Dept Otolaryngol, 1 Gustave L Levy Pl, New York, NY 10029 USA; [Entenberg, David; Condeelis, John] Albert Einstein Coll Med, Dept Anat & Struct Biol, Integrated Imaging Program, Gruss Lipper Biophoton Ctr, 1300 Morris Pk Ave, New York, NY 10461 USA; [Hosseini, Hedayatollah; Klein, Christoph A.] Univ Regensburg, Expt Med & Therapy Res, D-93053 Regensburg, Germany; [Girnius, Nomeda; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumour Therapy, D-93053 Regensburg, Germany; [Sosa, Maria Soledad] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pharmacol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Yeshiva University; University of Regensburg; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Fraunhofer Gesellschaft; Icahn School of Medicine at Mount Sinai	Sosa, MS; Aguirre-Ghiso, JA (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, Dept Oncol Sci,Tisch Canc Inst, Div Hematol & Oncol,Dept Med,Dept Otolaryngol, 1 Gustave L Levy Pl, New York, NY 10029 USA.; Sosa, MS (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pharmacol Sci, 1 Gustave L Levy Pl, New York, NY 10029 USA.	maria.sosa@mssm.edu; julio.aguirre-ghiso@mssm.edu	Entenberg, David/AAT-2722-2020	Entenberg, David/0000-0003-0422-7264; Nobre, Ana Rita/0000-0002-5509-904X; Girnius, Nomeda/0000-0002-7267-5950; Klein, Christoph A./0000-0001-7128-1725; Cheung, Julie/0000-0003-1346-0930; Davis, Roger/0000-0002-0130-1652	HHMI; SWCRF [CA109182, CA196521, CA163131, CA100324, F31CA183185, BC132674, BC112380]; NIH [1S10RR024745]; Microscopy CoRE at ISMMS; DFG [KL 1233/10-1]; ERC [322602]; NATIONAL CANCER INSTITUTE [F31CA183185, U54CA163131, P30CA196521, R01CA109182, P01CA100324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024745] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); SWCRF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Microscopy CoRE at ISMMS; DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank R. Parsons and P. Polulikakos for PI3K and AKT inhibitors, S. Aaronson and H.-C. Wen for WNT3A, SFRP1 and DKK1 reagents and expertise. Grant support:. HHMI (R.J.D.). SWCRF (J.A.A.-G. and E.F.F.), CA109182, CA196521 (J.A.A.-G.), CA163131 (J.A.A-G and J.C.), CA100324 (J.C), F31CA183185 (K.H.), BC132674 (J.A.A.-G and J.C.), BC112380 (M.S.S.). NIH 1S10RR024745. Microscopy CoRE at ISMMS. DFG KL 1233/10-1 and the ERC (322602) (C.A.K.).	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Brisken C, 2000, GENE DEV, V14, P650; Brugge J. S., 2013, METHODS, V3, P256; Cardiff RD, 2001, MICROSC RES TECHNIQ, V52, P224, DOI 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.3.CO;2-1; Debnath J., 2015, NAT REV CANCER, V5, P675; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fizazi K, 2015, ANN ONCOL, V26, pV133, DOI 10.1093/annonc/mdv305; Gozdecka M, 2014, CELL REP, V9, P1361, DOI 10.1016/j.celrep.2014.10.043; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosseini H., 2016, NATURE; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Rhim AD, 2014, GASTROENTEROLOGY, V146, P647, DOI 10.1053/j.gastro.2013.12.007; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schmidt JM, 2015, CELL REP, V10, P131, DOI 10.1016/j.celrep.2014.12.032; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wen HC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001684	35	292	298	6	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					588	+		10.1038/nature20609	http://dx.doi.org/10.1038/nature20609			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27974798	Green Accepted			2022-12-28	WOS:000391190500053
J	Sklaroff, RB				Sklaroff, Robert B.			Physicians, Patients, and Firearms	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sklaroff, Robert B.] Nazareth Hosp, Philadelphia, PA 19152 USA		Sklaroff, RB (corresponding author), Nazareth Hosp, Philadelphia, PA 19152 USA.							Centers for Disease Control and Prevention, 2012, MORBIDITY MORTALITY; Sklaroff RB, 2015, ONSLAUGHT SCI SUPPOR; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Wintemute GJ, 2016, ANN INTERN MED, V165, P205, DOI 10.7326/M15-2905	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					892	893		10.7326/L16-0545	http://dx.doi.org/10.7326/L16-0545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992911				2022-12-28	WOS:000391236900030
J	Wald, A; Timmler, B; Magaret, A; Warren, T; Tyring, S; Johnston, C; Fife, K; Selke, S; Huang, ML; Stobernack, HP; Zimmermann, H; Corey, L; Birkmann, A; Ruebsamen-Schaeff, H				Wald, Anna; Timmler, Burkhard; Magaret, Amalia; Warren, Terri; Tyring, Stephen; Johnston, Christine; Fife, Kenneth; Selke, Stacy; Huang, Meei-Li; Stobernack, Hans-Peter; Zimmermann, Holger; Corey, Lawrence; Birkmann, Alexander; Ruebsamen-Schaeff, Helga			Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HERPES-SIMPLEX-VIRUS; ANTIVIRAL THERAPY; TRANSMISSION; REACTIVATION; ACYCLOVIR; EPISODES; TYPE-2; DNA	IMPORTANCE Current therapy of herpes infections relies on nucleoside analogues. Pritelivir is a well-tolerated novel herpes simplex virus (HSV) helicase-primase inhibitor that reduced genital shedding and lesions. OBJECTIVE To compare the efficacy of pritelivir with valacyclovir for suppression of genital HSV-2 infection. DESIGN, SETTING, AND PARTICIPANTS A phase 2, randomized, double-blind, crossover clinical trial at clinical research centers in 4 US cities (October 2012-July 2013) compared daily oral doses of 100mg of pritelivir with 500mg of valacyclovir. The planned sample size was 98 adults, allowing for detection of a 50% reduction in viral shedding between the study treatments. Healthy adults with 4 to 9 annual genital HSV-2 recurrences were eligible. Ninety-one participants were randomized to receive pritelivir and 46 to receive valacyclovir first when the US Food and Drug Administration placed the trial on clinical hold based on findings in a concurrent nonclinical toxicity study, and the sponsor terminated the study. INTERVENTIONS Participants took the first drug for 28 days followed by 28 days of washout before taking the second drug for 28 days. Throughout treatment, the participants collected genital swabs 4 times daily for testing by HSV polymerase chain reaction assays. MAIN OUTCOMES AND MEASURES The primary end pointwas within-participant genital HSV shedding while receiving pritelivir compared with valacyclovir. Secondary end points included the quantity of HSV in positive swabs and the frequency of genital lesions and shedding episodes. RESULTS Of the 91 randomized participants (median age, 48 years; 57 women [63%]), 56 had completed both treatment periods at the time of the study's termination. In intent-to-treat analyses, HSV shedding was detected in 2.4%(173 of 7276) of swabs during pritelivir treatment compared with 5.3%(392 of 7453) during valacyclovir treatment (relative risk [RR], 42; 95% CI, 0.21 to 0.82; P = .01). In swabs with HSV, the mean quantity of HSV was 3.2 log10 copies/mL during pritelivir treatment vs 3.7 log10 copies/mL during valacyclovir treatment (difference, -0.1; 95% CI, -0.6 to 0.5; P = .83). Genital lesions were present on 1.9% of days in the pritelivir group vs 3.9% in the valacyclovir group (RR, 0.40; 95% CI, 0.17-0.96; P = .04). The frequency of shedding episodes did not differ by group, with 1.3 per person-month for pritelivir and 1.6 per person-month for valacyclovir (RR, 0.80; 95% CI, 0.52 to 1.22; P = .29). Treatment-emergent adverse events occurred in 62.3% of participants in the pritelivir group and 69.2% of participants in the valacyclovir group. CONCLUSIONS AND RELEVANCE Among adults with frequently recurring genital HSV-2, the use of pritelivir compared with valacyclovir resulted in a lower percentage of swabs with HSV detection over 28 days. Further research is needed to assess longer-term efficacy and safety.	[Wald, Anna; Magaret, Amalia; Johnston, Christine; Selke, Stacy; Huang, Meei-Li; Corey, Lawrence] Univ Washington, Seattle, WA 98195 USA; [Wald, Anna; Magaret, Amalia; Johnston, Christine; Selke, Stacy; Huang, Meei-Li; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Timmler, Burkhard; Stobernack, Hans-Peter; Zimmermann, Holger; Birkmann, Alexander; Ruebsamen-Schaeff, Helga] AiCuris Antiinfect Cures GmbH, Wuppertal, Germany; [Warren, Terri] Westover Hts Clin, Portland, OR USA; [Tyring, Stephen] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Tyring, Stephen] Ctr Clin Studies, Houston, TX USA; [Fife, Kenneth] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Indiana University System; Indiana University Bloomington	Wald, A (corresponding author), Univ Washington, Virol Res Clin, POB 359928,325 Ninth Ave, Seattle, WA 98104 USA.	annawald@u.washington.edu	Warren, Terri/AAJ-1650-2021; Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Birkmann, Alexander/0000-0001-5670-4814; Johnston, Christine/0000-0002-3073-0843	AiCuris GmbH Co KG	AiCuris GmbH Co KG	This study was supported by AiCuris GmbH & Co KG.	[Anonymous], 2007, ZOV; [Anonymous], 2014, DIV AIDS DAIDS TABL; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Dieffenbach CW, 2012, CURR OPIN HIV AIDS, V7, P106, DOI 10.1097/COH.0b013e32834f3f13; Edlefsen PT, 2016, J INFECT DIS, V214, P258, DOI 10.1093/infdis/jiw129; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; ENGEL JP, 1990, JAMA-J AM MED ASSOC, V263, P1662, DOI 10.1001/jama.263.12.1662; Field HJ, 2011, DRUG RESIST UPDATE, V14, P45, DOI 10.1016/j.drup.2010.11.002; Jerome KR, 2002, J CLIN MICROBIOL, V40, P2609, DOI 10.1128/JCM.40.7.2609-2611.2002; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392; Magaret A, 2016, COLLECTION BIOSTATIS; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; MINDEL A, 1988, LANCET, V1, P926; Patel R, 1999, SEX TRANSM INFECT, V75, P398, DOI 10.1136/sti.75.6.398; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Schiffer JT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6654; Wald A, 2014, NEW ENGL J MED, V370, P201, DOI 10.1056/NEJMoa1301150; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	23	42	45	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2495	2503		10.1001/jama.2016.18189	http://dx.doi.org/10.1001/jama.2016.18189			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997653	Green Published, Bronze			2022-12-28	WOS:000390959300017
J	Liu, FG; Clark, W; Luo, GZ; Wang, XY; Fu, Y; Wei, JB; Wang, X; Hao, ZY; Dai, Q; Zheng, GQ; Ma, HH; Han, DL; Evans, M; Klungland, A; Pan, T; He, C				Liu, Fange; Clark, Wesley; Luo, Guanzheng; Wang, Xiaoyun; Fu, Ye; Wei, Jiangbo; Wang, Xiao; Hao, Ziyang; Dai, Qing; Zheng, Guanqun; Ma, Honghui; Han, Dali; Evans, Molly; Klungland, Arne; Pan, Tao; He, Chuan			ALKBH1-Mediated tRNA Demethylation Regulates Translation (vol 167, pg 816, 2016)	CELL			English	Correction												taopan@uchicago.edu; chuanhe@uchicago.edu		Wang, Xiao/0000-0002-3090-9894; Klungland, Arne/0000-0001-7274-3661; Liu, Fange/0000-0002-3235-9996; Wei, Jiangbo/0000-0003-2691-6490; Fu, Ye/0000-0002-3807-9717; Fu, Ye/0000-0003-4434-6014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071440] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038	1	40	40	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1897	1897		10.1016/j.cell.2016.11.045	http://dx.doi.org/10.1016/j.cell.2016.11.045			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984735	Bronze			2022-12-28	WOS:000393114700025
J	Park, JJ; Coumbe, BGT; Park, EHG; Tse, G; Subramanian, SV; Chen, JT				Park, John J.; Coumbe, Ben G. T.; Park, Esther H. G.; Tse, George; Subramanian, S. V.; Chen, Jarvis T.			Dispelling the nice or naughty myth: retrospective observational study of Santa Claus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								OBJECTIVE To determine which factors influence whether Santa Claus will visit children in hospital on Christmas Day. DESIGN Retrospective observational study. SETTING Paediatric wards in England, Northern Ireland, Scotland, and Wales. PARTICIPANTS 186 members of staff who worked on the paediatric wards (n=186) during Christmas 2015. MAIN OUTCOME MEASURES Presence or absence of Santa Claus on the paediatric ward during Christmas 2015. This was correlated with rates of absenteeism from primary school, conviction rates in young people (aged 10-17 years), distance from hospital to North Pole (closest city or town to the hospital in kilometres, as the reindeer flies), and contextual socioeconomic deprivation (index of multiple deprivation). RESULTS Santa Claus visited most of the paediatric wards in all four countries: 89% in England, 100% in Northern Ireland, 93% in Scotland, and 92% in Wales. The odds of him not visiting, however, were significantly higher for paediatric wards in areas of higher socioeconomic deprivation in England (odds ratio 1.31 (95% confidence interval 1.04 to 1.71) in England, 1.23 (1.00 to 1.54) in the UK). In contrast, there was no correlation with school absenteeism, conviction rates, or distance to the North Pole. CONCLUSION The results of this study dispel the traditional belief that Santa Claus rewards children based on how nice or naughty they have been in the previous year. Santa Claus is less likely to visit children in hospitals in the most deprived areas. Potential solutions include a review of Santa's contract or employment of local Santas in poorly represented regions.	[Park, John J.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Coumbe, Ben G. T.] UCL, Sch Med, Royal Free Hosp, London, England; [Park, Esther H. G.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Tse, George] Sheffield Teaching Hosp NHS Fdn Trust, Northern Gen Hosp, Dept Radiol, Sheffield, S Yorkshire, England; [Subramanian, S. V.; Chen, Jarvis T.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Edinburgh; Northern General Hospital; University of Sheffield; Harvard University; Harvard T.H. Chan School of Public Health	Park, JJ (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	john.park@mail.harvard.edu	Tse, Gary/P-1171-2015	Tse, Gary/0000-0001-5510-1253				[Anonymous], 2010, NO IR MULT DEPR MEAS; [Anonymous], 2014, ABS PRIM SCH; [Anonymous], WAL IND MULT DEPR; [Anonymous], ATT GRANT AID PRIM P; Department for Communities and Local Government, 2015, ENGL IND DEPR 2015; Fischer D, HAS SANTA CLAUS GOOD; Gosnell EJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7269; High Level Summary of Statistics Trend, HIGH LEV SUMM STAT T; Ministry of Justice. UK, YOUTH JUST ANN STAT; National Statistics, PUP ABS SCH ENGL 201; Payne RA, 2012, HLTH STAT Q, P53; R Development Core Team, 2009, R LANG ENV STAT COMP; Scottish Government, SCOTT IND MULT DEPR; Wilcock DA, 2013, SANTAS CHRISTMAS VIS	14	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2016	355								i6355	10.1136/bmj.i6355	http://dx.doi.org/10.1136/bmj.i6355			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JS	27974338	Green Published, hybrid			2022-12-28	WOS:000390151300004
J	Howe, KB; Suharlim, C; Ueda, P; Howe, D; Kawachi, I; Rimm, EB				Howe, Katherine B.; Suharlim, Christian; Ueda, Peter; Howe, Daniel; Kawachi, Ichiro; Rimm, Eric B.			Gotta catch'em all! Pokemon GO and physical activity among young adults: difference in differences study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDATION; HEALTH	OBJECTIVE To estimate the effect of playing Pokemon GO on the number of steps taken daily up to six weeks after installation of the game. DESIGN Cohort study using online survey data. PARTICIPANTS Survey participants of Amazon Mechanical Turk (n=1182) residing in the United States, aged 18 to 35 years and using iPhone 6 series smartphones. MAIN OUTCOME MEASURES Number of daily steps taken each of the four weeks before and six weeks after installation of Pokemon GO, automatically recorded in the "Health" application of the iPhone 6 series smartphones and reported by the participants. A difference in difference regression model was used to estimate the change in daily steps in players of Pokemon GO compared with non-players. RESULTS 560 (47.4%) of the survey participants reported playing Pokemon GO and walked on average 4256 steps (SD 2697) each day in the four weeks before installation of the game. The difference in difference analysis showed that the daily average steps for Pokemon GO players during the first week of installation increased by 955 additional steps (95% confidence interval 697 to 1213), and then this increase gradually attenuated over the subsequent five weeks. By the sixth week after installation, the number of daily steps had gone back to pre-installation levels. No significant effect modification of Pokemon GO was found by sex, age, race group, bodyweight status, urbanity, or walkability of the area of residence. CONCLUSIONS Pokemon GO was associated with an increase in the daily number of steps after installation of the game. The association was, however, moderate and no longer observed after six weeks.	[Howe, Katherine B.; Rimm, Eric B.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Howe, Katherine B.; Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Suharlim, Christian] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth & Decis Sci, Boston, MA USA; [Ueda, Peter] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Ueda, Peter] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Solna, Sweden; [Rimm, Eric B.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Rimm, Eric B.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Howe, KB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Howe, KB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	khowe@mail.harvard.edu	Ueda, Peter/AGH-9915-2022; Ueda, Peter/AAB-8961-2020	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743				[Anonymous], 2016, GUARDIAN; Antoun C, 2016, FIELD METHOD, V28, P231, DOI 10.1177/1525822X15603149; Ayers JW, 2016, JAMA INTERN MED, V176, P1865, DOI 10.1001/jamainternmed.2016.6274; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Boulos MNK, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-18; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Carr LJ, 2011, BRIT J SPORT MED, V45, P1144, DOI 10.1136/bjsm.2009.069609; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Duncan DT, 2011, INT J ENV RES PUB HE, V8, P4160, DOI 10.3390/ijerph8114160; Knoblauch R. L., 1996, TRANSPORT RES, V1538, P27, DOI DOI 10.3141/1538-04; McCartney M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4306; Middelweerd A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0097-9; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Serino M, 2016, CURR OPIN PEDIATR, V28, P673, DOI 10.1097/MOP.0000000000000409; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P3; World Health Organization, 2010, Global recommendations on physical activity for health	20	124	125	0	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2016	355								i6270	10.1136/bmj.i6270	http://dx.doi.org/10.1136/bmj.i6270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JN	27965211	Green Published, hybrid			2022-12-28	WOS:000390150800004
J	Himelstein, AL; Foster, JC; Khatcheressian, JL; Roberts, JD; Seisler, DK; Novotny, PJ; Qin, R; Go, RS; Grubbs, SS; O'Connor, T; Velasco, MR; Weckstein, D; O'Mara, A; Loprinzi, CL; Shapiro, CL				Himelstein, Andrew L.; Foster, Jared C.; Khatcheressian, James L.; Roberts, John D.; Seisler, Drew K.; Novotny, Paul J.; Qin, Rui; Go, Ronald S.; Grubbs, Stephen S.; O'Connor, Tracey; Velasco, Mario R., Jr.; Weckstein, Douglas; O'Mara, Ann; Loprinzi, Charles L.; Shapiro, Charles L.			Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; BREAST-CANCER; PREVENTION; CARCINOMA; PHASE-3	IMPORTANCE Zoledronic acid, a third-generation aminobisphosphonate, reduces the incidence of skeletal-related events and pain in patients with bone metastases. The optimal dosing interval for zoledronic acid is uncertain. OBJECTIVE To determine whether zoledronic acid administered every 12 weeks is noninferior to zoledronic acid administered every 4 weeks. DESIGN, SETTING, PARTICIPANTS Randomized, open-label clinical trial conducted at 269 academic and community sites in the United States. Patients (n = 1822) with metastatic breast cancer, metastatic prostate cancer, or multiple myeloma who had at least 1 site of bone involvement were enrolled between May 2009 and April 2012; follow-up concluded in April 2014. INTERVENTIONS Patients were randomized to receive zoledronic acid administered intravenously every 4 weeks (n = 911) vs every 12 weeks (n = 911) for 2 years. MAIN OUTCOMES AND MEASURES The primary end point was the proportion of patients having at least 1 skeletal-related event (defined as clinical fracture, spinal cord compression, radiation to bone, or surgery involving bone) within 2 years after randomization and a between-group absolute difference of 7% as the noninferiority margin. Secondary end points included the proportion of patients with at least 1 skeletal-related event by disease type, pain as assessed by the Brief Pain Inventory (range, 0-10; higher scores indicate worse pain), Eastern Cooperative Oncology Group performance status (range, 0-4; higher scores indicate worse disability), incidence of osteonecrosis of the jaw, kidney dysfunction, skeletal morbidity rate (mean number of skeletal-related events per year), and, in a subset of 553 patients, suppression of bone turnover (assessed by C-terminal telopeptide levels). RESULTS Among 1822 patients who were randomized (median age, 65 years; 980 [53.8%] women; 855 with breast cancer, 689 with prostate cancer, and 278 with multiple myeloma), 795 completed the study at 2 years. A total of 260 patients (29.5%) in the zoledronic acid every 4-week dosing group and 253 patients (28.6%) in the every 12-week dosing group experienced at least 1 skeletal-related event within 2 years of randomization (risk difference of -0.3%[1-sided 95% CI, -4% to infinity]; P<.001 for noninferiority). The proportions of skeletal-related events did not differ significantly between the every 4-week dosing group vs the every 12-week dosing group for patients with breast cancer, prostate cancer, or multiple myeloma. Pain scores, performance status scores, incidence of jaw osteonecrosis, and kidney dysfunction did not differ significantly between the treatment groups. Skeletal morbidity rates were numerically identical in both groups, but bone turnover was greater (C-terminal telopeptide levels were higher) among patients who received zoledronic acid every 12 weeks. CONCLUSIONS AND RELEVANCE Among patients with bone metastases due to breast cancer, prostate cancer, or multiple myeloma, the use of zoledronic acid every 12 weeks compared with the standard dosing interval of every 4 weeks did not result in an increased risk of skeletal events over 2 years. This longer interval may be an acceptable treatment option.	[Himelstein, Andrew L.; Grubbs, Stephen S.] Canc Ctr & Res Inst, 4701 Ogletown Stanton Rd,Ste 3400, Newark, DE 19713 USA; [Foster, Jared C.; Seisler, Drew K.; Novotny, Paul J.; Qin, Rui] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA; [Khatcheressian, James L.] Virginia Canc Inst, Richmond, VA USA; [Roberts, John D.] VCU Massey Canc Ctr, Richmond, VA USA; [Roberts, John D.] Yale Univ, New Haven, CT USA; [Qin, Rui] Regeneron Pharmaceut, Basking Ridge, NJ USA; [Go, Ronald S.] Gundersen Hlth Syst, La Crosse, WI USA; [Go, Ronald S.; Loprinzi, Charles L.] Mayo Clin, Rochester, MN USA; [Grubbs, Stephen S.] Amer Soc Clin Oncol, Alexandria, VA USA; [O'Connor, Tracey] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Velasco, Mario R., Jr.] Decatur Mem Hosp, Decatur, IL USA; [Weckstein, Douglas] New Hampshire Oncol Hematol PA, Hooksett, NH USA; [O'Mara, Ann] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [Shapiro, Charles L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Helen F. Graham Cancer Center & Research Institute; Mayo Clinic; Virginia Commonwealth University; Yale University; Mayo Clinic; American Society of Clinical Oncology; Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai	Himelstein, AL (corresponding author), Canc Ctr & Res Inst, 4701 Ogletown Stanton Rd,Ste 3400, Newark, DE 19713 USA.	ahimelstein@cbg.org			National Cancer Institute, National Institutes of Health [UG1CA189823, U10CA016359, U10CA037404, U10CA037447, U10CA059518, U10CA180790, U10CA045418, U10CA180866, UG1CA189819]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001070]; NATIONAL CANCER INSTITUTE [U10CA052784, U10CA037404, U10CA074811, U10CA037447, UG1CA189825, U10CA180867, U10CA045418, U10CA077440, UG1CA189805, U10CA041287, UG1CA189830, UG1CA189861, U10CA180850, UG1CA189850, U10CA035272, U10CA180857, P30CA016359, U10CA035279, U10CA047559, U10CA077658, U10CA059518, UG1CA232760, UG1CA189817, U10CA180836, UG1CA189819, UG1CA189853, UG1CA189823, U10CA180790, U10CA180866, U10CA047577, UG1CA189870] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863, UL1TR001070] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by grants UG1CA189823 (awarded to the Alliance for Clinical Trials in Oncology), U10CA016359, U10CA037404, U10CA037447, U10CA059518, U10CA180790, U10CA045418, U10CA180866, and UG1CA189819 from the National Cancer Institute, National Institutes of Health. The C-terminal telopeptide assays were supported by grant UL1TR001070 from the National Center for Advancing Translational Sciences, National Institutes of Health.	Amadori D, 2013, LANCET ONCOL, V14, P663, DOI 10.1016/S1470-2045(13)70174-8; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Chew HK, 2014, J CLIN ONCOL S, V32; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Kohno N, 2005, J CLIN ONCOL, V23, P3314, DOI 10.1200/JCO.2005.05.116; Lipton A, 2003, CANCER, V98, P962, DOI 10.1002/cncr.11571; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; National Research Council, 2010, PREVENTION TREATMENT; Novartis Inc, 2005, ZOM PRESCR INF; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pavlakis N, 2005, COCHRANE DB SYST REV, V3; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Van Poznak CH, 2011, J CLIN ONCOL, V29, P1221, DOI 10.1200/JCO.2010.32.5209; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	19	194	196	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2017	317	1					48	58		10.1001/jama.2016.19425	http://dx.doi.org/10.1001/jama.2016.19425			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG4JE	28030702	Green Accepted, Bronze			2022-12-28	WOS:000391009100019
J	Nicholson, T; Wilkinson, A				Nicholson, Tony; Wilkinson, Alan			Michael John Imrie OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		IMRIE MJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2016	355								i6834	10.1136/bmj.i6834	http://dx.doi.org/10.1136/bmj.i6834			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG6RH	28039341				2022-12-28	WOS:000391173100010
J	Potisek, N; Weihe, J				Potisek, Nicholas; Weihe, James			Infected Urachal Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Potisek, Nicholas; Weihe, James] Wake Forest Sch Med, Winston Salem, NC 27101 USA	Wake Forest University	Potisek, N (corresponding author), Wake Forest Sch Med, Winston Salem, NC 27101 USA.	npotisek@wakehealth.edu	Potisek, Nicholas/L-8883-2019						0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 29	2016	375	26					2582	2582		10.1056/NEJMicm1601380	http://dx.doi.org/10.1056/NEJMicm1601380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG6SC	28029928				2022-12-28	WOS:000391175300011
J	Voelker, R				Voelker, Rebecca			Inflammatory Bowel Disease Is More Common Than Earlier Studies Showed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2590	2590		10.1001/jama.2016.18375	http://dx.doi.org/10.1001/jama.2016.18375			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9VN	28027380				2022-12-28	WOS:000394968300008
J	Ghajar, CM; Bissell, MJ				Ghajar, Cyrus M.; Bissell, Mina J.			METASTASIS Pathways of parallel progression	NATURE			English	Editorial Material							CARCINOMA IN-SITU; BREAST-CANCER; TUMOR-CELLS; BONE-MARROW; DISSEMINATION	Two studies in mice identify mechanisms by which tumour cells disseminate in very early breast cancer. Both show that these cells colonize distant tissues more efficiently than their later counterparts. See Article p.552 & Letter p.588	[Ghajar, Cyrus M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, Seattle, WA 98109 USA; [Ghajar, Cyrus M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Bissell, Mina J.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Ghajar, CM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, Seattle, WA 98109 USA.; Ghajar, CM (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA.	cghajar@fredhutch.org; mjbissell@lbl.gov			NCI NIH HHS [R01 CA064786] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064786] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; BlueRibbonPanel, 2016, CANC MOONSH BLUE RIB; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Gruber IV, 2016, ANTICANCER RES, V36, P2345; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Narod SA, 2015, JAMA ONCOL, V1, P888, DOI 10.1001/jamaoncol.2015.2510; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100	14	22	22	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					528	529		10.1038/nature21104	http://dx.doi.org/10.1038/nature21104			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG6XV	27974802				2022-12-28	WOS:000391190500037
J	Saito, M; Hatakeyama, S				Saito, Makoto; Hatakeyama, Shuji			Acute Rheumatic Fever with Erythema Marginatum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Saito, Makoto] Tokyo Univ Hosp, Tokyo, Japan; [Hatakeyama, Shuji] Jichi Med Univ, Shimotsuke, Tochigi, Japan	University of Tokyo; Jichi Medical University	Hatakeyama, S (corresponding author), Jichi Med Univ, Shimotsuke, Tochigi, Japan.	shatake-tky@umin.ac.jp	Saito, Makoto/O-7383-2019	Saito, Makoto/0000-0002-1667-9287					0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2480	2480		10.1056/NEJMicm1601782	http://dx.doi.org/10.1056/NEJMicm1601782			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1NL	28002702				2022-12-28	WOS:000390091500011
J	Sigmon, SC; Ochalek, TA; Meyer, AC; Hruska, B; Heil, SH; Badger, GJ; Rose, G; Brooklyn, JR; Schwartz, RP; Moore, BA; Higgins, ST				Sigmon, Stacey C.; Ochalek, Taylor A.; Meyer, Andrew C.; Hruska, Bryce; Heil, Sarah H.; Badger, Gary J.; Rose, Gail; Brooklyn, John R.; Schwartz, Robert P.; Moore, Brent A.; Higgins, Stephen T.			Interim Buprenorphine vs. Waiting List for Opioid Dependence	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							UNITED-STATES; MORTALITY		[Sigmon, Stacey C.; Ochalek, Taylor A.; Meyer, Andrew C.; Hruska, Bryce; Heil, Sarah H.; Badger, Gary J.; Rose, Gail; Brooklyn, John R.; Higgins, Stephen T.] Univ Vermont, Burlington, VT 05405 USA; [Schwartz, Robert P.] Friends Res Inst, Baltimore, MD USA; [Moore, Brent A.] Yale Univ, Sch Med, New Haven, CT USA	University of Vermont; Yale University	Brooklyn, JR (corresponding author), Univ Vermont, Burlington, VT 05405 USA.	stacey.sigmon@uvm.edu	Hruska, Bryce/AAO-8780-2020; Rose, Gail L/F-1516-2016; Moore, Brent/O-4867-2015	Hruska, Bryce/0000-0002-8651-5827; Rose, Gail L/0000-0003-4997-401X; Brooklyn, John/0000-0003-2632-9456; Moore, Brent/0000-0003-0123-6616	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA037385, T32DA007242, R01DA034678] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001863] Funding Source: Medline; NIDA NIH HHS [T32 DA007242, R34 DA037385, R01 DA034678] Funding Source: Medline; NIGMS NIH HHS [P20 GM103644] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; Paulozzi LJ, 2008, PHARMACOEPIDEM DR S, V17, P997, DOI 10.1002/pds.1626; Peles E, 2013, J ADDICT MED, V7, P177, DOI 10.1097/ADM.0b013e318287cfc9; Sigmon SC, 2015, ADDICT BEHAV, V51, P136, DOI 10.1016/j.addbeh.2015.07.030	5	59	59	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 22	2016	375	25					2504	2505		10.1056/NEJMc1610047	http://dx.doi.org/10.1056/NEJMc1610047			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1NL	28002704	Bronze, Green Accepted			2022-12-28	WOS:000390091500027
J	Friedrich, MJ				Friedrich, M. J.			Industrial Pollution Threatens Millions in Developing World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2473	2473		10.1001/jama.2016.17431	http://dx.doi.org/10.1001/jama.2016.17431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27997664				2022-12-28	WOS:000390959300004
J	Hunter, BR				Hunter, Benton R.			Therapeutic hypothermia during CPR did not improve survival to discharge in out-of-hospital cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hunter, Benton R.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Hunter, BR (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Heard KJ, 2010, RESUSCITATION, V81, P9, DOI 10.1016/j.resuscitation.2009.09.015; Nie CR, 2016, AM J EMERG MED, V34, P2209, DOI 10.1016/j.ajem.2016.09.007; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					JC70	JC70		10.7326/ACPJC-2016-165-12-070	http://dx.doi.org/10.7326/ACPJC-2016-165-12-070			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27992926				2022-12-28	WOS:000391236900009
J	Oppenheimer, M; Alley, RB				Oppenheimer, Michael; Alley, Richard B.			How high will the seas rise?	SCIENCE			English	Editorial Material							LEVEL RISE		[Oppenheimer, Michael] Princeton Univ, Dept Geosci, Robertson Hall 448, Princeton, NJ 08544 USA; [Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch, Robertson Hall 448, Princeton, NJ 08544 USA; [Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, 517 Deike Bldg, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Dept Geosci, 517 Deike Bldg, University Pk, PA 16802 USA	Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Oppenheimer, M (corresponding author), Princeton Univ, Dept Geosci, Robertson Hall 448, Princeton, NJ 08544 USA.; Oppenheimer, M (corresponding author), Princeton Univ, Woodrow Wilson Sch, Robertson Hall 448, Princeton, NJ 08544 USA.	omichael@princeton.edu		Oppenheimer, Michael/0000-0002-9708-5914				Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; [Anonymous], 2016, ROY SOC LOND WORKSH; Church J.A., 2001, CONTRIBUTION WORKING; Church J. A, 2013, CONTRIBUTION WORKING; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Delta Commissie, 2008, WORK TOG WAT LIV LAN; Hoffman S. J., 1983, PROJECTING FUTURE SE; IPCC, 2007, CONTRIBUTION WORKING; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Mengel M, 2016, P NATL ACAD SCI USA, V113, P2597, DOI 10.1073/pnas.1500515113; National Academies of Sciences, 2015, STRAT VIS NSF INV AN; Sayvetz O.A., 2015, THESIS	14	40	42	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1375	1377		10.1126/science.aak9460	http://dx.doi.org/10.1126/science.aak9460			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF3YN	27980170				2022-12-28	WOS:000390261300019
J	Stone, R; Izadi, B				Stone, Richard; Izadi, Bahman			SOME LIKE IT HOT	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1366	1368		10.1126/science.354.6318.1366	http://dx.doi.org/10.1126/science.354.6318.1366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980167				2022-12-28	WOS:000390261300016
J	Whitesides, GM				Whitesides, George M.			John D. Roberts (1918-2016)	SCIENCE			English	Biographical-Item									[Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu						ROBERTS JBM, PUBLICATION LIST	1	0	0	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2016	354	6318					1382	1382		10.1126/science.aal4869	http://dx.doi.org/10.1126/science.aal4869			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EF3YN	27980174				2022-12-28	WOS:000390261300023
J	Bjerkeli, P; van der Wiel, MHD; Harsono, D; Ramsey, JP; Jorgensen, JK				Bjerkeli, Per; van der Wiel, Matthijs H. D.; Harsono, Daniel; Ramsey, Jon P.; Jorgensen, Jes K.			Resolved images of a protostellar outflow driven by an extended disk wind	NATURE			English	Article							YOUNG STARS; ROTATION; JET; ENVELOPE; TAURI; TRANSITION; CHONDRULES; FLOWS; CO	Young stars are associated with prominent outflows of molecular gas(1,2). The ejection of gas is believed to remove angular momentum from the protostellar system, permitting young stars to grow by the accretion of material from the protostellar disk(2). The underlying mechanism for outflow ejection is not yet understood(2), but is believed to be closely linked to the protostellar disk(3). Various models have been proposed to explain the outflows, differing mainly in the region where acceleration of material takes place: close to the protostar itself ('X-wind'(4,5), or stellar wind(6)), in a larger region throughout the protostellar disk (disk wind(7-9)), or at the interface between the two(10). Outflow launching regions have so far been probed only by indirect extrapolation(11-13) because of observational limits. Here we report resolved images of carbon monoxide towards the outflow associated with the TMC1A protostellar system. These data show that gas is ejected from a region extending up to a radial distance of 25 astronomical units from the central protostar, and that angular momentum is removed from an extended region of the disk. This demonstrates that the outflowing gas is launched by an extended disk wind from a Keplerian disk.	[Bjerkeli, Per; van der Wiel, Matthijs H. D.; Ramsey, Jon P.; Jorgensen, Jes K.] Univ Copenhagen, Niels Bohr Inst, Ctr Star & Planet Format, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark; [Bjerkeli, Per; van der Wiel, Matthijs H. D.; Ramsey, Jon P.; Jorgensen, Jes K.] Univ Copenhagen, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark; [Bjerkeli, Per] Chalmers Univ Technol, Onsala Space Observ, Dept Earth & Space Sci, S-43992 Onsala, Sweden; [van der Wiel, Matthijs H. D.] Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [Harsono, Daniel] Heidelberg Univ, Inst Theoret Astrophys, Ctr Astron, Albert Ueberle Str 2, D-69120 Heidelberg, Germany	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Chalmers University of Technology; Ruprecht Karls University Heidelberg	Bjerkeli, P (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Star & Planet Format, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.; Bjerkeli, P (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.; Bjerkeli, P (corresponding author), Chalmers Univ Technol, Onsala Space Observ, Dept Earth & Space Sci, S-43992 Onsala, Sweden.	per.bjerkeli@bjerkeli.se	Jørgensen, Jes Kristian/AAB-2190-2020; Jørgensen, Jes Kristian/L-7936-2014; van der Wiel, Matthijs/M-4531-2014	Jørgensen, Jes Kristian/0000-0001-9133-8047; Jørgensen, Jes Kristian/0000-0001-9133-8047; Ramsey, Jonathan/0000-0002-3835-3990; Harsono, Daniel/0000-0001-6307-4195; Bjerkeli, Per/0000-0002-7993-4118; van der Wiel, Matthijs/0000-0002-4325-3011	Swedish Research Council [637-2013-472]; Lundbeck Foundation Junior Group Leader Fellowship; European Research Council (ERC) under the European Union [646908]; ERC Consolidator Grant 'S4F'; Danish National Research Foundation; Deutsche Forschungsgemeinschaft Schwerpunktprogramm [DFG SPP 1385]; Lundbeck Foundation [R52-2010-4810] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck Foundation Junior Group Leader Fellowship; European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC Consolidator Grant 'S4F'; Danish National Research Foundation(Danmarks Grundforskningsfond); Deutsche Forschungsgemeinschaft Schwerpunktprogramm(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	We thank M. Bizzarro and L. Kristensen for suggestions that improved the paper. This research was supported by the Swedish Research Council through contract 637-2013-472 (to P.B.). M.H.D.v.d.W. and J.K.J. acknowledge support by a Lundbeck Foundation Junior Group Leader Fellowship as well as the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 646908) through ERC Consolidator Grant 'S4F'. The Centre for Star and Planet Formation is funded by the Danish National Research Foundation. D.H. is funded by the Deutsche Forschungsgemeinschaft Schwerpunktprogramm (DFG SPP 1385) 'The First 10 Million Years of the Solar System-A Planetary Materials Approach'. We also thank the staff at the Nordic ALMA Regional Centre node for assistance with the preparation and calibration of the data. D.H. thanks Leiden Observatory for providing the computing facilities. This paper makes use of ALMA data (see Methods section 'Data availability'). ALMA is a partnership of the ESO (representing its member states), the NSF (USA) and NINS (Japan), together with the NRC (Canada), the NSC and ASIAA (Taiwan), and the KASI (South Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by the ESO, AUI/ NRAO and NAOJ.	Alexander CMO, 2008, SCIENCE, V320, P1617, DOI 10.1126/science.1156561; Anderson JM, 2003, ASTROPHYS J, V590, pL107, DOI 10.1086/376824; Arce HG, 2006, ASTROPHYS J, V646, P1070, DOI 10.1086/505104; Aso Y, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/27; Bacciotti F, 2002, ASTROPHYS J, V576, P222, DOI 10.1086/341725; Bai XN, 2016, ASTROPHYS J, V821, DOI 10.3847/0004-637X/821/2/80; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; Bouvier J., 2014, PROTOSTARS PLANETS, VVI, P433, DOI [10.2458/azuuapress9780816531240-ch019, DOI 10.2458/AZUUAPRESS9780816531240-CH019, DOI 10.2458/AZU_UAPRESS_9780816531240-CH019]; Bruderer S, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118218; CABRIT S, 1990, ASTROPHYS J, V354, P687, DOI 10.1086/168725; Chandler CJ, 2000, ASTROPHYS J, V530, P851, DOI 10.1086/308401; Chandler CJ, 1996, ASTROPHYS J, V471, P308, DOI 10.1086/177971; Coffey D, 2007, ASTROPHYS J, V663, P350, DOI 10.1086/518100; Dullemond CP, 2004, ASTRON ASTROPHYS, V417, P159, DOI 10.1051/0004-6361:20031768; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Ferreira J, 2006, ASTRON ASTROPHYS, V453, P785, DOI 10.1051/0004-6361:20054231; Frank A., 2014, PROTOSTARS PLANETS, VVI, P451, DOI [DOI 10.2458/AZU_UAPRESS_9780816531240-CH020, 10.2458/azu_uapress_9780816531240-ch020]; Hansen EC, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/41; Harsono D, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201424550; Harsono D, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322646; Hogbom J. A., 1974, Astronomy and Astrophysics Supplement Series, V15, P417; Jorgensen JK, 2007, ASTROPHYS J, V659, P479, DOI 10.1086/512230; Lee CF, 2000, ASTROPHYS J, V542, P925, DOI 10.1086/317056; Lee CF, 2010, ASTROPHYS J, V725, P712, DOI 10.1088/0004-637X/725/1/712; McMullin JP, 2007, ASTR SOC P, V376, P127; Ouyed R, 1997, NATURE, V385, P409, DOI 10.1038/385409a0; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; Sakai N, 2016, ASTROPHYS J LETT, V820, DOI 10.3847/2041-8205/820/2/L34; Salmeron R, 2012, EARTH PLANET SC LETT, V327, P61, DOI 10.1016/j.epsl.2012.01.033; San Jose-Garcia I, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220472; Shang H., 2007, PROTOSTARS PLANETS; SHU F, 1994, ASTROPHYS J, V429, P781, DOI 10.1086/174363; SNELL RL, 1980, ASTROPHYS J, V239, pL17, DOI 10.1086/183283; Yildiz UA, 2015, ASTRON ASTROPHYS, V576, DOI 10.1051/0004-6361/201424538; Zanni C, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220168	38	87	87	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					406	+		10.1038/nature20600	http://dx.doi.org/10.1038/nature20600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27974756	Green Submitted			2022-12-28	WOS:000389716800036
J	Chi, AS; Cahill, DP; Larvie, M; Louis, DN				Chi, Andrew S.; Cahill, Daniel P.; Larvie, Mykol; Louis, David N.			Case 38-2016: A 52-Year-Old Woman with Recurrent Oligodendroglioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-GRADE GLIOMA; TERM-FOLLOW-UP; ANAPLASTIC OLIGODENDROGLIOMA; VINCRISTINE CHEMOTHERAPY; RANDOMIZED-TRIAL; CLASSIFICATION; RADIOTHERAPY; PROCARBAZINE; ASTROCYTOMA; MUTATIONS		[Chi, Andrew S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Larvie, Mykol] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chi, Andrew S.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Cahill, Daniel P.] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Larvie, Mykol] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Louis, David N.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chi, AS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Chi, AS (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.			Cahill, Daniel/0000-0003-2552-6546				Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bleggi-Torres LF, 2000, CANCER, V88, P862; Burger PC, 1997, ARCH PATHOL LAB MED, V121, P477; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Coons SW, 1997, NEUROSURGERY, V41, P878, DOI 10.1097/00006123-199710000-00021; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; GLANTZ MJ, 1991, NEUROLOGY, V41, P1741, DOI 10.1212/WNL.41.11.1741; Habets EJJ, 2014, J NEURO-ONCOL, V116, P161, DOI 10.1007/s11060-013-1278-0; Jackson RJ, 2001, NEURO-ONCOLOGY, V3, P193, DOI 10.1093/neuonc/3.3.193; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim BYS, 2014, J NEURO-ONCOL, V118, P405, DOI 10.1007/s11060-014-1451-0; Kros JM, 1996, CANCER, V78, P1107, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1107::AID-CNCR22>3.0.CO;2-5; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Louis, 2016, WHO CLASSIFICATION G; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Sasaki H, 2002, J NEUROPATH EXP NEUR, V61, P58, DOI 10.1093/jnen/61.1.58; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Shaw EG, 2012, J CLIN ONCOL, V30, P3065, DOI 10.1200/JCO.2011.35.8598; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052	27	3	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2381	2389		10.1056/NEJMcpc1610101	http://dx.doi.org/10.1056/NEJMcpc1610101			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	27974037				2022-12-28	WOS:000390036500011
J	Kruger, RP				Kruger, Robert P.			Harvesting Benefits from Cannabinoids	CELL			English	Editorial Material																		Herbert-Chatelain E., 2016, NATURE; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Kerbrat A, 2016, NEW ENGL J MED, V375, P1717, DOI 10.1056/NEJMoa1604221; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Shao Z, 2016, NATURE; Younts TJ, 2016, NEURON, V92, P479, DOI 10.1016/j.neuron.2016.09.040	6	1	1	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2016	167	7					1663	1665		10.1016/j.cell.2016.12.001	http://dx.doi.org/10.1016/j.cell.2016.12.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ3LW	27984713	Bronze			2022-12-28	WOS:000393114700001
J	Ladher, N				Ladher, Navjoyt			Questions and answers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nladher@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 15	2016	355								i6701	10.1136/bmj.i6701	http://dx.doi.org/10.1136/bmj.i6701			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF2JU	27979853	Bronze			2022-12-28	WOS:000390151500005
J	Hutchinson, PJ; Kolias, AG; Menon, DK				Hutchinson, Peter J.; Kolias, Angelos G.; Menon, David K.			Craniectomy for Traumatic Intracranial Hypertension Reply	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Hutchinson, Peter J.; Kolias, Angelos G.; Menon, David K.] Univ Cambridge, Cambridge, England	University of Cambridge	Hutchinson, PJ (corresponding author), Univ Cambridge, Cambridge, England.	pjah2@cam.ac.uk		Kolias, Angelos/0000-0003-3992-0587	Medical Research Council [G0601025] Funding Source: Medline; Department of Health [NIHR-RP-R3-12-013] Funding Source: Medline; National Institute for Health Research [NIHR-RP-R3-12-013] Funding Source: researchfish; MRC [G0601025] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	5	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2403	2404						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	28032968	Green Published, Green Accepted			2022-12-28	WOS:000390036500020
J	Kieny, MP; Longini, IM; Henao-Restrepo, AM; Watson, CH; Egger, M; Edmunds, WJ				Kieny, Marie Paule; Longini, Ira M.; Henao-Restrepo, Ana Maria; Watson, Conall H.; Egger, Matthias; Edmunds, W. John			Changes in the primary outcome in Ebola vaccine trial Reply	LANCET			English	Letter									[Kieny, Marie Paule; Henao-Restrepo, Ana Maria] Hlth Syst & Innovat, CH-1211 Geneva 27, Switzerland; [Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA; [Watson, Conall H.; Edmunds, W. John] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Egger, Matthias] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa	State University System of Florida; University of Florida; University of London; London School of Hygiene & Tropical Medicine; University of Bern; University of Cape Town	Kieny, MP (corresponding author), Hlth Syst & Innovat, CH-1211 Geneva 27, Switzerland.	kienym@who.int	Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; Diatta, Ibrahima Dina/0000-0002-9342-0252; Hossmann, Stefanie/0000-0003-1600-5925; Mandal, Sema/0000-0003-3379-3118; Egger, Matthias/0000-0001-7462-5132; Trelle, Sven/0000-0002-8162-8910; Gunther, Stephan/0000-0002-6562-0230; Watson, Conall/0000-0002-2469-791X; Carroll, Miles/0000-0002-7026-7187; Freeman Grais, Rebecca/0000-0002-5037-8218				Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Halloran ME., 2010, DESIGN ANAL VACCINE; Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5	4	188	197	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2016	387	10027					1509	1510		10.1016/S0140-6736(16)00686-3	http://dx.doi.org/10.1016/S0140-6736(16)00686-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI8HH	27115974	Bronze			2022-12-28	WOS:000373741600023
J	Chesnut, RM				Chesnut, Randall M.			Craniectomy for Traumatic Intracranial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							BRAIN-INJURY		[Chesnut, Randall M.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chesnut, RM (corresponding author), Univ Washington, Seattle, WA 98195 USA.	chesnutr@uw.edu		Kolias, Angelos/0000-0003-3992-0587	Medical Research Council [G0601025] Funding Source: Medline; Department of Health [NIHR-RP-R3-12-013] Funding Source: Medline; National Institute for Health Research [NIHR-RP-R3-12-013] Funding Source: researchfish; MRC [G0601025] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrews PJD, 2016, NEW ENGL J MED, V374, P1385, DOI 10.1056/NEJMc1600339; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2403	2403						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF0SO	28032968	Green Accepted, Green Published			2022-12-28	WOS:000390036500019
